Name	Gene(s)	Protein change	Condition(s)	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	Variant type	Molecular consequence	Germline classification	Germline date last evaluated	Germline review status	Somatic clinical impact	Somatic clinical impact date last evaluated	Somatic clinical impact review status	Oncogenicity classification	Oncogenicity date last evaluated	Oncogenicity review status	
GRCh38/hg38 10p15.1-q11.22(chr10:4604734-48074662)x3	ABI1|ACBD5|ACBD7|ACBD7-DCLRE1CP1|AGAP10|AGAP4|AGAP9|AKR1C1|AKR1C2|AKR1C3|AKR1C4|AKR1C8|AKR1E2|ALOX5|ANKRD16|ANKRD26|ANKRD30A|ANTXRL|ANXA8|ANXA8L1|APBB1IP|ARHGAP12|ARHGAP21|ARL5B|ARMC3|ASB13|ATP5F1C|BAMBI|BEND7|BEND7-DT|BMI1|BMS1|C10orf113|C10orf126|C10orf67|C10orf67-AS1|C1QL3|CACNB2|CALML3|CALML3-AS1|CALML5|CAMK1D|CCDC3|CCDC7|CCNY|CCNY-AS1|CDC123|CDNF|CELF2|CELF2-AS1|CELF2-AS2|CELF2-DT|COMMD3|COMMD3-BMI1|CREM|CSGALNACT2|CSGALNACT2-DT|CUBN|CUL2|CXCL12|DCLRE1C|DEPP1|DHTKD1|DNAJC1|EBLN1|ECHDC3|ENKUR|EPC1|EPC1-AS1|FAM107B|FAM171A1|FAM238A|FAM238B|FAM238C|FAM245B|FAM25C|FAM25E|FAM25G|FBH1|FRMD4A|FRMD4A-AS2|FXYD4|FZD8|GAD2|GATA3|GATA3-AS1|GDF10|GDF2|GDI2|GJD4|GPR158|GPR158-AS1|GPRIN2|HACD1|HNRNPF|HSPA14|IATPR|IL15RA|IL2RA|ITGA8|ITGB1|ITGB1-DT|ITIH2|ITIH5|JCAD|KIAA1217|KIF5B|KIN|LASTR|LINC00619|LINC00705|LINC00706|LINC00707|LINC00708|LINC00709|LINC00710|LINC00836|LINC00837|LINC00838|LINC00839|LINC00840|LINC00841|LINC00842|LINC00993|LINC00999|LINC01264|LINC01516|LINC01517|LINC01518|LINC02561|LINC02623|LINC02628|LINC02629|LINC02630|LINC02632|LINC02634|LINC02637|LINC02642|LINC02643|LINC02644|LINC02648|LINC02649|LINC02652|LINC02654|LINC02656|LINC02658|LINC02659|LINC02664|LINC02665|LINC02670|LINC02673|LINC02676|LINC02677|LINC02678|LINC02881|LINC02916|LINC03027|LINC03028|LINC03029|LINP1|LOC100130992|LOC100505502|LOC101928051|LOC101928272|LOC101928453|LOC101929073|LOC101929279|LOC101929431|LOC102724323|LOC102724593|LOC105376384|LOC105376387|LOC105376390|LOC105376398|LOC105376420|LOC105378269|LOC105378289|LOC105378577|LOC106736614|LOC106783505|LOC106783576|LOC107001062|LOC107275222|LOC107275223|LOC107275226|LOC108004524|LOC108353817|LOC108353819|LOC108903148|LOC108903149|LOC110121348|LOC110121355|LOC110121399|LOC110121405|LOC110121406|LOC110121476|LOC110121478|LOC110121502|LOC110121503|LOC110121506|LOC110121507|LOC111464994|LOC111501766|LOC111589212|LOC111818964|LOC111818965|LOC111818966|LOC111818967|LOC111946222|LOC111946223|LOC111946224|LOC111946225|LOC111946226|LOC111946227|LOC111946228|LOC111946229|LOC111946230|LOC111946231|LOC111946232|LOC111946234|LOC111946236|LOC111946237|LOC111946238|LOC111946239|LOC111946241|LOC111946242|LOC111946244|LOC111946245|LOC111946246|LOC111946251|LOC111946252|LOC114827857|LOC116216107|LOC116216108|LOC116216109|LOC116216110|LOC116216111|LOC116216112|LOC121366038|LOC121366039|LOC121366040|LOC121366041|LOC121366042|LOC121366043|LOC121366044|LOC121366045|LOC121366046|LOC121366047|LOC121366048|LOC121366049|LOC121366050|LOC121366051|LOC121366052|LOC121366053|LOC121366054|LOC121811723|LOC121811724|LOC121811725|LOC121811726|LOC121811727|LOC121811728|LOC121811729|LOC121811730|LOC124403905|LOC124403906|LOC124403907|LOC124403908|LOC124403909|LOC124403910|LOC124403911|LOC124403912|LOC124403913|LOC124403914|LOC124403915|LOC124403916|LOC124403917|LOC124403918|LOC124403919|LOC124403920|LOC124403921|LOC124403922|LOC124403923|LOC124403924|LOC124403925|LOC124403926|LOC124403927|LOC124403928|LOC124403929|LOC124403930|LOC124403931|LOC124403932|LOC124403933|LOC124403934|LOC124403935|LOC124403936|LOC124403937|LOC124403938|LOC124403939|LOC124403940|LOC124403941|LOC124403942|LOC124403943|LOC124403944|LOC124403945|LOC124403946|LOC124403948|LOC124403949|LOC126860845|LOC126860846|LOC126860847|LOC126860848|LOC126860849|LOC126860850|LOC126860851|LOC126860852|LOC126860853|LOC126860854|LOC126860855|LOC126860856|LOC126860857|LOC126860858|LOC126860859|LOC126860860|LOC126860861|LOC126860862|LOC126860863|LOC126860864|LOC126860865|LOC126860866|LOC126860867|LOC126860868|LOC126860869|LOC126860870|LOC126860871|LOC126860872|LOC126860873|LOC126860874|LOC126860875|LOC126860876|LOC126860877|LOC126860878|LOC126860879|LOC126860880|LOC126860881|LOC126860882|LOC126860883|LOC126860884|LOC126860885|LOC126860886|LOC126860887|LOC126860888|LOC126860889|LOC126860890|LOC126860891|LOC126860892|LOC126860893|LOC126860894|LOC126860895|LOC126860896|LOC126860897|LOC126860898|LOC126860899|LOC126860900|LOC126860901|LOC126860902|LOC126860903|LOC126860904|LOC126860905|LOC126860906|LOC126860907|LOC126860908|LOC126860909|LOC126860910|LOC126860911|LOC126860912|LOC126860913|LOC126860914|LOC126860915|LOC126860916|LOC126860917|LOC126860918|LOC126860919|LOC126860920|LOC126860921|LOC126860922|LOC126860923|LOC126860924|LOC126860925|LOC126860926|LOC126860927|LOC126860928|LOC126860929|LOC128462383|LOC128462384|LOC128462385|LOC128462386|LOC128462408|LOC129390123|LOC129390124|LOC129390125|LOC129390126|LOC129390127|LOC129390128|LOC129390129|LOC129390130|LOC129390131|LOC129390132|LOC129390133|LOC129390134|LOC129390135|LOC129390136|LOC129390137|LOC129390138|LOC129390139|LOC129390140|LOC129390141|LOC129390142|LOC129390143|LOC129390144|LOC129390145|LOC129390146|LOC129390147|LOC129390148|LOC129390149|LOC129390150|LOC129390151|LOC129390152|LOC129390153|LOC129390154|LOC129390155|LOC129390156|LOC129390157|LOC129390158|LOC129390159|LOC129390160|LOC129390161|LOC129390162|LOC129390163|LOC129390164|LOC129390165|LOC129390166|LOC129390167|LOC129390168|LOC129390169|LOC130003192|LOC130003193|LOC130003194|LOC130003195|LOC130003196|LOC130003197|LOC130003198|LOC130003199|LOC130003200|LOC130003201|LOC130003202|LOC130003203|LOC130003204|LOC130003205|LOC130003206|LOC130003207|LOC130003208|LOC130003209|LOC130003210|LOC130003211|LOC130003212|LOC130003213|LOC130003214|LOC130003215|LOC130003216|LOC130003217|LOC130003218|LOC130003219|LOC130003220|LOC130003221|LOC130003222|LOC130003223|LOC130003224|LOC130003225|LOC130003226|LOC130003227|LOC130003228|LOC130003229|LOC130003230|LOC130003231|LOC130003232|LOC130003233|LOC130003234|LOC130003235|LOC130003236|LOC130003237|LOC130003238|LOC130003239|LOC130003240|LOC130003241|LOC130003242|LOC130003243|LOC130003244|LOC130003245|LOC130003246|LOC130003247|LOC130003248|LOC130003249|LOC130003250|LOC130003251|LOC130003252|LOC130003253|LOC130003254|LOC130003255|LOC130003256|LOC130003257|LOC130003258|LOC130003259|LOC130003260|LOC130003261|LOC130003262|LOC130003263|LOC130003264|LOC130003265|LOC130003266|LOC130003267|LOC130003268|LOC130003269|LOC130003270|LOC130003271|LOC130003272|LOC130003273|LOC130003274|LOC130003275|LOC130003276|LOC130003277|LOC130003278|LOC130003279|LOC130003280|LOC130003281|LOC130003282|LOC130003283|LOC130003284|LOC130003285|LOC130003286|LOC130003287|LOC130003288|LOC130003289|LOC130003290|LOC130003291|LOC130003292|LOC130003293|LOC130003294|LOC130003295|LOC130003296|LOC130003297|LOC130003298|LOC130003299|LOC130003300|LOC130003301|LOC130003302|LOC130003303|LOC130003304|LOC130003305|LOC130003306|LOC130003307|LOC130003308|LOC130003309|LOC130003310|LOC130003311|LOC130003312|LOC130003313|LOC130003314|LOC130003315|LOC130003316|LOC130003317|LOC130003318|LOC130003319|LOC130003320|LOC130003321|LOC130003322|LOC130003323|LOC130003324|LOC130003325|LOC130003326|LOC130003327|LOC130003328|LOC130003329|LOC130003330|LOC130003331|LOC130003332|LOC130003333|LOC130003334|LOC130003335|LOC130003336|LOC130003337|LOC130003338|LOC130003339|LOC130003340|LOC130003341|LOC130003342|LOC130003343|LOC130003344|LOC130003345|LOC130003346|LOC130003347|LOC130003348|LOC130003349|LOC130003350|LOC130003351|LOC130003352|LOC130003353|LOC130003354|LOC130003355|LOC130003356|LOC130003357|LOC130003358|LOC130003359|LOC130003360|LOC130003361|LOC130003362|LOC130003363|LOC130003364|LOC130003365|LOC130003366|LOC130003367|LOC130003368|LOC130003369|LOC130003370|LOC130003371|LOC130003372|LOC130003373|LOC130003374|LOC130003375|LOC130003376|LOC130003377|LOC130003378|LOC130003379|LOC130003380|LOC130003381|LOC130003382|LOC130003383|LOC130003384|LOC130003385|LOC130003386|LOC130003387|LOC130003388|LOC130003389|LOC130003390|LOC130003391|LOC130003392|LOC130003393|LOC130003394|LOC130003395|LOC130003396|LOC130003397|LOC130003398|LOC130003399|LOC130003400|LOC130003401|LOC130003402|LOC130003403|LOC130003404|LOC130003405|LOC130003406|LOC130003407|LOC130003408|LOC130003409|LOC130003410|LOC130003411|LOC130003412|LOC130003413|LOC130003414|LOC130003415|LOC130003416|LOC130003417|LOC130003418|LOC130003419|LOC130003420|LOC130003421|LOC130003422|LOC130003423|LOC130003424|LOC130003425|LOC130003426|LOC130003427|LOC130003428|LOC130003429|LOC130003430|LOC130003431|LOC130003432|LOC130003433|LOC130003434|LOC130003435|LOC130003436|LOC130003437|LOC130003438|LOC130003439|LOC130003440|LOC130003441|LOC130003442|LOC130003443|LOC130003444|LOC130003445|LOC130003446|LOC130003447|LOC130003448|LOC130003449|LOC130003450|LOC130003451|LOC130003452|LOC130003453|LOC130003454|LOC130003455|LOC130003456|LOC130003457|LOC130003458|LOC130003459|LOC130003460|LOC130003461|LOC130003462|LOC130003463|LOC130003464|LOC130003465|LOC130003466|LOC130003467|LOC130003468|LOC130003469|LOC130003470|LOC130003471|LOC130003472|LOC130003473|LOC130003474|LOC130003475|LOC130003476|LOC130003477|LOC130003478|LOC130003479|LOC130003480|LOC130003481|LOC130003482|LOC130003483|LOC130003484|LOC130003485|LOC130003486|LOC130003487|LOC130003488|LOC130003489|LOC130003490|LOC130003491|LOC130003492|LOC130003493|LOC130003494|LOC130003495|LOC130003496|LOC130003497|LOC130003498|LOC130003499|LOC130003500|LOC130003501|LOC130003502|LOC130003503|LOC130003504|LOC130003505|LOC130003506|LOC130003507|LOC130003508|LOC130003509|LOC130003510|LOC130003511|LOC130003512|LOC130003513|LOC130003514|LOC130003515|LOC130003516|LOC130003517|LOC130003518|LOC130003519|LOC130003520|LOC130003521|LOC130003522|LOC130003523|LOC130003524|LOC130003525|LOC130003526|LOC130003527|LOC130003528|LOC130003529|LOC130003530|LOC130003531|LOC130003532|LOC130003533|LOC130003534|LOC130003535|LOC130003536|LOC130003537|LOC130003538|LOC130003539|LOC130003540|LOC130003541|LOC130003542|LOC130003543|LOC130003544|LOC130003545|LOC130003546|LOC130003547|LOC130003548|LOC130003549|LOC130003550|LOC130003551|LOC130003552|LOC130003553|LOC130003554|LOC130003555|LOC130003556|LOC130003557|LOC130003558|LOC130003559|LOC130003560|LOC130003561|LOC130003562|LOC130003563|LOC130003564|LOC130003565|LOC130003566|LOC130003567|LOC130003568|LOC130003569|LOC130003570|LOC130003571|LOC130003572|LOC130003573|LOC130003574|LOC130003575|LOC130003576|LOC130003577|LOC130003578|LOC130003579|LOC130003580|LOC130003581|LOC130003582|LOC130003583|LOC130003584|LOC130003585|LOC130003586|LOC130003587|LOC130003588|LOC130003589|LOC130003590|LOC130003591|LOC130003592|LOC130003593|LOC130003594|LOC130003595|LOC130003596|LOC130003597|LOC130003598|LOC130003599|LOC130003600|LOC130003601|LOC130003602|LOC130003603|LOC130003604|LOC130003605|LOC130003606|LOC130003607|LOC130003608|LOC130003609|LOC130003610|LOC130003611|LOC130003612|LOC130003613|LOC130003614|LOC130003615|LOC130003616|LOC130003617|LOC130003618|LOC130003619|LOC130003620|LOC130003621|LOC130003622|LOC130003623|LOC130003624|LOC130003625|LOC130003626|LOC130003627|LOC130003628|LOC130003629|LOC130003630|LOC130003631|LOC130003632|LOC130003633|LOC130003634|LOC130003635|LOC130003636|LOC130003637|LOC130003638|LOC130003639|LOC130003640|LOC130003641|LOC130003642|LOC130003643|LOC130003644|LOC130003645|LOC130003646|LOC130003647|LOC130003648|LOC130003649|LOC130003650|LOC130003651|LOC130003652|LOC130003653|LOC130003654|LOC130003655|LOC130003656|LOC130003657|LOC130003658|LOC130003659|LOC130003660|LOC130003661|LOC130003662|LOC130003663|LOC130003664|LOC130003665|LOC130003666|LOC130003667|LOC130003668|LOC130003669|LOC130003670|LOC130003671|LOC130003672|LOC130003673|LOC130003674|LOC130003675|LOC130003676|LOC130003677|LOC130003678|LOC130003679|LOC130003680|LOC130003681|LOC130003682|LOC130003683|LOC130003684|LOC130003685|LOC130003686|LOC130003687|LOC130003688|LOC130003689|LOC130003690|LOC130003691|LOC130003692|LOC130003693|LOC130003694|LOC130003695|LOC130003696|LOC130003697|LOC130003698|LOC130003699|LOC130003700|LOC130003701|LOC130003702|LOC130003703|LOC130003704|LOC130003705|LOC130003706|LOC130003707|LOC130003708|LOC130003709|LOC130003710|LOC130003711|LOC130003712|LOC130003713|LOC130003714|LOC130003715|LOC130003716|LOC130003717|LOC130003718|LOC130003719|LOC130003720|LOC130003721|LOC130003722|LOC130003723|LOC130003724|LOC130003725|LOC130003726|LOC130003727|LOC130003728|LOC130003729|LOC130003730|LOC130003731|LOC130003732|LOC130003733|LOC130003734|LOC130003735|LOC130003736|LOC130003737|LOC130003738|LOC130003739|LOC130003740|LOC130003741|LOC130003742|LOC130003743|LOC130003744|LOC130003745|LOC130003746|LOC130003747|LOC130003748|LOC130003749|LOC130003750|LOC130003751|LOC130003752|LOC130003753|LOC130003754|LOC130003755|LOC130003756|LOC130003757|LOC130003758|LOC130003759|LOC130003760|LOC130003761|LOC130003762|LOC130003763|LOC130003764|LOC130003765|LOC130003766|LOC130003767|LOC130003768|LOC130003769|LOC130003770|LOC130003771|LOC130003772|LOC130003773|LOC130003774|LOC132089762|LOC132089763|LOC132089764|LOC132089765|LOC132089766|LOC132089767|LOC132089768|LOC132089769|LOC132089770|LOC132089771|LOC132089772|LOC132089773|LOC132089774|LOC132089775|LOC132089776|LOC132089777|LOC132089778|LOC132089779|LOC132089780|LOC132089781|LOC132089782|LOC132089783|LOC132089784|LOC132089785|LOC132089786|LOC132089787|LOC132089788|LOC132089789|LOC132089790|LOC132089792|LOC132089800|LOC132089802|LOC132089803|LOC132089848|LOC132089861|LOC132089878|LOC132090804|LOC132090805|LOC132090806|LOC132090807|LOC132090808|LOC132090809|LOC132090810|LOC283028|LYZL1|LYZL2|MACORIS|MALRD1|MALRD1-AS1|MANCR|MAP3K8|MARCHF8|MASTL|MCM10|MCS+9.7|MEIG1|MINDY3|MIR1265|MIR1915|MIR1915HG|MIR3155A|MIR3155B|MIR3156-1|MIR3611|MIR4293|MIR4480|MIR4481|MIR4675|MIR4683|MIR5100|MIR511|MIR548AK|MIR548Q|MIR603|MIR604|MIR7162|MIR8086|MIR938|MKX|MKX-AS1|MLLT10|MPP7|MRC1|MSANTD7|MSMB|MSRB2|MTPAP|MTRNR2L7|MYO3A|NCOA4|NEBL|NEBL-AS1|NET1|NMT2|NPY4R|NPY4R2|NRP1|NSUN6|NUDT5|ODAD2|OLAH|OPTN|OR13A1|OTUD1|PARD3|PARD3-DT|PCAT5|PDSS1|PFKFB3|PHYH|PIP4K2A|PLXDC2|PRINS|PRKCQ|PRKCQ-AS1|PROSER2|PROSER2-AS1|PRPF18|PRTFDC1|PTCHD3|PTER|PTF1A|PTPN20|RAB18|RASGEF1A|RASSF4|RBM17|RBP3|RET|RPP38|RPP38-DT|RSU1|SEC61A2|SEPHS1|SFMBT2|SKIDA1|SLC39A12|SLC39A12-AS1|SNORA74C-1|SNORA86|SNORD129|SNORD130|SNORD3J|SPAG6|ST8SIA6|ST8SIA6-AS1|STAM|STAM-DT|SUV39H2|SUV39H2-DT|SVIL|SVIL-AS1|SYT15|SYT15-AS1|SYT15B|TAF3|TASOR2|THNSL1|TIMM23|TMEM236|TMEM72|TMEM72-AS1|TRDMT1|TRN-GTT2-3|TRV-TAC3-1|TUBAL3|UCMA|UCN3|UPF2|USP6NL|USP6NL-AS1|VIM|VIM-AS1|WAC|WAC-AS1|WASHC2C|YME1L1|ZEB1|ZEB1-AS1|ZFAND4|ZNF22|ZNF22-AS1|ZNF239|ZNF248|ZNF248-AS1|ZNF25|ZNF32|ZNF32-AS1|ZNF32-AS2|ZNF32-AS3|ZNF33A|ZNF33B|ZNF37A|ZNF438|ZNF485|ZNF487|ZNF488		See cases	VCV000152998	10	4646926 - 47531169	10	4604734 - 48074662	152998	162749			copy number gain		Benign	Feb 4, 2013	no assertion criteria provided							
GRCh38/hg38 10q11.21-21.3(chr10:42112187-67400675)x3	A1CF|ADO|AGAP10|AGAP4|AGAP6|AGAP9|ALOX5|ANK3|ANK3-DT|ANTXRL|ANXA8|ANXA8L1|ARHGAP22|ARHGAP22-IT1|ARID5B|ASAH2|ASAH2B|BICC1|BMS1|C10orf53|C10orf71|C10orf71-AS1|CABCOCO1|CCDC6|CCEPR|CDK1|CHAT|CISD1|CSGALNACT2|CSGALNACT2-DT|CSTF2T|CTNNA3|CXCL12|DEPP1|DKK1|DRGX|EGR2|ERCC6|FAM13C|FAM170B|FAM170B-AS1|FAM245B|FAM25C|FAM25E|FAM25G|FRMPD2|FXYD4|GDF10|GDF2|GPRIN2|HNRNPF|IPMK|JMJD1C|JMJD1C-AS1|JMJD1C-AS2|LINC00619|LINC00839|LINC00840|LINC00841|LINC00842|LINC00844|LINC00845|LINC01264|LINC01515|LINC01518|LINC01553|LINC02621|LINC02623|LINC02632|LINC02637|LINC02658|LINC02659|LINC02671|LINC02672|LINC02881|LINC02916|LINC03029|LNCAROD|LOC101928961|LOC102724323|LOC102724593|LOC102724719|LOC105378269|LOC105378289|LOC105378305|LOC105378311|LOC105378328|LOC105378577|LOC106736614|LOC107001062|LOC107984236|LOC110121478|LOC110121502|LOC110121503|LOC110121506|LOC110121507|LOC111818966|LOC111818967|LOC111946237|LOC111946238|LOC111946239|LOC111946240|LOC111946243|LOC111946244|LOC111946247|LOC111946248|LOC111946249|LOC112268068|LOC113939916|LOC114827857|LOC116216113|LOC121366050|LOC121366051|LOC121366052|LOC121366053|LOC121366054|LOC121366055|LOC121366056|LOC121366057|LOC121811730|LOC121815939|LOC121815940|LOC121815941|LOC121815942|LOC124403943|LOC124403944|LOC124403945|LOC124403946|LOC124403948|LOC124403949|LOC124403950|LOC124403951|LOC124403952|LOC124403953|LOC124403954|LOC124403955|LOC124403956|LOC124403957|LOC124403958|LOC124403959|LOC124403960|LOC124403961|LOC124403962|LOC124403963|LOC124403966|LOC124403967|LOC124403968|LOC124403969|LOC124403970|LOC126860919|LOC126860920|LOC126860921|LOC126860922|LOC126860923|LOC126860924|LOC126860925|LOC126860926|LOC126860927|LOC126860928|LOC126860929|LOC126860930|LOC126860931|LOC126860932|LOC126860933|LOC126860934|LOC126860935|LOC126860936|LOC126860937|LOC126860938|LOC126860939|LOC126860940|LOC126860941|LOC126860942|LOC126860943|LOC126860944|LOC126860945|LOC126860946|LOC126860947|LOC126860948|LOC129390166|LOC129390167|LOC129390168|LOC129390169|LOC129390170|LOC129390171|LOC129390172|LOC129390173|LOC129390174|LOC129390175|LOC129390176|LOC129390177|LOC129390178|LOC129390179|LOC129390180|LOC129390181|LOC129390182|LOC129390183|LOC129390184|LOC129390185|LOC129390186|LOC129390187|LOC130003699|LOC130003700|LOC130003701|LOC130003702|LOC130003703|LOC130003704|LOC130003705|LOC130003706|LOC130003707|LOC130003708|LOC130003709|LOC130003710|LOC130003711|LOC130003712|LOC130003713|LOC130003714|LOC130003715|LOC130003716|LOC130003717|LOC130003718|LOC130003719|LOC130003720|LOC130003721|LOC130003722|LOC130003723|LOC130003724|LOC130003725|LOC130003726|LOC130003727|LOC130003728|LOC130003729|LOC130003730|LOC130003731|LOC130003732|LOC130003733|LOC130003734|LOC130003735|LOC130003736|LOC130003737|LOC130003738|LOC130003739|LOC130003740|LOC130003741|LOC130003742|LOC130003743|LOC130003744|LOC130003745|LOC130003746|LOC130003747|LOC130003748|LOC130003749|LOC130003750|LOC130003751|LOC130003752|LOC130003753|LOC130003754|LOC130003755|LOC130003756|LOC130003757|LOC130003758|LOC130003759|LOC130003760|LOC130003761|LOC130003762|LOC130003763|LOC130003764|LOC130003765|LOC130003766|LOC130003767|LOC130003768|LOC130003769|LOC130003770|LOC130003771|LOC130003772|LOC130003773|LOC130003774|LOC130003775|LOC130003776|LOC130003777|LOC130003778|LOC130003779|LOC130003780|LOC130003781|LOC130003782|LOC130003783|LOC130003784|LOC130003785|LOC130003786|LOC130003787|LOC130003788|LOC130003789|LOC130003790|LOC130003791|LOC130003792|LOC130003793|LOC130003794|LOC130003795|LOC130003796|LOC130003797|LOC130003798|LOC130003799|LOC130003800|LOC130003801|LOC130003802|LOC130003803|LOC130003804|LOC130003805|LOC130003806|LOC130003807|LOC130003808|LOC130003809|LOC130003810|LOC130003811|LOC130003812|LOC130003813|LOC130003814|LOC130003815|LOC130003816|LOC130003817|LOC130003818|LOC130003819|LOC130003820|LOC130003821|LOC130003822|LOC130003823|LOC130003824|LOC130003825|LOC130003826|LOC130003827|LOC130003828|LOC130003829|LOC130003830|LOC130003831|LOC130003832|LOC130003833|LOC130003834|LOC130003835|LOC130003836|LOC130003837|LOC130003838|LOC130003839|LOC130003840|LOC130003841|LOC130003842|LOC130003843|LOC130003844|LOC130003845|LOC130003846|LOC130003847|LOC130003848|LOC130003849|LOC130003850|LOC130003851|LOC130003852|LOC130003853|LOC130003854|LOC130003855|LOC130003856|LOC130003857|LOC130003858|LOC130003859|LOC130003860|LOC130003861|LOC130003862|LOC130003863|LOC130003864|LOC130003865|LOC130003866|LOC130003867|LOC130003868|LOC130003869|LOC130003870|LOC130003871|LOC130003872|LOC130003873|LOC130003874|LOC130003875|LOC130003876|LOC130003877|LOC130003878|LOC130003879|LOC130003880|LOC130003881|LOC130003882|LOC130003883|LOC130003884|LOC130003885|LOC130003886|LOC130003887|LOC130003888|LOC130003889|LOC130003890|LOC130003891|LOC130003892|LOC130003893|LOC130003894|LOC130003895|LOC130003896|LOC130003897|LOC130003898|LOC130003899|LOC130003900|LOC130003901|LOC130003902|LOC130003903|LOC130003904|LOC130003905|LOC130003906|LOC130003907|LOC130003908|LOC130003909|LOC130003910|LOC130003911|LOC130003912|LOC130003913|LOC130003914|LOC130003915|LOC130003916|LOC130003917|LOC130003918|LOC130003919|LOC130003920|LOC130003921|LOC130003922|LOC130003923|LOC130003924|LOC130003925|LOC130003926|LOC130003927|LOC130003928|LOC130003929|LOC130003930|LOC130003931|LOC132089774|LOC132089775|LOC132089776|LOC132089777|LOC132089778|LOC132089779|LOC132089780|LOC132089781|LOC132089782|LOC132089783|LOC132089784|LOC132089791|LOC132089793|LOC132089794|LOC132089795|LOC132089796|LOC132089797|LOC132089798|LOC132089799|LOC132089801|LOC132089804|LOC132089805|LOC132089806|LOC132089807|LOC132089808|LOC132089809|LOC132089810|LOC132089811|LOC132089812|LOC132089813|LOC132089814|LOC132089815|LOC132089816|LOC132089817|LOC132089818|LOC132089819|LOC132089820|LOC132089821|LOC132089822|LOC132089823|LOC132089824|LOC132089825|LOC132090807|LOC132090808|LOC132090809|LOC132090810|LOC132090811|LOC132090812|LOC132090813|LOC132090814|LOC132090815|LOC132090816|LOC132211101|LOC283028|LOC283045|LRRC18|LRRTM3|MAPK8|MARCHF8|MBL2|MCS+9.7|MIR1296|MIR3156-1|MIR3924|MIR4294|MIR5100|MIR548F1|MIR605|MRLN|MSMB|MTRNR2L5|NCOA4|NPY4R|NPY4R2|NRBF2|OGDHL|OR13A1|PARG|PCDH15|PGBD3|PHYHIPL|PRKG1|PRKG1-AS1|PTPN20|RASGEF1A|RASSF4|RBP3|REEP3|RET|RHOBTB1|RTKN2|SGMS1|SGMS1-AS1|SLC16A9|SLC18A3|SNORA74C-1|SNORA74C-2|SNORD3J|SYT15|SYT15-AS1|SYT15B|TFAM|TIMM23|TIMM23B|TIMM23B-AGAP6|TMEM26|TMEM26-AS1|TMEM273|TMEM72|TMEM72-AS1|UBE2D1|VSTM4|WASHC2A|WASHC2C|WDFY4|ZFAND4|ZNF22|ZNF22-AS1|ZNF239|ZNF32|ZNF32-AS1|ZNF32-AS2|ZNF32-AS3|ZNF33B|ZNF365|ZNF485|ZNF487|ZNF488|ZWINT		See cases	VCV000154900	10	42607635 - 69160433	10	42112187 - 67400675	154900	164654			copy number gain		Pathogenic	Aug 20, 2012	no assertion criteria provided							
GRCh38/hg38 10q11.21-11.23(chr10:42395201-50877059)x3	LOC130003758|LOC130003759|LOC130003760|LOC130003761|LOC130003762|LOC130003763|LOC130003764|LOC130003765|LOC130003766|LOC130003767|LOC130003768|LOC130003769|LOC130003770|LOC130003771|LOC130003772|LOC130003773|LOC130003774|LOC130003775|LOC130003776|LOC130003777|LOC130003778|LOC130003779|LOC130003780|LOC130003781|LOC130003782|LOC130003783|LOC130003784|LOC130003785|LOC130003786|LOC130003787|LOC130003788|LOC130003789|LOC130003790|LOC130003791|LOC130003792|LOC130003793|LOC130003794|LOC130003795|LOC130003796|LOC130003797|LOC130003798|LOC130003799|LOC130003800|LOC130003801|LOC130003802|LOC130003803|LOC130003804|LOC130003805|LOC130003806|LOC130003807|LOC130003808|LOC130003809|LOC130003810|LOC130003811|LOC130003812|LOC130003813|LOC130003814|LOC130003815|LOC130003816|LOC130003817|LOC130003818|LOC130003819|LOC130003820|LOC130003821|LOC130003822|LOC130003823|LOC130003824|LOC130003825|LOC130003826|LOC130003827|LOC130003828|LOC130003829|LOC130003830|LOC130003831|LOC130003832|LOC130003833|LOC130003834|LOC132089774|LOC132089775|LOC132089776|LOC132089777|LOC132089778|LOC132089779|LOC132089780|LOC132089781|LOC132089782|LOC132089783|LOC132089784|LOC132090807|LOC132090808|LOC132090809|LOC132090810|LOC283028|LRRC18|MAPK8|MARCHF8|MCS+9.7|MIR3156-1|MIR4294|MIR5100|MSMB|NCOA4|NPY4R|NPY4R2|OGDHL|OR13A1|PARG|PGBD3|PTPN20|RASGEF1A|RASSF4|RBP3|RET|SGMS1|SGMS1-AS1|SLC18A3|SNORA74C-1|SNORA74C-2|SNORD3J|SYT15|SYT15-AS1|SYT15B|TIMM23|TIMM23B|TIMM23B-AGAP6|TMEM273|TMEM72|TMEM72-AS1|VSTM4|WASHC2A|WASHC2C|WDFY4|ZFAND4|ZNF22|ZNF22-AS1|ZNF239|ZNF32|ZNF32-AS1|ZNF32-AS2|ZNF32-AS3|ZNF33B|ZNF485|ZNF487|ZNF488|A1CF|AGAP10|AGAP4|AGAP6|AGAP9|ALOX5|ANTXRL|ANXA8|ANXA8L1|ARHGAP22|ARHGAP22-IT1|ASAH2|ASAH2B|BMS1|C10orf53|C10orf71|C10orf71-AS1|CHAT|CSGALNACT2|CSGALNACT2-DT|CXCL12|DEPP1|DRGX|ERCC6|FAM170B|FAM170B-AS1|FAM245B|FAM25C|FAM25E|FAM25G|FRMPD2|FXYD4|GDF10|GDF2|GPRIN2|HNRNPF|LINC00619|LINC00839|LINC00840|LINC00841|LINC00842|LINC01264|LINC01518|LINC02623|LINC02632|LINC02637|LINC02658|LINC02659|LINC02881|LINC02916|LINC03029|LOC102724323|LOC102724593|LOC105378269|LOC105378289|LOC105378577|LOC106736614|LOC107001062|LOC110121478|LOC110121502|LOC110121503|LOC110121506|LOC110121507|LOC111818966|LOC111818967|LOC111946237|LOC111946238|LOC111946239|LOC111946240|LOC111946243|LOC111946244|LOC113939916|LOC114827857|LOC121366050|LOC121366051|LOC121366052|LOC121366053|LOC121366054|LOC121366055|LOC121811730|LOC124403943|LOC124403944|LOC124403945|LOC124403946|LOC124403948|LOC124403949|LOC124403950|LOC124403951|LOC124403952|LOC124403953|LOC124403954|LOC124403955|LOC126860919|LOC126860920|LOC126860921|LOC126860922|LOC126860923|LOC126860924|LOC126860925|LOC126860926|LOC126860927|LOC126860928|LOC126860929|LOC126860930|LOC126860931|LOC126860932|LOC126860933|LOC129390166|LOC129390167|LOC129390168|LOC129390169|LOC129390170|LOC130003703|LOC130003704|LOC130003705|LOC130003706|LOC130003707|LOC130003708|LOC130003709|LOC130003710|LOC130003711|LOC130003712|LOC130003713|LOC130003714|LOC130003715|LOC130003716|LOC130003717|LOC130003718|LOC130003719|LOC130003720|LOC130003721|LOC130003722|LOC130003723|LOC130003724|LOC130003725|LOC130003726|LOC130003727|LOC130003728|LOC130003729|LOC130003730|LOC130003731|LOC130003732|LOC130003733|LOC130003734|LOC130003735|LOC130003736|LOC130003737|LOC130003738|LOC130003739|LOC130003740|LOC130003741|LOC130003742|LOC130003743|LOC130003744|LOC130003745|LOC130003746|LOC130003747|LOC130003748|LOC130003749|LOC130003750|LOC130003751|LOC130003752|LOC130003753|LOC130003754|LOC130003755|LOC130003756|LOC130003757		See cases	VCV000145479	10	42890649 - 52636819	10	42395201 - 50877059	145479	155230			copy number gain		Pathogenic	Sep 30, 2010	no assertion criteria provided							
GRCh38/hg38 10q11.21(chr10:42395216-43234240)x3	BMS1|CSGALNACT2|CSGALNACT2-DT|LINC00839|LINC01264|LINC01518|LINC02623|LINC02632|LOC105378269|LOC106736614|LOC110121502|LOC110121503|LOC110121506|LOC110121507|LOC111946237|LOC124403943|LOC124403944|LOC126860919|LOC130003703|LOC130003704|LOC130003705|LOC130003706|LOC130003707|LOC130003708|LOC130003709|LOC130003710|LOC130003711|LOC130003712|LOC130003713|LOC130003714|LOC130003715|LOC130003716|LOC130003717|LOC130003718|LOC130003719|LOC130003720|LOC132089774|LOC283028|MCS+9.7|MIR5100|RASGEF1A|RET|ZNF33B		See cases	VCV000148036	10	42890664 - 43729688	10	42395216 - 43234240	148036	157787			copy number gain		Uncertain significance	Dec 22, 2010	no assertion criteria provided							
GRCh38/hg38 10q11.21-22.2(chr10:42685306-73715908)x3	A1CF|ADAMTS14|ADO|AGAP10|AGAP4|AGAP5|AGAP6|AGAP9|AIFM2|ALOX5|ANAPC16|ANK3|ANK3-DT|ANTXRL|ANXA7|ANXA8|ANXA8L1|ARHGAP22|ARHGAP22-IT1|ARID5B|ASAH2|ASAH2B|ASCC1|ATOH7|BICC1|BMS1|C10orf105|C10orf53|C10orf71|C10orf71-AS1|CABCOCO1|CCAR1|CCDC6|CCEPR|CDH23|CDH23-AS1|CDK1|CFAP70|CHAT|CHST3|CISD1|COL13A1|CSGALNACT2|CSGALNACT2-DT|CSTF2T|CTNNA3|CXCL12|DDIT4|DDIT4-AS1|DDX21|DDX50|DEPP1|DKK1|DNA2|DNAJB12|DNAJC12|DNAJC9|DNAJC9-AS1|DRGX|ECD|EGR2|EIF4EBP2|ERCC6|FAM13C|FAM149B1|FAM170B|FAM170B-AS1|FAM241B|FAM245B|FAM25C|FAM25E|FAM25G|FRMPD2|FXYD4|GDF10|GDF2|GPRIN2|HERC4|HK1|HKDC1|HNRNPF|HNRNPH3|IPMK|JMJD1C|JMJD1C-AS1|JMJD1C-AS2|KIFBP|LINC00619|LINC00840|LINC00841|LINC00842|LINC00844|LINC00845|LINC01264|LINC01515|LINC01518|LINC01553|LINC02621|LINC02622|LINC02623|LINC02632|LINC02636|LINC02637|LINC02651|LINC02658|LINC02659|LINC02671|LINC02672|LINC02881|LINC02916|LINC03029|LNCAROD|LOC101928961|LOC101928994|LOC102724323|LOC102724593|LOC102724719|LOC105378269|LOC105378289|LOC105378305|LOC105378311|LOC105378328|LOC105378577|LOC106736614|LOC107001062|LOC107832851|LOC107984236|LOC108178982|LOC110121478|LOC110121502|LOC110121503|LOC110121506|LOC110121507|LOC111365158|LOC111365196|LOC111818966|LOC111818967|LOC111946237|LOC111946238|LOC111946239|LOC111946240|LOC111946243|LOC111946244|LOC111946247|LOC111946248|LOC111946249|LOC111946250|LOC111949323|LOC111982863|LOC111982864|LOC111982865|LOC111982866|LOC111982867|LOC111982868|LOC111982869|LOC111982870|LOC112268068|LOC113939916|LOC114827857|LOC116216113|LOC116216114|LOC120807611|LOC121366050|LOC121366051|LOC121366052|LOC121366053|LOC121366054|LOC121366055|LOC121366056|LOC121366057|LOC121366058|LOC121366059|LOC121366060|LOC121366061|LOC121366062|LOC121811730|LOC121815939|LOC121815940|LOC121815941|LOC121815942|LOC121815943|LOC121815944|LOC121815945|LOC121815946|LOC121815947|LOC121815948|LOC121815949|LOC124403944|LOC124403945|LOC124403946|LOC124403948|LOC124403949|LOC124403950|LOC124403951|LOC124403952|LOC124403953|LOC124403954|LOC124403955|LOC124403956|LOC124403957|LOC124403958|LOC124403959|LOC124403960|LOC124403961|LOC124403962|LOC124403963|LOC124403966|LOC124403967|LOC124403968|LOC124403969|LOC124403970|LOC124403971|LOC124403972|LOC124403973|LOC124403974|LOC124403975|LOC124403976|LOC124416833|LOC124416834|LOC124416835|LOC124416836|LOC124416837|LOC124416838|LOC124416839|LOC126860919|LOC126860920|LOC126860921|LOC126860922|LOC126860923|LOC126860924|LOC126860925|LOC126860926|LOC126860927|LOC126860928|LOC126860929|LOC126860930|LOC126860931|LOC126860932|LOC126860933|LOC126860934|LOC126860935|LOC126860936|LOC126860937|LOC126860938|LOC126860939|LOC126860940|LOC126860941|LOC126860942|LOC126860943|LOC126860944|LOC126860945|LOC126860946|LOC126860947|LOC126860948|LOC126860949|LOC126860950|LOC126860951|LOC126860952|LOC126860953|LOC126860954|LOC126860955|LOC129390166|LOC129390167|LOC129390168|LOC129390169|LOC129390170|LOC129390171|LOC129390172|LOC129390173|LOC129390174|LOC129390175|LOC129390176|LOC129390177|LOC129390178|LOC129390179|LOC129390180|LOC129390181|LOC129390182|LOC129390183|LOC129390184|LOC129390185|LOC129390186|LOC129390187|LOC129390188|LOC129390189|LOC129390190|LOC129390191|LOC129390192|LOC129390193|LOC129390194|LOC129390195|LOC129390196|LOC129390197|LOC129390198|LOC129390199|LOC129390200|LOC129390201|LOC130003704|LOC130003705|LOC130003706|LOC130003707|LOC130003708|LOC130003709|LOC130003710|LOC130003711|LOC130003712|LOC130003713|LOC130003714|LOC130003715|LOC130003716|LOC130003717|LOC130003718|LOC130003719|LOC130003720|LOC130003721|LOC130003722|LOC130003723|LOC130003724|LOC130003725|LOC130003726|LOC130003727|LOC130003728|LOC130003729|LOC130003730|LOC130003731|LOC130003732|LOC130003733|LOC130003734|LOC130003735|LOC130003736|LOC130003737|LOC130003738|LOC130003739|LOC130003740|LOC130003741|LOC130003742|LOC130003743|LOC130003744|LOC130003745|LOC130003746|LOC130003747|LOC130003748|LOC130003749|LOC130003750|LOC130003751|LOC130003752|LOC130003753|LOC130003754|LOC130003755|LOC130003756|LOC130003757|LOC130003758|LOC130003759|LOC130003760|LOC130003761|LOC130003762|LOC130003763|LOC130003764|LOC130003765|LOC130003766|LOC130003767|LOC130003768|LOC130003769|LOC130003770|LOC130003771|LOC130003772|LOC130003773|LOC130003774|LOC130003775|LOC130003776|LOC130003777|LOC130003778|LOC130003779|LOC130003780|LOC130003781|LOC130003782|LOC130003783|LOC130003784|LOC130003785|LOC130003786|LOC130003787|LOC130003788|LOC130003789|LOC130003790|LOC130003791|LOC130003792|LOC130003793|LOC130003794|LOC130003795|LOC130003796|LOC130003797|LOC130003798|LOC130003799|LOC130003800|LOC130003801|LOC130003802|LOC130003803|LOC130003804|LOC130003805|LOC130003806|LOC130003807|LOC130003808|LOC130003809|LOC130003810|LOC130003811|LOC130003812|LOC130003813|LOC130003814|LOC130003815|LOC130003816|LOC130003817|LOC130003818|LOC130003819|LOC130003820|LOC130003821|LOC130003822|LOC130003823|LOC130003824|LOC130003825|LOC130003826|LOC130003827|LOC130003828|LOC130003829|LOC130003830|LOC130003831|LOC130003832|LOC130003833|LOC130003834|LOC130003835|LOC130003836|LOC130003837|LOC130003838|LOC130003839|LOC130003840|LOC130003841|LOC130003842|LOC130003843|LOC130003844|LOC130003845|LOC130003846|LOC130003847|LOC130003848|LOC130003849|LOC130003850|LOC130003851|LOC130003852|LOC130003853|LOC130003854|LOC130003855|LOC130003856|LOC130003857|LOC130003858|LOC130003859|LOC130003860|LOC130003861|LOC130003862|LOC130003863|LOC130003864|LOC130003865|LOC130003866|LOC130003867|LOC130003868|LOC130003869|LOC130003870|LOC130003871|LOC130003872|LOC130003873|LOC130003874|LOC130003875|LOC130003876|LOC130003877|LOC130003878|LOC130003879|LOC130003880|LOC130003881|LOC130003882|LOC130003883|LOC130003884|LOC130003885|LOC130003886|LOC130003887|LOC130003888|LOC130003889|LOC130003890|LOC130003891|LOC130003892|LOC130003893|LOC130003894|LOC130003895|LOC130003896|LOC130003897|LOC130003898|LOC130003899|LOC130003900|LOC130003901|LOC130003902|LOC130003903|LOC130003904|LOC130003905|LOC130003906|LOC130003907|LOC130003908|LOC130003909|LOC130003910|LOC130003911|LOC130003912|LOC130003913|LOC130003914|LOC130003915|LOC130003916|LOC130003917|LOC130003918|LOC130003919|LOC130003920|LOC130003921|LOC130003922|LOC130003923|LOC130003924|LOC130003925|LOC130003926|LOC130003927|LOC130003928|LOC130003929|LOC130003930|LOC130003931|LOC130003932|LOC130003933|LOC130003934|LOC130003935|LOC130003936|LOC130003937|LOC130003938|LOC130003939|LOC130003940|LOC130003941|LOC130003942|LOC130003943|LOC130003944|LOC130003945|LOC130003946|LOC130003947|LOC130003948|LOC130003949|LOC130003950|LOC130003951|LOC130003952|LOC130003953|LOC130003954|LOC130003955|LOC130003956|LOC130003957|LOC130003958|LOC130003959|LOC130003960|LOC130003961|LOC130003962|LOC130003963|LOC130003964|LOC130003965|LOC130003966|LOC130003967|LOC130003968|LOC130003969|LOC130003970|LOC130003971|LOC130003972|LOC130003973|LOC130003974|LOC130003975|LOC130003976|LOC130003977|LOC130003978|LOC130003979|LOC130003980|LOC130003981|LOC130003982|LOC130003983|LOC130003984|LOC130003985|LOC130003986|LOC130003987|LOC130003988|LOC130003989|LOC130003990|LOC130003991|LOC130003992|LOC130003993|LOC130003994|LOC130003995|LOC130003996|LOC130003997|LOC130003998|LOC130003999|LOC130004000|LOC130004001|LOC130004002|LOC130004003|LOC130004004|LOC130004005|LOC130004006|LOC130004007|LOC130004008|LOC130004009|LOC130004010|LOC130004011|LOC130004012|LOC130004013|LOC130004014|LOC130004015|LOC130004016|LOC130004017|LOC130004018|LOC130004019|LOC130004020|LOC130004021|LOC130004022|LOC130004023|LOC130004024|LOC130004025|LOC130004026|LOC130004027|LOC130004028|LOC130004029|LOC130004030|LOC130004031|LOC130004032|LOC130004033|LOC130004034|LOC130004035|LOC130004036|LOC130004037|LOC130004038|LOC130004039|LOC130004040|LOC130004041|LOC130004042|LOC130004043|LOC130004044|LOC130004045|LOC130004046|LOC130004047|LOC130004048|LOC130004049|LOC130004050|LOC130004051|LOC130004052|LOC130004053|LOC130004054|LOC130004055|LOC130004056|LOC130004057|LOC130004058|LOC130004059|LOC130004060|LOC130004061|LOC130004062|LOC130004063|LOC130004064|LOC130004065|LOC130004066|LOC130004067|LOC130004068|LOC130004069|LOC130004070|LOC130004071|LOC130004072|LOC130004073|LOC130004074|LOC130004075|LOC130004076|LOC130004077|LOC130004078|LOC130004079|LOC130004080|LOC130004081|LOC130004082|LOC130004083|LOC130004084|LOC132089774|LOC132089775|LOC132089776|LOC132089777|LOC132089778|LOC132089779|LOC132089780|LOC132089781|LOC132089782|LOC132089783|LOC132089784|LOC132089791|LOC132089793|LOC132089794|LOC132089795|LOC132089796|LOC132089797|LOC132089798|LOC132089799|LOC132089801|LOC132089804|LOC132089805|LOC132089806|LOC132089807|LOC132089808|LOC132089809|LOC132089810|LOC132089811|LOC132089812|LOC132089813|LOC132089814|LOC132089815|LOC132089816|LOC132089817|LOC132089818|LOC132089819|LOC132089820|LOC132089821|LOC132089822|LOC132089823|LOC132089824|LOC132089825|LOC132089826|LOC132089827|LOC132089828|LOC132089829|LOC132089830|LOC132089831|LOC132089832|LOC132089833|LOC132089834|LOC132089835|LOC132089836|LOC132089837|LOC132089838|LOC132089839|LOC132089840|LOC132089841|LOC132089842|LOC132089843|LOC132089844|LOC132089845|LOC132089846|LOC132089847|LOC132089849|LOC132089850|LOC132089851|LOC132089852|LOC132089853|LOC132089854|LOC132089855|LOC132089856|LOC132089857|LOC132089858|LOC132089859|LOC132089860|LOC132089862|LOC132089863|LOC132089864|LOC132089865|LOC132089866|LOC132090807|LOC132090808|LOC132090809|LOC132090810|LOC132090811|LOC132090812|LOC132090813|LOC132090814|LOC132090815|LOC132090816|LOC132090817|LOC132090818|LOC132090819|LOC132090820|LOC132090821|LOC132090822|LOC132090823|LOC132211101|LOC132211102|LOC283028|LOC283045|LRRC18|LRRC20|LRRTM3|MACROH2A2|MAPK8|MARCHF8|MBL2|MCS+9.7|MCU|MICU1|MIR1296|MIR3156-1|MIR3924|MIR4294|MIR4676|MIR5100|MIR548F1|MIR605|MIR7151|MIR7152|MRLN|MRPS16|MSMB|MSS51|MTRNR2L5|MYOZ1|MYPN|NCOA4|NEUROG3|NODAL|NPFFR1|NPY4R|NPY4R2|NRBF2|NUDT13|OGDHL|OIT3|OR13A1|P4HA1|PALD1|PARG|PBLD|PCBD1|PCDH15|PGBD3|PHYHIPL|PLA2G12B|PPA1|PPP3CB|PPP3CB-AS1|PRF1|PRKG1|PRKG1-AS1|PSAP|PTPN20|RASGEF1A|RASSF4|RBP3|REEP3|RET|RHOBTB1|RTKN2|RUFY2|SAR1A|SGMS1|SGMS1-AS1|SGPL1|SIRT1|SLC16A9|SLC18A3|SLC25A16|SLC29A3|SNORA11F|SNORA74C-1|SNORA74C-2|SNORD3J|SNORD98|SPOCK2|SRGN|STOX1|SUPV3L1|SYNPO2L|SYNPO2L-AS1|SYT15|SYT15-AS1|SYT15B|TACR2|TBATA|TET1|TFAM|TIMM23|TIMM23B|TIMM23B-AGAP6|TMEM26|TMEM26-AS1|TMEM273|TMEM72|TMEM72-AS1|TRS-TGA1-1|TSPAN15|TYSND1|UBE2D1|UNC5B|UNC5B-AS1|USP54|VPS26A|VSIR|VSTM4|WASHC2A|WASHC2C|WDFY4|ZFAND4|ZNF22|ZNF22-AS1|ZNF239|ZNF32|ZNF32-AS1|ZNF32-AS2|ZNF32-AS3|ZNF365|ZNF485|ZNF487|ZNF488|ZWINT		See cases	VCV000145481	10	43180754 - 75475666	10	42685306 - 73715908	145481	155232			copy number gain		Pathogenic	Sep 30, 2010	no assertion criteria provided							
GRCh38/hg38 10q11.21-21.1(chr10:42884294-52265317)x3	FAM170B|FAM170B-AS1|FAM245B|FAM25C|FAM25E|FAM25G|FRMPD2|FXYD4|GDF10|GDF2|GPRIN2|HNRNPF|LINC00619|LINC00840|LINC00841|LINC00842|LINC01264|LINC02637|LINC02658|LINC02659|LINC02881|LINC02916|LINC03029|LOC102724323|LOC102724593|LOC102724719|LOC105378289|LOC105378577|LOC106736614|LOC107001062|LOC110121478|LOC110121502|LOC110121503|LOC110121506|LOC110121507|LOC111818966|LOC111818967|LOC111946237|LOC111946238|LOC111946239|LOC111946240|LOC111946243|LOC111946244|LOC113939916|LOC114827857|LOC121366050|LOC121366051|LOC121366052|LOC121366053|LOC121366054|LOC121366055|LOC121811730|LOC124403945|LOC124403946|LOC124403948|LOC124403949|LOC124403950|LOC124403951|LOC124403952|LOC124403953|LOC124403954|LOC124403955|LOC124403956|LOC124403957|LOC126860919|LOC126860920|LOC126860921|LOC126860922|LOC126860923|LOC126860924|LOC126860925|LOC126860926|LOC126860927|LOC126860928|LOC126860929|LOC126860930|LOC126860931|LOC126860932|LOC126860933|LOC129390166|LOC129390167|LOC129390168|LOC129390169|LOC129390170|LOC130003705|LOC130003706|LOC130003707|LOC130003708|LOC130003709|LOC130003710|LOC130003711|LOC130003712|LOC130003713|LOC130003714|LOC130003715|LOC130003716|LOC130003717|LOC130003718|LOC130003719|LOC130003720|LOC130003721|LOC130003722|LOC130003723|LOC130003724|LOC130003725|LOC130003726|LOC130003727|LOC130003728|LOC130003729|LOC130003730|LOC130003731|LOC130003732|LOC130003733|LOC130003734|LOC130003735|LOC130003736|LOC130003737|LOC130003738|LOC130003739|LOC130003740|LOC130003741|LOC130003742|LOC130003743|LOC130003744|LOC130003745|LOC130003746|LOC130003747|LOC130003748|LOC130003749|LOC130003750|LOC130003751|LOC130003752|LOC130003753|LOC130003754|LOC130003755|LOC130003756|LOC130003757|LOC130003758|LOC130003759|LOC130003760|LOC130003761|LOC130003762|LOC130003763|LOC130003764|LOC130003765|LOC130003766|LOC130003767|LOC130003768|LOC130003769|LOC130003770|LOC130003771|LOC130003772|LOC130003773|LOC130003774|LOC130003775|LOC130003776|LOC130003777|LOC130003778|LOC130003779|LOC130003780|LOC130003781|LOC130003782|LOC130003783|LOC130003784|LOC130003785|LOC130003786|LOC130003787|LOC130003788|LOC130003789|LOC130003790|LOC130003791|LOC130003792|LOC130003793|LOC130003794|LOC130003795|LOC130003796|LOC130003797|LOC130003798|LOC130003799|LOC130003800|LOC130003801|LOC130003802|LOC130003803|LOC130003804|LOC130003805|LOC130003806|LOC130003807|LOC130003808|LOC130003809|LOC130003810|LOC130003811|LOC130003812|LOC130003813|LOC130003814|LOC130003815|LOC130003816|LOC130003817|LOC130003818|LOC130003819|LOC130003820|LOC130003821|LOC130003822|LOC130003823|LOC130003824|LOC130003825|LOC130003826|LOC130003827|LOC130003828|LOC130003829|LOC130003830|LOC130003831|LOC130003832|LOC130003833|LOC130003834|LOC130003835|LOC130003836|LOC130003837|LOC132089774|LOC132089775|LOC132089776|LOC132089777|LOC132089778|LOC132089779|LOC132089780|LOC132089781|LOC132089782|LOC132089783|LOC132089784|LOC132090807|LOC132090808|LOC132090809|LOC132090810|LRRC18|MAPK8|MARCHF8|MCS+9.7|MIR3156-1|MIR4294|MIR5100|MIR605|MSMB|NCOA4|NPY4R|NPY4R2|OGDHL|OR13A1|PARG|PGBD3|PRKG1|PTPN20|RASGEF1A|RASSF4|RBP3|RET|SGMS1|SGMS1-AS1|SLC18A3|SNORA74C-1|SNORA74C-2|SNORD3J|SYT15|SYT15-AS1|SYT15B|TIMM23|TIMM23B|TIMM23B-AGAP6|TMEM273|TMEM72|TMEM72-AS1|VSTM4|WASHC2A|WASHC2C|WDFY4|ZFAND4|ZNF22|ZNF22-AS1|ZNF239|ZNF32|ZNF32-AS1|ZNF32-AS2|ZNF32-AS3|ZNF485|ZNF487|ZNF488|A1CF|AGAP10|AGAP4|AGAP6|AGAP9|ALOX5|ANTXRL|ANXA8|ANXA8L1|ARHGAP22|ARHGAP22-IT1|ASAH2|ASAH2B|C10orf53|C10orf71|C10orf71-AS1|CHAT|CSGALNACT2|CSGALNACT2-DT|CSTF2T|CXCL12|DEPP1|DRGX|ERCC6		See cases	VCV000144977	10	43379742 - 54025077	10	42884294 - 52265317	144977	154728			copy number gain		Pathogenic	Nov 30, 2010	no assertion criteria provided							
NC_000010.11:g.43076732C>A	LOC106736614|RET		not provided	VCV001186865	10	43572180	10	43076732	1186865	1177309	rs3097561	NC_000010.11:43076731:C:A	single nucleotide variant		Likely benign	Feb 24, 2019	criteria provided, single submitter							
NC_000010.11:g.43076848G>A	LOC106736614|RET		not provided	VCV001250759	10	43572296	10	43076848	1250759	1238568	rs115549558	NC_000010.11:43076847:G:A	single nucleotide variant		Benign	May 6, 2019	criteria provided, single submitter							
NC_000010.11:g.43076978C>T	LOC106736614|RET		not provided	VCV001195506	10	43572426	10	43076978	1195506	1184365	rs528835015	NC_000010.11:43076977:C:T	single nucleotide variant		Likely benign	Apr 1, 2020	criteria provided, single submitter							
NC_000010.11:g.43077015GCCCC[4]	LOC106736614|RET		Multiple endocrine neoplasia type 2A	VCV000036721	10	43572458 - 43572459	10	43077010 - 43077011	36721	45382	rs386134265	NC_000010.11:43077010:CCCCGCCCCGCCCCGCCCC:CCCCGCCCCGCCCCGCCCCGCCCC	Microsatellite	genic upstream transcript variant	Uncertain significance	Aug 18, 2011	criteria provided, single submitter							
NC_000010.11:g.43077033C>T	LOC106736614|RET		not provided	VCV001189242	10	43572481	10	43077033	1189242	1180673	rs540926474	NC_000010.11:43077032:C:T	single nucleotide variant		Likely benign	Jun 21, 2018	criteria provided, single submitter							
NC_000010.11:g.43077059A>G	LOC106736614|RET		Multiple endocrine neoplasia|not provided|Pheochromocytoma|Hirschsprung Disease, Dominant|Renal hypodysplasia/aplasia 1	VCV000368898	10	43572507	10	43077059	368898	353127	rs10900296	NC_000010.11:43077058:A:G	single nucleotide variant		Benign	Jun 24, 2018	criteria provided, multiple submitters, no conflicts							
NM_020975.5(RET):c.-196C>A	LOC106736614|RET		Pheochromocytoma|Hirschsprung Disease, Dominant|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia|not provided	VCV000368899	10	43572511	10	43077063	368899	353128	rs10900297	NC_000010.11:43077062:C:A	single nucleotide variant		Benign/Likely benign	Jun 15, 2018	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.-187C>A	LOC106736614|RET		Multiple endocrine neoplasia|Pheochromocytoma|Renal hypodysplasia/aplasia 1|Hirschsprung Disease, Dominant	VCV000299883	10	43572520	10	43077072	299883	322063	rs886046983	NC_000010.11:43077071:C:A	single nucleotide variant	5 prime UTR variant	Uncertain significance	Jun 14, 2016	criteria provided, single submitter							
NM_020975.6(RET):c.-173A>G	LOC106736614|RET		Renal hypodysplasia/aplasia 1|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia	VCV000877684	10	43572534	10	43077086	877684	865863	rs1359755826	NC_000010.11:43077085:A:G	single nucleotide variant	5 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.-160G>T	LOC106736614|RET		Renal hypodysplasia/aplasia 1|Hirschsprung disease, susceptibility to, 1|not provided|Pheochromocytoma|Multiple endocrine neoplasia	VCV000877685	10	43572547	10	43077099	877685	865864	rs567112195	NC_000010.11:43077098:G:T	single nucleotide variant	5 prime UTR variant	Benign/Likely benign	Jan 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.-158G>A	LOC106736614|RET		Multiple endocrine neoplasia|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Renal hypodysplasia/aplasia 1	VCV000299884	10	43572549	10	43077101	299884	315391	rs886046984	NC_000010.11:43077100:G:A	single nucleotide variant	5 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.-132G>T	LOC106736614|RET		Multiple endocrine neoplasia|Hereditary cancer-predisposing syndrome|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Renal hypodysplasia/aplasia 1	VCV000299885	10	43572575	10	43077127	299885	310269	rs886046985	NC_000010.11:43077126:G:T	single nucleotide variant	5 prime UTR variant	Conflicting classifications of pathogenicity	Jun 1, 2021	criteria provided, conflicting classifications							
NM_020975.6(RET):c.-68C>T	LOC106736614|RET		not provided	VCV001225708	10	43572639	10	43077191	1225708	1215681	rs3128725	NC_000010.11:43077190:C:T	single nucleotide variant	5 prime UTR variant	Benign	Mar 3, 2015	criteria provided, single submitter							
NM_020975.6(RET):c.-51C>T	LOC106736614|RET		Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1	VCV000878710	10	43572656	10	43077208	878710	865865	rs765384640	NC_000010.11:43077207:C:T	single nucleotide variant	5 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.-37G>C	LOC106736614|RET		Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|not provided	VCV000477374	10	43572670	10	43077222	477374	460664	rs751005619	NC_000010.11:43077221:G:C	single nucleotide variant	5 prime UTR variant	Conflicting classifications of pathogenicity	Feb 16, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.-30C>T	LOC106736614|RET		not specified	VCV003256491	10	43572677	10	43077229	3256491	3415253		NC_000010.11:43077228:C:T	single nucleotide variant	5 prime UTR variant	Likely benign	Jul 31, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.-23C>T	LOC106736614|RET		RET-related disorder	VCV003054907	10	43572684	10	43077236	3054907	3219567		NC_000010.11:43077235:C:T	single nucleotide variant	5 prime UTR variant	Likely benign	Oct 6, 2020	no assertion criteria provided							
NC_000010.10:g.(?_43572697)_(43623727_?)dup	LOC110121502|LOC130003705|LOC130003706|LOC130003709|LOC130003710|LOC106736614|LOC130003707|LOC130003708|MCS+9.7|RET		Multiple endocrine neoplasia, type 2	VCV000662839	10	43572697 - 43623727	10	43077249 - 43128279	662839	651962			Duplication		Uncertain significance	Apr 3, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.-7_-4del	LOC106736614|RET		Hereditary cancer-predisposing syndrome	VCV001756637	10	43572700 - 43572703	10	43077252 - 43077255	1756637	1822449		NC_000010.11:43077251:ACGG:	Deletion	5 prime UTR variant	Uncertain significance	Jul 26, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.-6C>T	LOC106736614|RET		not provided	VCV001321691	10	43572701	10	43077253	1321691	1311972	rs1261228095	NC_000010.11:43077252:C:T	single nucleotide variant	5 prime UTR variant	Uncertain significance	May 13, 2021	criteria provided, single submitter							
NC_000010.10:g.(?_43572701)_(43623723_?)dup	LOC130003709|LOC130003710|MCS+9.7|LOC106736614|LOC110121502|LOC130003705|LOC130003706|LOC130003707|LOC130003708|RET		Multiple endocrine neoplasia, type 2	VCV000477299	10	43572701 - 43623723	10	43077253 - 43128275	477299	460024			Duplication		Uncertain significance	Mar 7, 2017	criteria provided, single submitter							
NM_020975.6(RET):c.2_7dup (p.Ala2_Lys3insMetAla)	LOC106736614|RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002447524	10	43572702 - 43572703	10	43077254 - 43077255	2447524	2432418		NC_000010.11:43077254:GGCGATGGCGA:GGCGATGGCGATGGCGA	Duplication	inframe_indel|inframe_insertion|initiator_codon_variant	Conflicting classifications of pathogenicity	Jul 22, 2023	criteria provided, conflicting classifications							
NM_020975.6(RET):c.-5G>C	LOC106736614|RET		Hereditary cancer-predisposing syndrome	VCV001751015	10	43572702	10	43077254	1751015	1800744		NC_000010.11:43077253:G:C	single nucleotide variant	5 prime UTR variant	Uncertain significance	Sep 2, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.-4G>T	LOC106736614|RET		Multiple endocrine neoplasia, type 2	VCV003074853	10	43572703	10	43077255	3074853	3229819		NC_000010.11:43077254:G:T	single nucleotide variant	5 prime UTR variant	Uncertain significance	Dec 13, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.-4G>A	LOC106736614|RET		Hereditary cancer-predisposing syndrome	VCV000825359	10	43572703	10	43077255	825359	809870	rs1456639441	NC_000010.11:43077254:G:A	single nucleotide variant	5 prime UTR variant	Uncertain significance	Jun 30, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.-3G>C	LOC106736614|RET		Hereditary cancer-predisposing syndrome	VCV003432230	10	43572704	10	43077256	3432230	3593426		NC_000010.11:43077255:G:C	single nucleotide variant	5 prime UTR variant	Uncertain significance	Jul 11, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.-3G>A	LOC106736614|RET		Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	VCV001736907	10	43572704	10	43077256	1736907	1793949		NC_000010.11:43077255:G:A	single nucleotide variant	5 prime UTR variant	Uncertain significance	Aug 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.-2C>A	LOC106736614|RET		Hereditary cancer-predisposing syndrome|not specified|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Familial medullary thyroid carcinoma|not provided	VCV000229201	10	43572705	10	43077257	229201	229791	rs876657980	NC_000010.11:43077256:C:A	single nucleotide variant	5 prime UTR variant	Conflicting classifications of pathogenicity	May 6, 2022	criteria provided, conflicting classifications							
NM_020975.6(RET):c.-1G>A	LOC106736614|RET		Hereditary cancer-predisposing syndrome	VCV001784210	10	43572706	10	43077258	1784210	1849769		NC_000010.11:43077257:G:A	single nucleotide variant	5 prime UTR variant	Uncertain significance	Jan 17, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.5_28dup (p.Ala9_Gly10insAlaLysAlaThrSerGlyAlaAla)	LOC106736614|RET		not specified|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001020843	10	43572708 - 43572709	10	43077260 - 43077261	1020843	1008978	rs1837063549	NC_000010.11:43077260:GGCGAAGGCGACGTCCGGTGCCGCGG:GGCGAAGGCGACGTCCGGTGCCGCGGCGAAGGCGACGTCCGGTGCCGCGG	Duplication	inframe_indel|inframe_insertion|initiator_codon_variant	Uncertain significance	Aug 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.5C>A (p.Ala2Glu)	LOC106736614|RET	A2E	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002914324	10	43572711	10	43077263	2914324	3071136		NC_000010.11:43077262:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.6G>T (p.Ala2=)	LOC106736614|RET		Multiple endocrine neoplasia, type 2	VCV002733287	10	43572712	10	43077264	2733287	2890747		NC_000010.11:43077263:G:T	single nucleotide variant	synonymous variant	Likely benign	May 27, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.6G>A (p.Ala2=)	LOC106736614|RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000767548	10	43572712	10	43077264	767548	701341	rs1243883489	NC_000010.11:43077263:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 30, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.7A>G (p.Lys3Glu)	LOC106736614|RET	K3E	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000584566	10	43572713	10	43077265	584566	575550	rs1564480827	NC_000010.11:43077264:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.8A>G (p.Lys3Arg)	LOC106736614|RET	K3R	not provided	VCV003600946	10	43572714	10	43077266	3600946	3733560		NC_000010.11:43077265:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 23, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.10G>A (p.Ala4Thr)	LOC106736614|RET	A4T	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001023866	10	43572716	10	43077268	1023866	1008979	rs1837063785	NC_000010.11:43077267:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.11C>T (p.Ala4Val)	LOC106736614|RET	A4V	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000860225	10	43572717	10	43077269	860225	836802	rs1837063876	NC_000010.11:43077268:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.13A>G (p.Thr5Ala)	LOC106736614|RET	T5A	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001771753	10	43572719	10	43077271	1771753	1829565		NC_000010.11:43077270:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 23, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.14C>T (p.Thr5Met)	LOC106736614|RET	T5M	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001486379	10	43572720	10	43077272	1486379	1491480	rs1444096302	NC_000010.11:43077271:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.14C>G (p.Thr5Arg)	LOC106736614|RET	T5R	Multiple endocrine neoplasia, type 2	VCV000840153	10	43572720	10	43077272	840153	836803	rs1444096302	NC_000010.11:43077271:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 29, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.15G>A (p.Thr5=)	LOC106736614|RET		Multiple endocrine neoplasia, type 2	VCV001962949	10	43572721	10	43077273	1962949	2020500		NC_000010.11:43077272:G:A	single nucleotide variant	synonymous variant	Likely benign	May 27, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.15G>T (p.Thr5=)	LOC106736614|RET		Hereditary cancer-predisposing syndrome	VCV001776161	10	43572721	10	43077273	1776161	1837391		NC_000010.11:43077272:G:T	single nucleotide variant	synonymous variant	Likely benign	Oct 6, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.15G>C (p.Thr5=)	LOC106736614|RET		not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000819613	10	43572721	10	43077273	819613	809871	rs1226499208	NC_000010.11:43077272:G:C	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 31, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.16T>C (p.Ser6Pro)	LOC106736614|RET	S6P	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001011760	10	43572722	10	43077274	1011760	993797	rs1588848475	NC_000010.11:43077273:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.16T>G (p.Ser6Ala)	LOC106736614|RET	S6A	Multiple endocrine neoplasia, type 2	VCV000655125	10	43572722	10	43077274	655125	638860	rs1588848475	NC_000010.11:43077273:T:G	single nucleotide variant	missense variant	Uncertain significance	Jul 11, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.18C>G (p.Ser6=)	LOC106736614|RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001782267	10	43572724	10	43077276	1782267	1842651		NC_000010.11:43077275:C:G	single nucleotide variant	synonymous variant	Likely benign	Oct 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.18C>A (p.Ser6=)	LOC106736614|RET		Hereditary cancer-predisposing syndrome	VCV001782262	10	43572724	10	43077276	1782262	1842646		NC_000010.11:43077275:C:A	single nucleotide variant	synonymous variant	Likely benign	Dec 26, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.18C>T (p.Ser6=)	LOC106736614|RET		Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	VCV000477331	10	43572724	10	43077276	477331	459973	rs1185431356	NC_000010.11:43077275:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Dec 15, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.19G>C (p.Gly7Arg)	LOC106736614|RET	G7R	Multiple endocrine neoplasia, type 2	VCV002717904	10	43572725	10	43077277	2717904	2869839		NC_000010.11:43077276:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 16, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.19G>A (p.Gly7Ser)	LOC106736614|RET	G7S	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001001221	10	43572725	10	43077277	1001221	993798	rs1257661718	NC_000010.11:43077276:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.20G>T (p.Gly7Val)	LOC106736614|RET	G7V	Multiple endocrine neoplasia, type 2	VCV001406841	10	43572726	10	43077278	1406841	1486899	rs1366681125	NC_000010.11:43077277:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 20, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.20G>A (p.Gly7Asp)	LOC106736614|RET	G7D	Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2	VCV000486313	10	43572726	10	43077278	486313	475258	rs1366681125	NC_000010.11:43077277:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.21T>C (p.Gly7=)	LOC106736614|RET		Hereditary cancer-predisposing syndrome	VCV002568372	10	43572727	10	43077279	2568372	2734908		NC_000010.11:43077278:T:C	single nucleotide variant	synonymous variant	Likely benign	May 23, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.22G>A (p.Ala8Thr)	LOC106736614|RET	A8T	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV003313699	10	43572728	10	43077280	3313699	3465429		NC_000010.11:43077279:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.22G>T (p.Ala8Ser)	LOC106736614|RET	A8S	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000842268	10	43572728	10	43077280	842268	836804	rs1476325851	NC_000010.11:43077279:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 26, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.23C>T (p.Ala8Val)	LOC106736614|RET	A8V	Hereditary cancer-predisposing syndrome	VCV001790712	10	43572729	10	43077281	1790712	1841613		NC_000010.11:43077280:C:T	single nucleotide variant	missense variant	Uncertain significance	May 13, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.24C>T (p.Ala8=)	LOC106736614|RET		Hereditary cancer-predisposing syndrome	VCV001792215	10	43572730	10	43077282	1792215	1841803		NC_000010.11:43077281:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 22, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.25G>T (p.Ala9Ser)	LOC106736614|RET	A9S	Multiple endocrine neoplasia, type 2	VCV003070336	10	43572731	10	43077283	3070336	3231824		NC_000010.11:43077282:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.27G>C (p.Ala9=)	LOC106736614|RET		Hereditary cancer-predisposing syndrome	VCV001796199	10	43572733	10	43077285	1796199	1852634		NC_000010.11:43077284:G:C	single nucleotide variant	synonymous variant	Likely benign	Oct 5, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.27G>A (p.Ala9=)	LOC106736614|RET		Hereditary cancer-predisposing syndrome	VCV001796194	10	43572733	10	43077285	1796194	1852629		NC_000010.11:43077284:G:A	single nucleotide variant	synonymous variant	Likely benign	May 3, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.28G>A (p.Gly10Arg)	LOC106736614|RET	G10R	Multiple endocrine neoplasia, type 2	VCV002713355	10	43572734	10	43077286	2713355	2875653		NC_000010.11:43077285:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 27, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.29G>C (p.Gly10Ala)	LOC106736614|RET	G10A	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001426573	10	43572735	10	43077287	1426573	1366246	rs1303812507	NC_000010.11:43077286:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.35_55dup (p.Leu18_Leu19insArgLeuLeuLeuLeuLeuLeu)	LOC106736614|RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001061842	10	43572735 - 43572736	10	43077287 - 43077288	1061842	1046520	rs1467944441	NC_000010.11:43077287:GCTGCGTCTGCTGTTGCTGCTGCTGC:GCTGCGTCTGCTGTTGCTGCTGCTGCGTCTGCTGTTGCTGCTGCTGC	Duplication	inframe_indel|inframe_insertion	Uncertain significance	Oct 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.35_52dup (p.Leu17_Leu18insArgLeuLeuLeuLeuLeu)	LOC106736614|RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001053894	10	43572735 - 43572736	10	43077287 - 43077288	1053894	1046519	rs1837065209	NC_000010.11:43077287:GCTGCGTCTGCTGTTGCTGCTGC:GCTGCGTCTGCTGTTGCTGCTGCGTCTGCTGTTGCTGCTGC	Duplication	inframe_indel|inframe_insertion	Uncertain significance	Oct 27, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.29G>A (p.Gly10Glu)	LOC106736614|RET	G10E	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001035794	10	43572735	10	43077287	1035794	1029524	rs1303812507	NC_000010.11:43077286:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.29G>T (p.Gly10Val)	LOC106736614|RET	G10V	Multiple endocrine neoplasia, type 2	VCV000936337	10	43572735	10	43077287	936337	935016	rs1303812507	NC_000010.11:43077286:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 20, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.30G>T (p.Gly10=)	LOC106736614|RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000662154	10	43572736	10	43077288	662154	638861	rs1050242868	NC_000010.11:43077287:G:T	single nucleotide variant	synonymous variant	Likely benign	Oct 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.30G>A (p.Gly10=)	LOC106736614|RET		Multiple endocrine neoplasia, type 2|not provided|Hereditary cancer-predisposing syndrome	VCV000477365	10	43572736	10	43077288	477365	460235	rs1050242868	NC_000010.11:43077287:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 2, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.31C>A (p.Leu11Met)	LOC106736614|RET	L11M	not specified|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome	VCV000486316	10	43572737	10	43077289	486316	475250	rs587780812	NC_000010.11:43077288:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 14, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.31C>T (p.Leu11=)	LOC106736614|RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2	VCV000477368	10	43572737	10	43077289	477368	459768	rs587780812	NC_000010.11:43077288:C:T	single nucleotide variant	synonymous variant	Likely benign	May 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.31C>G (p.Leu11Val)	LOC106736614|RET	L11V	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000136117	10	43572737	10	43077289	136117	139829	rs587780812	NC_000010.11:43077288:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.34C>T (p.Arg12Cys)	RET	R12C	Multiple endocrine neoplasia, type 2	VCV002785488	10	43572740	10	43077292	2785488	2945335		NC_000010.11:43077291:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 30, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.34C>G (p.Arg12Gly)	RET	R12G	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001352051	10	43572740	10	43077292	1352051	1482587	rs2132498232	NC_000010.11:43077291:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.35G>A (p.Arg12His)	RET	R12H	Multiple endocrine neoplasia, type 2	VCV001510726	10	43572741	10	43077293	1510726	1465403	rs2132498277	NC_000010.11:43077292:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 6, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.43_51dup (p.Leu19_Pro20insLeuLeuLeu)	RET		not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000824772	10	43572742 - 43572743	10	43077294 - 43077295	824772	809872	rs1488217326	NC_000010.11:43077294:CTGCTGTTGCTGCTG:CTGCTGTTGCTGCTGTTGCTGCTG	Duplication	inframe_indel|inframe_insertion	Conflicting classifications of pathogenicity	Jan 13, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.43_48dup (p.Leu19_Pro20insLeuLeu)	RET		Multiple endocrine neoplasia, type 2	VCV003022887	10	43572743 - 43572744	10	43077295 - 43077296	3022887	3172791		NC_000010.11:43077295:TGCTGTTGCTG:TGCTGTTGCTGTTGCTG	Duplication	inframe_indel|inframe_insertion	Uncertain significance	Dec 9, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.40_41insGGTTGC (p.Leu13_Leu14insArgLeu)	RET		Multiple endocrine neoplasia, type 2	VCV000943957	10	43572743 - 43572744	10	43077295 - 43077296	943957	925792	rs1157129061	NC_000010.11:43077295:TGC:TGCGGTTGC	Insertion	inframe_indel|inframe_insertion	Uncertain significance	Aug 28, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.43_51del (p.Leu17_Leu19del)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000580433	10	43572743 - 43572751	10	43077295 - 43077303	580433	566257	rs1488217326	NC_000010.11:43077294:CTGCTGTTGCTGCTG:CTGCTG	Deletion	inframe_indel|inframe_deletion	Conflicting classifications of pathogenicity	Nov 30, 2023	criteria provided, conflicting classifications							
NM_020975.6(RET):c.39G>C (p.Leu13=)	RET		Multiple endocrine neoplasia, type 2	VCV001932474	10	43572745	10	43077297	1932474	1988773		NC_000010.11:43077296:G:C	single nucleotide variant	synonymous variant	Likely benign	Jun 13, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.39G>A (p.Leu13=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001736876	10	43572745	10	43077297	1736876	1793918		NC_000010.11:43077296:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.41_43delinsGGTTGCTGC (p.Leu13_Leu14insArgLeu)	RET		Hereditary cancer-predisposing syndrome	VCV001737851	10	43572747 - 43572749	10	43077299 - 43077301	1737851	1787714		NC_000010.11:43077298:TGT:GGTTGCTGC	Indel	inframe_indel|inframe_insertion	Uncertain significance	Oct 29, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.41T>C (p.Leu14Pro)	RET	L14P	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001472013	10	43572747	10	43077299	1472013	1385161	rs2132498406	NC_000010.11:43077298:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.42G>C (p.Leu14=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV003432239	10	43572748	10	43077300	3432239	3593435		NC_000010.11:43077299:G:C	single nucleotide variant	synonymous variant	Likely benign	Nov 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.43_44insGGC (p.Leu14_Leu15insTrp)	RET		Multiple endocrine neoplasia, type 2	VCV001388329	10	43572749 - 43572750	10	43077301 - 43077302	1388329	1371070	rs2132498515	NC_000010.11:43077301::GGC	Insertion	inframe_indel|inframe_insertion	Uncertain significance	May 7, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.44TGC[7] (p.Leu19_Pro20insLeuLeu)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001367349	10	43572749 - 43572750	10	43077301 - 43077302	1367349	1405069	rs768132465	NC_000010.11:43077301:TGCTGCTGCTGCTGC:TGCTGCTGCTGCTGCTGCTGC	Microsatellite	inframe_indel|inframe_insertion	Conflicting classifications of pathogenicity	Jan 30, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.43T>C (p.Leu15=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001112203	10	43572749	10	43077301	1112203	1098666	rs1418746925	NC_000010.11:43077300:T:C	single nucleotide variant	synonymous variant	Likely benign	May 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.44TGC[6] (p.Leu19_Pro20insLeu)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000648453	10	43572749 - 43572750	10	43077301 - 43077302	648453	638862	rs768132465	NC_000010.11:43077301:TGCTGCTGCTGCTGC:TGCTGCTGCTGCTGCTGC	Microsatellite	inframe_indel|inframe_insertion	Conflicting classifications of pathogenicity	Jan 29, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.44TGC[8] (p.Leu19_Pro20insLeuLeuLeu)	RET		Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not specified	VCV000216728	10	43572749 - 43572750	10	43077301 - 43077302	216728	212764	rs768132465	NC_000010.11:43077301:TGCTGCTGCTGCTGC:TGCTGCTGCTGCTGCTGCTGCTGC	Microsatellite	inframe_indel|inframe_insertion	Conflicting classifications of pathogenicity	Jan 6, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.44TGC[2] (p.Leu17_Leu19del)	RET		Hereditary cancer-predisposing syndrome	VCV002454134	10	43572750 - 43572758	10	43077302 - 43077310	2454134	2424023		NC_000010.11:43077301:TGCTGCTGCTGCTGC:TGCTGC	Microsatellite	inframe_indel|inframe_deletion	Likely benign	Dec 23, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.45dup (p.Leu16fs)	RET	L16fs	Hereditary cancer-predisposing syndrome	VCV001741794	10	43572750 - 43572751	10	43077302 - 43077303	1741794	1801438		NC_000010.11:43077302:G:GG	Duplication	frameshift variant	Pathogenic	Aug 31, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.44T>C (p.Leu15Ser)	RET	L15S	Multiple endocrine neoplasia, type 2	VCV001427613	10	43572750	10	43077302	1427613	1441147	rs2132498541	NC_000010.11:43077301:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 30, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.44TGC[3] (p.Leu18_Leu19del)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000835920	10	43572750 - 43572755	10	43077302 - 43077307	835920	836805	rs768132465	NC_000010.11:43077301:TGCTGCTGCTGCTGC:TGCTGCTGC	Microsatellite	inframe_indel|inframe_deletion	Conflicting classifications of pathogenicity	Dec 29, 2023	criteria provided, conflicting classifications							
NM_020975.6(RET):c.44TGC[4] (p.Leu19del)	RET	L19del	Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000543749	10	43572762 - 43572764	10	43077302 - 43077304	543749	525390	rs768132465	NC_000010.11:43077301:TGCTGCTGCTGCTGC:TGCTGCTGCTGC	Microsatellite	inframe_indel|inframe_deletion	Conflicting classifications of pathogenicity	Nov 9, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.45G>A (p.Leu15=)	RET		not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000233052	10	43572751	10	43077303	233052	233774	rs876660157	NC_000010.11:43077302:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.46C>G (p.Leu16Val)	RET	L16V	Hereditary cancer-predisposing syndrome	VCV003227559	10	43572752	10	43077304	3227559	3390770		NC_000010.11:43077303:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.46C>T (p.Leu16=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000477376	10	43572752	10	43077304	477376	460237	rs1309896929	NC_000010.11:43077303:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.47T>C (p.Leu16Pro)	RET	L16P	Hereditary cancer-predisposing syndrome	VCV003432281	10	43572753	10	43077305	3432281	3593477		NC_000010.11:43077304:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 19, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.47T>A (p.Leu16Gln)	RET	L16Q	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1	VCV000572655	10	43572753	10	43077305	572655	569614	rs1564480893	NC_000010.11:43077304:T:A	single nucleotide variant	missense variant	Uncertain significance	Apr 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.48G>A (p.Leu16=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001743969	10	43572754	10	43077306	1743969	1798866		NC_000010.11:43077305:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.49C>A (p.Leu17Met)	RET	L17M	Hereditary cancer-predisposing syndrome	VCV001744661	10	43572755	10	43077307	1744661	1809441		NC_000010.11:43077306:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 11, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.49C>T (p.Leu17=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not provided	VCV000762646	10	43572755	10	43077307	762646	767715	rs1328756940	NC_000010.11:43077306:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.50T>C (p.Leu17Pro)	RET	L17P	Multiple endocrine neoplasia, type 2|Breast carcinoma|Family history of cancer	VCV001039584	10	43572756	10	43077308	1039584	1029525	rs1837066964	NC_000010.11:43077307:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 24, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.57_65dup (p.Leu22_Gly23insProLeuLeu)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000241364	10	43572756 - 43572757	10	43077308 - 43077309	241364	240782	rs878855065	NC_000010.11:43077308:GCTGCTGCCGCTGCT:GCTGCTGCCGCTGCTGCCGCTGCT	Duplication	inframe_indel|inframe_insertion	Uncertain significance	Sep 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.51G>C (p.Leu17=)	RET		Hereditary cancer-predisposing syndrome	VCV003227561	10	43572757	10	43077309	3227561	3390772		NC_000010.11:43077308:G:C	single nucleotide variant	synonymous variant	Likely benign	Jan 20, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.51G>A (p.Leu17=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000760678	10	43572757	10	43077309	760678	767716	rs1270163145	NC_000010.11:43077308:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 24, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.52C>T (p.Leu18=)	RET		Multiple endocrine neoplasia, type 2	VCV001090285	10	43572758	10	43077310	1090285	1077025	rs2132498926	NC_000010.11:43077309:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 17, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.53T>C (p.Leu18Pro)	RET	L18P	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001480994	10	43572759	10	43077311	1480994	1429205	rs2132498957	NC_000010.11:43077310:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.54G>A (p.Leu18=)	RET		Hereditary cancer-predisposing syndrome	VCV001747958	10	43572760	10	43077312	1747958	1810147		NC_000010.11:43077311:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 7, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.55C>A (p.Leu19Met)	RET	L19M	Hereditary cancer-predisposing syndrome	VCV001748549	10	43572761	10	43077313	1748549	1806797		NC_000010.11:43077312:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 7, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.56T>C (p.Leu19Pro)	RET	L19P	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002107657	10	43572762	10	43077314	2107657	2166821		NC_000010.11:43077313:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.59_61dup (p.Pro20_Leu21insPro)	RET		not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000423618	10	43572762 - 43572763	10	43077314 - 43077315	423618	407855	rs1064796534	NC_000010.11:43077314:GCCGC:GCCGCCGC	Duplication	inframe_indel|inframe_insertion	Uncertain significance	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.57G>T (p.Leu19=)	RET		RET-related disorder	VCV003344343	10	43572763	10	43077315	3344343	3505329		NC_000010.11:43077314:G:T	single nucleotide variant	synonymous variant	Likely benign	Jul 29, 2024	no assertion criteria provided							
NM_020975.6(RET):c.57G>C (p.Leu19=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000755049	10	43572763	10	43077315	755049	767717	rs1316429203	NC_000010.11:43077314:G:C	single nucleotide variant	synonymous variant	Likely benign	Oct 13, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.58C>T (p.Pro20Ser)	RET	P20S	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000543729	10	43572764	10	43077316	543729	525395	rs1205904653	NC_000010.11:43077315:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.59C>T (p.Pro20Leu)	RET	P20L	Multiple endocrine neoplasia, type 2	VCV001448380	10	43572765	10	43077317	1448380	1400390	rs1837067697	NC_000010.11:43077316:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 26, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.59C>G (p.Pro20Arg)	RET	P20R	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000965788	10	43572765	10	43077317	965788	956040	rs1837067697	NC_000010.11:43077316:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.59C>A (p.Pro20Gln)	RET	P20Q	Multiple endocrine neoplasia, type 2|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B|Hereditary cancer-predisposing syndrome|not provided	VCV000952569	10	43572765	10	43077317	952569	925793	rs1837067697	NC_000010.11:43077316:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.60G>T (p.Pro20=)	RET		Hereditary cancer-predisposing syndrome	VCV003313745	10	43572766	10	43077318	3313745	3465475		NC_000010.11:43077317:G:T	single nucleotide variant	synonymous variant	Likely benign	Jun 12, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.60G>A (p.Pro20=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001608560	10	43572766	10	43077318	1608560	1659978	rs1263991822	NC_000010.11:43077317:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.60G>C (p.Pro20=)	RET		Multiple endocrine neoplasia, type 2	VCV001548581	10	43572766	10	43077318	1548581	1657948	rs1263991822	NC_000010.11:43077317:G:C	single nucleotide variant	synonymous variant	Likely benign	Apr 8, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.60_65del (p.Leu21_Leu22del)	RET		Multiple endocrine neoplasia, type 2	VCV000946053	10	43572766 - 43572771	10	43077318 - 43077323	946053	925794	rs1837067951	NC_000010.11:43077317:GCTGCT:	Deletion	inframe_indel|inframe_deletion	Uncertain significance	Jul 3, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.61C>T (p.Leu21=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001085791	10	43572767	10	43077319	1085791	1077026	rs2132499288	NC_000010.11:43077318:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.63_64delinsCT (p.Leu21_Leu22=)	RET		Multiple endocrine neoplasia, type 2	VCV002084198	10	43572769 - 43572770	10	43077321 - 43077322	2084198	2133087		NC_000010.11:43077320:GC:CT	Indel	synonymous variant	Likely benign	Jan 16, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.63G>A (p.Leu21=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001134102	10	43572769	10	43077321	1134102	1120252	rs944333660	NC_000010.11:43077320:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.67G>A (p.Gly23Ser)	RET	G23S	Multiple endocrine neoplasia, type 2	VCV003075550	10	43572773	10	43077325	3075550	3233115		NC_000010.11:43077324:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 24, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.67G>C (p.Gly23Arg)	RET	G23R	Hereditary cancer-predisposing syndrome	VCV001755516	10	43572773	10	43077325	1755516	1818806		NC_000010.11:43077324:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.68G>T (p.Gly23Val)	RET	G23V	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000950776	10	43572774	10	43077326	950776	925795	rs1554815546	NC_000010.11:43077325:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 17, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.68G>A (p.Gly23Asp)	RET	G23D	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000486342	10	43572774	10	43077326	486342	475261	rs1554815546	NC_000010.11:43077325:G:A	single nucleotide variant	missense variant	Uncertain significance	May 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.69C>T (p.Gly23=)	RET		Multiple endocrine neoplasia, type 2	VCV001386322	10	43572775	10	43077327	1386322	1361330	rs2132499469	NC_000010.11:43077326:C:T	single nucleotide variant	synonymous variant	Uncertain significance	Nov 3, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.69C>G (p.Gly23=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001140737	10	43572775	10	43077327	1140737	1120253	rs2132499469	NC_000010.11:43077326:C:G	single nucleotide variant	synonymous variant	Likely benign	Jan 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.70A>G (p.Lys24Glu)	RET	K24E	Hereditary cancer-predisposing syndrome	VCV001757154	10	43572776	10	43077328	1757154	1819159		NC_000010.11:43077327:A:G	single nucleotide variant	missense variant	Likely benign	Sep 1, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.72A>G (p.Lys24=)	RET		Hereditary cancer-predisposing syndrome	VCV001758176	10	43572778	10	43077330	1758176	1822693		NC_000010.11:43077329:A:G	single nucleotide variant	synonymous variant	Likely benign	Dec 3, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.73+3G>A	RET		Multiple endocrine neoplasia, type 2	VCV002809347	10	43572782	10	43077334	2809347	2975143		NC_000010.11:43077333:G:A	single nucleotide variant	intron variant	Uncertain significance	Mar 17, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.73+9dup	RET		Multiple endocrine neoplasia, type 2	VCV002918367	10	43572787 - 43572788	10	43077339 - 43077340	2918367	3080487		NC_000010.11:43077339:T:TT	Duplication	intron variant	Likely benign	Aug 16, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.73+8C>T	RET		Multiple endocrine neoplasia, type 2	VCV001656664	10	43572787	10	43077339	1656664	1562049	rs1193805611	NC_000010.11:43077338:C:T	single nucleotide variant	intron variant	Likely benign	Jan 22, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.73+8C>G	RET		Multiple endocrine neoplasia, type 2	VCV001108933	10	43572787	10	43077339	1108933	1098667	rs1193805611	NC_000010.11:43077338:C:G	single nucleotide variant	intron variant	Likely benign	May 6, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.73+9del	RET		Multiple endocrine neoplasia, type 2	VCV000792378	10	43572788	10	43077340	792378	787663	rs1588848600	NC_000010.11:43077339:T:	Deletion	intron variant	Likely benign	Oct 30, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.73+9T>G	RET		Multiple endocrine neoplasia, type 2	VCV000543783	10	43572788	10	43077340	543783	525284	rs1041204849	NC_000010.11:43077339:T:G	single nucleotide variant	intron variant	Likely benign	Oct 15, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.73+10G>A	RET		Multiple endocrine neoplasia, type 2	VCV001141262	10	43572789	10	43077341	1141262	1141110	rs1052703455	NC_000010.11:43077340:G:A	single nucleotide variant	intron variant	Likely benign	Nov 22, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.73+10G>C	RET		Multiple endocrine neoplasia, type 2	VCV000413478	10	43572789	10	43077341	413478	397673	rs1052703455	NC_000010.11:43077340:G:C	single nucleotide variant	intron variant	Likely benign	Oct 9, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.73+11C>T	RET		Multiple endocrine neoplasia, type 2	VCV002086153	10	43572790	10	43077342	2086153	2133742		NC_000010.11:43077341:C:T	single nucleotide variant	intron variant	Likely benign	Sep 3, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.73+12C>A	RET		Multiple endocrine neoplasia, type 2	VCV001661705	10	43572791	10	43077343	1661705	1608066	rs2132499693	NC_000010.11:43077342:C:A	single nucleotide variant	intron variant	Likely benign	Jul 28, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.73+13G>A	RET		Multiple endocrine neoplasia, type 2	VCV002072250	10	43572792	10	43077344	2072250	2120190		NC_000010.11:43077343:G:A	single nucleotide variant	intron variant	Likely benign	Jun 9, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.73+13G>T	RET		Multiple endocrine neoplasia, type 2	VCV001947605	10	43572792	10	43077344	1947605	2006461		NC_000010.11:43077343:G:T	single nucleotide variant	intron variant	Likely benign	Feb 1, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.73+14G>A	RET		Multiple endocrine neoplasia, type 2	VCV001996446	10	43572793	10	43077345	1996446	2053521		NC_000010.11:43077344:G:A	single nucleotide variant	intron variant	Likely benign	Aug 4, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.73+15C>G	RET		Multiple endocrine neoplasia, type 2	VCV002817141	10	43572794	10	43077346	2817141	2980799		NC_000010.11:43077345:C:G	single nucleotide variant	intron variant	Likely benign	Nov 28, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.73+15C>T	RET		Multiple endocrine neoplasia, type 2	VCV002713646	10	43572794	10	43077346	2713646	2872070		NC_000010.11:43077345:C:T	single nucleotide variant	intron variant	Likely benign	Dec 14, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.73+16C>T	RET		Multiple endocrine neoplasia, type 2	VCV002916695	10	43572795	10	43077347	2916695	3080123		NC_000010.11:43077346:C:T	single nucleotide variant	intron variant	Likely benign	Mar 24, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.73+16C>A	RET		Multiple endocrine neoplasia, type 2	VCV002904935	10	43572795	10	43077347	2904935	3069129		NC_000010.11:43077346:C:A	single nucleotide variant	intron variant	Likely benign	Jun 5, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.73+17G>T	RET		Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2	VCV001592544	10	43572796	10	43077348	1592544	1556590	rs763327195	NC_000010.11:43077347:G:T	single nucleotide variant	intron variant	Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.73+18C>T	RET		Multiple endocrine neoplasia, type 2	VCV002073740	10	43572797	10	43077349	2073740	2120390		NC_000010.11:43077348:C:T	single nucleotide variant	intron variant	Likely benign	Jan 6, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.73+19C>G	RET		Multiple endocrine neoplasia, type 2	VCV002723664	10	43572798	10	43077350	2723664	2881577		NC_000010.11:43077349:C:G	single nucleotide variant	intron variant	Likely benign	Apr 16, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.73+53G>A	RET		not provided|Multiple endocrine neoplasia type 2A	VCV001229273	10	43572832	10	43077384	1229273	1221821	rs12267460	NC_000010.11:43077383:G:A	single nucleotide variant	intron variant	Benign	Aug 6, 2019	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.73+104C>T	RET		not provided	VCV000676894	10	43572883	10	43077435	676894	664773	rs111514357	NC_000010.11:43077434:C:T	single nucleotide variant	intron variant	Likely benign	Jun 16, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.73+171_73+172del	RET		not provided	VCV001293631	10	43572950 - 43572951	10	43077502 - 43077503	1293631	1283433	rs1425791427	NC_000010.11:43077501:AA:	Deletion	intron variant	Benign	Mar 3, 2015	criteria provided, single submitter							
NM_020975.6(RET):c.73+173_73+174insCGGGCGGCG	RET		not provided	VCV001286547	10	43572951 - 43572952	10	43077503 - 43077504	1286547	1276384	rs1483784179	NC_000010.11:43077503:G:GCGGGCGGCG	Microsatellite	intron variant	Benign	Jun 24, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.73+172A>C	RET		not provided	VCV001242123	10	43572951	10	43077503	1242123	1231667	rs12246856	NC_000010.11:43077502:A:C	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.73+188G>A	RET		not provided	VCV001216709	10	43572967	10	43077519	1216709	1206689	rs866591037	NC_000010.11:43077518:G:A	single nucleotide variant	intron variant	Likely benign	Dec 26, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.73+9189C>A	LOC110121502|MCS+9.7|RET		not provided	VCV001290350	10	43581968	10	43086520	1290350	1280178	rs73266197	NC_000010.11:43086519:C:A	single nucleotide variant	intron variant	Benign	Jun 15, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.73+9189C>T	LOC110121502|MCS+9.7|RET		not provided	VCV001254248	10	43581968	10	43086520	1254248	1244184	rs73266197	NC_000010.11:43086519:C:T	single nucleotide variant	intron variant	Likely benign	Jul 26, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.73+9201C>T	LOC110121502|MCS+9.7|RET		not specified	VCV000378478	10	43581980	10	43086532	378478	371670	rs2506005	NC_000010.11:43086531:C:T	single nucleotide variant	intron variant	Benign	May 5, 2016	criteria provided, single submitter							
NM_020975.6(RET):c.73+9277T>C	LOC110121502|MCS+9.7|RET		not provided|not specified|Aganglionic megacolon|Multiple endocrine neoplasia, type 2	VCV000013952	10	43582056	10	43086608	13952	28991	rs2435357	NC_000010.11:43086607:T:C	single nucleotide variant	intron variant	Benign; risk factor	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.73+9278G>A	MCS+9.7|LOC110121502|RET		Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A	VCV000372083	10	43582057	10	43086609	372083	358819	rs537638504	NC_000010.11:43086608:G:A	single nucleotide variant	intron variant	Likely benign	May 19, 2016	criteria provided, single submitter							
NM_020975.6(RET):c.73+9331A>G	LOC110121502|MCS+9.7|RET		not provided	VCV001229701	10	43582110	10	43086662	1229701	1220955	rs73266201	NC_000010.11:43086661:A:G	single nucleotide variant	intron variant	Benign	Jun 15, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.73+9385_73+9395del	LOC110121502|MCS+9.7|RET		not provided|Multiple endocrine neoplasia, type 2	VCV001189903	10	43582163 - 43582173	10	43086715 - 43086725	1189903	1180674	rs368137511	NC_000010.11:43086714:AAGCAACTGCCA:A	Deletion	intron variant	Benign/Likely benign	Jul 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.73+9390C>T	LOC110121502|MCS+9.7|RET		RET-related disorder	VCV003029773	10	43582169	10	43086721	3029773	3189639		NC_000010.11:43086720:C:T	single nucleotide variant	intron variant	Likely benign	Jan 10, 2023	no assertion criteria provided							
NM_020975.6(RET):c.73+9398G>A	LOC110121502|MCS+9.7|RET		RET-related disorder	VCV003053801	10	43582177	10	43086729	3053801	3221221		NC_000010.11:43086728:G:A	single nucleotide variant	intron variant	Likely benign	Dec 4, 2020	no assertion criteria provided							
NM_020975.6(RET):c.73+9405G>A	LOC110121502|MCS+9.7|RET		RET-related disorder	VCV003048275	10	43582184	10	43086736	3048275	3204656		NC_000010.11:43086735:G:A	single nucleotide variant	intron variant	Likely benign	Dec 23, 2019	no assertion criteria provided							
NM_020975.6(RET):c.73+9408A>G	LOC110121502|MCS+9.7|RET		RET-related disorder	VCV003036896	10	43582187	10	43086739	3036896	3202810		NC_000010.11:43086738:A:G	single nucleotide variant	intron variant	Likely benign	Nov 23, 2021	no assertion criteria provided							
NM_020975.6(RET):c.73+9494A>C	LOC110121502|MCS+9.7|RET		not provided|Multiple endocrine neoplasia, type 2	VCV000695195	10	43582273	10	43086825	695195	685271	rs2506004	NC_000010.11:43086824:A:C	single nucleotide variant	intron variant	Benign	Dec 18, 2021	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.74-158G>T	RET		not provided	VCV000677842	10	43595749	10	43100301	677842	664776	rs112834982	NC_000010.11:43100300:G:T	single nucleotide variant	intron variant	Likely benign	Jun 12, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.74-126G>T	RET		Multiple endocrine neoplasia, type 2|not provided	VCV000677050	10	43595781	10	43100333	677050	664781	rs2565206	NC_000010.11:43100332:G:T	single nucleotide variant	intron variant	Benign	Dec 18, 2021	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.74-57dup	RET		not provided	VCV001280354	10	43595836 - 43595837	10	43100388 - 43100389	1280354	1270218	rs57003029	NC_000010.11:43100388:TTTTTTTTTTTTTT:TTTTTTTTTTTTTTT	Duplication	intron variant	Benign	Aug 16, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.74-58_74-57dup	RET		not provided	VCV001181790	10	43595836 - 43595837	10	43100388 - 43100389	1181790	1172102	rs57003029	NC_000010.11:43100388:TTTTTTTTTTTTTT:TTTTTTTTTTTTTTTT	Duplication	intron variant	Likely benign	Aug 16, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.74-57del	RET		not provided	VCV001258537	10	43595837	10	43100389	1258537	1248031	rs57003029	NC_000010.11:43100388:TTTTTTTTTTTTTT:TTTTTTTTTTTTT	Deletion	intron variant	Benign	Aug 16, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.74-50G>T	RET		Multiple endocrine neoplasia type 2A	VCV000802567	10	43595857	10	43100409	802567	790958	rs766786245	NC_000010.11:43100408:G:T	single nucleotide variant	intron variant	Benign	May 28, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.74-20C>T	RET		Multiple endocrine neoplasia, type 2	VCV001998468	10	43595887	10	43100439	1998468	2050389		NC_000010.11:43100438:C:T	single nucleotide variant	intron variant	Likely benign	Dec 4, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.74-12_74-5del	RET		Multiple endocrine neoplasia, type 2	VCV001626009	10	43595888 - 43595895	10	43100440 - 43100447	1626009	1575224	rs2132655890	NC_000010.11:43100439:ACTTCCCTACTTCCC:ACTTCCC	Deletion	intron variant	Likely benign	Jul 6, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.74-18C>T	RET		Multiple endocrine neoplasia, type 2	VCV002785464	10	43595889	10	43100441	2785464	2945311		NC_000010.11:43100440:C:T	single nucleotide variant	intron variant	Likely benign	Oct 15, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.74-17T>G	RET		Multiple endocrine neoplasia, type 2	VCV002882220	10	43595890	10	43100442	2882220	3042823		NC_000010.11:43100441:T:G	single nucleotide variant	intron variant	Likely benign	Sep 29, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.74-15C>G	RET		Multiple endocrine neoplasia, type 2	VCV003714864	10	43595892	10	43100444	3714864	3838383		NC_000010.11:43100443:C:G	single nucleotide variant	intron variant	Likely benign	Sep 12, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.74-11_74-10dup	RET		Multiple endocrine neoplasia, type 2	VCV001653287	10	43595895 - 43595896	10	43100447 - 43100448	1653287	1547860	rs1453857349	NC_000010.11:43100447:AC:ACAC	Duplication	intron variant	Likely benign	Jan 5, 2025	criteria provided, single submitter							
NC_000010.11:g.(?_43100449)_(43102639_?)del	RET		Multiple endocrine neoplasia, type 2	VCV000653522	10	43595897 - 43598087	10	43100449 - 43102639	653522	651964			Deletion		Likely pathogenic	Sep 26, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.74-7C>T	RET		Multiple endocrine neoplasia, type 2	VCV000764947	10	43595900	10	43100452	764947	775664	rs778358165	NC_000010.11:43100451:C:T	single nucleotide variant	intron variant	Likely benign	Jul 12, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.74-5C>T	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000477386	10	43595902	10	43100454	477386	460666	rs1554817349	NC_000010.11:43100453:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 20, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.74-2A>T	RET		Multiple endocrine neoplasia, type 2	VCV001499429	10	43595905	10	43100457	1499429	1389132	rs2132656224	NC_000010.11:43100456:A:T	single nucleotide variant	splice acceptor variant|intron variant	Likely pathogenic	May 17, 2021	criteria provided, single submitter							
NC_000010.11:g.(?_43100459)_(43102629_?)del	RET		Multiple endocrine neoplasia, type 2	VCV000417359	10	43595907 - 43598077	10	43100459 - 43102629	417359	397516			Deletion		Uncertain significance	Nov 23, 2016	criteria provided, single submitter							
NM_020975.6(RET):c.76G>A (p.Ala26Thr)	RET	A26T	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001964452	10	43595909	10	43100461	1964452	2021139		NC_000010.11:43100460:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.76G>T (p.Ala26Ser)	RET	A26S	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000477387	10	43595909	10	43100461	477387	459772	rs1554817350	NC_000010.11:43100460:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.77C>T (p.Ala26Val)	RET	A26V	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|not provided	VCV003016033	10	43595910	10	43100462	3016033	3171157		NC_000010.11:43100461:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.78A>T (p.Ala26=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001593575	10	43595911	10	43100463	1593575	1589646	rs2132656403	NC_000010.11:43100462:A:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.79T>C (p.Leu27=)	RET		Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|not provided|Hereditary cancer-predisposing syndrome	VCV000413462	10	43595912	10	43100464	413462	397432	rs377160777	NC_000010.11:43100463:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.81G>A (p.Leu27=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|not provided	VCV000477388	10	43595914	10	43100466	477388	459774	rs369519655	NC_000010.11:43100465:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.82G>A (p.Gly28Ser)	RET	G28S	Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B|not provided|Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000651895	10	43595915	10	43100467	651895	638863	rs779905135	NC_000010.11:43100466:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 8, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.87C>G (p.Leu29=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000765499	10	43595920	10	43100472	765499	767718	rs1588862351	NC_000010.11:43100471:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.89A>G (p.Tyr30Cys)	RET	Y30C	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001378130	10	43595922	10	43100474	1378130	1469934	rs2132656815	NC_000010.11:43100473:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.90C>T (p.Tyr30=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000762105	10	43595923	10	43100475	762105	767719	rs1588862357	NC_000010.11:43100474:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.95C>G (p.Ser32Trp)	RET	S32W	RET-related disorder	VCV003345040	10	43595928	10	43100480	3345040	3503391		NC_000010.11:43100479:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 7, 2024	no assertion criteria provided							
NM_020975.6(RET):c.95C>T (p.Ser32Leu)	RET	S32L	Multiple endocrine neoplasia, type 2	VCV000013923	10	43595928	10	43100480	13923	28962	rs76764689	NC_000010.11:43100479:C:T	single nucleotide variant	missense variant	Likely pathogenic	Aug 20, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.96G>T (p.Ser32=)	RET		Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2	VCV001149781	10	43595929	10	43100481	1149781	1141111	rs139821724	NC_000010.11:43100480:G:T	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Jun 19, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.96G>A (p.Ser32=)	RET		Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000543774	10	43595929	10	43100481	543774	525287	rs139821724	NC_000010.11:43100480:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.99_100del (p.Asp34fs)	RET	D34fs	Colorectal cancer	VCV000998155	10	43595931 - 43595932	10	43100483 - 43100484	998155	985865	rs1837613320	NC_000010.11:43100482:GGG:G	Deletion	frameshift variant	Pathogenic		no assertion criteria provided							
NM_020975.6(RET):c.99G>A (p.Arg33=)	RET		Multiple endocrine neoplasia, type 2	VCV003612769	10	43595932	10	43100484	3612769	3748760		NC_000010.11:43100483:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 10, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.100G>A (p.Asp34Asn)	RET	D34N	Multiple endocrine neoplasia, type 2	VCV001363081	10	43595933	10	43100485	1363081	1396401	rs1837613489	NC_000010.11:43100484:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 30, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.100G>T (p.Asp34Tyr)	RET	D34Y	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000951605	10	43595933	10	43100485	951605	925796	rs1837613489	NC_000010.11:43100484:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 23, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.101A>G (p.Asp34Gly)	RET	D34G	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001392266	10	43595934	10	43100486	1392266	1409607	rs2132657310	NC_000010.11:43100485:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 24, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.102T>C (p.Asp34=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001583149	10	43595935	10	43100487	1583149	1535387	rs1837613563	NC_000010.11:43100486:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.103G>A (p.Ala35Thr)	RET	A35T	Multiple endocrine neoplasia, type 2	VCV000954184	10	43595936	10	43100488	954184	946872	rs984301854	NC_000010.11:43100487:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 21, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.104C>T (p.Ala35Val)	RET	A35V	Hereditary cancer-predisposing syndrome	VCV003227500	10	43595937	10	43100489	3227500	3390712		NC_000010.11:43100488:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 10, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.104C>G (p.Ala35Gly)	RET	A35G	Hereditary cancer-predisposing syndrome	VCV002561470	10	43595937	10	43100489	2561470	2728236		NC_000010.11:43100488:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 11, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.108C>T (p.Tyr36=)	RET		Multiple endocrine neoplasia, type 2|not specified|Hereditary cancer-predisposing syndrome	VCV002703074	10	43595941	10	43100493	2703074	2862770		NC_000010.11:43100492:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.109T>C (p.Trp37Arg)	RET	W37R	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000477304	10	43595942	10	43100494	477304	460239	rs777042445	NC_000010.11:43100493:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 15, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.111G>A (p.Trp37Ter)	RET	W37*	Aganglionic megacolon	VCV000599630	10	43595944	10	43100496	599630	590966	rs1564489315	NC_000010.11:43100495:G:A	single nucleotide variant	nonsense	Pathogenic	Jan 1, 2013	no assertion criteria provided							
NM_020975.6(RET):c.113A>T (p.Glu38Val)	RET	E38V	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000647519	10	43595946	10	43100498	647519	638864	rs1588862401	NC_000010.11:43100497:A:T	single nucleotide variant	missense variant	Uncertain significance	May 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.114G>A (p.Glu38=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001159316	10	43595947	10	43100499	1159316	1141112	rs762096025	NC_000010.11:43100498:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Feb 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.117G>A (p.Lys39=)	RET		Multiple endocrine neoplasia, type 2	VCV002089022	10	43595950	10	43100502	2089022	2148122		NC_000010.11:43100501:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 22, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.118C>T (p.Leu40=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000699886	10	43595951	10	43100503	699886	687627	rs373420806	NC_000010.11:43100502:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.122A>T (p.Tyr41Phe)	RET	Y41F	Hereditary cancer-predisposing syndrome	VCV001755119	10	43595955	10	43100507	1755119	1822208		NC_000010.11:43100506:A:T	single nucleotide variant	missense variant	Uncertain significance	Jul 21, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.123T>C (p.Tyr41=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000759529	10	43595956	10	43100508	759529	767720	rs1588862420	NC_000010.11:43100507:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.124G>A (p.Val42Met)	RET	V42M	Multiple endocrine neoplasia, type 2	VCV003690585	10	43595957	10	43100509	3690585	3831261		NC_000010.11:43100508:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 23, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.124G>T (p.Val42Leu)	RET	V42L	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001379127	10	43595957	10	43100509	1379127	1486356	rs2132658120	NC_000010.11:43100508:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 18, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.125T>C (p.Val42Ala)	RET	V42A	Multiple endocrine neoplasia, type 2	VCV001502569	10	43595958	10	43100510	1502569	1504338	rs773375434	NC_000010.11:43100509:T:C	single nucleotide variant	missense variant	Uncertain significance	May 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.129C>G (p.Asp43Glu)	RET	D43E	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001951525	10	43595962	10	43100514	1951525	2014253		NC_000010.11:43100513:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.129C>A (p.Asp43Glu)	RET	D43E	Hereditary cancer-predisposing syndrome|Pheochromocytoma|Multiple endocrine neoplasia type 2B|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2	VCV000818716	10	43595962	10	43100514	818716	809873	rs1488040686	NC_000010.11:43100513:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.132G>C (p.Gln44His)	RET	Q44H	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001524310	10	43595965	10	43100517	1524310	1382872	rs2132658453	NC_000010.11:43100516:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.133G>A (p.Ala45Thr)	RET	A45T	Multiple endocrine neoplasia, type 2	VCV001441566	10	43595966	10	43100518	1441566	1381643	rs2132658488	NC_000010.11:43100517:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 29, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.134C>A (p.Ala45Glu)	RET	A45E	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000486324	10	43595967	10	43100519	486324	475056	rs763526874	NC_000010.11:43100518:C:A	single nucleotide variant	missense variant	Uncertain significance	May 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.134C>T (p.Ala45Val)	RET	A45V	not provided|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|not specified|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000405538	10	43595967	10	43100519	405538	397244	rs763526874	NC_000010.11:43100518:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.135_136delinsGT (p.Ala46Ser)	RET	A46S	Multiple endocrine neoplasia, type 2	VCV001975405	10	43595968 - 43595969	10	43100520 - 43100521	1975405	2026812		NC_000010.11:43100519:AG:GT	Indel	missense variant	Uncertain significance	May 30, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.135A>T (p.Ala45=)	RET		Multiple endocrine neoplasia, type 2	VCV001154058	10	43595968	10	43100520	1154058	1141113	rs1800858	NC_000010.11:43100519:A:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 19, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.135A>G (p.Ala45=)	RET		not specified|Pheochromocytoma|Multiple endocrine neoplasia type 2B|not provided|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1	VCV000167589	10	43595968	10	43100520	167589	174942	rs1800858	NC_000010.11:43100519:A:G	single nucleotide variant	synonymous variant|intron variant	Benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.135= (p.Ala45=)	RET		not provided|not specified|Multiple endocrine neoplasia, type 2	VCV000013940	10	43595968	10	43100520	13940	28979	rs1800858	NC_000010.11:43100519:A:A	single nucleotide variant	synonymous variant|no sequence alteration|intron variant	Benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.136G>T (p.Ala46Ser)	RET	A46S	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000819010	10	43595969	10	43100521	819010	809874	rs1419255561	NC_000010.11:43100520:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.137C>T (p.Ala46Val)	RET	A46V	Multiple endocrine neoplasia, type 2	VCV001018976	10	43595970	10	43100522	1018976	1008981	rs1837615394	NC_000010.11:43100521:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 1, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.138C>T (p.Ala46=)	RET		Multiple endocrine neoplasia, type 2|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Hereditary cancer-predisposing syndrome	VCV000737891	10	43595971	10	43100523	737891	752094	rs1177522214	NC_000010.11:43100522:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 9, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.139G>C (p.Gly47Arg)	RET	G47R	Hereditary cancer-predisposing syndrome	VCV001771741	10	43595972	10	43100524	1771741	1832937		NC_000010.11:43100523:G:C	single nucleotide variant	missense variant	Uncertain significance	May 21, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.139G>A (p.Gly47Ser)	RET	G47S	Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|not specified|Multiple endocrine neoplasia, type 2	VCV000241335	10	43595972	10	43100524	241335	240783	rs529018971	NC_000010.11:43100523:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 27, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.143C>T (p.Thr48Met)	RET	T48M	not provided|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000819219	10	43595976	10	43100528	819219	809875	rs1427186016	NC_000010.11:43100527:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 4, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.144G>T (p.Thr48=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001606749	10	43595977	10	43100529	1606749	1658612	rs759872307	NC_000010.11:43100528:G:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.144G>A (p.Thr48=)	RET		not provided|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000215905	10	43595977	10	43100529	215905	212765	rs759872307	NC_000010.11:43100528:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.147C>T (p.Pro49=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001109524	10	43595980	10	43100532	1109524	1098668	rs1219548567	NC_000010.11:43100531:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.147C>G (p.Pro49=)	RET		Multiple endocrine neoplasia, type 2	VCV000543764	10	43595980	10	43100532	543764	525586	rs1219548567	NC_000010.11:43100531:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 4, 2017	criteria provided, single submitter							
NM_020975.6(RET):c.153G>C (p.Leu51=)	RET		Multiple endocrine neoplasia, type 2	VCV002151444	10	43595986	10	43100538	2151444	1885010		NC_000010.11:43100537:G:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 12, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.153G>A (p.Leu51=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001149729	10	43595986	10	43100538	1149729	1141114	rs1837615966	NC_000010.11:43100537:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.154T>C (p.Tyr52His)	RET	Y52H	Hereditary cancer-predisposing syndrome	VCV001775033	10	43595987	10	43100539	1775033	1833618		NC_000010.11:43100538:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 11, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.155A>C (p.Tyr52Ser)	RET	Y52S	Hereditary cancer-predisposing syndrome	VCV003227510	10	43595988	10	43100540	3227510	3390722		NC_000010.11:43100539:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 11, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.156C>T (p.Tyr52=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000477320	10	43595989	10	43100541	477320	459777	rs866099980	NC_000010.11:43100540:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.157G>A (p.Val53Ile)	RET	V53I	Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2	VCV000405545	10	43595990	10	43100542	405545	397674	rs547308774	NC_000010.11:43100541:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.158T>C (p.Val53Ala)	RET	V53A	Hirschsprung disease, susceptibility to, 1	VCV001709068	10	43595991	10	43100543	1709068	1707422		NC_000010.11:43100542:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.159C>G (p.Val53=)	RET		Multiple endocrine neoplasia, type 2	VCV002693112	10	43595992	10	43100544	2693112	2857096		NC_000010.11:43100543:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 4, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.159C>T (p.Val53=)	RET		not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000220665	10	43595992	10	43100544	220665	221944	rs753523209	NC_000010.11:43100543:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 31, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.160C>T (p.His54Tyr)	RET	H54Y	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001056765	10	43595993	10	43100545	1056765	1046521	rs2132659466	NC_000010.11:43100544:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.161A>G (p.His54Arg)	RET	H54R	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not provided	VCV001406391	10	43595994	10	43100546	1406391	1408412	rs756858300	NC_000010.11:43100545:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.162T>C (p.His54=)	RET		Multiple endocrine neoplasia, type 2	VCV001146631	10	43595995	10	43100547	1146631	1141115	rs2132659548	NC_000010.11:43100546:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 10, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.163G>T (p.Ala55Ser)	RET	A55S	Hereditary cancer-predisposing syndrome	VCV003432296	10	43595996	10	43100548	3432296	3593492		NC_000010.11:43100547:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 23, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.164C>T (p.Ala55Val)	RET	A55V	Hereditary cancer-predisposing syndrome	VCV003313707	10	43595997	10	43100549	3313707	3465437		NC_000010.11:43100548:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 19, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.165C>G (p.Ala55=)	RET		Multiple endocrine neoplasia, type 2	VCV001615957	10	43595998	10	43100550	1615957	1613677	rs778409475	NC_000010.11:43100549:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 10, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.166C>T (p.Leu56=)	RET		Hereditary cancer-predisposing syndrome	VCV001777656	10	43595999	10	43100551	1777656	1828158		NC_000010.11:43100550:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Feb 1, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.166C>A (p.Leu56Met)	RET	L56M	Renal hypodysplasia/aplasia 1|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia|not provided|Pheochromocytoma|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|not specified	VCV000036723	10	43595999	10	43100551	36723	45384	rs145633958	NC_000010.11:43100550:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 4, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.169C>G (p.Arg57Gly)	RET	R57G	Multiple endocrine neoplasia, type 2	VCV002813389	10	43596002	10	43100554	2813389	2973190		NC_000010.11:43100553:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 10, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.169C>T (p.Arg57Trp)	RET	R57W	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000229939	10	43596002	10	43100554	229939	233775	rs876658284	NC_000010.11:43100553:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.170G>A (p.Arg57Gln)	RET	R57Q	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|not provided	VCV000477323	10	43596003	10	43100555	477323	459980	rs779915615	NC_000010.11:43100554:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.171G>A (p.Arg57=)	RET		Hereditary cancer-predisposing syndrome	VCV001778726	10	43596004	10	43100556	1778726	1831310		NC_000010.11:43100555:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 5, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.172G>A (p.Asp58Asn)	RET	D58N	Multiple endocrine neoplasia, type 2	VCV001059977	10	43596005	10	43100557	1059977	1046522	rs1321002969	NC_000010.11:43100556:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 26, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.174C>T (p.Asp58=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000702979	10	43596007	10	43100559	702979	692828	rs746943314	NC_000010.11:43100558:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.175G>A (p.Ala59Thr)	RET	A59T	not provided|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000423343	10	43596008	10	43100560	423343	407856	rs376565365	NC_000010.11:43100559:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 22, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.176C>T (p.Ala59Val)	RET	A59V	Multiple endocrine neoplasia, type 2	VCV000477326	10	43596009	10	43100561	477326	460246	rs1554817372	NC_000010.11:43100560:C:T	single nucleotide variant	missense variant	Uncertain significance	May 15, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.177C>G (p.Ala59=)	RET		Hereditary cancer-predisposing syndrome	VCV001779943	10	43596010	10	43100562	1779943	1838595		NC_000010.11:43100561:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Feb 18, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.177C>A (p.Ala59=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000543778	10	43596010	10	43100562	543778	525396	rs370622218	NC_000010.11:43100561:C:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.178C>T (p.Pro60Ser)	RET	P60S	Multiple endocrine neoplasia, type 2|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000864094	10	43596011	10	43100563	864094	836806	rs748402485	NC_000010.11:43100562:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.178C>A (p.Pro60Thr)	RET	P60T	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000405543	10	43596011	10	43100563	405543	397775	rs748402485	NC_000010.11:43100562:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.179C>T (p.Pro60Leu)	RET	P60L	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	VCV001449642	10	43596012	10	43100564	1449642	1416698	rs1405257965	NC_000010.11:43100563:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.180T>G (p.Pro60=)	RET		Multiple endocrine neoplasia, type 2	VCV001101434	10	43596013	10	43100565	1101434	1098669	rs2132660228	NC_000010.11:43100564:T:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 13, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.181G>A (p.Glu61Lys)	RET	E61K	Multiple endocrine neoplasia, type 2	VCV002916819	10	43596014	10	43100566	2916819	3076881		NC_000010.11:43100565:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 16, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.182A>C (p.Glu61Ala)	RET	E61A	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000584562	10	43596015	10	43100567	584562	575551	rs1564489398	NC_000010.11:43100566:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 5, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.183G>A (p.Glu61=)	RET		Hereditary cancer-predisposing syndrome	VCV001781132	10	43596016	10	43100568	1781132	1839400		NC_000010.11:43100567:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 24, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.183G>C (p.Glu61Asp)	RET	E61D	Multiple endocrine neoplasia, type 2	VCV000854084	10	43596016	10	43100568	854084	836807	rs1235890606	NC_000010.11:43100567:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 23, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.186G>C (p.Glu62Asp)	RET	E62D	Multiple endocrine neoplasia, type 2	VCV002701823	10	43596019	10	43100571	2701823	2859406		NC_000010.11:43100570:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 9, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.186G>A (p.Glu62=)	RET		Pheochromocytoma|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000749796	10	43596019	10	43100571	749796	752095	rs1588862529	NC_000010.11:43100570:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.187G>A (p.Val63Met)	RET	V63M	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002018422	10	43596020	10	43100572	2018422	2072506		NC_000010.11:43100571:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.187G>T (p.Val63Leu)	RET	V63L	Hereditary cancer-predisposing syndrome	VCV001781872	10	43596020	10	43100572	1781872	1835268		NC_000010.11:43100571:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 5, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.189G>A (p.Val63=)	RET		Multiple endocrine neoplasia, type 2	VCV002915939	10	43596022	10	43100574	2915939	3071448		NC_000010.11:43100573:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 17, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.189G>T (p.Val63=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000477332	10	43596022	10	43100574	477332	460669	rs773428442	NC_000010.11:43100573:G:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.190C>T (p.Pro64Ser)	RET	P64S	Hereditary cancer-predisposing syndrome	VCV001782480	10	43596023	10	43100575	1782480	1842864		NC_000010.11:43100574:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 16, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.191C>T (p.Pro64Leu)	RET	P64L	Multiple endocrine neoplasia, type 2	VCV000013924	10	43596024	10	43100576	13924	28963	rs77596424	NC_000010.11:43100575:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.192C>T (p.Pro64=)	RET		Hereditary cancer-predisposing syndrome	VCV001782843	10	43596025	10	43100577	1782843	1846207		NC_000010.11:43100576:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 30, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.193A>T (p.Ser65Cys)	RET	S65C	Hereditary cancer-predisposing syndrome	VCV001783026	10	43596026	10	43100578	1783026	1842971		NC_000010.11:43100577:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 23, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.193A>G (p.Ser65Gly)	RET	S65G	Hereditary cancer-predisposing syndrome	VCV001783023	10	43596026	10	43100578	1783023	1000694	rs1162598981	NC_000010.11:43100577:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 1, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.195C>T (p.Ser65=)	RET		Hereditary cancer-predisposing syndrome	VCV001783394	10	43596028	10	43100580	1783394	1843339		NC_000010.11:43100579:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 25, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.196T>A (p.Phe66Ile)	RET	F66I	Hereditary cancer-predisposing syndrome	VCV003432263	10	43596029	10	43100581	3432263	3593459		NC_000010.11:43100580:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 19, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.199C>G (p.Arg67Gly)	RET	R67G	Hirschsprung disease, susceptibility to, 1	VCV000997535	10	43596032	10	43100584	997535	985268	rs749390385	NC_000010.11:43100583:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 23, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.199C>T (p.Arg67Cys)	RET	R67C	Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Familial medullary thyroid carcinoma	VCV000477335	10	43596032	10	43100584	477335	459794	rs749390385	NC_000010.11:43100583:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.200G>T (p.Arg67Leu)	RET	R67L	Hereditary cancer-predisposing syndrome	VCV003432222	10	43596033	10	43100585	3432222	3593418		NC_000010.11:43100584:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 20, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.200G>A (p.Arg67His)	RET	R67H	Multiple endocrine neoplasia, type 2|Renal hypodysplasia/aplasia 1|not specified|Multiple endocrine neoplasia|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|not provided|Hereditary cancer-predisposing syndrome|Pheochromocytoma	VCV000041839	10	43596033	10	43100585	41839	50278	rs192489011	NC_000010.11:43100584:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.201C>A (p.Arg67=)	RET		Hereditary cancer-predisposing syndrome	VCV003313726	10	43596034	10	43100586	3313726	3465456		NC_000010.11:43100585:C:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 22, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.201C>T (p.Arg67=)	RET		Multiple endocrine neoplasia, type 2	VCV001647573	10	43596034	10	43100586	1647573	1566301	rs200328158	NC_000010.11:43100585:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 3, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.202C>A (p.Leu68Met)	RET	L68M	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001060415	10	43596035	10	43100587	1060415	1046523	rs1588862565	NC_000010.11:43100586:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.202C>T (p.Leu68=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000760674	10	43596035	10	43100587	760674	767721	rs1588862565	NC_000010.11:43100586:C:T	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Jul 29, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.203T>A (p.Leu68Gln)	RET	L68Q	Hereditary cancer-predisposing syndrome	VCV001784885	10	43596036	10	43100588	1784885	1843530		NC_000010.11:43100587:T:A	single nucleotide variant	missense variant	Uncertain significance	Apr 30, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.204G>C (p.Leu68=)	RET		Multiple endocrine neoplasia, type 2	VCV001896694	10	43596037	10	43100589	1896694	1956080		NC_000010.11:43100588:G:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 9, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.204G>A (p.Leu68=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000820588	10	43596037	10	43100589	820588	809876	rs148874112	NC_000010.11:43100588:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.204G>T (p.Leu68=)	RET		Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	VCV000477338	10	43596037	10	43100589	477338	459990	rs148874112	NC_000010.11:43100588:G:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.205G>A (p.Gly69Ser)	RET	G69S	Multiple endocrine neoplasia, type 2	VCV001498747	10	43596038	10	43100590	1498747	1395648	rs2132661153	NC_000010.11:43100589:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 16, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.206G>A (p.Gly69Asp)	RET	G69D	Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2	VCV001462621	10	43596039	10	43100591	1462621	1433024	rs2132661188	NC_000010.11:43100590:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.208C>T (p.Gln70Ter)	RET	Q70*	RET-related disorder	VCV002629603	10	43596041	10	43100593	2629603	2803060		NC_000010.11:43100592:C:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Jan 9, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.208C>A (p.Gln70Lys)	RET	Q70K	Hereditary cancer-predisposing syndrome	VCV002587891	10	43596041	10	43100593	2587891	2760715		NC_000010.11:43100592:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 30, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.209A>G (p.Gln70Arg)	RET	Q70R	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	VCV000859252	10	43596042	10	43100594	859252	836808	rs1329573334	NC_000010.11:43100593:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.212A>G (p.His71Arg)	RET	H71R	Multiple endocrine neoplasia, type 2	VCV001003396	10	43596045	10	43100597	1003396	993800	rs1837618595	NC_000010.11:43100596:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 8, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.214C>T (p.Leu72Phe)	RET	L72F	Hereditary cancer-predisposing syndrome	VCV002447531	10	43596047	10	43100599	2447531	2432425		NC_000010.11:43100598:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 25, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.219C>T (p.Tyr73=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000477340	10	43596052	10	43100604	477340	459995	rs761460588	NC_000010.11:43100603:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.220G>C (p.Gly74Arg)	RET	G74R	Multiple endocrine neoplasia, type 2	VCV003387582	10	43596053	10	43100605	3387582	3546715		NC_000010.11:43100604:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 22, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.220G>A (p.Gly74Ser)	RET	G74S	Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia|Pheochromocytoma|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Ovarian cancer	VCV000299886	10	43596053	10	43100605	299886	322066	rs764938319	NC_000010.11:43100604:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 29, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.224C>G (p.Thr75Arg)	RET	T75R	Multiple endocrine neoplasia, type 2	VCV003387583	10	43596057	10	43100609	3387583	3546716		NC_000010.11:43100608:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 20, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.224C>T (p.Thr75Met)	RET	T75M	Ovarian cancer|Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	VCV000569870	10	43596057	10	43100609	569870	564563	rs142641173	NC_000010.11:43100608:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 20, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.225G>T (p.Thr75=)	RET		Hereditary cancer-predisposing syndrome	VCV001788606	10	43596058	10	43100610	1788606	1844666		NC_000010.11:43100609:G:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 16, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.225G>A (p.Thr75=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Pheochromocytoma|not specified|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia, type 2	VCV000184368	10	43596058	10	43100610	184368	182944	rs151267865	NC_000010.11:43100609:G:A	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Jan 28, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.229C>G (p.Arg77Gly)	RET	R77G	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002447530	10	43596062	10	43100614	2447530	2432424		NC_000010.11:43100613:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.229C>T (p.Arg77Cys)	RET	R77C	Multiple endocrine neoplasia, type 2|not provided	VCV001069381	10	43596062	10	43100614	1069381	1061896	rs1588862595	NC_000010.11:43100613:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jun 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.229C>A (p.Arg77Ser)	RET	R77S	Hereditary cancer-predisposing syndrome	VCV000821050	10	43596062	10	43100614	821050	809877	rs1588862595	NC_000010.11:43100613:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 26, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.230G>A (p.Arg77His)	RET	R77H	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	VCV000477344	10	43596063	10	43100615	477344	459998	rs570176656	NC_000010.11:43100614:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 24, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.231C>T (p.Arg77=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000706783	10	43596064	10	43100616	706783	692829	rs3123654	NC_000010.11:43100615:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.232A>C (p.Thr78Pro)	RET	T78P	Multiple endocrine neoplasia, type 2	VCV001439349	10	43596065	10	43100617	1439349	1349749	rs2132662087	NC_000010.11:43100616:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 18, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.235C>A (p.Arg79=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001790127	10	43596068	10	43100620	1790127	1844874		NC_000010.11:43100619:C:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.235C>T (p.Arg79Trp)	RET	R79W	Pheochromocytoma|Multiple endocrine neoplasia, type 2|not provided|Hirschsprung disease, susceptibility to, 1|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia|Hereditary cancer-predisposing syndrome|Renal hypodysplasia/aplasia 1	VCV000405541	10	43596068	10	43100620	405541	397680	rs537523906	NC_000010.11:43100619:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 28, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.236G>A (p.Arg79Gln)	RET	R79Q	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|not provided|Multiple endocrine neoplasia, type 2	VCV000477345	10	43596069	10	43100621	477345	459798	rs1318325737	NC_000010.11:43100620:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 21, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.237G>T (p.Arg79=)	RET		Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	VCV000543769	10	43596070	10	43100622	543769	525401	rs1554817395	NC_000010.11:43100621:G:T	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Aug 27, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.238C>T (p.Leu80=)	RET		Multiple endocrine neoplasia, type 2	VCV000756377	10	43596071	10	43100623	756377	767722	rs1588862612	NC_000010.11:43100622:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 29, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.240G>A (p.Leu80=)	RET		Hereditary cancer-predisposing syndrome	VCV003432304	10	43596073	10	43100625	3432304	3593500		NC_000010.11:43100624:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 6, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.241C>G (p.His81Asp)	RET	H81D	Hereditary cancer-predisposing syndrome	VCV002587888	10	43596074	10	43100626	2587888	2760712		NC_000010.11:43100625:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 2, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.241C>T (p.His81Tyr)	RET	H81Y	Hereditary cancer-predisposing syndrome	VCV001790999	10	43596074	10	43100626	1790999	1851360		NC_000010.11:43100625:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 25, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.242A>G (p.His81Arg)	RET	H81R	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1	VCV001064183	10	43596075	10	43100627	1064183	1046524	rs1217729118	NC_000010.11:43100626:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.243T>A (p.His81Gln)	RET	H81Q	Hereditary cancer-predisposing syndrome	VCV001791315	10	43596076	10	43100628	1791315	1848135		NC_000010.11:43100627:T:A	single nucleotide variant	missense variant	Uncertain significance	Jun 4, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.244G>A (p.Glu82Lys)	RET	E82K	Multiple endocrine neoplasia, type 2	VCV003387584	10	43596077	10	43100629	3387584	3546717		NC_000010.11:43100628:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 10, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.246G>A (p.Glu82=)	RET		Hereditary cancer-predisposing syndrome	VCV001791758	10	43596079	10	43100631	1791758	1845191		NC_000010.11:43100630:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 18, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.249C>T (p.Asn83=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000413459	10	43596082	10	43100634	413459	397776	rs1060504032	NC_000010.11:43100633:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.252C>G (p.Asn84Lys)	RET	N84K	Multiple endocrine neoplasia, type 2	VCV002744330	10	43596085	10	43100637	2744330	2903807		NC_000010.11:43100636:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 28, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.252C>T (p.Asn84=)	RET		Multiple endocrine neoplasia, type 2	VCV002124549	10	43596085	10	43100637	2124549	2185010		NC_000010.11:43100636:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 11, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.255G>A (p.Trp85Ter)	RET	W85*	Multiple endocrine neoplasia, type 2	VCV002698901	10	43596088	10	43100640	2698901	2855192		NC_000010.11:43100639:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Nov 25, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.256A>T (p.Ile86Phe)	RET	I86F	Hereditary cancer-predisposing syndrome	VCV001793210	10	43596089	10	43100641	1793210	1848723		NC_000010.11:43100640:A:T	single nucleotide variant	missense variant	Uncertain significance	Feb 22, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.258C>A (p.Ile86=)	RET		Multiple endocrine neoplasia, type 2	VCV002031576	10	43596091	10	43100643	2031576	2089481		NC_000010.11:43100642:C:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 30, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.260G>A (p.Cys87Tyr)	RET	C87Y	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002587894	10	43596093	10	43100645	2587894	2760718		NC_000010.11:43100644:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.261C>T (p.Cys87=)	RET		Multiple endocrine neoplasia, type 2	VCV002913872	10	43596094	10	43100646	2913872	3073726		NC_000010.11:43100645:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 4, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.262A>C (p.Ile88Leu)	RET	I88L	Multiple endocrine neoplasia, type 2	VCV002812459	10	43596095	10	43100647	2812459	2965851		NC_000010.11:43100646:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 24, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.262A>G (p.Ile88Val)	RET	I88V	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|not specified|Multiple endocrine neoplasia type 2B	VCV000188305	10	43596095	10	43100647	188305	186115	rs141679950	NC_000010.11:43100646:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 28, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.264C>T (p.Ile88=)	RET		Hereditary cancer-predisposing syndrome	VCV002454130	10	43596097	10	43100649	2454130	2424019		NC_000010.11:43100648:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 19, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.265C>A (p.Gln89Lys)	RET	Q89K	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not provided	VCV001389003	10	43596098	10	43100650	1389003	1476583	rs2132663101	NC_000010.11:43100649:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.266A>G (p.Gln89Arg)	RET	Q89R	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not provided|Hirschsprung disease, susceptibility to, 1	VCV000570756	10	43596099	10	43100651	570756	564565	rs1564489449	NC_000010.11:43100650:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.268G>T (p.Glu90Ter)	RET	E90*	Multiple endocrine neoplasia, type 2	VCV000642786	10	43596101	10	43100653	642786	638865	rs1588862638	NC_000010.11:43100652:G:T	single nucleotide variant	nonsense	Pathogenic	Jul 30, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.269A>G (p.Glu90Gly)	RET	E90G	Multiple endocrine neoplasia, type 2	VCV002808322	10	43596102	10	43100654	2808322	2968124		NC_000010.11:43100653:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 20, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.270G>A (p.Glu90=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000413471	10	43596103	10	43100655	413471	397249	rs755967110	NC_000010.11:43100654:G:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.271G>T (p.Asp91Tyr)	RET	D91Y	Multiple endocrine neoplasia, type 2	VCV001909905	10	43596104	10	43100656	1909905	1972716		NC_000010.11:43100655:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 22, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.273C>T (p.Asp91=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000821747	10	43596106	10	43100658	821747	809878	rs761325339	NC_000010.11:43100657:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.274A>G (p.Thr92Ala)	RET	T92A	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	VCV001493320	10	43596107	10	43100659	1493320	1355518	rs1188786351	NC_000010.11:43100658:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.275C>G (p.Thr92Ser)	RET	T92S	Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome	VCV003227540	10	43596108	10	43100660	3227540	3390751		NC_000010.11:43100659:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.276C>G (p.Thr92=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not specified	VCV001140187	10	43596109	10	43100661	1140187	1120254	rs886042820	NC_000010.11:43100660:C:G	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Jun 9, 2023	criteria provided, conflicting classifications							
NM_020975.6(RET):c.276C>T (p.Thr92=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not provided	VCV000284199	10	43596109	10	43100661	284199	268436	rs886042820	NC_000010.11:43100660:C:T	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Oct 6, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.277G>A (p.Gly93Ser)	RET	G93S	Hirschsprung disease, susceptibility to, 1	VCV003065760	10	43596110	10	43100662	3065760	3225779		NC_000010.11:43100661:G:A	single nucleotide variant	missense variant|intron variant	Likely pathogenic	Mar 29, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.278G>A (p.Gly93Asp)	RET	G93D	Multiple endocrine neoplasia, type 2	VCV002131000	10	43596111	10	43100663	2131000	2186295		NC_000010.11:43100662:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 28, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.279C>T (p.Gly93=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002145433	10	43596112	10	43100664	2145433	1879919		NC_000010.11:43100663:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.279C>A (p.Gly93=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001153998	10	43596112	10	43100664	1153998	1141116	rs1168926729	NC_000010.11:43100663:C:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 31, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.280C>G (p.Leu94Val)	RET	L94V	Multiple endocrine neoplasia, type 2	VCV000972422	10	43596113	10	43100665	972422	956041	rs1837621025	NC_000010.11:43100664:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 24, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.282C>T (p.Leu94=)	RET		Hereditary cancer-predisposing syndrome	VCV001796567	10	43596115	10	43100667	1796567	1855142		NC_000010.11:43100666:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 6, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.288C>T (p.Tyr96=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000757609	10	43596121	10	43100673	757609	767723	rs1431744747	NC_000010.11:43100672:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.289C>G (p.Leu97Val)	RET	L97V	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002568330	10	43596122	10	43100674	2568330	2734867		NC_000010.11:43100673:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.292A>C (p.Asn98His)	RET	N98H	Hereditary cancer-predisposing syndrome	VCV003432221	10	43596125	10	43100677	3432221	3593417		NC_000010.11:43100676:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 25, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.294C>T (p.Asn98=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000822347	10	43596127	10	43100679	822347	809879	rs1470411479	NC_000010.11:43100678:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 27, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.295C>T (p.Arg99Trp)	RET	R99W	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000486331	10	43596128	10	43100680	486331	475065	rs1333641674	NC_000010.11:43100679:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 10, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.296G>A (p.Arg99Gln)	RET	R99Q	not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000241354	10	43596129	10	43100681	241354	240784	rs749500174	NC_000010.11:43100680:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 21, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.297G>A (p.Arg99=)	RET		Multiple endocrine neoplasia, type 2	VCV002103150	10	43596130	10	43100682	2103150	2158454		NC_000010.11:43100681:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.299G>A (p.Ser100Asn)	RET	S100N	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000486346	10	43596132	10	43100684	486346	475262	rs1554817407	NC_000010.11:43100683:G:A	single nucleotide variant	missense variant	Uncertain significance	May 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.300C>T (p.Ser100=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000822570	10	43596133	10	43100685	822570	809880	rs898964408	NC_000010.11:43100684:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.304G>C (p.Asp102His)	RET	D102H	Multiple endocrine neoplasia, type 2	VCV003069567	10	43596137	10	43100689	3069567	3230192		NC_000010.11:43100688:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 24, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.304G>A (p.Asp102Asn)	RET	D102N	Multiple endocrine neoplasia type 2A|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia, type 2|RET-related disorder|Hereditary cancer-predisposing syndrome	VCV000135183	10	43596137	10	43100689	135183	138922	rs201244749	NC_000010.11:43100688:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 11, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.306C>T (p.Asp102=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not provided	VCV000705405	10	43596139	10	43100691	705405	692830	rs1588862691	NC_000010.11:43100690:C:T	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Dec 8, 2023	criteria provided, conflicting classifications							
NM_020975.6(RET):c.307C>T (p.His103Tyr)	RET	H103Y	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000941689	10	43596140	10	43100692	941689	935017	rs1217820916	NC_000010.11:43100691:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 19, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.308A>G (p.His103Arg)	RET	H103R	Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia, type 2	VCV000216724	10	43596141	10	43100693	216724	212766	rs375390467	NC_000010.11:43100692:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 4, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.309T>C (p.His103=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV003070554	10	43596142	10	43100694	3070554	3230312		NC_000010.11:43100693:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.311G>T (p.Ser104Ile)	RET	S104I	Multiple endocrine neoplasia, type 2	VCV003666254	10	43596144	10	43100696	3666254	3792060		NC_000010.11:43100695:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 26, 2025	criteria provided, single submitter							
NM_020975.6(RET):c.312C>A (p.Ser104Arg)	RET	S104R	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000822958	10	43596145	10	43100697	822958	809881	rs746378333	NC_000010.11:43100696:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.314C>T (p.Ser105Phe)	RET	S105F	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000647509	10	43596147	10	43100699	647509	638866	rs1588862705	NC_000010.11:43100698:C:T	single nucleotide variant	missense variant	Uncertain significance	May 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.315C>T (p.Ser105=)	RET		Hereditary cancer-predisposing syndrome	VCV001728281	10	43596148	10	43100700	1728281	1791681		NC_000010.11:43100699:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 18, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.317G>A (p.Trp106Ter)	RET	W106*	Multiple endocrine neoplasia, type 2	VCV001405715	10	43596150	10	43100702	1405715	1480655	rs2132664970	NC_000010.11:43100701:G:A	single nucleotide variant	nonsense	Pathogenic	Jul 21, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.318G>A (p.Trp106Ter)	RET	W106*	Multiple endocrine neoplasia, type 2	VCV001069637	10	43596151	10	43100703	1069637	1061897	rs2132664999	NC_000010.11:43100702:G:A	single nucleotide variant	nonsense	Pathogenic	Oct 13, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.319G>A (p.Glu107Lys)	RET	E107K	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not provided|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1	VCV001063665	10	43596152	10	43100704	1063665	1046525	rs1025290394	NC_000010.11:43100703:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.320A>G (p.Glu107Gly)	RET	E107G	Multiple endocrine neoplasia, type 2	VCV001435924	10	43596153	10	43100705	1435924	1500920	rs2132665054	NC_000010.11:43100704:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 13, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.321G>A (p.Glu107=)	RET		Hereditary cancer-predisposing syndrome	VCV003313728	10	43596154	10	43100706	3313728	3465458		NC_000010.11:43100705:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 22, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.322A>G (p.Lys108Glu)	RET	K108E	Hereditary cancer-predisposing syndrome	VCV001729164	10	43596155	10	43100707	1729164	1785453		NC_000010.11:43100706:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 11, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.322A>C (p.Lys108Gln)	RET	K108Q	not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2B	VCV000477370	10	43596155	10	43100707	477370	460000	rs567877611	NC_000010.11:43100706:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 6, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.324G>C (p.Lys108Asn)	RET	K108N	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001006705	10	43596157	10	43100709	1006705	993801	rs775974393	NC_000010.11:43100708:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.328A>C (p.Ser110Arg)	RET	S110R	Hereditary cancer-predisposing syndrome	VCV001729813	10	43596161	10	43100713	1729813	1792020		NC_000010.11:43100712:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 1, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.329G>A (p.Ser110Asn)	RET	S110N	Multiple endocrine neoplasia, type 2	VCV000566200	10	43596162	10	43100714	566200	566262	rs764421264	NC_000010.11:43100713:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 10, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.330T>C (p.Ser110=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001539938	10	43596163	10	43100715	1539938	1630255	rs1264565618	NC_000010.11:43100714:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Feb 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.332T>C (p.Val111Ala)	RET	V111A	Hereditary cancer-predisposing syndrome	VCV003432301	10	43596165	10	43100717	3432301	3593497		NC_000010.11:43100716:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 28, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.332T>G (p.Val111Gly)	RET	V111G	Hereditary cancer-predisposing syndrome	VCV001730307	10	43596165	10	43100717	1730307	1788642		NC_000010.11:43100716:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 11, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.333C>T (p.Val111=)	RET		Hereditary cancer-predisposing syndrome	VCV001730394	10	43596166	10	43100718	1730394	1788728		NC_000010.11:43100717:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 16, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.333C>G (p.Val111=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000703888	10	43596166	10	43100718	703888	692831	rs772779267	NC_000010.11:43100717:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.334C>T (p.Arg112Cys)	RET	R112C	not provided|Congenital anomaly of kidney and urinary tract|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2|Renal hypodysplasia/aplasia 1|Pheochromocytoma|Multiple endocrine neoplasia type 2A	VCV000216726	10	43596167	10	43100719	216726	212767	rs762626209	NC_000010.11:43100718:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.335G>T (p.Arg112Leu)	RET	R112L	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001730602	10	43596168	10	43100720	1730602	1788935		NC_000010.11:43100719:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.335G>A (p.Arg112His)	RET	R112H	Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|not provided|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia type 2B	VCV000136120	10	43596168	10	43100720	136120	139832	rs587780814	NC_000010.11:43100719:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 6, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.336C>T (p.Arg112=)	RET		Multiple endocrine neoplasia, type 2	VCV002888058	10	43596169	10	43100721	2888058	3054470		NC_000010.11:43100720:C:T	single nucleotide variant	synonymous variant|intron variant	Uncertain significance	Jul 16, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.336C>A (p.Arg112=)	RET		Multiple endocrine neoplasia, type 2	VCV002852352	10	43596169	10	43100721	2852352	3009996		NC_000010.11:43100720:C:A	single nucleotide variant	intron variant|synonymous variant	Uncertain significance	Apr 6, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.337A>G (p.Asn113Asp)	RET	N113D, S113G, T113A, R113G	Multiple endocrine neoplasia, type 2	VCV002048904	10	43596170	10	43100722	2048904	2114547		NC_000010.11:43100721:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 22, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.337+6G>A	RET		Multiple endocrine neoplasia, type 2	VCV002169095	10	43596176	10	43100728	2169095	1906919		NC_000010.11:43100727:G:A	single nucleotide variant	intron variant	Uncertain significance	Jan 24, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.337+8_337+9delinsTA	RET		Multiple endocrine neoplasia, type 2	VCV002061820	10	43596178 - 43596179	10	43100730 - 43100731	2061820	2120968		NC_000010.11:43100729:AG:TA	Indel	intron variant	Uncertain significance	Jul 7, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.337+12_337+14del	RET		Multiple endocrine neoplasia, type 2	VCV001114085	10	43596179 - 43596181	10	43100731 - 43100733	1114085	1098670	rs2132665877	NC_000010.11:43100730:GCCGCC:GCC	Microsatellite	intron variant	Likely benign	Jul 9, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.337+9G>A	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Renal hypodysplasia/aplasia 1|Pheochromocytoma|not specified|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia|not provided	VCV000095996	10	43596179	10	43100731	95996	101891	rs2435351	NC_000010.11:43100730:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.337+10C>T	RET		Multiple endocrine neoplasia, type 2	VCV001127921	10	43596180	10	43100732	1127921	1120255	rs1837623555	NC_000010.11:43100731:C:T	single nucleotide variant	intron variant	Likely benign	Nov 19, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.337+11C>A	RET		Multiple endocrine neoplasia, type 2	VCV001548718	10	43596181	10	43100733	1548718	1658085	rs754967305	NC_000010.11:43100732:C:A	single nucleotide variant	intron variant	Likely benign	Oct 9, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.337+11C>T	RET		Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A|not specified|not provided	VCV000548834	10	43596181	10	43100733	548834	539277	rs754967305	NC_000010.11:43100732:C:T	single nucleotide variant	intron variant	Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.337+17_337+28dup	RET		Multiple endocrine neoplasia, type 2	VCV001543581	10	43596182 - 43596183	10	43100734 - 43100735	1543581	1557736	rs1837623791	NC_000010.11:43100734:CCCCAACACCCACCCC:CCCCAACACCCACCCCAACACCCACCCC	Duplication	intron variant	Likely benign	Jan 22, 2025	criteria provided, single submitter							
NM_020975.6(RET):c.337+12G>A	RET		Hirschsprung Disease, Dominant|Multiple endocrine neoplasia|Multiple endocrine neoplasia type 2A|Renal hypodysplasia/aplasia 1|not provided|Multiple endocrine neoplasia, type 2|Pheochromocytoma|Multiple endocrine neoplasia type 2B|Hereditary cancer-predisposing syndrome|not specified	VCV000299887	10	43596182	10	43100734	299887	321368	rs200468424	NC_000010.11:43100733:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.337+14C>T	RET		Multiple endocrine neoplasia, type 2	VCV003649269	10	43596184	10	43100736	3649269	3781278		NC_000010.11:43100735:C:T	single nucleotide variant	intron variant	Likely benign	Oct 24, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.337+16C>T	RET		Multiple endocrine neoplasia, type 2	VCV003646674	10	43596186	10	43100738	3646674	3787227		NC_000010.11:43100737:C:T	single nucleotide variant	intron variant	Likely benign	Jun 7, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.337+19C>T	RET		Multiple endocrine neoplasia, type 2	VCV002751049	10	43596189	10	43100741	2751049	2913087		NC_000010.11:43100740:C:T	single nucleotide variant	intron variant	Likely benign	Dec 19, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.337+20A>C	RET		not specified	VCV002576505	10	43596190	10	43100742	2576505	2741401		NC_000010.11:43100741:A:C	single nucleotide variant	intron variant	Likely benign	Aug 15, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.337+24A>C	RET		not specified	VCV001697456	10	43596194	10	43100746	1697456	1689842	rs1364998745	NC_000010.11:43100745:A:C	single nucleotide variant	intron variant	Likely benign	Aug 15, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.337+29G>A	RET		Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A	VCV000372085	10	43596199	10	43100751	372085	358820	rs578158807	NC_000010.11:43100750:G:A	single nucleotide variant	intron variant	Likely benign	Jun 3, 2016	criteria provided, single submitter							
NM_020975.6(RET):c.337+34C>T	RET		not provided|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A	VCV000372092	10	43596204	10	43100756	372092	358821	rs368088467	NC_000010.11:43100755:C:T	single nucleotide variant	intron variant	Likely benign	Jul 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.337+137G>T	RET		not provided	VCV000677056	10	43596307	10	43100859	677056	664821	rs2505530	NC_000010.11:43100858:G:T	single nucleotide variant	intron variant	Benign	Jun 15, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.337+196G>A	RET		not provided	VCV001189719	10	43596366	10	43100918	1189719	1180675	rs115330432	NC_000010.11:43100917:G:A	single nucleotide variant	intron variant	Likely benign	Oct 14, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.337+247C>T	RET		not provided	VCV000676895	10	43596417	10	43100969	676895	664783	rs112451273	NC_000010.11:43100968:C:T	single nucleotide variant	intron variant	Likely benign	Jun 12, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.337+258G>T	RET		not provided	VCV001223741	10	43596428	10	43100980	1223741	1214014	rs191765389	NC_000010.11:43100979:G:T	single nucleotide variant	intron variant	Likely benign	Apr 24, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.338-201C>G	RET		not provided	VCV000676909	10	43597589	10	43102141	676909	664247	rs112976896	NC_000010.11:43102140:C:G	single nucleotide variant	intron variant	Likely benign	Jun 12, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.338-174_338-162del	RET		not provided	VCV001254437	10	43597609 - 43597621	10	43102161 - 43102173	1254437	1244371	rs148863289	NC_000010.11:43102160:GCAGCAGGGCTGTGCAGCAG:GCAGCAG	Deletion	intron variant	Likely benign	Mar 10, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.338-106G>A	RET		not provided	VCV001293633	10	43597684	10	43102236	1293633	1283435	rs73252046	NC_000010.11:43102235:G:A	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, single submitter							
NM_020975.6(RET):c.338-25_338-17del	RET		Multiple endocrine neoplasia, type 2	VCV001552593	10	43597763 - 43597771	10	43102315 - 43102323	1552593	1586672	rs1404649841	NC_000010.11:43102314:CCCCACAGACC:CC	Deletion	intron variant	Likely benign	Aug 17, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.338-18C>T	RET		Multiple endocrine neoplasia, type 2	VCV003725346	10	43597772	10	43102324	3725346	3851249		NC_000010.11:43102323:C:T	single nucleotide variant	intron variant	Likely benign	Nov 16, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.338-17C>G	RET		Multiple endocrine neoplasia, type 2	VCV002748008	10	43597773	10	43102325	2748008	2912219		NC_000010.11:43102324:C:G	single nucleotide variant	intron variant	Likely benign	Jul 29, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.338-15G>C	RET		Multiple endocrine neoplasia, type 2	VCV003640276	10	43597775	10	43102327	3640276	3775290		NC_000010.11:43102326:G:C	single nucleotide variant	intron variant	Likely benign	Feb 12, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.338-14A>C	RET		Multiple endocrine neoplasia, type 2	VCV002095797	10	43597776	10	43102328	2095797	2149714		NC_000010.11:43102327:A:C	single nucleotide variant	intron variant	Likely benign	Feb 9, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.338-13C>T	RET		Multiple endocrine neoplasia, type 2	VCV002143642	10	43597777	10	43102329	2143642	1869879		NC_000010.11:43102328:C:T	single nucleotide variant	intron variant	Likely benign	Jun 10, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.338-10C>G	RET		Multiple endocrine neoplasia, type 2	VCV002791037	10	43597780	10	43102332	2791037	2953468		NC_000010.11:43102331:C:G	single nucleotide variant	intron variant	Likely benign	Jan 26, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.338-10C>T	RET		Multiple endocrine neoplasia, type 2	VCV001624776	10	43597780	10	43102332	1624776	1629395	rs375524825	NC_000010.11:43102331:C:T	single nucleotide variant	intron variant	Likely benign	Apr 24, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.338-9T>A	RET		Multiple endocrine neoplasia, type 2	VCV002765359	10	43597781	10	43102333	2765359	2926106		NC_000010.11:43102332:T:A	single nucleotide variant	intron variant	Uncertain significance	Oct 4, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.338-8C>T	RET		Multiple endocrine neoplasia, type 2	VCV003007771	10	43597782	10	43102334	3007771	3169346		NC_000010.11:43102333:C:T	single nucleotide variant	intron variant	Likely benign	May 26, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.338-7T>G	RET		Hirschsprung disease, susceptibility to, 1	VCV002692322	10	43597783	10	43102335	2692322	2853324		NC_000010.11:43102334:T:G	single nucleotide variant	intron variant	Uncertain significance	Aug 24, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.338-6C>T	RET		Multiple endocrine neoplasia, type 2	VCV001152345	10	43597784	10	43102336	1152345	1141117	rs2132677196	NC_000010.11:43102335:C:T	single nucleotide variant	intron variant	Likely benign	Aug 11, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.338-5T>C	RET		Hereditary cancer-predisposing syndrome	VCV003432219	10	43597785	10	43102337	3432219	3593415		NC_000010.11:43102336:T:C	single nucleotide variant	intron variant	Uncertain significance	Oct 18, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.338-4G>A	RET		Multiple endocrine neoplasia, type 2	VCV002162255	10	43597786	10	43102338	2162255	1884643		NC_000010.11:43102337:G:A	single nucleotide variant	intron variant	Likely benign	Aug 24, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.339C>A (p.Asn113Lys)	RET	N113K	Multiple endocrine neoplasia, type 2	VCV002892746	10	43597791	10	43102343	2892746	3045547		NC_000010.11:43102342:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 4, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.340C>T (p.Arg114Cys)	RET	R114C	Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia type 2B|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000560870	10	43597792	10	43102344	560870	551859	rs747483905	NC_000010.11:43102343:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.341G>T (p.Arg114Leu)	RET	R114L	Multiple endocrine neoplasia, type 2	VCV003012354	10	43597793	10	43102345	3012354	3173943		NC_000010.11:43102344:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 19, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.341G>A (p.Arg114His)	RET	R114H	Multiple endocrine neoplasia|Pheochromocytoma|not provided|Renal hypodysplasia/aplasia 1|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|not specified|Hirschsprung disease, susceptibility to, 1	VCV000013947	10	43597793	10	43102345	13947	28986	rs76397662	NC_000010.11:43102344:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.342C>T (p.Arg114=)	RET		Hereditary cancer-predisposing syndrome|not specified|Multiple endocrine neoplasia, type 2	VCV000477373	10	43597794	10	43102346	477373	460003	rs143083395	NC_000010.11:43102345:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.343G>A (p.Gly115Ser)	RET	G115S	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000823771	10	43597795	10	43102347	823771	809882	rs1588863889	NC_000010.11:43102346:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.346T>C (p.Phe116Leu)	RET	F116L	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001731727	10	43597798	10	43102350	1731727	1792631		NC_000010.11:43102349:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 7, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.346T>A (p.Phe116Ile)	RET	F116I	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001380130	10	43597798	10	43102350	1380130	1506179	rs1439820916	NC_000010.11:43102349:T:A	single nucleotide variant	missense variant	Uncertain significance	Nov 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.348T>C (p.Phe116=)	RET		Hereditary cancer-predisposing syndrome	VCV003313715	10	43597800	10	43102352	3313715	3465445		NC_000010.11:43102351:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 31, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.349C>G (p.Pro117Ala)	RET	P117A	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002587873	10	43597801	10	43102353	2587873	2760697		NC_000010.11:43102352:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.349C>T (p.Pro117Ser)	RET	P117S	Multiple endocrine neoplasia, type 2	VCV001008711	10	43597801	10	43102353	1008711	993802	rs868523779	NC_000010.11:43102352:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 13, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.350C>T (p.Pro117Leu)	RET	P117L	Multiple endocrine neoplasia, type 2	VCV002849014	10	43597802	10	43102354	2849014	3012658		NC_000010.11:43102353:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 21, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.350C>G (p.Pro117Arg)	RET	P117R	Multiple endocrine neoplasia, type 2	VCV001495306	10	43597802	10	43102354	1495306	1369091	rs763295929	NC_000010.11:43102353:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 13, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.350C>A (p.Pro117His)	RET	P117H	Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000543735	10	43597802	10	43102354	543735	525594	rs763295929	NC_000010.11:43102353:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.351C>G (p.Pro117=)	RET		Multiple endocrine neoplasia, type 2	VCV002082037	10	43597803	10	43102355	2082037	2135991		NC_000010.11:43102354:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.351C>T (p.Pro117=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000077949	10	43597803	10	43102355	77949	88840	rs267602487	NC_000010.11:43102354:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.354G>A (p.Leu118=)	RET		Multiple endocrine neoplasia, type 2	VCV003685425	10	43597806	10	43102358	3685425	3819598		NC_000010.11:43102357:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Feb 4, 2025	criteria provided, single submitter							
NM_020975.6(RET):c.354G>C (p.Leu118=)	RET		Multiple endocrine neoplasia, type 2	VCV002746417	10	43597806	10	43102358	2746417	2911927		NC_000010.11:43102357:G:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 25, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.355C>T (p.Leu119Phe)	RET	L119F	Hereditary cancer-predisposing syndrome	VCV001732683	10	43597807	10	43102359	1732683	1786370		NC_000010.11:43102358:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 7, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.356T>G (p.Leu119Arg)	RET	L119R	Hereditary cancer-predisposing syndrome	VCV000823944	10	43597808	10	43102360	823944	809883	rs1588863912	NC_000010.11:43102359:T:G	single nucleotide variant	missense variant	Uncertain significance	Feb 25, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.357C>T (p.Leu119=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001093067	10	43597809	10	43102361	1093067	1077027	rs2132677889	NC_000010.11:43102360:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 23, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.358A>G (p.Thr120Ala)	RET	T120A	Hereditary cancer-predisposing syndrome	VCV003432288	10	43597810	10	43102362	3432288	3593484		NC_000010.11:43102361:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 31, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.359C>T (p.Thr120Ile)	RET	T120I	Hereditary cancer-predisposing syndrome	VCV001733047	10	43597811	10	43102363	1733047	1796121		NC_000010.11:43102362:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 11, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.360C>T (p.Thr120=)	RET		Multiple endocrine neoplasia, type 2	VCV002136855	10	43597812	10	43102364	2136855	1877861		NC_000010.11:43102363:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 13, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.361G>A (p.Val121Ile)	RET	V121I	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|not specified|not provided	VCV000373412	10	43597813	10	43102365	373412	359961	rs770548816	NC_000010.11:43102364:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.362T>A (p.Val121Asp)	RET	V121D	Multiple endocrine neoplasia, type 2	VCV003649278	10	43597814	10	43102366	3649278	3781287		NC_000010.11:43102365:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 9, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.363C>T (p.Val121=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001108121	10	43597815	10	43102367	1108121	1098671	rs1837658478	NC_000010.11:43102366:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 3, 2021	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.366C>T (p.Tyr122=)	RET		Multiple endocrine neoplasia, type 2	VCV001936567	10	43597818	10	43102370	1936567	1993292		NC_000010.11:43102369:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 27, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.367C>A (p.Leu123Ile)	RET	L123I	Multiple endocrine neoplasia, type 2	VCV002759155	10	43597819	10	43102371	2759155	2917737		NC_000010.11:43102370:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 8, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.369C>A (p.Leu123=)	RET		Multiple endocrine neoplasia, type 2	VCV002034650	10	43597821	10	43102373	2034650	2089998		NC_000010.11:43102372:C:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 8, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.371A>G (p.Lys124Arg)	RET	K124R	Multiple endocrine neoplasia, type 2	VCV001369408	10	43597823	10	43102375	1369408	1414422	rs773868504	NC_000010.11:43102374:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.372G>C (p.Lys124Asn)	RET	K124N	Multiple endocrine neoplasia, type 2	VCV001443809	10	43597824	10	43102376	1443809	1487809	rs2132678369	NC_000010.11:43102375:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 26, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.373G>A (p.Val125Ile)	RET	V125I	Hereditary cancer-predisposing syndrome	VCV000824146	10	43597825	10	43102377	824146	809884	rs1588863924	NC_000010.11:43102376:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 28, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.375C>G (p.Val125=)	RET		Hereditary cancer-predisposing syndrome	VCV003227558	10	43597827	10	43102379	3227558	3390769		NC_000010.11:43102378:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 9, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.375C>T (p.Val125=)	RET		Multiple endocrine neoplasia, type 2	VCV002200425	10	43597827	10	43102379	2200425	1930860		NC_000010.11:43102378:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 17, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.375C>A (p.Val125=)	RET		not provided|Multiple endocrine neoplasia, type 2|Renal hypodysplasia/aplasia 1|Pheochromocytoma|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia|not specified|Hereditary cancer-predisposing syndrome	VCV000095997	10	43597827	10	43102379	95997	101892	rs1800859	NC_000010.11:43102378:C:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.376T>C (p.Phe126Leu)	RET	F126L	Ovarian cancer|Multiple endocrine neoplasia, type 2	VCV001505104	10	43597828	10	43102380	1505104	1413972	rs2132678531	NC_000010.11:43102379:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 15, 2023	criteria provided, conflicting classifications							
NM_020975.6(RET):c.378C>T (p.Phe126=)	RET		Multiple endocrine neoplasia, type 2	VCV003723576	10	43597830	10	43102382	3723576	3850787		NC_000010.11:43102381:C:T	single nucleotide variant	synonymous variant|intron variant	Uncertain significance	Oct 23, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.379C>A (p.Leu127Met)	RET	L127M	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002625018	10	43597831	10	43102383	2625018	2790513		NC_000010.11:43102382:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.379C>T (p.Leu127=)	RET		Multiple endocrine neoplasia, type 2	VCV002028780	10	43597831	10	43102383	2028780	2085415		NC_000010.11:43102382:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 4, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.381G>C (p.Leu127=)	RET		Multiple endocrine neoplasia, type 2	VCV001609337	10	43597833	10	43102385	1609337	1638850	rs2132678686	NC_000010.11:43102384:G:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 10, 2025	criteria provided, single submitter							
NM_020975.6(RET):c.383C>T (p.Ser128Leu)	RET	S128L	Multiple endocrine neoplasia, type 2	VCV003725756	10	43597835	10	43102387	3725756	3861264		NC_000010.11:43102386:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 21, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.384A>T (p.Ser128=)	RET		Hereditary cancer-predisposing syndrome	VCV001735496	10	43597836	10	43102388	1735496	1789990		NC_000010.11:43102387:A:T	single nucleotide variant	intron variant|synonymous variant	Likely benign	Aug 25, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.385C>G (p.Pro129Ala)	RET	P129A	Multiple endocrine neoplasia, type 2	VCV001056160	10	43597837	10	43102389	1056160	1046526	rs2132678836	NC_000010.11:43102388:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.387C>T (p.Pro129=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001094464	10	43597839	10	43102391	1094464	1077028	rs955600914	NC_000010.11:43102390:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 12, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.388A>G (p.Thr130Ala)	RET	T130A	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000644444	10	43597840	10	43102392	644444	638867	rs1588863938	NC_000010.11:43102391:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 30, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.389C>T (p.Thr130Ile)	RET	T130I	Hereditary cancer-predisposing syndrome	VCV003432291	10	43597841	10	43102393	3432291	3593487		NC_000010.11:43102392:C:T	single nucleotide variant	missense variant|intron variant	Likely benign	Nov 20, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.390A>G (p.Thr130=)	RET		Multiple endocrine neoplasia, type 2	VCV003070293	10	43597842	10	43102394	3070293	3231781		NC_000010.11:43102393:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 3, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.391T>A (p.Ser131Thr)	RET	S131T	Hereditary cancer-predisposing syndrome	VCV003432260	10	43597843	10	43102395	3432260	3593456		NC_000010.11:43102394:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 16, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.391T>C (p.Ser131Pro)	RET	S131P	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000650107	10	43597843	10	43102395	650107	638868	rs375576038	NC_000010.11:43102394:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.393C>G (p.Ser131=)	RET		Multiple endocrine neoplasia, type 2	VCV003717616	10	43597845	10	43102397	3717616	3852592		NC_000010.11:43102396:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 17, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.394C>T (p.Leu132Phe)	RET	L132F	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001521138	10	43597846	10	43102398	1521138	1446791	rs1554817540	NC_000010.11:43102397:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.394C>G (p.Leu132Val)	RET	L132V	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001051717	10	43597846	10	43102398	1051717	1046527	rs1554817540	NC_000010.11:43102397:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.394C>A (p.Leu132Ile)	RET	L132I	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000486339	10	43597846	10	43102398	486339	475264	rs1554817540	NC_000010.11:43102397:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.395T>G (p.Leu132Arg)	RET	L132R	Multiple endocrine neoplasia, type 2	VCV002133388	10	43597847	10	43102399	2133388	2190077		NC_000010.11:43102398:T:G	single nucleotide variant	missense variant	Uncertain significance	May 4, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.396T>G (p.Leu132=)	RET		Multiple endocrine neoplasia, type 2	VCV003069902	10	43597848	10	43102400	3069902	3233477		NC_000010.11:43102399:T:G	single nucleotide variant	intron variant|synonymous variant	Likely benign	Mar 23, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.396T>A (p.Leu132=)	RET		Multiple endocrine neoplasia, type 2	VCV001937853	10	43597848	10	43102400	1937853	1996727		NC_000010.11:43102399:T:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 8, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.396T>C (p.Leu132=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001116666	10	43597848	10	43102400	1116666	1098672	rs2132679255	NC_000010.11:43102399:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.397C>G (p.Arg133Gly)	RET	R133G	Hereditary cancer-predisposing syndrome	VCV002587886	10	43597849	10	43102401	2587886	2760710		NC_000010.11:43102400:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 30, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.397C>T (p.Arg133Cys)	RET	R133C	Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Multiple endocrine neoplasia, type 2	VCV000577359	10	43597849	10	43102401	577359	566263	rs1564490056	NC_000010.11:43102400:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.398G>T (p.Arg133Leu)	RET	R133L	Multiple endocrine neoplasia, type 2	VCV002732999	10	43597850	10	43102402	2732999	2894327		NC_000010.11:43102401:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 25, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.398G>C (p.Arg133Pro)	RET	R133P	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000824463	10	43597850	10	43102402	824463	809885	rs138265837	NC_000010.11:43102401:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 13, 2021	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.398G>A (p.Arg133His)	RET	R133H	Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Familial medullary thyroid carcinoma|Hereditary cancer-predisposing syndrome|not provided|not specified|Multiple endocrine neoplasia, type 2	VCV000568215	10	43597850	10	43102402	568215	564567	rs138265837	NC_000010.11:43102401:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 19, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.399T>C (p.Arg133=)	RET		Hereditary cancer-predisposing syndrome	VCV001736841	10	43597851	10	43102403	1736841	1793883		NC_000010.11:43102402:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 1, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.400G>A (p.Glu134Lys)	RET	E134K	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001495459	10	43597852	10	43102404	1495459	1462508	rs2132679409	NC_000010.11:43102403:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.402G>A (p.Glu134=)	RET		Hereditary cancer-predisposing syndrome	VCV002568334	10	43597854	10	43102406	2568334	2734871		NC_000010.11:43102405:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 3, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.405C>T (p.Gly135=)	RET		Hereditary cancer-predisposing syndrome|not provided|RET-related disorder|Hereditary cancer|Multiple endocrine neoplasia, type 2	VCV000141671	10	43597857	10	43102409	141671	151385	rs142345108	NC_000010.11:43102408:C:T	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Feb 3, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.406G>A (p.Glu136Lys)	RET	E136K	Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Ovarian cancer|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|not provided	VCV000216727	10	43597858	10	43102410	216727	212768	rs79014735	NC_000010.11:43102409:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.406G>T (p.Glu136Ter)	RET	E136*	Hirschsprung disease, susceptibility to, 1	VCV000013912	10	43597858	10	43102410	13912	28951	rs79014735	NC_000010.11:43102409:G:T	single nucleotide variant	nonsense	risk factor	Jan 27, 1994	no assertion criteria provided							
NM_020975.6(RET):c.407A>G (p.Glu136Gly)	RET	E136G	Multiple endocrine neoplasia, type 2	VCV002093435	10	43597859	10	43102411	2093435	2156515		NC_000010.11:43102410:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.408G>C (p.Glu136Asp)	RET	E136D	Multiple endocrine neoplasia, type 2	VCV003387585	10	43597860	10	43102412	3387585	3546718		NC_000010.11:43102411:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 6, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.408G>A (p.Glu136=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001737723	10	43597860	10	43102412	1737723	1787586		NC_000010.11:43102411:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.413A>G (p.Gln138Arg)	RET	Q138R	Multiple endocrine neoplasia, type 2|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B	VCV003594487	10	43597865	10	43102417	3594487	3729070		NC_000010.11:43102416:A:G	single nucleotide variant	intron variant|missense variant	Uncertain significance	May 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.414G>A (p.Gln138=)	RET		Multiple endocrine neoplasia, type 2	VCV000761424	10	43597866	10	43102418	761424	767724	rs1588863961	NC_000010.11:43102417:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.418C>G (p.Pro140Ala)	RET	P140A	Multiple endocrine neoplasia, type 2	VCV003071118	10	43597870	10	43102422	3071118	3228699		NC_000010.11:43102421:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 16, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.421G>A (p.Gly141Ser)	RET	G141S	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001738821	10	43597873	10	43102425	1738821	1787820		NC_000010.11:43102424:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 17, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.422G>C (p.Gly141Ala)	RET	G141A	Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV001002252	10	43597874	10	43102426	1002252	993803	rs770840152	NC_000010.11:43102425:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.423C>G (p.Gly141=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000640429	10	43597875	10	43102427	640429	638869	rs1554817548	NC_000010.11:43102426:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.423C>T (p.Gly141=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000486345	10	43597875	10	43102427	486345	475255	rs1554817548	NC_000010.11:43102426:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 5, 2021	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.426T>C (p.Cys142=)	RET		Multiple endocrine neoplasia, type 2	VCV003073409	10	43597878	10	43102430	3073409	3234365		NC_000010.11:43102429:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 17, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.428C>T (p.Ala143Val)	RET	A143V	Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome	VCV000584744	10	43597880	10	43102432	584744	575800	rs1564490082	NC_000010.11:43102431:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.429C>T (p.Ala143=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002909621	10	43597881	10	43102433	2909621	3078290		NC_000010.11:43102432:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Feb 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.430C>T (p.Arg144Cys)	RET	R144C	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2	VCV000824780	10	43597882	10	43102434	824780	809886	rs1588863984	NC_000010.11:43102433:C:T	single nucleotide variant	missense variant	Uncertain significance	May 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.431G>A (p.Arg144His)	RET	R144H	Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Familial medullary thyroid carcinoma|not provided	VCV000216729	10	43597883	10	43102435	216729	212769	rs551142665	NC_000010.11:43102434:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.432C>T (p.Arg144=)	RET		Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1	VCV000299888	10	43597884	10	43102436	299888	315392	rs756999107	NC_000010.11:43102435:C:T	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Jan 20, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.433G>A (p.Val145Ile)	RET	V145I	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Congenital central hypoventilation|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Familial medullary thyroid carcinoma|not provided	VCV000573409	10	43597885	10	43102437	573409	563694	rs1311922451	NC_000010.11:43102436:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 29, 2023	criteria provided, conflicting classifications							
NM_020975.6(RET):c.435A>G (p.Val145=)	RET		Multiple endocrine neoplasia, type 2	VCV002719570	10	43597887	10	43102439	2719570	2870206		NC_000010.11:43102438:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 30, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.436T>C (p.Tyr146His)	RET	Y146H	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002031394	10	43597888	10	43102440	2031394	2079036		NC_000010.11:43102439:T:C	single nucleotide variant	missense variant	Uncertain significance	May 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.438C>T (p.Tyr146=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001101423	10	43597890	10	43102442	1101423	1098673	rs1837660442	NC_000010.11:43102441:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.440_442del (p.Phe147del)	RET	F147del	not provided	VCV000988524	10	43597890 - 43597892	10	43102442 - 43102444	988524	976324	rs1837660523	NC_000010.11:43102441:CTTCT:CT	Deletion	inframe_indel|inframe_deletion	Pathogenic	Aug 31, 2015	criteria provided, single submitter							
NM_020975.6(RET):c.440T>C (p.Phe147Ser)	RET	F147S	Aganglionic megacolon	VCV000599631	10	43597892	10	43102444	599631	590967	rs1564490097	NC_000010.11:43102443:T:C	single nucleotide variant	missense variant	Likely pathogenic	Jan 1, 2013	no assertion criteria provided							
NM_020975.6(RET):c.443_445del (p.Ser148del)	RET	S148del	Multiple endocrine neoplasia, type 2|not provided|Hereditary cancer-predisposing syndrome	VCV002916120	10	43597893 - 43597895	10	43102445 - 43102447	2916120	3071629		NC_000010.11:43102444:CTCCT:CT	Deletion	inframe_indel|inframe_deletion|intron variant	Conflicting classifications of pathogenicity	May 1, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.443C>T (p.Ser148Phe)	RET	S148F	Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000856445	10	43597895	10	43102447	856445	836809	rs1837660663	NC_000010.11:43102446:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.444C>T (p.Ser148=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002703733	10	43597896	10	43102448	2703733	2856160		NC_000010.11:43102447:C:T	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Mar 28, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.445TTC[1] (p.Phe150del)	RET	F150del	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|not provided	VCV001016306	10	43597896 - 43597898	10	43102448 - 43102450	1016306	1008982	rs776989694	NC_000010.11:43102447:CTTCTTC:CTTC	Microsatellite	inframe_indel|inframe_deletion	Uncertain significance	May 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.444C>G (p.Ser148=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000486355	10	43597896	10	43102448	486355	475070	rs1554817550	NC_000010.11:43102447:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.446T>C (p.Phe149Ser)	RET	F149S	Hereditary cancer-predisposing syndrome	VCV003432247	10	43597898	10	43102450	3432247	3593443		NC_000010.11:43102449:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 22, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.447C>A (p.Phe149Leu)	RET	F149L	Hereditary cancer-predisposing syndrome	VCV003432283	10	43597899	10	43102451	3432283	3593479		NC_000010.11:43102450:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 14, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.447C>T (p.Phe149=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001609402	10	43597899	10	43102451	1609402	1638915	rs989787527	NC_000010.11:43102450:C:T	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Jun 16, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.450C>T (p.Phe150=)	RET		Multiple endocrine neoplasia, type 2	VCV001117863	10	43597902	10	43102454	1117863	1098674	rs2132680883	NC_000010.11:43102453:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 19, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.451A>G (p.Asn151Asp)	RET	N151D	Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	VCV001502247	10	43597903	10	43102455	1502247	1411463	rs1837661067	NC_000010.11:43102454:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.452A>T (p.Asn151Ile)	RET	N151I	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A	VCV001001213	10	43597904	10	43102456	1001213	993804	rs150261092	NC_000010.11:43102455:A:T	single nucleotide variant	missense variant	Uncertain significance	Jul 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.452A>G (p.Asn151Ser)	RET	N151S	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not provided|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A	VCV000486321	10	43597904	10	43102456	486321	475257	rs150261092	NC_000010.11:43102455:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 11, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.454A>G (p.Thr152Ala)	RET	T152A	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002454156	10	43597906	10	43102458	2454156	2424045		NC_000010.11:43102457:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Mar 31, 2023	criteria provided, conflicting classifications							
NM_020975.6(RET):c.455C>G (p.Thr152Ser)	RET	T152S	Hereditary cancer-predisposing syndrome	VCV002568359	10	43597907	10	43102459	2568359	2734895		NC_000010.11:43102458:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 25, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.455C>T (p.Thr152Ile)	RET	T152I	Multiple endocrine neoplasia, type 2	VCV001022158	10	43597907	10	43102459	1022158	1008983	rs1837661343	NC_000010.11:43102458:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 14, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.457T>A (p.Ser153Thr)	RET	S153T	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000486325	10	43597909	10	43102461	486325	475076	rs1341922880	NC_000010.11:43102460:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 25, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.458C>A (p.Ser153Tyr)	RET	S153Y	Multiple endocrine neoplasia, type 2	VCV003074062	10	43597910	10	43102462	3074062	3231198		NC_000010.11:43102461:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 23, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.462T>C (p.Phe154=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001095666	10	43597914	10	43102466	1095666	1077029	rs948436105	NC_000010.11:43102465:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Feb 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.463C>T (p.Pro155Ser)	RET	P155S	RET-related disorder	VCV002630957	10	43597915	10	43102467	2630957	2796712		NC_000010.11:43102466:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 27, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.464C>A (p.Pro155Gln)	RET	P155Q	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1	VCV000477375	10	43597916	10	43102468	477375	460247	rs999019810	NC_000010.11:43102467:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.467C>T (p.Ala156Val)	RET	A156V, T113I	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000825089	10	43597919	10	43102471	825089	809887	rs1588864039	NC_000010.11:43102470:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 13, 2023	criteria provided, conflicting classifications							
NM_020975.6(RET):c.468C>T (p.Ala156=)	RET		Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2|not specified|not provided|Hereditary cancer-predisposing syndrome	VCV000215531	10	43597920	10	43102472	215531	212770	rs141290380	NC_000010.11:43102471:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.471C>T (p.Cys157=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002065585	10	43597923	10	43102475	2065585	2118274		NC_000010.11:43102474:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.473G>A (p.Ser158Asn)	RET	S158N, S115N	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A	VCV000840446	10	43597925	10	43102477	840446	836810	rs780067540	NC_000010.11:43102476:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.475T>A (p.Ser159Thr)	RET	S159T, S116T	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001053217	10	43597927	10	43102479	1053217	1046528	rs2132681533	NC_000010.11:43102478:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 16, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.477C>T (p.Ser159=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001743032	10	43597929	10	43102481	1743032	1809113		NC_000010.11:43102480:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.478C>T (p.Leu160Phe)	RET	L160F, L117F	Hereditary cancer-predisposing syndrome|not provided|not specified|Multiple endocrine neoplasia, type 2	VCV000486343	10	43597930	10	43102482	486343	475081	rs747536732	NC_000010.11:43102481:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.480C>G (p.Leu160=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001577622	10	43597932	10	43102484	1577622	1553658	rs1837662149	NC_000010.11:43102483:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Feb 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.482A>G (p.Lys161Arg)	RET	K118R, K161R	Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A	VCV003594512	10	43597934	10	43102486	3594512	3729078		NC_000010.11:43102485:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 13, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.482A>C (p.Lys161Thr)	RET	K161T, K118T	Hereditary cancer-predisposing syndrome	VCV002568346	10	43597934	10	43102486	2568346	2734882		NC_000010.11:43102485:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 1, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.483G>T (p.Lys161Asn)	RET	K118N, K161N	Multiple endocrine neoplasia, type 2	VCV002413406	10	43597935	10	43102487	2413406	1946742		NC_000010.11:43102486:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 23, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.483G>A (p.Lys161=)	RET		Multiple endocrine neoplasia, type 2	VCV001112872	10	43597935	10	43102487	1112872	1098675	rs2132681767	NC_000010.11:43102486:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 14, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.484C>G (p.Pro162Ala)	RET	P119A, P162A	Multiple endocrine neoplasia, type 2	VCV003669444	10	43597936	10	43102488	3669444	3796720		NC_000010.11:43102487:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 27, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.484C>A (p.Pro162Thr)	RET	P162T, P119T	Multiple endocrine neoplasia, type 2	VCV000842398	10	43597936	10	43102488	842398	836811	rs1564490122	NC_000010.11:43102487:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.484C>T (p.Pro162Ser)	RET	P162S, P119S	Multiple endocrine neoplasia|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia, type 2|Renal hypodysplasia/aplasia 1	VCV000568416	10	43597936	10	43102488	568416	569630	rs1564490122	NC_000010.11:43102487:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.485C>G (p.Pro162Arg)	RET	P162R, P119R	Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV002138848	10	43597937	10	43102489	2138848	1878520		NC_000010.11:43102488:C:G	single nucleotide variant	missense variant	Uncertain significance	May 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.485C>T (p.Pro162Leu)	RET	P162L, P119L	Hereditary cancer-predisposing syndrome	VCV001743624	10	43597937	10	43102489	1743624	1801971		NC_000010.11:43102488:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 27, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.485C>A (p.Pro162His)	RET	P162H, P119H	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	VCV001480894	10	43597937	10	43102489	1480894	1429105	rs1205703835	NC_000010.11:43102488:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.486C>G (p.Pro162=)	RET		Multiple endocrine neoplasia, type 2	VCV002181052	10	43597938	10	43102490	2181052	1920153		NC_000010.11:43102489:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 14, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.487C>T (p.Arg163Trp)	RET	R163W, R120W	Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000992568	10	43597939	10	43102491	992568	980494	rs371153966	NC_000010.11:43102490:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.487C>A (p.Arg163=)	RET		Renal hypodysplasia/aplasia 1|Hereditary cancer-predisposing syndrome|not provided|Pheochromocytoma|Multiple endocrine neoplasia|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1	VCV000477377	10	43597939	10	43102491	477377	460677	rs371153966	NC_000010.11:43102490:C:A	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Feb 2, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.488G>T (p.Arg163Leu)	RET	R120L, R163L	not provided	VCV002574749	10	43597940	10	43102492	2574749	2739685		NC_000010.11:43102491:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 7, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.488G>A (p.Arg163Gln)	RET	R163Q, R120Q	Multiple endocrine neoplasia type 2A|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000135184	10	43597940	10	43102492	135184	138923	rs149403911	NC_000010.11:43102491:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 8, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.492G>C (p.Glu164Asp)	RET	E121D, E164D	Hereditary cancer-predisposing syndrome	VCV003227560	10	43597944	10	43102496	3227560	3390771		NC_000010.11:43102495:G:C	single nucleotide variant	missense variant|intron variant	Likely benign	Oct 19, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.498C>T (p.Cys166=)	RET		Hereditary cancer-predisposing syndrome	VCV001744576	10	43597950	10	43102502	1744576	1809357		NC_000010.11:43102501:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 17, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.499T>C (p.Phe167Leu)	RET	F124L, F167L	Multiple endocrine neoplasia, type 2	VCV003663519	10	43597951	10	43102503	3663519	3798110		NC_000010.11:43102502:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 27, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.499T>G (p.Phe167Val)	RET	F124V, F167V	not provided	VCV002497782	10	43597951	10	43102503	2497782	2472865		NC_000010.11:43102502:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 5, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.502C>G (p.Pro168Ala)	RET	P125A, P168A	Hereditary cancer-predisposing syndrome	VCV002305464	10	43597954	10	43102506	2305464	2293517		NC_000010.11:43102505:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 8, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.503C>T (p.Pro168Leu)	RET	P125L, P168L	Multiple endocrine neoplasia, type 2	VCV002715581	10	43597955	10	43102507	2715581	2872706		NC_000010.11:43102506:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 15, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.503C>A (p.Pro168Gln)	RET	P168Q, P125Q	Hereditary cancer-predisposing syndrome	VCV002587880	10	43597955	10	43102507	2587880	2760704		NC_000010.11:43102506:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 13, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.505G>C (p.Glu169Gln)	RET	E169Q, E126Q	Multiple endocrine neoplasia, type 2	VCV002817036	10	43597957	10	43102509	2817036	2980694		NC_000010.11:43102508:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 28, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.505G>A (p.Glu169Lys)	RET	E126K, E169K	Multiple endocrine neoplasia, type 2	VCV002806256	10	43597957	10	43102509	2806256	2971188		NC_000010.11:43102508:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.507G>C (p.Glu169Asp)	RET	E126D, E169D	Multiple endocrine neoplasia, type 2	VCV002700620	10	43597959	10	43102511	2700620	2855619		NC_000010.11:43102510:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 3, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.507G>A (p.Glu169=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001745209	10	43597959	10	43102511	1745209	1806055		NC_000010.11:43102510:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 16, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.509C>T (p.Thr170Ile)	RET	T170I, T127I	Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2B|not provided	VCV000041844	10	43597961	10	43102513	41844	50283	rs200547906	NC_000010.11:43102512:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.510A>T (p.Thr170=)	RET		Hereditary cancer-predisposing syndrome	VCV002587879	10	43597962	10	43102514	2587879	2760703		NC_000010.11:43102513:A:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 13, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.510A>G (p.Thr170=)	RET		Hereditary cancer-predisposing syndrome	VCV002454126	10	43597962	10	43102514	2454126	2424015		NC_000010.11:43102513:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 11, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.511A>C (p.Arg171=)	RET		Hereditary cancer-predisposing syndrome	VCV002568347	10	43597963	10	43102515	2568347	2734883		NC_000010.11:43102514:A:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 1, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.512G>T (p.Arg171Met)	RET	R171M, R128M	Multiple endocrine neoplasia, type 2	VCV003717083	10	43597964	10	43102516	3717083	3859078		NC_000010.11:43102515:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 14, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.512G>A (p.Arg171Lys)	RET	R128K, R171K	Hereditary cancer-predisposing syndrome	VCV001745536	10	43597964	10	43102516	1745536	1802588		NC_000010.11:43102515:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 27, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.516C>T (p.Pro172=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000825500	10	43597968	10	43102520	825500	809888	rs1588864070	NC_000010.11:43102519:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 2, 2021	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.517T>C (p.Ser173Pro)	RET	S173P, S130P	Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000220056	10	43597969	10	43102521	220056	221945	rs864622361	NC_000010.11:43102520:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.518C>T (p.Ser173Phe)	RET	S130F, S173F	Hirschsprung disease, susceptibility to, 1	VCV003240303	10	43597970	10	43102522	3240303	3399290		NC_000010.11:43102521:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 8, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.520T>G (p.Phe174Val)	RET	F174V, F131V	Multiple endocrine neoplasia, type 2	VCV003697829	10	43597972	10	43102524	3697829	3829424		NC_000010.11:43102523:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 12, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.525_530dup (p.Arg177_Glu178insIleArg)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002454139	10	43597974 - 43597975	10	43102526 - 43102527	2454139	2424028		NC_000010.11:43102526:CGCATTCG:CGCATTCGCATTCG	Duplication	inframe_indel|inframe_insertion|intron variant	Uncertain significance	Jan 31, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.522C>T (p.Phe174=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001746210	10	43597974	10	43102526	1746210	1809699		NC_000010.11:43102525:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 28, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.523C>G (p.Arg175Gly)	RET	R175G, R132G	Multiple endocrine neoplasia, type 2|not provided|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Hereditary cancer-predisposing syndrome	VCV000641521	10	43597975	10	43102527	641521	638870	rs1057521088	NC_000010.11:43102526:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.523C>T (p.Arg175Cys)	RET	R175C, R132C	not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000381592	10	43597975	10	43102527	381592	370742	rs1057521088	NC_000010.11:43102526:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.524G>C (p.Arg175Pro)	RET	R132P, R175P	not provided	VCV003337517	10	43597976	10	43102528	3337517	3496178		NC_000010.11:43102527:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 27, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.524G>T (p.Arg175Leu)	RET	R132L, R175L	Multiple endocrine neoplasia, type 2	VCV002113647	10	43597976	10	43102528	2113647	2161182		NC_000010.11:43102527:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 18, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.524G>A (p.Arg175His)	RET	R175H, R132H	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001351167	10	43597976	10	43102528	1351167	1407517	rs774097284	NC_000010.11:43102527:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.526A>T (p.Ile176Phe)	RET	I176F, I133F	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000650583	10	43597978	10	43102530	650583	638871	rs1588864080	NC_000010.11:43102529:A:T	single nucleotide variant	missense variant	Uncertain significance	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.528T>A (p.Ile176=)	RET		Multiple endocrine neoplasia, type 2	VCV000543780	10	43597980	10	43102532	543780	525078	rs556686338	NC_000010.11:43102531:T:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 6, 2017	criteria provided, single submitter							
NM_020975.6(RET):c.528T>G (p.Ile176Met)	RET	I176M, I133M	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000241363	10	43597980	10	43102532	241363	240785	rs556686338	NC_000010.11:43102531:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.529C>G (p.Arg177Gly)	RET	R134G, R177G	Multiple endocrine neoplasia, type 2	VCV003706449	10	43597981	10	43102533	3706449	3836021		NC_000010.11:43102532:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 1, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.532dup (p.Glu178fs)	RET	E178fs	Hereditary cancer-predisposing syndrome	VCV001746871	10	43597981 - 43597982	10	43102533 - 43102534	1746871	1806416		NC_000010.11:43102533:GGG:GGGG	Duplication	frameshift variant	Pathogenic	Sep 16, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.529C>T (p.Arg177Trp)	RET	R177W, R134W	Multiple endocrine neoplasia, type 2|not provided|Hereditary cancer-predisposing syndrome	VCV000405526	10	43597981	10	43102533	405526	397253	rs765654609	NC_000010.11:43102532:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.530G>A (p.Arg177Gln)	RET	R177Q, R134Q	not provided|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Familial medullary thyroid carcinoma	VCV000405549	10	43597982	10	43102534	405549	397681	rs759229505	NC_000010.11:43102533:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 21, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.531G>A (p.Arg177=)	RET		Multiple endocrine neoplasia, type 2	VCV003721615	10	43597983	10	43102535	3721615	3850116		NC_000010.11:43102534:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 27, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.535A>G (p.Asn179Asp)	RET	N179D, N136D	Multiple endocrine neoplasia, type 2	VCV001450359	10	43597987	10	43102539	1450359	1436239	rs2132682955	NC_000010.11:43102538:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 24, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.536A>G (p.Asn179Ser)	RET	N179S, N136S	Multiple endocrine neoplasia, type 2	VCV000405533	10	43597988	10	43102540	405533	397255	rs1060500757	NC_000010.11:43102539:A:G	single nucleotide variant	missense variant	Uncertain significance	May 5, 2016	criteria provided, single submitter							
NM_020975.6(RET):c.537C>T (p.Asn179=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001636291	10	43597989	10	43102541	1636291	1558198	rs1837664079	NC_000010.11:43102540:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.538C>G (p.Arg180Gly)	RET	R137G, R180G	Hereditary cancer-predisposing syndrome	VCV003227562	10	43597990	10	43102542	3227562	3390773		NC_000010.11:43102541:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 16, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.538C>T (p.Arg180Ter)	RET	R180*, R137*	Multiple endocrine neoplasia, type 2	VCV000013925	10	43597990	10	43102542	13925	28964	rs76449634	NC_000010.11:43102541:C:T	single nucleotide variant	nonsense	Pathogenic	Jun 19, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.539G>A (p.Arg180Gln)	RET	R180Q, R137Q	Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|Aganglionic megacolon|not provided|Hereditary cancer-predisposing syndrome	VCV000161360	10	43597991	10	43102543	161360	171124	rs370736139	NC_000010.11:43102542:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 27, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.541C>T (p.Pro181Ser)	RET	P138S, P181S	Multiple endocrine neoplasia, type 2	VCV002771183	10	43597993	10	43102545	2771183	2933199		NC_000010.11:43102544:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 23, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.541C>G (p.Pro181Ala)	RET	P138A, P181A	Hereditary cancer-predisposing syndrome	VCV001747425	10	43597993	10	43102545	1747425	1799723		NC_000010.11:43102544:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 16, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.542C>T (p.Pro181Leu)	RET	P181L, P138L	Hereditary cancer-predisposing syndrome	VCV000825727	10	43597994	10	43102546	825727	809889	rs1588864107	NC_000010.11:43102545:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 6, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.543C>T (p.Pro181=)	RET		Hereditary cancer-predisposing syndrome	VCV003313743	10	43597995	10	43102547	3313743	3465473		NC_000010.11:43102546:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 7, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.543C>G (p.Pro181=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000755947	10	43597995	10	43102547	755947	767725	rs1456922776	NC_000010.11:43102546:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.544C>A (p.Pro182Thr)	RET	P182T, P139T	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|not specified|not provided	VCV000505008	10	43597996	10	43102548	505008	496944	rs775086466	NC_000010.11:43102547:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.544C>T (p.Pro182Ser)	RET	P182S, P139S	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000232332	10	43597996	10	43102548	232332	233776	rs775086466	NC_000010.11:43102547:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 18, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.545C>T (p.Pro182Leu)	RET	P139L, P182L	Hereditary cancer-predisposing syndrome|not provided	VCV002568329	10	43597997	10	43102549	2568329	2734866		NC_000010.11:43102548:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.546A>G (p.Pro182=)	RET		Multiple endocrine neoplasia, type 2	VCV002140430	10	43597998	10	43102550	2140430	1878804		NC_000010.11:43102549:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 5, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.547G>A (p.Gly183Ser)	RET	G183S, G140S	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000405544	10	43597999	10	43102551	405544	397683	rs1060500760	NC_000010.11:43102550:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.548G>A (p.Gly183Asp)	RET	G183D, G140D	Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000188067	10	43598000	10	43102552	188067	186116	rs144801580	NC_000010.11:43102551:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 5, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.549C>G (p.Gly183=)	RET		Multiple endocrine neoplasia, type 2	VCV002816368	10	43598001	10	43102553	2816368	2977038		NC_000010.11:43102552:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 24, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.549C>T (p.Gly183=)	RET		Multiple endocrine neoplasia, type 2	VCV002022345	10	43598001	10	43102553	2022345	2080253		NC_000010.11:43102552:C:T	single nucleotide variant	intron variant|synonymous variant	Likely benign	Aug 7, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.550A>G (p.Thr184Ala)	RET	T184A, T141A	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000486341	10	43598002	10	43102554	486341	475082	rs753301491	NC_000010.11:43102553:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 24, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.551C>A (p.Thr184Asn)	RET	T141N, T184N	Hereditary cancer-predisposing syndrome	VCV003432235	10	43598003	10	43102555	3432235	3593431		NC_000010.11:43102554:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 18, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.551C>T (p.Thr184Ile)	RET	T184I, T141I	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000956314	10	43598003	10	43102555	956314	946873	rs1837665130	NC_000010.11:43102554:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.553T>G (p.Phe185Val)	RET	F185V, F142V	Hereditary cancer-predisposing syndrome	VCV000825816	10	43598005	10	43102557	825816	809890	rs1048022444	NC_000010.11:43102556:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.553T>C (p.Phe185Leu)	RET	F185L, F142L	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000486302	10	43598005	10	43102557	486302	475057	rs1048022444	NC_000010.11:43102556:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.555C>A (p.Phe185Leu)	RET	F185L, F142L	Multiple endocrine neoplasia, type 2	VCV002150730	10	43598007	10	43102559	2150730	1888225		NC_000010.11:43102558:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 1, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.555C>T (p.Phe185=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001077919	10	43598007	10	43102559	1077919	1077030	rs2132683519	NC_000010.11:43102558:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.556C>T (p.His186Tyr)	RET	H186Y, H143Y	Hereditary cancer-predisposing syndrome	VCV001748354	10	43598008	10	43102560	1748354	1806602		NC_000010.11:43102559:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 9, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.557A>T (p.His186Leu)	RET	H143L, H186L	Hereditary cancer-predisposing syndrome	VCV003432306	10	43598009	10	43102561	3432306	3593502		NC_000010.11:43102560:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 8, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.558C>T (p.His186=)	RET		Hereditary cancer-predisposing syndrome	VCV002568328	10	43598010	10	43102562	2568328	2734865		NC_000010.11:43102561:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 20, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.559C>G (p.Gln187Glu)	RET	Q187E, Q144E	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV003003809	10	43598011	10	43102563	3003809	3157692		NC_000010.11:43102562:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.560A>G (p.Gln187Arg)	RET	Q144R, Q187R	Multiple endocrine neoplasia, type 2	VCV003071794	10	43598012	10	43102564	3071794	3234059		NC_000010.11:43102563:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 26, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.561G>T (p.Gln187His)	RET	Q144H, Q187H	Multiple endocrine neoplasia, type 2	VCV002699147	10	43598013	10	43102565	2699147	2865270		NC_000010.11:43102564:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 27, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.561G>C (p.Gln187His)	RET	Q187H, Q144H	Multiple endocrine neoplasia, type 2	VCV001510055	10	43598013	10	43102565	1510055	1445974	rs764162555	NC_000010.11:43102564:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 1, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.561G>A (p.Gln187=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001096982	10	43598013	10	43102565	1096982	1077031	rs764162555	NC_000010.11:43102564:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.562T>G (p.Phe188Val)	RET	F188V, F145V	Hereditary cancer-predisposing syndrome	VCV002568348	10	43598014	10	43102566	2568348	2734884		NC_000010.11:43102565:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 1, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.564C>T (p.Phe188=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001748847	10	43598016	10	43102568	1748847	1803300		NC_000010.11:43102567:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.564C>A (p.Phe188Leu)	RET	F145L, F188L	Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001748837	10	43598016	10	43102568	1748837	1803290		NC_000010.11:43102567:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.565C>G (p.Arg189Gly)	RET	R189G, R146G	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001387427	10	43598017	10	43102569	1387427	1474152	rs1210452561	NC_000010.11:43102568:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.565C>T (p.Arg189Cys)	RET	R189C, R146C	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Familial medullary thyroid carcinoma	VCV001044947	10	43598017	10	43102569	1044947	1029526	rs1210452561	NC_000010.11:43102568:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.566G>T (p.Arg189Leu)	RET	R189L, R146L	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001019430	10	43598018	10	43102570	1019430	1008984	rs753707182	NC_000010.11:43102569:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 25, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.566G>A (p.Arg189His)	RET	R189H, R146H	Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1	VCV000477378	10	43598018	10	43102570	477378	460251	rs753707182	NC_000010.11:43102569:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 14, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.567C>T (p.Arg189=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001640900	10	43598019	10	43102571	1640900	1550571	rs2132683772	NC_000010.11:43102570:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.569TGC[1] (p.Leu191del)	RET	L191del, L148del	Multiple endocrine neoplasia, type 2	VCV001411855	10	43598020 - 43598022	10	43102572 - 43102574	1411855	1348995	rs2132683821	NC_000010.11:43102571:CTGCTGC:CTGC	Microsatellite	inframe_indel|inframe_deletion	Uncertain significance	Oct 21, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.569T>C (p.Leu190Pro)	RET	L147P, L190P	Multiple endocrine neoplasia, type 2	VCV003623962	10	43598021	10	43102573	3623962	3751761		NC_000010.11:43102572:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 30, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.572T>A (p.Leu191Gln)	RET	L191Q, L148Q	Multiple endocrine neoplasia, type 2	VCV002731565	10	43598024	10	43102576	2731565	2890320		NC_000010.11:43102575:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.572T>C (p.Leu191Pro)	RET	L191P, L148P	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001749328	10	43598024	10	43102576	1749328	1800356		NC_000010.11:43102575:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 11, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.575C>G (p.Pro192Arg)	RET	P192R, P149R	Hereditary cancer-predisposing syndrome	VCV001749468	10	43598027	10	43102579	1749468	1800496		NC_000010.11:43102578:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 27, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.576T>C (p.Pro192=)	RET		Hereditary cancer-predisposing syndrome	VCV002568322	10	43598028	10	43102580	2568322	2734859		NC_000010.11:43102579:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 15, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.577G>T (p.Val193Leu)	RET	V193L, V150L	Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000543721	10	43598029	10	43102581	543721	525596	rs1008123818	NC_000010.11:43102580:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.582G>C (p.Gln194His)	RET	Q194H, Q151H	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001505940	10	43598034	10	43102586	1505940	1339670	rs368116579	NC_000010.11:43102585:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.582G>A (p.Gln194=)	RET		Hereditary cancer-predisposing syndrome|not specified|Multiple endocrine neoplasia, type 2|not provided|Multiple endocrine neoplasia type 2B	VCV000216730	10	43598034	10	43102586	216730	212771	rs368116579	NC_000010.11:43102585:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.585C>T (p.Phe195=)	RET		not provided|Hereditary cancer-predisposing syndrome	VCV002496747	10	43598037	10	43102589	2496747	2467886		NC_000010.11:43102588:C:T	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Jan 24, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.586T>C (p.Leu196=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001115602	10	43598038	10	43102590	1115602	1098676	rs2132684088	NC_000010.11:43102589:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 7, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.588G>T (p.Leu196Phe)	RET	L153F, L196F	Multiple endocrine neoplasia, type 2	VCV003641644	10	43598040	10	43102592	3641644	3775801		NC_000010.11:43102591:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 13, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.588G>C (p.Leu196Phe)	RET	L196F, L153F	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001491746	10	43598040	10	43102592	1491746	1342783	rs2132684107	NC_000010.11:43102591:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.591C>T (p.Cys197=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001750494	10	43598043	10	43102595	1750494	1803644		NC_000010.11:43102594:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.592C>G (p.Pro198Ala)	RET	P198A, P155A	Hereditary cancer-predisposing syndrome	VCV001750544	10	43598044	10	43102596	1750544	1803694		NC_000010.11:43102595:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 15, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.592C>T (p.Pro198Ser)	RET	P198S, P155S	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma	VCV001481718	10	43598044	10	43102596	1481718	1367236	rs76736111	NC_000010.11:43102595:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.592C>A (p.Pro198Thr)	RET	P198T, P155T	Renal hypodysplasia/aplasia 1	VCV000013956	10	43598044	10	43102596	13956	28995	rs76736111	NC_000010.11:43102595:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 1, 2008	no assertion criteria provided							
NM_020975.6(RET):c.593C>T (p.Pro198Leu)	RET	P198L, P155L	Multiple endocrine neoplasia, type 2	VCV002796144	10	43598045	10	43102597	2796144	2958563		NC_000010.11:43102596:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.596A>G (p.Asn199Ser)	RET	N199S, N156S	Multiple endocrine neoplasia|Pheochromocytoma|Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia, type 2	VCV000299889	10	43598048	10	43102600	299889	321369	rs886046986	NC_000010.11:43102599:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.597C>A (p.Asn199Lys)	RET	N156K, N199K	Hereditary cancer-predisposing syndrome	VCV001750814	10	43598049	10	43102601	1750814	1803964		NC_000010.11:43102600:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 12, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.597C>T (p.Asn199=)	RET		Multiple endocrine neoplasia, type 2|not specified|Pheochromocytoma|not provided|Renal hypodysplasia/aplasia 1|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia|Hereditary cancer-predisposing syndrome	VCV000136121	10	43598049	10	43102601	136121	139833	rs55810667	NC_000010.11:43102600:C:T	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Jan 28, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.601A>C (p.Ser201Arg)	RET	S201R, S158R	Hereditary cancer-predisposing syndrome	VCV003432232	10	43598053	10	43102605	3432232	3593428		NC_000010.11:43102604:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 7, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.602G>A (p.Ser201Asn)	RET	S201N, S158N	Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A	VCV003594539	10	43598054	10	43102606	3594539	3725626		NC_000010.11:43102605:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 20, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.602G>C (p.Ser201Thr)	RET	S201T, S158T	Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia type 2B|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2|not provided|Hereditary cancer-predisposing syndrome	VCV000560871	10	43598054	10	43102606	560871	551860	rs898525501	NC_000010.11:43102605:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 26, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.603C>T (p.Ser201=)	RET		Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1	VCV000477379	10	43598055	10	43102607	477379	460686	rs780120451	NC_000010.11:43102606:C:T	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Apr 3, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.604G>C (p.Val202Leu)	RET	V202L, V159L	Aganglionic megacolon	VCV000599632	10	43598056	10	43102608	599632	590968	rs751572082	NC_000010.11:43102607:G:C	single nucleotide variant	missense variant	Likely pathogenic	Jan 1, 2013	no assertion criteria provided							
NM_020975.6(RET):c.604G>A (p.Val202Met)	RET	V202M, V159M	Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Medulloblastoma|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|not specified|not provided	VCV000184536	10	43598056	10	43102608	184536	182945	rs751572082	NC_000010.11:43102607:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.605T>C (p.Val202Ala)	RET	V159A, V202A	Hereditary cancer-predisposing syndrome	VCV003227563	10	43598057	10	43102609	3227563	3390774		NC_000010.11:43102608:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 29, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.607G>A (p.Ala203Thr)	RET	A203T, A160T	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000826172	10	43598059	10	43102611	826172	809891	rs755007607	NC_000010.11:43102610:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 14, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.609C>A (p.Ala203=)	RET		Multiple endocrine neoplasia, type 2	VCV002695590	10	43598061	10	43102613	2695590	2864277		NC_000010.11:43102612:C:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 13, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.610T>A (p.Tyr204Asn)	RET	Y204N, Y161N	Multiple endocrine neoplasia, type 2	VCV002702163	10	43598062	10	43102614	2702163	2855880		NC_000010.11:43102613:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 11, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.613A>T (p.Arg205Trp)	RET	R205W, R162W	Multiple endocrine neoplasia, type 2	VCV001411762	10	43598065	10	43102617	1411762	1448211	rs1564490234	NC_000010.11:43102616:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 22, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.613A>G (p.Arg205Gly)	RET	R205G, R162G	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	VCV000560872	10	43598065	10	43102617	560872	551861	rs1564490234	NC_000010.11:43102616:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.614G>T (p.Arg205Met)	RET	R205M, R162M	Multiple endocrine neoplasia, type 2	VCV001438591	10	43598066	10	43102618	1438591	1448317	rs1177806121	NC_000010.11:43102617:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 30, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.614G>A (p.Arg205Lys)	RET	R205K, R162K	Multiple endocrine neoplasia, type 2	VCV000966929	10	43598066	10	43102618	966929	956042	rs1177806121	NC_000010.11:43102617:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.615G>C (p.Arg205Ser)	RET	R162S, R205S	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001751943	10	43598067	10	43102619	1751943	1807624		NC_000010.11:43102618:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 23, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.616C>T (p.Leu206Phe)	RET	L206F, L163F	Multiple endocrine neoplasia, type 2	VCV002167280	10	43598068	10	43102620	2167280	1906400		NC_000010.11:43102619:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 18, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.618C>T (p.Leu206=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001561480	10	43598070	10	43102622	1561480	1554905	rs1377770977	NC_000010.11:43102621:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.618C>G (p.Leu206=)	RET		Hereditary cancer-predisposing syndrome	VCV000826231	10	43598070	10	43102622	826231	809892	rs1377770977	NC_000010.11:43102621:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 7, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.619C>T (p.Leu207=)	RET		Multiple endocrine neoplasia, type 2	VCV001652970	10	43598071	10	43102623	1652970	1579470	rs2132684723	NC_000010.11:43102622:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 17, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.621G>A (p.Leu207=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001115853	10	43598073	10	43102625	1115853	1098677	rs1343290853	NC_000010.11:43102624:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.622G>C (p.Glu208Gln)	RET	E208Q, E165Q	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000826259	10	43598074	10	43102626	826259	809893	rs1588864215	NC_000010.11:43102625:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.623A>C (p.Glu208Ala)	RET	E208A, E165A	Multiple endocrine neoplasia, type 2	VCV001447393	10	43598075	10	43102627	1447393	1503448	rs1170238577	NC_000010.11:43102626:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 22, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.624G>C (p.Glu208Asp)	RET	E208D, E165D	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002718478	10	43598076	10	43102628	2718478	2876874		NC_000010.11:43102627:G:C	single nucleotide variant	missense variant|intron variant	Likely benign	Apr 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.624G>T (p.Glu208Asp)	RET	E208D, E165D	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000241365	10	43598076	10	43102628	241365	240786	rs781750106	NC_000010.11:43102627:G:T	single nucleotide variant	missense variant	Benign/Likely benign	Dec 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.625G>A (p.Gly209Ser)	RET	G209S, D166N, G166S, D209N, G209R	Multiple endocrine neoplasia, type 2	VCV000477380	10	43598077	10	43102629	477380	460006	rs1407201816	NC_000010.11:43102628:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 8, 2017	criteria provided, single submitter							
NM_020975.6(RET):c.625+7G>A	RET		Multiple endocrine neoplasia, type 2	VCV001637434	10	43598084	10	43102636	1637434	1525462	rs2132684957	NC_000010.11:43102635:G:A	single nucleotide variant	intron variant	Likely benign	Apr 23, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.625+9C>T	RET		Multiple endocrine neoplasia, type 2	VCV000695637	10	43598086	10	43102638	695637	685272	rs201453349	NC_000010.11:43102637:C:T	single nucleotide variant	intron variant	Likely benign	Dec 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.625+10G>A	RET		not specified|Multiple endocrine neoplasia, type 2	VCV000701551	10	43598087	10	43102639	701551	689981	rs371974705	NC_000010.11:43102638:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Nov 6, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.625+11A>G	RET		Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia, type 2	VCV001560404	10	43598088	10	43102640	1560404	1575895	rs778239396	NC_000010.11:43102639:A:G	single nucleotide variant	intron variant	Likely benign	Dec 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.625+12C>A	RET		Multiple endocrine neoplasia, type 2	VCV003670929	10	43598089	10	43102641	3670929	3804365		NC_000010.11:43102640:C:A	single nucleotide variant	intron variant	Likely benign	Jan 7, 2025	criteria provided, single submitter							
NM_020975.6(RET):c.625+13C>T	RET		Multiple endocrine neoplasia, type 2	VCV001562309	10	43598090	10	43102642	1562309	1577373	rs961333253	NC_000010.11:43102641:C:T	single nucleotide variant	intron variant	Likely benign	Jan 12, 2025	criteria provided, single submitter							
NM_020975.6(RET):c.625+14T>C	RET		Multiple endocrine neoplasia, type 2	VCV002766510	10	43598091	10	43102643	2766510	2928973		NC_000010.11:43102642:T:C	single nucleotide variant	intron variant	Likely benign	May 22, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.625+16G>T	RET		Multiple endocrine neoplasia, type 2	VCV002093472	10	43598093	10	43102645	2093472	2156552		NC_000010.11:43102644:G:T	single nucleotide variant	intron variant	Likely benign	Feb 5, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.625+19G>A	RET		Multiple endocrine neoplasia, type 2	VCV001617955	10	43598096	10	43102648	1617955	1527277	rs2132685126	NC_000010.11:43102647:G:A	single nucleotide variant	intron variant	Likely benign	Nov 19, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.625+118A>G	RET		not provided	VCV000677057	10	43598195	10	43102747	677057	665133	rs2472739	NC_000010.11:43102746:A:G	single nucleotide variant	intron variant	Benign	Jun 15, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.625+139C>T	RET		not provided	VCV000679372	10	43598216	10	43102768	679372	664824	rs115766280	NC_000010.11:43102767:C:T	single nucleotide variant	intron variant	Likely benign	Jun 16, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.625+143C>T	RET		not provided	VCV001711256	10	43598220	10	43102772	1711256	1709672		NC_000010.11:43102771:C:T	single nucleotide variant	intron variant	Likely benign	Nov 1, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.626-189_626-180del	RET		not provided	VCV001216495	10	43600211 - 43600220	10	43104763 - 43104772	1216495	1206475	rs546164092	NC_000010.11:43104762:GCACAGTCAT:	Deletion	intron variant	Likely benign	Jul 6, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.626-151G>A	RET		not provided	VCV001208843	10	43600249	10	43104801	1208843	1198045	rs188616637	NC_000010.11:43104800:G:A	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	Jul 20, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.626-72_626-71del	RET		not provided	VCV001175432	10	43600325 - 43600326	10	43104877 - 43104878	1175432	1165011	rs144431581	NC_000010.11:43104876:CCCCC:CCC	Deletion	intron variant|5 prime UTR variant	Benign	Mar 3, 2015	criteria provided, single submitter							
NM_020975.6(RET):c.626-49C>T	RET		not specified	VCV001697457	10	43600351	10	43104903	1697457	1689843	rs1381620754	NC_000010.11:43104902:C:T	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	Aug 15, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.626-41G>A	RET		Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|not specified	VCV001697458	10	43600359	10	43104911	1697458	1689844	rs572623103	NC_000010.11:43104910:G:A	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	Aug 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.626-21C>T	RET		not specified	VCV001802778	10	43600379	10	43104931	1802778	1859809		NC_000010.11:43104930:C:T	single nucleotide variant	intron variant|5 prime UTR variant	Likely benign	Aug 15, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.626-19_626-18del	RET		Multiple endocrine neoplasia, type 2	VCV002184938	10	43600381 - 43600382	10	43104933 - 43104934	2184938	1917574		NC_000010.11:43104932:CT:	Deletion	5 prime UTR variant|intron variant	Likely benign	Nov 16, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.626-19C>T	RET		Multiple endocrine neoplasia, type 2	VCV001627032	10	43600381	10	43104933	1627032	1636725	rs1426050483	NC_000010.11:43104932:C:T	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	Oct 22, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.626-18T>C	RET		Multiple endocrine neoplasia, type 2	VCV002194140	10	43600382	10	43104934	2194140	1926340		NC_000010.11:43104933:T:C	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	Jan 28, 2025	criteria provided, single submitter							
NM_020975.6(RET):c.626-18T>G	RET		Multiple endocrine neoplasia, type 2	VCV002035516	10	43600382	10	43104934	2035516	2097300		NC_000010.11:43104933:T:G	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	Oct 14, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.626-17G>A	RET		Multiple endocrine neoplasia, type 2	VCV001564331	10	43600383	10	43104935	1564331	1654700	rs2132702512	NC_000010.11:43104934:G:A	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	Jun 6, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.626-15C>G	RET		Multiple endocrine neoplasia, type 2	VCV002052770	10	43600385	10	43104937	2052770	2111948		NC_000010.11:43104936:C:G	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	Aug 20, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.626-12C>T	RET		Multiple endocrine neoplasia, type 2	VCV003073559	10	43600388	10	43104940	3073559	3234515		NC_000010.11:43104939:C:T	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	Oct 2, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.626-9G>T	RET		Multiple endocrine neoplasia, type 2	VCV001083679	10	43600391	10	43104943	1083679	1077032	rs1333636410	NC_000010.11:43104942:G:T	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	Apr 28, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.626-8G>C	RET		Multiple endocrine neoplasia, type 2	VCV001912194	10	43600392	10	43104944	1912194	1969821		NC_000010.11:43104943:G:C	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	Mar 28, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.626-7T>C	RET		Multiple endocrine neoplasia, type 2	VCV000702618	10	43600393	10	43104945	702618	695475	rs768246167	NC_000010.11:43104944:T:C	single nucleotide variant	5 prime UTR variant|intron variant	Benign/Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.626-6_626-5delinsTT	RET		Hereditary cancer-predisposing syndrome	VCV003432226	10	43600394 - 43600395	10	43104946 - 43104947	3432226	3593422		NC_000010.11:43104945:GC:TT	Indel	5 prime UTR variant|intron variant	Uncertain significance	Sep 30, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.626-6G>T	RET		Multiple endocrine neoplasia, type 2	VCV000722391	10	43600394	10	43104946	722391	744506	rs913593524	NC_000010.11:43104945:G:T	single nucleotide variant	5 prime UTR variant|intron variant	Likely benign	May 28, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.626-5C>T	RET		Hereditary cancer-predisposing syndrome	VCV001752512	10	43600395	10	43104947	1752512	1804367		NC_000010.11:43104946:C:T	single nucleotide variant	5 prime UTR variant|intron variant	Uncertain significance	Oct 28, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.626-4G>A	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000413455	10	43600396	10	43104948	413455	397778	rs775956924	NC_000010.11:43104947:G:A	single nucleotide variant	5 prime UTR variant|intron variant	Benign/Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.626-3C>T	RET		Hereditary cancer-predisposing syndrome	VCV001752505	10	43600397	10	43104949	1752505	1804360		NC_000010.11:43104948:C:T	single nucleotide variant	5 prime UTR variant|intron variant	Uncertain significance	Aug 26, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.626G>A (p.Gly209Asp)	RET	G209D, S113N, G166D	Multiple endocrine neoplasia, type 2	VCV000937572	10	43600400	10	43104952	937572	935018	rs1837727267	NC_000010.11:43104951:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.628G>A (p.Glu210Lys)	RET	E210K, E167K, E114K	not provided|Hirschsprung disease, susceptibility to, 1|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia|Pheochromocytoma|Hereditary cancer-predisposing syndrome|not specified|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia, type 2	VCV000405554	10	43600402	10	43104954	405554	397444	rs1060500762	NC_000010.11:43104953:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.632G>A (p.Gly211Asp)	RET	G211D, G115D, G168D	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000405532	10	43600406	10	43104958	405532	397690	rs1060500756	NC_000010.11:43104957:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.633T>G (p.Gly211=)	RET		Hereditary cancer-predisposing syndrome	VCV003227564	10	43600407	10	43104959	3227564	3390775		NC_000010.11:43104958:T:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Dec 31, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.633T>C (p.Gly211=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000826332	10	43600407	10	43104959	826332	809894	rs1371983599	NC_000010.11:43104958:T:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Dec 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.634C>G (p.Leu212Val)	RET	L169V, L116V, L212V	Multiple endocrine neoplasia, type 2	VCV002718426	10	43600408	10	43104960	2718426	2876822		NC_000010.11:43104959:C:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Apr 11, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.635T>C (p.Leu212Pro)	RET	L212P, L116P, L169P	Multiple endocrine neoplasia, type 2	VCV002853090	10	43600409	10	43104961	2853090	3006908		NC_000010.11:43104960:T:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Apr 7, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.636G>C (p.Leu212=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001077887	10	43600410	10	43104962	1077887	1077033	rs2132702942	NC_000010.11:43104961:G:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Apr 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.637C>T (p.Pro213Ser)	RET	P213S, P117S, P170S	Multiple endocrine neoplasia, type 2	VCV000939922	10	43600411	10	43104963	939922	935019	rs1837727684	NC_000010.11:43104962:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 5, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.638C>A (p.Pro213His)	RET	P213H, P170H, P117H	Multiple endocrine neoplasia, type 2	VCV000644594	10	43600412	10	43104964	644594	638872	rs1313234246	NC_000010.11:43104963:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 22, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.638C>G (p.Pro213Arg)	RET	P213R, P117R, P170R	Multiple endocrine neoplasia, type 2	VCV000576086	10	43600412	10	43104964	576086	569631	rs1313234246	NC_000010.11:43104963:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.639C>A (p.Pro213=)	RET		Multiple endocrine neoplasia, type 2	VCV003387586	10	43600413	10	43104965	3387586	3546719		NC_000010.11:43104964:C:A	single nucleotide variant	5 prime UTR variant|synonymous variant|intron variant	Likely benign	Aug 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.639C>G (p.Pro213=)	RET		Hereditary cancer-predisposing syndrome	VCV001753270	10	43600413	10	43104965	1753270	1811594		NC_000010.11:43104964:C:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Mar 30, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.639C>T (p.Pro213=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001576393	10	43600413	10	43104965	1576393	1586724	rs1303761164	NC_000010.11:43104964:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Dec 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.640T>G (p.Phe214Val)	RET	F214V, F118V, F171V	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002568349	10	43600414	10	43104966	2568349	2734885		NC_000010.11:43104965:T:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Oct 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.642C>T (p.Phe214=)	RET		Hereditary cancer-predisposing syndrome	VCV001753477	10	43600416	10	43104968	1753477	1807860		NC_000010.11:43104967:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Oct 20, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.643C>G (p.Arg215Gly)	RET	R119G, R172G, R215G	Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A	VCV003594552	10	43600417	10	43104969	3594552	3725638		NC_000010.11:43104968:C:G	single nucleotide variant	5 prime UTR variant|missense variant|intron variant	Uncertain significance	Feb 8, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.643C>T (p.Arg215Cys)	RET	R119C, R172C, R215C	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV003070928	10	43600417	10	43104969	3070928	3230684		NC_000010.11:43104968:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Jun 27, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.644G>T (p.Arg215Leu)	RET	R215L, R119L, R172L	Multiple endocrine neoplasia, type 2	VCV000961395	10	43600418	10	43104970	961395	946874	rs748128929	NC_000010.11:43104969:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 20, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.644G>A (p.Arg215His)	RET	R215H, R119H, R172H	Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000826412	10	43600418	10	43104970	826412	809895	rs748128929	NC_000010.11:43104969:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.645C>A (p.Arg215=)	RET		Multiple endocrine neoplasia, type 2	VCV002699725	10	43600419	10	43104971	2699725	2861998		NC_000010.11:43104970:C:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Nov 29, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.645C>G (p.Arg215=)	RET		Multiple endocrine neoplasia, type 2	VCV000950315	10	43600419	10	43104971	950315	925797	rs1837728202	NC_000010.11:43104970:C:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.646T>C (p.Cys216Arg)	RET	C216R, C173R, C120R	Multiple endocrine neoplasia, type 2	VCV000857825	10	43600420	10	43104972	857825	836812	rs1837728315	NC_000010.11:43104971:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 3, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.647G>A (p.Cys216Tyr)	RET	C120Y, C216Y, C173Y	Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1	VCV002973642	10	43600421	10	43104973	2973642	3140061		NC_000010.11:43104972:G:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jan 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.648C>T (p.Cys216=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV003387588	10	43600422	10	43104974	3387588	3546721		NC_000010.11:43104973:C:T	single nucleotide variant	5 prime UTR variant|synonymous variant|intron variant	Likely benign	Sep 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.652_653dup (p.Asp219fs)	RET	D219fs	Hereditary cancer-predisposing syndrome	VCV001754024	10	43600423 - 43600424	10	43104975 - 43104976	1754024	1804579		NC_000010.11:43104975:CCCC:CCCCCC	Duplication	frameshift variant	Pathogenic	Aug 14, 2015	criteria provided, single submitter							
NM_020975.6(RET):c.649G>A (p.Ala217Thr)	RET	A217T, A121T, A174T	Multiple endocrine neoplasia, type 2	VCV001375505	10	43600423	10	43104975	1375505	1392277	rs1259626672	NC_000010.11:43104974:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 3, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.650C>T (p.Ala217Val)	RET	A217V, A121V, A174V	Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2	VCV000864118	10	43600424	10	43104976	864118	836813	rs1060500754	NC_000010.11:43104975:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.650C>A (p.Ala217Asp)	RET	A217D, A174D, A121D	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|RET-related disorder	VCV000405525	10	43600424	10	43104976	405525	397445	rs1060500754	NC_000010.11:43104975:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 30, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.651C>G (p.Ala217=)	RET		Multiple endocrine neoplasia, type 2	VCV002747033	10	43600425	10	43104977	2747033	2907793		NC_000010.11:43104976:C:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Jul 26, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.651C>T (p.Ala217=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000761295	10	43600425	10	43104977	761295	767726	rs1588865918	NC_000010.11:43104976:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Aug 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.652C>G (p.Pro218Ala)	RET	P122A, P175A, P218A	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002587875	10	43600426	10	43104978	2587875	2760699		NC_000010.11:43104977:C:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jul 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.652C>T (p.Pro218Ser)	RET	P218S, P122S, P175S	Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Multiple endocrine neoplasia type 2B|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A	VCV000584745	10	43600426	10	43104978	584745	575801	rs1009392744	NC_000010.11:43104977:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.653C>T (p.Pro218Leu)	RET	P122L, P175L, P218L	Hereditary cancer-predisposing syndrome	VCV003227565	10	43600427	10	43104979	3227565	3390776		NC_000010.11:43104978:C:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Likely benign	Feb 14, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.653C>G (p.Pro218Arg)	RET	P175R, P218R, P122R	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	VCV001754100	10	43600427	10	43104979	1754100	1804655		NC_000010.11:43104978:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.654G>T (p.Pro218=)	RET		Multiple endocrine neoplasia, type 2	VCV003730369	10	43600428	10	43104980	3730369	3862435		NC_000010.11:43104979:G:T	single nucleotide variant	5 prime UTR variant|synonymous variant|intron variant	Likely benign	Jun 17, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.654G>A (p.Pro218=)	RET		not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia|not specified|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2|Renal hypodysplasia/aplasia 1|Pheochromocytoma	VCV000220254	10	43600428	10	43104980	220254	221946	rs137928436	NC_000010.11:43104979:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.657C>G (p.Asp219Glu)	RET	D219E, D123E, D176E	Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001450795	10	43600431	10	43104983	1450795	1351316	rs1837729196	NC_000010.11:43104982:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.657C>T (p.Asp219=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001106390	10	43600431	10	43104983	1106390	1098678	rs1837729196	NC_000010.11:43104982:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	May 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.658A>T (p.Ser220Cys)	RET	S220C, S177C, S124C	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000543755	10	43600432	10	43104984	543755	525092	rs1484566321	NC_000010.11:43104983:A:T	single nucleotide variant	missense variant	Uncertain significance	Nov 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.659G>C (p.Ser220Thr)	RET	S124T, S177T, S220T	Multiple endocrine neoplasia, type 2	VCV001966010	10	43600433	10	43104985	1966010	2021401		NC_000010.11:43104984:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 17, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.659G>T (p.Ser220Ile)	RET	S220I, S124I, S177I	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001382106	10	43600433	10	43104985	1382106	1434535	rs1182941467	NC_000010.11:43104984:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 2, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.660C>T (p.Ser220=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000826511	10	43600434	10	43104986	826511	809896	rs1588865937	NC_000010.11:43104985:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	May 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.661C>T (p.Leu221=)	RET		Multiple endocrine neoplasia, type 2	VCV001110787	10	43600435	10	43104987	1110787	1098679	rs2132703566	NC_000010.11:43104986:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	May 12, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.663G>A (p.Leu221=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001754634	10	43600437	10	43104989	1754634	1812091		NC_000010.11:43104988:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Feb 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.664G>T (p.Glu222Ter)	RET	E126*, E179*, E222*	RET-related disorder	VCV002633813	10	43600438	10	43104990	2633813	2799140		NC_000010.11:43104989:G:T	single nucleotide variant	nonsense|5 prime UTR variant|intron variant	Likely pathogenic	Apr 3, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.664G>A (p.Glu222Lys)	RET	E222K, E179K, E126K	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	VCV001011103	10	43600438	10	43104990	1011103	993805	rs1837729713	NC_000010.11:43104989:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.668_669dup (p.Ser224Ter)	RET	S128*, S181*, S224*	Multiple endocrine neoplasia, type 2	VCV003644687	10	43600440 - 43600441	10	43104992 - 43104993	3644687	3786523		NC_000010.11:43104992:GTG:GTGTG	Duplication	5 prime UTR variant|nonsense|intron variant	Pathogenic	Mar 6, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.666G>A (p.Glu222=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000826543	10	43600440	10	43104992	826543	809897	rs1588865944	NC_000010.11:43104991:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.667G>A (p.Val223Met)	RET	V223M, V180M, V127M	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia type 2B|See cases	VCV000136122	10	43600441	10	43104993	136122	139834	rs587780815	NC_000010.11:43104992:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 27, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.670A>T (p.Ser224Cys)	RET	S128C, S181C, S224C	Multiple endocrine neoplasia, type 2	VCV001715177	10	43600444	10	43104996	1715177	1775322		NC_000010.11:43104995:A:T	single nucleotide variant	missense variant	Uncertain significance	Jul 15, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.671G>C (p.Ser224Thr)	RET	S224T, S128T, S181T	Multiple endocrine neoplasia, type 2	VCV001482887	10	43600445	10	43104997	1482887	1464870	rs1837729986	NC_000010.11:43104996:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 16, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.672C>T (p.Ser224=)	RET		Multiple endocrine neoplasia, type 2	VCV003619329	10	43600446	10	43104998	3619329	3756352		NC_000010.11:43104997:C:T	single nucleotide variant	5 prime UTR variant|synonymous variant|intron variant	Likely benign	Jun 4, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.673A>C (p.Thr225Pro)	RET	T182P, T129P, T225P	Hereditary cancer-predisposing syndrome	VCV003432201	10	43600447	10	43104999	3432201	3593398		NC_000010.11:43104998:A:C	single nucleotide variant	5 prime UTR variant|missense variant|intron variant	Uncertain significance	Nov 22, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.674C>T (p.Thr225Met)	RET	T225M, T129M, T182M	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|not provided	VCV001755230	10	43600448	10	43105000	1755230	1818520		NC_000010.11:43104999:C:T	single nucleotide variant	missense variant	Uncertain significance	May 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.675_676delinsTT (p.Arg226Cys)	RET	R130C, R183C, R226C	Multiple endocrine neoplasia, type 2	VCV002835911	10	43600449 - 43600450	10	43105001 - 43105002	2835911	2995743		NC_000010.11:43105000:GC:TT	Indel	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Feb 9, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.675G>T (p.Thr225=)	RET		Hereditary cancer-predisposing syndrome	VCV001755300	10	43600449	10	43105001	1755300	1818590		NC_000010.11:43105000:G:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Sep 6, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.675G>A (p.Thr225=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001755296	10	43600449	10	43105001	1755296	1818586		NC_000010.11:43105000:G:A	single nucleotide variant	intron variant|synonymous variant|5 prime UTR variant	Likely benign	Apr 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.675G>C (p.Thr225=)	RET		Multiple endocrine neoplasia, type 2	VCV001108075	10	43600449	10	43105001	1108075	1098680	rs1837730338	NC_000010.11:43105000:G:C	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Nov 30, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.676C>G (p.Arg226Gly)	RET	R130G, R183G, R226G	Multiple endocrine neoplasia, type 2	VCV002010434	10	43600450	10	43105002	2010434	2067098		NC_000010.11:43105001:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 25, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.676C>A (p.Arg226Ser)	RET	R130S, R183S, R226S	Hereditary cancer-predisposing syndrome	VCV001755332	10	43600450	10	43105002	1755332	1818622		NC_000010.11:43105001:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 3, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.676C>T (p.Arg226Cys)	RET	R226C, R130C, R183C	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000477381	10	43600450	10	43105002	477381	460688	rs1455266037	NC_000010.11:43105001:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.677G>A (p.Arg226His)	RET	R130H, R226H, R183H	Multiple endocrine neoplasia, type 2	VCV003719863	10	43600451	10	43105003	3719863	3849682		NC_000010.11:43105002:G:A	single nucleotide variant	intron variant|5 prime UTR variant|missense variant	Uncertain significance	Jun 19, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.677G>T (p.Arg226Leu)	RET	R130L, R183L, R226L	Multiple endocrine neoplasia, type 2	VCV003609527	10	43600451	10	43105003	3609527	3744392		NC_000010.11:43105002:G:T	single nucleotide variant	5 prime UTR variant|missense variant|intron variant	Uncertain significance	Aug 6, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.677G>C (p.Arg226Pro)	RET	R226P, R130P, R183P	Hereditary cancer-predisposing syndrome|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2	VCV000968066	10	43600451	10	43105003	968066	956043	rs937818626	NC_000010.11:43105002:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.678C>T (p.Arg226=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001113517	10	43600452	10	43105004	1113517	1098681	rs142421698	NC_000010.11:43105003:C:T	single nucleotide variant	5 prime UTR variant|synonymous variant|intron variant	Likely benign	Sep 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.679T>C (p.Trp227Arg)	RET	W131R, W184R, W227R	Hereditary cancer-predisposing syndrome	VCV003313714	10	43600453	10	43105005	3313714	3465444		NC_000010.11:43105004:T:C	single nucleotide variant	5 prime UTR variant|missense variant|intron variant	Likely benign	Apr 18, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.682G>A (p.Ala228Thr)	RET	A228T, A185T, A132T	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001364356	10	43600456	10	43105008	1364356	1386295	rs760813493	NC_000010.11:43105007:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.682G>C (p.Ala228Pro)	RET	A228P, A132P, A185P	not provided|Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2	VCV000220524	10	43600456	10	43105008	220524	221947	rs760813493	NC_000010.11:43105007:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 24, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.682G>T (p.Ala228Ser)	RET	A228S, A185S, A132S	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000186971	10	43600456	10	43105008	186971	182946	rs760813493	NC_000010.11:43105007:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.683C>A (p.Ala228Asp)	RET	A228D, A132D, A185D	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001424882	10	43600457	10	43105009	1424882	1353389	rs2132704146	NC_000010.11:43105008:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.685C>T (p.Leu229=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002760772	10	43600459	10	43105011	2760772	2918066		NC_000010.11:43105010:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Jul 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.686T>C (p.Leu229Pro)	RET	L229P, L133P, L186P	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000477382	10	43600460	10	43105012	477382	460691	rs767654905	NC_000010.11:43105011:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.692G>A (p.Arg231His)	RET	R231H, R135H, R188H	Hirschsprung disease, susceptibility to, 1	VCV000013937	10	43600466	10	43105018	13937	28976	rs79661516	NC_000010.11:43105017:G:A	single nucleotide variant	missense variant	risk factor	Sep 1, 1998	no assertion criteria provided							
NM_020975.6(RET):c.693C>T (p.Arg231=)	RET		Hirschsprung Disease, Dominant|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Hereditary cancer-predisposing syndrome|not provided|Pheochromocytoma|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia	VCV000136123	10	43600467	10	43105019	136123	139835	rs576806329	NC_000010.11:43105018:C:T	single nucleotide variant	synonymous variant|intron variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Jan 30, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.697C>G (p.Gln233Glu)	RET	Q137E, Q190E, Q233E	Multiple endocrine neoplasia, type 2	VCV001715206	10	43600471	10	43105023	1715206	1775351		NC_000010.11:43105022:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 5, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.698A>G (p.Gln233Arg)	RET	Q233R, Q190R, Q137R	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002447526	10	43600472	10	43105024	2447526	2432420		NC_000010.11:43105023:A:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Feb 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.698A>T (p.Gln233Leu)	RET	Q137L, Q190L, Q233L	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001756454	10	43600472	10	43105024	1756454	1822267		NC_000010.11:43105023:A:T	single nucleotide variant	missense variant	Uncertain significance	May 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.699G>T (p.Gln233His)	RET	Q233H, Q137H, Q190H	Multiple endocrine neoplasia, type 2	VCV001396794	10	43600473	10	43105025	1396794	1414669	rs786203642	NC_000010.11:43105024:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 8, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.699G>A (p.Gln233=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000187325	10	43600473	10	43105025	187325	182947	rs786203642	NC_000010.11:43105024:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Dec 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.700C>G (p.Arg234Gly)	RET	R138G, R191G, R234G	Multiple endocrine neoplasia, type 2	VCV003071464	10	43600474	10	43105026	3071464	3233730		NC_000010.11:43105025:C:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jun 8, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.700C>T (p.Arg234Trp)	RET	R234W, R138W, R191W	Multiple endocrine neoplasia, type 2	VCV001524442	10	43600474	10	43105026	1524442	1462917	rs2132704554	NC_000010.11:43105025:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 29, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.701G>A (p.Arg234Gln)	RET	R234Q, R138Q, R191Q	not provided|Hereditary cancer-predisposing syndrome|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A	VCV000662310	10	43600475	10	43105027	662310	638873	rs756216318	NC_000010.11:43105026:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 7, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.702G>T (p.Arg234=)	RET		Multiple endocrine neoplasia, type 2	VCV002864701	10	43600476	10	43105028	2864701	3019599		NC_000010.11:43105027:G:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	May 16, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.702G>A (p.Arg234=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000784862	10	43600476	10	43105028	784862	712366	rs764759271	NC_000010.11:43105027:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Apr 5, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.704A>C (p.Glu235Ala)	RET	E139A, E192A, E235A	Hereditary cancer-predisposing syndrome	VCV002454144	10	43600478	10	43105030	2454144	2424033		NC_000010.11:43105029:A:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Feb 15, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.705G>A (p.Glu235=)	RET		Multiple endocrine neoplasia, type 2	VCV000543772	10	43600479	10	43105031	543772	525402	rs1554817792	NC_000010.11:43105030:G:A	single nucleotide variant	synonymous variant|intron variant|5 prime UTR variant	Likely benign	Aug 31, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.706A>T (p.Lys236Ter)	RET	K140*, K193*, K236*	RET-related disorder	VCV003344646	10	43600480	10	43105032	3344646	3504313		NC_000010.11:43105031:A:T	single nucleotide variant	5 prime UTR variant|nonsense|intron variant	Likely pathogenic	Jul 18, 2024	no assertion criteria provided							
NM_020975.6(RET):c.707A>C (p.Lys236Thr)	RET	K236T, K140T, K193T	Hereditary cancer-predisposing syndrome	VCV002568350	10	43600481	10	43105033	2568350	2734886		NC_000010.11:43105032:A:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	May 1, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.708G>A (p.Lys236=)	RET		Hereditary cancer-predisposing syndrome	VCV001757090	10	43600482	10	43105034	1757090	1819095		NC_000010.11:43105033:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Jan 18, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.709T>G (p.Tyr237Asp)	RET	Y141D, Y194D, Y237D	Hereditary cancer-predisposing syndrome	VCV003227566	10	43600483	10	43105035	3227566	3390777		NC_000010.11:43105034:T:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jan 30, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.711C>T (p.Tyr237=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001757264	10	43600485	10	43105037	1757264	1819269		NC_000010.11:43105036:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Sep 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.712G>C (p.Glu238Gln)	RET	E142Q, E195Q, E238Q	Hirschsprung disease, susceptibility to, 1	VCV002678316	10	43600486	10	43105038	2678316	2833339		NC_000010.11:43105037:G:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Sep 6, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.712G>A (p.Glu238Lys)	RET	E238K, E195K, E142K	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001039313	10	43600486	10	43105038	1039313	1029527	rs1588866040	NC_000010.11:43105037:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.712G>T (p.Glu238Ter)	RET	E238*, E142*, E195*	Hirschsprung disease, susceptibility to, 1	VCV000692052	10	43600486	10	43105038	692052	679770	rs1588866040	NC_000010.11:43105037:G:T	single nucleotide variant	nonsense	Pathogenic	Sep 27, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.714G>A (p.Glu238=)	RET		Multiple endocrine neoplasia, type 2	VCV003001564	10	43600488	10	43105040	3001564	3164392		NC_000010.11:43105039:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Feb 5, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.714G>T (p.Glu238Asp)	RET	E238D, E195D, E142D	Multiple endocrine neoplasia, type 2	VCV000644521	10	43600488	10	43105040	644521	638874	rs1588866043	NC_000010.11:43105039:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 24, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.715C>T (p.Leu239=)	RET		Hereditary cancer-predisposing syndrome	VCV001757428	10	43600489	10	43105041	1757428	1815627		NC_000010.11:43105040:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Jul 21, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.715C>G (p.Leu239Val)	RET	L239V, L143V, L196V	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001470665	10	43600489	10	43105041	1470665	1394892	rs1837732123	NC_000010.11:43105040:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.716T>C (p.Leu239Pro)	RET	L143P, L239P, L196P	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001957836	10	43600490	10	43105042	1957836	2019261		NC_000010.11:43105041:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 6, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.717G>A (p.Leu239=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002454151	10	43600491	10	43105043	2454151	2424040		NC_000010.11:43105042:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Oct 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.718G>A (p.Val240Met)	RET	V144M, V240M, V197M	Hereditary cancer-predisposing syndrome	VCV001757586	10	43600492	10	43105044	1757586	1815784		NC_000010.11:43105043:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 7, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.718G>C (p.Val240Leu)	RET	V240L, V144L, V197L	Renal hypodysplasia/aplasia 1|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|not provided|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1	VCV000477383	10	43600492	10	43105044	477383	460008	rs375120544	NC_000010.11:43105043:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 26, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.720G>A (p.Val240=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000477384	10	43600494	10	43105046	477384	459809	rs779382077	NC_000010.11:43105045:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Oct 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.722C>T (p.Ala241Val)	RET	A241V, A198V, A145V	Multiple endocrine neoplasia, type 2	VCV000961551	10	43600496	10	43105048	961551	946875	rs1178140696	NC_000010.11:43105047:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 3, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.723C>G (p.Ala241=)	RET		Multiple endocrine neoplasia, type 2	VCV002193503	10	43600497	10	43105049	2193503	1929179		NC_000010.11:43105048:C:G	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Jul 6, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.723C>A (p.Ala241=)	RET		not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001098072	10	43600497	10	43105049	1098072	1077034	rs544252468	NC_000010.11:43105048:C:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Nov 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.723C>T (p.Ala241=)	RET		Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome	VCV000745515	10	43600497	10	43105049	745515	752096	rs544252468	NC_000010.11:43105048:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Nov 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.724G>C (p.Val242Leu)	RET	V199L, V242L, V146L	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001757914	10	43600498	10	43105050	1757914	1812795		NC_000010.11:43105049:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.724G>A (p.Val242Met)	RET	V242M, V199M, V146M	not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000972245	10	43600498	10	43105050	972245	956044	rs1264337497	NC_000010.11:43105049:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 18, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.726G>T (p.Val242=)	RET		Multiple endocrine neoplasia, type 2	VCV001950082	10	43600500	10	43105052	1950082	1999911		NC_000010.11:43105051:G:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Apr 22, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.726G>A (p.Val242=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000413463	10	43600500	10	43105052	413463	397261	rs377193354	NC_000010.11:43105051:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Sep 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.731C>A (p.Thr244Asn)	RET	T148N, T201N, T244N	Multiple endocrine neoplasia, type 2	VCV001971173	10	43600505	10	43105057	1971173	2022687		NC_000010.11:43105056:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 28, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.731C>T (p.Thr244Ile)	RET	T244I, T201I, T148I	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2	VCV000477385	10	43600505	10	43105057	477385	460009	rs145970248	NC_000010.11:43105056:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 14, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.732C>T (p.Thr244=)	RET		Hereditary cancer-predisposing syndrome	VCV001758357	10	43600506	10	43105058	1758357	1822874		NC_000010.11:43105057:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Jun 1, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.733G>T (p.Val245Leu)	RET	V245L, V149L, V202L	Multiple endocrine neoplasia, type 2	VCV001985140	10	43600507	10	43105059	1985140	2046893		NC_000010.11:43105058:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 21, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.733G>A (p.Val245Met)	RET	V245M, V149M, V202M	Hereditary cancer-predisposing syndrome|Ovarian cancer|Multiple endocrine neoplasia, type 2	VCV000851671	10	43600507	10	43105059	851671	836814	rs1837733068	NC_000010.11:43105058:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 31, 2023	criteria provided, conflicting classifications							
NM_020975.6(RET):c.734T>G (p.Val245Gly)	RET	V202G, V245G, V149G	Multiple endocrine neoplasia, type 2	VCV002779235	10	43600508	10	43105060	2779235	2940386		NC_000010.11:43105059:T:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Feb 14, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.735G>C (p.Val245=)	RET		Multiple endocrine neoplasia, type 2	VCV003665816	10	43600509	10	43105061	3665816	3795689		NC_000010.11:43105060:G:C	single nucleotide variant	intron variant|5 prime UTR variant|synonymous variant	Likely benign	Mar 16, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.735G>T (p.Val245=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001758508	10	43600509	10	43105061	1758508	1823025		NC_000010.11:43105060:G:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Dec 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.735G>A (p.Val245=)	RET		Multiple endocrine neoplasia, type 2	VCV001572335	10	43600509	10	43105061	1572335	1538404	rs1837733166	NC_000010.11:43105060:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Jul 17, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.736C>G (p.His246Asp)	RET	H150D, H203D, H246D	Hereditary cancer-predisposing syndrome	VCV003227567	10	43600510	10	43105062	3227567	3390778		NC_000010.11:43105061:C:G	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Likely benign	Feb 27, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.736C>T (p.His246Tyr)	RET	H246Y, H150Y, H203Y	Multiple endocrine neoplasia, type 2	VCV000647022	10	43600510	10	43105062	647022	638875	rs780756440	NC_000010.11:43105061:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 29, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.736C>A (p.His246Asn)	RET	H246N, H203N, H150N	Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|not provided|Hereditary cancer-predisposing syndrome	VCV000486315	10	43600510	10	43105062	486315	475260	rs780756440	NC_000010.11:43105061:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 3, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.737A>T (p.His246Leu)	RET	H150L, H203L, H246L	Hirschsprung disease, susceptibility to, 1	VCV002678318	10	43600511	10	43105063	2678318	2833341		NC_000010.11:43105062:A:T	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Sep 4, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.738C>G (p.His246Gln)	RET	H150Q, H246Q, H203Q	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001758639	10	43600512	10	43105064	1758639	1819350		NC_000010.11:43105063:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.738C>A (p.His246Gln)	RET	H246Q, H203Q, H150Q	Multiple endocrine neoplasia, type 2	VCV001394332	10	43600512	10	43105064	1394332	1338355	rs769279838	NC_000010.11:43105063:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 27, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.738C>T (p.His246=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001100012	10	43600512	10	43105064	1100012	1098682	rs769279838	NC_000010.11:43105063:C:T	single nucleotide variant	5 prime UTR variant|synonymous variant|intron variant	Likely benign	Oct 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.739G>A (p.Ala247Thr)	RET	A247T, A151T, A204T	Multiple endocrine neoplasia, type 2	VCV000858205	10	43600513	10	43105065	858205	836815	rs1837733537	NC_000010.11:43105064:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.740C>T (p.Ala247Val)	RET	A247V, A151V, A204V	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000486312	10	43600514	10	43105066	486312	475266	rs61843232	NC_000010.11:43105065:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 14, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.741C>A (p.Ala247=)	RET		Hereditary cancer-predisposing syndrome	VCV001758822	10	43600515	10	43105067	1758822	1819533		NC_000010.11:43105066:C:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	May 11, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.741C>T (p.Ala247=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000486310	10	43600515	10	43105067	486310	475066	rs777733752	NC_000010.11:43105066:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.742G>A (p.Gly248Ser)	RET	G248S, G152S, G205S	Hereditary cancer-predisposing syndrome|not specified|Multiple endocrine neoplasia, type 2	VCV000960888	10	43600516	10	43105068	960888	946876	rs1837733775	NC_000010.11:43105067:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 21, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.743G>C (p.Gly248Ala)	RET	G248A, G152A, G205A	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001039438	10	43600517	10	43105069	1039438	1029528	rs749189193	NC_000010.11:43105068:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.744C>T (p.Gly248=)	RET		Multiple endocrine neoplasia, type 2	VCV000543740	10	43600518	10	43105070	543740	525407	rs1554817806	NC_000010.11:43105069:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Aug 1, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.745G>A (p.Ala249Thr)	RET	A249T, A153T, A206T	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000570369	10	43600519	10	43105071	570369	569635	rs1564491259	NC_000010.11:43105070:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.746C>T (p.Ala249Val)	RET	A206V, A153V, A249V	Multiple endocrine neoplasia, type 2	VCV003633149	10	43600520	10	43105072	3633149	3773335		NC_000010.11:43105071:C:T	single nucleotide variant	5 prime UTR variant|missense variant|intron variant	Uncertain significance	May 26, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.748C>T (p.Arg250Cys)	RET	R250C, R154C, R207C	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000827079	10	43600522	10	43105074	827079	809898	rs1299878945	NC_000010.11:43105073:C:T	single nucleotide variant	missense variant	Uncertain significance	May 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.749G>A (p.Arg250His)	RET	R207H, R250H, R154H	Multiple endocrine neoplasia, type 2	VCV002871313	10	43600523	10	43105075	2871313	3034491		NC_000010.11:43105074:G:A	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Jan 11, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.749G>T (p.Arg250Leu)	RET	R154L, R207L, R250L	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002778092	10	43600523	10	43105075	2778092	2946586		NC_000010.11:43105074:G:T	single nucleotide variant	missense variant|intron variant|5 prime UTR variant	Conflicting classifications of pathogenicity	Aug 1, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.750C>T (p.Arg250=)	RET		Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000939898	10	43600524	10	43105076	939898	935020	rs1013952995	NC_000010.11:43105075:C:T	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Mar 20, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.751G>A (p.Glu251Lys)	RET	E251K, E208K, E155K	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	VCV001037025	10	43600525	10	43105077	1037025	1029529	rs562449603	NC_000010.11:43105076:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.752AGG[1] (p.Glu252del)	RET	E252del, E156del, E209del	Multiple endocrine neoplasia, type 2	VCV000543753	10	43600525 - 43600527	10	43105077 - 43105079	543753	525606	rs1554817809	NC_000010.11:43105076:GAGGAGG:GAGG	Microsatellite	inframe_indel|inframe_deletion	Uncertain significance	Jul 17, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.754G>A (p.Glu252Lys)	RET	E252K, E156K, E209K	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000582550	10	43600528	10	43105080	582550	566266	rs950977184	NC_000010.11:43105079:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 30, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.755A>T (p.Glu252Val)	RET	E252V, E156V, E209V	Hereditary cancer-predisposing syndrome	VCV003432286	10	43600529	10	43105081	3432286	3593482		NC_000010.11:43105080:A:T	single nucleotide variant	5 prime UTR variant|missense variant|intron variant	Uncertain significance	Oct 28, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.757GTG[1] (p.Val254del)	RET	V158del, V254del, V211del	Hereditary cancer-predisposing syndrome	VCV003432244	10	43600530 - 43600532	10	43105082 - 43105084	3432244	3593440		NC_000010.11:43105081:GGTGGTG:GGTG	Microsatellite	5 prime UTR variant|inframe_indel|intron variant	Uncertain significance	Sep 3, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.756G>C (p.Glu252Asp)	RET	E156D, E209D, E252D	Hereditary cancer-predisposing syndrome	VCV003227568	10	43600530	10	43105082	3227568	3390779		NC_000010.11:43105081:G:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Likely benign	Feb 28, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.758dup (p.Val254fs)	RET	V158fs, V254fs, V211fs	Multiple endocrine neoplasia, type 2	VCV003661014	10	43600531 - 43600532	10	43105083 - 43105084	3661014	3790673		NC_000010.11:43105083:T:TT	Duplication	5 prime UTR variant|frameshift variant|intron variant	Pathogenic	Jul 31, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.757G>C (p.Val253Leu)	RET	V253L, V157L, V210L	Multiple endocrine neoplasia, type 2	VCV002768907	10	43600531	10	43105083	2768907	2927057		NC_000010.11:43105082:G:C	single nucleotide variant	missense variant|5 prime UTR variant|intron variant	Uncertain significance	Oct 16, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.757G>A (p.Val253Met)	RET	V253M, V210M, V157M	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1	VCV000136124	10	43600531	10	43105083	136124	139836	rs587780816	NC_000010.11:43105082:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 19, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.758T>A (p.Val253Glu)	RET	V253E, V210E, V157E	Hereditary cancer-predisposing syndrome	VCV000486352	10	43600532	10	43105084	486352	475267	rs1554817812	NC_000010.11:43105083:T:A	single nucleotide variant	missense variant	Likely benign	Feb 10, 2017	criteria provided, single submitter							
NM_020975.6(RET):c.759G>A (p.Val253=)	RET		Multiple endocrine neoplasia, type 2	VCV002810358	10	43600533	10	43105085	2810358	2968886		NC_000010.11:43105084:G:A	single nucleotide variant	synonymous variant|5 prime UTR variant|intron variant	Likely benign	Oct 10, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.760G>T (p.Val254Leu)	RET	V211L, V254L, V158L	Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001759791	10	43600534	10	43105086	1759791	1813392		NC_000010.11:43105085:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.760G>C (p.Val254Leu)	RET	V254L, V158L, V211L	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001040003	10	43600534	10	43105086	1040003	1029530	rs554862459	NC_000010.11:43105085:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.760G>A (p.Val254Met)	RET	V254M, V158M, V211M	Multiple endocrine neoplasia, type 2|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B|Hereditary cancer-predisposing syndrome	VCV000660498	10	43600534	10	43105086	660498	638876	rs554862459	NC_000010.11:43105085:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.763A>G (p.Met255Val)	RET	M159V, M1V, M212V, M255V	Hereditary cancer-predisposing syndrome	VCV003227569	10	43600537	10	43105089	3227569	3390780		NC_000010.11:43105088:A:G	single nucleotide variant	missense variant|initiator_codon_variant|intron variant	Uncertain significance	Dec 1, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.764T>C (p.Met255Thr)	RET	M212T, M159T, M1T, M255T	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002618562	10	43600538	10	43105090	2618562	2785818		NC_000010.11:43105089:T:C	single nucleotide variant	missense variant|initiator_codon_variant|intron variant	Uncertain significance	Jun 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.765G>T (p.Met255Ile)	RET	M255I, M1I, M159I, M212I	Hereditary cancer-predisposing syndrome	VCV000584565	10	43600539	10	43105091	584565	575552	rs1564491302	NC_000010.11:43105090:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 1, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.768G>T (p.Val256=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001760149	10	43600542	10	43105094	1760149	1823385		NC_000010.11:43105093:G:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.768G>C (p.Val256=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000793177	10	43600542	10	43105094	793177	783586	rs1588866143	NC_000010.11:43105093:G:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 26, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.769C>T (p.Pro257Ser)	RET	P257S, P3S, P161S, P214S	Multiple endocrine neoplasia, type 2	VCV002813925	10	43600543	10	43105095	2813925	2966039		NC_000010.11:43105094:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 28, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.769C>A (p.Pro257Thr)	RET	P161T, P214T, P3T, P257T	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001760176	10	43600543	10	43105095	1760176	1823412		NC_000010.11:43105094:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.770C>T (p.Pro257Leu)	RET	P257L, P3L, P161L, P214L	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	VCV000847756	10	43600544	10	43105096	847756	836816	rs1277252937	NC_000010.11:43105095:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.771C>T (p.Pro257=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002716921	10	43600545	10	43105097	2716921	2876619		NC_000010.11:43105096:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.773T>A (p.Phe258Tyr)	RET	F162Y, F215Y, F258Y, F4Y	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002801337	10	43600547	10	43105099	2801337	2959863		NC_000010.11:43105098:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.774C>G (p.Phe258Leu)	RET	F162L, F4L, F215L, F258L	Hereditary cancer-predisposing syndrome	VCV003432300	10	43600548	10	43105100	3432300	3593496		NC_000010.11:43105099:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 28, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.774C>T (p.Phe258=)	RET		Hereditary cancer-predisposing syndrome	VCV003313729	10	43600548	10	43105100	3313729	3465459		NC_000010.11:43105099:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 23, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.776C>T (p.Pro259Leu)	RET	P259L, P5L, P163L, P216L	Hereditary cancer-predisposing syndrome|not provided|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2	VCV000405523	10	43600550	10	43105102	405523	397783	rs759812068	NC_000010.11:43105101:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.777G>A (p.Pro259=)	RET		not specified|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000486327	10	43600551	10	43105103	486327	475279	rs1279646689	NC_000010.11:43105102:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.783C>G (p.Thr261=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001760843	10	43600557	10	43105109	1760843	1816458		NC_000010.11:43105108:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.783C>A (p.Thr261=)	RET		Hereditary cancer-predisposing syndrome	VCV001760837	10	43600557	10	43105109	1760837	1816452		NC_000010.11:43105108:C:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 8, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.783C>T (p.Thr261=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001127790	10	43600557	10	43105109	1127790	1120256	rs1488169498	NC_000010.11:43105108:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.784G>A (p.Val262Met)	RET	V8M, V166M, V262M, V219M	Hereditary cancer-predisposing syndrome	VCV001760886	10	43600558	10	43105110	1760886	1816501		NC_000010.11:43105109:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 4, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.785T>C (p.Val262Ala)	RET	V262A, V8A, V219A, V166A	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Renal hypodysplasia/aplasia 1|not specified|Multiple endocrine neoplasia|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Pheochromocytoma|not provided	VCV000041845	10	43600559	10	43105111	41845	50284	rs139790943	NC_000010.11:43105110:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 4, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.786G>A (p.Val262=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000413473	10	43600560	10	43105112	413473	397787	rs1060504035	NC_000010.11:43105111:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 26, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.788A>G (p.Tyr263Cys)	RET	Y263C, Y9C, Y167C, Y220C	Multiple endocrine neoplasia, type 2	VCV000953882	10	43600562	10	43105114	953882	946877	rs1837736594	NC_000010.11:43105113:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.789C>T (p.Tyr263=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000765520	10	43600563	10	43105115	765520	767727	rs1190726328	NC_000010.11:43105114:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.791A>G (p.Asp264Gly)	RET	D10G, D264G, D221G, D168G	Multiple endocrine neoplasia, type 2	VCV000939953	10	43600565	10	43105117	939953	935021	rs1393343313	NC_000010.11:43105116:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 19, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.792C>T (p.Asp264=)	RET		Hereditary cancer-predisposing syndrome	VCV002568363	10	43600566	10	43105118	2568363	2734899		NC_000010.11:43105117:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 14, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.792C>G (p.Asp264Glu)	RET	D264E, D10E, D168E, D221E	not specified|Multiple endocrine neoplasia, type 2	VCV000633392	10	43600566	10	43105118	633392	621315	rs1564491360	NC_000010.11:43105117:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 9, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.793G>A (p.Glu265Lys)	RET	E222K, E265K, E11K, E169K	not provided|Multiple endocrine neoplasia, type 2	VCV002128265	10	43600567	10	43105119	2128265	2182268		NC_000010.11:43105118:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 22, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.794A>G (p.Glu265Gly)	RET	E11G, E222G, E169G, E265G	Hereditary cancer-predisposing syndrome	VCV003432203	10	43600568	10	43105120	3432203	3593400		NC_000010.11:43105119:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 9, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.795G>C (p.Glu265Asp)	RET	E11D, E265D, E222D, E169D	Multiple endocrine neoplasia, type 2	VCV001511388	10	43600569	10	43105121	1511388	1458869	rs1554817821	NC_000010.11:43105120:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 29, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.795G>A (p.Glu265=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000543779	10	43600569	10	43105121	543779	525093	rs1554817821	NC_000010.11:43105120:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.796G>A (p.Asp266Asn)	RET	D266N, D12N, D223N, D170N	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1	VCV000543748	10	43600570	10	43105122	543748	525607	rs1554817823	NC_000010.11:43105121:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.798C>T (p.Asp266=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000713086	10	43600572	10	43105124	713086	723946	rs1588866198	NC_000010.11:43105123:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 31, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.801C>T (p.Asp267=)	RET		Hereditary cancer-predisposing syndrome	VCV003227570	10	43600575	10	43105127	3227570	3390781		NC_000010.11:43105126:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 14, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.802T>G (p.Ser268Ala)	RET	S14A, S225A, S268A, S172A	Hereditary cancer-predisposing syndrome	VCV002568343	10	43600576	10	43105128	2568343	2734879		NC_000010.11:43105127:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 5, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.803C>G (p.Ser268Trp)	RET	S172W, S268W, S225W, S14W	Multiple endocrine neoplasia, type 2	VCV002738024	10	43600577	10	43105129	2738024	2895375		NC_000010.11:43105128:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 8, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.804G>T (p.Ser268=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001761805	10	43600578	10	43105130	1761805	1823747		NC_000010.11:43105129:G:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.804G>A (p.Ser268=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000827415	10	43600578	10	43105130	827415	809899	rs942287684	NC_000010.11:43105129:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.805G>C (p.Ala269Pro)	RET	A269P, A15P, A173P, A226P	Multiple endocrine neoplasia, type 2	VCV000565969	10	43600579	10	43105131	565969	563695	rs1564491376	NC_000010.11:43105130:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 17, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.806C>T (p.Ala269Val)	RET	A15V, A173V, A226V, A269V	Hereditary cancer-predisposing syndrome	VCV003227571	10	43600580	10	43105132	3227571	3390782		NC_000010.11:43105131:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 20, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.807G>C (p.Ala269=)	RET		Multiple endocrine neoplasia, type 2	VCV003074393	10	43600581	10	43105133	3074393	3231527		NC_000010.11:43105132:G:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 2, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.807G>A (p.Ala269=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001586967	10	43600581	10	43105133	1586967	1628907	rs2132707887	NC_000010.11:43105132:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.808C>A (p.Pro270Thr)	RET	P16T, P174T, P227T, P270T	Multiple endocrine neoplasia, type 2	VCV003074392	10	43600582	10	43105134	3074392	3231526		NC_000010.11:43105133:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 2, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.810C>A (p.Pro270=)	RET		Multiple endocrine neoplasia, type 2|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome	VCV001613163	10	43600584	10	43105136	1613163	1663314	rs1160403666	NC_000010.11:43105135:C:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.810C>T (p.Pro270=)	RET		not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001577879	10	43600584	10	43105136	1577879	1522307	rs1160403666	NC_000010.11:43105135:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.810C>G (p.Pro270=)	RET		Multiple endocrine neoplasia, type 2	VCV000761682	10	43600584	10	43105136	761682	767728	rs1160403666	NC_000010.11:43105135:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 26, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.812C>A (p.Thr271Asn)	RET	T175N, T17N, T271N, T228N	Hereditary cancer-predisposing syndrome	VCV003313737	10	43600586	10	43105138	3313737	3465467		NC_000010.11:43105137:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 19, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.812C>T (p.Thr271Ile)	RET	T17I, T271I, T228I, T175I	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000827467	10	43600586	10	43105138	827467	809900	rs1361019662	NC_000010.11:43105137:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.813C>T (p.Thr271=)	RET		Multiple endocrine neoplasia, type 2	VCV003690341	10	43600587	10	43105139	3690341	3820639		NC_000010.11:43105138:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 10, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.813C>A (p.Thr271=)	RET		Hereditary cancer-predisposing syndrome	VCV001762150	10	43600587	10	43105139	1762150	1820286		NC_000010.11:43105138:C:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 29, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.814T>C (p.Phe272Leu)	RET	F176L, F272L, F229L, F18L	Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A	VCV003594588	10	43600588	10	43105140	3594588	3725669		NC_000010.11:43105139:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 4, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.814T>A (p.Phe272Ile)	RET	F272I, F18I, F176I, F229I	Hereditary cancer-predisposing syndrome	VCV001762192	10	43600588	10	43105140	1762192	1820328		NC_000010.11:43105139:T:A	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.815T>G (p.Phe272Cys)	RET	F229C, F18C, F272C, F176C	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001970597	10	43600589	10	43105141	1970597	2025440		NC_000010.11:43105140:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.815T>C (p.Phe272Ser)	RET	F18S, F272S, F176S, F229S	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001408723	10	43600589	10	43105141	1408723	1500389	rs2132708113	NC_000010.11:43105140:T:C	single nucleotide variant	missense variant	Uncertain significance	May 26, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.816C>T (p.Phe272=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000698232	10	43600590	10	43105142	698232	687628	rs754428451	NC_000010.11:43105141:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.817C>T (p.Pro273Ser)	RET	P19S, P230S, P273S, P177S	Multiple endocrine neoplasia, type 2	VCV002719572	10	43600591	10	43105143	2719572	2870208		NC_000010.11:43105142:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 25, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.817C>A (p.Pro273Thr)	RET	P273T, P19T, P230T, P177T	Multiple endocrine neoplasia, type 2	VCV000863875	10	43600591	10	43105143	863875	836817	rs1588866219	NC_000010.11:43105142:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 25, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.817C>G (p.Pro273Ala)	RET	P273A, P19A, P177A, P230A	Hereditary cancer-predisposing syndrome	VCV000827490	10	43600591	10	43105143	827490	809901	rs1588866219	NC_000010.11:43105142:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 2, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.818C>T (p.Pro273Leu)	RET	P177L, P273L, P19L, P230L	Hereditary cancer-predisposing syndrome	VCV003432231	10	43600592	10	43105144	3432231	3593427		NC_000010.11:43105143:C:T	single nucleotide variant	missense variant|intron variant	Likely benign	Jul 5, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.818C>A (p.Pro273His)	RET	P177H, P19H, P230H, P273H	Ovarian cancer	VCV002445369	10	43600592	10	43105144	2445369	2419095		NC_000010.11:43105143:C:A	single nucleotide variant	missense variant	Likely pathogenic	Jan 1, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.819C>G (p.Pro273=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000706930	10	43600593	10	43105145	706930	692832	rs864622467	NC_000010.11:43105144:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.819C>T (p.Pro273=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000220298	10	43600593	10	43105145	220298	221948	rs864622467	NC_000010.11:43105144:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.820G>A (p.Ala274Thr)	RET	A20T, A274T, A178T, A231T	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000840514	10	43600594	10	43105146	840514	836818	rs1837738287	NC_000010.11:43105145:G:A	single nucleotide variant	missense variant	Uncertain significance	May 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.821C>T (p.Ala274Val)	RET	A178V, A274V, A20V, A231V	Hereditary cancer-predisposing syndrome	VCV001762508	10	43600595	10	43105147	1762508	1816907		NC_000010.11:43105146:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 30, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.822G>A (p.Ala274=)	RET		Multiple endocrine neoplasia, type 2	VCV002025500	10	43600596	10	43105148	2025500	2080848		NC_000010.11:43105147:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 18, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.822G>C (p.Ala274=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001762553	10	43600596	10	43105148	1762553	1816951		NC_000010.11:43105147:G:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 12, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.822G>T (p.Ala274=)	RET		Multiple endocrine neoplasia, type 2	VCV001622496	10	43600596	10	43105148	1622496	1561343	rs1287128584	NC_000010.11:43105147:G:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Feb 18, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.824G>T (p.Gly275Val)	RET	G232V, G21V, G179V, G275V	Hereditary cancer-predisposing syndrome	VCV002618723	10	43600598	10	43105150	2618723	2782468		NC_000010.11:43105149:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 28, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.824G>A (p.Gly275Asp)	RET	G179D, G232D, G275D, G21D	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001762625	10	43600598	10	43105150	1762625	1817023		NC_000010.11:43105149:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 21, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.824G>C (p.Gly275Ala)	RET	G21A, G275A, G179A, G232A	Multiple endocrine neoplasia, type 2	VCV001006047	10	43600598	10	43105150	1006047	993806	rs143209223	NC_000010.11:43105149:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 22, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.824_825delinsTT (p.Gly275Val)	RET	G21V, G275V, G232V, G179V	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	VCV000961833	10	43600598 - 43600599	10	43105150 - 43105151	961833	946878	rs1837738788	NC_000010.11:43105149:GC:TT	Indel	missense variant	Uncertain significance	Jul 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.825C>T (p.Gly275=)	RET		Familial medullary thyroid carcinoma|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|not provided	VCV000697406	10	43600599	10	43105151	697406	687629	rs150797149	NC_000010.11:43105150:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.826G>T (p.Val276Phe)	RET	V276F, V22F, V233F, V180F	Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000576885	10	43600600	10	43105152	576885	563710	rs139213499	NC_000010.11:43105151:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.827T>C (p.Val276Ala)	RET	V180A, V22A, V233A, V276A	Hereditary cancer-predisposing syndrome	VCV003313711	10	43600601	10	43105153	3313711	3465441		NC_000010.11:43105152:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 27, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.827T>G (p.Val276Gly)	RET	V180G, V22G, V233G, V276G	Hereditary cancer-predisposing syndrome	VCV003227572	10	43600601	10	43105153	3227572	3390783		NC_000010.11:43105152:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 14, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.828C>T (p.Val276=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001543398	10	43600602	10	43105154	1543398	1632855	rs876660380	NC_000010.11:43105153:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.828C>G (p.Val276=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000233400	10	43600602	10	43105154	233400	233777	rs876660380	NC_000010.11:43105153:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.829G>T (p.Asp277Tyr)	RET	D234Y, D23Y, D277Y, D181Y	Hereditary cancer-predisposing syndrome	VCV003432264	10	43600603	10	43105155	3432264	3593460		NC_000010.11:43105154:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 19, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.829G>A (p.Asp277Asn)	RET	D23N, D277N, D234N, D181N	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000856805	10	43600603	10	43105155	856805	836819	rs1027662469	NC_000010.11:43105154:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.830A>G (p.Asp277Gly)	RET	D23G, D277G, D181G, D234G	Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2	VCV002061872	10	43600604	10	43105156	2061872	2121020		NC_000010.11:43105155:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.832A>G (p.Thr278Ala)	RET	T278A, T24A, T235A, T182A	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2A	VCV000220205	10	43600606	10	43105158	220205	221949	rs541929171	NC_000010.11:43105157:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.833C>T (p.Thr278Ile)	RET	T278I, T235I, T182I, T24I	Hereditary cancer-predisposing syndrome	VCV003432207	10	43600607	10	43105159	3432207	3593404		NC_000010.11:43105158:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 28, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.833C>G (p.Thr278Ser)	RET	T235S, T24S, T182S, T278S	Multiple endocrine neoplasia, type 2	VCV002719573	10	43600607	10	43105159	2719573	2870209		NC_000010.11:43105158:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 1, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.833C>A (p.Thr278Asn)	RET	T278N, T24N, T235N, T182N	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not specified|Renal hypodysplasia/aplasia 1|not provided|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Multiple endocrine neoplasia	VCV000041846	10	43600607	10	43105159	41846	50285	rs35118262	NC_000010.11:43105158:C:A	single nucleotide variant	missense variant	Benign/Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.834C>A (p.Thr278=)	RET		Multiple endocrine neoplasia, type 2	VCV002914647	10	43600608	10	43105160	2914647	3079386		NC_000010.11:43105159:C:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 22, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.834C>T (p.Thr278=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000705456	10	43600608	10	43105160	705456	692833	rs41306550	NC_000010.11:43105159:C:T	single nucleotide variant	intron variant|synonymous variant	Likely benign	Sep 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.835G>A (p.Ala279Thr)	RET	A279T, A25T, A183T, A236T	Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000405524	10	43600609	10	43105161	405524	397793	rs777221273	NC_000010.11:43105160:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.838A>G (p.Ser280Gly)	RET	S280G, S26G, S184G, S237G	Multiple endocrine neoplasia, type 2	VCV001473932	10	43600612	10	43105164	1473932	1387928	rs749244375	NC_000010.11:43105163:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 28, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.839G>T (p.Ser280Ile)	RET	S184I, S26I, S280I, S237I	Multiple endocrine neoplasia, type 2	VCV003723013	10	43600613	10	43105165	3723013	3854105		NC_000010.11:43105164:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 16, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.840C>T (p.Ser280=)	RET		Multiple endocrine neoplasia, type 2	VCV002965422	10	43600614	10	43105166	2965422	3127540		NC_000010.11:43105165:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 12, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.841G>A (p.Ala281Thr)	RET	A281T, A27T, A185T, A238T	Multiple endocrine neoplasia, type 2	VCV002993424	10	43600615	10	43105167	2993424	3144742		NC_000010.11:43105166:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 30, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.842C>G (p.Ala281Gly)	RET	A27G, A281G, A238G, A185G	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000945519	10	43600616	10	43105168	945519	925798	rs745642574	NC_000010.11:43105167:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.843C>T (p.Ala281=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000822420	10	43600617	10	43105169	822420	809902	rs770794801	NC_000010.11:43105168:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 29, 2020	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.843C>G (p.Ala281=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000745405	10	43600617	10	43105169	745405	752097	rs770794801	NC_000010.11:43105168:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.844G>T (p.Val282Leu)	RET	V239L, V28L, V186L, V282L	Multiple endocrine neoplasia, type 2	VCV002735388	10	43600618	10	43105170	2735388	2901413		NC_000010.11:43105169:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 14, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.844G>A (p.Val282Met)	RET	V282M, V28M, V239M, V186M	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000822449	10	43600618	10	43105170	822449	809903	rs1588866293	NC_000010.11:43105169:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.845T>C (p.Val282Ala)	RET	V239A, V282A, V186A, V28A	Hereditary cancer-predisposing syndrome	VCV003432305	10	43600619	10	43105171	3432305	3593501		NC_000010.11:43105170:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 7, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.845T>G (p.Val282Gly)	RET	V186G, V239G, V28G, V282G	Hereditary cancer-predisposing syndrome	VCV002568352	10	43600619	10	43105171	2568352	2734888		NC_000010.11:43105170:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 1, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.846G>T (p.Val282=)	RET		Hereditary cancer-predisposing syndrome	VCV001763501	10	43600620	10	43105172	1763501	1824225		NC_000010.11:43105171:G:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 30, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.846G>C (p.Val282=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001107464	10	43600620	10	43105172	1107464	1098683	rs1221096250	NC_000010.11:43105171:G:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 27, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.846G>A (p.Val282=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000699187	10	43600620	10	43105172	699187	687630	rs1221096250	NC_000010.11:43105171:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.847G>C (p.Val283Leu)	RET	V29L, V240L, V283L, V187L	Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1	VCV001763538	10	43600621	10	43105173	1763538	1824262		NC_000010.11:43105172:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.850_852del (p.Glu284del)	RET	E188del, E241del, E284del, E30del	Multiple endocrine neoplasia, type 2	VCV003724165	10	43600623 - 43600625	10	43105175 - 43105177	3724165	3857377		NC_000010.11:43105174:GGAG:G	Deletion	intron variant	Uncertain significance	Oct 30, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.849G>A (p.Val283=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000822511	10	43600623	10	43105175	822511	809904	rs1588866305	NC_000010.11:43105174:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.850G>A (p.Glu284Lys)	RET	E284K, E30K, E188K, E241K	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000641201	10	43600624	10	43105176	641201	638877	rs1588866311	NC_000010.11:43105175:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.851A>T (p.Glu284Val)	RET	E188V, E241V, E284V, E30V	Hereditary cancer-predisposing syndrome	VCV001763705	10	43600625	10	43105177	1763705	1820572		NC_000010.11:43105176:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 4, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.852G>A (p.Glu284=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001763759	10	43600626	10	43105178	1763759	1820625		NC_000010.11:43105177:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.853T>A (p.Phe285Ile)	RET	F242I, F285I, F31I, F189I	Multiple endocrine neoplasia, type 2	VCV003645141	10	43600627	10	43105179	3645141	3783556		NC_000010.11:43105178:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 9, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.853T>G (p.Phe285Val)	RET	F242V, F31V, F189V, F285V	Hereditary cancer-predisposing syndrome	VCV002568373	10	43600627	10	43105179	2568373	2734909		NC_000010.11:43105178:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 28, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.853T>C (p.Phe285Leu)	RET	F285L, F31L, F189L, F242L	Multiple endocrine neoplasia, type 2	VCV000543732	10	43600627	10	43105179	543732	525610	rs1554817836	NC_000010.11:43105178:T:C	single nucleotide variant	missense variant	Uncertain significance	May 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.855C>A (p.Phe285Leu)	RET	F285L, F242L, F31L, F189L	Hereditary cancer-predisposing syndrome	VCV001763844	10	43600629	10	43105181	1763844	1820710		NC_000010.11:43105180:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 9, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.855C>G (p.Phe285Leu)	RET	F285L, F31L, F189L, F242L	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001000866	10	43600629	10	43105181	1000866	993807	rs778909045	NC_000010.11:43105180:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.857A>C (p.Lys286Thr)	RET	K286T, K32T, K243T, K190T	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000863961	10	43600631	10	43105183	863961	836820	rs745710576	NC_000010.11:43105182:A:C	single nucleotide variant	missense variant	Uncertain significance	Oct 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.859C>A (p.Arg287=)	RET		Multiple endocrine neoplasia, type 2	VCV001607997	10	43600633	10	43105185	1607997	1539436	rs1588866335	NC_000010.11:43105184:C:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 6, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.860G>T (p.Arg287Leu)	RET	R287L, R33L, R191L, R244L	Aganglionic megacolon	VCV000692071	10	43600634	10	43105186	692071	679771	rs1564491460	NC_000010.11:43105185:G:T	single nucleotide variant	missense variant	Likely pathogenic	Jan 25, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.860G>A (p.Arg287Gln)	RET	R287Q, R33Q, R191Q, R244Q	Aganglionic megacolon	VCV000560625	10	43600634	10	43105186	560625	551710	rs1564491460	NC_000010.11:43105185:G:A	single nucleotide variant	missense variant	Pathogenic	Nov 3, 2006	no assertion criteria provided							
NM_020975.6(RET):c.861G>A (p.Arg287=)	RET		Hereditary cancer-predisposing syndrome	VCV001764066	10	43600635	10	43105187	1764066	1820929		NC_000010.11:43105186:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 25, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.864G>A (p.Lys288=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000477389	10	43600638	10	43105190	477389	460695	rs1227666582	NC_000010.11:43105189:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.865G>A (p.Glu289Lys)	RET	E35K, E246K, E193K, E289K	Multiple endocrine neoplasia, type 2	VCV003674710	10	43600639	10	43105191	3674710	3809900		NC_000010.11:43105190:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 14, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.865G>C (p.Glu289Gln)	RET	E289Q, E35Q, E246Q, E193Q	Multiple endocrine neoplasia, type 2	VCV001039962	10	43600639	10	43105191	1039962	1029531	rs1837741195	NC_000010.11:43105190:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 19, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.866A>C (p.Glu289Ala)	RET	E289A, E35A, E193A, E246A	Hereditary cancer-predisposing syndrome	VCV001764233	10	43600640	10	43105192	1764233	1817360		NC_000010.11:43105191:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 29, 2017	criteria provided, single submitter							
NM_020975.6(RET):c.867+3G>A	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001346773	10	43600644	10	43105196	1346773	1452886	rs2132709323	NC_000010.11:43105195:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jul 29, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.867+4C>G	RET		Renal hypodysplasia/aplasia 1|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia	VCV000877981	10	43600645	10	43105197	877981	868471	rs1837741280	NC_000010.11:43105196:C:G	single nucleotide variant	intron variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.867+4del	RET		not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000095998	10	43600645	10	43105197	95998	101893	rs398124368	NC_000010.11:43105196:C:	Deletion	intron variant	Uncertain significance	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.867+6T>C	RET		Multiple endocrine neoplasia, type 2	VCV003020159	10	43600647	10	43105199	3020159	3183026		NC_000010.11:43105198:T:C	single nucleotide variant	intron variant	Uncertain significance	Dec 6, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.867+7G>C	RET		Multiple endocrine neoplasia, type 2	VCV000702359	10	43600648	10	43105200	702359	695476	rs1588866349	NC_000010.11:43105199:G:C	single nucleotide variant	intron variant	Likely benign	Apr 30, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.867+8T>A	RET		Multiple endocrine neoplasia, type 2	VCV002117359	10	43600649	10	43105201	2117359	2183000		NC_000010.11:43105200:T:A	single nucleotide variant	intron variant	Likely benign	Dec 20, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.867+9C>T	RET		not provided	VCV001319670	10	43600650	10	43105202	1319670	1309921	rs2132709396	NC_000010.11:43105201:C:T	single nucleotide variant	intron variant	Uncertain significance	Nov 3, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.867+10C>G	RET		Multiple endocrine neoplasia, type 2	VCV002701231	10	43600651	10	43105203	2701231	2862225		NC_000010.11:43105202:C:G	single nucleotide variant	intron variant	Likely benign	Dec 6, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.867+10C>T	RET		Multiple endocrine neoplasia, type 2	VCV001135045	10	43600651	10	43105203	1135045	1120257	rs2132709415	NC_000010.11:43105202:C:T	single nucleotide variant	intron variant	Likely benign	Jul 11, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.867+14C>G	RET		Multiple endocrine neoplasia, type 2	VCV002730412	10	43600655	10	43105207	2730412	2887012		NC_000010.11:43105206:C:G	single nucleotide variant	intron variant	Likely benign	Feb 24, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.867+15G>T	RET		Multiple endocrine neoplasia, type 2	VCV001593647	10	43600656	10	43105208	1593647	1655066	rs760940841	NC_000010.11:43105207:G:T	single nucleotide variant	intron variant	Likely benign	Jan 15, 2025	criteria provided, single submitter							
NM_020975.6(RET):c.867+17_867+18del	RET		Multiple endocrine neoplasia, type 2	VCV002999751	10	43600658 - 43600659	10	43105210 - 43105211	2999751	3163874		NC_000010.11:43105209:GC:	Deletion	intron variant	Likely benign	Jan 10, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.867+17G>A	RET		Multiple endocrine neoplasia, type 2	VCV002874620	10	43600658	10	43105210	2874620	3035191		NC_000010.11:43105209:G:A	single nucleotide variant	intron variant	Likely benign	Jan 22, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.867+18C>T	RET		Multiple endocrine neoplasia, type 2	VCV002800986	10	43600659	10	43105211	2800986	2959514		NC_000010.11:43105210:C:T	single nucleotide variant	intron variant	Likely benign	Aug 6, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.867+19T>C	RET		Multiple endocrine neoplasia, type 2	VCV002783624	10	43600660	10	43105212	2783624	2948223		NC_000010.11:43105211:T:C	single nucleotide variant	intron variant	Likely benign	May 17, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.867+20G>A	RET		Multiple endocrine neoplasia, type 2	VCV002173876	10	43600661	10	43105213	2173876	1897546		NC_000010.11:43105212:G:A	single nucleotide variant	intron variant	Likely benign	Nov 9, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.867+48A>G	RET		Multiple endocrine neoplasia, type 2|not provided|not specified|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B|Pheochromocytoma	VCV000261398	10	43600689	10	43105241	261398	253762	rs2435352	NC_000010.11:43105240:A:G	single nucleotide variant	intron variant	Benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.867+166G>A	RET		not provided	VCV001216482	10	43600807	10	43105359	1216482	1206462	rs112933094	NC_000010.11:43105358:G:A	single nucleotide variant	intron variant	Likely benign	Jun 23, 2018	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.867+171A>T	RET		not provided	VCV000676872	10	43600812	10	43105364	676872	664249	rs3026739	NC_000010.11:43105363:A:T	single nucleotide variant	intron variant	Likely benign	Jun 12, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.867+223A>T	RET		not provided	VCV000677051	10	43600864	10	43105416	677051	664254	rs1864406	NC_000010.11:43105415:A:T	single nucleotide variant	intron variant	Benign	Jun 16, 2018	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.868-265G>A	LOC130003706|RET		not provided	VCV001286863	10	43601559	10	43106111	1286863	1276699	rs12764797	NC_000010.11:43106110:G:A	single nucleotide variant	intron variant	Benign	Apr 9, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.868-86A>G	RET		not provided	VCV000676910	10	43601738	10	43106290	676910	664261	rs112753528	NC_000010.11:43106289:A:G	single nucleotide variant	intron variant	Likely benign	Jun 12, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.868-75T>C	RET		not provided	VCV001222122	10	43601749	10	43106301	1222122	1213684	rs2742243	NC_000010.11:43106300:T:C	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.868-63G>C	RET		not provided	VCV001201042	10	43601761	10	43106313	1201042	1191056	rs146623661	NC_000010.11:43106312:G:C	single nucleotide variant	intron variant	Likely benign	Jul 22, 2018	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.868-39A>G	RET		not specified	VCV003256492	10	43601785	10	43106337	3256492	3415254		NC_000010.11:43106336:A:G	single nucleotide variant	intron variant	Likely benign	Jul 31, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.868-20A>G	RET		Multiple endocrine neoplasia, type 2	VCV002196268	10	43601804	10	43106356	2196268	1923742		NC_000010.11:43106355:A:G	single nucleotide variant	intron variant	Likely benign	Jul 22, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.868-19C>T	RET		Multiple endocrine neoplasia, type 2	VCV001545853	10	43601805	10	43106357	1545853	1612525	rs1415274397	NC_000010.11:43106356:C:T	single nucleotide variant	intron variant	Likely benign	Apr 29, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.868-18G>T	RET		Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma	VCV001662743	10	43601806	10	43106358	1662743	1555549	rs57098408	NC_000010.11:43106357:G:T	single nucleotide variant	intron variant	Likely benign	Oct 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.868-18G>A	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A|not provided|Multiple endocrine neoplasia type 2B|not specified	VCV000220722	10	43601806	10	43106358	220722	221950	rs57098408	NC_000010.11:43106357:G:A	single nucleotide variant	intron variant	Benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.868-17C>T	RET		Multiple endocrine neoplasia, type 2	VCV002160953	10	43601807	10	43106359	2160953	1894545		NC_000010.11:43106358:C:T	single nucleotide variant	intron variant	Likely benign	Jul 7, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.868-16C>T	RET		Multiple endocrine neoplasia, type 2	VCV003718566	10	43601808	10	43106360	3718566	3859271		NC_000010.11:43106359:C:T	single nucleotide variant	intron variant	Likely benign	Jul 23, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.868-15C>G	RET		Hirschsprung disease, susceptibility to, 1	VCV003393131	10	43601809	10	43106361	3393131	3552208		NC_000010.11:43106360:C:G	single nucleotide variant	intron variant	Uncertain significance	Dec 19, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.868-15C>T	RET		Multiple endocrine neoplasia, type 2	VCV002197651	10	43601809	10	43106361	2197651	1927232		NC_000010.11:43106360:C:T	single nucleotide variant	intron variant	Likely benign	Nov 18, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.868-13C>G	RET		Multiple endocrine neoplasia, type 2	VCV002717019	10	43601811	10	43106363	2717019	2876717		NC_000010.11:43106362:C:G	single nucleotide variant	intron variant	Likely benign	Jun 30, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.868-11G>T	RET		Multiple endocrine neoplasia, type 2	VCV001602586	10	43601813	10	43106365	1602586	1557543	rs1395130256	NC_000010.11:43106364:G:T	single nucleotide variant	intron variant	Likely benign	Nov 29, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.868-11G>A	RET		Multiple endocrine neoplasia, type 2	VCV001596907	10	43601813	10	43106365	1596907	1602502	rs1395130256	NC_000010.11:43106364:G:A	single nucleotide variant	intron variant	Likely benign	Jul 12, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.868-9A>C	RET		Multiple endocrine neoplasia, type 2	VCV002883563	10	43601815	10	43106367	2883563	3046318		NC_000010.11:43106366:A:C	single nucleotide variant	intron variant	Likely benign	Nov 7, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.868-9A>G	RET		Multiple endocrine neoplasia, type 2	VCV000136125	10	43601815	10	43106367	136125	139837	rs201766252	NC_000010.11:43106366:A:G	single nucleotide variant	intron variant	Likely benign	Nov 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.868-7C>T	RET		Multiple endocrine neoplasia, type 2	VCV003675451	10	43601817	10	43106369	3675451	3816949		NC_000010.11:43106368:C:T	single nucleotide variant	intron variant	Likely benign	Jun 17, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.868-6C>T	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not specified|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia type 2A	VCV000261399	10	43601818	10	43106370	261399	253763	rs367688294	NC_000010.11:43106369:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Dec 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.868-4G>T	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001764294	10	43601820	10	43106372	1764294	1817421		NC_000010.11:43106371:G:T	single nucleotide variant	intron variant	Likely benign	Oct 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.868-4del	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001574514	10	43601820	10	43106372	1574514	1659699	rs1837775018	NC_000010.11:43106371:G:	Deletion	intron variant	Likely benign	Sep 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.868-4G>A	RET		Multiple endocrine neoplasia, type 2	VCV001121495	10	43601820	10	43106372	1121495	1120258	rs1414580503	NC_000010.11:43106371:G:A	single nucleotide variant	intron variant	Likely benign	Jun 27, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.868-2A>G	RET		Multiple endocrine neoplasia, type 2	VCV003073317	10	43601822	10	43106374	3073317	3234273		NC_000010.11:43106373:A:G	single nucleotide variant	splice acceptor variant|intron variant	Uncertain significance	Sep 4, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.870C>G (p.Asp290Glu)	RET	D290E, D36E, D194E, D247E	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001386010	10	43601826	10	43106378	1386010	1361018	rs2132718797	NC_000010.11:43106377:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.871A>T (p.Thr291Ser)	RET	T195S, T248S, T291S, T37S	not provided	VCV003602517	10	43601827	10	43106379	3602517	3735189		NC_000010.11:43106378:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 30, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.873C>T (p.Thr291=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000704191	10	43601829	10	43106381	704191	692834	rs1342683619	NC_000010.11:43106380:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.874G>T (p.Val292Leu)	RET	V292L, V38L, V196L, V249L	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001764535	10	43601830	10	43106382	1764535	1814356		NC_000010.11:43106381:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.874G>A (p.Val292Met)	RET	V38M, V196M, V249M	Multiple endocrine neoplasia type 2B|Hereditary cancer|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Pheochromocytoma|not provided|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1|not specified	VCV000024880	10	43601830	10	43106382	24880	36221	rs34682185	NC_000010.11:43106381:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 30, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.875T>G (p.Val292Gly)	RET	V196G, V249G, V292G, V38G	Multiple endocrine neoplasia, type 2	VCV003069952	10	43601831	10	43106383	3069952	3233527		NC_000010.11:43106382:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 28, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.877G>A (p.Val293Met)	RET	V197M, V250M, V293M, V39M	Hereditary cancer-predisposing syndrome	VCV003227574	10	43601833	10	43106385	3227574	3390785		NC_000010.11:43106384:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 29, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.880G>T (p.Ala294Ser)	RET	A251S, A198S, A40S, A294S	not provided	VCV003393846	10	43601836	10	43106388	3393846	3552921		NC_000010.11:43106387:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 3, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.882C>T (p.Ala294=)	RET		Multiple endocrine neoplasia, type 2	VCV002765026	10	43601838	10	43106390	2765026	2928792		NC_000010.11:43106389:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 4, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.884C>A (p.Thr295Lys)	RET	T41K, T295K, T199K, T252K	Hereditary cancer-predisposing syndrome	VCV001764868	10	43601840	10	43106392	1764868	1814689		NC_000010.11:43106391:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 8, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.884C>T (p.Thr295Met)	RET	T295M, T41M, T252M, T199M	RET-related disorder|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|not provided	VCV000549769	10	43601840	10	43106392	549769	540533	rs758159521	NC_000010.11:43106391:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 9, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.884C>G (p.Thr295Arg)	RET	T295R, T41R, T199R, T252R	Hereditary cancer-predisposing syndrome	VCV000486350	10	43601840	10	43106392	486350	475084	rs758159521	NC_000010.11:43106391:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.885G>T (p.Thr295=)	RET		Multiple endocrine neoplasia, type 2	VCV001609880	10	43601841	10	43106393	1609880	1550836	rs1202206539	NC_000010.11:43106392:G:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 24, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.885G>A (p.Thr295=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000822779	10	43601841	10	43106393	822779	809905	rs1202206539	NC_000010.11:43106392:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.887T>A (p.Leu296Gln)	RET	L253Q, L296Q, L200Q, L42Q	Hereditary cancer-predisposing syndrome	VCV001764966	10	43601843	10	43106395	1764966	1824460		NC_000010.11:43106394:T:A	single nucleotide variant	missense variant	Uncertain significance	Jun 7, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.888G>T (p.Leu296=)	RET		Multiple endocrine neoplasia, type 2	VCV003650679	10	43601844	10	43106396	3650679	3781409		NC_000010.11:43106395:G:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 24, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.889C>A (p.Arg297Ser)	RET	R254S, R297S, R201S, R43S	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002127520	10	43601845	10	43106397	2127520	2175058		NC_000010.11:43106396:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.889C>T (p.Arg297Cys)	RET	R254C, R201C, R297C, R43C	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1	VCV001765018	10	43601845	10	43106397	1765018	1824512		NC_000010.11:43106396:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.890dup (p.Val298fs)	RET	V44fs, V298fs	not provided	VCV000280193	10	43601845 - 43601846	10	43106397 - 43106398	280193	264456	rs886041443	NC_000010.11:43106397:G:GG	Duplication	frameshift variant	Pathogenic	Jan 8, 2016	criteria provided, single submitter							
NM_020975.6(RET):c.890G>C (p.Arg297Pro)	RET	R254P, R297P, R201P, R43P	Multiple endocrine neoplasia, type 2	VCV002131866	10	43601846	10	43106398	2131866	2189854		NC_000010.11:43106397:G:C	single nucleotide variant	missense variant	Uncertain significance	May 22, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.890G>A (p.Arg297His)	RET	R43H, R297H, R201H, R254H	not provided|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome	VCV000822820	10	43601846	10	43106398	822820	809906	rs1480040525	NC_000010.11:43106397:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 28, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.891T>C (p.Arg297=)	RET		Hereditary cancer-predisposing syndrome	VCV000486348	10	43601847	10	43106399	486348	475087	rs1554817976	NC_000010.11:43106398:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 31, 2016	criteria provided, single submitter							
NM_020975.6(RET):c.892G>A (p.Val298Ile)	RET	V298I, V44I, V255I, V202I	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000862876	10	43601848	10	43106400	862876	836821	rs1837776673	NC_000010.11:43106399:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.895T>G (p.Phe299Val)	RET	F299V, F45V, F203V, F256V	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001366196	10	43601851	10	43106403	1366196	1411538	rs1837776769	NC_000010.11:43106402:T:G	single nucleotide variant	missense variant	Uncertain significance	Jan 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.897C>T (p.Phe299=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2	VCV000477390	10	43601853	10	43106405	477390	460697	rs529153319	NC_000010.11:43106404:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.898G>A (p.Asp300Asn)	RET	D300N, D46N, D204N, D257N	Hirschsprung disease, susceptibility to, 1	VCV001065487	10	43601854	10	43106406	1065487	1053767	rs2132719351	NC_000010.11:43106405:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 6, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.900T>C (p.Asp300=)	RET		Multiple endocrine neoplasia, type 2	VCV001117849	10	43601856	10	43106408	1117849	1098684	rs2132719382	NC_000010.11:43106407:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 13, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.902C>T (p.Ala301Val)	RET	A301V, A47V, A258V, A205V	Multiple endocrine neoplasia, type 2	VCV002825824	10	43601858	10	43106410	2825824	2979217		NC_000010.11:43106409:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 4, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.903_905dup (p.Ala301_Asp302insGlu)	RET		RET-related disorder	VCV002629812	10	43601858 - 43601859	10	43106410 - 43106411	2629812	2800650		NC_000010.11:43106410:AGA:AGAAGA	Duplication	inframe_indel|inframe_insertion|intron variant	Likely pathogenic	Mar 16, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.902C>A (p.Ala301Glu)	RET	A205E, A258E, A301E, A47E	Multiple endocrine neoplasia, type 2	VCV001721457	10	43601858	10	43106410	1721457	1772791		NC_000010.11:43106409:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 12, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.903A>T (p.Ala301=)	RET		Multiple endocrine neoplasia, type 2	VCV003387589	10	43601859	10	43106411	3387589	3546722		NC_000010.11:43106410:A:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 20, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.903A>G (p.Ala301=)	RET		Hereditary cancer-predisposing syndrome	VCV001765552	10	43601859	10	43106411	1765552	1821192		NC_000010.11:43106410:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 29, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.906C>T (p.Asp302=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000413464	10	43601862	10	43106414	413464	397262	rs768934031	NC_000010.11:43106413:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.907G>C (p.Val303Leu)	RET	V303L, V207L, V260L, V49L	Multiple endocrine neoplasia, type 2	VCV002761196	10	43601863	10	43106415	2761196	2924962		NC_000010.11:43106414:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 17, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.907G>A (p.Val303Met)	RET	V303M, V49M, V260M, V207M	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000657691	10	43601863	10	43106415	657691	638878	rs1588867164	NC_000010.11:43106414:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.909_910delinsAA (p.Val304Ile)	RET	V261I, V304I, V50I, V208I	Hereditary cancer-predisposing syndrome	VCV003432245	10	43601865 - 43601866	10	43106417 - 43106418	3432245	3593441		NC_000010.11:43106416:GG:AA	Indel	missense variant|intron variant	Uncertain significance	Sep 9, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.909G>A (p.Val303=)	RET		Hereditary cancer-predisposing syndrome	VCV001691916	10	43601865	10	43106417	1691916	1684358	rs1478633054	NC_000010.11:43106416:G:A	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Aug 18, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.910G>A (p.Val304Ile)	RET	V261I, V208I, V304I, V50I	not provided|Multiple endocrine neoplasia, type 2	VCV002170182	10	43601866	10	43106418	2170182	1896437		NC_000010.11:43106417:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.913C>T (p.Pro305Ser)	RET	P209S, P262S, P305S, P51S	Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A	VCV003594598	10	43601869	10	43106421	3594598	3725676		NC_000010.11:43106420:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 15, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.915T>A (p.Pro305=)	RET		Multiple endocrine neoplasia, type 2	VCV002134967	10	43601871	10	43106423	2134967	2190375		NC_000010.11:43106422:T:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 7, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.916G>C (p.Ala306Pro)	RET	A210P, A263P, A306P, A52P	Multiple endocrine neoplasia, type 2	VCV003612340	10	43601872	10	43106424	3612340	3738571		NC_000010.11:43106423:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 8, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.916G>T (p.Ala306Ser)	RET	A306S, A52S, A210S, A263S	Multiple endocrine neoplasia, type 2	VCV001021592	10	43601872	10	43106424	1021592	1008985	rs1837777521	NC_000010.11:43106423:G:T	single nucleotide variant	missense variant	Uncertain significance	May 1, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.918A>G (p.Ala306=)	RET		not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000413468	10	43601874	10	43106426	413468	397449	rs1060504034	NC_000010.11:43106425:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.919T>C (p.Ser307Pro)	RET	S264P, S307P, S211P, S53P	Multiple endocrine neoplasia, type 2	VCV002760659	10	43601875	10	43106427	2760659	2921838		NC_000010.11:43106426:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 14, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.920C>T (p.Ser307Leu)	RET	S307L, S53L, S264L, S211L	Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2	VCV000486328	10	43601876	10	43106428	486328	475265	rs1554817979	NC_000010.11:43106427:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.921A>C (p.Ser307=)	RET		Multiple endocrine neoplasia, type 2	VCV001620707	10	43601877	10	43106429	1620707	1549179	rs748294306	NC_000010.11:43106428:A:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 11, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.921A>T (p.Ser307=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001610640	10	43601877	10	43106429	1610640	1585458	rs748294306	NC_000010.11:43106428:A:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.921A>G (p.Ser307=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|not provided|Multiple endocrine neoplasia, type 2	VCV000413472	10	43601877	10	43106429	413472	397695	rs748294306	NC_000010.11:43106428:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.922G>A (p.Gly308Arg)	RET	G308R, G54R, G212R, G265R	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000405557	10	43601878	10	43106430	405557	397807	rs1060500763	NC_000010.11:43106429:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.923G>T (p.Gly308Val)	RET	G265V, G54V, G212V, G308V	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002496750	10	43601879	10	43106431	2496750	2467889		NC_000010.11:43106430:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.924G>A (p.Gly308=)	RET		Multiple endocrine neoplasia, type 2	VCV001971468	10	43601880	10	43106432	1971468	2032755		NC_000010.11:43106431:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 11, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.925G>A (p.Glu309Lys)	RET	E55K, E309K, E213K, E266K	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001510945	10	43601881	10	43106433	1510945	1465622	rs769894584	NC_000010.11:43106432:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.927G>A (p.Glu309=)	RET		Multiple endocrine neoplasia, type 2	VCV000743413	10	43601883	10	43106435	743413	752098	rs1588867192	NC_000010.11:43106434:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 13, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.930G>C (p.Leu310=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002032651	10	43601886	10	43106438	2032651	2082869		NC_000010.11:43106437:G:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.931G>C (p.Val311Leu)	RET	V311L, V57L, V215L, V268L	Multiple endocrine neoplasia, type 2	VCV000940438	10	43601887	10	43106439	940438	935022	rs1311500725	NC_000010.11:43106438:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 2, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.931G>A (p.Val311Met)	RET	V311M, V57M, V215M, V268M	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000823168	10	43601887	10	43106439	823168	809907	rs1311500725	NC_000010.11:43106438:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.931G>T (p.Val311Leu)	RET	V311L, V57L, V215L, V268L	RET-related disorder|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000486319	10	43601887	10	43106439	486319	475270	rs1311500725	NC_000010.11:43106438:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.933G>A (p.Val311=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000762696	10	43601889	10	43106441	762696	767729	rs1210305963	NC_000010.11:43106440:G:A	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Sep 13, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.935G>A (p.Arg312Lys)	RET	R216K, R312K, R58K, R269K	Hereditary cancer-predisposing syndrome	VCV001766678	10	43601891	10	43106443	1766678	1824921		NC_000010.11:43106442:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 14, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.936_939del (p.Arg312fs)	RET	R312fs, R58fs	Multiple endocrine neoplasia, type 2	VCV000963299	10	43601891 - 43601894	10	43106443 - 43106446	963299	946879	rs1837778621	NC_000010.11:43106442:GGCGG:G	Deletion	frameshift variant	Pathogenic	Jul 11, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.936G>A (p.Arg312=)	RET		Hereditary cancer-predisposing syndrome|not provided	VCV001012555	10	43601892	10	43106444	1012555	1000695	rs1837778702	NC_000010.11:43106443:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.937C>T (p.Arg313Trp)	RET	R313W, R59W, R270W, R217W	Hereditary cancer-predisposing syndrome|not specified|Multiple endocrine neoplasia, type 2|not provided	VCV000381593	10	43601893	10	43106445	381593	371671	rs1057521089	NC_000010.11:43106444:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.938G>T (p.Arg313Leu)	RET	R59L, R313L, R270L, R217L	not specified|Multiple endocrine neoplasia, type 2	VCV000850811	10	43601894	10	43106446	850811	836822	rs77702891	NC_000010.11:43106445:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 6, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.938G>A (p.Arg313Gln)	RET	R313Q, R59Q, R217Q, R270Q	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2|not provided|Multiple endocrine neoplasia type 2A	VCV000013932	10	43601894	10	43106446	13932	28971	rs77702891	NC_000010.11:43106445:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.942C>T (p.Tyr314=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000543782	10	43601898	10	43106450	543782	525409	rs1554817988	NC_000010.11:43106449:C:T	single nucleotide variant	intron variant|synonymous variant	Likely benign	Aug 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.943A>C (p.Thr315Pro)	RET	T315P, T61P, T272P, T219P	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|not provided|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1	VCV000477391	10	43601899	10	43106451	477391	460259	rs774637214	NC_000010.11:43106450:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 14, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.944C>T (p.Thr315Ile)	RET	T272I, T61I, T219I, T315I	Multiple endocrine neoplasia, type 2	VCV002754460	10	43601900	10	43106452	2754460	2913902		NC_000010.11:43106451:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 22, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.947G>C (p.Ser316Thr)	RET	S273T, S220T, S316T, S62T	Hereditary cancer-predisposing syndrome	VCV001767094	10	43601903	10	43106455	1767094	1821436		NC_000010.11:43106454:G:C	single nucleotide variant	missense variant	Uncertain significance	May 21, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.947G>A (p.Ser316Asn)	RET	S62N, S316N, S220N, S273N	Hereditary cancer-predisposing syndrome	VCV000823276	10	43601903	10	43106455	823276	809908	rs1060499894	NC_000010.11:43106454:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 22, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.947G>T (p.Ser316Ile)	RET	S316I, S62I, S220I, S273I	Hereditary cancer-predisposing syndrome|not specified	VCV000403371	10	43601903	10	43106455	403371	389953	rs1060499894	NC_000010.11:43106454:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 21, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.948C>T (p.Ser316=)	RET		Multiple endocrine neoplasia, type 2	VCV001522540	10	43601904	10	43106456	1522540	1369483	rs2132720146	NC_000010.11:43106455:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.950C>G (p.Thr317Arg)	RET	T221R, T317R, T274R, T63R	Multiple endocrine neoplasia, type 2	VCV003641829	10	43601906	10	43106458	3641829	3772551		NC_000010.11:43106457:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 18, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.950C>T (p.Thr317Met)	RET	T317M, T63M, T221M, T274M	RET-related disorder|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1	VCV000578566	10	43601906	10	43106458	578566	566270	rs760322514	NC_000010.11:43106457:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.951G>T (p.Thr317=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001610304	10	43601907	10	43106459	1610304	1519658	rs375812189	NC_000010.11:43106458:G:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.951G>A (p.Thr317=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2B|not specified	VCV000219685	10	43601907	10	43106459	219685	221951	rs375812189	NC_000010.11:43106458:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.952C>G (p.Leu318Val)	RET	L318V, L64V, L222V, L275V	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000823318	10	43601908	10	43106460	823318	809909	rs1235573033	NC_000010.11:43106459:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.952C>T (p.Leu318=)	RET		Multiple endocrine neoplasia, type 2|not provided|Hereditary cancer-predisposing syndrome	VCV000761869	10	43601908	10	43106460	761869	767730	rs1235573033	NC_000010.11:43106459:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.955C>T (p.Leu319Phe)	RET	L223F, L276F, L319F, L65F	Hereditary cancer-predisposing syndrome	VCV003227575	10	43601911	10	43106463	3227575	3390786		NC_000010.11:43106462:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 29, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.957C>T (p.Leu319=)	RET		Multiple endocrine neoplasia, type 2	VCV001156679	10	43601913	10	43106465	1156679	1141118	rs149926238	NC_000010.11:43106464:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 29, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.957C>G (p.Leu319=)	RET		Hereditary cancer-predisposing syndrome|not provided	VCV000793725	10	43601913	10	43106465	793725	783587	rs149926238	NC_000010.11:43106464:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 16, 2020	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.957C>A (p.Leu319=)	RET		not specified|not provided|Multiple endocrine neoplasia|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000184139	10	43601913	10	43106465	184139	182948	rs149926238	NC_000010.11:43106464:C:A	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Feb 3, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.958C>G (p.Pro320Ala)	RET	P66A, P224A, P277A, P320A	Multiple endocrine neoplasia, type 2	VCV002801647	10	43601914	10	43106466	2801647	2956289		NC_000010.11:43106465:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 31, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.958C>T (p.Pro320Ser)	RET	P224S, P320S, P66S, P277S	Multiple endocrine neoplasia, type 2	VCV002772874	10	43601914	10	43106466	2772874	2930152		NC_000010.11:43106465:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 30, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.958C>A (p.Pro320Thr)	RET	P224T, P320T, P66T, P277T	Hereditary cancer-predisposing syndrome	VCV002618941	10	43601914	10	43106466	2618941	2782686		NC_000010.11:43106465:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 24, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.959C>G (p.Pro320Arg)	RET	P320R, P66R, P224R, P277R	Multiple endocrine neoplasia, type 2|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Familial medullary thyroid carcinoma	VCV001432768	10	43601915	10	43106467	1432768	1481023	rs1837779952	NC_000010.11:43106466:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.959C>T (p.Pro320Leu)	RET	P320L, P66L, P277L, P224L	Hereditary cancer-predisposing syndrome|Ovarian cancer|Multiple endocrine neoplasia, type 2	VCV001023335	10	43601915	10	43106467	1023335	1008986	rs1837779952	NC_000010.11:43106466:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 18, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.960C>T (p.Pro320=)	RET		Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|not specified|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001106240	10	43601916	10	43106468	1106240	1098685	rs756761746	NC_000010.11:43106467:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jul 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.960C>A (p.Pro320=)	RET		Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000937428	10	43601916	10	43106468	937428	935023	rs756761746	NC_000010.11:43106467:C:A	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Jan 30, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.961G>C (p.Gly321Arg)	RET	G225R, G67R, G278R, G321R	Hereditary cancer-predisposing syndrome	VCV003313706	10	43601917	10	43106469	3313706	3465436		NC_000010.11:43106468:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 8, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.961G>T (p.Gly321Trp)	RET	G321W, G67W, G225W, G278W	Multiple endocrine neoplasia, type 2	VCV000644076	10	43601917	10	43106469	644076	638879	rs377767388	NC_000010.11:43106468:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 4, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.961G>A (p.Gly321Arg)	RET	G67R, G278R, G225R	RET-related disorder|not provided|Multiple endocrine neoplasia type 2A|Medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|not specified	VCV000024881	10	43601917	10	43106469	24881	36222	rs377767388	NC_000010.11:43106468:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 3, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.962G>A (p.Gly321Glu)	RET	G321E, G225E, G278E, G67E	Multiple endocrine neoplasia, type 2	VCV002043838	10	43601918	10	43106470	2043838	2103011		NC_000010.11:43106469:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 12, 2025	criteria provided, single submitter							
NM_020975.6(RET):c.963G>A (p.Gly321=)	RET		Multiple endocrine neoplasia, type 2	VCV001114858	10	43601919	10	43106471	1114858	1098686	rs1837780326	NC_000010.11:43106470:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 13, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.964G>C (p.Asp322His)	RET	D279H, D226H, D68H, D322H	Hereditary cancer-predisposing syndrome	VCV003432229	10	43601920	10	43106472	3432229	3593425		NC_000010.11:43106471:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 28, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.964G>T (p.Asp322Tyr)	RET	D322Y, D68Y, D226Y, D279Y	Multiple endocrine neoplasia, type 2	VCV001518745	10	43601920	10	43106472	1518745	1342939	rs1060500755	NC_000010.11:43106471:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 23, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.964G>A (p.Asp322Asn)	RET	D322N, D68N, D226N, D279N	not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000405530	10	43601920	10	43106472	405530	397697	rs1060500755	NC_000010.11:43106471:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.966C>T (p.Asp322=)	RET		Multiple endocrine neoplasia, type 2	VCV001158152	10	43601922	10	43106474	1158152	1141119	rs2132720531	NC_000010.11:43106473:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 14, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.967A>T (p.Thr323Ser)	RET	T280S, T323S, T227S, T69S	Hereditary cancer-predisposing syndrome	VCV003432272	10	43601923	10	43106475	3432272	3593468		NC_000010.11:43106474:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 25, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.968C>T (p.Thr323Ile)	RET	T227I, T280I, T323I, T69I	Hereditary cancer-predisposing syndrome	VCV003227576	10	43601924	10	43106476	3227576	3390787		NC_000010.11:43106475:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 2, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.968C>A (p.Thr323Asn)	RET	T323N, T227N, T69N, T280N	Multiple endocrine neoplasia, type 2	VCV002016304	10	43601924	10	43106476	2016304	2075510		NC_000010.11:43106475:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 3, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.970T>G (p.Trp324Gly)	RET	W70G, W324G, W281G, W228G	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000947638	10	43601926	10	43106478	947638	925799	rs1837780573	NC_000010.11:43106477:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.971G>A (p.Trp324Ter)	RET	W228*, W281*, W324*, W70*	RET-related disorder	VCV002584517	10	43601927	10	43106479	2584517	2752080		NC_000010.11:43106478:G:A	single nucleotide variant	nonsense|intron variant	Pathogenic		criteria provided, single submitter							
NM_020975.6(RET):c.972G>T (p.Trp324Cys)	RET	W324C, W281C, W70C, W228C	Multiple endocrine neoplasia, type 2	VCV003662817	10	43601928	10	43106480	3662817	3791187		NC_000010.11:43106479:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 31, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.972G>C (p.Trp324Cys)	RET	W324C, W70C, W281C, W228C	Multiple endocrine neoplasia type 2B|Pheochromocytoma|Renal hypodysplasia/aplasia 1|Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|not provided|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia	VCV000188078	10	43601928	10	43106480	188078	186117	rs758298916	NC_000010.11:43106479:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 19, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.973G>C (p.Ala325Pro)	RET	A325P, A282P, A229P, A71P	Hereditary cancer-predisposing syndrome	VCV002568368	10	43601929	10	43106481	2568368	2734904		NC_000010.11:43106480:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 21, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.973G>A (p.Ala325Thr)	RET	A325T, A71T, A229T, A282T	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A|not provided|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1	VCV000477393	10	43601929	10	43106481	477393	460013	rs779719517	NC_000010.11:43106480:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 12, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.974C>T (p.Ala325Val)	RET	A71V, A325V, A229V, A282V	Multiple endocrine neoplasia, type 2	VCV002122442	10	43601930	10	43106482	2122442	2184202		NC_000010.11:43106481:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 10, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.975C>T (p.Ala325=)	RET		Hereditary cancer-predisposing syndrome	VCV001768100	10	43601931	10	43106483	1768100	1825533		NC_000010.11:43106482:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 13, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.975C>G (p.Ala325=)	RET		Multiple endocrine neoplasia, type 2	VCV001655782	10	43601931	10	43106483	1655782	1529029	rs754806583	NC_000010.11:43106482:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 14, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.977A>C (p.Gln326Pro)	RET	Q326P, Q72P, Q230P, Q283P	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002587890	10	43601933	10	43106485	2587890	2760714		NC_000010.11:43106484:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.977A>G (p.Gln326Arg)	RET	Q326R, Q72R, Q283R, Q230R	Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|not provided|Multiple endocrine neoplasia type 2A	VCV000216731	10	43601933	10	43106485	216731	212772	rs863224778	NC_000010.11:43106484:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 10, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.978G>C (p.Gln326His)	RET	Q72H, Q326H, Q283H, Q230H	Multiple endocrine neoplasia, type 2	VCV000861186	10	43601934	10	43106486	861186	836823	rs1837781231	NC_000010.11:43106485:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 27, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.980A>C (p.Gln327Pro)	RET	Q327P, Q73P, Q231P, Q284P	Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1	VCV000946687	10	43601936	10	43106488	946687	925800	rs1837781306	NC_000010.11:43106487:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.981G>A (p.Gln327=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001146110	10	43601937	10	43106489	1146110	1141120	rs876658331	NC_000010.11:43106488:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 13, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.981G>C (p.Gln327His)	RET	Q327H, Q73H, Q231H, Q284H	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000230010	10	43601937	10	43106489	230010	233778	rs876658331	NC_000010.11:43106488:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.982A>G (p.Thr328Ala)	RET	T232A, T285A, T328A, T74A	Hereditary cancer-predisposing syndrome	VCV003313735	10	43601938	10	43106490	3313735	3465465		NC_000010.11:43106489:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 16, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.983C>A (p.Thr328Asn)	RET	T232N, T285N, T328N, T74N	RET-related disorder	VCV003353966	10	43601939	10	43106491	3353966	3513187		NC_000010.11:43106490:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 25, 2024	no assertion criteria provided							
NM_020975.6(RET):c.983C>T (p.Thr328Ile)	RET	T232I, T285I, T328I, T74I	Hirschsprung disease, susceptibility to, 1	VCV002678315	10	43601939	10	43106491	2678315	2833338		NC_000010.11:43106490:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 6, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.984C>T (p.Thr328=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000543762	10	43601940	10	43106492	543762	525612	rs1453202992	NC_000010.11:43106491:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.988C>T (p.Arg330Trp)	RET	R330W, R76W, R287W, R234W	not provided|Multiple endocrine neoplasia, type 2	VCV000449410	10	43601944	10	43106496	449410	444602	rs1172318035	NC_000010.11:43106495:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.989G>A (p.Arg330Gln)	RET	R330Q, R76Q, R287Q, R234Q	Hirschsprung disease, susceptibility to, 1|not provided|Multiple endocrine neoplasia, type 2	VCV000013926	10	43601945	10	43106497	13926	28965	rs80236571	NC_000010.11:43106496:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 22, 2023	criteria provided, conflicting classifications							
NM_020975.6(RET):c.990G>C (p.Arg330=)	RET		Multiple endocrine neoplasia, type 2	VCV001130196	10	43601946	10	43106498	1130196	1120259	rs1362958958	NC_000010.11:43106497:G:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 26, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.991G>A (p.Val331Met)	RET	V235M, V77M, V288M, V331M	Hereditary cancer-predisposing syndrome	VCV003313704	10	43601947	10	43106499	3313704	3465434		NC_000010.11:43106498:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 26, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.991G>T (p.Val331Leu)	RET	V331L, V77L, V288L, V235L	Multiple endocrine neoplasia, type 2|not provided|Hereditary cancer-predisposing syndrome	VCV000837327	10	43601947	10	43106499	837327	836824	rs1420717222	NC_000010.11:43106498:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.993G>A (p.Val331=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001768676	10	43601949	10	43106501	1768676	1829085		NC_000010.11:43106500:G:A	single nucleotide variant	intron variant|synonymous variant	Likely benign	Aug 9, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.996A>C (p.Glu332Asp)	RET	E236D, E332D, E289D, E78D	Hereditary cancer-predisposing syndrome	VCV003313690	10	43601952	10	43106504	3313690	3465420		NC_000010.11:43106503:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 12, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.996A>G (p.Glu332=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001151149	10	43601952	10	43106504	1151149	1141121	rs2132721019	NC_000010.11:43106503:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.997C>T (p.His333Tyr)	RET	H79Y, H333Y, H290Y, H237Y	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000823588	10	43601953	10	43106505	823588	809910	rs1554818012	NC_000010.11:43106504:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.997C>G (p.His333Asp)	RET	H333D, H79D, H237D, H290D	Hereditary cancer-predisposing syndrome	VCV000486349	10	43601953	10	43106505	486349	475090	rs1554818012	NC_000010.11:43106504:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 28, 2016	criteria provided, single submitter							
NM_020975.6(RET):c.999C>T (p.His333=)	RET		Hereditary cancer-predisposing syndrome	VCV002496743	10	43601955	10	43106507	2496743	2467882		NC_000010.11:43106506:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 16, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.999C>G (p.His333Gln)	RET	H333Q, H79Q, H290Q, H237Q	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000576787	10	43601955	10	43106507	576787	566278	rs1564492193	NC_000010.11:43106506:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1000T>C (p.Trp334Arg)	RET	W80R, W334R, W238R, W291R	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001505889	10	43601956	10	43106508	1505889	1339619	rs2132721114	NC_000010.11:43106507:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1001G>A (p.Trp334Ter)	RET	W238*, W334*, W80*, W291*	Multiple endocrine neoplasia, type 2	VCV002024200	10	43601957	10	43106509	2024200	2076977		NC_000010.11:43106508:G:A	single nucleotide variant	nonsense	Pathogenic	Aug 15, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1002G>C (p.Trp334Cys)	RET	W334C, W291C, W238C, W80C	Hereditary cancer-predisposing syndrome	VCV003313722	10	43601958	10	43106510	3313722	3465452		NC_000010.11:43106509:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 18, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1003C>G (p.Pro335Ala)	RET	P292A, P239A, P335A, P81A	Multiple endocrine neoplasia, type 2	VCV002050083	10	43601959	10	43106511	2050083	2104087		NC_000010.11:43106510:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 20, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1003C>T (p.Pro335Ser)	RET	P292S, P335S, P81S, P239S	Hereditary cancer-predisposing syndrome	VCV001775438	10	43601959	10	43106511	1775438	1830635		NC_000010.11:43106510:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 4, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1003C>A (p.Pro335Thr)	RET	P335T, P81T, P239T, P292T	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000960644	10	43601959	10	43106511	960644	946880	rs1837782662	NC_000010.11:43106510:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 17, 2021	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1007A>G (p.Asn336Ser)	RET	N82S, N293S, N336S, N240S	Multiple endocrine neoplasia, type 2	VCV002858167	10	43601963	10	43106515	2858167	3018213		NC_000010.11:43106514:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 10, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1010_1017del (p.Glu337fs)	RET	E83fs, E337fs	Hereditary cancer-predisposing syndrome	VCV001798724	10	43601964 - 43601971	10	43106516 - 43106523	1798724	1855993		NC_000010.11:43106515:CGAGACCTCG:CG	Deletion	frameshift variant	Pathogenic	Apr 28, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1008C>T (p.Asn336=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000732162	10	43601964	10	43106516	732162	737485	rs144981275	NC_000010.11:43106515:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1008C>G (p.Asn336Lys)	RET	N336K, N82K, N293K, N240K	Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A	VCV000657732	10	43601964	10	43106516	657732	638880	rs144981275	NC_000010.11:43106515:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 19, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1009G>C (p.Glu337Gln)	RET	E337Q, E83Q, E241Q, E294Q	Multiple endocrine neoplasia type 2B|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001407975	10	43601965	10	43106517	1407975	1506853	rs1161270866	NC_000010.11:43106516:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1009G>A (p.Glu337Lys)	RET	E337K, E83K, E294K, E241K	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1	VCV000432780	10	43601965	10	43106517	432780	425873	rs1161270866	NC_000010.11:43106516:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1010A>G (p.Glu337Gly)	RET	E294G, E337G, E241G, E83G	Multiple endocrine neoplasia, type 2	VCV003658182	10	43601966	10	43106518	3658182	3800409		NC_000010.11:43106517:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 29, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1011G>A (p.Glu337=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002915865	10	43601967	10	43106519	2915865	3074415		NC_000010.11:43106518:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1013C>A (p.Thr338Asn)	RET	T338N, T84N, T242N, T295N	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000859730	10	43601969	10	43106521	859730	836825	rs377767433	NC_000010.11:43106520:C:A	single nucleotide variant	missense variant	Uncertain significance	May 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1013C>T (p.Thr338Ile)	RET	T338I, T84I, T242I, T295I	not provided|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia type 2B|Hereditary cancer-predisposing syndrome	VCV000038594	10	43601969	10	43106521	38594	47198	rs377767433	NC_000010.11:43106520:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 28, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1014C>G (p.Thr338=)	RET		Multiple endocrine neoplasia, type 2	VCV002131106	10	43601970	10	43106522	2131106	2191241		NC_000010.11:43106521:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 28, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1014C>T (p.Thr338=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001739614	10	43601970	10	43106522	1739614	1797983		NC_000010.11:43106521:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1015T>C (p.Ser339Pro)	RET	S85P, S339P, S243P, S296P	Multiple endocrine neoplasia, type 2	VCV000858919	10	43601971	10	43106523	858919	836826	rs1837782901	NC_000010.11:43106522:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 26, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.1016C>G (p.Ser339Trp)	RET	S243W, S85W, S296W, S339W	Hereditary cancer-predisposing syndrome	VCV001744895	10	43601972	10	43106524	1744895	1805741		NC_000010.11:43106523:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1016C>T (p.Ser339Leu)	RET	S339L, S85L, S296L, S243L	Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2	VCV000548870	10	43601972	10	43106524	548870	539278	rs774829203	NC_000010.11:43106523:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 13, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1017G>C (p.Ser339=)	RET		Hereditary cancer-predisposing syndrome	VCV003432205	10	43601973	10	43106525	3432205	3593402		NC_000010.11:43106524:G:C	single nucleotide variant	intron variant|synonymous variant	Likely benign	Nov 23, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1017G>T (p.Ser339=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001080654	10	43601973	10	43106525	1080654	1077035	rs369810881	NC_000010.11:43106524:G:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1017G>A (p.Ser339=)	RET		not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B|not specified	VCV000220952	10	43601973	10	43106525	220952	221952	rs369810881	NC_000010.11:43106524:G:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1018G>T (p.Val340Phe)	RET	V340F, V86F, V297F, V244F	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A	VCV000405542	10	43601974	10	43106526	405542	397451	rs367737920	NC_000010.11:43106525:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1019T>C (p.Val340Ala)	RET	V86A, V297A, V340A, V244A	Multiple endocrine neoplasia, type 2	VCV003713470	10	43601975	10	43106527	3713470	3837853		NC_000010.11:43106526:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 8, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1021C>G (p.Gln341Glu)	RET	Q341E, Q87E, Q245E, Q298E	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000822026	10	43601977	10	43106529	822026	809911	rs1588867362	NC_000010.11:43106528:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2019	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1022A>C (p.Gln341Pro)	RET	Q245P, Q298P, Q341P, Q87P	Hereditary cancer-predisposing syndrome	VCV003227499	10	43601978	10	43106530	3227499	3390711		NC_000010.11:43106529:A:C	single nucleotide variant	missense variant|intron variant	Likely benign	Nov 18, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1026C>G (p.Ala342=)	RET		Hereditary cancer-predisposing syndrome	VCV001769579	10	43601982	10	43106534	1769579	1836014		NC_000010.11:43106533:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Feb 28, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1027A>C (p.Asn343His)	RET	N300H, N89H, N247H, N343H	Multiple endocrine neoplasia, type 2	VCV002114501	10	43601983	10	43106535	2114501	2168506		NC_000010.11:43106534:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 19, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1028A>G (p.Asn343Ser)	RET	N300S, N89S, N247S, N343S	Multiple endocrine neoplasia, type 2	VCV002906941	10	43601984	10	43106536	2906941	3065747		NC_000010.11:43106535:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 31, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1029C>T (p.Asn343=)	RET		Hereditary cancer-predisposing syndrome|not specified|Multiple endocrine neoplasia, type 2|not provided	VCV000261393	10	43601985	10	43106537	261393	253764	rs764668178	NC_000010.11:43106536:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1030G>T (p.Gly344Cys)	RET	G90C, G344C, G301C, G248C	Hereditary cancer-predisposing syndrome	VCV003313710	10	43601986	10	43106538	3313710	3465440		NC_000010.11:43106537:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 24, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1030G>C (p.Gly344Arg)	RET	G301R, G248R, G344R, G90R	Multiple endocrine neoplasia, type 2	VCV002751314	10	43601986	10	43106538	2751314	2908610		NC_000010.11:43106537:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 9, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1030G>A (p.Gly344Ser)	RET	G344S, G90S, G248S, G301S	Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000838975	10	43601986	10	43106538	838975	836827	rs749883001	NC_000010.11:43106537:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1031G>A (p.Gly344Asp)	RET	G90D, G248D, G301D, G344D	Hereditary cancer-predisposing syndrome	VCV002587872	10	43601987	10	43106539	2587872	2760696		NC_000010.11:43106538:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 2, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1032C>G (p.Gly344=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002454123	10	43601988	10	43106540	2454123	2424012		NC_000010.11:43106539:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1034G>A (p.Ser345Asn)	RET	S91N, S302N, S249N, S345N	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001772123	10	43601990	10	43106542	1772123	1829934		NC_000010.11:43106541:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1035C>T (p.Ser345=)	RET		Multiple endocrine neoplasia, type 2	VCV001626532	10	43601991	10	43106543	1626532	1583536	rs2132721753	NC_000010.11:43106542:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 5, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1037T>G (p.Phe346Cys)	RET	F346C, F92C, F303C, F250C	Multiple endocrine neoplasia, type 2	VCV001420042	10	43601993	10	43106545	1420042	1502823	rs2132721788	NC_000010.11:43106544:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1038C>G (p.Phe346Leu)	RET	F346L, F92L, F303L, F250L	Multiple endocrine neoplasia, type 2	VCV001516931	10	43601994	10	43106546	1516931	1495704	rs1240935395	NC_000010.11:43106545:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1038C>T (p.Phe346=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000706913	10	43601994	10	43106546	706913	692835	rs1240935395	NC_000010.11:43106545:C:T	single nucleotide variant	intron variant|synonymous variant	Likely benign	Aug 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1039G>C (p.Val347Leu)	RET	V347L, V93L, V304L, V251L	Hereditary cancer-predisposing syndrome|not provided	VCV000822071	10	43601995	10	43106547	822071	809913	rs1467660660	NC_000010.11:43106546:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1039G>A (p.Val347Met)	RET	V347M, V93M, V304M, V251M	not provided|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000822070	10	43601995	10	43106547	822070	809912	rs1467660660	NC_000010.11:43106546:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1041G>A (p.Val347=)	RET		Multiple endocrine neoplasia, type 2	VCV003070485	10	43601997	10	43106549	3070485	3231973		NC_000010.11:43106548:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 10, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1044_1051dup (p.Val351fs)	RET	V351fs, V97fs	Multiple endocrine neoplasia, type 2	VCV002123266	10	43601997 - 43601998	10	43106549 - 43106550	2123266	2181159		NC_000010.11:43106549:CGGGCGACCG:CGGGCGACCGGGCGACCG	Duplication	frameshift variant	Pathogenic	Apr 10, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1041G>T (p.Val347=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000486337	10	43601997	10	43106549	486337	475069	rs1191152389	NC_000010.11:43106548:G:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1042C>T (p.Arg348Trp)	RET	R348W, R94W, R252W, R305W	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001011863	10	43601998	10	43106550	1011863	993808	rs1183365192	NC_000010.11:43106549:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1043G>A (p.Arg348Gln)	RET	R94Q, R348Q, R305Q, R252Q	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000864362	10	43601999	10	43106551	864362	836828	rs751518221	NC_000010.11:43106550:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1046C>A (p.Ala349Glu)	RET	A306E, A95E, A253E, A349E	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV003432282	10	43602002	10	43106554	3432282	3593478		NC_000010.11:43106553:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1046C>T (p.Ala349Val)	RET	A349V, A95V, A253V, A306V	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001059168	10	43602002	10	43106554	1059168	1046529	rs754859905	NC_000010.11:43106553:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1046C>G (p.Ala349Gly)	RET	A349G, A95G, A253G, A306G	Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Pheochromocytoma|Hereditary cancer-predisposing syndrome	VCV001019731	10	43602002	10	43106554	1019731	1008987	rs754859905	NC_000010.11:43106553:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1047G>A (p.Ala349=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000543777	10	43602003	10	43106555	543777	525415	rs373208682	NC_000010.11:43106554:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1049C>T (p.Thr350Ile)	RET	T350I, T96I, T307I, T254I	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000135185	10	43602005	10	43106557	135185	138924	rs587778660	NC_000010.11:43106556:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1050C>T (p.Thr350=)	RET		Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|not provided|Hereditary cancer-predisposing syndrome	VCV000241332	10	43602006	10	43106558	241332	240787	rs142188675	NC_000010.11:43106557:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1051G>A (p.Val351Ile)	RET	V351I, V97I, V308I, V255I	Hereditary cancer-predisposing syndrome|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia, type 2	VCV000187498	10	43602007	10	43106559	187498	182949	rs777716061	NC_000010.11:43106558:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 12, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1052T>C (p.Val351Ala)	RET	V351A, V308A, V255A, V97A	Multiple endocrine neoplasia, type 2	VCV002762260	10	43602008	10	43106560	2762260	2930756		NC_000010.11:43106559:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 21, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1052T>A (p.Val351Glu)	RET	V351E, V97E, V255E, V308E	Hereditary cancer-predisposing syndrome|Ovarian cancer|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A	VCV000219791	10	43602008	10	43106560	219791	221953	rs749449032	NC_000010.11:43106559:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 27, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1055A>T (p.His352Leu)	RET	H256L, H352L, H309L, H98L	Hereditary cancer-predisposing syndrome	VCV002568332	10	43602011	10	43106563	2568332	2734869		NC_000010.11:43106562:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 3, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1055A>G (p.His352Arg)	RET	H352R, H98R, H309R, H256R	Multiple endocrine neoplasia, type 2|not provided	VCV000429554	10	43602011	10	43106563	429554	421787	rs1131691450	NC_000010.11:43106562:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 12, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1056T>C (p.His352=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001778745	10	43602012	10	43106564	1778745	1831329		NC_000010.11:43106563:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1057G>T (p.Asp353Tyr)	RET	D99Y, D353Y, D257Y, D310Y	Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A	VCV000838771	10	43602013	10	43106565	838771	836829	rs1837785429	NC_000010.11:43106564:G:T	single nucleotide variant	missense variant	Uncertain significance	May 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1058A>C (p.Asp353Ala)	RET	D353A, D99A, D257A, D310A	Multiple endocrine neoplasia, type 2	VCV001008979	10	43602014	10	43106566	1008979	993809	rs1837785512	NC_000010.11:43106565:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 17, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1059C>T (p.Asp353=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000759034	10	43602015	10	43106567	759034	767731	rs1290621703	NC_000010.11:43106566:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1061A>G (p.Tyr354Cys)	RET	Y258C, Y354C, Y100C, Y311C	not provided|Multiple endocrine neoplasia, type 2	VCV002765969	10	43602017	10	43106569	2765969	2931875		NC_000010.11:43106568:A:G	single nucleotide variant	intron variant|missense variant	Uncertain significance	Oct 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1062T>C (p.Tyr354=)	RET		Renal hypodysplasia/aplasia 1|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia|Pheochromocytoma|Multiple endocrine neoplasia, type 2	VCV000849703	10	43602018	10	43106570	849703	836830	rs1837785673	NC_000010.11:43106569:T:C	single nucleotide variant	synonymous variant|intron variant	Uncertain significance	Apr 10, 2019	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1063A>C (p.Arg355=)	RET		Hereditary cancer-predisposing syndrome	VCV002454121	10	43602019	10	43106571	2454121	2424010		NC_000010.11:43106570:A:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 22, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1063A>G (p.Arg355Gly)	RET	R101G, R355G, R259G, R312G	Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000666109	10	43602019	10	43106571	666109	638881	rs145402131	NC_000010.11:43106570:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 27, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1063A>T (p.Arg355Trp)	RET	R101W, R355W, R259W, R312W	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000653698	10	43602019	10	43106571	653698	638882	rs145402131	NC_000010.11:43106570:A:T	single nucleotide variant	missense variant	Uncertain significance	Sep 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1063+6_1063+7del	RET		Multiple endocrine neoplasia, type 2	VCV002707737	10	43602023 - 43602024	10	43106575 - 43106576	2707737	2877769		NC_000010.11:43106574:AGAG:AG	Microsatellite	intron variant	Uncertain significance	Jan 9, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1063+6del	RET		Multiple endocrine neoplasia, type 2	VCV002810325	10	43602025	10	43106577	2810325	2968853		NC_000010.11:43106576:A:	Deletion	intron variant	Uncertain significance	Nov 30, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1063+6A>G	RET		Multiple endocrine neoplasia, type 2	VCV002772556	10	43602025	10	43106577	2772556	2933708		NC_000010.11:43106576:A:G	single nucleotide variant	intron variant	Uncertain significance	Oct 29, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1063+7G>A	RET		Multiple endocrine neoplasia, type 2	VCV000215904	10	43602026	10	43106578	215904	212773	rs863224425	NC_000010.11:43106577:G:A	single nucleotide variant	intron variant	Likely benign	Jul 17, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1063+9G>A	RET		not provided|Multiple endocrine neoplasia|Pheochromocytoma|Renal hypodysplasia/aplasia 1|not specified|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2	VCV000241333	10	43602028	10	43106580	241333	240788	rs765463636	NC_000010.11:43106579:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 30, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1063+10G>C	RET		Multiple endocrine neoplasia, type 2	VCV003007529	10	43602029	10	43106581	3007529	3158826		NC_000010.11:43106580:G:C	single nucleotide variant	intron variant	Likely benign	Oct 20, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1063+10G>A	RET		Multiple endocrine neoplasia, type 2	VCV000703720	10	43602029	10	43106581	703720	695477	rs374666249	NC_000010.11:43106580:G:A	single nucleotide variant	intron variant	Likely benign	Oct 16, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1063+12T>A	RET		Multiple endocrine neoplasia, type 2	VCV002050287	10	43602031	10	43106583	2050287	2104290		NC_000010.11:43106582:T:A	single nucleotide variant	intron variant	Likely benign	Jul 10, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1063+13G>A	RET		Multiple endocrine neoplasia, type 2	VCV003667505	10	43602032	10	43106584	3667505	3796081		NC_000010.11:43106583:G:A	single nucleotide variant	intron variant	Likely benign	Mar 28, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1063+17G>A	RET		Multiple endocrine neoplasia, type 2	VCV001938340	10	43602036	10	43106588	1938340	1993770		NC_000010.11:43106587:G:A	single nucleotide variant	intron variant	Likely benign	Jul 16, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1063+19A>G	RET		Multiple endocrine neoplasia, type 2	VCV003005784	10	43602038	10	43106590	3005784	3158375		NC_000010.11:43106589:A:G	single nucleotide variant	intron variant	Likely benign	Dec 11, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1063+20del	RET		Multiple endocrine neoplasia, type 2	VCV002698698	10	43602039	10	43106591	2698698	2854989		NC_000010.11:43106590:C:	Deletion	intron variant	Likely benign	Nov 27, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1063+20C>T	RET		not provided|Multiple endocrine neoplasia, type 2	VCV000560858	10	43602039	10	43106591	560858	551862	rs769558279	NC_000010.11:43106590:C:T	single nucleotide variant	intron variant	Likely benign	Dec 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1063+47G>A	RET		not provided|not specified	VCV001224786	10	43602066	10	43106618	1224786	1217340	rs372177579	NC_000010.11:43106617:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Aug 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1063+145A>G	RET		not provided	VCV000679509	10	43602164	10	43106716	679509	664826	rs182113946	NC_000010.11:43106715:A:G	single nucleotide variant	intron variant	Likely benign	Jun 17, 2018	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1064-114G>A	RET		not provided	VCV001205518	10	43604365	10	43108917	1205518	1194335	rs3026742	NC_000010.11:43108916:G:A	single nucleotide variant	intron variant	Likely benign	Jun 23, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.1064-89A>T	RET		not provided	VCV001277152	10	43604390	10	43108942	1277152	1267021	rs1864404	NC_000010.11:43108941:A:T	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1064-22A>G	RET		not specified	VCV002575138	10	43604457	10	43109009	2575138	2740075		NC_000010.11:43109008:A:G	single nucleotide variant	intron variant	Likely benign	Aug 15, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1064-17_1064-15del	RET		Multiple endocrine neoplasia, type 2	VCV002042699	10	43604458 - 43604460	10	43109010 - 43109012	2042699	2095424		NC_000010.11:43109009:TTGTTGT:TTGT	Microsatellite	intron variant	Likely benign	Dec 30, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1064-18T>C	RET		not provided|Multiple endocrine neoplasia, type 2|not specified	VCV000560859	10	43604461	10	43109013	560859	551863	rs546346375	NC_000010.11:43109012:T:C	single nucleotide variant	intron variant	Benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1064-16G>A	RET		Multiple endocrine neoplasia, type 2	VCV003618446	10	43604463	10	43109015	3618446	3750121		NC_000010.11:43109014:G:A	single nucleotide variant	intron variant	Likely benign	Nov 21, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1064-16G>T	RET		Multiple endocrine neoplasia, type 2	VCV001541466	10	43604463	10	43109015	1541466	1631349	rs373327241	NC_000010.11:43109014:G:T	single nucleotide variant	intron variant	Likely benign	Nov 16, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1064-14G>T	RET		Multiple endocrine neoplasia, type 2	VCV001588115	10	43604465	10	43109017	1588115	1574658	rs375815926	NC_000010.11:43109016:G:T	single nucleotide variant	intron variant	Likely benign	Jan 27, 2025	criteria provided, single submitter							
NM_020975.6(RET):c.1064-13C>T	RET		Multiple endocrine neoplasia, type 2	VCV002801478	10	43604466	10	43109018	2801478	2956121		NC_000010.11:43109017:C:T	single nucleotide variant	intron variant	Likely benign	Jul 17, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1064-12C>T	RET		Multiple endocrine neoplasia, type 2	VCV002863813	10	43604467	10	43109019	2863813	3026178		NC_000010.11:43109018:C:T	single nucleotide variant	intron variant	Likely benign	May 13, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1064-10C>G	RET		Multiple endocrine neoplasia, type 2	VCV003660047	10	43604469	10	43109021	3660047	3800995		NC_000010.11:43109020:C:G	single nucleotide variant	intron variant	Likely benign	Jul 21, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1064-10_1064-9insG	RET		Multiple endocrine neoplasia, type 2	VCV003073153	10	43604469 - 43604470	10	43109021 - 43109022	3073153	1388709	rs1837849125	NC_000010.11:43109021::G	Insertion	intron variant	Likely benign	Aug 23, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1064-10C>T	RET		Multiple endocrine neoplasia, type 2	VCV001150762	10	43604469	10	43109021	1150762	1141122	rs747466717	NC_000010.11:43109020:C:T	single nucleotide variant	intron variant	Likely benign	Aug 29, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1064-9delinsGG	RET		Multiple endocrine neoplasia, type 2	VCV002776207	10	43604470	10	43109022	2776207	2936499		NC_000010.11:43109021:T:GG	Indel	intron variant	Uncertain significance	Nov 26, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1064-9T>G	RET		Multiple endocrine neoplasia, type 2	VCV002418221	10	43604470	10	43109022	2418221	1948172		NC_000010.11:43109021:T:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Mar 21, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1064-8A>G	RET		Multiple endocrine neoplasia, type 2	VCV002791414	10	43604471	10	43109023	2791414	2953845		NC_000010.11:43109022:A:G	single nucleotide variant	intron variant	Likely benign	Aug 2, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1064-6C>A	RET		Multiple endocrine neoplasia, type 2	VCV000839294	10	43604473	10	43109025	839294	851373	rs768878280	NC_000010.11:43109024:C:A	single nucleotide variant	intron variant	Likely benign	Feb 27, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1064-6C>T	RET		Multiple endocrine neoplasia, type 2|not provided	VCV000220068	10	43604473	10	43109025	220068	221954	rs768878280	NC_000010.11:43109024:C:T	single nucleotide variant	intron variant	Likely benign	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1064-4G>T	RET		not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|not specified	VCV001559462	10	43604475	10	43109027	1559462	1629913	rs1837849469	NC_000010.11:43109026:G:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Nov 28, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1064-3C>T	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000543790	10	43604476	10	43109028	543790	525614	rs1286466592	NC_000010.11:43109027:C:T	single nucleotide variant	intron variant	Uncertain significance	Jun 9, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1064G>A (p.Arg355Lys)	RET	R355K, R101K, R113K, G209E, G25E, R259K, R312K	Multiple endocrine neoplasia, type 2	VCV001468388	10	43604479	10	43109031	1468388	1362632	rs1837849583	NC_000010.11:43109030:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 12, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.1065G>T (p.Arg355Ser)	RET	R101S, R259S, R355S, R113S, R312S	Multiple endocrine neoplasia, type 2	VCV002161441	10	43604480	10	43109032	2161441	1887220		NC_000010.11:43109031:G:T	single nucleotide variant	missense variant|synonymous variant	Uncertain significance	Feb 22, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1066C>A (p.Leu356Met)	RET	L102M, L356M, L210M, L260M, L313M, L114M, L26M	Multiple endocrine neoplasia, type 2	VCV001478920	10	43604481	10	43109033	1478920	1426291	rs876660102	NC_000010.11:43109032:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 9, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1066C>T (p.Leu356=)	RET		Hereditary cancer-predisposing syndrome	VCV000232967	10	43604481	10	43109033	232967	233779	rs876660102	NC_000010.11:43109032:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 14, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1068G>T (p.Leu356=)	RET		Multiple endocrine neoplasia, type 2	VCV002418758	10	43604483	10	43109035	2418758	1941360		NC_000010.11:43109034:G:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1069G>A (p.Val357Ile)	RET	V27I, V314I, V103I, V115I, V261I, V357I, V211I	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002562603	10	43604484	10	43109036	2562603	2717445		NC_000010.11:43109035:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1075A>C (p.Asn359His)	RET	N117H, N29H, N316H, N263H, N105H, N213H, N359H	Multiple endocrine neoplasia, type 2	VCV002078219	10	43604490	10	43109042	2078219	2138734		NC_000010.11:43109041:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 29, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1076A>C (p.Asn359Thr)	RET	N29T, N117T, N105T, N213T, N316T, N359T, N263T	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002733453	10	43604491	10	43109043	2733453	2890912		NC_000010.11:43109042:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1076A>G (p.Asn359Ser)	RET	N105S, N29S, N359S, N117S, N263S, N316S, N213S	Multiple endocrine neoplasia, type 2	VCV002171532	10	43604491	10	43109043	2171532	1900256		NC_000010.11:43109042:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 30, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1076A>T (p.Asn359Ile)	RET	N105I, N359I, N213I, N263I, N29I, N316I, N117I	Multiple endocrine neoplasia, type 2	VCV001011282	10	43604491	10	43109043	1011282	993810	rs1204350955	NC_000010.11:43109042:A:T	single nucleotide variant	missense variant	Uncertain significance	May 31, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.1078C>T (p.Arg360Trp)	RET	R106W, R30W, R118W, R264W, R360W, R214W, R317W	Multiple endocrine neoplasia, type 2|not provided	VCV002136856	10	43604493	10	43109045	2136856	1877862		NC_000010.11:43109044:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 8, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1078C>A (p.Arg360=)	RET		Multiple endocrine neoplasia, type 2|not provided	VCV000560860	10	43604493	10	43109045	560860	551864	rs1424549058	NC_000010.11:43109044:C:A	single nucleotide variant	synonymous variant|intron variant	Uncertain significance	Sep 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1079_1080delinsAA (p.Arg360Gln)	RET	R106Q, R264Q, R214Q, R30Q, R118Q, R317Q, R360Q	Hereditary cancer-predisposing syndrome	VCV001785569	10	43604494 - 43604495	10	43109046 - 43109047	1785569	1840366		NC_000010.11:43109045:GG:AA	Indel	missense variant	Uncertain significance	Dec 29, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1079G>A (p.Arg360Gln)	RET	R360Q, R106Q, R118Q, R214Q, R264Q, R317Q, R30Q	not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1	VCV000543747	10	43604494	10	43109046	543747	525292	rs762472027	NC_000010.11:43109045:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1080G>A (p.Arg360=)	RET		Hereditary cancer-predisposing syndrome	VCV001786393	10	43604495	10	43109047	1786393	1847143		NC_000010.11:43109046:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 13, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1082A>T (p.Asn361Ile)	RET	N318I, N107I, N119I, N215I, N361I, N265I, N31I	Multiple endocrine neoplasia, type 2	VCV002146155	10	43604497	10	43109049	2146155	1876759		NC_000010.11:43109048:A:T	single nucleotide variant	missense variant	Uncertain significance	May 29, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1083C>T (p.Asn361=)	RET		Hereditary cancer-predisposing syndrome	VCV002587892	10	43604498	10	43109050	2587892	2760716		NC_000010.11:43109049:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 29, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1083C>A (p.Asn361Lys)	RET	N361K, N107K, N215K, N265K, N31K, N119K, N318K	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|not provided|not specified|Hirschsprung disease, susceptibility to, 1|RET-related disorder	VCV000548864	10	43604498	10	43109050	548864	539279	rs770587835	NC_000010.11:43109049:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 2, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1084C>A (p.Leu362Ile)	RET	L362I, L108I, L319I, L120I, L216I, L266I, L32I	Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|not provided|Multiple endocrine neoplasia, type 2|not specified|Hereditary cancer-predisposing syndrome	VCV000477301	10	43604499	10	43109051	477301	459816	rs773935854	NC_000010.11:43109050:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 8, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1086C>G (p.Leu362=)	RET		Multiple endocrine neoplasia, type 2	VCV001674513	10	43604501	10	43109053	1674513	1532519	rs2132743034	NC_000010.11:43109052:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 28, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1087T>C (p.Ser363Pro)	RET	S121P, S109P, S217P, S33P, S320P, S363P, S267P	Multiple endocrine neoplasia, type 2	VCV002770186	10	43604502	10	43109054	2770186	2930054		NC_000010.11:43109053:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 5, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1088C>G (p.Ser363Cys)	RET	S109C, S121C, S217C, S267C, S320C, S33C, S363C	Hereditary cancer-predisposing syndrome|not provided	VCV002507348	10	43604503	10	43109055	2507348	2672338		NC_000010.11:43109054:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1088C>T (p.Ser363Phe)	RET	S363F, S109F, S121F, S320F, S33F, S217F, S267F	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000477302	10	43604503	10	43109055	477302	460017	rs766881522	NC_000010.11:43109054:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1089C>T (p.Ser363=)	RET		Hereditary cancer-predisposing syndrome	VCV002562598	10	43604504	10	43109056	2562598	2717440		NC_000010.11:43109055:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 18, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1090A>G (p.Ile364Val)	RET	I364V, I110V, I122V, I34V, I218V, I268V, I321V	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|not provided|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1	VCV000477303	10	43604505	10	43109057	477303	460261	rs1308447836	NC_000010.11:43109056:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1091T>C (p.Ile364Thr)	RET	I218T, I321T, I364T, I122T, I34T, I110T, I268T	Hereditary cancer-predisposing syndrome	VCV003313723	10	43604506	10	43109058	3313723	3465453		NC_000010.11:43109057:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 22, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1091_1104del (p.Ile364fs)	RET	I34fs, I364fs, I122fs, I268fs, I110fs, I218fs, I321fs	Multiple endocrine neoplasia, type 2	VCV002866872	10	43604506 - 43604519	10	43109058 - 43109071	2866872	3030364		NC_000010.11:43109057:TCTCGGAGAACCGC:	Deletion	frameshift variant|intron variant	Pathogenic	May 22, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1092C>T (p.Ile364=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000241334	10	43604507	10	43109059	241334	240789	rs759548155	NC_000010.11:43109058:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1094C>T (p.Ser365Leu)	RET	S365L, S111L, S35L, S219L, S123L, S322L, S269L	Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	VCV000567350	10	43604509	10	43109061	567350	563715	rs763670106	NC_000010.11:43109060:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1095G>T (p.Ser365=)	RET		Hereditary cancer-predisposing syndrome	VCV003432254	10	43604510	10	43109062	3432254	3593450		NC_000010.11:43109061:G:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 3, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1095G>A (p.Ser365=)	RET		Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000136094	10	43604510	10	43109062	136094	139806	rs201992974	NC_000010.11:43109061:G:A	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Jan 27, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1097A>T (p.Glu366Val)	RET	E112V, E270V, E323V, E366V, E36V, E124V, E220V	Multiple endocrine neoplasia, type 2	VCV002829759	10	43604512	10	43109064	2829759	2990421		NC_000010.11:43109063:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 18, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1098G>T (p.Glu366Asp)	RET	E366D, E36D, E270D, E323D, E124D, E112D, E220D	Multiple endocrine neoplasia, type 2	VCV003718912	10	43604513	10	43109065	3718912	3856025		NC_000010.11:43109064:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 3, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1098G>C (p.Glu366Asp)	RET	E112D, E366D, E124D, E220D, E270D, E323D, E36D	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|not provided	VCV000988371	10	43604513	10	43109065	988371	976325	rs1362164894	NC_000010.11:43109064:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 2, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1099A>G (p.Asn367Asp)	RET	N125D, N324D, N221D, N367D, N113D, N271D, N37D	Hereditary cancer-predisposing syndrome	VCV001791470	10	43604514	10	43109066	1791470	1848289		NC_000010.11:43109065:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 7, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1100A>G (p.Asn367Ser)	RET	N367S, N125S, N271S, N324S, N113S, N221S, N37S	Hereditary cancer-predisposing syndrome	VCV001792266	10	43604515	10	43109067	1792266	1841854		NC_000010.11:43109066:A:G	single nucleotide variant	missense variant	Likely benign	Oct 12, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1101C>T (p.Asn367=)	RET		Hereditary cancer-predisposing syndrome	VCV001792521	10	43604516	10	43109068	1792521	1842109		NC_000010.11:43109067:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 1, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.1102C>T (p.Arg368Cys)	RET	R368C, R114C, R272C, R126C, R325C, R38C, R222C	Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|not provided	VCV000486314	10	43604517	10	43109069	486314	475289	rs754116867	NC_000010.11:43109068:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 29, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1103G>T (p.Arg368Leu)	RET	R126L, R325L, R222L, R272L, R38L, R114L, R368L	Multiple endocrine neoplasia, type 2	VCV003670882	10	43604518	10	43109070	3670882	3804318		NC_000010.11:43109069:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 27, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1103G>A (p.Arg368His)	RET	R368H, R114H, R325H, R222H, R38H, R272H, R126H	Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|RET-related disorder|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1	VCV000216712	10	43604518	10	43109070	216712	212774	rs199529397	NC_000010.11:43109069:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1104C>T (p.Arg368=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002568357	10	43604519	10	43109071	2568357	2734893		NC_000010.11:43109070:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1105A>G (p.Thr369Ala)	RET	T39A, T273A, T369A, T115A, T223A, T127A, T326A	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV003003828	10	43604520	10	43109072	3003828	3157711		NC_000010.11:43109071:A:G	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Dec 4, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1106C>G (p.Thr369Ser)	RET	T273S, T115S, T127S, T223S, T369S, T326S, T39S	Hereditary cancer-predisposing syndrome	VCV003432256	10	43604521	10	43109073	3432256	3593452		NC_000010.11:43109072:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 5, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1106C>A (p.Thr369Asn)	RET	T223N, T273N, T369N, T39N, T115N, T127N, T326N	Multiple endocrine neoplasia, type 2	VCV002098775	10	43604521	10	43109073	2098775	2154090		NC_000010.11:43109072:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 18, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1107C>T (p.Thr369=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001087895	10	43604522	10	43109074	1087895	1077036	rs1837851951	NC_000010.11:43109073:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 3, 2020	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1108A>G (p.Met370Val)	RET	M370V, M116V, M327V, M224V, M40V, M128V, M274V	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001040589	10	43604523	10	43109075	1040589	1029532	rs1280159133	NC_000010.11:43109074:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1109T>C (p.Met370Thr)	RET	M40T, M224T, M116T, M274T, M370T, M128T, M327T	Hereditary cancer-predisposing syndrome	VCV001794621	10	43604524	10	43109076	1794621	1852367		NC_000010.11:43109075:T:C	single nucleotide variant	missense variant	Likely benign	Oct 1, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1109T>A (p.Met370Lys)	RET	M370K, M116K, M327K, M274K, M224K, M40K, M128K	Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1	VCV000299890	10	43604524	10	43109076	299890	310270	rs886046987	NC_000010.11:43109075:T:A	single nucleotide variant	missense variant	Uncertain significance	Dec 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1111C>G (p.Gln371Glu)	RET	Q371E, Q117E, Q328E, Q129E, Q275E, Q41E, Q225E	Multiple endocrine neoplasia, type 2	VCV000944446	10	43604526	10	43109078	944446	925801	rs1242961674	NC_000010.11:43109077:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.1112A>G (p.Gln371Arg)	RET	Q117R, Q129R, Q225R, Q275R, Q328R, Q371R, Q41R	Multiple endocrine neoplasia, type 2	VCV003070013	10	43604527	10	43109079	3070013	3233588		NC_000010.11:43109078:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 28, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1113G>A (p.Gln371=)	RET		Multiple endocrine neoplasia, type 2	VCV002693571	10	43604528	10	43109080	2693571	2853704		NC_000010.11:43109079:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 6, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1114C>T (p.Leu372=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000743293	10	43604529	10	43109081	743293	752099	rs1588869319	NC_000010.11:43109080:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1116G>C (p.Leu372=)	RET		Multiple endocrine neoplasia, type 2	VCV002131511	10	43604531	10	43109083	2131511	2189499		NC_000010.11:43109082:G:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 28, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1118C>A (p.Ala373Glu)	RET	A119E, A373E, A330E, A131E, A277E, A43E, A227E	Multiple endocrine neoplasia, type 2	VCV000936891	10	43604533	10	43109085	936891	935024	rs546866208	NC_000010.11:43109084:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 24, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1118C>T (p.Ala373Val)	RET	A373V, A119V, A330V, A43V, A131V, A277V, A227V	Pheochromocytoma|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not specified|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia|Hirschsprung Disease, Dominant	VCV000188268	10	43604533	10	43109085	188268	186118	rs546866208	NC_000010.11:43109084:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1119G>A (p.Ala373=)	RET		Pheochromocytoma|Multiple endocrine neoplasia|Hereditary cancer-predisposing syndrome|not specified|Hirschsprung disease, susceptibility to, 1|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia, type 2|not provided	VCV000287736	10	43604534	10	43109086	287736	271973	rs113931414	NC_000010.11:43109085:G:A	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Feb 2, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1120G>C (p.Val374Leu)	RET	V331L, V374L, V44L, V120L, V228L, V278L, V132L	Multiple endocrine neoplasia, type 2	VCV003726105	10	43604535	10	43109087	3726105	3858013		NC_000010.11:43109086:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 26, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1122G>A (p.Val374=)	RET		Multiple endocrine neoplasia, type 2	VCV001987096	10	43604537	10	43109089	1987096	2043638		NC_000010.11:43109088:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 25, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1123C>T (p.Leu375=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001609831	10	43604538	10	43109090	1609831	1550787	rs2132744116	NC_000010.11:43109089:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1124T>A (p.Leu375Gln)	RET	L375Q, L121Q, L279Q, L332Q, L133Q, L229Q, L45Q	Congenital central hypoventilation|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not provided|not specified	VCV000220574	10	43604539	10	43109091	220574	221955	rs142338976	NC_000010.11:43109090:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 30, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1125G>T (p.Leu375=)	RET		Multiple endocrine neoplasia, type 2	VCV000750927	10	43604540	10	43109092	750927	767732	rs1588869346	NC_000010.11:43109091:G:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 31, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.1126G>A (p.Val376Ile)	RET	V333I, V122I, V134I, V230I, V280I, V376I, V46I	Hereditary cancer-predisposing syndrome	VCV001799202	10	43604541	10	43109093	1799202	1854811		NC_000010.11:43109092:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 25, 2014	criteria provided, single submitter							
NM_020975.6(RET):c.1129A>G (p.Asn377Asp)	RET	N281D, N135D, N231D, N123D, N334D, N377D, N47D	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002161746	10	43604544	10	43109096	2161746	1887525		NC_000010.11:43109095:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1130A>G (p.Asn377Ser)	RET	N377S, N123S, N281S, N334S, N47S, N231S, N135S	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000822221	10	43604545	10	43109097	822221	809914	rs1588869351	NC_000010.11:43109096:A:G	single nucleotide variant	missense variant	Uncertain significance	May 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1131T>C (p.Asn377=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002026424	10	43604546	10	43109098	2026424	2088180		NC_000010.11:43109097:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1132G>A (p.Asp378Asn)	RET	D124N, D378N, D136N, D335N, D48N, D232N, D282N	Multiple endocrine neoplasia, type 2	VCV001486515	10	43604547	10	43109099	1486515	1491616	rs2132744359	NC_000010.11:43109098:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 8, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1133A>T (p.Asp378Val)	RET	D282V, D335V, D124V, D378V, D136V, D232V, D48V	Hereditary cancer-predisposing syndrome	VCV003432275	10	43604548	10	43109100	3432275	3593471		NC_000010.11:43109099:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 1, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1138G>C (p.Asp380His)	RET	D126H, D138H, D234H, D284H, D337H, D380H, D50H	Multiple endocrine neoplasia, type 2	VCV003605250	10	43604553	10	43109105	3605250	3736665		NC_000010.11:43109104:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 9, 2025	criteria provided, single submitter							
NM_020975.6(RET):c.1138G>A (p.Asp380Asn)	RET	D380N, D126N, D138N, D284N, D234N, D337N, D50N	Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|not provided	VCV000543723	10	43604553	10	43109105	543723	525416	rs1394361948	NC_000010.11:43109104:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1139A>C (p.Asp380Ala)	RET	D126A, D380A, D138A, D337A, D284A, D234A, D50A	Multiple endocrine neoplasia, type 2	VCV000652094	10	43604554	10	43109106	652094	638883	rs755400887	NC_000010.11:43109105:A:C	single nucleotide variant	missense variant	Uncertain significance	Jul 25, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1140C>A (p.Asp380Glu)	RET	D126E, D138E, D234E, D284E, D337E, D380E, D50E	Hereditary cancer-predisposing syndrome	VCV001731082	10	43604555	10	43109107	1731082	1795456		NC_000010.11:43109106:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 16, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1141T>C (p.Phe381Leu)	RET	F381L, F127L, F235L, F338L, F139L, F285L, F51L	not provided|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome	VCV000822241	10	43604556	10	43109108	822241	809915	rs781362020	NC_000010.11:43109107:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 18, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1142T>G (p.Phe381Cys)	RET	F127C, F139C, F381C, F338C, F235C, F285C, F51C	Multiple endocrine neoplasia, type 2|Familial medullary thyroid carcinoma|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Familial medullary thyroid carcinoma	VCV002178070	10	43604557	10	43109109	2178070	1915880		NC_000010.11:43109108:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1144C>T (p.Gln382Ter)	RET	Q128*, Q140*, Q236*, Q286*, Q339*, Q382*, Q52*	not provided	VCV003365564	10	43604559	10	43109111	3365564	3524771		NC_000010.11:43109110:C:T	single nucleotide variant	nonsense|intron variant	Pathogenic	Apr 15, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1146G>A (p.Gln382=)	RET		not specified|not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000706850	10	43604561	10	43109113	706850	692836	rs770637118	NC_000010.11:43109112:G:A	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Aug 15, 2023	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1147G>A (p.Gly383Ser)	RET	G53S, G237S, G287S, G340S, G129S, G141S, G383S	Multiple endocrine neoplasia, type 2	VCV002131587	10	43604562	10	43109114	2131587	2189575		NC_000010.11:43109113:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 28, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1148G>A (p.Gly383Asp)	RET	G287D, G237D, G383D, G53D, G129D, G141D, G340D	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002089401	10	43604563	10	43109115	2089401	2144731		NC_000010.11:43109114:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1149C>T (p.Gly383=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001733323	10	43604564	10	43109116	1733323	1792945		NC_000010.11:43109115:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1149C>A (p.Gly383=)	RET		Multiple endocrine neoplasia, type 2	VCV001139537	10	43604564	10	43109116	1139537	1120260	rs1254273557	NC_000010.11:43109115:C:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 17, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.1151del (p.Pro384fs)	RET	P130fs, P384fs	Multiple endocrine neoplasia, type 2	VCV000969297	10	43604564	10	43109116	969297	956045	rs1837854100	NC_000010.11:43109115:CCC:CC	Deletion	frameshift variant	Pathogenic	Aug 4, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.1150C>G (p.Pro384Ala)	RET	P384A, P130A, P142A, P288A, P341A, P238A, P54A	not provided|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome	VCV000216713	10	43604565	10	43109117	216713	212775	rs536298339	NC_000010.11:43109116:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 28, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1151C>G (p.Pro384Arg)	RET	P384R, P130R, P238R, P341R, P142R, P288R, P54R	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|not provided|Congenital central hypoventilation|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A	VCV000405529	10	43604566	10	43109118	405529	397267	rs771679592	NC_000010.11:43109117:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1152A>G (p.Pro384=)	RET		Hereditary cancer-predisposing syndrome	VCV003313721	10	43604567	10	43109119	3313721	3465451		NC_000010.11:43109118:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 14, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1153G>A (p.Gly385Arg)	RET	G289R, G342R, G385R, G131R, G143R, G239R, G55R	Hereditary cancer-predisposing syndrome	VCV001734719	10	43604568	10	43109120	1734719	1796511		NC_000010.11:43109119:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 28, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.1154G>A (p.Gly385Glu)	RET	G131E, G385E, G143E, G289E, G342E, G55E, G239E	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not provided	VCV002073024	10	43604569	10	43109121	2073024	2127096		NC_000010.11:43109120:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1154G>T (p.Gly385Val)	RET	G385V, G131V, G342V, G143V, G289V, G55V, G239V	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A	VCV000543752	10	43604569	10	43109121	543752	525420	rs906695652	NC_000010.11:43109120:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1155A>G (p.Gly385=)	RET		Hereditary cancer-predisposing syndrome	VCV001735071	10	43604570	10	43109122	1735071	1793410		NC_000010.11:43109121:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 14, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1157C>T (p.Ala386Val)	RET	A386V, A132V, A290V, A343V, A56V, A144V, A240V	Multiple endocrine neoplasia, type 2|not specified|Hereditary cancer-predisposing syndrome|not provided	VCV000135186	10	43604572	10	43109124	135186	138925	rs115272158	NC_000010.11:43109123:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 3, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1160del (p.Gly387fs)	RET	G387fs, G57fs, G145fs, G344fs, G133fs, G241fs, G291fs	Multiple endocrine neoplasia, type 2	VCV002817143	10	43604573	10	43109125	2817143	2980801		NC_000010.11:43109124:GGG:GG	Deletion	frameshift variant|intron variant	Pathogenic	Dec 15, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1158G>C (p.Ala386=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001735928	10	43604573	10	43109125	1735928	1787089		NC_000010.11:43109124:G:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 9, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1158G>A (p.Ala386=)	RET		not specified|Multiple endocrine neoplasia type 2A|not provided|Renal hypodysplasia/aplasia 1|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000136095	10	43604573	10	43109125	136095	139807	rs373540097	NC_000010.11:43109124:G:A	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Jan 29, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1159G>A (p.Gly387Ser)	RET	G145S, G387S, G133S, G241S, G291S, G344S, G57S	Multiple endocrine neoplasia, type 2	VCV001896959	10	43604574	10	43109126	1896959	1952894		NC_000010.11:43109125:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 9, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1160G>C (p.Gly387Ala)	RET	G133A, G145A, G241A, G291A, G344A, G387A, G57A	Multiple endocrine neoplasia, type 2	VCV003074605	10	43604575	10	43109127	3074605	3229572		NC_000010.11:43109126:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 20, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1161C>T (p.Gly387=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000477305	10	43604576	10	43109128	477305	460710	rs763967472	NC_000010.11:43109127:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1162G>T (p.Val388Phe)	RET	V388F, V134F, V292F, V58F, V345F, V146F, V242F	Multiple endocrine neoplasia type 2B	VCV000931231	10	43604577	10	43109129	931231	919267	rs776223166	NC_000010.11:43109128:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 27, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.1162G>A (p.Val388Ile)	RET	V388I, V134I, V146I, V58I, V242I, V292I, V345I	Multiple endocrine neoplasia|Multiple endocrine neoplasia, type 2|Pheochromocytoma|Renal hypodysplasia/aplasia 1|Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|not provided	VCV000299891	10	43604577	10	43109129	299891	321370	rs776223166	NC_000010.11:43109128:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 30, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1163T>C (p.Val388Ala)	RET	V388A, V134A, V242A, V58A, V345A, V146A, V292A	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	VCV000477306	10	43604578	10	43109130	477306	460717	rs751939820	NC_000010.11:43109129:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 6, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1164C>T (p.Val388=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001106580	10	43604579	10	43109131	1106580	1098687	rs1837855415	NC_000010.11:43109130:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1165C>T (p.Leu389Phe)	RET	L389F, L135F, L243F, L346F, L147F, L293F, L59F	Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia|Pheochromocytoma|Renal hypodysplasia/aplasia 1|Hereditary cancer-predisposing syndrome	VCV000405539	10	43604580	10	43109132	405539	397699	rs895556824	NC_000010.11:43109131:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 31, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1170G>C (p.Leu390Phe)	RET	L347F, L60F, L136F, L244F, L294F, L148F, L390F	Multiple endocrine neoplasia, type 2	VCV002883571	10	43604585	10	43109137	2883571	3046326		NC_000010.11:43109136:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 4, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1170G>A (p.Leu390=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001151810	10	43604585	10	43109137	1151810	1141123	rs1588869424	NC_000010.11:43109136:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1171C>A (p.Leu391Ile)	RET	L295I, L245I, L391I, L61I, L137I, L149I, L348I	Hereditary cancer-predisposing syndrome	VCV003313738	10	43604586	10	43109138	3313738	3465468		NC_000010.11:43109137:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 26, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1173C>G (p.Leu391=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000413477	10	43604588	10	43109140	413477	397700	rs757868491	NC_000010.11:43109139:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1175A>G (p.His392Arg)	RET	H138R, H392R, H150R, H296R, H246R, H349R, H62R	Multiple endocrine neoplasia, type 2	VCV001504491	10	43604590	10	43109142	1504491	1417242	rs2132745297	NC_000010.11:43109141:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 16, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1176C>G (p.His392Gln)	RET	H138Q, H246Q, H62Q, H150Q, H296Q, H349Q, H392Q	Hereditary cancer-predisposing syndrome	VCV002568375	10	43604591	10	43109143	2568375	2734911		NC_000010.11:43109142:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 1, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1176C>T (p.His392=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001122790	10	43604591	10	43109143	1122790	1120261	rs1193035007	NC_000010.11:43109142:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1179C>A (p.Phe393Leu)	RET	F393L, F139L, F247L, F350L, F63L, F151L, F297L	Hirschsprung disease, susceptibility to, 1	VCV000013927	10	43604594	10	43109146	13927	28966	rs78098482	NC_000010.11:43109145:C:A	single nucleotide variant	missense variant	risk factor	Jan 27, 1994	no assertion criteria provided							
NM_020975.6(RET):c.1182C>A (p.Asn394Lys)	RET	N140K, N351K, N152K, N248K, N298K, N394K, N64K	Multiple endocrine neoplasia, type 2	VCV003651549	10	43604597	10	43109149	3651549	3788260		NC_000010.11:43109148:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 29, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1182C>G (p.Asn394Lys)	RET	N64K, N140K, N248K, N351K, N394K, N298K, N152K	Hereditary cancer-predisposing syndrome	VCV002447527	10	43604597	10	43109149	2447527	2432421		NC_000010.11:43109148:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 12, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1182C>T (p.Asn394=)	RET		Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia type 2B	VCV000136096	10	43604597	10	43109149	136096	139808	rs376465385	NC_000010.11:43109148:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1183G>A (p.Val395Met)	RET	V141M, V395M, V299M, V65M, V153M, V249M, V352M	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|not provided	VCV000863819	10	43604598	10	43109150	863819	836831	rs1452469572	NC_000010.11:43109149:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1183G>C (p.Val395Leu)	RET	V395L, V141L, V352L, V65L, V299L, V153L, V249L	Hereditary cancer-predisposing syndrome|Pheochromocytoma|Multiple endocrine neoplasia, type 2|not provided|Multiple endocrine neoplasia type 2A	VCV000584746	10	43604598	10	43109150	584746	575802	rs1452469572	NC_000010.11:43109149:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1185G>A (p.Val395=)	RET		Hereditary cancer-predisposing syndrome	VCV001743287	10	43604600	10	43109152	1743287	1805433		NC_000010.11:43109151:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 13, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.1187C>T (p.Ser396Leu)	RET	S396L, S142L, S300L, S66L, S250L, S154L, S353L	Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia, type 2|not specified|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A	VCV000372081	10	43604602	10	43109154	372081	358822	rs781646869	NC_000010.11:43109153:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1188G>C (p.Ser396=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000818539	10	43604603	10	43109155	818539	809916	rs758510657	NC_000010.11:43109154:G:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 12, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1188G>A (p.Ser396=)	RET		not provided|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome	VCV000216714	10	43604603	10	43109155	216714	212776	rs758510657	NC_000010.11:43109154:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1189G>A (p.Val397Met)	RET	V397M, V143M, V354M, V155M, V67M, V251M, V301M	Hereditary cancer-predisposing syndrome|Ovarian cancer|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2	VCV000477307	10	43604604	10	43109156	477307	460265	rs183729115	NC_000010.11:43109155:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 30, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1191G>A (p.Val397=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000477308	10	43604606	10	43109158	477308	460267	rs1351206662	NC_000010.11:43109157:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Feb 16, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1193T>G (p.Leu398Arg)	RET	L252R, L302R, L398R, L144R, L355R, L68R, L156R	Multiple endocrine neoplasia, type 2	VCV003717869	10	43604608	10	43109160	3717869	3852843		NC_000010.11:43109159:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 18, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1193T>C (p.Leu398Pro)	RET	L156P, L355P, L252P, L302P, L398P, L68P, L144P	Multiple endocrine neoplasia, type 2	VCV002735389	10	43604608	10	43109160	2735389	2901414		NC_000010.11:43109159:T:C	single nucleotide variant	intron variant|missense variant	Uncertain significance	Feb 8, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1194G>A (p.Leu398=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000818509	10	43604609	10	43109161	818509	809917	rs1588869481	NC_000010.11:43109160:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1195C>T (p.Pro399Ser)	RET	P303S, P399S, P69S, P157S, P356S, P145S, P253S	Hereditary cancer-predisposing syndrome	VCV002454140	10	43604610	10	43109162	2454140	2424029		NC_000010.11:43109161:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 16, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1196C>G (p.Pro399Arg)	RET	P356R, P399R, P157R, P303R, P69R, P145R, P253R	Multiple endocrine neoplasia, type 2	VCV002064529	10	43604611	10	43109163	2064529	2128512		NC_000010.11:43109162:C:G	single nucleotide variant	missense variant	Uncertain significance	May 29, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1196C>T (p.Pro399Leu)	RET	P399L, P145L, P253L, P356L, P157L, P303L, P69L	not specified|Multiple endocrine neoplasia, type 2	VCV000274004	10	43604611	10	43109163	274004	263840	rs1554818362	NC_000010.11:43109162:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 16, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1197G>C (p.Pro399=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV003074499	10	43604612	10	43109164	3074499	3229466		NC_000010.11:43109163:G:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1197G>T (p.Pro399=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001642292	10	43604612	10	43109164	1642292	1552390	rs148371113	NC_000010.11:43109163:G:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 26, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1197G>A (p.Pro399=)	RET		not specified|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000184610	10	43604612	10	43109164	184610	182950	rs148371113	NC_000010.11:43109163:G:A	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1198G>A (p.Val400Ile)	RET	V146I, V158I, V254I, V304I, V357I, V400I, V70I	RET-related disorder	VCV003344443	10	43604613	10	43109165	3344443	3505429		NC_000010.11:43109164:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 11, 2024	no assertion criteria provided							
NM_020975.6(RET):c.1198G>T (p.Val400Phe)	RET	V146F, V304F, V357F, V158F, V254F, V400F, V70F	Hereditary cancer-predisposing syndrome	VCV002568382	10	43604613	10	43109165	2568382	2734918		NC_000010.11:43109164:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 10, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1201A>T (p.Ser401Cys)	RET	S401C, S147C, S255C, S358C, S71C, S159C, S305C	Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Congenital anomaly of kidney and urinary tract|Hereditary cancer-predisposing syndrome|not provided	VCV000224354	10	43604616	10	43109168	224354	226087	rs140638866	NC_000010.11:43109167:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 23, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1202G>A (p.Ser401Asn)	RET	S401N, S147N, S305N, S358N, S71N, S159N, S255N	Hereditary cancer-predisposing syndrome|Ependymoma	VCV000620604	10	43604617	10	43109169	620604	612011	rs1564493414	NC_000010.11:43109168:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 11, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1203C>T (p.Ser401=)	RET		Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	VCV001077934	10	43604618	10	43109170	1077934	1077037	rs781623106	NC_000010.11:43109169:C:T	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Jul 29, 2021	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1203C>A (p.Ser401Arg)	RET	S401R, S147R, S305R, S159R, S71R, S255R, S358R	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000936665	10	43604618	10	43109170	936665	935025	rs781623106	NC_000010.11:43109169:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 23, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1204C>T (p.Leu402=)	RET		Hereditary cancer-predisposing syndrome	VCV003227501	10	43604619	10	43109171	3227501	3390713		NC_000010.11:43109170:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Feb 11, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1206G>A (p.Leu402=)	RET		Multiple endocrine neoplasia, type 2	VCV002779877	10	43604621	10	43109173	2779877	2947073		NC_000010.11:43109172:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 12, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1207C>T (p.His403Tyr)	RET	H149Y, H403Y, H161Y, H73Y, H360Y, H257Y, H307Y	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001525236	10	43604622	10	43109174	1525236	1359697	rs1449633271	NC_000010.11:43109173:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2021	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1209C>T (p.His403=)	RET		Multiple endocrine neoplasia, type 2	VCV003709887	10	43604624	10	43109176	3709887	3836865		NC_000010.11:43109175:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 13, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1210C>T (p.Leu404=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001648881	10	43604625	10	43109177	1648881	1662533	rs2132746193	NC_000010.11:43109176:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 25, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1212G>A (p.Leu404=)	RET		Hereditary cancer-predisposing syndrome	VCV002454142	10	43604627	10	43109179	2454142	2424031		NC_000010.11:43109178:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 19, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1214C>G (p.Pro405Arg)	RET	P151R, P75R, P163R, P362R, P405R, P259R, P309R	Hereditary cancer-predisposing syndrome	VCV002625016	10	43604629	10	43109181	2625016	2790511		NC_000010.11:43109180:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 18, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1214C>T (p.Pro405Leu)	RET	P151L, P163L, P309L, P362L, P259L, P75L, P405L	Hereditary cancer-predisposing syndrome	VCV001751188	10	43604629	10	43109181	1751188	1800917		NC_000010.11:43109180:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 14, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1215C>G (p.Pro405=)	RET		Multiple endocrine neoplasia, type 2	VCV002190496	10	43604630	10	43109182	2190496	1915312		NC_000010.11:43109181:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 21, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1215C>T (p.Pro405=)	RET		not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001103082	10	43604630	10	43109182	1103082	1098688	rs748588678	NC_000010.11:43109181:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1216A>C (p.Ser406Arg)	RET	S260R, S76R, S310R, S152R, S164R, S406R, S363R	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002562597	10	43604631	10	43109183	2562597	2717439		NC_000010.11:43109182:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1216A>G (p.Ser406Gly)	RET	S406G, S152G, S310G, S164G, S363G, S76G, S260G	not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Ovarian cancer	VCV000480783	10	43604631	10	43109183	480783	475271	rs756532455	NC_000010.11:43109182:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 5, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1218T>C (p.Ser406=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002764133	10	43604633	10	43109185	2764133	2922302		NC_000010.11:43109184:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1219A>G (p.Thr407Ala)	RET	T153A, T261A, T311A, T77A, T407A, T165A, T364A	Hereditary cancer-predisposing syndrome	VCV002568335	10	43604634	10	43109186	2568335	2734872		NC_000010.11:43109185:A:G	single nucleotide variant	missense variant|intron variant	Likely benign	Apr 3, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1220C>T (p.Thr407Ile)	RET	T153I, T407I, T165I, T261I, T364I, T311I, T77I	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000963025	10	43604635	10	43109187	963025	946881	rs1837858286	NC_000010.11:43109186:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1221C>A (p.Thr407=)	RET		Hereditary cancer-predisposing syndrome	VCV001753145	10	43604636	10	43109188	1753145	1811469		NC_000010.11:43109187:C:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 16, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1221C>G (p.Thr407=)	RET		Multiple endocrine neoplasia, type 2	VCV001668928	10	43604636	10	43109188	1668928	1602814	rs1222385123	NC_000010.11:43109187:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 19, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1221C>T (p.Thr407=)	RET		Hereditary cancer-predisposing syndrome|not specified|Multiple endocrine neoplasia, type 2	VCV000517867	10	43604636	10	43109188	517867	503619	rs1222385123	NC_000010.11:43109187:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1222T>C (p.Tyr408His)	RET	Y154H, Y408H, Y166H, Y78H, Y262H, Y365H, Y312H	Multiple endocrine neoplasia, type 2	VCV000661224	10	43604637	10	43109189	661224	638884	rs778754580	NC_000010.11:43109188:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 22, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.1222T>A (p.Tyr408Asn)	RET	Y408N, Y154N, Y166N, Y262N, Y365N, Y78N, Y312N	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000543751	10	43604637	10	43109189	543751	525098	rs778754580	NC_000010.11:43109188:T:A	single nucleotide variant	missense variant	Uncertain significance	Dec 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1223A>G (p.Tyr408Cys)	RET	Y262C, Y365C, Y312C, Y408C, Y78C, Y166C, Y154C	Hereditary cancer-predisposing syndrome	VCV001753597	10	43604638	10	43109190	1753597	1807979		NC_000010.11:43109189:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 8, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1223A>T (p.Tyr408Phe)	RET	Y408F, Y154F, Y166F, Y365F, Y262F, Y312F, Y78F	Multiple endocrine neoplasia, type 2	VCV000220164	10	43604638	10	43109190	220164	221956	rs864622405	NC_000010.11:43109189:A:T	single nucleotide variant	missense variant	Uncertain significance	Sep 5, 2015	criteria provided, single submitter							
NM_020975.6(RET):c.1224C>T (p.Tyr408=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000477309	10	43604639	10	43109191	477309	460021	rs745479264	NC_000010.11:43109190:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1225T>G (p.Ser409Ala)	RET	S155A, S167A, S263A, S313A, S366A, S409A, S79A	Multiple endocrine neoplasia, type 2	VCV003072726	10	43604640	10	43109192	3072726	3228998		NC_000010.11:43109191:T:G	single nucleotide variant	intron variant|missense variant	Uncertain significance	Aug 15, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1225T>A (p.Ser409Thr)	RET	S155T, S409T, S263T, S79T, S167T, S313T, S366T	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001754186	10	43604640	10	43109192	1754186	1804741		NC_000010.11:43109191:T:A	single nucleotide variant	missense variant	Uncertain significance	Apr 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1226C>A (p.Ser409Tyr)	RET	S366Y, S167Y, S313Y, S155Y, S263Y, S409Y, S79Y	Multiple endocrine neoplasia, type 2	VCV003702852	10	43604641	10	43109193	3702852	3838903		NC_000010.11:43109192:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 16, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1226C>T (p.Ser409Phe)	RET	S155F, S167F, S263F, S313F, S366F, S409F, S79F	Hereditary cancer-predisposing syndrome	VCV003227502	10	43604641	10	43109193	3227502	3390714		NC_000010.11:43109192:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 25, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1226C>G (p.Ser409Cys)	RET	S263C, S313C, S366C, S409C, S155C, S167C, S79C	Multiple endocrine neoplasia, type 2	VCV002826603	10	43604641	10	43109193	2826603	2989824		NC_000010.11:43109192:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 18, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1228C>T (p.Leu410Phe)	RET	L156F, L410F, L367F, L264F, L80F, L314F, L168F	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001364973	10	43604643	10	43109195	1364973	1502019	rs1588869546	NC_000010.11:43109194:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 2, 2023	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1229T>A (p.Leu410His)	RET	L264H, L314H, L156H, L168H, L367H, L410H, L80H	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001755052	10	43604644	10	43109196	1755052	1822141		NC_000010.11:43109195:T:A	single nucleotide variant	missense variant	Uncertain significance	Jan 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1230C>T (p.Leu410=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001755444	10	43604645	10	43109197	1755444	1818734		NC_000010.11:43109196:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1230C>G (p.Leu410=)	RET		Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001538693	10	43604645	10	43109197	1538693	1544178	rs995081128	NC_000010.11:43109196:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1232C>G (p.Ser411Cys)	RET	S157C, S411C, S315C, S368C, S81C, S265C, S169C	Multiple endocrine neoplasia, type 2|Familial medullary thyroid carcinoma|Hereditary cancer-predisposing syndrome	VCV001327060	10	43604647	10	43109199	1327060	1317560	rs2132746693	NC_000010.11:43109198:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1233C>T (p.Ser411=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001124191	10	43604648	10	43109200	1124191	1120262	rs779374978	NC_000010.11:43109199:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1234G>A (p.Val412Met)	RET	V412M, V158M, V82M, V266M, V316M, V369M, V170M	Multiple endocrine neoplasia, type 2|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Hereditary cancer-predisposing syndrome	VCV000640598	10	43604649	10	43109201	640598	638885	rs746970700	NC_000010.11:43109200:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1236G>C (p.Val412=)	RET		Multiple endocrine neoplasia, type 2	VCV000405552	10	43604651	10	43109203	405552	397810	rs1060500761	NC_000010.11:43109202:G:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Feb 24, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1240_1251del (p.Arg415_Arg418del)	RET		Multiple endocrine neoplasia, type 2	VCV002707340	10	43604653 - 43604664	10	43109205 - 43109216	2707340	2867031		NC_000010.11:43109204:GCAGGAGGGCTCGC:GC	Deletion	inframe_indel|inframe_deletion|intron variant	Uncertain significance	Jan 4, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1238G>A (p.Ser413Asn)	RET	S159N, S413N, S171N, S267N, S317N, S370N, S83N	Multiple endocrine neoplasia, type 2	VCV001366298	10	43604653	10	43109205	1366298	1411640	rs1837859435	NC_000010.11:43109204:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 8, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1239C>T (p.Ser413=)	RET		Multiple endocrine neoplasia, type 2	VCV001580907	10	43604654	10	43109206	1580907	1566034	rs1837859530	NC_000010.11:43109205:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 23, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1239C>A (p.Ser413Arg)	RET	S159R, S413R, S171R, S317R, S370R, S83R, S267R	Multiple endocrine neoplasia, type 2	VCV000963289	10	43604654	10	43109206	963289	946882	rs1837859530	NC_000010.11:43109205:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 1, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.1240A>G (p.Arg414Gly)	RET	R414G, R268G, R84G, R172G, R318G, R371G, R160G	Hereditary cancer-predisposing syndrome	VCV002568336	10	43604655	10	43109207	2568336	2734873		NC_000010.11:43109206:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 5, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1244G>T (p.Arg415Met)	RET	R161M, R319M, R372M, R173M, R269M, R415M, R85M	Multiple endocrine neoplasia, type 2	VCV003723497	10	43604659	10	43109211	3723497	3850708		NC_000010.11:43109210:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 22, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1244G>A (p.Arg415Lys)	RET	R161K, R173K, R269K, R319K, R372K, R415K, R85K	Hereditary cancer-predisposing syndrome	VCV003227503	10	43604659	10	43109211	3227503	3390715		NC_000010.11:43109210:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 15, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1245G>C (p.Arg415Ser)	RET	R319S, R161S, R173S, R372S, R269S, R415S, R85S	Hereditary cancer-predisposing syndrome	VCV001759437	10	43604660	10	43109212	1759437	1816344		NC_000010.11:43109211:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 18, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1245G>A (p.Arg415=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001082148	10	43604660	10	43109212	1082148	1077038	rs2132746989	NC_000010.11:43109211:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1247C>T (p.Ala416Val)	RET	A162V, A373V, A416V, A86V, A174V, A270V, A320V	Hereditary cancer-predisposing syndrome	VCV001759815	10	43604662	10	43109214	1759815	1813416		NC_000010.11:43109213:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 10, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1249C>T (p.Arg417Cys)	RET	R417C, R163C, R175C, R87C, R271C, R321C, R374C	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000843191	10	43604664	10	43109216	843191	836832	rs1478152005	NC_000010.11:43109215:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 22, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1249C>G (p.Arg417Gly)	RET	R417G, R163G, R321G, R87G, R175G, R271G, R374G	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000818706	10	43604664	10	43109216	818706	809918	rs1478152005	NC_000010.11:43109215:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1250G>C (p.Arg417Pro)	RET	R163P, R321P, R175P, R271P, R87P, R374P, R417P	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002454122	10	43604665	10	43109217	2454122	2424011		NC_000010.11:43109216:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1250G>A (p.Arg417His)	RET	R417H, R163H, R175H, R271H, R321H, R87H, R374H	not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000405555	10	43604665	10	43109217	405555	397703	rs201030628	NC_000010.11:43109216:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 11, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1251C>G (p.Arg417=)	RET		Hereditary cancer-predisposing syndrome	VCV002496751	10	43604666	10	43109218	2496751	2467890		NC_000010.11:43109217:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 11, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1252C>T (p.Arg418Ter)	RET	R418*, R164*, R375*, R88*, R272*, R176*, R322*	Multiple endocrine neoplasia, type 2	VCV001403312	10	43604667	10	43109219	1403312	1470535	rs2132747295	NC_000010.11:43109218:C:T	single nucleotide variant	nonsense	Pathogenic	May 5, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1253G>A (p.Arg418Gln)	RET	R418Q, R164Q, R176Q, R375Q, R88Q, R322Q, R272Q	not provided|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1	VCV000219872	10	43604668	10	43109220	219872	221957	rs371731991	NC_000010.11:43109219:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1253G>C (p.Arg418Pro)	RET	R418P, R164P, R272P, R88P, R176P, R322P, R375P	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A	VCV000219396	10	43604668	10	43109220	219396	221958	rs371731991	NC_000010.11:43109219:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1256T>A (p.Phe419Tyr)	RET	F419Y, F165Y, F273Y, F323Y, F89Y, F177Y, F376Y	Multiple endocrine neoplasia, type 2	VCV000651594	10	43604671	10	43109223	651594	638886	rs1588869586	NC_000010.11:43109222:T:A	single nucleotide variant	missense variant	Uncertain significance	Sep 6, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.1258G>T (p.Ala420Ser)	RET	A90S, A178S, A274S, A324S, A420S, A166S, A377S	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002618978	10	43604673	10	43109225	2618978	2782723		NC_000010.11:43109224:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1258G>A (p.Ala420Thr)	RET	A377T, A178T, A274T, A90T, A324T, A420T, A166T	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001762391	10	43604673	10	43109225	1762391	1816790		NC_000010.11:43109224:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1259C>T (p.Ala420Val)	RET	A166V, A178V, A274V, A324V, A377V, A420V, A90V	Multiple endocrine neoplasia, type 2	VCV003074492	10	43604674	10	43109226	3074492	3229459		NC_000010.11:43109225:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 20, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1259C>G (p.Ala420Gly)	RET	A420G, A166G, A90G, A324G, A377G, A178G, A274G	Multiple endocrine neoplasia, type 2	VCV001493098	10	43604674	10	43109226	1493098	1515934	rs1837860722	NC_000010.11:43109225:C:G	single nucleotide variant	missense variant	Uncertain significance	May 20, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1262A>C (p.Gln421Pro)	RET	Q167P, Q179P, Q275P, Q325P, Q378P, Q421P, Q91P	Multiple endocrine neoplasia, type 2	VCV003609675	10	43604677	10	43109229	3609675	3744540		NC_000010.11:43109228:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 4, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1263+3G>A	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002454120	10	43604681	10	43109233	2454120	2424009		NC_000010.11:43109232:G:A	single nucleotide variant	intron variant	Uncertain significance	Mar 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1263+6C>T	RET		Multiple endocrine neoplasia, type 2	VCV003673045	10	43604684	10	43109236	3673045	3803883		NC_000010.11:43109235:C:T	single nucleotide variant	intron variant	Uncertain significance	Oct 15, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1263+7C>G	RET		Multiple endocrine neoplasia, type 2	VCV000543786	10	43604685	10	43109237	543786	525293	rs1554818384	NC_000010.11:43109236:C:G	single nucleotide variant	intron variant	Likely benign	Apr 24, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1263+8C>T	RET		Multiple endocrine neoplasia, type 2	VCV002767176	10	43604686	10	43109238	2767176	2926620		NC_000010.11:43109237:C:T	single nucleotide variant	intron variant	Likely benign	Jan 30, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1263+9A>C	RET		Multiple endocrine neoplasia, type 2	VCV001117531	10	43604687	10	43109239	1117531	1098689	rs1837861041	NC_000010.11:43109238:A:C	single nucleotide variant	intron variant	Likely benign	Jan 28, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1263+9A>G	RET		Multiple endocrine neoplasia, type 2	VCV001014445	10	43604687	10	43109239	1014445	1008988	rs1837861041	NC_000010.11:43109238:A:G	single nucleotide variant	intron variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1263+12C>T	RET		Multiple endocrine neoplasia, type 2	VCV003673632	10	43604690	10	43109242	3673632	3806257		NC_000010.11:43109241:C:T	single nucleotide variant	intron variant	Likely benign	May 2, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1263+12C>A	RET		Multiple endocrine neoplasia, type 2	VCV002899632	10	43604690	10	43109242	2899632	3067719		NC_000010.11:43109241:C:A	single nucleotide variant	intron variant	Likely benign	Jan 16, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1263+15A>G	RET		Multiple endocrine neoplasia, type 2	VCV001921334	10	43604693	10	43109245	1921334	1969023		NC_000010.11:43109244:A:G	single nucleotide variant	intron variant	Likely benign	Mar 14, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1263+18G>A	RET		Multiple endocrine neoplasia, type 2	VCV001911567	10	43604696	10	43109248	1911567	1973080		NC_000010.11:43109247:G:A	single nucleotide variant	intron variant	Likely benign	Dec 15, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1263+19C>T	RET		Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Familial medullary thyroid carcinoma	VCV001654274	10	43604697	10	43109249	1654274	1527092	rs371417381	NC_000010.11:43109248:C:T	single nucleotide variant	intron variant	Likely benign	Dec 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1263+20C>T	RET		Multiple endocrine neoplasia, type 2	VCV001906440	10	43604698	10	43109250	1906440	1961924		NC_000010.11:43109249:C:T	single nucleotide variant	intron variant	Likely benign	Oct 15, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1263+57del	RET		not provided	VCV001201664	10	43604731	10	43109283	1201664	1191057	rs34903010	NC_000010.11:43109282:GGGGG:GGGG	Deletion	intron variant	Likely benign	Jul 26, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.1263+272A>G	RET		not provided	VCV001283827	10	43604950	10	43109502	1283827	1272386	rs1864403	NC_000010.11:43109501:A:G	single nucleotide variant	intron variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.1264-196G>A	RET		not provided	VCV001214114	10	43606459	10	43111011	1214114	1204100	rs77890871	NC_000010.11:43111010:G:A	single nucleotide variant	intron variant	Likely benign	Jul 2, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.1264-55dup	RET		Multiple endocrine neoplasia type 2A	VCV000036722	10	43606598 - 43606599	10	43111150 - 43111151	36722	45383	rs193922698	NC_000010.11:43111150:GG:GGG	Duplication	intron variant	Uncertain significance	Aug 18, 2011	criteria provided, single submitter							
NM_020975.6(RET):c.1264-43C>T	RET		not specified	VCV002576506	10	43606612	10	43111164	2576506	2741402		NC_000010.11:43111163:C:T	single nucleotide variant	intron variant	Likely benign	Aug 15, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1264-20G>T	RET		Multiple endocrine neoplasia, type 2	VCV003679660	10	43606635	10	43111187	3679660	3814684		NC_000010.11:43111186:G:T	single nucleotide variant	intron variant	Likely benign	Sep 4, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1264-20G>C	RET		Multiple endocrine neoplasia, type 2	VCV002862108	10	43606635	10	43111187	2862108	3025759		NC_000010.11:43111186:G:C	single nucleotide variant	intron variant	Likely benign	May 5, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1264-17C>T	RET		Multiple endocrine neoplasia, type 2	VCV001610076	10	43606638	10	43111190	1610076	1551032	rs768193163	NC_000010.11:43111189:C:T	single nucleotide variant	intron variant	Likely benign	Sep 23, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1264-15C>T	RET		Multiple endocrine neoplasia, type 2	VCV001623325	10	43606640	10	43111192	1623325	1540527	rs781151199	NC_000010.11:43111191:C:T	single nucleotide variant	intron variant	Likely benign	Dec 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1264-14_1264-13del	RET		Multiple endocrine neoplasia, type 2	VCV003387590	10	43606641 - 43606642	10	43111193 - 43111194	3387590	3546723		NC_000010.11:43111192:CT:	Deletion	intron variant	Likely benign	Apr 25, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1264-13T>C	RET		Multiple endocrine neoplasia, type 2	VCV001937163	10	43606642	10	43111194	1937163	2003784		NC_000010.11:43111193:T:C	single nucleotide variant	intron variant	Likely benign	Jul 30, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1264-12G>C	RET		Multiple endocrine neoplasia, type 2	VCV003730646	10	43606643	10	43111195	3730646	3862981		NC_000010.11:43111194:G:C	single nucleotide variant	intron variant	Likely benign	Jun 26, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1264-12G>A	RET		Multiple endocrine neoplasia, type 2	VCV001569856	10	43606643	10	43111195	1569856	1559825	rs370613696	NC_000010.11:43111194:G:A	single nucleotide variant	intron variant	Likely benign	Aug 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1264-11T>C	RET		Multiple endocrine neoplasia, type 2	VCV001930626	10	43606644	10	43111196	1930626	1988221		NC_000010.11:43111195:T:C	single nucleotide variant	intron variant	Uncertain significance	May 20, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1264-4dup	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001166918	10	43606645 - 43606646	10	43111197 - 43111198	1166918	1156414	rs1814685980	NC_000010.11:43111197:CCCCCC:CCCCCCC	Duplication	intron variant	Benign/Likely benign	Jun 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1264-10G>A	RET		Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A	VCV000838741	10	43606645	10	43111197	838741	851772	rs1837911590	NC_000010.11:43111196:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Feb 17, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1264-9C>A	RET		Multiple endocrine neoplasia, type 2	VCV002709549	10	43606646	10	43111198	2709549	2878294		NC_000010.11:43111197:C:A	single nucleotide variant	intron variant	Likely benign	Jan 16, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1264-4del	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002066039	10	43606646	10	43111198	2066039	2128724		NC_000010.11:43111197:CCCCCC:CCCCC	Deletion	intron variant	Conflicting classifications of pathogenicity	Apr 29, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1264-9C>T	RET		Multiple endocrine neoplasia, type 2	VCV001110224	10	43606646	10	43111198	1110224	1098690	rs886636715	NC_000010.11:43111197:C:T	single nucleotide variant	intron variant	Likely benign	Feb 3, 2025	criteria provided, single submitter							
NM_020975.6(RET):c.1264-8C>T	RET		Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia|Pheochromocytoma|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1	VCV000477310	10	43606647	10	43111199	477310	459817	rs769595884	NC_000010.11:43111198:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1264-7C>T	RET		Multiple endocrine neoplasia, type 2	VCV000413456	10	43606648	10	43111200	413456	397708	rs772930754	NC_000010.11:43111199:C:T	single nucleotide variant	intron variant	Likely benign	Dec 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1264-6C>G	RET		Multiple endocrine neoplasia, type 2	VCV002697034	10	43606649	10	43111201	2697034	2854604		NC_000010.11:43111200:C:G	single nucleotide variant	intron variant	Likely benign	Nov 18, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1264-6C>T	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001691911	10	43606649	10	43111201	1691911	1684353	rs1255010070	NC_000010.11:43111200:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Nov 20, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1264-6C>A	RET		Multiple endocrine neoplasia, type 2	VCV000580055	10	43606649	10	43111201	580055	563725	rs1255010070	NC_000010.11:43111200:C:A	single nucleotide variant	intron variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1264-5C>A	RET		Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|not provided	VCV001201517	10	43606650	10	43111202	1201517	1191058	rs9282835	NC_000010.11:43111201:C:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Oct 16, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1264-5C>G	RET		Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000220306	10	43606650	10	43111202	220306	221959	rs9282835	NC_000010.11:43111201:C:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Sep 28, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1264-5C>T	RET		Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|not provided|Hirschsprung disease, susceptibility to, 1|not specified|Multiple endocrine neoplasia|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Pheochromocytoma	VCV000132713	10	43606650	10	43111202	132713	136461	rs9282835	NC_000010.11:43111201:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1264-4C>T	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2B|not provided|Multiple endocrine neoplasia type 2A|not specified	VCV000136097	10	43606651	10	43111203	136097	139809	rs587780806	NC_000010.11:43111202:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1264-3T>C	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001432228	10	43606652	10	43111204	1432228	1484339	rs2132765385	NC_000010.11:43111203:T:C	single nucleotide variant	intron variant	Uncertain significance	Mar 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1264-3del	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000861854	10	43606652	10	43111204	861854	852246	rs1837912264	NC_000010.11:43111203:T:	Deletion	intron variant	Uncertain significance	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1266C>T (p.Ile422=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000232505	10	43606657	10	43111209	232505	233780	rs759582152	NC_000010.11:43111208:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1267G>T (p.Gly423Trp)	RET	G169W, G181W, G248W, G277W, G291W, G327W, G380W, G423W, G93W	Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome	VCV002577901	10	43606658	10	43111210	2577901	2742789		NC_000010.11:43111209:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1267G>A (p.Gly423Arg)	RET	G423R, G169R, G248R, G327R, G93R, G181R, G277R, G291R, G380R	not provided|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000548849	10	43606658	10	43111210	548849	539280	rs767601598	NC_000010.11:43111209:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1268G>A (p.Gly423Glu)	RET	G169E, G181E, G93E, G277E, G327E, G248E, G423E, G291E, G380E	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002568323	10	43606659	10	43111211	2568323	2734860		NC_000010.11:43111210:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1268G>T (p.Gly423Val)	RET	G181V, G327V, G380V, G93V, G169V, G423V, G248V, G277V, G291V	Hereditary cancer-predisposing syndrome	VCV001764655	10	43606659	10	43111211	1764655	1814476		NC_000010.11:43111210:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 2, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1269G>A (p.Gly423=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002454133	10	43606660	10	43111212	2454133	2424022		NC_000010.11:43111211:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1269G>C (p.Gly423=)	RET		Multiple endocrine neoplasia, type 2	VCV000761306	10	43606660	10	43111212	761306	767733	rs1588870990	NC_000010.11:43111211:G:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 23, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.1271A>G (p.Lys424Arg)	RET	K424R, K170R, K182R, K249R, K94R, K328R, K278R, K292R, K381R	not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000645134	10	43606662	10	43111214	645134	638887	rs1176090269	NC_000010.11:43111213:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 9, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1273G>T (p.Val425Phe)	RET	V171F, V425F, V250F, V279F, V329F, V293F, V382F, V95F, V183F	Multiple endocrine neoplasia, type 2	VCV000660858	10	43606664	10	43111216	660858	638888	rs764558748	NC_000010.11:43111215:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 17, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.1273G>A (p.Val425Ile)	RET	V425I, V171I, V279I, V382I, V183I, V250I, V293I, V329I, V95I	Multiple endocrine neoplasia, type 2	VCV000477311	10	43606664	10	43111216	477311	460719	rs764558748	NC_000010.11:43111215:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 20, 2017	criteria provided, single submitter							
NM_020975.6(RET):c.1275C>G (p.Val425=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001419358	10	43606666	10	43111218	1419358	1387037	rs200458714	NC_000010.11:43111217:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1280_1281del (p.Val427fs)	RET	V173fs, V427fs	Sensorineural hearing loss disorder|Hirschsprung disease, susceptibility to, 1	VCV000590798	10	43606667 - 43606668	10	43111219 - 43111220	590798	581736	rs1564494285	NC_000010.11:43111218:TGTGTG:TGTG	Microsatellite	frameshift variant	Pathogenic	Nov 6, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.1277G>C (p.Cys426Ser)	RET	C172S, C184S, C294S, C330S, C426S, C251S, C383S, C96S, C280S	Multiple endocrine neoplasia, type 2	VCV003716093	10	43606668	10	43111220	3716093	3852359		NC_000010.11:43111219:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 21, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1277G>T (p.Cys426Phe)	RET	C172F, C426F, C280F, C383F, C184F, C251F, C96F, C294F, C330F	Multiple endocrine neoplasia, type 2	VCV001358584	10	43606668	10	43111220	1358584	1360745	rs1387494484	NC_000010.11:43111219:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 24, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.1277G>A (p.Cys426Tyr)	RET	C426Y, C172Y, C294Y, C330Y, C251Y, C280Y, C184Y, C383Y, C96Y	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not provided|not specified|Hirschsprung disease, susceptibility to, 1	VCV000570796	10	43606668	10	43111220	570796	566279	rs1387494484	NC_000010.11:43111219:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1279G>C (p.Val427Leu)	RET	V384L, V97L, V185L, V252L, V331L, V427L, V173L, V281L, V295L	Hereditary cancer-predisposing syndrome	VCV003313717	10	43606670	10	43111222	3313717	3465447		NC_000010.11:43111221:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 24, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1279G>A (p.Val427Met)	RET	V252M, V173M, V185M, V281M, V331M, V427M, V295M, V97M, V384M	Hereditary cancer-predisposing syndrome	VCV001767389	10	43606670	10	43111222	1767389	1821729		NC_000010.11:43111221:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 9, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1279G>T (p.Val427Leu)	RET	V173L, V427L, V331L, V185L, V384L, V97L, V252L, V281L, V295L	Multiple endocrine neoplasia, type 2	VCV001377273	10	43606670	10	43111222	1377273	1405201	rs1356436038	NC_000010.11:43111221:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 29, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1280T>C (p.Val427Ala)	RET	V281A, V331A, V384A, V185A, V97A, V252A, V427A, V173A, V295A	Multiple endocrine neoplasia, type 2	VCV002864153	10	43606671	10	43111223	2864153	3026518		NC_000010.11:43111222:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 13, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1282G>A (p.Glu428Lys)	RET	E428K, E174K, E296K, E332K, E186K, E385K, E98K, E253K, E282K	Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	VCV000664592	10	43606673	10	43111225	664592	638889	rs1327111345	NC_000010.11:43111224:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1283A>G (p.Glu428Gly)	RET	E174G, E428G, E282G, E98G, E253G, E296G, E385G, E332G, E186G	Multiple endocrine neoplasia, type 2	VCV001464954	10	43606674	10	43111226	1464954	1514665	rs2132766146	NC_000010.11:43111225:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 25, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.1284A>G (p.Glu428=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000761932	10	43606675	10	43111227	761932	767734	rs757632555	NC_000010.11:43111226:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 25, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1285A>G (p.Asn429Asp)	RET	N254D, N333D, N187D, N297D, N175D, N386D, N99D, N283D, N429D	Multiple endocrine neoplasia, type 2	VCV002167546	10	43606676	10	43111228	2167546	1902788		NC_000010.11:43111227:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 21, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1285A>T (p.Asn429Tyr)	RET	N429Y, N175Y, N283Y, N187Y, N297Y, N386Y, N99Y, N254Y, N333Y	Multiple endocrine neoplasia, type 2	VCV000838326	10	43606676	10	43111228	838326	836833	rs779625196	NC_000010.11:43111227:A:T	single nucleotide variant	missense variant	Uncertain significance	Dec 30, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.1287C>T (p.Asn429=)	RET		Hereditary cancer-predisposing syndrome	VCV002587874	10	43606678	10	43111230	2587874	2760698		NC_000010.11:43111229:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 30, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1287C>A (p.Asn429Lys)	RET	N175K, N429K, N254K, N99K, N386K, N187K, N283K, N297K, N333K	Multiple endocrine neoplasia, type 2	VCV001038338	10	43606678	10	43111230	1038338	1029533	rs1324777252	NC_000010.11:43111229:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 15, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1288T>C (p.Cys430Arg)	RET	C100R, C255R, C284R, C298R, C430R, C176R, C188R, C334R, C387R	Hereditary cancer-predisposing syndrome	VCV003432257	10	43606679	10	43111231	3432257	3593453		NC_000010.11:43111230:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 9, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1289G>T (p.Cys430Phe)	RET	C100F, C176F, C334F, C387F, C284F, C298F, C188F, C255F, C430F	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV003021513	10	43606680	10	43111232	3021513	3172718		NC_000010.11:43111231:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1289G>A (p.Cys430Tyr)	RET	C176Y, C430Y, C334Y, C188Y, C255Y, C284Y, C100Y, C298Y, C387Y	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001062209	10	43606680	10	43111232	1062209	1046530	rs1837913861	NC_000010.11:43111231:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1291C>G (p.Gln431Glu)	RET	Q388E, Q177E, Q285E, Q101E, Q299E, Q335E, Q431E, Q189E, Q256E	Hereditary cancer-predisposing syndrome	VCV002625017	10	43606682	10	43111234	2625017	2790512		NC_000010.11:43111233:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 1, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1292A>T (p.Gln431Leu)	RET	Q431L, Q177L, Q189L, Q285L, Q335L, Q101L, Q256L, Q388L, Q299L	Hereditary cancer-predisposing syndrome	VCV003313730	10	43606683	10	43111235	3313730	3465460		NC_000010.11:43111234:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 28, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1294G>T (p.Ala432Ser)	RET	A178S, A190S, A336S, A257S, A286S, A300S, A389S, A432S, A102S	Multiple endocrine neoplasia, type 2	VCV002702162	10	43606685	10	43111237	2702162	2855879		NC_000010.11:43111236:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 11, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1294_1296delinsACG (p.Ala432Thr)	RET	A178T, A432T, A190T, A286T, A300T, A389T, A257T, A102T, A336T	not provided|Hereditary cancer-predisposing syndrome	VCV000818826	10	43606685 - 43606687	10	43111237 - 43111239	818826	809919	rs1588871051	NC_000010.11:43111236:GCA:ACG	Indel	missense variant	Uncertain significance	Apr 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1294G>A (p.Ala432Thr)	RET	A178T, A432T, A102T, A286T, A190T, A336T, A389T, A300T, A257T	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000639960	10	43606685	10	43111237	639960	638890	rs780630024	NC_000010.11:43111236:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1295C>T (p.Ala432Val)	RET	A102V, A300V, A257V, A178V, A190V, A336V, A286V, A389V, A432V	not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2	VCV001769192	10	43606686	10	43111238	1769192	1835629		NC_000010.11:43111237:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1295_1296delinsGG (p.Ala432Gly)	RET	A178G, A432G, A102G, A257G, A336G, A190G, A286G, A389G, A300G	Multiple endocrine neoplasia, type 2	VCV001489156	10	43606686 - 43606687	10	43111238 - 43111239	1489156	1498648	rs386743165	NC_000010.11:43111237:CA:GG	Indel	missense variant	Uncertain significance	Mar 26, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1295_1296delinsAG (p.Ala432Glu)	RET	A178E, A432E, A102E, A286E, A336E, A257E, A300E, A389E, A190E	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000643435	10	43606686 - 43606687	10	43111238 - 43111239	643435	638891	rs386743165	NC_000010.11:43111237:CA:AG	Indel	missense variant	Conflicting classifications of pathogenicity	Jan 29, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1295_1296inv (p.Ala432Val)	RET	A432V, A178V, A190V, A257V, A300V, A286V, A336V, A102V, A389V	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2|RET-related disorder	VCV000477312	10	43606686 - 43606687	10	43111238 - 43111239	477312	460723		NC_000010.11:43111237:CA:TG	Inversion	missense variant	Conflicting classifications of pathogenicity	Jan 29, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1296= (p.Ala432=)	RET		not specified	VCV003076059	10	43606687	10	43111239	3076059	3235345		NC_000010.11:43111238:A:A	Variation	synonymous variant|no sequence alteration|intron variant	Benign	Mar 12, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.1296A>C (p.Ala432=)	RET		Hereditary cancer-predisposing syndrome	VCV001769206	10	43606687	10	43111239	1769206	1835643		NC_000010.11:43111238:A:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 12, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1296_1297delinsGC (p.Phe433Leu)	RET	F191L, F337L, F433L, F258L, F287L, F301L, F103L, F179L, F390L	Hereditary cancer-predisposing syndrome	VCV001769201	10	43606687 - 43606688	10	43111239 - 43111240	1769201	1835638		NC_000010.11:43111238:AT:GC	Indel	missense variant	Uncertain significance	May 4, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1296A>G (p.Ala432=)	RET		Multiple endocrine neoplasia, type 2|Renal hypodysplasia/aplasia 1|Pheochromocytoma|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|not specified|Multiple endocrine neoplasia|not provided|Hereditary cancer-predisposing syndrome	VCV000095995	10	43606687	10	43111239	95995	101890	rs1800860	NC_000010.11:43111238:A:G	single nucleotide variant	synonymous variant|intron variant	Benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1297T>C (p.Phe433Leu)	RET	F337L, F179L, F191L, F258L, F301L, F390L, F433L, F103L, F287L	Hereditary cancer-predisposing syndrome	VCV001769253	10	43606688	10	43111240	1769253	1835690		NC_000010.11:43111239:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 22, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1299C>T (p.Phe433=)	RET		Hereditary cancer-predisposing syndrome	VCV003227504	10	43606690	10	43111242	3227504	3390716		NC_000010.11:43111241:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 22, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1299C>G (p.Phe433Leu)	RET	F433L, F179L, F258L, F287L, F337L, F301L, F103L, F191L, F390L	Multiple endocrine neoplasia, type 2|not provided|Hereditary cancer-predisposing syndrome	VCV000543743	10	43606690	10	43111242	543743	525617	rs1554818526	NC_000010.11:43111241:C:G	single nucleotide variant	missense variant	Uncertain significance	May 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1300A>G (p.Ser434Gly)	RET	S434G, S180G, S259G, S288G, S192G, S338G, S104G, S302G, S391G	Multiple endocrine neoplasia type 2B|Familial medullary thyroid carcinoma|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|not provided|Hereditary cancer-predisposing syndrome	VCV000198583	10	43606691	10	43111243	198583	195744	rs794727875	NC_000010.11:43111242:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1301G>A (p.Ser434Asn)	RET	S259N, S288N, S302N, S338N, S391N, S434N, S104N, S180N, S192N	Multiple endocrine neoplasia, type 2	VCV002421320	10	43606692	10	43111244	2421320	1948816		NC_000010.11:43111243:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 18, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1303G>A (p.Gly435Ser)	RET	G105S, G181S, G193S, G260S, G289S, G303S, G339S, G392S, G435S	Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1	VCV002678319	10	43606694	10	43111246	2678319	2833342		NC_000010.11:43111245:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1305C>G (p.Gly435=)	RET		Multiple endocrine neoplasia, type 2	VCV003660949	10	43606696	10	43111248	3660949	3790608		NC_000010.11:43111247:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 7, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1305C>T (p.Gly435=)	RET		Multiple endocrine neoplasia, type 2	VCV000860955	10	43606696	10	43111248	860955	836834	rs749093977	NC_000010.11:43111247:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1306A>G (p.Ile436Val)	RET	I436V, I182V, I290V, I393V, I304V, I340V, I106V, I194V, I261V	Hereditary cancer-predisposing syndrome|not specified|Multiple endocrine neoplasia, type 2	VCV000477313	10	43606697	10	43111249	477313	459821	rs770736612	NC_000010.11:43111248:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 7, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1308C>T (p.Ile436=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001591921	10	43606699	10	43111251	1591921	1643384	rs1053415087	NC_000010.11:43111250:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 16, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1310A>C (p.Asn437Thr)	RET	N107T, N183T, N195T, N262T, N291T, N305T, N341T, N394T, N437T	Multiple endocrine neoplasia, type 2	VCV003071808	10	43606701	10	43111253	3071808	3234073		NC_000010.11:43111252:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 26, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1310A>G (p.Asn437Ser)	RET	N437S, N183S, N195S, N262S, N341S, N107S, N305S, N291S, N394S	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001038426	10	43606701	10	43111253	1038426	1029534	rs1260532632	NC_000010.11:43111252:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1311C>T (p.Asn437=)	RET		Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000700002	10	43606702	10	43111254	700002	687631	rs1190189942	NC_000010.11:43111253:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1312G>T (p.Val438Phe)	RET	V108F, V184F, V196F, V263F, V292F, V306F, V342F, V395F, V438F	Multiple endocrine neoplasia, type 2	VCV003628782	10	43606703	10	43111255	3628782	3756113		NC_000010.11:43111254:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 9, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1312G>A (p.Val438Ile)	RET	V438I, V184I, V292I, V108I, V196I, V306I, V263I, V342I, V395I	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|RET-related disorder|Multiple endocrine neoplasia type 2A	VCV000477314	10	43606703	10	43111255	477314	459825	rs774474422	NC_000010.11:43111254:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1314C>G (p.Val438=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001769740	10	43606705	10	43111257	1769740	1832226		NC_000010.11:43111256:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1314C>T (p.Val438=)	RET		Multiple endocrine neoplasia, type 2	VCV000752388	10	43606705	10	43111257	752388	767735	rs1588871110	NC_000010.11:43111256:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 4, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1315C>T (p.Gln439Ter)	RET	Q185*, Q439*, Q197*, Q293*, Q264*, Q343*, Q396*, Q307*, Q109*	Multiple endocrine neoplasia, type 2	VCV001452055	10	43606706	10	43111258	1452055	1438813	rs2132767341	NC_000010.11:43111257:C:T	single nucleotide variant	nonsense	Pathogenic	Jun 21, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1316A>G (p.Gln439Arg)	RET	Q185R, Q197R, Q293R, Q343R, Q396R, Q264R, Q307R, Q109R, Q439R	Hereditary cancer-predisposing syndrome	VCV003432292	10	43606707	10	43111259	3432292	3593488		NC_000010.11:43111258:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 10, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1317G>A (p.Gln439=)	RET		Multiple endocrine neoplasia, type 2	VCV001948844	10	43606708	10	43111260	1948844	1996520		NC_000010.11:43111259:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 25, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1317G>C (p.Gln439His)	RET	Q109H, Q185H, Q197H, Q264H, Q293H, Q307H, Q343H, Q396H, Q439H	Multiple endocrine neoplasia, type 2	VCV001720253	10	43606708	10	43111260	1720253	1779292		NC_000010.11:43111259:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 23, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1323G>A (p.Lys441=)	RET		Multiple endocrine neoplasia, type 2	VCV002808651	10	43606714	10	43111266	2808651	2968452		NC_000010.11:43111265:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 31, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1326G>A (p.Leu442=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001077584	10	43606717	10	43111269	1077584	1077039	rs746055866	NC_000010.11:43111268:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1326G>T (p.Leu442=)	RET		Renal hypodysplasia/aplasia 1|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia	VCV000878084	10	43606717	10	43111269	878084	865866	rs746055866	NC_000010.11:43111268:G:T	single nucleotide variant	synonymous variant|intron variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.1327C>T (p.His443Tyr)	RET	H443Y, H189Y, H201Y, H347Y, H113Y, H311Y, H400Y, H268Y, H297Y	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000653361	10	43606718	10	43111270	653361	638892	rs772292843	NC_000010.11:43111269:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 25, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1328A>T (p.His443Leu)	RET	H189L, H443L, H113L, H297L, H400L, H311L, H201L, H268L, H347L	Multiple endocrine neoplasia, type 2	VCV001359461	10	43606719	10	43111271	1359461	1370641	rs2132767831	NC_000010.11:43111270:A:T	single nucleotide variant	missense variant	Uncertain significance	Jun 6, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1329T>C (p.His443=)	RET		Multiple endocrine neoplasia, type 2	VCV001103375	10	43606720	10	43111272	1103375	1098691	rs2132767896	NC_000010.11:43111271:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 19, 2025	criteria provided, single submitter							
NM_020975.6(RET):c.1330T>C (p.Ser444Pro)	RET	S202P, S269P, S298P, S114P, S312P, S401P, S444P, S190P, S348P	Multiple endocrine neoplasia, type 2	VCV001953093	10	43606721	10	43111273	1953093	2014527		NC_000010.11:43111272:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1334C>G (p.Ser445Cys)	RET	S115C, S203C, S191C, S270C, S299C, S445C, S313C, S349C, S402C	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002454127	10	43606725	10	43111277	2454127	2424016		NC_000010.11:43111276:C:G	single nucleotide variant	intron variant|missense variant	Uncertain significance	Jun 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1335T>A (p.Ser445=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002708708	10	43606726	10	43111278	2708708	2870999		NC_000010.11:43111277:T:A	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Jan 10, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1335T>C (p.Ser445=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000486336	10	43606726	10	43111278	486336	475071	rs1554818529	NC_000010.11:43111277:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1336G>A (p.Gly446Ser)	RET	G300S, G403S, G204S, G271S, G116S, G192S, G314S, G350S, G446S	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002447529	10	43606727	10	43111279	2447529	2432423		NC_000010.11:43111278:G:A	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Oct 29, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1336G>C (p.Gly446Arg)	RET	G446R, G192R, G116R, G204R, G314R, G271R, G403R, G300R, G350R	Renal hypodysplasia/aplasia 1|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia|not specified|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia, type 2|not provided|Hereditary cancer-predisposing syndrome|Pheochromocytoma	VCV000135187	10	43606727	10	43111279	135187	138926	rs115423919	NC_000010.11:43111278:G:C	single nucleotide variant	missense variant	Benign/Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1338T>C (p.Gly446=)	RET		Multiple endocrine neoplasia, type 2	VCV001569199	10	43606729	10	43111281	1569199	1603747	rs2132768199	NC_000010.11:43111280:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 29, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1339G>C (p.Ala447Pro)	RET	A404P, A447P, A272P, A117P, A205P, A315P, A351P, A193P, A301P	Hereditary cancer-predisposing syndrome	VCV001770309	10	43606730	10	43111282	1770309	1829414		NC_000010.11:43111281:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 12, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1339G>A (p.Ala447Thr)	RET	A193T, A447T, A117T, A301T, A315T, A404T, A205T, A272T, A351T	Multiple endocrine neoplasia, type 2	VCV001523517	10	43606730	10	43111282	1523517	1346814	rs2132768249	NC_000010.11:43111281:G:A	single nucleotide variant	missense variant	Uncertain significance	May 8, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1341del (p.Asn448fs)	RET	N302fs, N273fs, N352fs, N194fs, N316fs, N448fs, N118fs, N206fs, N405fs	Multiple endocrine neoplasia, type 2	VCV003661947	10	43606731	10	43111283	3661947	3797812		NC_000010.11:43111282:CC:C	Deletion	frameshift variant|intron variant	Pathogenic	Aug 11, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1340C>T (p.Ala447Val)	RET	A205V, A272V, A447V, A193V, A315V, A117V, A301V, A404V, A351V	Hereditary cancer-predisposing syndrome	VCV001770354	10	43606731	10	43111283	1770354	1829459		NC_000010.11:43111282:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 26, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.1340C>A (p.Ala447Asp)	RET	A447D, A193D, A272D, A404D, A117D, A205D, A301D, A315D, A351D	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000818895	10	43606731	10	43111283	818895	809920	rs1588871155	NC_000010.11:43111282:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1341C>T (p.Ala447=)	RET		Hereditary cancer-predisposing syndrome	VCV000232392	10	43606732	10	43111284	232392	233781	rs876659737	NC_000010.11:43111283:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 16, 2015	criteria provided, single submitter							
NM_020975.6(RET):c.1343A>G (p.Asn448Ser)	RET	N194S, N448S, N352S, N405S, N206S, N302S, N316S, N118S, N273S	Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000648291	10	43606734	10	43111286	648291	638893	rs760832715	NC_000010.11:43111285:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 29, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1344C>A (p.Asn448Lys)	RET	N118K, N302K, N194K, N206K, N352K, N448K, N273K, N316K, N405K	Hereditary cancer-predisposing syndrome	VCV003432234	10	43606735	10	43111287	3432234	3593430		NC_000010.11:43111286:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 18, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1344C>G (p.Asn448Lys)	RET	N448K, N194K, N302K, N405K, N273K, N316K, N118K, N206K, N352K	Multiple endocrine neoplasia, type 2|not provided|Pilocytic astrocytoma|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia type 2B|Hereditary cancer-predisposing syndrome	VCV000136098	10	43606735	10	43111287	136098	139810	rs549907428	NC_000010.11:43111286:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 15, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1345T>C (p.Cys449Arg)	RET	C195R, C449R, C207R, C303R, C406R, C317R, C353R, C119R, C274R	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|not provided	VCV000836366	10	43606736	10	43111288	836366	836835	rs1158236145	NC_000010.11:43111287:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1347C>A (p.Cys449Ter)	RET	C195*, C274*, C119*, C303*, C317*, C449*, C207*, C353*, C406*	Multiple endocrine neoplasia, type 2	VCV002819743	10	43606738	10	43111290	2819743	2988098		NC_000010.11:43111289:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Dec 9, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1347C>T (p.Cys449=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001158529	10	43606738	10	43111290	1158529	1141124	rs2132768560	NC_000010.11:43111289:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 31, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1348A>C (p.Ser450Arg)	RET	S120R, S196R, S208R, S275R, S304R, S318R, S354R, S407R, S450R	Hereditary cancer-predisposing syndrome	VCV003227505	10	43606739	10	43111291	3227505	3390717		NC_000010.11:43111290:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 15, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1348A>G (p.Ser450Gly)	RET	S450G, S196G, S318G, S354G, S120G, S304G, S407G, S208G, S275G	Multiple endocrine neoplasia, type 2	VCV001040021	10	43606739	10	43111291	1040021	1029535	rs1837916996	NC_000010.11:43111290:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 25, 2015	criteria provided, single submitter							
NM_020975.6(RET):c.1349G>A (p.Ser450Asn)	RET	S196N, S318N, S275N, S354N, S407N, S450N, S120N, S208N, S304N	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001770550	10	43606740	10	43111292	1770550	1826252		NC_000010.11:43111291:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1349G>T (p.Ser450Ile)	RET	S196I, S450I, S318I, S275I, S304I, S120I, S208I, S354I, S407I	not provided	VCV001319674	10	43606740	10	43111292	1319674	1309925	rs2132768628	NC_000010.11:43111291:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 3, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1350C>G (p.Ser450Arg)	RET	S407R, S208R, S275R, S354R, S450R, S120R, S304R, S196R, S318R	Hereditary cancer-predisposing syndrome	VCV003313708	10	43606741	10	43111293	3313708	3465438		NC_000010.11:43111292:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 19, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1352C>T (p.Thr451Met)	RET	T451M, T197M, T121M, T319M, T209M, T276M, T305M, T408M, T355M	Hereditary cancer-predisposing syndrome|not specified|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1	VCV000187665	10	43606743	10	43111295	187665	182951	rs774092678	NC_000010.11:43111294:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1353G>C (p.Thr451=)	RET		Hereditary cancer-predisposing syndrome	VCV003432294	10	43606744	10	43111296	3432294	3593490		NC_000010.11:43111295:G:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 14, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1353G>A (p.Thr451=)	RET		not specified|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000514580	10	43606744	10	43111296	514580	502791	rs201568301	NC_000010.11:43111295:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1353G>T (p.Thr451=)	RET		Renal hypodysplasia/aplasia 1|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000413457	10	43606744	10	43111296	413457	397269	rs201568301	NC_000010.11:43111295:G:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Nov 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1354C>A (p.Leu452Ile)	RET	L452I, L198I, L122I, L277I, L306I, L356I, L409I, L210I, L320I	Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A|not provided|Hereditary cancer-predisposing syndrome	VCV000413461	10	43606745	10	43111297	413461	397813	rs151148041	NC_000010.11:43111296:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 24, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1356A>C (p.Leu452=)	RET		Hereditary cancer-predisposing syndrome	VCV003227506	10	43606747	10	43111299	3227506	3390718		NC_000010.11:43111298:A:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 12, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1356A>G (p.Leu452=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000818994	10	43606747	10	43111299	818994	809921	rs1588871179	NC_000010.11:43111298:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1358G>C (p.Gly453Ala)	RET	G199A, G453A, G321A, G357A, G211A, G278A, G123A, G307A, G410A	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001010476	10	43606749	10	43111301	1010476	993811	rs1837917640	NC_000010.11:43111300:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1359G>A (p.Gly453=)	RET		Hereditary cancer-predisposing syndrome	VCV003227507	10	43606750	10	43111302	3227507	3390719		NC_000010.11:43111301:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 31, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1359G>C (p.Gly453=)	RET		Multiple endocrine neoplasia, type 2	VCV000793040	10	43606750	10	43111302	793040	783588	rs1588871195	NC_000010.11:43111301:G:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 13, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1360G>A (p.Val454Met)	RET	V124M, V200M, V212M, V279M, V308M, V322M, V358M, V411M, V454M	Multiple endocrine neoplasia, type 2	VCV003070310	10	43606751	10	43111303	3070310	3231798		NC_000010.11:43111302:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 28, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1360G>C (p.Val454Leu)	RET	V212L, V279L, V454L, V308L, V411L, V124L, V200L, V322L, V358L	Multiple endocrine neoplasia, type 2	VCV002066274	10	43606751	10	43111303	2066274	2128959		NC_000010.11:43111302:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 5, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1361T>C (p.Val454Ala)	RET	V279A, V322A, V308A, V454A, V200A, V212A, V358A, V124A, V411A	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002859014	10	43606752	10	43111304	2859014	3025229		NC_000010.11:43111303:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1362G>T (p.Val454=)	RET		Multiple endocrine neoplasia, type 2	VCV001559231	10	43606753	10	43111305	1559231	1629682	rs35717926	NC_000010.11:43111304:G:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 16, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1363G>C (p.Val455Leu)	RET	V323L, V280L, V309L, V359L, V412L, V455L, V213L, V125L, V201L	Hereditary cancer-predisposing syndrome	VCV002587896	10	43606754	10	43111306	2587896	2760720		NC_000010.11:43111305:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 14, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1363G>T (p.Val455Phe)	RET	V323F, V412F, V125F, V201F, V213F, V359F, V455F, V280F, V309F	not specified|Multiple endocrine neoplasia, type 2	VCV002146706	10	43606754	10	43111306	2146706	1873811		NC_000010.11:43111305:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1363G>A (p.Val455Ile)	RET	V201I, V455I, V213I, V280I, V412I, V309I, V323I, V359I, V125I	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma	VCV000818987	10	43606754	10	43111306	818987	809922	rs145966037	NC_000010.11:43111305:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 19, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1364T>C (p.Val455Ala)	RET	V455A, V201A, V213A, V280A, V323A, V125A, V359A, V309A, V412A	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000543759	10	43606755	10	43111307	543759	525100	rs752267460	NC_000010.11:43111306:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 26, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1365C>T (p.Val455=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002454124	10	43606756	10	43111308	2454124	2424013		NC_000010.11:43111307:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1366A>G (p.Thr456Ala)	RET	T324A, T360A, T413A, T214A, T281A, T310A, T456A, T126A, T202A	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002037943	10	43606757	10	43111309	2037943	2090703		NC_000010.11:43111308:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1367C>T (p.Thr456Ile)	RET	T202I, T456I, T214I, T281I, T324I, T413I, T310I, T126I, T360I	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001419859	10	43606758	10	43111310	1419859	1410077	rs1286634866	NC_000010.11:43111309:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1367C>G (p.Thr456Ser)	RET	T456S, T202S, T126S, T214S, T413S, T281S, T310S, T324S, T360S	Multiple endocrine neoplasia, type 2	VCV001371570	10	43606758	10	43111310	1371570	1450008	rs1286634866	NC_000010.11:43111309:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 17, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1368C>T (p.Thr456=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002454125	10	43606759	10	43111311	2454125	2424014		NC_000010.11:43111310:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1370C>T (p.Ser457Leu)	RET	S203L, S457L, S127L, S282L, S361L, S215L, S325L, S311L, S414L	Multiple endocrine neoplasia, type 2	VCV000854722	10	43606761	10	43111313	854722	836836	rs1837918176	NC_000010.11:43111312:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 12, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1371A>G (p.Ser457=)	RET		Hereditary cancer-predisposing syndrome	VCV002454143	10	43606762	10	43111314	2454143	2424032		NC_000010.11:43111313:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 23, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1371A>T (p.Ser457=)	RET		Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000543787	10	43606762	10	43111314	543787	525105	rs376464605	NC_000010.11:43111313:A:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1372G>T (p.Ala458Ser)	RET	A458S, A204S, A362S, A216S, A283S, A312S, A326S, A415S, A128S	Hereditary cancer-predisposing syndrome	VCV000819036	10	43606763	10	43111315	819036	809923	rs1588871212	NC_000010.11:43111314:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 13, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.1374C>T (p.Ala458=)	RET		Hereditary cancer-predisposing syndrome|not provided|not specified|Multiple endocrine neoplasia, type 2	VCV000517909	10	43606765	10	43111317	517909	503625	rs190750926	NC_000010.11:43111316:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1375G>C (p.Glu459Gln)	RET	E129Q, E284Q, E327Q, E363Q, E416Q, E205Q, E217Q, E313Q, E459Q	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001771147	10	43606766	10	43111318	1771147	1836285		NC_000010.11:43111317:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1375G>A (p.Glu459Lys)	RET	E459K, E205K, E284K, E313K, E416K, E129K, E217K, E327K, E363K	Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome	VCV000405546	10	43606766	10	43111318	405546	397452	rs539995816	NC_000010.11:43111317:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1376A>T (p.Glu459Val)	RET	E205V, E363V, E459V, E129V, E217V, E284V, E313V, E327V, E416V	Hereditary cancer-predisposing syndrome	VCV001771161	10	43606767	10	43111319	1771161	1836299		NC_000010.11:43111318:A:T	single nucleotide variant	missense variant	Uncertain significance	Oct 14, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.1377G>T (p.Glu459Asp)	RET	E459D, E205D, E284D, E313D, E129D, E327D, E416D, E217D, E363D	Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A	VCV000584747	10	43606768	10	43111320	584747	575803	rs1564494424	NC_000010.11:43111319:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 3, 2020	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1378G>T (p.Asp460Tyr)	RET	D460Y, D206Y, D364Y, D417Y, D285Y, D130Y, D314Y, D328Y, D218Y	not provided|Hereditary cancer-predisposing syndrome	VCV000426763	10	43606769	10	43111321	426763	415222	rs1085307787	NC_000010.11:43111320:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 30, 2020	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1380C>G (p.Asp460Glu)	RET	D417E, D206E, D328E, D364E, D460E, D130E, D285E, D314E, D218E	Hereditary cancer-predisposing syndrome	VCV001771277	10	43606771	10	43111323	1771277	1836415		NC_000010.11:43111322:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 1, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1380C>T (p.Asp460=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001582113	10	43606771	10	43111323	1582113	1654074	rs2132769875	NC_000010.11:43111322:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1381A>T (p.Thr461Ser)	RET	T329S, T131S, T219S, T418S, T286S, T365S, T461S, T207S, T315S	Hereditary cancer-predisposing syndrome	VCV001771292	10	43606772	10	43111324	1771292	1836430		NC_000010.11:43111323:A:T	single nucleotide variant	missense variant	Uncertain significance	Mar 1, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1382C>T (p.Thr461Ile)	RET	T365I, T131I, T207I, T286I, T315I, T329I, T219I, T418I, T461I	Hereditary cancer-predisposing syndrome	VCV001771321	10	43606773	10	43111325	1771321	1832518		NC_000010.11:43111324:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 30, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1383C>T (p.Thr461=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001771337	10	43606774	10	43111326	1771337	1832533		NC_000010.11:43111325:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 28, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1385C>G (p.Ser462Trp)	RET	S132W, S220W, S330W, S419W, S287W, S208W, S316W, S366W, S462W	Hereditary cancer-predisposing syndrome	VCV001771376	10	43606776	10	43111328	1771376	1832572		NC_000010.11:43111327:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 11, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1385C>T (p.Ser462Leu)	RET	S462L, S208L, S132L, S366L, S287L, S316L, S419L, S220L, S330L	Ovarian cancer|Multiple endocrine neoplasia, type 2|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B|Hereditary cancer-predisposing syndrome	VCV000956150	10	43606776	10	43111328	956150	946883	rs1313331250	NC_000010.11:43111327:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 26, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1386G>A (p.Ser462=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not specified	VCV000136099	10	43606777	10	43111329	136099	139811	rs587780807	NC_000010.11:43111328:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1389G>A (p.Gly463=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002051690	10	43606780	10	43111332	2051690	2104398		NC_000010.11:43111331:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1390A>T (p.Ile464Phe)	RET	I368F, I210F, I332F, I134F, I222F, I289F, I318F, I421F, I464F	Multiple endocrine neoplasia, type 2	VCV003675561	10	43606781	10	43111333	3675561	3817059		NC_000010.11:43111332:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 29, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1390A>G (p.Ile464Val)	RET	I134V, I210V, I222V, I289V, I318V, I332V, I368V, I421V, I464V	not provided	VCV003390690	10	43606781	10	43111333	3390690	3549819		NC_000010.11:43111332:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 12, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1393C>T (p.Leu465=)	RET		Hereditary cancer-predisposing syndrome	VCV002454147	10	43606784	10	43111336	2454147	2424036		NC_000010.11:43111335:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Feb 14, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1398T>C (p.Phe466=)	RET		Multiple endocrine neoplasia, type 2	VCV003653564	10	43606789	10	43111341	3653564	3788997		NC_000010.11:43111340:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 16, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1398T>G (p.Phe466Leu)	RET	F212L, F224L, F370L, F136L, F320L, F423L, F466L, F334L, F291L	Hereditary cancer-predisposing syndrome	VCV001771686	10	43606789	10	43111341	1771686	1832882		NC_000010.11:43111340:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 3, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1399G>C (p.Val467Leu)	RET	V467L, V213L, V225L, V137L, V292L, V321L, V371L, V424L, V335L	Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Familial medullary thyroid carcinoma|not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1	VCV000432998	10	43606790	10	43111342	432998	425874	rs200334340	NC_000010.11:43111341:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1401G>A (p.Val467=)	RET		Hereditary cancer-predisposing syndrome	VCV001771817	10	43606792	10	43111344	1771817	1829629		NC_000010.11:43111343:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 4, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1402A>T (p.Asn468Tyr)	RET	N226Y, N293Y, N372Y, N468Y, N138Y, N336Y, N214Y, N322Y, N425Y	Hereditary cancer-predisposing syndrome	VCV001771833	10	43606793	10	43111345	1771833	1829645		NC_000010.11:43111344:A:T	single nucleotide variant	missense variant	Uncertain significance	Mar 29, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1402A>G (p.Asn468Asp)	RET	N468D, N214D, N372D, N425D, N226D, N293D, N322D, N138D, N336D	Multiple endocrine neoplasia, type 2	VCV000477315	10	43606793	10	43111345	477315	459829	rs1554818536	NC_000010.11:43111344:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 10, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.1403A>G (p.Asn468Ser)	RET	N214S, N468S, N322S, N138S, N293S, N336S, N226S, N372S, N425S	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000844785	10	43606794	10	43111346	844785	836837	rs1467587616	NC_000010.11:43111345:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1404T>C (p.Asn468=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000219479	10	43606795	10	43111347	219479	221960	rs864622112	NC_000010.11:43111346:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 3, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1405G>A (p.Asp469Asn)	RET	D215N, D469N, D139N, D337N, D373N, D227N, D294N, D323N, D426N	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001481075	10	43606796	10	43111348	1481075	1451513	rs772489699	NC_000010.11:43111347:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 25, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1405G>T (p.Asp469Tyr)	RET	D215Y, D469Y, D337Y, D373Y, D294Y, D426Y, D139Y, D227Y, D323Y	not provided|Multiple endocrine neoplasia, type 2	VCV001352598	10	43606796	10	43111348	1352598	1505807	rs772489699	NC_000010.11:43111347:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1405G>C (p.Asp469His)	RET	D469H, D215H, D139H, D227H, D323H, D373H, D294H, D337H, D426H	Hereditary cancer-predisposing syndrome|not provided	VCV000184923	10	43606796	10	43111348	184923	182952	rs772489699	NC_000010.11:43111347:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1406A>T (p.Asp469Val)	RET	D469V, D215V, D337V, D139V, D323V, D373V, D426V, D227V, D294V	Multiple endocrine neoplasia, type 2	VCV000844795	10	43606797	10	43111349	844795	836838	rs1588871253	NC_000010.11:43111348:A:T	single nucleotide variant	missense variant	Uncertain significance	Jan 29, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.1406A>G (p.Asp469Gly)	RET	D215G, D469G, D294G, D426G, D227G, D337G, D139G, D323G, D373G	Multiple endocrine neoplasia, type 2	VCV000650849	10	43606797	10	43111349	650849	638894	rs1588871253	NC_000010.11:43111348:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 3, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.1407C>G (p.Asp469Glu)	RET	D215E, D469E, D337E, D139E, D426E, D294E, D373E, D227E, D323E	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000858312	10	43606798	10	43111350	858312	836839	rs1357302036	NC_000010.11:43111349:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1407C>T (p.Asp469=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000819131	10	43606798	10	43111350	819131	809924	rs1357302036	NC_000010.11:43111349:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1408A>C (p.Thr470Pro)	RET	T374P, T216P, T228P, T338P, T470P, T140P, T295P, T324P, T427P	Hereditary cancer-predisposing syndrome	VCV003432267	10	43606799	10	43111351	3432267	3593463		NC_000010.11:43111350:A:C	single nucleotide variant	missense variant|intron variant	Likely benign	Oct 4, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1408A>G (p.Thr470Ala)	RET	T374A, T216A, T228A, T295A, T324A, T338A, T140A, T427A, T470A	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001771950	10	43606799	10	43111351	1771950	1829762		NC_000010.11:43111350:A:G	single nucleotide variant	missense variant	Uncertain significance	May 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1409C>T (p.Thr470Ile)	RET	T470I, T216I, T140I, T228I, T338I, T427I, T295I, T374I, T324I	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000849510	10	43606800	10	43111352	849510	836840	rs925104163	NC_000010.11:43111351:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1410C>G (p.Thr470=)	RET		Multiple endocrine neoplasia, type 2	VCV001665723	10	43606801	10	43111353	1665723	1590106	rs2132771143	NC_000010.11:43111352:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 24, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.1410C>T (p.Thr470=)	RET		Multiple endocrine neoplasia, type 2	VCV001629764	10	43606801	10	43111353	1629764	1596287	rs2132771143	NC_000010.11:43111352:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 29, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1412A>C (p.Lys471Thr)	RET	K217T, K471T, K325T, K375T, K428T, K229T, K296T, K141T, K339T	Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1	VCV001461344	10	43606803	10	43111355	1461344	1498175	rs2132771245	NC_000010.11:43111354:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1413G>A (p.Lys471=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000762497	10	43606804	10	43111356	762497	767736	rs1588871281	NC_000010.11:43111355:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1414G>A (p.Ala472Thr)	RET	A218T, A472T, A326T, A142T, A297T, A340T, A376T, A230T, A429T	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001402339	10	43606805	10	43111357	1402339	1454149	rs1253227059	NC_000010.11:43111356:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 15, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1416C>T (p.Ala472=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001634014	10	43606807	10	43111359	1634014	1661415	rs1564494451	NC_000010.11:43111358:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1416C>G (p.Ala472=)	RET		not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000560861	10	43606807	10	43111359	560861	551865	rs1564494451	NC_000010.11:43111358:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 20, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1417C>T (p.Leu473=)	RET		Multiple endocrine neoplasia, type 2	VCV001160842	10	43606808	10	43111360	1160842	1141125	rs1419101284	NC_000010.11:43111359:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 18, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.1420C>G (p.Arg474Gly)	RET	R474G, R220G, R144G, R342G, R328G, R299G, R378G, R431G, R232G	Multiple endocrine neoplasia, type 2	VCV001515812	10	43606811	10	43111363	1515812	1407091	rs775842917	NC_000010.11:43111362:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1420C>T (p.Arg474Trp)	RET	R474W, R220W, R342W, R144W, R299W, R232W, R328W, R378W, R431W	Hirschsprung Disease, Dominant|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia|not provided|Hirschsprung disease, susceptibility to, 1|RET-related disorder|Multiple endocrine neoplasia, type 2|Pheochromocytoma|Hereditary cancer-predisposing syndrome	VCV000299892	10	43606811	10	43111363	299892	322067	rs775842917	NC_000010.11:43111362:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 22, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1421G>A (p.Arg474Gln)	RET	R220Q, R474Q, R342Q, R431Q, R144Q, R328Q, R232Q, R299Q, R378Q	Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Multiple endocrine neoplasia type 2B|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000646237	10	43606812	10	43111364	646237	638895	rs747139265	NC_000010.11:43111363:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 17, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1422G>A (p.Arg474=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV003313751	10	43606813	10	43111365	3313751	3465481		NC_000010.11:43111364:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1422G>T (p.Arg474=)	RET		Multiple endocrine neoplasia, type 2	VCV001581894	10	43606813	10	43111365	1581894	1600453	rs2132771819	NC_000010.11:43111364:G:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 12, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1423C>A (p.Arg475=)	RET		Multiple endocrine neoplasia, type 2	VCV003695338	10	43606814	10	43111366	3695338	3821746		NC_000010.11:43111365:C:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 26, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1423C>T (p.Arg475Trp)	RET	R475W, R221W, R300W, R329W, R145W, R432W, R233W, R343W, R379W	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1	VCV000572175	10	43606814	10	43111366	572175	563727	rs746512075	NC_000010.11:43111365:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1425dup (p.Pro476fs)	RET	P476fs, P222fs	Inborn genetic diseases	VCV000521303	10	43606814 - 43606815	10	43111366 - 43111367	521303	511870	rs1554818540	NC_000010.11:43111366:GG:GGG	Duplication	frameshift variant	Pathogenic	Oct 24, 2016	criteria provided, single submitter							
NM_020975.6(RET):c.1424G>T (p.Arg475Leu)	RET	R145L, R221L, R300L, R475L, R233L, R343L, R432L, R329L, R379L	Hereditary cancer-predisposing syndrome	VCV003432280	10	43606815	10	43111367	3432280	3593476		NC_000010.11:43111366:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 13, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1424G>A (p.Arg475Gln)	RET	R475Q, R221Q, R145Q, R343Q, R432Q, R329Q, R233Q, R300Q, R379Q	Multiple endocrine neoplasia type 2A|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Aganglionic megacolon|not provided	VCV000135188	10	43606815	10	43111367	135188	138927	rs138624658	NC_000010.11:43111366:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1425G>A (p.Arg475=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001122462	10	43606816	10	43111368	1122462	1120263	rs2132772107	NC_000010.11:43111367:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1426C>T (p.Pro476Ser)	RET	P146S, P380S, P301S, P222S, P234S, P330S, P433S, P476S, P344S	Hereditary cancer-predisposing syndrome	VCV002587877	10	43606817	10	43111369	2587877	2760701		NC_000010.11:43111368:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 3, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1426C>A (p.Pro476Thr)	RET	P222T, P476T, P301T, P330T, P433T, P234T, P146T, P344T, P380T	Appendicitis	VCV000995822	10	43606817	10	43111369	995822	983517	rs1588871312	NC_000010.11:43111368:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 17, 2020	no assertion criteria provided							
NM_020975.6(RET):c.1427C>T (p.Pro476Leu)	RET	P222L, P476L, P234L, P380L, P433L, P146L, P330L, P344L, P301L	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000936267	10	43606818	10	43111370	936267	935026	rs762335805	NC_000010.11:43111369:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1427C>G (p.Pro476Arg)	RET	P476R, P222R, P380R, P301R, P344R, P146R, P234R, P330R, P433R	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000480798	10	43606818	10	43111370	480798	475290	rs762335805	NC_000010.11:43111369:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1429A>G (p.Lys477Glu)	RET	K147E, K477E, K223E, K331E, K381E, K235E, K302E, K345E, K434E	Hereditary cancer-predisposing syndrome	VCV002568367	10	43606820	10	43111372	2568367	2734903		NC_000010.11:43111371:A:G	single nucleotide variant	missense variant|intron variant	Likely benign	May 20, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1430A>C (p.Lys477Thr)	RET	K345T, K223T, K477T, K147T, K235T, K331T, K434T, K302T, K381T	Multiple endocrine neoplasia, type 2	VCV002819399	10	43606821	10	43111373	2819399	2987754		NC_000010.11:43111372:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 8, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1432T>C (p.Cys478Arg)	RET	C478R, C224R, C303R, C236R, C346R, C435R, C148R, C332R, C382R	Multiple endocrine neoplasia, type 2	VCV000936943	10	43606823	10	43111375	936943	935027	rs1837921298	NC_000010.11:43111374:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 26, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1433G>A (p.Cys478Tyr)	RET	C224Y, C478Y, C382Y, C236Y, C303Y, C346Y, C148Y, C332Y, C435Y	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001493908	10	43606824	10	43111376	1493908	1449410	rs1459885382	NC_000010.11:43111375:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1437C>G (p.Ala479=)	RET		Multiple endocrine neoplasia, type 2	VCV003075400	10	43606828	10	43111380	3075400	3232967		NC_000010.11:43111379:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1437C>A (p.Ala479=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000232678	10	43606828	10	43111380	232678	233782	rs576806356	NC_000010.11:43111379:C:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1437C>T (p.Ala479=)	RET		Multiple endocrine neoplasia, type 2|not provided|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome	VCV000136100	10	43606828	10	43111380	136100	139812	rs576806356	NC_000010.11:43111379:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1438G>T (p.Glu480Ter)	RET	E150*, E226*, E238*, E305*, E334*, E348*, E384*, E437*, E480*	Hirschsprung disease, susceptibility to, 1	VCV001709650	10	43606829	10	43111381	1709650	1708004		NC_000010.11:43111380:G:T	single nucleotide variant	nonsense	Likely pathogenic	Jul 13, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1438G>A (p.Glu480Lys)	RET	E480K, E226K, E238K, E305K, E348K, E334K, E150K, E384K, E437K	Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000135189	10	43606829	10	43111381	135189	138928	rs537874538	NC_000010.11:43111380:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 29, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1440A>G (p.Glu480=)	RET		Hereditary cancer-predisposing syndrome	VCV001772691	10	43606831	10	43111383	1772691	1836535		NC_000010.11:43111382:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 28, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1440A>T (p.Glu480Asp)	RET	E226D, E480D, E238D, E150D, E348D, E437D, E305D, E334D, E384D	Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2	VCV000845362	10	43606831	10	43111383	845362	836841	rs763296134	NC_000010.11:43111382:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 25, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1440A>C (p.Glu480Asp)	RET	E226D, E480D, E238D, E334D, E384D, E437D, E305D, E150D, E348D	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000819224	10	43606831	10	43111383	819224	809925	rs763296134	NC_000010.11:43111382:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 14, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1441C>G (p.Leu481Val)	RET	L481V, L227V, L151V, L335V, L438V, L239V, L349V, L385V, L306V	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2	VCV000477316	10	43606832	10	43111384	477316	460727	rs767210575	NC_000010.11:43111383:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 27, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1444C>T (p.His482Tyr)	RET	H228Y, H482Y, H240Y, H336Y, H350Y, H307Y, H386Y, H439Y, H152Y	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001384063	10	43606835	10	43111387	1384063	1447659	rs2132773139	NC_000010.11:43111386:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1445A>G (p.His482Arg)	RET	H482R, H228R, H240R, H336R, H386R, H152R, H307R, H350R, H439R	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000232529	10	43606836	10	43111388	232529	233783	rs876659821	NC_000010.11:43111387:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 3, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1447T>C (p.Tyr483His)	RET	Y440H, Y153H, Y229H, Y241H, Y351H, Y387H, Y308H, Y337H, Y483H	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002734134	10	43606838	10	43111390	2734134	2898466		NC_000010.11:43111389:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1448A>G (p.Tyr483Cys)	RET	Y483C, Y229C, Y308C, Y337C, Y387C, Y241C, Y153C, Y351C, Y440C	Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Congenital central hypoventilation|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A	VCV000405534	10	43606839	10	43111391	405534	397271	rs752322996	NC_000010.11:43111390:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1450A>T (p.Met484Leu)	RET	M230L, M484L, M242L, M441L, M154L, M352L, M388L, M309L, M338L	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Familial medullary thyroid carcinoma|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A	VCV001063711	10	43606841	10	43111393	1063711	1046531	rs755660496	NC_000010.11:43111392:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1450A>C (p.Met484Leu)	RET	M230L, M484L, M154L, M352L, M441L, M242L, M309L, M338L, M388L	Multiple endocrine neoplasia, type 2	VCV000971648	10	43606841	10	43111393	971648	956046	rs755660496	NC_000010.11:43111392:A:C	single nucleotide variant	missense variant	Uncertain significance	Jul 29, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1450A>G (p.Met484Val)	RET	M484V, M230V, M154V, M242V, M309V, M338V, M388V, M441V, M352V	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A	VCV000579366	10	43606841	10	43111393	579366	563732	rs755660496	NC_000010.11:43111392:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 1, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1451T>C (p.Met484Thr)	RET	M154T, M230T, M242T, M484T, M309T, M388T, M441T, M338T, M352T	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001772967	10	43606842	10	43111394	1772967	1836810		NC_000010.11:43111393:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 22, 2023	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1452G>C (p.Met484Ile)	RET	M338I, M484I, M388I, M230I, M309I, M352I, M154I, M242I, M441I	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001941410	10	43606843	10	43111395	1941410	1997695		NC_000010.11:43111394:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1453G>T (p.Val485Leu)	RET	V155L, V310L, V339L, V231L, V389L, V442L, V485L, V353L, V243L	Multiple endocrine neoplasia, type 2	VCV002141072	10	43606844	10	43111396	2141072	1875570		NC_000010.11:43111395:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 10, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1453G>A (p.Val485Met)	RET	V485M, V231M, V310M, V389M, V155M, V243M, V339M, V353M, V442M	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000960728	10	43606844	10	43111396	960728	946884	rs1837922208	NC_000010.11:43111395:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1456G>C (p.Val486Leu)	RET	V232L, V311L, V354L, V156L, V340L, V390L, V443L, V486L, V244L	Hereditary cancer-predisposing syndrome	VCV002568383	10	43606847	10	43111399	2568383	2734919		NC_000010.11:43111398:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 10, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1456G>A (p.Val486Met)	RET	V232M, V486M, V354M, V156M, V244M, V311M, V340M, V390M, V443M	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000950634	10	43606847	10	43111399	950634	925802	rs1588871361	NC_000010.11:43111398:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1456G>T (p.Val486Leu)	RET	V232L, V486L, V354L, V156L, V244L, V390L, V443L, V311L, V340L	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	VCV000656087	10	43606847	10	43111399	656087	638896	rs1588871361	NC_000010.11:43111398:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1458G>A (p.Val486=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001130714	10	43606849	10	43111401	1130714	1120264	rs2132774203	NC_000010.11:43111400:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1460C>T (p.Ala487Val)	RET	A233V, A487V, A341V, A355V, A245V, A391V, A157V, A312V, A444V	Multiple endocrine neoplasia, type 2	VCV001060374	10	43606851	10	43111403	1060374	1046532	rs1837922418	NC_000010.11:43111402:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 29, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.1460C>G (p.Ala487Gly)	RET	A487G, A233G, A157G, A245G, A312G, A341G, A355G, A391G, A444G	Multiple endocrine neoplasia, type 2	VCV000941266	10	43606851	10	43111403	941266	935028	rs1837922418	NC_000010.11:43111402:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 17, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1461C>T (p.Ala487=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002568345	10	43606852	10	43111404	2568345	2734881		NC_000010.11:43111403:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1462A>G (p.Thr488Ala)	RET	T234A, T488A, T246A, T313A, T342A, T356A, T445A, T158A, T392A	Multiple endocrine neoplasia, type 2	VCV001480095	10	43606853	10	43111405	1480095	1364765	rs753733901	NC_000010.11:43111404:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 28, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1462A>T (p.Thr488Ser)	RET	T488S, T234S, T246S, T313S, T342S, T392S, T445S, T158S, T356S	not provided|Multiple endocrine neoplasia|Pheochromocytoma|Renal hypodysplasia/aplasia 1|Hereditary cancer-predisposing syndrome|not specified|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2	VCV000241336	10	43606853	10	43111405	241336	240790	rs753733901	NC_000010.11:43111404:A:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 2, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1463C>G (p.Thr488Ser)	RET	T342S, T246S, T445S, T158S, T356S, T392S, T488S, T234S, T313S	Multiple endocrine neoplasia, type 2	VCV003644713	10	43606854	10	43111406	3644713	3786549		NC_000010.11:43111405:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 6, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1463C>A (p.Thr488Asn)	RET	T392N, T488N, T234N, T313N, T342N, T445N, T158N, T246N, T356N	Multiple endocrine neoplasia, type 2	VCV002133008	10	43606854	10	43111406	2133008	2191847		NC_000010.11:43111405:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 14, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1463C>T (p.Thr488Ile)	RET	T234I, T488I, T445I, T392I, T158I, T342I, T246I, T313I, T356I	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001484300	10	43606854	10	43111406	1484300	1455230	rs1218693745	NC_000010.11:43111405:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Apr 30, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1464C>A (p.Thr488=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001389205	10	43606855	10	43111407	1389205	1476785	rs921948385	NC_000010.11:43111406:C:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1464C>T (p.Thr488=)	RET		not specified|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000413458	10	43606855	10	43111407	413458	397814	rs921948385	NC_000010.11:43111406:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1465G>A (p.Asp489Asn)	RET	D489N, D235N, D159N, D343N, D357N, D393N, D247N, D314N, D446N	Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia, type 2|not provided|not specified|Hereditary cancer-predisposing syndrome	VCV000135190	10	43606856	10	43111408	135190	138929	rs9282834	NC_000010.11:43111407:G:A	single nucleotide variant	missense variant	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1466A>T (p.Asp489Val)	RET	D489V, D235V, D247V, D343V, D159V, D357V, D446V, D314V, D393V	Multiple endocrine neoplasia type 2A	VCV000584748	10	43606857	10	43111409	584748	575804	rs923351888	NC_000010.11:43111408:A:T	single nucleotide variant	missense variant	Uncertain significance	Jul 2, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.1467C>T (p.Asp489=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002496748	10	43606858	10	43111410	2496748	2467887		NC_000010.11:43111409:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1467C>G (p.Asp489Glu)	RET	D235E, D489E, D343E, D393E, D159E, D314E, D357E, D247E, D446E	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001001110	10	43606858	10	43111410	1001110	993812	rs372648203	NC_000010.11:43111409:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 26, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1467C>A (p.Asp489Glu)	RET	D489E, D235E, D343E, D247E, D314E, D357E, D446E, D159E, D393E	Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Familial medullary thyroid carcinoma	VCV000136101	10	43606858	10	43111410	136101	139813	rs372648203	NC_000010.11:43111409:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1468C>G (p.Gln490Glu)	RET	Q236E, Q490E, Q160E, Q344E, Q358E, Q315E, Q394E, Q248E, Q447E	Multiple endocrine neoplasia, type 2|not specified	VCV001686285	10	43606859	10	43111411	1686285	1678293	rs1588871393	NC_000010.11:43111410:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 4, 2022	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1468C>A (p.Gln490Lys)	RET	Q490K, Q236K, Q344K, Q248K, Q358K, Q394K, Q160K, Q315K, Q447K	Multiple endocrine neoplasia, type 2	VCV000653895	10	43606859	10	43111411	653895	638897	rs1588871393	NC_000010.11:43111410:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 18, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1469A>G (p.Gln490Arg)	RET	Q236R, Q490R, Q344R, Q394R, Q447R, Q315R, Q160R, Q248R, Q358R	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000644326	10	43606860	10	43111412	644326	638898	rs750291418	NC_000010.11:43111411:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 12, 2022	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1470G>T (p.Gln490His)	RET	Q160H, Q394H, Q490H, Q447H, Q236H, Q315H, Q344H, Q248H, Q358H	Hereditary cancer-predisposing syndrome	VCV001773356	10	43606861	10	43111413	1773356	1833250		NC_000010.11:43111412:G:T	single nucleotide variant	missense variant	Likely benign	Feb 12, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1470G>A (p.Gln490=)	RET		not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000560862	10	43606861	10	43111413	560862	551866	rs1564494516	NC_000010.11:43111412:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1471C>G (p.Gln491Glu)	RET	Q395E, Q237E, Q161E, Q249E, Q345E, Q448E, Q491E, Q316E, Q359E	Hereditary cancer-predisposing syndrome	VCV003432218	10	43606862	10	43111414	3432218	3593414		NC_000010.11:43111413:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 2, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1471C>T (p.Gln491Ter)	RET	Q491*, Q237*, Q316*, Q395*, Q161*, Q249*, Q345*, Q359*, Q448*	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000819313	10	43606862	10	43111414	819313	809926	rs1397494237	NC_000010.11:43111413:C:T	single nucleotide variant	nonsense	Pathogenic	Jun 7, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1472A>G (p.Gln491Arg)	RET	Q161R, Q237R, Q249R, Q316R, Q345R, Q359R, Q395R, Q448R, Q491R	Multiple endocrine neoplasia, type 2	VCV003069961	10	43606863	10	43111415	3069961	3233536		NC_000010.11:43111414:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1476C>T (p.Thr492=)	RET		Hereditary cancer-predisposing syndrome	VCV001773466	10	43606867	10	43111419	1773466	1833360		NC_000010.11:43111418:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 19, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.1476C>G (p.Thr492=)	RET		Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	VCV000215906	10	43606867	10	43111419	215906	212777	rs758249079	NC_000010.11:43111418:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1477T>G (p.Ser493Ala)	RET	S163A, S239A, S347A, S397A, S493A, S251A, S318A, S361A, S450A	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002454146	10	43606868	10	43111420	2454146	2424035		NC_000010.11:43111419:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1477T>C (p.Ser493Pro)	RET	S239P, S493P, S318P, S361P, S347P, S163P, S251P, S397P, S450P	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000954387	10	43606868	10	43111420	954387	946885	rs780467203	NC_000010.11:43111419:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1479T>C (p.Ser493=)	RET		Multiple endocrine neoplasia, type 2	VCV001081420	10	43606870	10	43111422	1081420	1077040	rs2132775475	NC_000010.11:43111421:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 1, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1480A>G (p.Arg494Gly)	RET	R164G, R451G, R494G, R252G, R348G, R362G, R398G, R240G, R319G	Hereditary cancer-predisposing syndrome	VCV003432298	10	43606871	10	43111423	3432298	3593494		NC_000010.11:43111422:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 24, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1480A>T (p.Arg494Trp)	RET	R494W, R240W, R252W, R362W, R164W, R319W, R348W, R451W, R398W	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000954388	10	43606871	10	43111423	954388	946886	rs1837924019	NC_000010.11:43111422:A:T	single nucleotide variant	missense variant	Uncertain significance	Oct 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1481G>A (p.Arg494Lys)	RET	R252K, R348K, R319K, R451K, R494K, R164K, R240K, R362K, R398K	Multiple endocrine neoplasia, type 2	VCV002118080	10	43606872	10	43111424	2118080	2179848		NC_000010.11:43111423:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 9, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1486GCCCAG[3] (p.Gln499_Leu500insAlaGln)	RET		Multiple endocrine neoplasia, type 2	VCV003720926	10	43606873 - 43606874	10	43111425 - 43111426	3720926	3856728		NC_000010.11:43111425:CAGGCCCAGGCCCAG:CAGGCCCAGGCCCAGGCCCAG	Microsatellite	intron variant	Uncertain significance	Feb 21, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1482G>T (p.Arg494Ser)	RET	R164S, R240S, R252S, R319S, R348S, R362S, R398S, R451S, R494S	not provided	VCV003375731	10	43606873	10	43111425	3375731	3534911		NC_000010.11:43111424:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 8, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1482G>A (p.Arg494=)	RET		Multiple endocrine neoplasia, type 2	VCV002802285	10	43606873	10	43111425	2802285	2962970		NC_000010.11:43111424:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 15, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1483C>G (p.Gln495Glu)	RET	Q241E, Q363E, Q399E, Q452E, Q495E, Q165E, Q253E, Q320E, Q349E	Multiple endocrine neoplasia, type 2	VCV003648775	10	43606874	10	43111426	3648775	3784632		NC_000010.11:43111425:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 4, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1483C>A (p.Gln495Lys)	RET	Q165K, Q363K, Q452K, Q241K, Q320K, Q399K, Q495K, Q253K, Q349K	Multiple endocrine neoplasia, type 2	VCV002807636	10	43606874	10	43111426	2807636	2974707		NC_000010.11:43111425:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 18, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1484A>G (p.Gln495Arg)	RET	Q495R, Q241R, Q320R, Q349R, Q363R, Q452R, Q165R, Q253R, Q399R	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000581344	10	43606875	10	43111427	581344	563733	rs1474283003	NC_000010.11:43111426:A:G	single nucleotide variant	missense variant	Uncertain significance	May 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1486G>T (p.Ala496Ser)	RET	A166S, A364S, A254S, A350S, A453S, A400S, A242S, A321S, A496S	Multiple endocrine neoplasia, type 2	VCV002012055	10	43606877	10	43111429	2012055	2067432		NC_000010.11:43111428:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 29, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1486G>A (p.Ala496Thr)	RET	A242T, A496T, A166T, A350T, A254T, A400T, A453T, A321T, A364T	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001362518	10	43606877	10	43111429	1362518	1373266	rs1172578380	NC_000010.11:43111428:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1487C>T (p.Ala496Val)	RET	A496V, A242V, A166V, A321V, A364V, A400V, A453V, A254V, A350V	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000584561	10	43606878	10	43111430	584561	575553	rs1356271817	NC_000010.11:43111429:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1488C>G (p.Ala496=)	RET		Hereditary cancer-predisposing syndrome	VCV001773712	10	43606879	10	43111431	1773712	1830218		NC_000010.11:43111430:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 17, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.1488C>T (p.Ala496=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001628282	10	43606879	10	43111431	1628282	1584850	rs747196645	NC_000010.11:43111430:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1491G>C (p.Gln497His)	RET	Q351H, Q243H, Q322H, Q365H, Q255H, Q401H, Q167H, Q454H, Q497H	Multiple endocrine neoplasia, type 2	VCV002135764	10	43606882	10	43111434	2135764	2187192		NC_000010.11:43111433:G:C	single nucleotide variant	missense variant	Uncertain significance	May 9, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1492G>A (p.Ala498Thr)	RET	A168T, A244T, A256T, A323T, A352T, A366T, A402T, A455T, A498T	Multiple endocrine neoplasia, type 2	VCV003619762	10	43606883	10	43111435	3619762	3753602		NC_000010.11:43111434:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 23, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1493C>G (p.Ala498Gly)	RET	A244G, A498G, A366G, A256G, A323G, A352G, A455G, A402G, A168G	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001502321	10	43606884	10	43111436	1502321	1504093	rs375677628	NC_000010.11:43111435:C:G	single nucleotide variant	missense variant	Uncertain significance	May 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1493C>T (p.Ala498Val)	RET	A498V, A244V, A168V, A256V, A323V, A402V, A366V, A352V, A455V	Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|not provided|Hereditary cancer-predisposing syndrome	VCV000486306	10	43606884	10	43111436	486306	475272	rs375677628	NC_000010.11:43111435:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1494C>T (p.Ala498=)	RET		not provided	VCV003342159	10	43606885	10	43111437	3342159	3501391		NC_000010.11:43111436:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 1, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1495C>T (p.Gln499Ter)	RET	Q257*, Q324*, Q367*, Q403*, Q499*, Q245*, Q456*, Q169*, Q353*	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001773874	10	43606886	10	43111438	1773874	1830380		NC_000010.11:43111437:C:T	single nucleotide variant	nonsense	Pathogenic	Aug 22, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1497G>T (p.Gln499His)	RET	Q169H, Q245H, Q257H, Q324H, Q353H, Q367H, Q403H, Q456H, Q499H	Hereditary cancer-predisposing syndrome	VCV003227508	10	43606888	10	43111440	3227508	3390720		NC_000010.11:43111439:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 11, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1498C>A (p.Leu500Met)	RET	L170M, L258M, L325M, L354M, L404M, L457M, L246M, L368M, L500M	not provided|Hereditary cancer-predisposing syndrome	VCV001773919	10	43606889	10	43111441	1773919	1827025		NC_000010.11:43111440:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1500G>T (p.Leu500=)	RET		Multiple endocrine neoplasia, type 2	VCV000765555	10	43606891	10	43111443	765555	767737	rs1588871441	NC_000010.11:43111442:G:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 8, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1501C>T (p.Leu501Phe)	RET	L501F, L247F, L326F, L259F, L355F, L171F, L369F, L405F, L458F	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000486354	10	43606892	10	43111444	486354	475292	rs199572076	NC_000010.11:43111443:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 6, 2021	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1503T>C (p.Leu501=)	RET		Hereditary cancer-predisposing syndrome	VCV001774054	10	43606894	10	43111446	1774054	1827160		NC_000010.11:43111445:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 23, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.1504G>T (p.Val502Leu)	RET	V327L, V406L, V172L, V260L, V370L, V459L, V502L, V248L, V356L	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002568339	10	43606895	10	43111447	2568339	2734876		NC_000010.11:43111446:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1504G>C (p.Val502Leu)	RET	V248L, V502L, V260L, V172L, V327L, V370L, V459L, V406L, V356L	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000819408	10	43606895	10	43111447	819408	809928	rs770395347	NC_000010.11:43111446:G:C	single nucleotide variant	missense variant	Uncertain significance	May 3, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1504G>A (p.Val502Ile)	RET	V502I, V248I, V172I, V260I, V356I, V327I, V370I, V406I, V459I	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000819407	10	43606895	10	43111447	819407	809927	rs770395347	NC_000010.11:43111446:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1507A>G (p.Thr503Ala)	RET	T173A, T249A, T357A, T503A, T261A, T407A, T460A, T328A, T371A	Multiple endocrine neoplasia, type 2|not provided	VCV002916327	10	43606898	10	43111450	2916327	3071835		NC_000010.11:43111449:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1509A>C (p.Thr503=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001774129	10	43606900	10	43111452	1774129	1827235		NC_000010.11:43111451:A:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 26, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1509A>T (p.Thr503=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001099391	10	43606900	10	43111452	1099391	1098692	rs1837925419	NC_000010.11:43111451:A:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Feb 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1510G>T (p.Val504Leu)	RET	V174L, V250L, V262L, V329L, V358L, V372L, V408L, V461L, V504L	Multiple endocrine neoplasia, type 2	VCV003069701	10	43606901	10	43111453	3069701	3233277		NC_000010.11:43111452:G:T	single nucleotide variant	intron variant|missense variant	Uncertain significance	Feb 24, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1510G>A (p.Val504Met)	RET	V358M, V250M, V262M, V504M, V329M, V408M, V174M, V372M, V461M	Hereditary cancer-predisposing syndrome	VCV002568324	10	43606901	10	43111453	2568324	2734861		NC_000010.11:43111452:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 17, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1511T>G (p.Val504Gly)	RET	V329G, V174G, V372G, V461G, V250G, V262G, V358G, V408G, V504G	Hereditary cancer-predisposing syndrome	VCV001774224	10	43606902	10	43111454	1774224	1827330		NC_000010.11:43111453:T:G	single nucleotide variant	missense variant	Uncertain significance	Jan 18, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1511T>C (p.Val504Ala)	RET	V250A, V504A, V174A, V358A, V372A, V461A, V262A, V408A, V329A	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000964909	10	43606902	10	43111454	964909	956047	rs1837925624	NC_000010.11:43111453:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1512G>A (p.Val504=)	RET		Multiple endocrine neoplasia, type 2	VCV002104477	10	43606903	10	43111455	2104477	2162240		NC_000010.11:43111454:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Feb 28, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1513G>A (p.Glu505Lys)	RET	E251K, E505K, E175K, E409K, E462K, E330K, E359K, E373K, E263K	Multiple endocrine neoplasia, type 2	VCV000852929	10	43606904	10	43111456	852929	836842	rs1837925799	NC_000010.11:43111455:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 22, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.1514A>T (p.Glu505Val)	RET	E251V, E505V, E373V, E409V, E263V, E462V, E330V, E175V, E359V	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000962595	10	43606905	10	43111457	962595	946887	rs1837925886	NC_000010.11:43111456:A:T	single nucleotide variant	missense variant	Uncertain significance	Jun 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1515G>A (p.Glu505=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001566323	10	43606906	10	43111458	1566323	1656261	rs924204743	NC_000010.11:43111457:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1516G>A (p.Gly506Arg)	RET	G252R, G506R, G176R, G374R, G264R, G331R, G463R, G360R, G410R	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001352080	10	43606907	10	43111459	1352080	1482616	rs763356763	NC_000010.11:43111458:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1517G>C (p.Gly506Ala)	RET	G176A, G252A, G264A, G331A, G360A, G374A, G410A, G463A, G506A	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV003073934	10	43606908	10	43111460	3073934	3232804		NC_000010.11:43111459:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1517G>A (p.Gly506Glu)	RET	G252E, G360E, G176E, G264E, G331E, G463E, G506E, G374E, G410E	Multiple endocrine neoplasia, type 2	VCV002812998	10	43606908	10	43111460	2812998	2972800		NC_000010.11:43111459:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 8, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1518G>A (p.Gly506=)	RET		Hereditary cancer-predisposing syndrome	VCV002454153	10	43606909	10	43111461	2454153	2424042		NC_000010.11:43111460:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Feb 23, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1518G>C (p.Gly506=)	RET		Multiple endocrine neoplasia, type 2	VCV002059534	10	43606909	10	43111461	2059534	2113524		NC_000010.11:43111460:G:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 25, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1518G>T (p.Gly506=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001774363	10	43606909	10	43111461	1774363	1836902		NC_000010.11:43111460:G:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1519T>A (p.Ser507Thr)	RET	S253T, S507T, S177T, S332T, S375T, S361T, S265T, S464T, S411T	Multiple endocrine neoplasia, type 2	VCV000945518	10	43606910	10	43111462	945518	925803	rs1588871498	NC_000010.11:43111461:T:A	single nucleotide variant	missense variant	Uncertain significance	Jun 14, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.1521A>C (p.Ser507=)	RET		Multiple endocrine neoplasia, type 2	VCV003073388	10	43606912	10	43111464	3073388	3234344		NC_000010.11:43111463:A:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 17, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1521A>G (p.Ser507=)	RET		Multiple endocrine neoplasia, type 2|not provided|Hereditary cancer-predisposing syndrome	VCV001450437	10	43606912	10	43111464	1450437	1436317	rs876660561	NC_000010.11:43111463:A:G	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Jan 1, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1521A>T (p.Ser507=)	RET		not provided|Hereditary cancer-predisposing syndrome	VCV000233668	10	43606912	10	43111464	233668	233784	rs876660561	NC_000010.11:43111463:A:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1522T>C (p.Tyr508His)	RET	Y254H, Y508H, Y266H, Y362H, Y376H, Y412H, Y465H, Y178H, Y333H	not provided|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000855948	10	43606913	10	43111465	855948	836843	rs775152474	NC_000010.11:43111464:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1522+1G>A	RET		Hirschsprung disease, susceptibility to, 1	VCV001805786	10	43606914	10	43111466	1805786	1862797		NC_000010.11:43111465:G:A	single nucleotide variant	splice donor variant|intron variant	Likely pathogenic	May 26, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.1522+2T>C	RET		Multiple endocrine neoplasia, type 2	VCV001065971	10	43606915	10	43111467	1065971	1055905	rs2132777891	NC_000010.11:43111466:T:C	single nucleotide variant	splice donor variant|intron variant	Likely pathogenic	Jun 30, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.1522+3G>A	RET		Hereditary cancer-predisposing syndrome	VCV001774447	10	43606916	10	43111468	1774447	1836986		NC_000010.11:43111467:G:A	single nucleotide variant	intron variant	Uncertain significance	Sep 22, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1522+5G>A	RET		Multiple endocrine neoplasia, type 2	VCV003641950	10	43606918	10	43111470	3641950	3772672		NC_000010.11:43111469:G:A	single nucleotide variant	intron variant	Uncertain significance	Feb 19, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1522+7G>T	RET		Multiple endocrine neoplasia, type 2	VCV001118953	10	43606920	10	43111472	1118953	1098693	rs1257123535	NC_000010.11:43111471:G:T	single nucleotide variant	intron variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1522+7G>A	RET		Multiple endocrine neoplasia, type 2	VCV000798123	10	43606920	10	43111472	798123	787643	rs1257123535	NC_000010.11:43111471:G:A	single nucleotide variant	intron variant	Likely benign	Jan 20, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.1522+10T>C	RET		Multiple endocrine neoplasia, type 2	VCV000413452	10	43606923	10	43111475	413452	397815	rs1060504030	NC_000010.11:43111474:T:C	single nucleotide variant	intron variant	Likely benign	Jul 25, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1522+13T>A	RET		Multiple endocrine neoplasia, type 2	VCV003724953	10	43606926	10	43111478	3724953	3850856		NC_000010.11:43111477:T:A	single nucleotide variant	intron variant	Likely benign	Nov 10, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1522+13T>C	RET		Multiple endocrine neoplasia, type 2	VCV001643419	10	43606926	10	43111478	1643419	1587376	rs1156386471	NC_000010.11:43111477:T:C	single nucleotide variant	intron variant	Likely benign	Jan 15, 2025	criteria provided, single submitter							
NM_020975.6(RET):c.1522+14C>A	RET		Multiple endocrine neoplasia, type 2	VCV002017166	10	43606927	10	43111479	2017166	2068676		NC_000010.11:43111478:C:A	single nucleotide variant	intron variant	Likely benign	Jul 14, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1522+14C>G	RET		Multiple endocrine neoplasia, type 2	VCV001625682	10	43606927	10	43111479	1625682	1607242	rs1837926900	NC_000010.11:43111478:C:G	single nucleotide variant	intron variant	Likely benign	Apr 6, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1522+16A>G	RET		Multiple endocrine neoplasia, type 2	VCV002835726	10	43606929	10	43111481	2835726	2995558		NC_000010.11:43111480:A:G	single nucleotide variant	intron variant	Likely benign	Feb 9, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1522+16A>T	RET		Multiple endocrine neoplasia, type 2	VCV002073927	10	43606929	10	43111481	2073927	2120575		NC_000010.11:43111480:A:T	single nucleotide variant	intron variant	Likely benign	Feb 11, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1522+17G>C	RET		Multiple endocrine neoplasia, type 2	VCV003683141	10	43606930	10	43111482	3683141	3811867		NC_000010.11:43111481:G:C	single nucleotide variant	intron variant	Likely benign	Nov 18, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1522+17G>T	RET		Multiple endocrine neoplasia, type 2	VCV001963299	10	43606930	10	43111482	1963299	2016971		NC_000010.11:43111481:G:T	single nucleotide variant	intron variant	Likely benign	Jul 29, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1522+17G>A	RET		Multiple endocrine neoplasia, type 2|not provided	VCV000560863	10	43606930	10	43111482	560863	551867	rs760269666	NC_000010.11:43111481:G:A	single nucleotide variant	intron variant	Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1522+18G>A	RET		Multiple endocrine neoplasia, type 2	VCV001620615	10	43606931	10	43111483	1620615	1549087	rs763517546	NC_000010.11:43111482:G:A	single nucleotide variant	intron variant	Likely benign	Jan 20, 2025	criteria provided, single submitter							
NM_020975.6(RET):c.1522+19G>A	RET		Multiple endocrine neoplasia, type 2	VCV003678180	10	43606932	10	43111484	3678180	3810778		NC_000010.11:43111483:G:A	single nucleotide variant	intron variant	Likely benign	Dec 31, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1522+20A>T	RET		not specified	VCV002576507	10	43606933	10	43111485	2576507	2741403		NC_000010.11:43111484:A:T	single nucleotide variant	intron variant	Likely benign	Aug 15, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1522+20A>G	RET		Multiple endocrine neoplasia, type 2|not specified	VCV001597383	10	43606933	10	43111485	1597383	1664918	rs1053383471	NC_000010.11:43111484:A:G	single nucleotide variant	intron variant	Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1522+30G>A	RET		RET-related disorder	VCV003045447	10	43606943	10	43111495	3045447	3211341		NC_000010.11:43111494:G:A	single nucleotide variant	intron variant	Likely benign	Dec 2, 2021	no assertion criteria provided							
NM_020975.6(RET):c.1522+35C>T	RET		not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia, type 2|not specified	VCV000241337	10	43606948	10	43111500	241337	240791	rs377130948	NC_000010.11:43111499:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Oct 15, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1522+42dup	RET		RET-related disorder	VCV003031437	10	43606950 - 43606951	10	43111502 - 43111503	3031437	3189989		NC_000010.11:43111502:GGGGG:GGGGGG	Duplication	intron variant	Likely benign	Mar 11, 2022	no assertion criteria provided							
NM_020975.6(RET):c.1522+41G>T	RET		RET-related disorder	VCV003033570	10	43606954	10	43111506	3033570	3202087		NC_000010.11:43111505:G:T	single nucleotide variant	intron variant	Likely benign	Jun 12, 2019	no assertion criteria provided							
NM_020975.6(RET):c.1522+308C>G	RET		not provided	VCV001261574	10	43607221	10	43111773	1261574	1251481	rs3026748	NC_000010.11:43111772:C:G	single nucleotide variant	intron variant	Benign	Feb 28, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.1523-236C>G	RET		Hereditary cancer-predisposing syndrome	VCV000224005	10	43607311	10	43111863	224005	225733	rs183398018	NC_000010.11:43111862:C:G	single nucleotide variant	intron variant	Likely benign	Dec 1, 2015	no assertion criteria provided							
NM_020975.6(RET):c.1523-20T>C	RET		Multiple endocrine neoplasia, type 2	VCV003721692	10	43607527	10	43112079	3721692	3850192		NC_000010.11:43112078:T:C	single nucleotide variant	intron variant	Likely benign	Sep 28, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1523-19G>A	RET		Multiple endocrine neoplasia, type 2	VCV002857992	10	43607528	10	43112080	2857992	3018038		NC_000010.11:43112079:G:A	single nucleotide variant	intron variant	Likely benign	Sep 1, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1523-14T>C	RET		Multiple endocrine neoplasia, type 2	VCV001975926	10	43607533	10	43112085	1975926	2023574		NC_000010.11:43112084:T:C	single nucleotide variant	intron variant	Likely benign	Aug 17, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1523-12T>C	RET		Multiple endocrine neoplasia, type 2	VCV001605751	10	43607535	10	43112087	1605751	1646803	rs1429462039	NC_000010.11:43112086:T:C	single nucleotide variant	intron variant	Likely benign	Jan 16, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1523-12T>G	RET		Multiple endocrine neoplasia, type 2|not specified	VCV000518009	10	43607535	10	43112087	518009	502794	rs1429462039	NC_000010.11:43112086:T:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jul 30, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1523-7C>T	RET		Multiple endocrine neoplasia|Pheochromocytoma|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Renal hypodysplasia/aplasia 1|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A	VCV000299893	10	43607540	10	43112092	299893	310276	rs567967877	NC_000010.11:43112091:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1523-6C>T	RET		Multiple endocrine neoplasia, type 2	VCV002171705	10	43607541	10	43112093	2171705	1900429		NC_000010.11:43112092:C:T	single nucleotide variant	intron variant	Likely benign	Mar 19, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1523-5T>C	RET		Hereditary cancer-predisposing syndrome|not specified|Multiple endocrine neoplasia, type 2	VCV000702836	10	43607542	10	43112094	702836	695478	rs1373899196	NC_000010.11:43112093:T:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Oct 29, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1523-4G>A	RET		Multiple endocrine neoplasia, type 2	VCV000543761	10	43607543	10	43112095	543761	525421	rs1554818618	NC_000010.11:43112094:G:A	single nucleotide variant	intron variant	Likely benign	Apr 6, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1523A>T (p.Tyr508Phe)	RET	Y178F, Y254F, Y362F, Y465F, Y508F, D166V, D209V, D25V, Y333F, N113I, Y412F, Y266F, Y376F	Multiple endocrine neoplasia, type 2	VCV002969737	10	43607547	10	43112099	2969737	3128828		NC_000010.11:43112098:A:T	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1524T>C (p.Tyr508=)	RET		Multiple endocrine neoplasia, type 2	VCV002730234	10	43607548	10	43112100	2730234	2886835		NC_000010.11:43112099:T:C	single nucleotide variant	synonymous variant	Likely benign	Dec 23, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1527G>T (p.Val509=)	RET		Multiple endocrine neoplasia, type 2	VCV002859068	10	43607551	10	43112103	2859068	3025283		NC_000010.11:43112102:G:T	single nucleotide variant	synonymous variant	Likely benign	Apr 25, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1528G>T (p.Ala510Ser)	RET	A115S, A168S, A180S, A268S, A378S, A27S, A414S, A211S, A364S, A256S, A335S, A467S, A510S	Hereditary cancer-predisposing syndrome	VCV001774564	10	43607552	10	43112104	1774564	1837103		NC_000010.11:43112103:G:T	single nucleotide variant	missense variant	Uncertain significance	May 3, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1528G>A (p.Ala510Thr)	RET	A510T, A256T, A168T, A335T, A364T, A378T, A414T, A180T, A211T, A268T, A467T, A115T, A27T	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001514936	10	43607552	10	43112104	1514936	1482125	rs989627119	NC_000010.11:43112103:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1529C>T (p.Ala510Val)	RET	A256V, A211V, A335V, A467V, A115V, A168V, A180V, A27V, A378V, A268V, A364V, A414V	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia type 2A	VCV000024882	10	43607553	10	43112105	24882	36223	rs201745826	NC_000010.11:43112104:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 31, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1530C>T (p.Ala510=)	RET		Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A	VCV000219959	10	43607554	10	43112106	219959	221961	rs553492964	NC_000010.11:43112105:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Dec 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1531G>A (p.Glu511Lys)	RET	E257K, E181K, E212K, E336K, E116K, E28K, E365K, E169K, E269K, E468K, E379K, E415K	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A|not provided|not specified	VCV000024883	10	43607555	10	43112107	24883	36224	rs201553718	NC_000010.11:43112106:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 3, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1532A>G (p.Glu511Gly)	RET	E116G, E169G, E181G, E212G, E257G, E269G, E28G, E336G, E365G, E379G, E415G, E468G, E511G	Hereditary cancer-predisposing syndrome	VCV003227509	10	43607556	10	43112108	3227509	3390721		NC_000010.11:43112107:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1533G>A (p.Glu511=)	RET		Hereditary cancer-predisposing syndrome	VCV002587881	10	43607557	10	43112109	2587881	2760705		NC_000010.11:43112108:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 15, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1533G>T (p.Glu511Asp)	RET	E257D, E511D, E365D, E379D, E269D, E415D, E116D, E212D, E28D, E468D, E169D, E181D, E336D	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000647026	10	43607557	10	43112109	647026	638899	rs1588872048	NC_000010.11:43112108:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1536G>A (p.Glu512=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001774722	10	43607560	10	43112112	1774722	1837258		NC_000010.11:43112111:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1537G>A (p.Ala513Thr)	RET	A259T, A513T, A214T, A470T, A271T, A381T, A171T, A183T, A30T, A367T, A417T, A118T, A338T	Multiple endocrine neoplasia, type 2	VCV001016740	10	43607561	10	43112113	1016740	1008989	rs1837949233	NC_000010.11:43112112:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 4, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.1538C>G (p.Ala513Gly)	RET	A513G, A259G, A118G, A171G, A183G, A30G, A417G, A470G, A214G, A271G, A338G, A381G, A367G	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not provided	VCV000543750	10	43607562	10	43112114	543750	525294	rs149238501	NC_000010.11:43112113:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1538C>T (p.Ala513Val)	RET	A513V, A259V, A171V, A30V, A417V, A183V, A271V, A338V, A381V, A118V, A214V, A367V, A470V	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A	VCV000241338	10	43607562	10	43112114	241338	240792	rs149238501	NC_000010.11:43112113:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1539G>A (p.Ala513=)	RET		Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B	VCV000477317	10	43607563	10	43112115	477317	460271	rs761430718	NC_000010.11:43112114:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1540G>A (p.Gly514Ser)	RET	G272S, G514S, G31S, G418S, G471S, G119S, G184S, G215S, G260S, G339S, G172S, G368S, G382S	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001774846	10	43607564	10	43112116	1774846	1833432		NC_000010.11:43112115:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 21, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1541G>A (p.Gly514Asp)	RET	G339D, G382D, G215D, G260D, G272D, G119D, G172D, G418D, G514D, G184D, G31D, G368D, G471D	Multiple endocrine neoplasia, type 2	VCV003653751	10	43607565	10	43112117	3653751	3785755		NC_000010.11:43112116:G:A	single nucleotide variant	missense variant	Uncertain significance	May 18, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1542C>T (p.Gly514=)	RET		Hereditary cancer-predisposing syndrome	VCV002568364	10	43607566	10	43112118	2568364	2734900		NC_000010.11:43112117:C:T	single nucleotide variant	synonymous variant	Likely benign	May 14, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1544G>T (p.Cys515Phe)	RET	C515F, C261F, C273F, C419F, C32F, C340F, C383F, C472F, C173F, C185F, C216F, C120F, C369F	Hereditary cancer-predisposing syndrome	VCV003432209	10	43607568	10	43112120	3432209	540535	rs1468917724	NC_000010.11:43112119:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 21, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1544G>C (p.Cys515Ser)	RET	C120S, C173S, C185S, C216S, C261S, C273S, C32S, C340S, C369S, C383S, C419S, C472S, C515S	Multiple endocrine neoplasia, type 2	VCV003387593	10	43607568	10	43112120	3387593	3546726		NC_000010.11:43112119:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 23, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1544G>A (p.Cys515Tyr)	RET	C120Y, C173Y, C185Y, C216Y, C261Y, C273Y, C32Y, C340Y, C369Y, C383Y, C419Y, C472Y, C515Y	Multiple endocrine neoplasia, type 2	VCV003387592	10	43607568	10	43112120	3387592	3546725		NC_000010.11:43112119:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 5, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1546C>G (p.Pro516Ala)	RET	P121A, P217A, P370A, P384A, P186A, P262A, P473A, P516A, P274A, P33A, P174A, P341A, P420A	Multiple endocrine neoplasia, type 2	VCV003727452	10	43607570	10	43112122	3727452	3861677		NC_000010.11:43112121:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 17, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1546C>T (p.Pro516Ser)	RET	P121S, P174S, P186S, P217S, P262S, P274S, P33S, P341S, P370S, P384S, P420S, P473S, P516S	Multiple endocrine neoplasia, type 2	VCV003070781	10	43607570	10	43112122	3070781	3230538		NC_000010.11:43112121:C:T	single nucleotide variant	missense variant	Uncertain significance	May 4, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1546C>A (p.Pro516Thr)	RET	P262T, P516T, P186T, P217T, P33T, P341T, P384T, P121T, P274T, P174T, P370T, P473T, P420T	Multiple endocrine neoplasia, type 2	VCV000651958	10	43607570	10	43112122	651958	638900	rs1588872077	NC_000010.11:43112121:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 15, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.1547C>T (p.Pro516Leu)	RET	P121L, P33L, P420L, P274L, P473L, P186L, P217L, P370L, P174L, P262L, P341L, P384L, P516L	Hereditary cancer-predisposing syndrome	VCV001774959	10	43607571	10	43112123	1774959	1833544		NC_000010.11:43112122:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 27, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.1547C>G (p.Pro516Arg)	RET	P516R, P262R, P274R, P370R, P420R, P174R, P473R, P186R, P217R, P33R, P121R, P341R, P384R	not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A	VCV000570220	10	43607571	10	43112123	570220	563735	rs1194200337	NC_000010.11:43112122:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1548C>A (p.Pro516=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000543766	10	43607572	10	43112124	543766	525428	rs1246004706	NC_000010.11:43112123:C:A	single nucleotide variant	synonymous variant	Likely benign	May 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1549C>T (p.Leu517=)	RET		Hereditary cancer-predisposing syndrome	VCV003313702	10	43607573	10	43112125	3313702	3465432		NC_000010.11:43112124:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 22, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1549C>A (p.Leu517Met)	RET	L122M, L218M, L474M, L187M, L342M, L517M, L263M, L275M, L175M, L34M, L371M, L385M, L421M	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001774993	10	43607573	10	43112125	1774993	1833578		NC_000010.11:43112124:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1549C>G (p.Leu517Val)	RET	L517V, L263V, L218V, L175V, L275V, L187V, L385V, L342V, L371V, L122V, L34V, L421V, L474V	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2	VCV000486307	10	43607573	10	43112125	486307	475303	rs764616982	NC_000010.11:43112124:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1550T>C (p.Leu517Pro)	RET	L122P, L218P, L263P, L371P, L187P, L34P, L421P, L517P, L175P, L474P, L275P, L342P, L385P	Hereditary cancer-predisposing syndrome	VCV002587883	10	43607574	10	43112126	2587883	2760707		NC_000010.11:43112125:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 27, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1550T>G (p.Leu517Arg)	RET	L175R, L187R, L371R, L385R, L275R, L34R, L122R, L218R, L342R, L421R, L474R, L263R, L517R	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Familial medullary thyroid carcinoma	VCV001775057	10	43607574	10	43112126	1775057	1833642		NC_000010.11:43112125:T:G	single nucleotide variant	missense variant	Uncertain significance	Feb 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1551G>C (p.Leu517=)	RET		Hereditary cancer-predisposing syndrome	VCV003432227	10	43607575	10	43112127	3432227	3593423		NC_000010.11:43112126:G:C	single nucleotide variant	synonymous variant	Likely benign	Jun 27, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1551G>A (p.Leu517=)	RET		Multiple endocrine neoplasia, type 2	VCV001127462	10	43607575	10	43112127	1127462	1120265	rs750411593	NC_000010.11:43112126:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 24, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.1552T>A (p.Ser518Thr)	RET	S176T, S219T, S343T, S123T, S264T, S276T, S188T, S372T, S518T, S35T, S386T, S422T, S475T	Hereditary cancer-predisposing syndrome	VCV003432297	10	43607576	10	43112128	3432297	3593493		NC_000010.11:43112127:T:A	single nucleotide variant	missense variant	Uncertain significance	Nov 23, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1553C>T (p.Ser518Phe)	RET	S264F, S518F, S219F, S35F, S372F, S176F, S188F, S386F, S422F, S123F, S276F, S475F, S343F	Multiple endocrine neoplasia, type 2	VCV001504488	10	43607577	10	43112129	1504488	1417239	rs2132797325	NC_000010.11:43112128:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 25, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1553C>A (p.Ser518Tyr)	RET	S264Y, S518Y, S188Y, S276Y, S475Y, S123Y, S35Y, S422Y, S176Y, S219Y, S372Y, S386Y, S343Y	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001439057	10	43607577	10	43112129	1439057	1349459	rs2132797325	NC_000010.11:43112128:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1554C>T (p.Ser518=)	RET		Multiple endocrine neoplasia, type 2	VCV003069332	10	43607578	10	43112130	3069332	3229958		NC_000010.11:43112129:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 30, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1554C>G (p.Ser518=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001775120	10	43607578	10	43112130	1775120	1833705		NC_000010.11:43112129:C:G	single nucleotide variant	synonymous variant	Likely benign	Nov 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1557T>C (p.Cys519=)	RET		Multiple endocrine neoplasia, type 2	VCV001572234	10	43607581	10	43112133	1572234	1538303	rs2132797536	NC_000010.11:43112132:T:C	single nucleotide variant	synonymous variant	Likely benign	Feb 7, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1558G>T (p.Ala520Ser)	RET	A125S, A266S, A424S, A520S, A178S, A278S, A345S, A374S, A190S, A37S, A221S, A388S, A477S	Hereditary cancer-predisposing syndrome	VCV003313724	10	43607582	10	43112134	3313724	3465454		NC_000010.11:43112133:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 22, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1562T>C (p.Val521Ala)	RET	V521A, V267A, V375A, V38A, V191A, V279A, V389A, V425A, V478A, V126A, V179A, V346A, V222A	Multiple endocrine neoplasia, type 2	VCV000936243	10	43607586	10	43112138	936243	935029	rs1837950711	NC_000010.11:43112137:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 16, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.1564A>T (p.Ser522Cys)	RET	S268C, S522C, S192C, S390C, S479C, S127C, S180C, S376C, S39C, S426C, S223C, S280C, S347C	Multiple endocrine neoplasia, type 2	VCV000960136	10	43607588	10	43112140	960136	946888	rs1837950789	NC_000010.11:43112139:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1565G>A (p.Ser522Asn)	RET	S127N, S280N, S39N, S426N, S479N, S223N, S390N, S522N, S268N, S347N, S180N, S192N, S376N	Multiple endocrine neoplasia, type 2	VCV002766677	10	43607589	10	43112141	2766677	2929139		NC_000010.11:43112140:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 18, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1566C>T (p.Ser522=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000477318	10	43607590	10	43112142	477318	460272	rs929663686	NC_000010.11:43112141:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Sep 12, 2023	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1567A>C (p.Lys523Gln)	RET	K523Q, K269Q, K181Q, K224Q, K377Q, K391Q, K427Q, K40Q, K128Q, K281Q, K480Q, K193Q, K348Q	not provided|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1	VCV000477319	10	43607591	10	43112143	477319	460278	rs766278774	NC_000010.11:43112142:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1568A>G (p.Lys523Arg)	RET	K523R, K269R, K128R, K40R, K427R, K193R, K377R, K224R, K480R, K181R, K281R, K348R, K391R	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000819536	10	43607592	10	43112144	819536	809929	rs1588872122	NC_000010.11:43112143:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1569G>T (p.Lys523Asn)	RET	K128N, K181N, K193N, K224N, K269N, K281N, K348N, K377N, K391N, K40N, K427N, K480N, K523N	Multiple endocrine neoplasia, type 2|RET-related disorder	VCV001718527	10	43607593	10	43112145	1718527	1778887		NC_000010.11:43112144:G:T	single nucleotide variant	missense variant	Uncertain significance	May 9, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1569G>A (p.Lys523=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000486322	10	43607593	10	43112145	486322	475273	rs751464792	NC_000010.11:43112144:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1571G>A (p.Arg524Lys)	RET	R194K, R270K, R349K, R225K, R282K, R378K, R481K, R524K, R182K, R428K, R129K, R392K, R41K	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002024487	10	43607595	10	43112147	2024487	2077264		NC_000010.11:43112146:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1573C>A (p.Arg525=)	RET		Hereditary cancer-predisposing syndrome	VCV001691912	10	43607597	10	43112149	1691912	1684354	rs545625150	NC_000010.11:43112148:C:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	May 25, 2022	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1573C>G (p.Arg525Gly)	RET	R525G, R271G, R183G, R195G, R226G, R283G, R393G, R130G, R350G, R429G, R379G, R42G, R482G	not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1	VCV000571739	10	43607597	10	43112149	571739	563738	rs545625150	NC_000010.11:43112148:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1573C>T (p.Arg525Trp)	RET	R525W, R271W, R393W, R429W, R482W, R130W, R183W, R226W, R283W, R350W, R42W, R195W, R379W	Multiple endocrine neoplasia type 2A|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|RET-related disorder|not provided	VCV000135191	10	43607597	10	43112149	135191	138930	rs545625150	NC_000010.11:43112148:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1574G>T (p.Arg525Leu)	RET	R271L, R283L, R350L, R379L, R393L, R429L, R42L, R482L, R525L, R130L, R183L, R195L, R226L	Multiple endocrine neoplasia, type 2	VCV003387594	10	43607598	10	43112150	3387594	3546727		NC_000010.11:43112149:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 6, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1574G>A (p.Arg525Gln)	RET	R525Q, R271Q, R183Q, R379Q, R393Q, R429Q, R283Q, R350Q, R42Q, R130Q, R195Q, R226Q, R482Q	Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000477321	10	43607598	10	43112150	477321	460023	rs752830820	NC_000010.11:43112149:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 10, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1575G>A (p.Arg525=)	RET		Hereditary cancer-predisposing syndrome	VCV003227511	10	43607599	10	43112151	3227511	3390723		NC_000010.11:43112150:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 22, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1575G>T (p.Arg525=)	RET		Hereditary cancer-predisposing syndrome	VCV001775582	10	43607599	10	43112151	1775582	1830779		NC_000010.11:43112150:G:T	single nucleotide variant	synonymous variant	Likely benign	Aug 28, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1577T>A (p.Leu526Gln)	RET	L272Q, L526Q, L227Q, L284Q, L43Q, L483Q, L184Q, L380Q, L430Q, L131Q, L196Q, L351Q, L394Q	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001483430	10	43607601	10	43112153	1483430	1380549	rs756248937	NC_000010.11:43112152:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1577T>C (p.Leu526Pro)	RET	L272P, L526P, L131P, L394P, L483P, L184P, L227P, L430P, L43P, L196P, L284P, L351P, L380P	Multiple endocrine neoplasia, type 2	VCV001372193	10	43607601	10	43112153	1372193	1365702	rs756248937	NC_000010.11:43112152:T:C	single nucleotide variant	missense variant	Uncertain significance	May 10, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1586_1594dup (p.Cys531_Gly532insGluGluCys)	RET		Familial medullary thyroid carcinoma	VCV000013941	10	43607601 - 43607602	10	43112153 - 43112154	13941	28980	rs377767434	NC_000010.11:43112153:GGAGTGTGAGGAGTGTG:GGAGTGTGAGGAGTGTGAGGAGTGTG	Duplication	inframe_indel|inframe_insertion	Pathogenic	May 1, 1999	no assertion criteria provided							
NM_020975.6(RET):c.1578G>A (p.Leu526=)	RET		Multiple endocrine neoplasia, type 2	VCV002778316	10	43607602	10	43112154	2778316	2946809		NC_000010.11:43112153:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 26, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1579G>A (p.Glu527Lys)	RET	E273K, E527K, E185K, E197K, E381K, E395K, E132K, E484K, E285K, E352K, E228K, E431K, E44K	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001021065	10	43607603	10	43112155	1021065	1008990	rs1837951863	NC_000010.11:43112154:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1580A>T (p.Glu527Val)	RET	E285V, E352V, E431V, E132V, E185V, E197V, E395V, E484V, E228V, E527V, E273V, E381V, E44V	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001775688	10	43607604	10	43112156	1775688	1827488		NC_000010.11:43112155:A:T	single nucleotide variant	missense variant	Uncertain significance	Jan 17, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1580A>C (p.Glu527Ala)	RET	E273A, E527A, E395A, E132A, E185A, E285A, E352A, E44A, E484A, E197A, E228A, E381A, E431A	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000645447	10	43607604	10	43112156	645447	638901	rs1588872141	NC_000010.11:43112155:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1581G>A (p.Glu527=)	RET		Multiple endocrine neoplasia, type 2	VCV003726533	10	43607605	10	43112157	3726533	3855023		NC_000010.11:43112156:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 23, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1581G>C (p.Glu527Asp)	RET	E527D, E273D, E132D, E228D, E381D, E395D, E352D, E431D, E185D, E197D, E285D, E44D, E484D	Multiple endocrine neoplasia, type 2	VCV001496599	10	43607605	10	43112157	1496599	1359631	rs2132799116	NC_000010.11:43112156:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 19, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1584T>C (p.Cys528=)	RET		Multiple endocrine neoplasia, type 2	VCV000799659	10	43607608	10	43112160	799659	783589	rs1588872149	NC_000010.11:43112159:T:C	single nucleotide variant	synonymous variant	Likely benign	Dec 31, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.1585G>A (p.Glu529Lys)	RET	E134K, E287K, E529K, E199K, E354K, E383K, E433K, E46K, E275K, E486K, E187K, E230K, E397K	Multiple endocrine neoplasia, type 2	VCV003719530	10	43607609	10	43112161	3719530	3853214		NC_000010.11:43112160:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 22, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1585GAG[1] (p.Glu530del)	RET	E231del, E288del, E47del, E487del, E276del, E530del, E188del, E355del, E384del, E398del, E135del, E200del, E434del	Hereditary cancer-predisposing syndrome	VCV003432278	10	43607609 - 43607611	10	43112161 - 43112163	3432278	3593474		NC_000010.11:43112160:GAGGAG:GAG	Microsatellite	inframe_indel	Uncertain significance	Oct 25, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1587G>A (p.Glu529=)	RET		Hereditary cancer-predisposing syndrome	VCV001775834	10	43607611	10	43112163	1775834	1827634		NC_000010.11:43112162:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 30, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.1588G>C (p.Glu530Gln)	RET	E276Q, E530Q, E188Q, E135Q, E231Q, E434Q, E288Q, E47Q, E200Q, E355Q, E384Q, E398Q, E487Q	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000856007	10	43607612	10	43112164	856007	836844	rs1372959588	NC_000010.11:43112163:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1590G>A (p.Glu530=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000793078	10	43607614	10	43112166	793078	783590	rs1226909381	NC_000010.11:43112165:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1591T>C (p.Cys531Arg)	RET	C277R, C232R, C289R, C189R, C201R, C356R, C399R, C48R, C136R, C385R, C435R, C488R	not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000024885	10	43607615	10	43112167	24885	36226	rs377767390	NC_000010.11:43112166:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 12, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1592G>T (p.Cys531Phe)	RET	C201F, C289F, C356F, C385F, C488F, C48F, C136F, C277F, C189F, C232F, C399F, C435F, C531F	Multiple endocrine neoplasia, type 2	VCV003664802	10	43607616	10	43112168	3664802	3801924		NC_000010.11:43112167:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 1, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1592G>A (p.Cys531Tyr)	RET	C277Y, C399Y, C531Y, C201Y, C356Y, C435Y, C488Y, C136Y, C232Y, C289Y, C385Y, C48Y, C189Y	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1	VCV001775944	10	43607616	10	43112168	1775944	1827744		NC_000010.11:43112167:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1594G>A (p.Gly532Ser)	RET	G278S, G532S, G190S, G436S, G202S, G357S, G386S, G489S, G290S, G49S, G137S, G233S, G400S	Multiple endocrine neoplasia, type 2	VCV001039688	10	43607618	10	43112170	1039688	1029536	rs1837952811	NC_000010.11:43112169:G:A	single nucleotide variant	missense variant	Uncertain significance	May 11, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.1596C>A (p.Gly532=)	RET		Multiple endocrine neoplasia, type 2	VCV000754136	10	43607620	10	43112172	754136	767738	rs144460361	NC_000010.11:43112171:C:A	single nucleotide variant	synonymous variant	Likely benign	Sep 7, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.1596C>T (p.Gly532=)	RET		not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B	VCV000413470	10	43607620	10	43112172	413470	397710	rs144460361	NC_000010.11:43112171:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1597G>A (p.Gly533Ser)	RET	G279S, G291S, G358S, G401S, G191S, G437S, G138S, G50S, G203S, G234S, G387S, G490S	Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1|not provided|Multiple endocrine neoplasia, type 2	VCV000024887	10	43607621	10	43112173	24887	36228	rs75873440	NC_000010.11:43112172:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 28, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1597G>T (p.Gly533Cys)	RET	G533C, G279C, G203C, G234C, G191C, G387C, G401C, G437C, G490C, G358C, G138C, G291C, G50C	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A	VCV000013950	10	43607621	10	43112173	13950	28989	rs75873440	NC_000010.11:43112172:G:T	single nucleotide variant	missense variant	Pathogenic	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1598G>C (p.Gly533Ala)	RET	G234A, G50A, G191A, G279A, G358A, G533A, G291A, G437A, G138A, G203A, G387A, G401A, G490A	Multiple endocrine neoplasia, type 2	VCV003644736	10	43607622	10	43112174	3644736	3786572		NC_000010.11:43112173:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 6, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1599C>T (p.Gly533=)	RET		Multiple endocrine neoplasia, type 2	VCV003387595	10	43607623	10	43112175	3387595	3546728		NC_000010.11:43112174:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 22, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1599C>A (p.Gly533=)	RET		Hereditary cancer-predisposing syndrome	VCV001776054	10	43607623	10	43112175	1776054	1827853		NC_000010.11:43112174:C:A	single nucleotide variant	synonymous variant	Likely benign	Jul 9, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1600C>T (p.Leu534=)	RET		Hereditary cancer-predisposing syndrome	VCV003227512	10	43607624	10	43112176	3227512	3390724		NC_000010.11:43112175:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 31, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1600C>G (p.Leu534Val)	RET	L192V, L280V, L402V, L438V, L534V, L139V, L204V, L292V, L388V, L51V, L235V, L359V, L491V	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001776170	10	43607624	10	43112176	1776170	1837400		NC_000010.11:43112175:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1601T>C (p.Leu534Pro)	RET	L534P, L280P, L359P, L402P, L491P, L192P, L235P, L438P, L51P, L139P, L204P, L292P, L388P	Pheochromocytoma|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia|Hereditary cancer-predisposing syndrome|Renal hypodysplasia/aplasia 1	VCV000877094	10	43607625	10	43112177	877094	865867	rs1206429429	NC_000010.11:43112176:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1606_1617del (p.Ser536_Gly539del)	RET		Multiple endocrine neoplasia, type 2	VCV002766814	10	43607627 - 43607638	10	43112179 - 43112190	2766814	2926259		NC_000010.11:43112178:GGCTCCCCAACAGGC:GGC	Deletion	inframe_indel|inframe_deletion	Uncertain significance	Oct 8, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1605C>T (p.Gly535=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001776263	10	43607629	10	43112181	1776263	1837493		NC_000010.11:43112180:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1609C>T (p.Pro537Ser)	RET	P537S, P283S, P405S, P441S, P494S, P142S, P195S, P207S, P362S, P238S, P54S, P295S, P391S	not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000560864	10	43607633	10	43112185	560864	551868	rs1438717389	NC_000010.11:43112184:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1610C>T (p.Pro537Leu)	RET	P142L, P195L, P537L, P207L, P283L, P362L, P391L, P405L, P494L, P54L, P238L, P295L, P441L	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001776381	10	43607634	10	43112186	1776381	1837611		NC_000010.11:43112185:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 9, 2022	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1611A>G (p.Pro537=)	RET		Hereditary cancer-predisposing syndrome	VCV001776392	10	43607635	10	43112187	1776392	1837622		NC_000010.11:43112186:A:G	single nucleotide variant	synonymous variant	Likely benign	Aug 13, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1612A>G (p.Thr538Ala)	RET	T239A, T296A, T538A, T55A, T143A, T392A, T196A, T284A, T495A, T208A, T363A, T406A, T442A	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A	VCV002562607	10	43607636	10	43112188	2562607	2717449		NC_000010.11:43112187:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1613C>G (p.Thr538Arg)	RET	T284R, T538R, T392R, T442R, T143R, T406R, T495R, T296R, T363R, T196R, T208R, T239R, T55R	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001434991	10	43607637	10	43112189	1434991	1507195	rs148406803	NC_000010.11:43112188:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1614A>G (p.Thr538=)	RET		Multiple endocrine neoplasia, type 2	VCV001100355	10	43607638	10	43112190	1100355	1098694	rs1564494925	NC_000010.11:43112189:A:G	single nucleotide variant	synonymous variant	Likely benign	Nov 14, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.1615G>A (p.Gly539Ser)	RET	G285S, G496S, G209S, G393S, G56S, G240S, G364S, G539S, G144S, G197S, G297S, G407S, G443S	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001776478	10	43607639	10	43112191	1776478	1837708		NC_000010.11:43112190:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1616G>A (p.Gly539Asp)	RET	G393D, G496D, G144D, G197D, G240D, G285D, G364D, G297D, G539D, G56D, G209D, G407D, G443D	Multiple endocrine neoplasia, type 2	VCV002756396	10	43607640	10	43112192	2756396	2914541		NC_000010.11:43112191:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 2, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1617C>A (p.Gly539=)	RET		Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001093517	10	43607641	10	43112193	1093517	1077041	rs1554818648	NC_000010.11:43112192:C:A	single nucleotide variant	synonymous variant	Likely benign	Dec 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1617C>G (p.Gly539=)	RET		Multiple endocrine neoplasia, type 2	VCV000543781	10	43607641	10	43112193	543781	525109	rs1554818648	NC_000010.11:43112192:C:G	single nucleotide variant	synonymous variant	Likely benign	Feb 18, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1618A>G (p.Arg540Gly)	RET	R540G, R286G, R210G, R198G, R298G, R241G, R408G, R497G, R57G, R145G, R365G, R394G, R444G	Multiple endocrine neoplasia|Pheochromocytoma|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Hirschsprung disease, susceptibility to, 1|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A|Ovarian cancer	VCV000299894	10	43607642	10	43112194	299894	315393	rs543376293	NC_000010.11:43112193:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 15, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1619G>A (p.Arg540Lys)	RET	R286K, R540K, R298K, R408K, R145K, R365K, R198K, R394K, R210K, R241K, R444K, R497K, R57K	Hereditary cancer-predisposing syndrome	VCV000819683	10	43607643	10	43112195	819683	809930	rs1588872239	NC_000010.11:43112194:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 16, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.1620G>A (p.Arg540=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001612428	10	43607644	10	43112196	1612428	1601511	rs776381183	NC_000010.11:43112195:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Apr 22, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1622G>A (p.Cys541Tyr)	RET	C498Y, C211Y, C242Y, C395Y, C409Y, C199Y, C287Y, C445Y, C58Y, C146Y, C299Y, C366Y, C541Y	Multiple endocrine neoplasia, type 2	VCV002133665	10	43607646	10	43112198	2133665	2188211		NC_000010.11:43112197:G:A	single nucleotide variant	missense variant	Likely pathogenic	May 20, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1624G>C (p.Glu542Gln)	RET	E200Q, E499Q, E542Q, E59Q, E243Q, E367Q, E446Q, E300Q, E396Q, E410Q, E147Q, E212Q, E288Q	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV003432258	10	43607648	10	43112200	3432258	3593454		NC_000010.11:43112199:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1624G>A (p.Glu542Lys)	RET	E288K, E542K, E200K, E212K, E410K, E59K, E147K, E300K, E243K, E446K, E499K, E367K, E396K	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001410514	10	43607648	10	43112200	1410514	1513821	rs1837954784	NC_000010.11:43112199:G:A	single nucleotide variant	missense variant	Uncertain significance	May 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1626G>A (p.Glu542=)	RET		Multiple endocrine neoplasia, type 2	VCV002191765	10	43607650	10	43112202	2191765	1928736		NC_000010.11:43112201:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1631G>A (p.Arg544Lys)	RET	R290K, R544K, R369K, R448K, R202K, R245K, R412K, R501K, R149K, R214K, R302K, R398K, R61K	Multiple endocrine neoplasia, type 2	VCV000839678	10	43607655	10	43112207	839678	836845	rs1837954895	NC_000010.11:43112206:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 15, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1632G>A (p.Arg544=)	RET		Multiple endocrine neoplasia, type 2	VCV002147936	10	43607656	10	43112208	2147936	1877248		NC_000010.11:43112207:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 31, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1633C>A (p.Gln545Lys)	RET	Q291K, Q545K, Q150K, Q246K, Q399K, Q413K, Q449K, Q502K, Q215K, Q370K, Q62K, Q203K, Q303K	Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|not provided	VCV001312671	10	43607657	10	43112209	1312671	1302932	rs890269439	NC_000010.11:43112208:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1637G>A (p.Gly546Glu)	RET	G151E, G204E, G216E, G247E, G292E, G304E, G371E, G400E, G414E, G450E, G503E, G546E, G63E	Hereditary cancer-predisposing syndrome	VCV003227513	10	43607661	10	43112213	3227513	3390725		NC_000010.11:43112212:G:A	single nucleotide variant	missense variant	Uncertain significance	May 12, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1638A>G (p.Gly546=)	RET		Hereditary cancer-predisposing syndrome	VCV003432223	10	43607662	10	43112214	3432223	3593419		NC_000010.11:43112213:A:G	single nucleotide variant	synonymous variant	Uncertain significance	Aug 6, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1638A>T (p.Gly546=)	RET		Multiple endocrine neoplasia, type 2	VCV001509190	10	43607662	10	43112214	1509190	1452307	rs1412128218	NC_000010.11:43112213:A:T	single nucleotide variant	synonymous variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1639G>T (p.Asp547Tyr)	RET	D248Y, D415Y, D152Y, D293Y, D305Y, D451Y, D401Y, D205Y, D217Y, D372Y, D504Y, D547Y, D64Y	Hereditary cancer-predisposing syndrome	VCV001776994	10	43607663	10	43112215	1776994	1830886		NC_000010.11:43112214:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 7, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1639G>A (p.Asp547Asn)	RET	D293N, D547N, D152N, D401N, D64N, D205N, D415N, D248N, D217N, D305N, D372N, D451N, D504N	Multiple endocrine neoplasia, type 2	VCV001002265	10	43607663	10	43112215	1002265	993813	rs1837955355	NC_000010.11:43112214:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 16, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1641T>C (p.Asp547=)	RET		Hereditary cancer-predisposing syndrome	VCV001777067	10	43607665	10	43112217	1777067	1830959		NC_000010.11:43112216:T:C	single nucleotide variant	synonymous variant	Likely benign	Nov 13, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1642G>A (p.Gly548Ser)	RET	G548S, G294S, G306S, G505S, G65S, G218S, G249S, G373S, G153S, G206S, G416S, G402S, G452S	Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|not provided|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia type 2B	VCV000136102	10	43607666	10	43112218	136102	139814	rs374461212	NC_000010.11:43112217:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 9, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1644C>G (p.Gly548=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001777104	10	43607668	10	43112220	1777104	1830996		NC_000010.11:43112219:C:G	single nucleotide variant	synonymous variant	Likely benign	Mar 9, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1646A>G (p.Lys549Arg)	RET	K295R, K549R, K154R, K207R, K307R, K453R, K66R, K250R, K374R, K506R, K219R, K403R, K417R	Multiple endocrine neoplasia, type 2	VCV000864073	10	43607670	10	43112222	864073	836846	rs1837955731	NC_000010.11:43112221:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 3, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.1647A>C (p.Lys549Asn)	RET	K295N, K417N, K453N, K549N, K374N, K207N, K307N, K403N, K66N, K154N, K219N, K250N, K506N	Multiple endocrine neoplasia, type 2	VCV002733455	10	43607671	10	43112223	2733455	2890914		NC_000010.11:43112222:A:C	single nucleotide variant	missense variant	Uncertain significance	Feb 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1648G>T (p.Gly550Trp)	RET	G208W, G220W, G251W, G375W, G550W, G155W, G296W, G404W, G454W, G67W, G308W, G418W, G507W	Multiple endocrine neoplasia, type 2	VCV002044491	10	43607672	10	43112224	2044491	2095916		NC_000010.11:43112223:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 16, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1648+4A>C	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000848850	10	43607676	10	43112228	848850	851375	rs1837955885	NC_000010.11:43112227:A:C	single nucleotide variant	intron variant	Uncertain significance	Jul 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1648+5G>A	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Pheochromocytoma	VCV000216715	10	43607677	10	43112229	216715	212778	rs863224776	NC_000010.11:43112228:G:A	single nucleotide variant	intron variant	Uncertain significance	Jun 9, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1648+6C>T	RET		Multiple endocrine neoplasia, type 2	VCV003606725	10	43607678	10	43112230	3606725	3740298		NC_000010.11:43112229:C:T	single nucleotide variant	intron variant	Uncertain significance	Oct 12, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1648+7C>T	RET		Multiple endocrine neoplasia, type 2	VCV001135635	10	43607679	10	43112231	1135635	1120266	rs1588872274	NC_000010.11:43112230:C:T	single nucleotide variant	intron variant	Likely benign	Mar 8, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.1648+7C>G	RET		Multiple endocrine neoplasia, type 2	VCV000766158	10	43607679	10	43112231	766158	775666	rs1588872274	NC_000010.11:43112230:C:G	single nucleotide variant	intron variant	Likely benign	Feb 14, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1648+10G>A	RET		not specified|Multiple endocrine neoplasia, type 2	VCV000723375	10	43607682	10	43112234	723375	744443	rs762545740	NC_000010.11:43112233:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jul 25, 2023	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1648+14A>G	RET		Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2	VCV001584253	10	43607686	10	43112238	1584253	1591890	rs1356301733	NC_000010.11:43112237:A:G	single nucleotide variant	intron variant	Likely benign	Dec 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1648+15C>T	RET		Multiple endocrine neoplasia, type 2	VCV001594475	10	43607687	10	43112239	1594475	1568479	rs1014808066	NC_000010.11:43112238:C:T	single nucleotide variant	intron variant	Likely benign	Jan 19, 2025	criteria provided, single submitter							
NM_020975.6(RET):c.1648+16G>A	RET		Multiple endocrine neoplasia, type 2	VCV001583911	10	43607688	10	43112240	1583911	1528357	rs1282483080	NC_000010.11:43112239:G:A	single nucleotide variant	intron variant	Likely benign	Jan 22, 2025	criteria provided, single submitter							
NM_020975.6(RET):c.1648+19C>A	RET		Multiple endocrine neoplasia, type 2	VCV002978669	10	43607691	10	43112243	2978669	3131275		NC_000010.11:43112242:C:A	single nucleotide variant	intron variant	Likely benign	Nov 24, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1648+20A>G	RET		Multiple endocrine neoplasia, type 2	VCV001573630	10	43607692	10	43112244	1573630	1637345	rs1354240192	NC_000010.11:43112243:A:G	single nucleotide variant	intron variant	Likely benign	Oct 12, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1648+24G>A	RET		Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A	VCV000372084	10	43607696	10	43112248	372084	358823	rs1057517640	NC_000010.11:43112247:G:A	single nucleotide variant	intron variant	Likely benign	May 23, 2016	criteria provided, single submitter							
NM_020975.6(RET):c.1648+188G>A	RET		not provided	VCV001247920	10	43607860	10	43112412	1247920	1237874	rs3026753	NC_000010.11:43112411:G:A	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, single submitter							
NM_020975.6(RET):c.1649-187C>T	RET		not provided	VCV000677077	10	43608114	10	43112666	677077	664267	rs7358114	NC_000010.11:43112665:C:T	single nucleotide variant	intron variant	Benign	Jun 12, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.1649-20C>T	RET		Multiple endocrine neoplasia, type 2	VCV002861978	10	43608281	10	43112833	2861978	3029340		NC_000010.11:43112832:C:T	single nucleotide variant	intron variant	Likely benign	May 5, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1649-20C>A	RET		Multiple endocrine neoplasia, type 2	VCV002758068	10	43608281	10	43112833	2758068	2914911		NC_000010.11:43112832:C:A	single nucleotide variant	intron variant	Likely benign	Sep 4, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1649-17C>T	RET		Multiple endocrine neoplasia, type 2	VCV001566291	10	43608284	10	43112836	1566291	1656229	rs2132812441	NC_000010.11:43112835:C:T	single nucleotide variant	intron variant	Likely benign	Jun 11, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1649-17C>G	RET		Multiple endocrine neoplasia, type 2	VCV001477738	10	43608284	10	43112836	1477738	1436617	rs2132812441	NC_000010.11:43112835:C:G	single nucleotide variant	intron variant	Likely benign	Apr 10, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1649-15G>C	RET		Multiple endocrine neoplasia, type 2	VCV003069886	10	43608286	10	43112838	3069886	3233462		NC_000010.11:43112837:G:C	single nucleotide variant	intron variant	Likely benign	Mar 9, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1649-14T>C	RET		Multiple endocrine neoplasia, type 2	VCV002851095	10	43608287	10	43112839	2851095	3009597		NC_000010.11:43112838:T:C	single nucleotide variant	intron variant	Likely benign	Mar 31, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1649-13G>A	RET		Multiple endocrine neoplasia, type 2	VCV001652947	10	43608288	10	43112840	1652947	1579447	rs1837970784	NC_000010.11:43112839:G:A	single nucleotide variant	intron variant	Likely benign	Jul 12, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1649-11G>C	RET		Multiple endocrine neoplasia, type 2	VCV001573531	10	43608290	10	43112842	1573531	1637246	rs746325077	NC_000010.11:43112841:G:C	single nucleotide variant	intron variant	Likely benign	Jan 27, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1649-11G>T	RET		not provided|Multiple endocrine neoplasia, type 2	VCV000669432	10	43608290	10	43112842	669432	664788	rs746325077	NC_000010.11:43112841:G:T	single nucleotide variant	intron variant	Likely benign	Jan 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1649-10T>C	RET		Multiple endocrine neoplasia, type 2	VCV003615801	10	43608291	10	43112843	3615801	3749632		NC_000010.11:43112842:T:C	single nucleotide variant	intron variant	Likely benign	Oct 15, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1649-7T>C	RET		Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Pheochromocytoma	VCV000700047	10	43608294	10	43112846	700047	689982	rs758817204	NC_000010.11:43112845:T:C	single nucleotide variant	intron variant	Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1649-5T>C	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000230288	10	43608296	10	43112848	230288	233785	rs876658485	NC_000010.11:43112847:T:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Nov 25, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1649-4G>T	RET		Multiple endocrine neoplasia, type 2	VCV002004558	10	43608297	10	43112849	2004558	2058624		NC_000010.11:43112848:G:T	single nucleotide variant	intron variant	Likely benign	Jun 10, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1649-4G>A	RET		Multiple endocrine neoplasia|not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Renal hypodysplasia/aplasia 1	VCV000548897	10	43608297	10	43112849	548897	539281	rs369769303	NC_000010.11:43112848:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 17, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1649G>A (p.Gly550Glu)	RET	G550E, G296E, G155E, G208E, G220E, G375E, G404E, G418E, G251E, G308E, G454E, G507E, G67E	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000477322	10	43608301	10	43112853	477322	460729	rs747844360	NC_000010.11:43112852:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 4, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1653C>A (p.Ile551=)	RET		Multiple endocrine neoplasia, type 2	VCV003713678	10	43608305	10	43112857	3713678	3838061		NC_000010.11:43112856:C:A	single nucleotide variant	synonymous variant	Likely benign	Jun 8, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1657_1671del (p.Arg553_Thr557del)	RET		RET-related disorder	VCV003346775	10	43608305 - 43608319	10	43112857 - 43112871	3346775	3503808		NC_000010.11:43112856:CACCAGGAACTTCTCCACC:CACC	Deletion	inframe_deletion|inframe_indel	Uncertain significance	Sep 26, 2024	no assertion criteria provided							
NM_020975.6(RET):c.1655C>T (p.Thr552Ile)	RET	T552I, T298I, T253I, T377I, T456I, T406I, T157I, T222I, T310I, T210I, T420I, T509I, T69I	Multiple endocrine neoplasia, type 2	VCV001371199	10	43608307	10	43112859	1371199	1427405	rs2132813020	NC_000010.11:43112858:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 31, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1656C>T (p.Thr552=)	RET		Hereditary cancer-predisposing syndrome	VCV001777361	10	43608308	10	43112860	1777361	1831253		NC_000010.11:43112859:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 18, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1656C>A (p.Thr552=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000763023	10	43608308	10	43112860	763023	767739	rs1348246688	NC_000010.11:43112859:C:A	single nucleotide variant	synonymous variant	Likely benign	Jan 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1658G>A (p.Arg553Lys)	RET	R553K, R299K, R421K, R510K, R211K, R254K, R70K, R158K, R223K, R311K, R378K, R407K, R457K	Multiple endocrine neoplasia, type 2	VCV000962053	10	43608310	10	43112862	962053	946889	rs1837971610	NC_000010.11:43112861:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 12, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1659G>A (p.Arg553=)	RET		Hereditary cancer-predisposing syndrome	VCV003432265	10	43608311	10	43112863	3432265	3593461		NC_000010.11:43112862:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 19, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1660A>G (p.Asn554Asp)	RET	N300D, N554D, N224D, N255D, N379D, N458D, N212D, N312D, N159D, N408D, N422D, N511D, N71D	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001395671	10	43608312	10	43112864	1395671	1425070	rs1837971699	NC_000010.11:43112863:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1661A>T (p.Asn554Ile)	RET	N300I, N554I, N379I, N422I, N159I, N255I, N408I, N458I, N212I, N312I, N224I, N511I, N71I	Multiple endocrine neoplasia, type 2	VCV000859565	10	43608313	10	43112865	859565	836847	rs200047805	NC_000010.11:43112864:A:T	single nucleotide variant	missense variant	Uncertain significance	Sep 6, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1661A>G (p.Asn554Ser)	RET	N554S, N300S, N255S, N408S, N458S, N511S, N212S, N224S, N312S, N159S, N379S, N422S, N71S	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000819742	10	43608313	10	43112865	819742	809931	rs200047805	NC_000010.11:43112864:A:G	single nucleotide variant	missense variant	Uncertain significance	May 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1662C>T (p.Asn554=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000764504	10	43608314	10	43112866	764504	767740	rs1253582681	NC_000010.11:43112865:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Nov 21, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1664T>A (p.Phe555Tyr)	RET	F160Y, F213Y, F225Y, F256Y, F301Y, F313Y, F380Y, F409Y, F423Y, F459Y, F512Y, F555Y, F72Y	Multiple endocrine neoplasia, type 2	VCV003387596	10	43608316	10	43112868	3387596	3546729		NC_000010.11:43112867:T:A	single nucleotide variant	missense variant	Uncertain significance	Apr 25, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1664T>G (p.Phe555Cys)	RET	F213C, F423C, F459C, F512C, F555C, F72C, F301C, F256C, F313C, F160C, F225C, F380C, F409C	Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma	VCV001777553	10	43608316	10	43112868	1777553	1828055		NC_000010.11:43112867:T:G	single nucleotide variant	missense variant	Likely pathogenic	Jan 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1665C>T (p.Phe555=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000543784	10	43608317	10	43112869	543784	525112	rs761815073	NC_000010.11:43112868:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1666T>G (p.Ser556Ala)	RET	S161A, S214A, S226A, S257A, S302A, S314A, S381A, S410A, S424A, S460A, S513A, S556A, S73A	Multiple endocrine neoplasia, type 2	VCV001720474	10	43608318	10	43112870	1720474	1776656		NC_000010.11:43112869:T:G	single nucleotide variant	missense variant	Uncertain significance	Sep 27, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1668C>T (p.Ser556=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000772972	10	43608320	10	43112872	772972	701342	rs141771814	NC_000010.11:43112871:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1668C>G (p.Ser556=)	RET		not specified|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia type 2A	VCV000261394	10	43608320	10	43112872	261394	253765	rs141771814	NC_000010.11:43112871:C:G	single nucleotide variant	synonymous variant	Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1670C>T (p.Thr557Ile)	RET	T162I, T461I, T557I, T258I, T382I, T303I, T411I, T514I, T74I, T215I, T227I, T315I, T425I	Hereditary cancer-predisposing syndrome	VCV001777678	10	43608322	10	43112874	1777678	1828180		NC_000010.11:43112873:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 2, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1671C>G (p.Thr557=)	RET		Multiple endocrine neoplasia, type 2	VCV003655683	10	43608323	10	43112875	3655683	3786399		NC_000010.11:43112874:C:G	single nucleotide variant	synonymous variant	Likely benign	Jun 5, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1671C>A (p.Thr557=)	RET		Multiple endocrine neoplasia, type 2	VCV002769301	10	43608323	10	43112875	2769301	2923576		NC_000010.11:43112874:C:A	single nucleotide variant	synonymous variant	Likely benign	Oct 17, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1671C>T (p.Thr557=)	RET		Hereditary cancer-predisposing syndrome	VCV001777705	10	43608323	10	43112875	1777705	1828207		NC_000010.11:43112874:C:T	single nucleotide variant	synonymous variant	Uncertain significance	Mar 28, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1674C>T (p.Cys558=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001565026	10	43608326	10	43112878	1565026	1567980	rs2132813703	NC_000010.11:43112877:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jun 21, 2023	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1676C>T (p.Ser559Phe)	RET	S463F, S217F, S229F, S260F, S317F, S384F, S164F, S305F, S427F, S76F, S413F, S516F, S559F	Hereditary cancer-predisposing syndrome	VCV003432253	10	43608328	10	43112880	3432253	3593449		NC_000010.11:43112879:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 2, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1677T>C (p.Ser559=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000543770	10	43608329	10	43112881	543770	525297	rs1554818698	NC_000010.11:43112880:T:C	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jul 10, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1678C>G (p.Pro560Ala)	RET	P218A, P261A, P318A, P517A, P77A, P230A, P428A, P464A, P165A, P414A, P306A, P385A, P560A	Multiple endocrine neoplasia, type 2	VCV002710271	10	43608330	10	43112882	2710271	2871295		NC_000010.11:43112881:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1678C>T (p.Pro560Ser)	RET	P560S, P306S, P261S, P77S, P230S, P385S, P165S, P218S, P318S, P414S, P428S, P464S, P517S	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Hereditary cancer	VCV000220113	10	43608330	10	43112882	220113	221962	rs748852160	NC_000010.11:43112881:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 24, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1680C>G (p.Pro560=)	RET		RET-related disorder	VCV003349076	10	43608332	10	43112884	3349076	3508304		NC_000010.11:43112883:C:G	single nucleotide variant	synonymous variant	Likely benign	Mar 9, 2024	no assertion criteria provided							
NM_020975.6(RET):c.1681A>G (p.Ser561Gly)	RET	S166G, S465G, S231G, S262G, S307G, S319G, S219G, S386G, S561G, S415G, S429G, S518G, S78G	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002568380	10	43608333	10	43112885	2568380	2734916		NC_000010.11:43112884:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1681A>C (p.Ser561Arg)	RET	S561R, S307R, S415R, S386R, S429R, S166R, S219R, S231R, S319R, S465R, S518R, S78R, S262R	Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2	VCV000665308	10	43608333	10	43112885	665308	638902	rs201972250	NC_000010.11:43112884:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1681A>T (p.Ser561Cys)	RET	S561C, S307C, S166C, S231C, S386C, S219C, S319C, S518C, S465C, S262C, S415C, S429C, S78C	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000543726	10	43608333	10	43112885	543726	525627	rs201972250	NC_000010.11:43112884:A:T	single nucleotide variant	missense variant	Uncertain significance	Nov 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1682G>A (p.Ser561Asn)	RET	S429N, S78N, S231N, S319N, S415N, S166N, S219N, S307N, S386N, S518N, S262N, S465N, S561N	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002071519	10	43608334	10	43112886	2071519	2126880		NC_000010.11:43112885:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1682G>C (p.Ser561Thr)	RET	S561T, S307T, S262T, S386T, S415T, S465T, S166T, S219T, S231T, S319T, S518T, S78T, S429T	Multiple endocrine neoplasia, type 2	VCV000571445	10	43608334	10	43112886	571445	569645	rs1161678851	NC_000010.11:43112885:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 15, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1683C>T (p.Ser561=)	RET		Hereditary cancer-predisposing syndrome	VCV003227514	10	43608335	10	43112887	3227514	3390726		NC_000010.11:43112886:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 18, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1683C>A (p.Ser561Arg)	RET	S307R, S561R, S262R, S319R, S429R, S415R, S78R, S166R, S518R, S219R, S231R, S386R, S465R	Multiple endocrine neoplasia, type 2	VCV001004827	10	43608335	10	43112887	1004827	993814	rs1837973045	NC_000010.11:43112886:C:A	single nucleotide variant	missense variant	Uncertain significance	May 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1684A>T (p.Thr562Ser)	RET	T562S, T308S, T167S, T387S, T430S, T320S, T519S, T79S, T263S, T220S, T232S, T416S, T466S	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001448643	10	43608336	10	43112888	1448643	1423342	rs759342879	NC_000010.11:43112887:A:T	single nucleotide variant	missense variant	Uncertain significance	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1684A>C (p.Thr562Pro)	RET	T562P, T308P, T167P, T232P, T263P, T320P, T416P, T79P, T387P, T519P, T220P, T430P, T466P	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000819826	10	43608336	10	43112888	819826	809932	rs759342879	NC_000010.11:43112887:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 30, 2021	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1685C>T (p.Thr562Ile)	RET	T308I, T387I, T167I, T416I, T430I, T220I, T263I, T466I, T519I, T232I, T320I, T562I, T79I	Multiple endocrine neoplasia, type 2	VCV001932746	10	43608337	10	43112889	1932746	1985165		NC_000010.11:43112888:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 7, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1686C>G (p.Thr562=)	RET		Hereditary cancer-predisposing syndrome	VCV003227515	10	43608338	10	43112890	3227515	3390727		NC_000010.11:43112889:C:G	single nucleotide variant	synonymous variant	Uncertain significance	Jan 16, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1686C>T (p.Thr562=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not provided	VCV000543768	10	43608338	10	43112890	543768	525629	rs767502292	NC_000010.11:43112889:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Feb 4, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1687A>G (p.Lys563Glu)	RET	K309E, K563E, K221E, K321E, K520E, K168E, K264E, K388E, K233E, K431E, K417E, K467E, K80E	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001691913	10	43608339	10	43112891	1691913	1684355	rs1387381256	NC_000010.11:43112890:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1688A>G (p.Lys563Arg)	RET	K309R, K563R, K221R, K264R, K467R, K168R, K233R, K321R, K388R, K431R, K80R, K417R, K520R	Multiple endocrine neoplasia, type 2	VCV000845462	10	43608340	10	43112892	845462	836848	rs863224777	NC_000010.11:43112891:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 9, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1688A>C (p.Lys563Thr)	RET	K563T, K309T, K221T, K233T, K264T, K321T, K431T, K467T, K520T, K80T, K168T, K388T, K417T	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000216716	10	43608340	10	43112892	216716	212779	rs863224777	NC_000010.11:43112891:A:C	single nucleotide variant	missense variant	Uncertain significance	May 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1689G>C (p.Lys563Asn)	RET	K264N, K520N, K563N, K321N, K388N, K417N, K168N, K221N, K233N, K309N, K431N, K467N, K80N	Multiple endocrine neoplasia, type 2	VCV003011253	10	43608341	10	43112893	3011253	3180639		NC_000010.11:43112892:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 19, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1690A>T (p.Thr564Ser)	RET	T564S, T310S, T222S, T322S, T169S, T234S, T389S, T521S, T418S, T432S, T468S, T265S, T81S	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000819854	10	43608342	10	43112894	819854	809933	rs1588872756	NC_000010.11:43112893:A:T	single nucleotide variant	missense variant	Uncertain significance	May 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1698del (p.Asp567fs)	RET	D172fs, D313fs, D325fs, D567fs, D392fs, D421fs, D435fs, D84fs, D237fs, D268fs, D524fs, D225fs, D471fs	Multiple endocrine neoplasia, type 2	VCV002770994	10	43608347	10	43112899	2770994	2923968		NC_000010.11:43112898:CCCC:CCC	Deletion	frameshift variant	Pathogenic	Oct 22, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1695C>T (p.Cys565=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000215907	10	43608347	10	43112899	215907	212780	rs775079681	NC_000010.11:43112898:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1697C>T (p.Pro566Leu)	RET	P312L, P566L, P324L, P420L, P434L, P470L, P171L, P523L, P236L, P391L, P83L, P224L, P267L	Multiple endocrine neoplasia, type 2	VCV001020733	10	43608349	10	43112901	1020733	1008991	rs1319956362	NC_000010.11:43112900:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 17, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.1698C>T (p.Pro566=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000543765	10	43608350	10	43112902	543765	525123	rs760507059	NC_000010.11:43112901:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1699G>A (p.Asp567Asn)	RET	D471N, D524N, D567N, D313N, D268N, D84N, D237N, D325N, D435N, D392N, D172N, D225N, D421N	Hereditary cancer-predisposing syndrome|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2|not provided|not specified|Pheochromocytoma|Renal hypodysplasia/aplasia 1|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia	VCV000136103	10	43608351	10	43112903	136103	139815	rs147219360	NC_000010.11:43112902:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 31, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1701C>T (p.Asp567=)	RET		not provided|not specified|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000413460	10	43608353	10	43112905	413460	397453	rs201209972	NC_000010.11:43112904:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1702G>A (p.Gly568Ser)	RET	G568S, G314S, G238S, G326S, G436S, G472S, G85S, G393S, G226S, G525S, G173S, G269S, G422S	Multiple endocrine neoplasia type 2A|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|not provided|Hereditary cancer-predisposing syndrome	VCV000132762	10	43608354	10	43112906	132762	136510	rs140464432	NC_000010.11:43112905:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 28, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1705C>T (p.His569Tyr)	RET	H315Y, H569Y, H174Y, H270Y, H327Y, H394Y, H473Y, H239Y, H423Y, H526Y, H86Y, H227Y, H437Y	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000842662	10	43608357	10	43112909	842662	836849	rs1258200571	NC_000010.11:43112908:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1706A>G (p.His569Arg)	RET	H315R, H569R, H239R, H270R, H473R, H174R, H394R, H437R, H227R, H423R, H327R, H526R, H86R	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001437631	10	43608358	10	43112910	1437631	1514247	rs765256156	NC_000010.11:43112909:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1707C>T (p.His569=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001606732	10	43608359	10	43112911	1606732	1658595	rs2132815208	NC_000010.11:43112910:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 30, 2021	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1710C>T (p.Cys570=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001099994	10	43608362	10	43112914	1099994	1098695	rs144015580	NC_000010.11:43112913:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1711G>A (p.Asp571Asn)	RET	D571N, D317N, D229N, D475N, D272N, D528N, D88N, D176N, D425N, D439N, D241N, D329N, D396N	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000952258	10	43608363	10	43112915	952258	925804	rs750958377	NC_000010.11:43112914:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 6, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1713T>C (p.Asp571=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000707308	10	43608365	10	43112917	707308	692837	rs1588872813	NC_000010.11:43112916:T:C	single nucleotide variant	synonymous variant	Likely benign	May 5, 2021	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1715T>A (p.Val572Asp)	RET	V177D, V230D, V476D, V242D, V397D, V426D, V273D, V330D, V572D, V318D, V440D, V529D, V89D	Hereditary cancer-predisposing syndrome	VCV003313747	10	43608367	10	43112919	3313747	3465477		NC_000010.11:43112918:T:A	single nucleotide variant	missense variant	Uncertain significance	Jun 14, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1715T>C (p.Val572Ala)	RET	V177A, V318A, V426A, V476A, V230A, V242A, V397A, V572A, V89A, V273A, V330A, V440A, V529A	Hereditary cancer-predisposing syndrome	VCV001778624	10	43608367	10	43112919	1778624	1834595		NC_000010.11:43112918:T:C	single nucleotide variant	missense variant	Likely benign	Aug 23, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1717G>A (p.Val573Met)	RET	V573M, V319M, V231M, V331M, V427M, V477M, V243M, V178M, V274M, V398M, V530M, V441M, V90M	not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000819914	10	43608369	10	43112921	819914	809934	rs758766818	NC_000010.11:43112920:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 17, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1718T>C (p.Val573Ala)	RET	V274A, V331A, V530A, V231A, V243A, V441A, V319A, V398A, V427A, V477A, V178A, V573A, V90A	Hereditary cancer-predisposing syndrome	VCV002618782	10	43608370	10	43112922	2618782	2782527		NC_000010.11:43112921:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 6, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1724C>T (p.Thr575Ile)	RET	T575I, T321I, T443I, T532I, T233I, T245I, T333I, T400I, T479I, T92I, T180I, T276I, T429I	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A	VCV000136104	10	43608376	10	43112928	136104	139816	rs587780808	NC_000010.11:43112927:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1725C>A (p.Thr575=)	RET		Hereditary cancer-predisposing syndrome	VCV001778843	10	43608377	10	43112929	1778843	1831427		NC_000010.11:43112928:C:A	single nucleotide variant	synonymous variant	Likely benign	Apr 12, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1725C>G (p.Thr575=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000819940	10	43608377	10	43112929	819940	809935	rs780609440	NC_000010.11:43112928:C:G	single nucleotide variant	synonymous variant	Likely benign	Jun 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1726C>A (p.Gln576Lys)	RET	Q576K, Q322K, Q181K, Q334K, Q444K, Q480K, Q93K, Q234K, Q277K, Q430K, Q401K, Q246K, Q533K	Hereditary cancer-predisposing syndrome	VCV000819943	10	43608378	10	43112930	819943	809936	rs1588872829	NC_000010.11:43112929:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 7, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.1727A>G (p.Gln576Arg)	RET	Q322R, Q576R, Q401R, Q480R, Q533R, Q234R, Q246R, Q277R, Q444R, Q93R, Q181R, Q334R, Q430R	Multiple endocrine neoplasia, type 2	VCV000999555	10	43608379	10	43112931	999555	993815	rs1284377464	NC_000010.11:43112930:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1730A>T (p.Asp577Val)	RET	D323V, D577V, D335V, D431V, D235V, D182V, D247V, D278V, D402V, D534V, D445V, D481V, D94V	Multiple endocrine neoplasia, type 2	VCV001441502	10	43608382	10	43112934	1441502	1358770	rs2132816375	NC_000010.11:43112933:A:T	single nucleotide variant	missense variant	Uncertain significance	Dec 11, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1731C>T (p.Asp577=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001112993	10	43608383	10	43112935	1112993	1098696	rs1554818709	NC_000010.11:43112934:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 18, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1731C>G (p.Asp577Glu)	RET	D577E, D323E, D182E, D247E, D445E, D481E, D534E, D94E, D278E, D402E, D431E, D235E, D335E	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|not provided	VCV000477324	10	43608383	10	43112935	477324	459832	rs1554818709	NC_000010.11:43112934:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1732A>G (p.Ile578Val)	RET	I324V, I578V, I236V, I336V, I482V, I535V, I183V, I403V, I432V, I95V, I248V, I446V, I279V	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001369726	10	43608384	10	43112936	1369726	1437432	rs1837975551	NC_000010.11:43112935:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1733T>A (p.Ile578Asn)	RET	I336N, I432N, I482N, I403N, I446N, I535N, I578N, I183N, I248N, I324N, I236N, I279N, I95N	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002783302	10	43608385	10	43112937	2783302	2947901		NC_000010.11:43112936:T:A	single nucleotide variant	missense variant	Uncertain significance	Sep 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1733T>C (p.Ile578Thr)	RET	I236T, I336T, I432T, I482T, I535T, I578T, I183T, I279T, I324T, I95T, I248T, I403T, I446T	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002190010	10	43608385	10	43112937	2190010	1918760		NC_000010.11:43112936:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1734C>G (p.Ile578Met)	RET	I578M, I324M, I403M, I535M, I236M, I336M, I183M, I248M, I446M, I95M, I279M, I432M, I482M	Multiple endocrine neoplasia, type 2	VCV000570040	10	43608386	10	43112938	570040	563740	rs1564495318	NC_000010.11:43112937:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 2, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1737C>T (p.Asn579=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002741238	10	43608389	10	43112941	2741238	2900296		NC_000010.11:43112940:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1737C>G (p.Asn579Lys)	RET	N579K, N325K, N184K, N96K, N433K, N249K, N483K, N536K, N237K, N280K, N337K, N404K, N447K	not provided|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A	VCV000216717	10	43608389	10	43112941	216717	212781	rs144455821	NC_000010.11:43112940:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1740_1741dup (p.Cys581fs)	RET	C186fs, C239fs, C251fs, C282fs, C327fs, C339fs, C406fs, C435fs, C449fs, C485fs, C538fs, C581fs, C98fs	not provided	VCV003337733	10	43608390 - 43608391	10	43112942 - 43112943	3337733	3496394		NC_000010.11:43112942:TTT:TTTTT	Duplication	frameshift variant	Pathogenic	May 27, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1738A>C (p.Ile580Leu)	RET	I434L, I448L, I484L, I537L, I580L, I185L, I338L, I97L, I238L, I250L, I281L, I326L, I405L	Multiple endocrine neoplasia, type 2	VCV002810779	10	43608390	10	43112942	2810779	2965453		NC_000010.11:43112941:A:C	single nucleotide variant	missense variant	Uncertain significance	Oct 30, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1738A>G (p.Ile580Val)	RET	I185V, I250V, I281V, I434V, I97V, I238V, I326V, I338V, I405V, I448V, I537V, I484V, I580V	Multiple endocrine neoplasia, type 2	VCV002763351	10	43608390	10	43112942	2763351	2925390		NC_000010.11:43112941:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 26, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1740T>C (p.Ile580=)	RET		Multiple endocrine neoplasia, type 2	VCV003604492	10	43608392	10	43112944	3604492	3743243		NC_000010.11:43112943:T:C	single nucleotide variant	synonymous variant	Likely benign	Sep 23, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1746T>G (p.Pro582=)	RET		Hereditary cancer-predisposing syndrome	VCV001779310	10	43608398	10	43112950	1779310	1828525		NC_000010.11:43112949:T:G	single nucleotide variant	synonymous variant	Likely benign	Jan 20, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1747C>A (p.Gln583Lys)	RET	Q188K, Q241K, Q253K, Q408K, Q437K, Q540K, Q284K, Q341K, Q451K, Q583K, Q100K, Q329K, Q487K	Multiple endocrine neoplasia, type 2	VCV002772972	10	43608399	10	43112951	2772972	2930250		NC_000010.11:43112950:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 30, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1749G>A (p.Gln583=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000657218	10	43608401	10	43112953	657218	638903	rs1588872861	NC_000010.11:43112952:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1753T>C (p.Cys585Arg)	RET	C585R, C331R, C343R, C410R, C102R, C453R, C542R, C489R, C190R, C243R, C255R, C286R, C439R	Aganglionic megacolon	VCV000695031	10	43608405	10	43112957	695031	683144	rs1588872865	NC_000010.11:43112956:T:C	single nucleotide variant	missense variant	Likely pathogenic	Sep 19, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.1755C>T (p.Cys585=)	RET		Multiple endocrine neoplasia, type 2	VCV002811570	10	43608407	10	43112959	2811570	2972651		NC_000010.11:43112958:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 2, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1756C>T (p.Leu586Phe)	RET	L586F, L332F, L244F, L440F, L454F, L191F, L103F, L287F, L344F, L543F, L256F, L411F, L490F	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1	VCV000477325	10	43608408	10	43112960	477325	460282	rs777604634	NC_000010.11:43112959:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1757T>A (p.Leu586His)	RET	L586H, L332H, L191H, L244H, L411H, L440H, L103H, L256H, L344H, L490H, L543H, L287H, L454H	Multiple endocrine neoplasia, type 2	VCV001404658	10	43608409	10	43112961	1404658	1405419	rs2132817593	NC_000010.11:43112960:T:A	single nucleotide variant	missense variant	Uncertain significance	Aug 22, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1758C>T (p.Leu586=)	RET		Multiple endocrine neoplasia, type 2	VCV001496040	10	43608410	10	43112962	1496040	1362955	rs2132817702	NC_000010.11:43112961:C:T	single nucleotide variant	synonymous variant	Uncertain significance	Jun 3, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1759C>A (p.Arg587=)	RET	H288N, H192N	Hereditary cancer-predisposing syndrome	VCV001779527	10	43608411	10	43112963	1779527	1839093		NC_000010.11:43112962:C:A	single nucleotide variant	synonymous variant|missense variant	Likely benign	May 13, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1759C>G (p.Arg587Gly)	RET	R587G, R333G, H192D, H288D, R192G, R544G, R104G, R345G, R412G, R441G, R455G, R245G, R257G, R288G, R491G	Multiple endocrine neoplasia, type 2	VCV000851868	10	43608411	10	43112963	851868	836850	rs748905470	NC_000010.11:43112962:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 25, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.1759C>T (p.Arg587Trp)	RET	R333W, R587W, R104W, R192W, R257W, R441W, R412W, H288Y, R288W, R345W, R455W, R491W, R544W, H192Y, R245W	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A	VCV000820028	10	43608411	10	43112963	820028	809937	rs748905470	NC_000010.11:43112962:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1759+1G>A	RET		RET-related disorder	VCV002431628	10	43608412	10	43112964	2431628	2405132		NC_000010.11:43112963:G:A	single nucleotide variant	splice donor variant	Pathogenic/Likely pathogenic	Jun 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1759+6C>T	RET		not provided	VCV002497833	10	43608417	10	43112969	2497833	2472916		NC_000010.11:43112968:C:T	single nucleotide variant	intron variant	Uncertain significance	Oct 6, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1759+7A>G	RET		Multiple endocrine neoplasia, type 2	VCV002693557	10	43608418	10	43112970	2693557	2853690		NC_000010.11:43112969:A:G	single nucleotide variant	intron variant	Likely benign	Nov 6, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1759+8G>C	RET		Multiple endocrine neoplasia, type 2	VCV003606876	10	43608419	10	43112971	3606876	3736997		NC_000010.11:43112970:G:C	single nucleotide variant	intron variant	Likely benign	Dec 10, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1759+9G>A	RET		Multiple endocrine neoplasia, type 2	VCV001641821	10	43608420	10	43112972	1641821	1586219	rs1216094635	NC_000010.11:43112971:G:A	single nucleotide variant	intron variant	Likely benign	Dec 8, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1759+10G>C	RET		Multiple endocrine neoplasia, type 2	VCV002073067	10	43608421	10	43112973	2073067	2127139		NC_000010.11:43112972:G:C	single nucleotide variant	intron variant	Likely benign	Jan 3, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1759+10G>A	RET		Multiple endocrine neoplasia, type 2	VCV001561744	10	43608421	10	43112973	1561744	1608283	rs770586179	NC_000010.11:43112972:G:A	single nucleotide variant	intron variant	Likely benign	Sep 13, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1759+10G>T	RET		Multiple endocrine neoplasia, type 2	VCV000543724	10	43608421	10	43112973	543724	525127	rs770586179	NC_000010.11:43112972:G:T	single nucleotide variant	intron variant	Uncertain significance	Sep 14, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1759+12T>C	RET		Multiple endocrine neoplasia, type 2	VCV002762481	10	43608423	10	43112975	2762481	2930977		NC_000010.11:43112974:T:C	single nucleotide variant	intron variant	Uncertain significance	Sep 21, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1759+16T>C	RET		Multiple endocrine neoplasia, type 2	VCV002849531	10	43608427	10	43112979	2849531	3009320		NC_000010.11:43112978:T:C	single nucleotide variant	intron variant	Uncertain significance	Mar 26, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1759+17C>T	RET		Multiple endocrine neoplasia, type 2	VCV002791969	10	43608428	10	43112980	2791969	2960435		NC_000010.11:43112979:C:T	single nucleotide variant	intron variant	Likely benign	Nov 22, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1759+17C>G	RET		Multiple endocrine neoplasia, type 2	VCV002013871	10	43608428	10	43112980	2013871	2067954		NC_000010.11:43112979:C:G	single nucleotide variant	intron variant	Likely benign	Nov 29, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1759+19G>T	RET		Multiple endocrine neoplasia, type 2	VCV001550451	10	43608430	10	43112982	1550451	1574140	rs2132818296	NC_000010.11:43112981:G:T	single nucleotide variant	intron variant	Likely benign	Jun 8, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1759+111G>C	RET		not provided	VCV000677052	10	43608522	10	43113074	677052	664280	rs3026757	NC_000010.11:43113073:G:C	single nucleotide variant	intron variant	Benign	Jun 18, 2018	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1759+242G>A	RET		not provided	VCV001242352	10	43608653	10	43113205	1242352	1231895	rs78601594	NC_000010.11:43113204:G:A	single nucleotide variant	intron variant	Benign	Jun 22, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.1760-140C>G	RET		not provided	VCV001247892	10	43608864	10	43113416	1247892	1237846	rs3026758	NC_000010.11:43113415:C:G	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, single submitter							
NM_020975.6(RET):c.1760-57G>T	RET		not provided	VCV001272808	10	43608947	10	43113499	1272808	1262273	rs2132824724	NC_000010.11:43113498:G:T	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, single submitter							
NM_020975.6(RET):c.1760-20T>C	RET		Multiple endocrine neoplasia, type 2	VCV001611774	10	43608984	10	43113536	1611774	1552290	rs766839936	NC_000010.11:43113535:T:C	single nucleotide variant	intron variant	Likely benign	Jan 26, 2025	criteria provided, single submitter							
NM_020975.6(RET):c.1760-20T>G	RET		Multiple endocrine neoplasia, type 2	VCV001557596	10	43608984	10	43113536	1557596	1628039	rs766839936	NC_000010.11:43113535:T:G	single nucleotide variant	intron variant	Likely benign	Dec 11, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1760-19G>A	RET		Multiple endocrine neoplasia, type 2	VCV002142388	10	43608985	10	43113537	2142388	1879466		NC_000010.11:43113536:G:A	single nucleotide variant	intron variant	Likely benign	Oct 4, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1760-18G>A	RET		Multiple endocrine neoplasia, type 2	VCV001594322	10	43608986	10	43113538	1594322	1568326	rs2132825714	NC_000010.11:43113537:G:A	single nucleotide variant	intron variant	Likely benign	Jan 2, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1760-17G>T	RET		Multiple endocrine neoplasia, type 2	VCV001633535	10	43608987	10	43113539	1633535	1598460	rs2132825732	NC_000010.11:43113538:G:T	single nucleotide variant	intron variant	Likely benign	Apr 4, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1760-16C>T	RET		Multiple endocrine neoplasia, type 2	VCV003686745	10	43608988	10	43113540	3686745	3809437		NC_000010.11:43113539:C:T	single nucleotide variant	intron variant	Likely benign	Sep 17, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1760-13C>T	RET		Multiple endocrine neoplasia, type 2	VCV001596985	10	43608991	10	43113543	1596985	1602580	rs376709486	NC_000010.11:43113542:C:T	single nucleotide variant	intron variant	Likely benign	Oct 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1760-12G>A	RET		Multiple endocrine neoplasia, type 2|Hirschsprung Disease, Dominant|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|not provided|Pheochromocytoma|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1	VCV000024889	10	43608992	10	43113544	24889	36230	rs377767392	NC_000010.11:43113543:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Nov 26, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1760-11T>A	RET		Multiple endocrine neoplasia, type 2	VCV002102782	10	43608993	10	43113545	2102782	2161842		NC_000010.11:43113544:T:A	single nucleotide variant	intron variant	Likely benign	Feb 24, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1760-6C>G	RET		Multiple endocrine neoplasia, type 2	VCV002735691	10	43608998	10	43113550	2735691	2898702		NC_000010.11:43113549:C:G	single nucleotide variant	intron variant	Likely benign	Jul 3, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1760-3C>T	RET		Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000141420	10	43609001	10	43113553	141420	151134	rs587781734	NC_000010.11:43113552:C:T	single nucleotide variant	intron variant	Uncertain significance	May 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1760-2_1760-1del	RET		Hereditary cancer-predisposing syndrome|not provided	VCV001779564	10	43609002 - 43609003	10	43113554 - 43113555	1779564	1838217		NC_000010.11:43113553:AG:	Deletion	splice acceptor variant|intron variant	Likely pathogenic	Dec 24, 2021	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1760G>A (p.Arg587Gln)	RET	R192Q, R245Q, R333Q, R587Q, R104Q, R544Q, R257Q, R288Q, R441Q, R345Q, R412Q, R455Q, R491Q	Hereditary cancer-predisposing syndrome	VCV002568362	10	43609004	10	43113556	2568362	2734898		NC_000010.11:43113555:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 14, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1760_1761delinsAA (p.Arg587Gln)	RET	R104Q, R288Q, R192Q, R245Q, R257Q, R412Q, R441Q, R455Q, R587Q, R333Q, R345Q, R491Q, R544Q	Multiple endocrine neoplasia, type 2	VCV002184504	10	43609004 - 43609005	10	43113556 - 43113557	2184504	1921012		NC_000010.11:43113555:GG:AA	Indel	missense variant	Uncertain significance	Sep 21, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1761G>A (p.Arg587=)	RET		Hereditary cancer-predisposing syndrome	VCV003432225	10	43609005	10	43113557	3432225	3593421		NC_000010.11:43113556:G:A	single nucleotide variant	synonymous variant|intron variant	Uncertain significance	Jul 9, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1761G>T (p.Arg587=)	RET		Hereditary cancer-predisposing syndrome	VCV000820037	10	43609005	10	43113557	820037	809938	rs1291641320	NC_000010.11:43113556:G:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 29, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.1762G>A (p.Gly588Ser)	RET	G289S, G413S, G456S, G492S, G246S, G334S, G588S, G105S, G193S, G258S, G346S, G545S, G442S	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001779609	10	43609006	10	43113558	1779609	1838262		NC_000010.11:43113557:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1763G>A (p.Gly588Asp)	RET	G193D, G258D, G413D, G442D, G588D, G346D, G545D, G105D, G289D, G334D, G456D, G492D, G246D	Multiple endocrine neoplasia, type 2	VCV002735390	10	43609007	10	43113559	2735390	2901415		NC_000010.11:43113558:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 27, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1763G>T (p.Gly588Val)	RET	G442V, G456V, G246V, G346V, G545V, G105V, G258V, G289V, G334V, G413V, G193V, G492V, G588V	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001779627	10	43609007	10	43113559	1779627	1838280		NC_000010.11:43113558:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1764C>T (p.Gly588=)	RET		Hereditary cancer-predisposing syndrome	VCV003432240	10	43609008	10	43113560	3432240	3593436		NC_000010.11:43113559:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 28, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1764C>A (p.Gly588=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001081089	10	43609008	10	43113560	1081089	1077042	rs753557244	NC_000010.11:43113559:C:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1765A>T (p.Ser589Cys)	RET	S589C, S335C, S106C, S247C, S347C, S443C, S259C, S290C, S194C, S414C, S457C, S493C, S546C	not provided	VCV000618346	10	43609009	10	43113561	618346	609749	rs786202597	NC_000010.11:43113560:A:T	single nucleotide variant	missense variant	Uncertain significance	Dec 1, 2017	criteria provided, single submitter							
NM_020975.6(RET):c.1765A>C (p.Ser589Arg)	RET	S589R, S335R, S290R, S347R, S457R, S247R, S259R, S493R, S546R, S106R, S194R, S414R, S443R	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000185968	10	43609009	10	43113561	185968	182953	rs786202597	NC_000010.11:43113560:A:C	single nucleotide variant	missense variant	Uncertain significance	Jan 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1766G>A (p.Ser589Asn)	RET	S106N, S259N, S414N, S443N, S290N, S335N, S493N, S347N, S546N, S589N, S194N, S247N, S457N	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002568337	10	43609010	10	43113562	2568337	2734874		NC_000010.11:43113561:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1767C>T (p.Ser589=)	RET		Multiple endocrine neoplasia, type 2	VCV003655105	10	43609011	10	43113563	3655105	3789248		NC_000010.11:43113562:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 31, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1768A>G (p.Ile590Val)	RET	I336V, I590V, I248V, I291V, I458V, I494V, I107V, I260V, I415V, I444V, I195V, I348V, I547V	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000820042	10	43609012	10	43113564	820042	809939	rs1307072968	NC_000010.11:43113563:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 21, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1769T>G (p.Ile590Ser)	RET	I107S, I494S, I444S, I458S, I291S, I336S, I415S, I547S, I590S, I195S, I248S, I260S, I348S	Hereditary cancer-predisposing syndrome	VCV001779743	10	43609013	10	43113565	1779743	1838395		NC_000010.11:43113564:T:G	single nucleotide variant	missense variant	Uncertain significance	Apr 1, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1769T>C (p.Ile590Thr)	RET	I336T, I590T, I248T, I348T, I195T, I260T, I444T, I494T, I547T, I291T, I458T, I107T, I415T	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001510144	10	43609013	10	43113565	1510144	1442199	rs1348219647	NC_000010.11:43113564:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1770T>C (p.Ile590=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000772218	10	43609014	10	43113566	772218	701343	rs1160114479	NC_000010.11:43113565:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1771G>T (p.Val591Phe)	RET	V249F, V261F, V495F, V548F, V196F, V108F, V416F, V445F, V459F, V591F, V292F, V337F, V349F	Hereditary cancer-predisposing syndrome	VCV003313731	10	43609015	10	43113567	3313731	3465461		NC_000010.11:43113566:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 8, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1771G>A (p.Val591Ile)	RET	V591I, V337I, V445I, V495I, V261I, V196I, V416I, V459I, V548I, V108I, V249I, V292I, V349I	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	VCV000486326	10	43609015	10	43113567	486326	475305	rs776013456	NC_000010.11:43113566:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 12, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1772T>A (p.Val591Asp)	RET	V196D, V292D, V349D, V459D, V591D, V108D, V548D, V249D, V261D, V337D, V445D, V495D, V416D	Hereditary cancer-predisposing syndrome	VCV002568376	10	43609016	10	43113568	2568376	2734912		NC_000010.11:43113567:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 2, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1773T>C (p.Val591=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000820034	10	43609017	10	43113569	820034	809940	rs756902570	NC_000010.11:43113568:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1776G>C (p.Gly592=)	RET		Hereditary cancer-predisposing syndrome	VCV001779883	10	43609020	10	43113572	1779883	1838535		NC_000010.11:43113571:G:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 9, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1777G>A (p.Gly593Arg)	RET	G593R, G339R, G351R, G447R, G461R, G263R, G418R, G497R, G251R, G294R, G110R, G198R, G550R	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2	VCV000241339	10	43609021	10	43113573	241339	240793	rs878855059	NC_000010.11:43113572:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1778G>C (p.Gly593Ala)	RET	G110A, G198A, G251A, G263A, G294A, G339A, G351A, G418A, G447A, G461A, G497A, G550A, G593A	Multiple endocrine neoplasia, type 2	VCV003072099	10	43609022	10	43113574	3072099	3232276		NC_000010.11:43113573:G:C	single nucleotide variant	intron variant|missense variant	Uncertain significance	Jun 28, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1779A>C (p.Gly593=)	RET		Hereditary cancer-predisposing syndrome	VCV001779917	10	43609023	10	43113575	1779917	1838569		NC_000010.11:43113574:A:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 9, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.1780C>T (p.His594Tyr)	RET	H340Y, H594Y, H252Y, H419Y, H462Y, H498Y, H111Y, H264Y, H352Y, H448Y, H551Y, H199Y, H295Y	Multiple endocrine neoplasia, type 2	VCV000937751	10	43609024	10	43113576	937751	935030	rs778622905	NC_000010.11:43113575:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1782C>G (p.His594Gln)	RET	H111Q, H199Q, H252Q, H264Q, H295Q, H340Q, H352Q, H419Q, H448Q, H462Q, H498Q, H551Q, H594Q	Multiple endocrine neoplasia, type 2	VCV001717771	10	43609026	10	43113578	1717771	1771747		NC_000010.11:43113577:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 22, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1782C>T (p.His594=)	RET		Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	VCV000215908	10	43609026	10	43113578	215908	212782	rs863224426	NC_000010.11:43113577:C:T	single nucleotide variant	intron variant|synonymous variant	Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1783G>C (p.Glu595Gln)	RET	E595Q, E341Q, E200Q, E253Q, E296Q, E499Q, E449Q, E463Q, E552Q, E112Q, E265Q, E353Q, E420Q	Multiple endocrine neoplasia, type 2	VCV001406177	10	43609027	10	43113579	1406177	1493438	rs1483605155	NC_000010.11:43113578:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 14, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1783G>A (p.Glu595Lys)	RET	E595K, E341K, E112K, E420K, E499K, E200K, E449K, E552K, E353K, E463K, E253K, E265K, E296K	Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia, type 2	VCV000966506	10	43609027	10	43113579	966506	956048	rs1483605155	NC_000010.11:43113578:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1783G>T (p.Glu595Ter)	RET	E595*, E341*, E253*, E112*, E200*, E353*, E463*, E265*, E420*, E449*, E296*, E499*, E552*	Multiple endocrine neoplasia, type 2	VCV000657955	10	43609027	10	43113579	657955	638904	rs1483605155	NC_000010.11:43113578:G:T	single nucleotide variant	nonsense	Pathogenic	Aug 15, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.1785G>T (p.Glu595Asp)	RET	E341D, E595D, E253D, E265D, E353D, E112D, E200D, E420D, E463D, E449D, E296D, E499D, E552D	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001403891	10	43609029	10	43113581	1403891	1467257	rs1204846773	NC_000010.11:43113580:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 7, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1788T>G (p.Pro596=)	RET		Hereditary cancer-predisposing syndrome	VCV001780136	10	43609032	10	43113584	1780136	1834837		NC_000010.11:43113583:T:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 9, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.1789G>C (p.Gly597Arg)	RET	G114R, G202R, G255R, G267R, G298R, G343R, G355R, G422R, G451R, G465R, G501R, G554R, G597R	not provided	VCV002428945	10	43609033	10	43113585	2428945	2402387		NC_000010.11:43113584:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 5, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1791G>A (p.Gly597=)	RET		Multiple endocrine neoplasia, type 2	VCV002746479	10	43609035	10	43113587	2746479	2911989		NC_000010.11:43113586:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 25, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1792G>A (p.Glu598Lys)	RET	E598K, E344K, E115K, E203K, E268K, E356K, E502K, E256K, E299K, E452K, E555K, E423K, E466K	Multiple endocrine neoplasia, type 2	VCV001419374	10	43609036	10	43113588	1419374	1387053	rs2132827786	NC_000010.11:43113587:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 11, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1795C>T (p.Pro599Ser)	RET	P116S, P300S, P357S, P257S, P503S, P556S, P269S, P453S, P467S, P204S, P345S, P424S, P599S	Hereditary cancer-predisposing syndrome	VCV001780252	10	43609039	10	43113591	1780252	1834953		NC_000010.11:43113590:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 16, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1796C>A (p.Pro599His)	RET	P345H, P599H, P257H, P300H, P357H, P467H, P116H, P204H, P503H, P269H, P424H, P453H, P556H	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000961130	10	43609040	10	43113592	961130	946890	rs1468422135	NC_000010.11:43113591:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1798C>T (p.Arg600Trp)	RET	R600W, R346W, R301W, R358W, R425W, R504W, R557W, R258W, R270W, R468W, R117W, R205W, R454W	Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1	VCV000477327	10	43609042	10	43113594	477327	460025	rs745418960	NC_000010.11:43113593:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 24, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1799G>A (p.Arg600Gln)	RET	R346Q, R117Q, R258Q, R504Q, R205Q, R301Q, R425Q, R454Q, R270Q, R358Q, R468Q, R557Q	not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000024890	10	43609043	10	43113595	24890	36231	rs377767393	NC_000010.11:43113594:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1801G>A (p.Gly601Arg)	RET	G469R, G206R, G259R, G302R, G347R, G426R, G505R, G118R, G271R, G601R, G359R, G455R, G558R	Hereditary cancer-predisposing syndrome	VCV001780416	10	43609045	10	43113597	1780416	1831712		NC_000010.11:43113596:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 29, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.1803G>A (p.Gly601=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000755481	10	43609047	10	43113599	755481	767741	rs779889311	NC_000010.11:43113598:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1804A>T (p.Ile602Phe)	RET	I348F, I602F, I119F, I207F, I260F, I559F, I272F, I303F, I506F, I360F, I427F, I456F, I470F	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001041457	10	43609048	10	43113600	1041457	1029537	rs1837992915	NC_000010.11:43113599:A:T	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1806T>G (p.Ile602Met)	RET	I272M, I427M, I303M, I348M, I360M, I559M, I119M, I207M, I260M, I506M, I602M, I456M, I470M	Multiple endocrine neoplasia, type 2	VCV002745296	10	43609050	10	43113602	2745296	2907356		NC_000010.11:43113601:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 19, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1807A>C (p.Lys603Gln)	RET	K349Q, K208Q, K428Q, K273Q, K457Q, K471Q, K507Q, K120Q, K261Q, K304Q, K560Q, K361Q	Multiple endocrine neoplasia, type 2	VCV001406178	10	43609051	10	43113603	1406178	36232	rs377767394	NC_000010.11:43113602:A:C	single nucleotide variant	missense variant	Uncertain significance	Feb 20, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1810G>T (p.Ala604Ser)	RET	A429S, A508S, A604S, A274S, A472S, A561S, A350S, A362S, A458S, A121S, A209S, A262S, A305S	Multiple endocrine neoplasia, type 2	VCV003660146	10	43609054	10	43113606	3660146	3797287		NC_000010.11:43113605:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 22, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1811C>T (p.Ala604Val)	RET	A350V, A604V, A305V, A362V, A458V, A561V, A274V, A472V, A121V, A209V, A262V, A429V, A508V	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia type 2B|Familial medullary thyroid carcinoma|RET-related disorder	VCV000862826	10	43609055	10	43113607	862826	836851	rs1286776938	NC_000010.11:43113606:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1814G>T (p.Gly605Val)	RET	G605V, G351V, G306V, G210V, G473V, G263V, G363V, G430V, G459V, G122V, G275V, G509V, G562V	Multiple endocrine neoplasia, type 2	VCV000477328	10	43609058	10	43113610	477328	459835	rs1031388542	NC_000010.11:43113609:G:T	single nucleotide variant	missense variant	Uncertain significance	May 29, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1816T>C (p.Tyr606His)	RET	Y352H, Y606H, Y123H, Y307H, Y460H, Y211H, Y264H, Y431H, Y563H, Y276H, Y364H, Y474H, Y510H	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|not provided	VCV001360325	10	43609060	10	43113612	1360325	1363767	rs199921511	NC_000010.11:43113611:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1817A>T (p.Tyr606Phe)	RET	Y264F, Y307F, Y606F, Y364F, Y460F, Y276F, Y431F, Y510F, Y563F, Y123F, Y211F, Y352F, Y474F	Hereditary cancer-predisposing syndrome	VCV001780687	10	43609061	10	43113613	1780687	1831982		NC_000010.11:43113612:A:T	single nucleotide variant	missense variant	Likely benign	May 17, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1817A>G (p.Tyr606Cys)	RET	Y352C, Y211C, Y307C, Y364C, Y123C, Y264C, Y474C, Y563C, Y431C, Y276C, Y460C, Y510C	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000024892	10	43609061	10	43113613	24892	36233	rs377767395	NC_000010.11:43113612:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 14, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1819G>C (p.Gly607Arg)	RET	G353R, G365R, G511R, G607R, G212R, G432R, G265R, G308R, G475R, G124R, G277R, G461R, G564R	Hereditary cancer-predisposing syndrome	VCV003313749	10	43609063	10	43113615	3313749	3465479		NC_000010.11:43113614:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 15, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1820G>T (p.Gly607Val)	RET	G212V, G432V, G564V, G124V, G365V, G461V, G511V, G607V, G265V, G277V, G308V, G353V, G475V	Multiple endocrine neoplasia, type 2	VCV003632667	10	43609064	10	43113616	3632667	3763180		NC_000010.11:43113615:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 7, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1820G>A (p.Gly607Asp)	RET	G124D, G212D, G265D, G277D, G308D, G353D, G365D, G432D, G461D, G475D, G511D, G564D, G607D	Hirschsprung disease, susceptibility to, 1	VCV003240304	10	43609064	10	43113616	3240304	3399291		NC_000010.11:43113615:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 21, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1821C>T (p.Gly607=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001037635	10	43609065	10	43113617	1037635	1029538	rs1837993502	NC_000010.11:43113616:C:T	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Apr 22, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1822A>G (p.Thr608Ala)	RET	T278A, T354A, T433A, T512A, T476A, T565A, T125A, T213A, T266A, T366A, T608A, T309A, T462A	Multiple endocrine neoplasia, type 2	VCV001976621	10	43609066	10	43113618	1976621	2030607		NC_000010.11:43113617:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1828_1833dup (p.Cys611_Phe612insAsnCys)	RET		Hereditary cancer-predisposing syndrome	VCV003432279	10	43609067 - 43609068	10	43113619 - 43113620	3432279	3593475		NC_000010.11:43113619:CTGCAACTGC:CTGCAACTGCAACTGC	Duplication	intron variant|inframe_indel	Uncertain significance	Oct 26, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1823C>G (p.Thr608Ser)	RET	T266S, T278S, T309S, T462S, T512S, T354S, T125S, T213S, T366S, T433S, T476S, T565S, T608S	Hereditary cancer-predisposing syndrome	VCV003432251	10	43609067	10	43113619	3432251	3593447		NC_000010.11:43113618:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 31, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1824C>A (p.Thr608=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002561474	10	43609068	10	43113620	2561474	2728240		NC_000010.11:43113619:C:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 31, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1824C>T (p.Thr608=)	RET		Multiple endocrine neoplasia, type 2	VCV001960169	10	43609068	10	43113620	1960169	2016425		NC_000010.11:43113619:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 15, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1825T>G (p.Cys609Gly)	RET	C355G, C126G, C367G, C214G, C267G, C463G, C477G, C279G, C310G, C434G, C513G, C566G	Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome	VCV003254419	10	43609069	10	43113621	3254419	36235	rs77558292	NC_000010.11:43113620:T:G	single nucleotide variant	missense variant	Pathogenic	Aug 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1825T>C (p.Cys609Arg)	RET	C609R, C355R, C126R, C434R, C310R, C279R, C367R, C477R, C566R, C214R, C267R, C463R, C513R	not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000013944	10	43609069	10	43113621	13944	28983	rs77558292	NC_000010.11:43113620:T:C	single nucleotide variant	missense variant	Pathogenic	Jul 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1826G>C (p.Cys609Ser)	RET	C609S, C355S, C126S, C279S, C214S, C367S, C463S, C477S, C566S, C267S, C310S, C434S, C513S	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A	VCV001372611	10	43609070	10	43113622	1372611	47200	rs77939446	NC_000010.11:43113621:G:C	single nucleotide variant	missense variant	Pathogenic	Apr 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1826G>T (p.Cys609Phe)	RET	C355F, C214F, C279F, C367F, C463F, C477F, C126F, C434F, C513F, C566F, C267F, C310F	not specified|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000038284	10	43609070	10	43113622	38284	46839	rs77939446	NC_000010.11:43113621:G:T	single nucleotide variant	missense variant	Pathogenic	May 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1826G>A (p.Cys609Tyr)	RET	C609Y, C355Y, C279Y, C463Y, C513Y, C310Y, C477Y, C367Y, C126Y, C214Y, C267Y, C434Y, C566Y	Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	VCV000013933	10	43609070	10	43113622	13933	28972	rs77939446	NC_000010.11:43113621:G:A	single nucleotide variant	missense variant	Pathogenic	Jan 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1827C>T (p.Cys609=)	RET		not provided	VCV002683100	10	43609071	10	43113623	2683100	540538	rs377767396	NC_000010.11:43113622:C:T	single nucleotide variant	synonymous variant|intron variant	Uncertain significance	Apr 4, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1827C>G (p.Cys609Trp)	RET	C355W, C310W, C367W, C477W, C214W, C267W, C434W, C513W, C566W, C126W, C279W, C463W	Multiple endocrine neoplasia, type 2|not provided	VCV002497944	10	43609071	10	43113623	2497944	36236	rs377767396	NC_000010.11:43113622:C:G	single nucleotide variant	missense variant	Pathogenic	Mar 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1828A>C (p.Asn610His)	RET	N356H, N610H, N280H, N464H, N127H, N215H, N268H, N435H, N478H, N514H, N311H, N368H, N567H	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001008125	10	43609072	10	43113624	1008125	993816	rs1837994023	NC_000010.11:43113623:A:C	single nucleotide variant	missense variant	Uncertain significance	Dec 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1829A>C (p.Asn610Thr)	RET	N127T, N368T, N464T, N478T, N610T, N311T, N356T, N567T, N215T, N268T, N280T, N435T, N514T	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001780894	10	43609073	10	43113625	1780894	1839163		NC_000010.11:43113624:A:C	single nucleotide variant	missense variant	Uncertain significance	Oct 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1829A>G (p.Asn610Ser)	RET	N610S, N356S, N215S, N268S, N478S, N567S, N127S, N280S, N311S, N514S, N368S, N435S, N464S	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Pheochromocytoma|Multiple endocrine neoplasia type 2B|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A	VCV001430721	10	43609073	10	43113625	1430721	1471255	rs1837994115	NC_000010.11:43113624:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1831T>A (p.Cys611Ser)	RET	C611S, C357S, C281S, C312S, C436S, C479S, C515S, C568S, C369S, C128S, C465S, C216S, C269S	not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001780971	10	43609075	10	43113627	1780971	47201	rs377767391	NC_000010.11:43113626:T:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 25, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1831T>G (p.Cys611Gly)	RET	C357G, C281G, C436G, C465G, C369G, C216G, C269G, C312G, C479G, C515G, C128G, C568G	not provided	VCV000024897	10	43609075	10	43113627	24897	36238	rs377767391	NC_000010.11:43113626:T:G	single nucleotide variant	missense variant	Pathogenic	Oct 25, 2021	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1831T>C (p.Cys611Arg)	RET	C357R, C281R, C479R, C216R, C515R, C568R, C269R, C312R, C465R, C128R, C369R, C436R	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000024896	10	43609075	10	43113627	24896	36237	rs377767391	NC_000010.11:43113626:T:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1832_1833delinsAT (p.Cys611Tyr)	RET	C611Y, C357Y, C216Y, C281Y, C515Y, C128Y, C269Y, C479Y, C568Y, C312Y, C369Y, C436Y, C465Y	Multiple endocrine neoplasia, type 2	VCV002136858	10	43609076 - 43609077	10	43113628 - 43113629	2136858	47223	rs377767398	NC_000010.11:43113627:GC:AT	Indel	missense variant	Pathogenic	Apr 12, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1832G>T (p.Cys611Phe)	RET	C357F, C269F, C281F, C128F, C216F, C312F, C436F, C465F, C568F, C369F, C479F, C515F	Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000024899	10	43609076	10	43113628	24899	36240	rs377767397	NC_000010.11:43113627:G:T	single nucleotide variant	missense variant	Pathogenic	Jun 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1832G>A (p.Cys611Tyr)	RET	C357Y, C269Y, C479Y, C128Y, C216Y, C281Y, C312Y, C369Y, C436Y, C515Y, C465Y, C568Y	not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000024898	10	43609076	10	43113628	24898	36239	rs377767397	NC_000010.11:43113627:G:A	single nucleotide variant	missense variant	Pathogenic	Sep 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1833C>T (p.Cys611=)	RET		Multiple endocrine neoplasia, type 2	VCV000543771	10	43609077	10	43113629	543771	525299	rs80069458	NC_000010.11:43113628:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 28, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1833C>G (p.Cys611Trp)	RET	C611W, C357W, C369W, C436W, C128W, C216W, C479W, C269W, C281W, C465W, C568W, C312W, C515W	Multiple endocrine neoplasia, type 2	VCV000013913	10	43609077	10	43113629	13913	28952	rs80069458	NC_000010.11:43113628:C:G	single nucleotide variant	missense variant	Pathogenic	Dec 11, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1834T>C (p.Phe612Leu)	RET	F313L, F437L, F569L, F282L, F358L, F129L, F466L, F612L, F217L, F270L, F370L, F480L, F516L	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002166006	10	43609078	10	43113630	2166006	1902546		NC_000010.11:43113629:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1836C>T (p.Phe612=)	RET		Multiple endocrine neoplasia, type 2	VCV003670867	10	43609080	10	43113632	3670867	3804303		NC_000010.11:43113631:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 3, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1840GAG[4] (p.Glu616_Lys617insGlu)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001445581	10	43609083 - 43609084	10	43113635 - 43113636	1445581	1490452	rs377767399	NC_000010.11:43113635:GAGGAGGAG:GAGGAGGAGGAG	Microsatellite	inframe_indel|inframe_insertion	Uncertain significance	Jun 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1840G>A (p.Glu614Lys)	RET	E614K, E360K, E131K, E315K, E372K, E571K, E272K, E284K, E439K, E468K, E219K, E518K, E482K	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000659906	10	43609084	10	43113636	659906	638905	rs769971379	NC_000010.11:43113635:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1840GAG[2] (p.Glu616del)	RET	E616del, E362del, E317del, E441del, E520del, E221del, E274del, E286del, E470del, E133del, E484del, E573del, E374del	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2|not specified	VCV000024900	10	43609084 - 43609086	10	43113636 - 43113638	24900	36241	rs377767399	NC_000010.11:43113635:GAGGAGGAG:GAGGAG	Microsatellite	inframe_indel|inframe_deletion	Conflicting classifications of pathogenicity	Jan 7, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1842G>A (p.Glu614=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001059010	10	43609086	10	43113638	1059010	1046533	rs1423361859	NC_000010.11:43113637:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1843G>A (p.Glu615Lys)	RET	E615K, E361K, E220K, E285K, E316K, E483K, E373K, E469K, E519K, E572K, E132K, E273K, E440K	Multiple endocrine neoplasia, type 2	VCV000938077	10	43609087	10	43113639	938077	935031	rs1837995252	NC_000010.11:43113638:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1845G>A (p.Glu615=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001781233	10	43609089	10	43113641	1781233	1839501		NC_000010.11:43113640:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1846G>C (p.Glu616Gln)	RET	E616Q, E362Q, E221Q, E484Q, E520Q, E374Q, E441Q, E470Q, E274Q, E286Q, E317Q, E133Q, E573Q	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001781253	10	43609090	10	43113642	1781253	540539	rs1393753095	NC_000010.11:43113641:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1846G>A (p.Glu616Lys)	RET	E616K, E362K, E441K, E286K, E374K, E520K, E221K, E274K, E470K, E133K, E317K, E484K, E573K	Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2	VCV001370424	10	43609090	10	43113642	1370424	1352761	rs1393753095	NC_000010.11:43113641:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 5, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1848G>A (p.Glu616=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000413453	10	43609092	10	43113644	413453	397274	rs1060504031	NC_000010.11:43113643:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 28, 2021	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1850A>T (p.Lys617Met)	RET	K222M, K287M, K363M, K521M, K617M, K442M, K471M, K574M, K134M, K375M, K275M, K318M, K485M	Multiple endocrine neoplasia, type 2	VCV003653170	10	43609094	10	43113646	3653170	3778559		NC_000010.11:43113645:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 13, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1850A>G (p.Lys617Arg)	RET	K134R, K375R, K222R, K318R, K363R, K442R, K574R, K275R, K485R, K521R, K617R, K287R, K471R	Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A	VCV003594755	10	43609094	10	43113646	3594755	3725959		NC_000010.11:43113645:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 5, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1851G>A (p.Lys617=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001597385	10	43609095	10	43113647	1597385	1664920	rs2132830668	NC_000010.11:43113646:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1852T>A (p.Cys618Ser)	RET	C618S, C364S, C472S, C522S, C575S, C319S, C486S, C223S, C288S, C376S, C135S, C276S, C443S	Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000038601	10	43609096	10	43113648	38601	47205	rs76262710	NC_000010.11:43113647:T:A	single nucleotide variant	missense variant	Pathogenic	Jan 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1852T>C (p.Cys618Arg)	RET	C618R, C364R, C288R, C276R, C319R, C376R, C443R, C472R, C522R, C135R, C223R, C575R, C486R	Multiple endocrine neoplasia type 2B|not provided|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome	VCV000013929	10	43609096	10	43113648	13929	28968	rs76262710	NC_000010.11:43113647:T:C	single nucleotide variant	missense variant	Pathogenic	Jan 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1852T>G (p.Cys618Gly)	RET	C618G, C364G, C288G, C472G, C135G, C575G, C276G, C319G, C522G, C223G, C376G, C443G, C486G	Multiple endocrine neoplasia, type 2|not provided|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Congenital central hypoventilation|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1	VCV000013905	10	43609096	10	43113648	13905	28944	rs76262710	NC_000010.11:43113647:T:G	single nucleotide variant	missense variant	Pathogenic	Nov 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1853G>T (p.Cys618Phe)	RET	C364F, C135F, C276F, C522F, C288F, C319F, C376F, C486F, C223F, C472F, C575F, C443F	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A|not provided|Multiple endocrine neoplasia, type 2	VCV000024902	10	43609097	10	43113649	24902	36243	rs79781594	NC_000010.11:43113648:G:T	single nucleotide variant	missense variant	Pathogenic	Jan 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1853G>A (p.Cys618Tyr)	RET	C364Y, C223Y, C288Y, C522Y, C135Y, C276Y, C443Y, C472Y, C486Y, C575Y, C319Y, C376Y	not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000024901	10	43609097	10	43113649	24901	36242	rs79781594	NC_000010.11:43113648:G:A	single nucleotide variant	missense variant	Pathogenic	May 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1853G>C (p.Cys618Ser)	RET	C618S, C364S, C223S, C276S, C288S, C443S, C486S, C376S, C522S, C575S, C135S, C319S, C472S	Multiple endocrine neoplasia type 2A|not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000013914	10	43609097	10	43113649	13914	28953	rs79781594	NC_000010.11:43113648:G:C	single nucleotide variant	missense variant	Pathogenic	Oct 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1855T>C (p.Phe619Leu)	RET	F136L, F224L, F277L, F289L, F320L, F365L, F377L, F444L, F473L, F487L, F523L, F576L, F619L	Hereditary cancer-predisposing syndrome	VCV003227516	10	43609099	10	43113651	3227516	3390728		NC_000010.11:43113650:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 15, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1855T>G (p.Phe619Val)	RET	F136V, F277V, F320V, F365V, F444V, F473V, F224V, F289V, F523V, F576V, F619V, F377V, F487V	Hereditary cancer-predisposing syndrome	VCV001781398	10	43609099	10	43113651	1781398	1838745		NC_000010.11:43113650:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 16, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1857C>T (p.Phe619=)	RET		Multiple endocrine neoplasia, type 2	VCV003687928	10	43609101	10	43113653	3687928	36245	rs377767401	NC_000010.11:43113652:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 28, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1858T>A (p.Cys620Ser)	RET	C620S, C366S, C290S, C474S, C488S, C524S, C137S, C278S, C321S, C577S, C225S, C378S, C445S	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000038602	10	43609102	10	43113654	38602	47206	rs77316810	NC_000010.11:43113653:T:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 31, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1858T>G (p.Cys620Gly)	RET	C366G, C225G, C290G, C321G, C488G, C524G, C137G, C278G, C445G, C577G, C378G, C474G	Multiple endocrine neoplasia, type 2|Aganglionic megacolon|not provided|Multiple endocrine neoplasia, type 2|not specified|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A	VCV000024905	10	43609102	10	43113654	24905	36246	rs77316810	NC_000010.11:43113653:T:G	single nucleotide variant	missense variant	Pathogenic	Jun 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1858T>C (p.Cys620Arg)	RET	C620R, C366R, C137R, C321R, C474R, C524R, C278R, C445R, C378R, C225R, C290R, C488R, C577R	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|Aganglionic megacolon|not provided|Hirschsprung disease, susceptibility to, 1	VCV000013915	10	43609102	10	43113654	13915	28954	rs77316810	NC_000010.11:43113653:T:C	single nucleotide variant	missense variant	Pathogenic	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1859G>C (p.Cys620Ser)	RET	C620S, C366S, C225S, C278S, C137S, C474S, C290S, C321S, C445S, C488S, C577S, C378S, C524S	not provided|Multiple endocrine neoplasia, type 2|MEN2 phenotype: Unclassified|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A	VCV000013943	10	43609103	10	43113655	13943	28982	rs77503355	NC_000010.11:43113654:G:C	single nucleotide variant	missense variant	Pathogenic	Sep 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1859G>T (p.Cys620Phe)	RET	C620F, C366F, C225F, C321F, C488F, C290F, C278F, C474F, C137F, C378F, C445F, C524F, C577F	Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B|not specified|Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	VCV000013928	10	43609103	10	43113655	13928	28967	rs77503355	NC_000010.11:43113654:G:T	single nucleotide variant	missense variant	Pathogenic	Jun 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1859G>A (p.Cys620Tyr)	RET	C620Y, C366Y, C225Y, C321Y, C445Y, C488Y, C524Y, C278Y, C290Y, C378Y, C577Y, C137Y, C474Y	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not provided	VCV000013916	10	43609103	10	43113655	13916	28955	rs77503355	NC_000010.11:43113654:G:A	single nucleotide variant	missense variant	Pathogenic	Nov 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1860C>A (p.Cys620Ter)	RET	C137*, C225*, C278*, C290*, C321*, C366*, C378*, C445*, C474*, C488*, C524*, C577*, C620*	Aganglionic megacolon	VCV003076011	10	43609104	10	43113656	3076011	3235297		NC_000010.11:43113655:C:A	single nucleotide variant	nonsense|intron variant	Pathogenic	Jul 30, 2015	criteria provided, single submitter							
NM_020975.6(RET):c.1860C>T (p.Cys620=)	RET		Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Hereditary cancer-predisposing syndrome	VCV000549782	10	43609104	10	43113656	549782	540542	rs79890926	NC_000010.11:43113655:C:T	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Dec 22, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1860C>G (p.Cys620Trp)	RET	C620W, C366W, C137W, C278W, C378W, C225W, C321W, C524W, C290W, C445W, C474W, C488W, C577W	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not provided	VCV000013934	10	43609104	10	43113656	13934	28973	rs79890926	NC_000010.11:43113655:C:G	single nucleotide variant	missense variant	Pathogenic	Jun 10, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1861G>A (p.Glu621Lys)	RET	E291K, E367K, E379K, E446K, E525K, E578K, E322K, E138K, E226K, E279K, E475K, E489K, E621K	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002160183	10	43609105	10	43113657	2160183	1883866		NC_000010.11:43113656:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1863G>A (p.Glu621=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000705332	10	43609107	10	43113659	705332	692838	rs766438951	NC_000010.11:43113658:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1863G>C (p.Glu621Asp)	RET	E621D, E367D, E279D, E379D, E578D, E446D, E475D, E489D, E138D, E226D, E291D, E322D, E525D	Hereditary cancer-predisposing syndrome	VCV000486351	10	43609107	10	43113659	486351	475274	rs766438951	NC_000010.11:43113658:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 16, 2017	criteria provided, single submitter							
NM_020975.6(RET):c.1864C>T (p.Pro622Ser)	RET	P139S, P447S, P476S, P579S, P622S, P227S, P280S, P323S, P490S, P526S, P292S, P368S, P380S	Hereditary cancer-predisposing syndrome	VCV001781557	10	43609108	10	43113660	1781557	1838903		NC_000010.11:43113659:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 16, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1865_1866delinsTT (p.Pro622Leu)	RET	P368L, P622L, P227L, P447L, P490L, P139L, P292L, P526L, P579L, P280L, P323L, P380L, P476L	Multiple endocrine neoplasia, type 2	VCV001014605	10	43609109 - 43609110	10	43113661 - 43113662	1014605	1008992	rs1837996489	NC_000010.11:43113660:CC:TT	Indel	missense variant	Uncertain significance	May 13, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.1866C>T (p.Pro622=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia, type 2	VCV000486300	10	43609110	10	43113662	486300	475101	rs201979255	NC_000010.11:43113661:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1866C>G (p.Pro622=)	RET		Multiple endocrine neoplasia, type 2|not specified|Hereditary cancer-predisposing syndrome	VCV000241340	10	43609110	10	43113662	241340	240794	rs201979255	NC_000010.11:43113661:C:G	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1867G>C (p.Glu623Gln)	RET	E140Q, E228Q, E281Q, E293Q, E324Q, E369Q, E381Q, E448Q, E477Q, E491Q, E527Q, E580Q, E623Q	RET-related disorder	VCV003345149	10	43609111	10	43113663	3345149	3503500		NC_000010.11:43113662:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 26, 2024	no assertion criteria provided							
NM_020975.6(RET):c.1867G>A (p.Glu623Lys)	RET	E369K, E293K, E381K, E448K, E491K, E477K, E527K, E580K, E140K, E281K, E324K, E228K	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A|not provided|Pheochromocytoma|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma	VCV000024906	10	43609111	10	43113663	24906	36247	rs377767402	NC_000010.11:43113662:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 28, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1871A>G (p.Asp624Gly)	RET	D624G, D370G, D229G, D325G, D382G, D492G, D528G, D141G, D449G, D282G, D294G, D478G, D581G	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000477329	10	43609115	10	43113667	477329	460285	rs1224456563	NC_000010.11:43113666:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1872C>T (p.Asp624=)	RET		Hereditary cancer-predisposing syndrome	VCV001781709	10	43609116	10	43113668	1781709	1835106		NC_000010.11:43113667:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 6, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1874T>C (p.Ile625Thr)	RET	I479T, I142T, I283T, I371T, I383T, I625T, I230T, I450T, I529T, I582T, I295T, I326T, I493T	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002454132	10	43609118	10	43113670	2454132	2424021		NC_000010.11:43113669:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1875C>G (p.Ile625Met)	RET	I142M, I283M, I295M, I383M, I529M, I326M, I230M, I450M, I479M, I493M, I582M, I371M, I625M	Multiple endocrine neoplasia, type 2	VCV003022598	10	43609119	10	43113671	3022598	3176352		NC_000010.11:43113670:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 16, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1876C>A (p.Gln626Lys)	RET	Q626K, Q372K, Q231K, Q143K, Q296K, Q384K, Q494K, Q284K, Q480K, Q327K, Q451K, Q530K, Q583K	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2	VCV000548925	10	43609120	10	43113672	548925	539282	rs1255575160	NC_000010.11:43113671:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1877A>T (p.Gln626Leu)	RET	Q143L, Q231L, Q284L, Q296L, Q327L, Q372L, Q384L, Q451L, Q480L, Q494L, Q530L, Q583L, Q626L	Multiple endocrine neoplasia, type 2	VCV001719251	10	43609121	10	43113673	1719251	1774555		NC_000010.11:43113672:A:T	single nucleotide variant	missense variant	Uncertain significance	Sep 11, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1879+1del	RET		Hereditary cancer-predisposing syndrome	VCV002231143	10	43609122	10	43113674	2231143	2227071		NC_000010.11:43113673:GGG:GG	Deletion	splice donor variant|intron variant	Likely pathogenic	May 19, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1878G>C (p.Gln626His)	RET	Q372H, Q626H, Q530H, Q284H, Q451H, Q494H, Q296H, Q327H, Q143H, Q231H, Q384H, Q480H, Q583H	Multiple endocrine neoplasia, type 2	VCV001403841	10	43609122	10	43113674	1403841	1467207	rs147692872	NC_000010.11:43113673:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 9, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1878G>A (p.Gln626=)	RET		Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000405550	10	43609122	10	43113674	405550	397456	rs147692872	NC_000010.11:43113673:G:A	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Jan 29, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1879G>A (p.Asp627Asn)	RET	D373N, D627N, D144N, D452N, D481N, D495N, D531N, D297N, D328N, D385N, D232N, A328T, A584T, A627T, D285N, D584N	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001352643	10	43609123	10	43113675	1352643	1505852	rs2132832112	NC_000010.11:43113674:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1879+1G>A	RET		Hirschsprung disease, susceptibility to, 1|not provided|Multiple endocrine neoplasia, type 2	VCV000666595	10	43609124	10	43113676	666595	654156	rs1588873476	NC_000010.11:43113675:G:A	single nucleotide variant	splice donor variant|intron variant	Pathogenic/Likely pathogenic	Nov 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1879+3G>A	RET		Multiple endocrine neoplasia, type 2	VCV001486162	10	43609126	10	43113678	1486162	1468639	rs1588873478	NC_000010.11:43113677:G:A	single nucleotide variant	intron variant	Uncertain significance	Apr 29, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1879+6T>C	RET		Multiple endocrine neoplasia, type 2	VCV000666200	10	43609129	10	43113681	666200	652000	rs1588873485	NC_000010.11:43113680:T:C	single nucleotide variant	intron variant	Uncertain significance	Sep 30, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1879+7G>C	RET		Multiple endocrine neoplasia, type 2	VCV002907997	10	43609130	10	43113682	2907997	3059695		NC_000010.11:43113681:G:C	single nucleotide variant	intron variant	Likely benign	Jun 25, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1879+7G>A	RET		Multiple endocrine neoplasia, type 2	VCV000763148	10	43609130	10	43113682	763148	775668	rs1188339370	NC_000010.11:43113681:G:A	single nucleotide variant	intron variant	Likely benign	Jul 16, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.1879+8G>C	RET		Multiple endocrine neoplasia, type 2	VCV001977729	10	43609131	10	43113683	1977729	2024089		NC_000010.11:43113682:G:C	single nucleotide variant	intron variant	Likely benign	Jan 26, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1879+8G>A	RET		Multiple endocrine neoplasia, type 2	VCV001114555	10	43609131	10	43113683	1114555	1098697	rs2132832354	NC_000010.11:43113682:G:A	single nucleotide variant	intron variant	Likely benign	Nov 29, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.1879+9G>T	RET		Multiple endocrine neoplasia, type 2	VCV000793743	10	43609132	10	43113684	793743	787838	rs1588873489	NC_000010.11:43113683:G:T	single nucleotide variant	intron variant	Likely benign	Oct 25, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.1879+11_1879+12dup	RET		Multiple endocrine neoplasia, type 2	VCV002699381	10	43609133 - 43609134	10	43113685 - 43113686	2699381	2865504		NC_000010.11:43113685:GG:GGGG	Duplication	intron variant	Likely benign	Nov 29, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1879+10T>G	RET		Multiple endocrine neoplasia, type 2	VCV001608086	10	43609133	10	43113685	1608086	1539525	rs2132832411	NC_000010.11:43113684:T:G	single nucleotide variant	intron variant	Likely benign	Oct 4, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1879+11G>A	RET		Multiple endocrine neoplasia, type 2	VCV002765749	10	43609134	10	43113686	2765749	2922623		NC_000010.11:43113685:G:A	single nucleotide variant	intron variant	Likely benign	Oct 23, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1879+12del	RET		Multiple endocrine neoplasia, type 2	VCV001569443	10	43609134	10	43113686	1569443	1603988	rs2132832465	NC_000010.11:43113685:GG:G	Deletion	intron variant	Likely benign	Jun 30, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1879+13C>T	RET		Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia	VCV000372091	10	43609136	10	43113688	372091	358824	rs375573788	NC_000010.11:43113687:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Feb 2, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1879+14G>T	RET		Multiple endocrine neoplasia, type 2	VCV001549511	10	43609137	10	43113689	1549511	1636978	rs532810255	NC_000010.11:43113688:G:T	single nucleotide variant	intron variant	Likely benign	Jun 30, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1879+14G>A	RET		Multiple endocrine neoplasia|Multiple endocrine neoplasia, type 2|Renal hypodysplasia/aplasia 1|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A	VCV000299895	10	43609137	10	43113689	299895	321384	rs532810255	NC_000010.11:43113688:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 17, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1879+15G>T	RET		Multiple endocrine neoplasia, type 2	VCV001612742	10	43609138	10	43113690	1612742	1601825	rs2132832570	NC_000010.11:43113689:G:T	single nucleotide variant	intron variant	Likely benign	Jan 16, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1879+17del	RET		Multiple endocrine neoplasia, type 2	VCV001576564	10	43609139	10	43113691	1576564	1586895	rs1837997790	NC_000010.11:43113690:CC:C	Deletion	intron variant	Likely benign	Jun 30, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1879+17C>G	RET		Multiple endocrine neoplasia, type 2	VCV002828169	10	43609140	10	43113692	2828169	2990107		NC_000010.11:43113691:C:G	single nucleotide variant	intron variant	Likely benign	Dec 30, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1879+17C>A	RET		Multiple endocrine neoplasia, type 2	VCV001598367	10	43609140	10	43113692	1598367	1660973	rs369920430	NC_000010.11:43113691:C:A	single nucleotide variant	intron variant	Likely benign	Jun 15, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1879+17C>T	RET		Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A	VCV000372086	10	43609140	10	43113692	372086	358825	rs369920430	NC_000010.11:43113691:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1879+18G>A	RET		Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2	VCV001667342	10	43609141	10	43113693	1667342	1591280	rs368088386	NC_000010.11:43113692:G:A	single nucleotide variant	intron variant	Likely benign	Dec 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1879+18G>T	RET		Multiple endocrine neoplasia, type 2	VCV001561117	10	43609141	10	43113693	1561117	1641524	rs368088386	NC_000010.11:43113692:G:T	single nucleotide variant	intron variant	Likely benign	Jul 21, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1879+20G>A	RET		Multiple endocrine neoplasia, type 2	VCV001627901	10	43609143	10	43113695	1627901	1531119	rs779561398	NC_000010.11:43113694:G:A	single nucleotide variant	intron variant	Likely benign	Nov 10, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1879+355G>A	RET		not provided	VCV002640414	10	43609478	10	43114030	2640414	2813106		NC_000010.11:43114029:G:A	single nucleotide variant	intron variant	Likely benign	Nov 1, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1880-18C>T	RET		Multiple endocrine neoplasia, type 2	VCV001573768	10	43609910	10	43114462	1573768	1538972	rs2132842419	NC_000010.11:43114461:C:T	single nucleotide variant	intron variant	Likely benign	Jul 25, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1880-17A>C	RET		Multiple endocrine neoplasia, type 2	VCV002157545	10	43609911	10	43114463	2157545	1889851		NC_000010.11:43114462:A:C	single nucleotide variant	intron variant	Likely benign	Sep 24, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1880-16C>T	RET		Multiple endocrine neoplasia, type 2	VCV001559983	10	43609912	10	43114464	1559983	1606517	rs370491323	NC_000010.11:43114463:C:T	single nucleotide variant	intron variant	Benign	Jan 26, 2025	criteria provided, single submitter							
NM_020975.6(RET):c.1880-15C>G	RET		Multiple endocrine neoplasia, type 2	VCV003726584	10	43609913	10	43114465	3726584	3855074		NC_000010.11:43114464:C:G	single nucleotide variant	intron variant	Likely benign	Dec 4, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1880-15C>T	RET		Multiple endocrine neoplasia, type 2	VCV001555384	10	43609913	10	43114465	1555384	1550089	rs758004890	NC_000010.11:43114464:C:T	single nucleotide variant	intron variant	Likely benign	Mar 5, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1880-14A>G	RET		Multiple endocrine neoplasia, type 2	VCV001937329	10	43609914	10	43114466	1937329	2003949		NC_000010.11:43114465:A:G	single nucleotide variant	intron variant	Likely benign	Jan 8, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1880-13C>G	RET		Multiple endocrine neoplasia, type 2	VCV002883772	10	43609915	10	43114467	2883772	3046526		NC_000010.11:43114466:C:G	single nucleotide variant	intron variant	Likely benign	Jan 4, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1880-13C>T	RET		Multiple endocrine neoplasia, type 2	VCV001621928	10	43609915	10	43114467	1621928	1593131	rs948277023	NC_000010.11:43114466:C:T	single nucleotide variant	intron variant	Likely benign	Aug 24, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1880-13C>A	RET		Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2	VCV001534816	10	43609915	10	43114467	1534816	1617332	rs948277023	NC_000010.11:43114466:C:A	single nucleotide variant	intron variant	Likely benign	Dec 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1880-12C>A	RET		Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma	VCV002974183	10	43609916	10	43114468	2974183	3136667		NC_000010.11:43114467:C:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Apr 15, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1880-12C>G	RET		Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia, type 2	VCV001636595	10	43609916	10	43114468	1636595	1558502	rs374893494	NC_000010.11:43114467:C:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 2, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1880-11C>G	RET		Multiple endocrine neoplasia, type 2	VCV002912731	10	43609917	10	43114469	2912731	3070843		NC_000010.11:43114468:C:G	single nucleotide variant	intron variant	Likely benign	Jan 16, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1880-10C>T	RET		Multiple endocrine neoplasia, type 2	VCV003069978	10	43609918	10	43114470	3069978	3233553		NC_000010.11:43114469:C:T	single nucleotide variant	intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1880-8dup	RET		Multiple endocrine neoplasia, type 2	VCV001113416	10	43609919 - 43609920	10	43114471 - 43114472	1113416	1098699	rs1838016391	NC_000010.11:43114471:A:AA	Duplication	intron variant	Likely benign	May 21, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.1880-9C>T	RET		Multiple endocrine neoplasia, type 2	VCV001100616	10	43609919	10	43114471	1100616	1098698	rs1160839983	NC_000010.11:43114470:C:T	single nucleotide variant	intron variant	Likely benign	Jul 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1880-8A>T	RET		Multiple endocrine neoplasia, type 2	VCV001671399	10	43609920	10	43114472	1671399	1530289	rs1588873979	NC_000010.11:43114471:A:T	single nucleotide variant	intron variant	Likely benign	Jan 13, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1880-5C>T	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002083636	10	43609923	10	43114475	2083636	2136295		NC_000010.11:43114474:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Oct 19, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1880-5C>A	RET		Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia|Hereditary cancer-predisposing syndrome|Pheochromocytoma|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia, type 2	VCV000877158	10	43609923	10	43114475	877158	868472	rs1838016447	NC_000010.11:43114474:C:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Mar 17, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1880-3C>T	RET		Multiple endocrine neoplasia, type 2	VCV002027249	10	43609925	10	43114477	2027249	2081322		NC_000010.11:43114476:C:T	single nucleotide variant	intron variant	Uncertain significance	Aug 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1880-2A>G	RET		Hirschsprung disease, susceptibility to, 1	VCV000036725	10	43609926	10	43114478	36725	45386	rs193922699	NC_000010.11:43114477:A:G	single nucleotide variant	splice acceptor variant|intron variant	Likely pathogenic	Aug 18, 2011	criteria provided, single submitter							
NM_020975.6(RET):c.1882_1890dup (p.Cys630_Asp631insProLeuCys)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002714254	10	43609929 - 43609930	10	43114481 - 43114482	2714254	2868791		NC_000010.11:43114481:CCACTGTGC:CCACTGTGCCCACTGTGC	Duplication	inframe_indel|inframe_insertion|intron variant	Uncertain significance	Mar 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1882C>T (p.Pro628Ser)	RET	P374S, P628S, P193S, P286S, P453S, P532S, P329S, P386S, P482S, P145S, P289S, P233S, P298S, P496S, P585S	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001014472	10	43609930	10	43114482	1014472	1008993	rs754466051	NC_000010.11:43114481:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1882C>G (p.Pro628Ala)	RET	P628A, P374A, P145A, P298A, P453A, P496A, P329A, P482A, P193A, P386A, P233A, P286A, P289A, P532A, P585A	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000477330	10	43609930	10	43114482	477330	460289	rs754466051	NC_000010.11:43114481:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1883C>T (p.Pro628Leu)	RET	P193L, P298L, P453L, P585L, P286L, P374L, P532L, P289L, P329L, P482L, P496L, P628L, P145L, P233L, P386L	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002076484	10	43609931	10	43114483	2076484	2138287		NC_000010.11:43114482:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1884A>G (p.Pro628=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001140640	10	43609932	10	43114484	1140640	1120267	rs786202671	NC_000010.11:43114483:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1884A>T (p.Pro628=)	RET		Hereditary cancer-predisposing syndrome	VCV000186071	10	43609932	10	43114484	186071	182954	rs786202671	NC_000010.11:43114483:A:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 4, 2014	criteria provided, single submitter							
NM_020975.6(RET):c.1885C>T (p.Leu629=)	RET		Hereditary cancer-predisposing syndrome	VCV001781969	10	43609933	10	43114485	1781969	1835365		NC_000010.11:43114484:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Feb 12, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1885C>G (p.Leu629Val)	RET	L375V, L533V, L586V, L629V, L234V, L299V, L483V, L194V, L287V, L290V, L330V, L387V, L497V, L146V, L454V	Hereditary cancer-predisposing syndrome	VCV001781964	10	43609933	10	43114485	1781964	1835360		NC_000010.11:43114484:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 27, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1886T>G (p.Leu629Arg)	RET	L387R, L629R, L146R, L194R, L287R, L483R, L497R, L330R, L375R, L454R, L234R, L290R, L299R, L533R, L586R	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002618861	10	43609934	10	43114486	2618861	2782606		NC_000010.11:43114485:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1886T>C (p.Leu629Pro)	RET	L375P, L629P, L290P, L483P, L586P, L146P, L194P, L287P, L299P, L497P, L234P, L330P, L533P, L387P, L454P	Multiple endocrine neoplasia, type 2	VCV000972018	10	43609934	10	43114486	972018	956049	rs1838016977	NC_000010.11:43114485:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 23, 2025	criteria provided, single submitter							
NM_020975.6(RET):c.1887G>A (p.Leu629=)	RET		Hereditary cancer-predisposing syndrome	VCV003313696	10	43609935	10	43114487	3313696	3465426		NC_000010.11:43114486:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 24, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1888T>A (p.Cys630Ser)	RET	C147S, C235S, C288S, C300S, C455S, C587S, C331S, C376S, C498S, C534S, C195S, C291S, C388S, C484S, C630S	Hereditary cancer-predisposing syndrome	VCV001782016	10	43609936	10	43114488	1782016	1835411		NC_000010.11:43114487:T:A	single nucleotide variant	missense variant	Likely pathogenic	Jan 28, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1888T>G (p.Cys630Gly)	RET	C376G, C630G, C147G, C195G, C288G, C331G, C235G, C484G, C534G, C291G, C388G, C455G, C498G, C300G, C587G	Multiple endocrine neoplasia, type 2	VCV000958196	10	43609936	10	43114488	958196	946891	rs377767404	NC_000010.11:43114487:T:G	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1888T>C (p.Cys630Arg)	RET	C376R, C195R, C288R, C331R, C388R, C455R, C147R, C235R, C300R, C484R, C587R, C291R, C498R, C534R	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000024908	10	43609936	10	43114488	24908	36249	rs377767404	NC_000010.11:43114487:T:C	single nucleotide variant	missense variant	Pathogenic	Jul 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1889G>A (p.Cys630Tyr)	RET	C376Y, C195Y, C291Y, C388Y, C587Y, C147Y, C235Y, C331Y, C484Y, C288Y, C300Y, C498Y, C455Y, C534Y	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2	VCV000024909	10	43609937	10	43114489	24909	36250	rs377767405	NC_000010.11:43114488:G:A	single nucleotide variant	missense variant	Pathogenic	Apr 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1890CGA[1] (p.Asp631del)	RET	D631del, D377del, D236del, D301del, D499del, D535del, D148del, D289del, D292del, D485del, D196del, D332del, D389del, D456del, D588del	Multiple endocrine neoplasia, type 2	VCV000549788	10	43609938 - 43609940	10	43114490 - 43114492	549788	540543	rs377767435	NC_000010.11:43114489:CGACGA:CGA	Microsatellite	inframe_indel|inframe_deletion	Uncertain significance	Aug 2, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.1890C>T (p.Cys630=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia|not specified|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2|Renal hypodysplasia/aplasia 1|Pheochromocytoma|not provided	VCV000215909	10	43609938	10	43114490	215909	212783	rs781145070	NC_000010.11:43114489:C:T	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Jan 19, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1891G>T (p.Asp631Tyr)	RET	D377Y, D292Y, D389Y, D499Y, D588Y, D148Y, D236Y, D485Y, D301Y, D196Y, D289Y, D332Y, D456Y, D535Y	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not provided	VCV000024914	10	43609939	10	43114491	24914	36255	rs377767406	NC_000010.11:43114490:G:T	single nucleotide variant	missense variant	Pathogenic	Mar 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1891G>A (p.Asp631Asn)	RET	D631N, D377N, D332N, D389N, D499N, D301N, D289N, D485N, D535N, D588N, D148N, D196N, D236N, D292N, D456N	Multiple endocrine neoplasia type 2A|not specified|Hirschsprung disease, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Pheochromocytoma|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma	VCV000024913	10	43609939	10	43114491	24913	36254	rs377767406	NC_000010.11:43114490:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 27, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1892_1903dup (p.Cys634_Arg635insHisGluLeuCys)	RET		MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA, WITHOUT PHEOCHROMOCYTOMA	VCV000013930	10	43609939 - 43609940	10	43114491 - 43114492	13930	28969	rs377767436	NC_000010.11:43114491:ACGAGCTGTGCC:ACGAGCTGTGCCACGAGCTGTGCC	Duplication	inframe_indel|inframe_insertion	Pathogenic	Apr 1, 1997	no assertion criteria provided							
NM_020975.6(RET):c.1892A>T (p.Asp631Val)	RET	D377V, D485V, D148V, D196V, D236V, D389V, D535V, D588V, D332V, D456V, D292V, D301V, D289V, D499V	Multiple endocrine neoplasia, type 2	VCV000024917	10	43609940	10	43114492	24917	36258	rs121913308	NC_000010.11:43114491:A:T	single nucleotide variant	missense variant	Uncertain significance	Feb 19, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.1893C>G (p.Asp631Glu)	RET	D289E, D377E, D535E, D148E, D292E, D456E, D631E, D236E, D301E, D485E, D499E, D196E, D332E, D389E, D588E	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002123053	10	43609941	10	43114493	2123053	2180947		NC_000010.11:43114492:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1893_1898del (p.Asp631_Leu633delinsGlu)	RET		Multiple endocrine neoplasia type 2B	VCV000986727	10	43609941 - 43609946	10	43114493 - 43114498	986727	974878	rs121913307	NC_000010.11:43114492:CGAGCT:	Deletion	inframe_indel	Likely pathogenic	Nov 19, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.1893C>A (p.Asp631Glu)	RET	D631E, D377E, D289E, D332E, D485E, D535E, D148E, D196E, D588E, D389E, D456E, D499E, D236E, D292E, D301E	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not specified|Hirschsprung disease, susceptibility to, 1	VCV000549831	10	43609941	10	43114493	549831	36259	rs55846256	NC_000010.11:43114492:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1893C>T (p.Asp631=)	RET		not provided|Multiple endocrine neoplasia type 2A|not specified|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000024919	10	43609941	10	43114493	24919	36260	rs55846256	NC_000010.11:43114492:C:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1894G>C (p.Glu632Gln)	RET	E293Q, E302Q, E486Q, E290Q, E457Q, E632Q, E197Q, E333Q, E378Q, E390Q, E536Q, E589Q, E149Q, E237Q, E500Q	Hereditary cancer-predisposing syndrome	VCV002496741	10	43609942	10	43114494	2496741	2467880		NC_000010.11:43114493:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 29, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1894_1899del (p.Glu632_Leu633del)	RET		Multiple endocrine neoplasia, type 2	VCV000376313	10	43609942 - 43609947	10	43114494 - 43114499	376313	363192	rs121913312	NC_000010.11:43114493:GAGCTG:	Deletion	inframe_indel|inframe_deletion	Uncertain significance	Oct 16, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.1894G>A (p.Glu632Lys)	RET	E378K, E237K, E293K, E333K, E589K, E197K, E390K, E500K, E149K, E290K, E457K, E302K, E486K, E536K	not provided|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Pheochromocytoma|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma	VCV000024920	10	43609942	10	43114494	24920	36261	rs377767407	NC_000010.11:43114493:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 2, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1895A>G (p.Glu632Gly)	RET	E632G, E378G, E237G, E457G, E290G, E293G, E302G, E390G, E536G, E500G, E149G, E197G, E333G, E486G, E589G	not provided|Multiple endocrine neoplasia, type 2	VCV001707858	10	43609943	10	43114495	1707858	540544	rs1335705237	NC_000010.11:43114494:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1895A>T (p.Glu632Val)	RET	E378V, E632V, E197V, E302V, E333V, E457V, E486V, E500V, E536V, E589V, E293V, E390V, E149V, E237V, E290V	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000941914	10	43609943	10	43114495	941914	935032	rs1335705237	NC_000010.11:43114494:A:T	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1897_1899del (p.Leu633del)	RET	L150del, L198del, L238del, L291del, L294del, L303del, L334del, L379del, L391del, L458del, L487del, L501del, L537del, L590del, L633del	Multiple endocrine neoplasia type 2A	VCV001709666	10	43609944 - 43609946	10	43114496 - 43114498	1709666	1708020		NC_000010.11:43114495:GCTG:G	Deletion	inframe_indel|inframe_deletion	Uncertain significance	Jul 18, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1896G>C (p.Glu632Asp)	RET	E378D, E632D, E149D, E197D, E302D, E486D, E500D, E237D, E290D, E293D, E536D, E589D, E333D, E390D, E457D		VCV000242788	10	43609944	10	43114496	242788	28945	rs387906531	NC_000010.11:43114495:G:C	single nucleotide variant	missense variant	no classification for the single variant		no classification for the single variant	no classification for the single variant		no classification for the single variant	no classification for the single variant		no classification for the single variant	
NM_020975.6(RET):c.1897C>G (p.Leu633Val)	RET	L379V, L633V, L590V, L150V, L198V, L238V, L391V, L458V, L291V, L303V, L334V, L487V, L537V, L294V, L501V	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|not provided|Multiple endocrine neoplasia, type 2	VCV000216718	10	43609945	10	43114497	216718	38399	rs267607010	NC_000010.11:43114496:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1899_1900delinsTC (p.Cys634Arg)	RET	C304R, C392R, C239R, C335R, C459R, C488R, C591R, C151R, C199R, C292R, C295R, C380R, C502R, C538R, C634R	Multiple endocrine neoplasia, type 2	VCV002779200	10	43609947 - 43609948	10	43114499 - 43114500	2779200	2940351		NC_000010.11:43114498:GT:TC	Indel	missense variant|intron variant	Pathogenic	Feb 9, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1899G>A (p.Leu633=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001782223	10	43609947	10	43114499	1782223	1842607		NC_000010.11:43114498:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1899_1900delinsAA (p.Cys634Ser)	RET	C488S, C502S, C538S, C591S, C295S, C392S, C151S, C239S, C304S, C335S, C634S, C199S, C292S, C380S, C459S	Hereditary cancer-predisposing syndrome	VCV001782209	10	43609947 - 43609948	10	43114499 - 43114500	1782209	1842593		NC_000010.11:43114498:GT:AA	Indel	missense variant	Pathogenic	May 30, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1900_1901delinsCT (p.Cys634Leu)	RET	C380L, C634L, C151L, C292L, C304L, C459L, C488L, C295L, C335L, C199L, C239L, C538L, C591L, C392L, C502L	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000820303	10	43609948 - 43609949	10	43114500 - 43114501	820303	809941	rs1588874068	NC_000010.11:43114499:TG:CT	Indel	missense variant	Conflicting classifications of pathogenicity	Dec 12, 2023	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1900T>A (p.Cys634Ser)	RET	C634S, C380S, C199S, C239S, C292S, C392S, C488S, C502S, C591S, C335S, C459S, C151S, C295S, C304S, C538S	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000038605	10	43609948	10	43114500	38605	47209	rs75076352	NC_000010.11:43114499:T:A	single nucleotide variant	missense variant	Pathogenic	Jul 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1900T>C (p.Cys634Arg)	RET	C634R, C380R, C239R, C295R, C304R, C392R, C502R, C459R, C292R, C335R, C488R, C538R, C151R, C199R, C591R	Multiple endocrine neoplasia type 2A|not provided|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2|Thyroid gland carcinoma|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Multiple endocrine neoplasia type 2B|Hereditary cancer-predisposing syndrome	VCV000013917	10	43609948	10	43114500	13917	28956	rs75076352	NC_000010.11:43114499:T:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1900T>G (p.Cys634Gly)	RET	C634G, C380G, C304G, C335G, C488G, C199G, C239G, C295G, C392G, C502G, C538G, C151G, C459G, C591G, C292G	MEN2 phenotype: Unclassified|Hereditary cancer-predisposing syndrome|Familial medullary thyroid carcinoma|not provided|Multiple endocrine neoplasia, type 2	VCV000013908	10	43609948	10	43114500	13908	28947	rs75076352	NC_000010.11:43114499:T:G	single nucleotide variant	missense variant	Pathogenic	Jul 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.4(RET):c.[1896G>C;1897C>G;1900T>C]	RET	C634R, C380R, C239R, C295R, C304R, C392R, C502R, C459R, C292R, C335R, C488R, C538R, C151R, C199R, C591R, L379V, L633V, L590V, L150V, L198V, L238V, L391V, L458V, L291V, L303V, L334V, L487V, L537V, L294V, L501V, E378D, E632D, E149D, E197D, E302D, E486D, E500D, E237D, E290D, E293D, E536D, E589D, E333D, E390D, E457D	Multiple endocrine neoplasia type 2A	VCV000013906	10|10|10	43609948	10|10|10	43114500	13906	28956|38399|28945	rs75076352|rs267607010|rs387906531	NC_000010.11:43114499:T:C|NC_000010.11:43114496:C:G|NC_000010.11:43114495:G:C	Haplotype	missense variant	Pathogenic	Jan 1, 1994	no assertion criteria provided							
NM_020975.6(RET):c.1901_1902delinsTT (p.Cys634Phe)	RET	C151F, C392F, C199F, C295F, C304F, C488F, C591F, C292F, C380F, C502F, C239F, C335F, C459F, C538F, C634F	Multiple endocrine neoplasia, type 2	VCV002025097	10	43609949 - 43609950	10	43114501 - 43114502	2025097	2084300		NC_000010.11:43114500:GC:TT	Indel	missense variant	Pathogenic	Aug 20, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1901G>T (p.Cys634Phe)	RET	C634F, C380F, C295F, C459F, C335F, C392F, C488F, C199F, C292F, C304F, C502F, C538F, C151F, C239F, C591F	not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2	VCV000013911	10	43609949	10	43114501	13911	28950	rs75996173	NC_000010.11:43114500:G:T	single nucleotide variant	missense variant	Pathogenic	Apr 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1901G>C (p.Cys634Ser)	RET	C634S, C380S, C292S, C295S, C459S, C502S, C239S, C538S, C151S, C199S, C304S, C335S, C392S, C488S, C591S	not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2B	VCV000013910	10	43609949	10	43114501	13910	28949	rs75996173	NC_000010.11:43114500:G:C	single nucleotide variant	missense variant	Pathogenic	Aug 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1901G>A (p.Cys634Tyr)	RET	C634Y, C380Y, C292Y, C392Y, C502Y, C538Y, C239Y, C335Y, C459Y, C591Y, C199Y, C304Y, C488Y, C151Y, C295Y	Multiple endocrine neoplasia, type 2|not provided|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome	VCV000013909	10	43609949	10	43114501	13909	28948	rs75996173	NC_000010.11:43114500:G:A	single nucleotide variant	missense variant	Pathogenic	Nov 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1902_1903inv (p.Cys634_Arg635delinsTrpGly)	RET		Multiple endocrine neoplasia, type 2	VCV001458805	10	43609950 - 43609951	10	43114502 - 43114503	1458805	1491153		NC_000010.11:43114501:CC:GG	Inversion	missense variant	Pathogenic	Aug 6, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1902_1903delinsTT (p.Arg635Cys)	RET	R381C, R635C, R489C, R503C, R293C, R460C, R152C, R200C, R305C, R336C, R393C, R240C, R296C, R539C, R592C	not specified	VCV001338394	10	43609950 - 43609951	10	43114502 - 43114503	1338394	1329402	rs2132844768	NC_000010.11:43114501:CC:TT	Indel	missense variant	Uncertain significance	Apr 3, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.1902C>G (p.Cys634Trp)	RET	C634W, C380W, C199W, C292W, C304W, C459W, C538W, C239W, C335W, C591W, C295W, C392W, C151W, C488W, C502W	Multiple endocrine neoplasia, type 2|not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A	VCV000013918	10	43609950	10	43114502	13918	28957	rs77709286	NC_000010.11:43114501:C:G	single nucleotide variant	missense variant	Pathogenic	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1903C>T (p.Arg635Cys)	RET	R635C, R381C, R240C, R296C, R336C, R489C, R293C, R393C, R460C, R539C, R305C, R152C, R200C, R503C, R592C	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|not provided|Hirschsprung disease, susceptibility to, 1	VCV000477333	10	43609951	10	43114503	477333	459845	rs377767410	NC_000010.11:43114502:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1904G>T (p.Arg635Leu)	RET	R635L, R381L, R240L, R305L, R460L, R336L, R539L, R592L, R200L, R293L, R393L, R503L, R152L, R296L, R489L	Multiple endocrine neoplasia, type 2	VCV000571671	10	43609952	10	43114504	571671	563746	rs776164321	NC_000010.11:43114503:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 26, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1904G>A (p.Arg635His)	RET	R635H, R381H, R336H, R393H, R489H, R296H, R503H, R200H, R293H, R305H, R460H, R592H, R152H, R240H, R539H	Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia, type 2	VCV000220149	10	43609952	10	43114504	220149	221963	rs776164321	NC_000010.11:43114503:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1905C>G (p.Arg635=)	RET		Hereditary cancer-predisposing syndrome	VCV001782371	10	43609953	10	43114505	1782371	1842755		NC_000010.11:43114504:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 17, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1905C>T (p.Arg635=)	RET		Multiple endocrine neoplasia, type 2	VCV001419840	10	43609953	10	43114505	1419840	1410058	rs2132844912	NC_000010.11:43114504:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Feb 24, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1907C>T (p.Thr636Met)	RET	T636M, T382M, T201M, T241M, T394M, T540M, T297M, T306M, T593M, T294M, T504M, T153M, T337M, T461M, T490M	Hirschsprung disease, susceptibility to, 1|not provided|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|RET-related disorder|Multiple endocrine neoplasia, type 2	VCV000405553	10	43609955	10	43114507	405553	397281	rs1035958105	NC_000010.11:43114506:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1908G>A (p.Thr636=)	RET		Hereditary cancer-predisposing syndrome|not specified|not provided|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B	VCV000261395	10	43609956	10	43114508	261395	253766	rs886038663	NC_000010.11:43114507:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1909G>T (p.Val637Leu)	RET	V202L, V295L, V307L, V395L, V491L, V541L, V505L, V298L, V383L, V462L, V154L, V242L, V338L, V594L, V637L	Hereditary cancer-predisposing syndrome	VCV003313736	10	43609957	10	43114509	3313736	3465466		NC_000010.11:43114508:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 16, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1910T>C (p.Val637Ala)	RET	V295A, V298A, V338A, V491A, V541A, V637A, V154A, V307A, V395A, V462A, V594A, V202A, V242A, V383A, V505A	Hereditary cancer-predisposing syndrome	VCV003432211	10	43609958	10	43114510	3432211	3593407		NC_000010.11:43114509:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 11, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1910T>G (p.Val637Gly)	RET	V383G, V637G, V202G, V307G, V395G, V154G, V295G, V491G, V505G, V594G, V462G, V541G, V242G, V298G, V338G	Multiple endocrine neoplasia, type 2	VCV001021928	10	43609958	10	43114510	1021928	1008994	rs1713933379	NC_000010.11:43114509:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 22, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1911G>A (p.Val637=)	RET		Hereditary cancer-predisposing syndrome	VCV003227517	10	43609959	10	43114511	3227517	3390729		NC_000010.11:43114510:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 19, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1911G>T (p.Val637=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001108930	10	43609959	10	43114511	1108930	1098700	rs761187737	NC_000010.11:43114510:G:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1914C>G (p.Ile638Met)	RET	I203M, I243M, I492M, I506M, I339M, I384M, I396M, I463M, I155M, I299M, I595M, I638M, I296M, I308M, I542M	Hereditary cancer-predisposing syndrome	VCV001782552	10	43609962	10	43114514	1782552	1842936		NC_000010.11:43114513:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 15, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1914C>T (p.Ile638=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000820331	10	43609962	10	43114514	820331	809942	rs375041479	NC_000010.11:43114513:C:T	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Nov 16, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1915G>T (p.Ala639Ser)	RET	A639S, A385S, A204S, A297S, A464S, A244S, A300S, A507S, A309S, A493S, A543S, A596S, A156S, A340S, A397S	Multiple endocrine neoplasia, type 2	VCV001466483	10	43609963	10	43114515	1466483	1347842	rs777122776	NC_000010.11:43114514:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1915G>A (p.Ala639Thr)	RET	A639T, A385T, A300T, A397T, A507T, A309T, A596T, A156T, A204T, A297T, A340T, A493T, A244T, A464T, A543T	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1	VCV000241341	10	43609963	10	43114515	241341	240795	rs777122776	NC_000010.11:43114514:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Mar 24, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1917A>C (p.Ala639=)	RET		Hereditary cancer-predisposing syndrome	VCV003432198	10	43609965	10	43114517	3432198	3593395		NC_000010.11:43114516:A:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 2, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1917A>G (p.Ala639=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000820337	10	43609965	10	43114517	820337	809943	rs1343990457	NC_000010.11:43114516:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1918G>A (p.Ala640Thr)	RET	A640T, A386T, A301T, A398T, A508T, A544T, A157T, A245T, A341T, A465T, A205T, A310T, A494T, A597T, A298T	Multiple endocrine neoplasia, type 2	VCV000662696	10	43609966	10	43114518	662696	638906	rs1224994492	NC_000010.11:43114517:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 14, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1919C>G (p.Ala640Gly)	RET	A640G, A386G, A245G, A341G, A398G, A465G, A301G, A508G, A157G, A205G, A494G, A544G, A298G, A310G, A597G	Multiple endocrine neoplasia type 2A	VCV000013942	10	43609967	10	43114519	13942	28981	rs78935588	NC_000010.11:43114518:C:G	single nucleotide variant	missense variant	Pathogenic	Oct 1, 1999	no assertion criteria provided							
NM_020975.6(RET):c.1920C>A (p.Ala640=)	RET		Hereditary cancer-predisposing syndrome	VCV001782666	10	43609968	10	43114520	1782666	1846031		NC_000010.11:43114519:C:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 8, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1920C>T (p.Ala640=)	RET		Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Pheochromocytoma|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia|Multiple endocrine neoplasia, type 2	VCV000136105	10	43609968	10	43114520	136105	139817	rs149768519	NC_000010.11:43114519:C:T	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Dec 31, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1921G>C (p.Ala641Pro)	RET	A387P, A641P, A158P, A302P, A246P, A466P, A509P, A299P, A342P, A545P, A598P, A206P, A311P, A399P, A495P	not provided|Familial medullary thyroid carcinoma	VCV001698934	10	43609969	10	43114521	1698934	1691310	rs377767411	NC_000010.11:43114520:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 15, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1921G>T (p.Ala641Ser)	RET	A387S, A158S, A206S, A299S, A311S, A246S, A302S, A399S, A509S, A545S, A342S, A466S, A495S, A598S	Multiple endocrine neoplasia, type 2	VCV000549833	10	43609969	10	43114521	549833	36268	rs377767411	NC_000010.11:43114520:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1921G>A (p.Ala641Thr)	RET	A641T, A387T, A246T, A545T, A206T, A311T, A342T, A509T, A158T, A299T, A302T, A495T, A598T, A399T, A466T	Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000241342	10	43609969	10	43114521	241342	240796	rs377767411	NC_000010.11:43114520:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 12, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1923T>C (p.Ala641=)	RET		Multiple endocrine neoplasia, type 2	VCV003002062	10	43609971	10	43114523	3002062	3157239		NC_000010.11:43114522:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 17, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1924G>C (p.Val642Leu)	RET	V159L, V400L, V467L, V510L, V247L, V343L, V599L, V300L, V546L, V642L, V207L, V303L, V312L, V388L, V496L	Hereditary cancer-predisposing syndrome	VCV003313703	10	43609972	10	43114524	3313703	3465433		NC_000010.11:43114523:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 28, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1924G>A (p.Val642Ile)	RET	V300I, V303I, V312I, V467I, V546I, V159I, V207I, V247I, V388I, V496I, V343I, V400I, V510I, V599I, V642I	Multiple endocrine neoplasia, type 2	VCV002056611	10	43609972	10	43114524	2056611	2109314		NC_000010.11:43114523:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 30, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1927_1929del (p.Leu643del)	RET	L208del, L389del, L600del, L160del, L468del, L248del, L301del, L304del, L344del, L401del, L547del, L313del, L497del, L511del, L643del	Multiple endocrine neoplasia, type 2	VCV002121795	10	43609973 - 43609975	10	43114525 - 43114527	2121795	2176989		NC_000010.11:43114524:TCCTC:TC	Deletion	inframe_indel|inframe_deletion	Uncertain significance	Dec 14, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1926C>G (p.Val642=)	RET		not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000543792	10	43609974	10	43114526	543792	525302	rs766962871	NC_000010.11:43114525:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1927C>T (p.Leu643Phe)	RET	L160F, L208F, L248F, L301F, L304F, L313F, L344F, L389F, L401F, L468F, L497F, L511F, L547F, L600F, L643F	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV003387598	10	43609975	10	43114527	3387598	3546731		NC_000010.11:43114526:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1927C>G (p.Leu643Val)	RET	L208V, L248V, L304V, L389V, L497V, L547V, L313V, L643V, L344V, L401V, L468V, L160V, L301V, L511V, L600V	Hereditary cancer-predisposing syndrome	VCV002568381	10	43609975	10	43114527	2568381	2734917		NC_000010.11:43114526:C:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 5, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1928T>A (p.Leu643His)	RET	L248H, L344H, L468H, L643H, L389H, L497H, L511H, L160H, L301H, L304H, L313H, L401H, L600H, L208H, L547H	Hereditary cancer-predisposing syndrome	VCV003313732	10	43609976	10	43114528	3313732	3465462		NC_000010.11:43114527:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 8, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1928T>C (p.Leu643Pro)	RET	L389P, L643P, L208P, L248P, L301P, L304P, L313P, L468P, L600P, L160P, L401P, L344P, L497P, L511P, L547P	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001448097	10	43609976	10	43114528	1448097	1400109	rs2132846207	NC_000010.11:43114527:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 29, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1931T>G (p.Phe644Cys)	RET	F644C, F390C, F601C, F305C, F314C, F469C, F302C, F498C, F548C, F161C, F209C, F249C, F345C, F402C, F512C	Hereditary cancer-predisposing syndrome	VCV000486332	10	43609979	10	43114531	486332	475275	rs1554818910	NC_000010.11:43114530:T:G	single nucleotide variant	missense variant	Uncertain significance	Jan 21, 2016	criteria provided, single submitter							
NM_020975.6(RET):c.1932C>T (p.Phe644=)	RET		Multiple endocrine neoplasia, type 2	VCV002112025	10	43609980	10	43114532	2112025	2160846		NC_000010.11:43114531:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 14, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1934_1936del (p.Ser645del)	RET	S645del, S391del, S499del, S210del, S315del, S346del, S513del, S549del, S306del, S470del, S602del, S162del, S250del, S303del, S403del	Multiple endocrine neoplasia, type 2|not specified|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2B	VCV000543756	10	43609980 - 43609982	10	43114532 - 43114534	543756	525640	rs1416677590	NC_000010.11:43114531:CTCCT:CT	Deletion	inframe_indel|inframe_deletion	Uncertain significance	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1933T>C (p.Ser645Pro)	RET	S162P, S210P, S303P, S499P, S250P, S346P, S513P, S549P, S645P, S306P, S315P, S391P, S403P, S470P, S602P	Multiple endocrine neoplasia, type 2	VCV002849616	10	43609981	10	43114533	2849616	3009405		NC_000010.11:43114532:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 26, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1934C>T (p.Ser645Phe)	RET	S210F, S391F, S549F, S162F, S250F, S403F, S602F, S645F, S303F, S346F, S470F, S306F, S315F, S499F, S513F	Hereditary cancer-predisposing syndrome	VCV002568377	10	43609982	10	43114534	2568377	2734913		NC_000010.11:43114533:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 2, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1934C>G (p.Ser645Cys)	RET	S250C, S315C, S470C, S645C, S162C, S303C, S210C, S391C, S403C, S549C, S602C, S306C, S346C, S499C, S513C	Hereditary cancer-predisposing syndrome	VCV001782930	10	43609982	10	43114534	1782930	1846294		NC_000010.11:43114533:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1936T>G (p.Phe646Val)	RET	F163V, F211V, F251V, F304V, F307V, F316V, F347V, F392V, F404V, F471V, F500V, F514V, F550V, F603V, F646V	Multiple endocrine neoplasia, type 2	VCV001715209	10	43609984	10	43114536	1715209	1775354		NC_000010.11:43114535:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 5, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1939A>G (p.Ile647Val)	RET	I252V, I305V, I317V, I472V, I551V, I348V, I212V, I308V, I393V, I501V, I515V, I164V, I405V, I604V, I647V	Multiple endocrine neoplasia, type 2	VCV003631469	10	43609987	10	43114539	3631469	3772950		NC_000010.11:43114538:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 4, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1941C>T (p.Ile647=)	RET		Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A	VCV000013939	10	43609989	10	43114541	13939	28978	rs75225191	NC_000010.11:43114540:C:T	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Jan 28, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1942G>T (p.Val648Phe)	RET	V394F, V648F, V318F, V406F, V165F, V306F, V309F, V502F, V516F, V552F, V605F, V253F, V349F, V213F, V473F	Hereditary cancer-predisposing syndrome|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2|not provided	VCV000997472	10	43609990	10	43114542	997472	985269	rs77711105	NC_000010.11:43114541:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1942G>A (p.Val648Ile)	RET	V648I, V394I, V306I, V318I, V349I, V253I, V309I, V516I, V605I, V165I, V213I, V473I, V502I, V406I, V552I	not specified|not provided|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000013949	10	43609990	10	43114542	13949	28988	rs77711105	NC_000010.11:43114541:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 31, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1943T>C (p.Val648Ala)	RET	V648A, V394A, V213A, V318A, V605A, V309A, V502A, V165A, V253A, V473A, V516A, V306A, V349A, V406A, V552A	Multiple endocrine neoplasia, type 2|not provided	VCV000220384	10	43609991	10	43114543	220384	221964	rs864622505	NC_000010.11:43114542:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1944C>T (p.Val648=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000747818	10	43609992	10	43114544	747818	752100	rs1588874169	NC_000010.11:43114543:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 16, 2019	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1946C>T (p.Ser649Leu)	RET	S395L, S503L, S254L, S407L, S553L, S166L, S214L, S319L, S307L, S310L, S350L, S474L, S517L, S606L	not provided|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Pheochromocytoma|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1|not specified	VCV000024928	10	43609994	10	43114546	24928	36269	rs148935214	NC_000010.11:43114545:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 2, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1947G>C (p.Ser649=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001783153	10	43609995	10	43114547	1783153	1843098		NC_000010.11:43114546:G:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1947G>A (p.Ser649=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Congenital central hypoventilation|Familial medullary thyroid carcinoma|not provided	VCV000024929	10	43609995	10	43114547	24929	36270	rs377767412	NC_000010.11:43114546:G:A	single nucleotide variant	synonymous variant|intron variant	Pathogenic/Likely pathogenic	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1948G>A (p.Val650Met)	RET	V215M, V311M, V320M, V518M, V255M, V408M, V475M, V607M, V167M, V351M, V396M, V308M, V504M, V554M, V650M	Multiple endocrine neoplasia, type 2	VCV002808343	10	43609996	10	43114548	2808343	2968145		NC_000010.11:43114547:G:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 18, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1953G>C (p.Leu651=)	RET		Multiple endocrine neoplasia, type 2	VCV000764996	10	43610001	10	43114553	764996	767742	rs1588874175	NC_000010.11:43114552:G:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 6, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1956G>C (p.Leu652=)	RET		Hereditary cancer-predisposing syndrome	VCV002568344	10	43610004	10	43114556	2568344	2734880		NC_000010.11:43114555:G:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 28, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1956_1965delinsACCACTCTACCACAAGTT (p.Ser653fs)	RET	S399fs, S653fs	Multiple endocrine neoplasia, type 2	VCV002044531	10	43610004 - 43610013	10	43114556 - 43114565	2044531	2095956		NC_000010.11:43114555:GTCTGCCTTC:ACCACTCTACCACAAGTT	Indel	frameshift variant	Pathogenic	Dec 16, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1956G>A (p.Leu652=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000760115	10	43610004	10	43114556	760115	767743	rs954292063	NC_000010.11:43114555:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 4, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1957T>A (p.Ser653Thr)	RET	S170T, S218T, S258T, S311T, S314T, S323T, S354T, S399T, S411T, S478T, S507T, S521T, S557T, S610T, S653T	Multiple endocrine neoplasia, type 2	VCV003071183	10	43610005	10	43114557	3071183	3228764		NC_000010.11:43114556:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 16, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1958C>G (p.Ser653Cys)	RET	S653C, S399C, S411C, S323C, S478C, S507C, S218C, S311C, S314C, S521C, S557C, S610C, S170C, S258C, S354C	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000477334	10	43610006	10	43114558	477334	459848	rs753724503	NC_000010.11:43114557:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 17, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1961C>T (p.Ala654Val)	RET	A259V, A611V, A355V, A400V, A412V, A508V, A558V, A219V, A522V, A171V, A312V, A315V, A324V, A479V, A654V	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002900346	10	43610009	10	43114561	2900346	3060689		NC_000010.11:43114560:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Oct 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1962C>A (p.Ala654=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001119013	10	43610010	10	43114562	1119013	1098701	rs1350081720	NC_000010.11:43114561:C:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1963T>G (p.Phe655Val)	RET	F655V, F401V, F260V, F313V, F480V, F509V, F559V, F172V, F316V, F356V, F612V, F220V, F325V, F413V, F523V	Multiple endocrine neoplasia, type 2	VCV000945938	10	43610011	10	43114563	945938	925805	rs756978792	NC_000010.11:43114562:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 1, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1963T>C (p.Phe655Leu)	RET	F655L, F401L, F172L, F480L, F509L, F559L, F260L, F325L, F523L, F220L, F313L, F316L, F356L, F413L, F612L	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000543730	10	43610011	10	43114563	543730	525641	rs756978792	NC_000010.11:43114562:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 23, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1965C>G (p.Phe655Leu)	RET	F260L, F413L, F480L, F559L, F509L, F523L, F316L, F612L, F172L, F220L, F313L, F325L, F356L, F401L, F655L	Multiple endocrine neoplasia, type 2	VCV002180164	10	43610013	10	43114565	2180164	1912749		NC_000010.11:43114564:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 12, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1965C>T (p.Phe655=)	RET		Hereditary cancer-predisposing syndrome	VCV001783511	10	43610013	10	43114565	1783511	1839607		NC_000010.11:43114564:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 31, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.1968C>T (p.Cys656=)	RET		Multiple endocrine neoplasia, type 2|not provided|Hereditary cancer-predisposing syndrome	VCV001783556	10	43610016	10	43114568	1783556	1839652		NC_000010.11:43114567:C:T	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Nov 10, 2022	criteria provided, conflicting classifications							
NM_020975.6(RET):c.1969A>T (p.Ile657Phe)	RET	I174F, I318F, I262F, I415F, I482F, I358F, I403F, I525F, I657F, I222F, I315F, I327F, I511F, I561F, I614F	Multiple endocrine neoplasia, type 2	VCV002006211	10	43610017	10	43114569	2006211	2069306		NC_000010.11:43114568:A:T	single nucleotide variant	missense variant	Uncertain significance	Jun 14, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1971_1978del (p.His658fs)	RET	H175fs, H223fs, H263fs, H316fs, H319fs, H328fs, H359fs, H404fs, H416fs, H483fs, H512fs, H526fs, H562fs, H615fs, H658fs	RET-related disorder	VCV003061203	10	43610018 - 43610025	10	43114570 - 43114577	3061203	3193709		NC_000010.11:43114569:TCCACTGCT:T	Deletion	frameshift variant|intron variant	Likely pathogenic	Jan 31, 2024	no assertion criteria provided							
NM_020975.6(RET):c.1971C>T (p.Ile657=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002454150	10	43610019	10	43114571	2454150	2424039		NC_000010.11:43114570:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jun 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1971C>G (p.Ile657Met)	RET	I403M, I657M, I318M, I415M, I174M, I358M, I561M, I614M, I222M, I262M, I327M, I482M, I511M, I525M, I315M	Multiple endocrine neoplasia, type 2	VCV001061735	10	43610019	10	43114571	1061735	1046534	rs2132848081	NC_000010.11:43114570:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1972C>T (p.His658Tyr)	RET	H175Y, H223Y, H263Y, H316Y, H319Y, H328Y, H359Y, H404Y, H416Y, H483Y, H512Y, H526Y, H562Y, H615Y, H658Y	Multiple endocrine neoplasia, type 2	VCV001714564	10	43610020	10	43114572	1714564	1771181		NC_000010.11:43114571:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 15, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1973A>T (p.His658Leu)	RET	H175L, H319L, H328L, H512L, H223L, H316L, H359L, H416L, H526L, H615L, H263L, H562L, H658L, H404L, H483L	Hereditary cancer-predisposing syndrome	VCV001783659	10	43610021	10	43114573	1783659	1839755		NC_000010.11:43114572:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 12, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1973A>G (p.His658Arg)	RET	H658R, H404R, H263R, H526R, H359R, H512R, H562R, H316R, H319R, H328R, H416R, H483R, H175R, H223R, H615R	Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000575557	10	43610021	10	43114573	575557	569646	rs1274484329	NC_000010.11:43114572:A:G	single nucleotide variant	missense variant	Uncertain significance	May 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1974C>T (p.His658=)	RET		Hereditary cancer-predisposing syndrome	VCV001783674	10	43610022	10	43114574	1783674	1839770		NC_000010.11:43114573:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 17, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.1977C>G (p.Cys659Trp)	RET	C405W, C659W, C329W, C513W, C527W, C176W, C224W, C317W, C563W, C264W, C616W, C320W, C360W, C417W, C484W	Multiple endocrine neoplasia, type 2	VCV001392057	10	43610025	10	43114577	1392057	1409398	rs2132848413	NC_000010.11:43114576:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 19, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1978T>C (p.Tyr660His)	RET	Y406H, Y660H, Y318H, Y330H, Y528H, Y564H, Y617H, Y361H, Y485H, Y514H, Y177H, Y321H, Y225H, Y265H, Y418H	Multiple endocrine neoplasia, type 2	VCV001399257	10	43610026	10	43114578	1399257	1450552	rs2132848458	NC_000010.11:43114577:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 5, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.1980C>T (p.Tyr660=)	RET		Hereditary cancer-predisposing syndrome	VCV001783802	10	43610028	10	43114580	1783802	1839898		NC_000010.11:43114579:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 24, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.1981C>T (p.His661Tyr)	RET	H178Y, H226Y, H266Y, H319Y, H322Y, H331Y, H362Y, H407Y, H419Y, H486Y, H515Y, H529Y, H565Y, H618Y, H661Y	Hereditary cancer-predisposing syndrome	VCV003227518	10	43610029	10	43114581	3227518	3390730		NC_000010.11:43114580:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 22, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1982A>G (p.His661Arg)	RET	H407R, H661R, H178R, H319R, H529R, H565R, H618R, H266R, H486R, H515R, H226R, H331R, H362R, H419R, H322R	Multiple endocrine neoplasia, type 2	VCV001353140	10	43610030	10	43114582	1353140	1421122	rs1838023752	NC_000010.11:43114581:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 4, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1983C>T (p.His661=)	RET		Multiple endocrine neoplasia, type 2	VCV003728173	10	43610031	10	43114583	3728173	3855373		NC_000010.11:43114582:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 28, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1983C>G (p.His661Gln)	RET	H226Q, H362Q, H618Q, H322Q, H515Q, H661Q, H178Q, H319Q, H266Q, H331Q, H419Q, H486Q, H407Q, H529Q, H565Q	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001783841	10	43610031	10	43114583	1783841	1839937		NC_000010.11:43114582:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1984A>G (p.Lys662Glu)	RET	K408E, K662E, K227E, K516E, K267E, K320E, K530E, K566E, K619E, K179E, K487E, K323E, K332E, K363E, K420E	Multiple endocrine neoplasia, type 2	VCV000935423	10	43610032	10	43114584	935423	935033	rs1838023938	NC_000010.11:43114583:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 14, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.1985A>G (p.Lys662Arg)	RET	K408R, K662R, K267R, K420R, K487R, K516R, K619R, K320R, K332R, K566R, K179R, K323R, K227R, K363R, K530R	Multiple endocrine neoplasia, type 2	VCV001036436	10	43610033	10	43114585	1036436	1029539	rs1588874193	NC_000010.11:43114584:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 26, 2025	criteria provided, single submitter							
NM_020975.6(RET):c.1985A>C (p.Lys662Thr)	RET	K662T, K408T, K323T, K420T, K179T, K227T, K267T, K363T, K516T, K530T, K566T, K487T, K320T, K332T, K619T	Multiple endocrine neoplasia, type 2|Neoplasm	VCV000645616	10	43610033	10	43114585	645616	638907	rs1588874193	NC_000010.11:43114584:A:C	single nucleotide variant	missense variant	Uncertain significance	Dec 17, 2018	criteria provided, single submitter				Uncertain significance	Jul 31, 2024	criteria provided, single submitter	
NM_020975.6(RET):c.1986G>A (p.Lys662=)	RET		Multiple endocrine neoplasia, type 2	VCV001537924	10	43610034	10	43114586	1537924	1619151	rs1295196408	NC_000010.11:43114585:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Oct 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1990G>T (p.Ala664Ser)	RET	A410S, A664S, A229S, A518S, A568S, A334S, A489S, A181S, A325S, A532S, A621S, A269S, A322S, A365S, A422S	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000655947	10	43610038	10	43114590	655947	638908	rs1357060080	NC_000010.11:43114589:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1991C>A (p.Ala664Asp)	RET	A181D, A334D, A664D, A229D, A410D, A518D, A621D, A269D, A489D, A532D, A322D, A325D, A365D, A422D, A568D	Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A	VCV003594792	10	43610039	10	43114591	3594792	3726006		NC_000010.11:43114590:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 15, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1991C>T (p.Ala664Val)	RET	A664V, A410V, A422V, A532V, A568V, A229V, A325V, A334V, A518V, A322V, A365V, A621V, A181V, A269V, A489V	Multiple endocrine neoplasia, type 2	VCV001496887	10	43610039	10	43114591	1496887	1382289	rs2132848989	NC_000010.11:43114590:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 15, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1993C>T (p.His665Tyr)	RET	H665Y, H411Y, H230Y, H323Y, H490Y, H569Y, H366Y, H519Y, H622Y, H182Y, H335Y, H270Y, H326Y, H423Y, H533Y	Multiple endocrine neoplasia, type 2	VCV001366296	10	43610041	10	43114593	1366296	1411638	rs1228832134	NC_000010.11:43114592:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 13, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.1994A>G (p.His665Arg)	RET	H411R, H665R, H335R, H423R, H519R, H182R, H270R, H366R, H622R, H533R, H230R, H323R, H326R, H490R, H569R	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001041010	10	43610042	10	43114594	1041010	1029540	rs1838024434	NC_000010.11:43114593:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1995C>G (p.His665Gln)	RET	H411Q, H326Q, H423Q, H533Q, H182Q, H270Q, H323Q, H335Q, H366Q, H490Q, H569Q, H622Q, H230Q, H519Q	not provided	VCV002505989	10	43610043	10	43114595	2505989	36271	rs377767413	NC_000010.11:43114594:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 14, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1995C>T (p.His665=)	RET		Hereditary cancer-predisposing syndrome	VCV001784042	10	43610043	10	43114595	1784042	1849601		NC_000010.11:43114594:C:T	single nucleotide variant	intron variant|synonymous variant	Likely benign	Jul 11, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.1995C>A (p.His665Gln)	RET	H411Q, H665Q, H323Q, H326Q, H335Q, H423Q, H622Q, H182Q, H230Q, H270Q, H366Q, H519Q, H490Q, H533Q, H569Q	not provided|Multiple endocrine neoplasia, type 2	VCV000935830	10	43610043	10	43114595	935830	935034	rs377767413	NC_000010.11:43114594:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1996A>C (p.Lys666Gln)	RET	K412Q, K666Q, K183Q, K324Q, K327Q, K367Q, K271Q, K336Q, K520Q, K570Q, K231Q, K491Q, K534Q, K623Q, K424Q	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001045072	10	43610044	10	43114596	1045072	1029541	rs143795581	NC_000010.11:43114595:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1996_2001del (p.Lys666_Pro667del)	RET		Multiple endocrine neoplasia, type 2	VCV000860856	10	43610044 - 43610049	10	43114596 - 43114601	860856	836852	rs1838024811	NC_000010.11:43114595:AAGCCA:	Deletion	inframe_indel|inframe_deletion	Uncertain significance	Dec 3, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.1996A>G (p.Lys666Glu)	RET	K412E, K336E, K534E, K183E, K231E, K367E, K424E, K491E, K623E, K271E, K327E, K520E, K324E, K570E	Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Pheochromocytoma|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2	VCV000024931	10	43610044	10	43114596	24931	36272	rs143795581	NC_000010.11:43114595:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1997A>C (p.Lys666Thr)	RET	K666T, K412T, K271T, K491T, K367T, K534T, K183T, K231T, K336T, K424T, K570T, K324T, K327T, K520T, K623T	Multiple endocrine neoplasia, type 2	VCV003387599	10	43610045	10	43114597	3387599	540546	rs377767439	NC_000010.11:43114596:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 25, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1997A>G (p.Lys666Arg)	RET	K666R, K412R, K491R, K570R, K183R, K231R, K424R, K520R, K623R, K327R, K367R, K271R, K324R, K336R, K534R	Multiple endocrine neoplasia, type 2	VCV001406184	10	43610045	10	43114597	1406184	540547	rs377767439	NC_000010.11:43114596:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1998G>A (p.Lys666=)	RET		Multiple endocrine neoplasia, type 2	VCV002165108	10	43610046	10	43114598	2165108	1895248		NC_000010.11:43114597:G:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 18, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.1998delinsTTCT (p.Lys666delinsAsnSer)	RET		Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2	VCV001897685	10	43610046	10	43114598	1897685	36274	rs377767440	NC_000010.11:43114597:G:TTCT	Indel	inframe_indel	Likely pathogenic	Jan 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1998G>C (p.Lys666Asn)	RET	K666N, K412N, K183N, K491N, K570N, K623N, K336N, K424N, K271N, K327N, K231N, K324N, K367N, K520N, K534N	Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2|MEN2 phenotype: Unclassified|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A	VCV000230926	10	43610046	10	43114598	230926	233786	rs146646971	NC_000010.11:43114597:G:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.1998G>T (p.Lys666Asn)	RET	K412N, K324N, K336N, K570N, K183N, K231N, K271N, K367N, K491N, K534N, K623N, K520N, K327N, K424N	Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|RET-related disorder|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia type 2B|Familial medullary thyroid carcinoma|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2|not provided|Familial medullary thyroid carcinoma|Hereditary cancer-predisposing syndrome	VCV000024932	10	43610046	10	43114598	24932	36273	rs146646971	NC_000010.11:43114597:G:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2001A>T (p.Pro667=)	RET		Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome	VCV000136106	10	43610049	10	43114601	136106	139818	rs563316790	NC_000010.11:43114600:A:T	single nucleotide variant	synonymous variant|intron variant	Benign/Likely benign	Jan 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2002C>T (p.Pro668Ser)	RET	P273S, P493S, P233S, P326S, P338S, P426S, P522S, P536S, P572S, P668S, P369S, P625S, P185S, P329S, P414S	Hereditary cancer-predisposing syndrome	VCV002496749	10	43610050	10	43114602	2496749	2467888		NC_000010.11:43114601:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Feb 9, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2003C>T (p.Pro668Leu)	RET	P414L, P668L, P185L, P273L, P369L, P493L, P326L, P338L, P329L, P522L, P536L, P625L, P233L, P426L, P572L	Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000820522	10	43610051	10	43114603	820522	809944	rs1482522995	NC_000010.11:43114602:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2005A>T (p.Ile669Phe)	RET	I327F, I370F, I427F, I234F, I415F, I523F, I626F, I186F, I537F, I573F, I669F, I274F, I330F, I339F, I494F	Hereditary cancer-predisposing syndrome	VCV001784307	10	43610053	10	43114605	1784307	1849866		NC_000010.11:43114604:A:T	single nucleotide variant	missense variant	Uncertain significance	Nov 3, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.2005A>G (p.Ile669Val)	RET	I669V, I415V, I234V, I330V, I370V, I523V, I537V, I573V, I186V, I274V, I427V, I494V, I626V, I327V, I339V	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|not provided|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A	VCV000486308	10	43610053	10	43114605	486308	475105	rs776986585	NC_000010.11:43114604:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 8, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2007CTC[1] (p.Ser671del)	RET	S496del, S539del, S188del, S341del, S417del, S671del, S236del, S276del, S329del, S332del, S372del, S628del, S429del, S525del, S575del	not provided|Multiple endocrine neoplasia, type 2	VCV002735329	10	43610055 - 43610057	10	43114607 - 43114609	2735329	2901354		NC_000010.11:43114606:CTCCTC:CTC	Microsatellite	inframe_deletion|inframe_indel|intron variant	Uncertain significance	Oct 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2007C>A (p.Ile669=)	RET		Hereditary cancer-predisposing syndrome	VCV002568327	10	43610055	10	43114607	2568327	2734864		NC_000010.11:43114606:C:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Mar 18, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2007C>T (p.Ile669=)	RET		Hereditary cancer-predisposing syndrome	VCV002454131	10	43610055	10	43114607	2454131	2424020		NC_000010.11:43114606:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 11, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2010C>T (p.Ser670=)	RET		Hereditary cancer-predisposing syndrome	VCV002568365	10	43610058	10	43114610	2568365	2734901		NC_000010.11:43114609:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 14, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2014G>T (p.Ala672Ser)	RET	A672S, A418S, A333S, A430S, A237S, A342S, A373S, A540S, A189S, A277S, A330S, A497S, A526S, A576S, A629S	Multiple endocrine neoplasia, type 2	VCV000838707	10	43610062	10	43114614	838707	836853	rs1838026024	NC_000010.11:43114613:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 19, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.2018A>C (p.Glu673Ala)	RET	E673A, E419A, E238A, E329A, E334A, E498A, E331A, E628A, E630A, E190A, E343A, E374A, E431A, E585A, E278A, E527A, E541A, E577A	Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|not provided|not specified|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A	VCV000486320	10	43610066	10	43114618	486320	475276	rs770100231	NC_000010.11:43114617:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2019G>A (p.Glu673=)	RET		Multiple endocrine neoplasia, type 2	VCV002709785	10	43610067	10	43114619	2709785	2874683		NC_000010.11:43114618:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2021T>C (p.Met674Thr)	RET	M239T, M420T, M528T, M578T, M674T, M191T, M279T, M330T, M332T, M375T, M499T, M542T, M586T, M631T, M335T, M344T, M432T, M629T	Multiple endocrine neoplasia, type 2	VCV003724585	10	43610069	10	43114621	3724585	3854365		NC_000010.11:43114620:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 20, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2025C>A (p.Thr675=)	RET		Hereditary cancer-predisposing syndrome	VCV003227519	10	43610073	10	43114625	3227519	3390731		NC_000010.11:43114624:C:A	single nucleotide variant	synonymous variant	Likely benign	Nov 16, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2025C>G (p.Thr675=)	RET		Hereditary cancer-predisposing syndrome	VCV001784634	10	43610073	10	43114625	1784634	1846694		NC_000010.11:43114624:C:G	single nucleotide variant	synonymous variant	Likely benign	Nov 1, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.2025C>T (p.Thr675=)	RET		Multiple endocrine neoplasia, type 2	VCV001541825	10	43610073	10	43114625	1541825	1545580	rs2132850672	NC_000010.11:43114624:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 18, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2026T>A (p.Phe676Ile)	RET	F241I, F281I, F334I, F337I, F422I, F501I, F544I, F588I, F193I, F346I, F434I, F633I, F676I, F332I, F530I, F377I, F580I, F631I	Hereditary cancer-predisposing syndrome	VCV001784661	10	43610074	10	43114626	1784661	1846721		NC_000010.11:43114625:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 1, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2026T>C (p.Phe676Leu)	RET	F422L, F676L, F377L, F580L, F633L, F241L, F334L, F434L, F530L, F544L, F346L, F501L, F193L, F281L, F332L, F337L, F588L, F631L	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001490931	10	43610074	10	43114626	1490931	1512038	rs2132850697	NC_000010.11:43114625:T:C	single nucleotide variant	missense variant	Uncertain significance	May 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2029C>A (p.Arg677=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001691914	10	43610077	10	43114629	1691914	1684356	rs1432069386	NC_000010.11:43114628:C:A	single nucleotide variant	synonymous variant	Likely benign	Aug 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2029C>T (p.Arg677Trp)	RET	R423W, R677W, R282W, R333W, R502W, R634W, R335W, R338W, R435W, R545W, R347W, R531W, R194W, R242W, R378W, R581W, R589W, R632W	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000949163	10	43610077	10	43114629	949163	925806	rs1432069386	NC_000010.11:43114628:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2030G>A (p.Arg677Gln)	RET	R677Q, R423Q, R242Q, R282Q, R338Q, R531Q, R632Q, R634Q, R347Q, R435Q, R581Q, R589Q, R335Q, R378Q, R545Q, R194Q, R333Q, R502Q	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2	VCV000477336	10	43610078	10	43114630	477336	459850	rs536038262	NC_000010.11:43114629:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 24, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2032A>G (p.Arg678Gly)	RET	R195G, R243G, R283G, R334G, R336G, R339G, R348G, R379G, R424G, R436G, R503G, R532G, R546G, R582G, R590G, R633G, R635G, R678G	not provided	VCV003373688	10	43610080	10	43114632	3373688	3532877		NC_000010.11:43114631:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2034G>A (p.Arg678=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001613771	10	43610082	10	43114634	1613771	1536526	rs2132850963	NC_000010.11:43114633:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2037C>T (p.Pro679=)	RET		Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|not provided|Hereditary cancer-predisposing syndrome|Renal hypodysplasia/aplasia 1|Hirschsprung disease, susceptibility to, 1|not specified|Pheochromocytoma|Multiple endocrine neoplasia	VCV000136107	10	43610085	10	43114637	136107	139819	rs55862116	NC_000010.11:43114636:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2038G>T (p.Ala680Ser)	RET	A245S, A336S, A350S, A505S, A584S, A534S, A635S, A197S, A285S, A338S, A381S, A426S, A438S, A548S, A592S, A341S, A637S, A680S	Multiple endocrine neoplasia, type 2	VCV001984347	10	43610086	10	43114638	1984347	2039600		NC_000010.11:43114637:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2038G>A (p.Ala680Thr)	RET	A680T, A426T, A336T, A341T, A534T, A635T, A197T, A338T, A592T, A245T, A285T, A350T, A381T, A438T, A584T, A505T, A548T, A637T	Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome	VCV000405547	10	43610086	10	43114638	405547	397458	rs184498773	NC_000010.11:43114637:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2039C>T (p.Ala680Val)	RET	A426V, A680V, A338V, A341V, A438V, A548V, A584V, A381V, A505V, A592V, A637V, A285V, A534V, A197V, A245V, A336V, A350V, A635V	not provided|Multiple endocrine neoplasia, type 2	VCV001019429	10	43610087	10	43114639	1019429	1008995	rs1838027230	NC_000010.11:43114638:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2040C>T (p.Ala680=)	RET		Multiple endocrine neoplasia, type 2	VCV002982610	10	43610088	10	43114640	2982610	3149331		NC_000010.11:43114639:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 9, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2040C>G (p.Ala680=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001564243	10	43610088	10	43114640	1564243	1589264	rs1336334127	NC_000010.11:43114639:C:G	single nucleotide variant	synonymous variant	Likely benign	Mar 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2040C>A (p.Ala680=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000486340	10	43610088	10	43114640	486340	475281	rs1336334127	NC_000010.11:43114639:C:A	single nucleotide variant	synonymous variant	Likely benign	Jun 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2041C>T (p.Gln681Ter)	RET	Q351*, Q382*, Q427*, Q439*, Q535*, Q506*, Q549*, Q585*, Q286*, Q337*, Q339*, Q593*, Q636*, Q681*, Q198*, Q246*, Q342*, Q638*	Hereditary cancer-predisposing syndrome	VCV002587893	10	43610089	10	43114641	2587893	2760717		NC_000010.11:43114640:C:T	single nucleotide variant	nonsense	Pathogenic	Sep 15, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2041C>G (p.Gln681Glu)	RET	Q681E, Q427E, Q198E, Q337E, Q382E, Q593E, Q636E, Q638E, Q351E, Q549E, Q246E, Q286E, Q439E, Q585E, Q339E, Q342E, Q506E, Q535E	Hereditary cancer-predisposing syndrome|not specified|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1	VCV000477337	10	43610089	10	43114641	477337	460291	rs567241943	NC_000010.11:43114640:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 30, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2043G>T (p.Gln681His)	RET	Q246H, Q337H, Q427H, Q506H, Q593H, Q681H, Q198H, Q382H, Q638H, Q286H, Q339H, Q342H, Q351H, Q439H, Q535H, Q549H, Q585H, Q636H	Multiple endocrine neoplasia, type 2	VCV002767692	10	43610091	10	43114643	2767692	2932304		NC_000010.11:43114642:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 12, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2045C>T (p.Ala682Val)	RET	A682V, A428V, A586V, A594V, A199V, A287V, A340V, A343V, A383V, A637V, A639V, A247V, A338V, A352V, A440V, A507V, A536V, A550V	Multiple endocrine neoplasia, type 2	VCV001402201	10	43610093	10	43114645	1402201	1454011	rs1283566936	NC_000010.11:43114644:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 2, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2047T>G (p.Phe683Val)	RET	F339V, F344V, F429V, F595V, F683V, F200V, F384V, F587V, F638V, F288V, F341V, F353V, F508V, F640V, F248V, F441V, F537V, F551V	Hereditary cancer-predisposing syndrome	VCV002454136	10	43610095	10	43114647	2454136	2424025		NC_000010.11:43114646:T:G	single nucleotide variant	missense variant	Uncertain significance	Jan 12, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2049C>G (p.Phe683Leu)	RET	F248L, F341L, F344L, F551L, F384L, F429L, F537L, F200L, F353L, F441L, F508L, F587L, F595L, F288L, F339L, F638L, F640L, F683L	Hereditary cancer-predisposing syndrome	VCV001785015	10	43610097	10	43114649	1785015	1843660		NC_000010.11:43114648:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 10, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.2049C>T (p.Phe683=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001078649	10	43610097	10	43114649	1078649	1077043	rs2132851661	NC_000010.11:43114648:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 25, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2050C>T (p.Pro684Ser)	RET	P684S, P430S, P249S, P340S, P354S, P538S, P639S, P641S, P289S, P342S, P385S, P552S, P201S, P442S, P509S, P596S, P345S, P588S	not provided|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia|Pheochromocytoma|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000299896	10	43610098	10	43114650	299896	321385	rs141347316	NC_000010.11:43114649:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2051C>G (p.Pro684Arg)	RET	P201R, P249R, P289R, P340R, P342R, P345R, P354R, P385R, P430R, P442R, P509R, P538R, P552R, P588R, P596R, P639R, P641R, P684R	Hereditary cancer-predisposing syndrome	VCV003227520	10	43610099	10	43114651	3227520	3390732		NC_000010.11:43114650:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 28, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2051C>T (p.Pro684Leu)	RET	P430L, P684L, P201L, P538L, P552L, P342L, P354L, P509L, P641L, P249L, P289L, P340L, P345L, P442L, P588L, P385L, P596L, P639L	Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000820592	10	43610099	10	43114651	820592	809945	rs760088950	NC_000010.11:43114650:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2052G>T (p.Pro684=)	RET		Hereditary cancer-predisposing syndrome	VCV002454154	10	43610100	10	43114652	2454154	2424043		NC_000010.11:43114651:G:T	single nucleotide variant	synonymous variant	Likely benign	Feb 28, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2052G>A (p.Pro684=)	RET		Multiple endocrine neoplasia|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|not provided|Pheochromocytoma|Renal hypodysplasia/aplasia 1|Hirschsprung disease, susceptibility to, 1|not specified	VCV000241343	10	43610100	10	43114652	241343	240797	rs145122337	NC_000010.11:43114651:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Feb 2, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2053G>T (p.Val685Phe)	RET	V202F, V250F, V290F, V341F, V343F, V346F, V355F, V386F, V431F, V443F, V510F, V539F, V553F, V589F, V597F, V640F, V642F, V685F	Hereditary cancer-predisposing syndrome	VCV003227521	10	43610101	10	43114653	3227521	3390733		NC_000010.11:43114652:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 21, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2053G>A (p.Val685Ile)	RET	V431I, V685I, V341I, V443I, V539I, V343I, V589I, V640I, V202I, V250I, V290I, V346I, V355I, V597I, V386I, V510I, V553I, V642I	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	VCV000963206	10	43610101	10	43114653	963206	946892	rs753686782	NC_000010.11:43114652:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2054T>C (p.Val685Ala)	RET	V431A, V685A, V202A, V355A, V443A, V510A, V250A, V386A, V539A, V553A, V589A, V290A, V341A, V346A, V597A, V642A, V343A, V640A	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001060515	10	43610102	10	43114654	1060515	1046535	rs1422796781	NC_000010.11:43114653:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2055C>T (p.Val685=)	RET		Hereditary cancer-predisposing syndrome	VCV001785124	10	43610103	10	43114655	1785124	1843769		NC_000010.11:43114654:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 13, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.2056A>G (p.Ser686Gly)	RET	S344G, S347G, S686G, S291G, S511G, S554G, S598G, S643G, S342G, S356G, S387G, S444G, S203G, S251G, S432G, S540G, S590G, S641G	Multiple endocrine neoplasia, type 2	VCV002769687	10	43610104	10	43114656	2769687	2933002		NC_000010.11:43114655:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 5, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2058C>T (p.Ser686=)	RET		Multiple endocrine neoplasia, type 2	VCV001660065	10	43610106	10	43114658	1660065	1606436	rs757141171	NC_000010.11:43114657:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 9, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.2060A>G (p.Tyr687Cys)	RET	Y433C, Y687C, Y357C, Y388C, Y445C, Y252C, Y512C, Y555C, Y541C, Y591C, Y599C, Y644C, Y204C, Y292C, Y343C, Y345C, Y348C, Y642C	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000820626	10	43610108	10	43114660	820626	809946	rs778793244	NC_000010.11:43114659:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2061C>T (p.Tyr687=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001121144	10	43610109	10	43114661	1121144	1120268	rs1236296845	NC_000010.11:43114660:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2062T>G (p.Ser688Ala)	RET	S205A, S253A, S293A, S344A, S346A, S349A, S358A, S389A, S434A, S446A, S513A, S542A, S556A, S592A, S600A, S643A, S645A, S688A	Multiple endocrine neoplasia, type 2	VCV001718467	10	43610110	10	43114662	1718467	1778827		NC_000010.11:43114661:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2062T>C (p.Ser688Pro)	RET	S434P, S688P, S293P, S358P, S592P, S645P, S253P, S346P, S446P, S542P, S600P, S205P, S344P, S349P, S513P, S556P, S643P, S389P	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000820597	10	43610110	10	43114662	820597	809947	rs750681372	NC_000010.11:43114661:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2063C>G (p.Ser688Cys)	RET	S389C, S434C, S542C, S205C, S344C, S349C, S513C, S600C, S643C, S253C, S293C, S446C, S592C, S645C, S346C, S358C, S556C, S688C	Hereditary cancer-predisposing syndrome	VCV003313691	10	43610111	10	43114663	3313691	3465421		NC_000010.11:43114662:C:G	single nucleotide variant	missense variant	Uncertain significance	May 24, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2063C>T (p.Ser688Phe)	RET	S434F, S688F, S389F, S446F, S542F, S205F, S253F, S344F, S358F, S600F, S643F, S293F, S349F, S556F, S346F, S513F, S592F, S645F	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000651776	10	43610111	10	43114663	651776	638909	rs1588874330	NC_000010.11:43114662:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2064C>T (p.Ser688=)	RET		Multiple endocrine neoplasia, type 2	VCV001136894	10	43610112	10	43114664	1136894	1120269	rs1477614645	NC_000010.11:43114663:C:T	single nucleotide variant	synonymous variant	Likely benign	May 15, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2066C>T (p.Ser689Phe)	RET	S435F, S689F, S254F, S390F, S601F, S294F, S347F, S359F, S345F, S447F, S514F, S557F, S593F, S644F, S646F, S206F, S350F, S543F	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000664562	10	43610114	10	43114666	664562	638910	rs989429215	NC_000010.11:43114665:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2067T>G (p.Ser689=)	RET		Hereditary cancer-predisposing syndrome	VCV001785311	10	43610115	10	43114667	1785311	1840108		NC_000010.11:43114666:T:G	single nucleotide variant	synonymous variant	Likely benign	Dec 10, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2068T>G (p.Ser690Ala)	RET	S690A, S436A, S207A, S391A, S645A, S558A, S602A, S295A, S346A, S360A, S448A, S515A, S594A, S255A, S348A, S351A, S544A, S647A	Multiple endocrine neoplasia, type 2	VCV001046889	10	43610116	10	43114668	1046889	1029542	rs1838028995	NC_000010.11:43114667:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 14, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.2070C>A (p.Ser690=)	RET		Multiple endocrine neoplasia, type 2	VCV001508803	10	43610118	10	43114670	1508803	1451920	rs201550433	NC_000010.11:43114669:C:A	single nucleotide variant	synonymous variant	Likely benign	Dec 7, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2070C>T (p.Ser690=)	RET		Multiple endocrine neoplasia|Pheochromocytoma|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Renal hypodysplasia/aplasia 1|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A	VCV000299897	10	43610118	10	43114670	299897	321388	rs201550433	NC_000010.11:43114669:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Dec 25, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2071G>C (p.Gly691Arg)	RET	G691R, G437R, G347R, G516R, G296R, G361R, G545R, G646R, G256R, G392R, G449R, G559R, G595R, G648R, G208R, G349R, G352R, G603R	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000581727	10	43610119	10	43114671	581727	566283	rs1799939	NC_000010.11:43114670:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2071G>T (p.Gly691Cys)	RET	G691C, G437C, G208C, G296C, G545C, G595C, G646C, G256C, G347C, G349C, G449C, G516C, G352C, G361C, G648C, G392C, G559C, G603C	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000576718	10	43610119	10	43114671	576718	563748	rs1799939	NC_000010.11:43114670:G:T	single nucleotide variant	missense variant	Uncertain significance	Jun 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2071G>A (p.Gly691Ser)	RET	G437S, G347S, G349S, G392S, G545S, G603S, G648S, G296S, G352S, G361S, G516S, G646S, G449S, G559S, G208S, G256S, G595S	Multiple endocrine neoplasia type 2A|Renal hypodysplasia/aplasia 1|not provided|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|not specified	VCV000024934	10	43610119	10	43114671	24934	36275	rs1799939	NC_000010.11:43114670:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 4, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2072G>T (p.Gly691Val)	RET	G208V, G256V, G352V, G449V, G603V, G648V, G361V, G437V, G516V, G545V, G646V, G691V, G349V, G595V, G296V, G347V, G392V, G559V	Hereditary cancer-predisposing syndrome	VCV001785415	10	43610120	10	43114672	1785415	1840212		NC_000010.11:43114671:G:T	single nucleotide variant	missense variant	Uncertain significance	May 15, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2073T>C (p.Gly691=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001126022	10	43610121	10	43114673	1126022	1120270	rs1174566929	NC_000010.11:43114672:T:C	single nucleotide variant	synonymous variant	Likely benign	Oct 30, 2021	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2074G>A (p.Ala692Thr)	RET	A297T, A348T, A350T, A450T, A546T, A596T, A604T, A647T, A362T, A393T, A438T, A517T, A692T, A209T, A257T, A353T, A560T, A649T	Multiple endocrine neoplasia, type 2	VCV003658247	10	43610122	10	43114674	3658247	3800474		NC_000010.11:43114673:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 30, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2075_2076delinsAA (p.Ala692Glu)	RET	A297E, A350E, A604E, A692E, A209E, A353E, A438E, A560E, A596E, A649E, A257E, A348E, A362E, A546E, A393E, A450E, A517E, A647E	Multiple endocrine neoplasia, type 2	VCV001906422	10	43610123 - 43610124	10	43114675 - 43114676	1906422	1961906		NC_000010.11:43114674:CC:AA	Indel	missense variant	Uncertain significance	Jun 23, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2075C>A (p.Ala692Asp)	RET	A348D, A517D, A350D, A362D, A438D, A560D, A647D, A209D, A297D, A353D, A393D, A604D, A649D, A257D, A450D, A546D, A596D, A692D	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001785450	10	43610123	10	43114675	1785450	1840247		NC_000010.11:43114674:C:A	single nucleotide variant	missense variant	Uncertain significance	May 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2076C>G (p.Ala692=)	RET		Multiple endocrine neoplasia, type 2	VCV001377800	10	43610124	10	43114676	1377800	1469605	rs1414025702	NC_000010.11:43114675:C:G	single nucleotide variant	synonymous variant	Likely benign	Jan 29, 2025	criteria provided, single submitter							
NM_020975.6(RET):c.2077C>T (p.Arg693Cys)	RET	R349C, R451C, R605C, R258C, R298C, R439C, R597C, R351C, R363C, R518C, R547C, R561C, R650C, R210C, R354C, R394C, R648C, R693C	Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001785477	10	43610125	10	43114677	1785477	1840274		NC_000010.11:43114676:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2078G>A (p.Arg693His)	RET	R693H, R439H, R451H, R648H, R650H, R351H, R363H, R394H, R547H, R605H, R210H, R298H, R597H, R258H, R349H, R354H, R518H, R561H	Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|not specified|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000959187	10	43610126	10	43114678	959187	946893	rs1332256523	NC_000010.11:43114677:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2079C>G (p.Arg693=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000486299	10	43610127	10	43114679	486299	475307	rs747166722	NC_000010.11:43114678:C:G	single nucleotide variant	synonymous variant	Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2080C>T (p.Arg694Trp)	RET	R694W, R440W, R259W, R562W, R299W, R352W, R355W, R519W, R598W, R649W, R211W, R395W, R548W, R606W, R350W, R364W, R452W, R651W	RET-related disorder|not specified|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A	VCV000036727	10	43610128	10	43114680	36727	45388	rs193922700	NC_000010.11:43114679:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2081G>A (p.Arg694Gln)	RET	R694Q, R440Q, R211Q, R355Q, R364Q, R598Q, R606Q, R352Q, R395Q, R548Q, R562Q, R350Q, R259Q, R299Q, R452Q, R519Q, R649Q, R651Q	Pheochromocytoma|Renal hypodysplasia/aplasia 1|not specified|not provided|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia|Hereditary cancer-predisposing syndrome	VCV000161358	10	43610129	10	43114681	161358	171125	rs141185224	NC_000010.11:43114680:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2084C>G (p.Pro695Arg)	RET	P300R, P441R, P599R, P351R, P356R, P365R, P563R, P695R, P212R, P353R, P396R, P453R, P607R, P652R, P260R, P520R, P549R, P650R	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001785611	10	43610132	10	43114684	1785611	1840408		NC_000010.11:43114683:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2085C>A (p.Pro695=)	RET		Hereditary cancer-predisposing syndrome	VCV001785626	10	43610133	10	43114685	1785626	1849884		NC_000010.11:43114684:C:A	single nucleotide variant	synonymous variant	Likely benign	May 3, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2085C>T (p.Pro695=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000543785	10	43610133	10	43114685	543785	525132	rs571603831	NC_000010.11:43114684:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2085C>G (p.Pro695=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000241344	10	43610133	10	43114685	241344	240798	rs571603831	NC_000010.11:43114684:C:G	single nucleotide variant	synonymous variant	Likely benign	Sep 15, 2021	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2087C>T (p.Ser696Leu)	RET	S696L, S442L, S261L, S354L, S357L, S521L, S600L, S213L, S366L, S397L, S651L, S653L, S301L, S454L, S352L, S550L, S564L, S608L	Multiple endocrine neoplasia, type 2|not specified|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome	VCV000579439	10	43610135	10	43114687	579439	566284	rs1564496520	NC_000010.11:43114686:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2088G>T (p.Ser696=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000820691	10	43610136	10	43114688	820691	809948	rs150329150	NC_000010.11:43114687:G:T	single nucleotide variant	synonymous variant	Likely benign	May 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2088G>A (p.Ser696=)	RET		Hirschsprung disease, susceptibility to, 1|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia, type 2|not provided|Multiple endocrine neoplasia|not specified|Pheochromocytoma|Hereditary cancer-predisposing syndrome	VCV000215530	10	43610136	10	43114688	215530	212784	rs150329150	NC_000010.11:43114687:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2089C>T (p.Leu697=)	RET		Familial medullary thyroid carcinoma|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|not provided	VCV000698368	10	43610137	10	43114689	698368	687632	rs1588874416	NC_000010.11:43114688:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jul 18, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2090T>C (p.Leu697Pro)	RET	L443P, L697P, L353P, L358P, L455P, L601P, L262P, L355P, L398P, L551P, L609P, L214P, L302P, L522P, L565P, L654P, L367P, L652P	Multiple endocrine neoplasia, type 2|not specified	VCV001479159	10	43610138	10	43114690	1479159	1426530	rs1293039001	NC_000010.11:43114689:T:C	single nucleotide variant	missense variant	Uncertain significance	May 4, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2090T>A (p.Leu697Gln)	RET	L443Q, L697Q, L262Q, L302Q, L398Q, L522Q, L565Q, L358Q, L652Q, L654Q, L214Q, L353Q, L355Q, L367Q, L551Q, L601Q, L455Q, L609Q	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000651368	10	43610138	10	43114690	651368	638911	rs1293039001	NC_000010.11:43114689:T:A	single nucleotide variant	missense variant	Uncertain significance	Dec 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2092G>A (p.Asp698Asn)	RET	D354N, D552N, D263N, D399N, D444N, D655N, D303N, D359N, D456N, D602N, D610N, D698N, D215N, D356N, D368N, D523N, D566N, D653N	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001785752	10	43610140	10	43114692	1785752	1850010		NC_000010.11:43114691:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 5, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2093A>C (p.Asp698Ala)	RET	D523A, D602A, D610A, D354A, D359A, D456A, D566A, D655A, D263A, D303A, D444A, D653A, D698A, D215A, D356A, D368A, D399A, D552A	Multiple endocrine neoplasia, type 2	VCV003666029	10	43610141	10	43114693	3666029	3795902		NC_000010.11:43114692:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 4, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2098_2115dup (p.Ser705_Val706insMetGluAsnGlnValSer)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000477339	10	43610141 - 43610142	10	43114693 - 43114694	477339	460304	rs1345270276	NC_000010.11:43114693:CTCCATGGAGAACCAGGTCTCC:CTCCATGGAGAACCAGGTCTCCATGGAGAACCAGGTCTCC	Duplication	inframe_indel|inframe_insertion	Uncertain significance	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2094C>G (p.Asp698Glu)	RET	D263E, D356E, D359E, D399E, D523E, D354E, D444E, D456E, D610E, D655E, D368E, D566E, D215E, D303E, D552E, D602E, D653E, D698E	Hereditary cancer-predisposing syndrome	VCV001785769	10	43610142	10	43114694	1785769	1850027		NC_000010.11:43114693:C:G	single nucleotide variant	missense variant	Uncertain significance	May 1, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2095T>C (p.Ser699Pro)	RET	S216P, S264P, S304P, S355P, S357P, S360P, S369P, S400P, S445P, S457P, S524P, S553P, S567P, S603P, S611P, S654P, S656P, S699P	Multiple endocrine neoplasia, type 2	VCV003069623	10	43610143	10	43114695	3069623	3230248		NC_000010.11:43114694:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 24, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2096C>G (p.Ser699Cys)	RET	S216C, S264C, S304C, S355C, S357C, S360C, S369C, S400C, S445C, S457C, S524C, S553C, S567C, S603C, S611C, S654C, S656C, S699C	Multiple endocrine neoplasia, type 2	VCV003387601	10	43610144	10	43114696	3387601	3546733		NC_000010.11:43114695:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 6, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2096C>T (p.Ser699Phe)	RET	S445F, S699F, S264F, S611F, S357F, S360F, S369F, S400F, S553F, S567F, S603F, S216F, S304F, S355F, S457F, S524F, S654F, S656F	Multiple endocrine neoplasia, type 2	VCV001377980	10	43610144	10	43114696	1377980	1469785	rs1838030910	NC_000010.11:43114695:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 13, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2097C>T (p.Ser699=)	RET		Multiple endocrine neoplasia, type 2	VCV003387602	10	43610145	10	43114697	3387602	540549	rs1554818954	NC_000010.11:43114696:C:T	single nucleotide variant	synonymous variant	Likely benign	May 30, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2098A>T (p.Met700Leu)	RET	M700L, M446L, M217L, M305L, M401L, M554L, M657L, M356L, M358L, M361L, M458L, M604L, M265L, M370L, M525L, M655L, M568L, M612L	Multiple endocrine neoplasia, type 2	VCV002006375	10	43610146	10	43114698	2006375	47214	rs377767441	NC_000010.11:43114697:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 15, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2099T>C (p.Met700Thr)	RET	M305T, M568T, M604T, M401T, M525T, M612T, M356T, M361T, M655T, M217T, M265T, M358T, M370T, M446T, M458T, M554T, M657T, M700T	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001785847	10	43610147	10	43114699	1785847	1850105		NC_000010.11:43114698:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2100G>A (p.Met700Ile)	RET	M700I, M446I, M356I, M361I, M554I, M657I, M358I, M525I, M305I, M370I, M568I, M604I, M655I, M217I, M265I, M401I, M458I, M612I	not provided|Multiple endocrine neoplasia, type 2	VCV000560865	10	43610148	10	43114700	560865	551869	rs1564496551	NC_000010.11:43114699:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2104A>G (p.Asn702Asp)	RET	N219D, N267D, N307D, N358D, N360D, N363D, N372D, N403D, N448D, N460D, N527D, N556D, N570D, N606D, N614D, N657D, N659D, N702D	Multiple endocrine neoplasia, type 2	VCV003071737	10	43610152	10	43114704	3071737	3234002		NC_000010.11:43114703:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2105A>G (p.Asn702Ser)	RET	N702S, N448S, N267S, N360S, N372S, N403S, N570S, N527S, N556S, N606S, N307S, N358S, N657S, N219S, N363S, N460S, N614S, N659S	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000838671	10	43610153	10	43114705	838671	836854	rs1838031378	NC_000010.11:43114704:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2106C>T (p.Asn702=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001785993	10	43610154	10	43114706	1785993	1850250		NC_000010.11:43114705:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2107C>G (p.Gln703Glu)	RET	Q449E, Q703E, Q268E, Q571E, Q373E, Q615E, Q220E, Q359E, Q361E, Q404E, Q528E, Q660E, Q308E, Q364E, Q461E, Q557E, Q607E, Q658E	not provided|Multiple endocrine neoplasia, type 2	VCV001501230	10	43610155	10	43114707	1501230	1401978	rs2132854777	NC_000010.11:43114706:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2108A>G (p.Gln703Arg)	RET	Q449R, Q703R, Q364R, Q571R, Q607R, Q658R, Q268R, Q359R, Q461R, Q615R, Q361R, Q373R, Q557R, Q220R, Q308R, Q404R, Q528R, Q660R	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001020551	10	43610156	10	43114708	1020551	1008996	rs1838031470	NC_000010.11:43114707:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2109G>C (p.Gln703His)	RET	Q220H, Q308H, Q404H, Q461H, Q615H, Q703H, Q658H, Q268H, Q361H, Q373H, Q607H, Q359H, Q364H, Q449H, Q528H, Q557H, Q571H, Q660H	Multiple endocrine neoplasia, type 2	VCV001986555	10	43610157	10	43114709	1986555	2036704		NC_000010.11:43114708:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 21, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2110G>T (p.Val704Phe)	RET	V704F, V450F, V221F, V269F, V462F, V529F, V572F, V616F, V661F, V365F, V608F, V659F, V362F, V374F, V309F, V360F, V405F, V558F	Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2B|not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not specified|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A	VCV000372088	10	43610158	10	43114710	372088	358826	rs927029236	NC_000010.11:43114709:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2111T>A (p.Val704Asp)	RET	V360D, V374D, V405D, V450D, V462D, V608D, V661D, V365D, V572D, V704D, V221D, V269D, V558D, V616D, V659D, V309D, V362D, V529D	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2	VCV001913896	10	43610159	10	43114711	1913896	1970227		NC_000010.11:43114710:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 12, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2111T>C (p.Val704Ala)	RET	V450A, V704A, V362A, V529A, V221A, V269A, V365A, V309A, V374A, V462A, V572A, V608A, V616A, V659A, V661A, V360A, V405A, V558A	Multiple endocrine neoplasia, type 2|not provided	VCV001678413	10	43610159	10	43114711	1678413	1670102	rs770155054	NC_000010.11:43114710:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2112C>T (p.Val704=)	RET		Multiple endocrine neoplasia, type 2	VCV001087356	10	43610160	10	43114712	1087356	1077045	rs1209925911	NC_000010.11:43114711:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 6, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2112C>G (p.Val704=)	RET		Multiple endocrine neoplasia, type 2	VCV001080953	10	43610160	10	43114712	1080953	1077044	rs1209925911	NC_000010.11:43114711:C:G	single nucleotide variant	synonymous variant	Likely benign	May 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2115C>A (p.Ser705=)	RET		Hereditary cancer-predisposing syndrome	VCV002587885	10	43610163	10	43114715	2587885	2760709		NC_000010.11:43114714:C:A	single nucleotide variant	synonymous variant	Likely benign	Jul 27, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2115C>T (p.Ser705=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000696812	10	43610163	10	43114715	696812	684174	rs1247902894	NC_000010.11:43114714:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Aug 12, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2116G>T (p.Val706Leu)	RET	V452L, V706L, V311L, V618L, V663L, V223L, V271L, V407L, V610L, V367L, V376L, V464L, V362L, V364L, V531L, V560L, V574L, V661L	Multiple endocrine neoplasia, type 2	VCV000967060	10	43610164	10	43114716	967060	956050	rs137855422	NC_000010.11:43114715:G:T	single nucleotide variant	missense variant	Uncertain significance	Mar 5, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2116G>A (p.Val706Met)	RET	V706M, V452M, V376M, V610M, V618M, V661M, V663M, V223M, V271M, V311M, V407M, V531M, V560M, V574M, V364M, V362M, V367M, V464M	Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|not provided|Hirschsprung disease, susceptibility to, 1	VCV000372079	10	43610164	10	43114716	372079	358827	rs137855422	NC_000010.11:43114715:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 10, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2118G>A (p.Val706=)	RET		Multiple endocrine neoplasia, type 2	VCV002040985	10	43610166	10	43114718	2040985	2095007		NC_000010.11:43114717:G:A	single nucleotide variant	synonymous variant	Likely benign	May 21, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2119G>C (p.Asp707His)	RET	D363H, D408H, D611H, D707H, D368H, D312H, D453H, D532H, D561H, D575H, D664H, D224H, D272H, D365H, D377H, D465H, D619H, D662H	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001786207	10	43610167	10	43114719	1786207	1846959		NC_000010.11:43114718:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2120A>C (p.Asp707Ala)	RET	D312A, D365A, D453A, D707A, D272A, D363A, D465A, D575A, D224A, D377A, D619A, D368A, D408A, D532A, D561A, D611A, D662A, D664A	Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A	VCV003594872	10	43610168	10	43114720	3594872	3722586		NC_000010.11:43114719:A:C	single nucleotide variant	missense variant	Uncertain significance	Jan 2, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2120A>G (p.Asp707Gly)	RET	D224G, D453G, D465G, D575G, D365G, D377G, D611G, D619G, D363G, D408G, D532G, D561G, D662G, D707G, D272G, D312G, D368G, D664G	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV003012052	10	43610168	10	43114720	3012052	3173641		NC_000010.11:43114719:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2121T>C (p.Asp707=)	RET		Hereditary cancer-predisposing syndrome	VCV003313712	10	43610169	10	43114721	3313712	3465442		NC_000010.11:43114720:T:C	single nucleotide variant	synonymous variant	Likely benign	Mar 28, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2121T>A (p.Asp707Glu)	RET	D707E, D453E, D272E, D368E, D532E, D561E, D224E, D365E, D377E, D408E, D611E, D312E, D465E, D619E, D664E, D363E, D575E, D662E	Hereditary cancer-predisposing syndrome	VCV001786256	10	43610169	10	43114721	1786256	540550	rs1554818959	NC_000010.11:43114720:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 30, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2124C>T (p.Ala708=)	RET		Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000543773	10	43610172	10	43114724	543773	525135	rs749646777	NC_000010.11:43114723:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2125T>A (p.Phe709Ile)	RET	F577I, F226I, F370I, F563I, F621I, F666I, F314I, F367I, F455I, F613I, F664I, F709I, F274I, F365I, F379I, F410I, F467I, F534I	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002587878	10	43610173	10	43114725	2587878	2760702		NC_000010.11:43114724:T:A	single nucleotide variant	missense variant	Uncertain significance	Dec 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2125T>C (p.Phe709Leu)	RET	F226L, F274L, F314L, F365L, F367L, F370L, F379L, F410L, F455L, F467L, F534L, F563L, F577L, F613L, F621L, F664L, F666L, F709L	Multiple endocrine neoplasia, type 2	VCV001716515	10	43610173	10	43114725	1716515	1778196		NC_000010.11:43114724:T:C	single nucleotide variant	missense variant	Uncertain significance	Jul 17, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2128A>G (p.Lys710Glu)	RET	K710E, K456E, K614E, K275E, K366E, K371E, K468E, K535E, K578E, K665E, K667E, K227E, K368E, K564E, K315E, K380E, K411E, K622E	not provided|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome	VCV000405540	10	43610176	10	43114728	405540	397713	rs3026760	NC_000010.11:43114727:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2129A>G (p.Lys710Arg)	RET	K710R, K456R, K227R, K380R, K564R, K614R, K366R, K371R, K411R, K535R, K275R, K315R, K578R, K368R, K468R, K622R, K665R, K667R	Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Hereditary cancer-predisposing syndrome|Pheochromocytoma|Renal hypodysplasia/aplasia 1|not provided	VCV000580338	10	43610177	10	43114729	580338	569655	rs774983492	NC_000010.11:43114728:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 9, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2130G>A (p.Lys710=)	RET		Multiple endocrine neoplasia, type 2	VCV002111371	10	43610178	10	43114730	2111371	2163946		NC_000010.11:43114729:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 14, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2132T>A (p.Ile711Asn)	RET	I228N, I276N, I316N, I367N, I369N, I372N, I381N, I412N, I457N, I469N, I536N, I565N, I579N, I615N, I623N, I666N, I668N, I711N	Hereditary cancer-predisposing syndrome	VCV003227522	10	43610180	10	43114732	3227522	3390734		NC_000010.11:43114731:T:A	single nucleotide variant	missense variant	Uncertain significance	Oct 6, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2133C>A (p.Ile711=)	RET		Multiple endocrine neoplasia, type 2	VCV002733986	10	43610181	10	43114733	2733986	2898319		NC_000010.11:43114732:C:A	single nucleotide variant	synonymous variant	Likely benign	May 27, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2133C>T (p.Ile711=)	RET		Multiple endocrine neoplasia, type 2	VCV001140038	10	43610181	10	43114733	1140038	1120271	rs2132855814	NC_000010.11:43114732:C:T	single nucleotide variant	synonymous variant	Likely benign	May 13, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.2135T>C (p.Leu712Pro)	RET	L712P, L458P, L229P, L317P, L470P, L537P, L368P, L373P, L370P, L413P, L566P, L669P, L277P, L382P, L580P, L616P, L624P, L667P	not provided|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000405531	10	43610183	10	43114735	405531	397824	rs760272063	NC_000010.11:43114734:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 18, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2136+2T>G	RET		Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2	VCV001709192	10	43610186	10	43114738	1709192	1707546		NC_000010.11:43114737:T:G	single nucleotide variant	splice donor variant	Conflicting classifications of pathogenicity	Nov 30, 2023	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2136+6G>T	RET		Multiple endocrine neoplasia, type 2	VCV001930011	10	43610190	10	43114742	1930011	1981568		NC_000010.11:43114741:G:T	single nucleotide variant	intron variant	Uncertain significance	Mar 29, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2136+7G>A	RET		Multiple endocrine neoplasia, type 2	VCV002414562	10	43610191	10	43114743	2414562	1947133		NC_000010.11:43114742:G:A	single nucleotide variant	intron variant	Likely benign	Jan 18, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2136+9C>G	RET		Multiple endocrine neoplasia, type 2	VCV003663495	10	43610193	10	43114745	3663495	3798086		NC_000010.11:43114744:C:G	single nucleotide variant	intron variant	Likely benign	Oct 8, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2136+9C>T	RET		Multiple endocrine neoplasia, type 2|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B	VCV000706128	10	43610193	10	43114745	706128	695479	rs1331402266	NC_000010.11:43114744:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 24, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2136+15_2136+35del	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000219590	10	43610193 - 43610213	10	43114745 - 43114765	219590	221965	rs753686672	NC_000010.11:43114744:CCCTGCGGGGCAGGGAAGATCCCCTGC:CCCTGC	Deletion	intron variant	Conflicting classifications of pathogenicity	Jan 29, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2136+10C>T	RET		Multiple endocrine neoplasia, type 2	VCV002695764	10	43610194	10	43114746	2695764	2864451		NC_000010.11:43114745:C:T	single nucleotide variant	intron variant	Likely benign	Nov 14, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2136+10C>A	RET		Multiple endocrine neoplasia, type 2	VCV001976128	10	43610194	10	43114746	1976128	2023776		NC_000010.11:43114745:C:A	single nucleotide variant	intron variant	Likely benign	Aug 20, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2136+11C>G	RET		Multiple endocrine neoplasia, type 2	VCV002034689	10	43610195	10	43114747	2034689	2090037		NC_000010.11:43114746:C:G	single nucleotide variant	intron variant	Uncertain significance	Jul 17, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2136+11C>T	RET		Multiple endocrine neoplasia, type 2	VCV001615054	10	43610195	10	43114747	1615054	1578921	rs1232090564	NC_000010.11:43114746:C:T	single nucleotide variant	intron variant	Likely benign	May 13, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2136+12T>C	RET		Multiple endocrine neoplasia, type 2	VCV003658938	10	43610196	10	43114748	3658938	3793935		NC_000010.11:43114747:T:C	single nucleotide variant	intron variant	Likely benign	Jan 22, 2025	criteria provided, single submitter							
NM_020975.6(RET):c.2136+13G>A	RET		Multiple endocrine neoplasia, type 2	VCV002737468	10	43610197	10	43114749	2737468	2899115		NC_000010.11:43114748:G:A	single nucleotide variant	intron variant	Likely benign	Dec 20, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2136+14C>G	RET		Multiple endocrine neoplasia, type 2	VCV002162256	10	43610198	10	43114750	2162256	1884644		NC_000010.11:43114749:C:G	single nucleotide variant	intron variant	Likely benign	May 12, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2136+14C>T	RET		Multiple endocrine neoplasia, type 2	VCV001559607	10	43610198	10	43114750	1559607	1542198	rs368361145	NC_000010.11:43114749:C:T	single nucleotide variant	intron variant	Likely benign	Jan 13, 2025	criteria provided, single submitter							
NM_020975.6(RET):c.2136+14C>A	RET		Multiple endocrine neoplasia, type 2	VCV001542766	10	43610198	10	43114750	1542766	1523041	rs368361145	NC_000010.11:43114749:C:A	single nucleotide variant	intron variant	Likely benign	Jul 22, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2136+15G>A	RET		not provided|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia, type 2	VCV000372098	10	43610199	10	43114751	372098	358828	rs751183869	NC_000010.11:43114750:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Jan 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2136+17G>A	RET		Multiple endocrine neoplasia, type 2	VCV002162685	10	43610201	10	43114753	2162685	1894981		NC_000010.11:43114752:G:A	single nucleotide variant	intron variant	Likely benign	Sep 26, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2136+18G>A	RET		Multiple endocrine neoplasia, type 2	VCV001548776	10	43610202	10	43114754	1548776	1572891	rs761777383	NC_000010.11:43114753:G:A	single nucleotide variant	intron variant	Likely benign	Aug 24, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2136+18G>T	RET		Multiple endocrine neoplasia, type 2	VCV001422150	10	43610202	10	43114754	1422150	1415922	rs761777383	NC_000010.11:43114753:G:T	single nucleotide variant	intron variant	Likely benign	Nov 21, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2136+151G>A	RET		not provided	VCV002640415	10	43610335	10	43114887	2640415	2813107		NC_000010.11:43114886:G:A	single nucleotide variant	intron variant	Likely benign	Aug 1, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2136+182G>A	RET		not provided	VCV001226080	10	43610366	10	43114918	1226080	1214761	rs1864400	NC_000010.11:43114917:G:A	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, single submitter							
NM_020975.6(RET):c.2136+271T>C	RET		not provided	VCV001259561	10	43610455	10	43115007	1259561	1250324	rs1864399	NC_000010.11:43115006:T:C	single nucleotide variant	intron variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.2136+272G>A	RET		not provided	VCV001694560	10	43610456	10	43115008	1694560	1686993	rs768973064	NC_000010.11:43115007:G:A	single nucleotide variant	intron variant	Likely benign	Nov 1, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2136+400T>C	RET		not provided	VCV001677324	10	43610584	10	43115136	1677324	1669015	rs1838042375	NC_000010.11:43115135:T:C	single nucleotide variant	intron variant	Uncertain significance	Jul 7, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2136+437T>C	RET		not provided	VCV001675415	10	43610621	10	43115173	1675415	1666799	rs181457644	NC_000010.11:43115172:T:C	single nucleotide variant	intron variant	Likely benign	Dec 1, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2136+509G>T	RET		not provided	VCV002640416	10	43610693	10	43115245	2640416	2813108		NC_000010.11:43115244:G:T	single nucleotide variant	intron variant	Likely benign	Sep 1, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2136+763G>A	RET		not provided	VCV002640417	10	43610947	10	43115499	2640417	2813109		NC_000010.11:43115498:G:A	single nucleotide variant	intron variant	Likely benign	Jul 1, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2137-794T>C	RET		not provided	VCV001675416	10	43611238	10	43115790	1675416	1666800	rs780700885	NC_000010.11:43115789:T:C	single nucleotide variant	intron variant	Likely benign	Jul 1, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2137-744A>G	RET		not provided	VCV001694561	10	43611288	10	43115840	1694561	1686994	rs564936051	NC_000010.11:43115839:A:G	single nucleotide variant	intron variant	Likely benign	Oct 1, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2137-396G>A	RET		not provided	VCV001675417	10	43611636	10	43116188	1675417	1666801	rs568899039	NC_000010.11:43116187:G:A	single nucleotide variant	intron variant	Likely benign	May 1, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2137-384C>T	RET		not provided	VCV001879130	10	43611648	10	43116200	1879130	1935977		NC_000010.11:43116199:C:T	single nucleotide variant	intron variant	Likely benign	Oct 1, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2137-324A>G	RET		not provided	VCV001267407	10	43611708	10	43116260	1267407	1257744	rs741968	NC_000010.11:43116259:A:G	single nucleotide variant	intron variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.2137-253C>T	RET		not provided	VCV001224725	10	43611779	10	43116331	1224725	1217279	rs74135468	NC_000010.11:43116330:C:T	single nucleotide variant	intron variant	Benign	Mar 1, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.2137-251A>G	RET		not provided	VCV002498460	10	43611781	10	43116333	2498460	2476437		NC_000010.11:43116332:A:G	single nucleotide variant	intron variant	Likely benign	Mar 1, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2137-167T>C	RET		not provided	VCV000677053	10	43611865	10	43116417	677053	665137	rs2256550	NC_000010.11:43116416:T:C	single nucleotide variant	intron variant	Benign	Jun 15, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.2137-166G>A	RET		not provided	VCV002498461	10	43611866	10	43116418	2498461	2476438		NC_000010.11:43116417:G:A	single nucleotide variant	intron variant	Likely benign	Aug 1, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2137-31del	RET		Megacolon|Abnormal facial shape	VCV000633602	10	43612001	10	43116553	633602	622034	rs778378926	NC_000010.11:43116552:T:	Deletion	intron variant	Uncertain significance	May 26, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.2137-19T>C	RET		Multiple endocrine neoplasia, type 2	VCV001615153	10	43612013	10	43116565	1615153	1579020	rs2132901589	NC_000010.11:43116564:T:C	single nucleotide variant	intron variant	Likely benign	Jul 10, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2137-18C>A	RET		Multiple endocrine neoplasia, type 2	VCV002722047	10	43612014	10	43116566	2722047	2881257		NC_000010.11:43116565:C:A	single nucleotide variant	intron variant	Likely benign	Jan 31, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2137-18C>T	RET		Multiple endocrine neoplasia, type 2	VCV001631196	10	43612014	10	43116566	1631196	1543607	rs959581002	NC_000010.11:43116565:C:T	single nucleotide variant	intron variant	Likely benign	Dec 18, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2137-16del	RET		Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A	VCV000548901	10	43612014	10	43116566	548901	539283	rs1409965349	NC_000010.11:43116565:CCC:CC	Deletion	intron variant	Likely benign	May 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2137-17C>G	RET		Multiple endocrine neoplasia, type 2	VCV001631184	10	43612015	10	43116567	1631184	1543595	rs1287152318	NC_000010.11:43116566:C:G	single nucleotide variant	intron variant	Likely benign	Nov 27, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2137-16C>G	RET		Multiple endocrine neoplasia, type 2	VCV001593369	10	43612016	10	43116568	1593369	1589441	rs369817691	NC_000010.11:43116567:C:G	single nucleotide variant	intron variant	Likely benign	Jan 30, 2025	criteria provided, single submitter							
NM_020975.6(RET):c.2137-14C>T	RET		Multiple endocrine neoplasia, type 2	VCV001663841	10	43612018	10	43116570	1663841	1588663	rs2132901790	NC_000010.11:43116569:C:T	single nucleotide variant	intron variant	Likely benign	Feb 3, 2025	criteria provided, single submitter							
NM_020975.6(RET):c.2137-13A>C	RET		Multiple endocrine neoplasia, type 2	VCV001611708	10	43612019	10	43116571	1611708	1552224	rs1314541806	NC_000010.11:43116570:A:C	single nucleotide variant	intron variant	Likely benign	Oct 19, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2137-13A>G	RET		Multiple endocrine neoplasia, type 2|not provided	VCV000995140	10	43612019	10	43116571	995140	982746	rs1314541806	NC_000010.11:43116570:A:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Aug 19, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2137-11T>G	RET		Multiple endocrine neoplasia, type 2	VCV001659108	10	43612021	10	43116573	1659108	1640652	rs1247657169	NC_000010.11:43116572:T:G	single nucleotide variant	intron variant	Likely benign	Dec 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2137-10T>C	RET		Multiple endocrine neoplasia, type 2	VCV000219390	10	43612022	10	43116574	219390	221966	rs864622066	NC_000010.11:43116573:T:C	single nucleotide variant	intron variant	Likely benign	Jul 20, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2137-8C>T	RET		Multiple endocrine neoplasia, type 2	VCV002777253	10	43612024	10	43116576	2777253	2939703		NC_000010.11:43116575:C:T	single nucleotide variant	intron variant	Likely benign	Nov 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2137-7A>G	RET		Multiple endocrine neoplasia, type 2	VCV001672145	10	43612025	10	43116577	1672145	1647454	rs2132902032	NC_000010.11:43116576:A:G	single nucleotide variant	intron variant	Likely benign	Oct 9, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2137-6A>T	RET		Multiple endocrine neoplasia, type 2	VCV002701180	10	43612026	10	43116578	2701180	2862174		NC_000010.11:43116577:A:T	single nucleotide variant	intron variant	Likely benign	Dec 6, 2023	criteria provided, single submitter							
NC_000010.11:g.43116583GGA[1]	RET		Multiple endocrine neoplasia, type 2	VCV000964918	10	43612030 - 43612032	10	43116582 - 43116584	964918	959415	rs1838075264	NC_000010.11:43116581:AGGAGGA:AGGA	Microsatellite		Uncertain significance	Mar 16, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2137-1G>A	RET		not provided	VCV001197458	10	43612031	10	43116583	1197458	1187593	rs2132902301	NC_000010.11:43116582:G:A	single nucleotide variant	splice acceptor variant	Pathogenic	Feb 28, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.2138A>T (p.Glu713Val)	RET	E278V, E371V, E459V, E230V, E318V, E374V, E414V, E471V, E538V, E567V, E670V, E713V, E369V, E383V, E581V, E617V, E668V, E625V	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV003432262	10	43612033	10	43116585	3432262	3593458		NC_000010.11:43116584:A:T	single nucleotide variant	missense variant	Uncertain significance	Sep 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2139G>A (p.Glu713=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000701903	10	43612034	10	43116586	701903	687633	rs149460492	NC_000010.11:43116585:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2140G>A (p.Asp714Asn)	RET	D231N, D279N, D319N, D370N, D372N, D375N, D384N, D415N, D460N, D472N, D539N, D568N, D582N, D618N, D626N, D669N, D671N, D714N	RET-related disorder	VCV002635239	10	43612035	10	43116587	2635239	2802140		NC_000010.11:43116586:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 3, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2141A>C (p.Asp714Ala)	RET	D460A, D714A, D415A, D539A, D568A, D582A, D626A, D671A, D375A, D618A, D279A, D319A, D370A, D384A, D231A, D372A, D472A, D669A	Multiple endocrine neoplasia, type 2	VCV001504808	10	43612036	10	43116588	1504808	1417558	rs2132902595	NC_000010.11:43116587:A:C	single nucleotide variant	missense variant	Uncertain significance	Dec 2, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.2143C>G (p.Pro715Ala)	RET	P232A, P540A, P569A, P627A, P672A, P320A, P376A, P473A, P619A, P280A, P371A, P416A, P715A, P373A, P385A, P461A, P583A, P670A	Multiple endocrine neoplasia, type 2	VCV002833076	10	43612038	10	43116590	2833076	3001403		NC_000010.11:43116589:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 6, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2143C>A (p.Pro715Thr)	RET	P461T, P715T, P280T, P373T, P416T, P583T, P670T, P232T, P320T, P371T, P627T, P385T, P540T, P569T, P672T, P376T, P473T, P619T	Multiple endocrine neoplasia, type 2	VCV000856856	10	43612038	10	43116590	856856	836855	rs1838075429	NC_000010.11:43116589:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 29, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2144C>T (p.Pro715Leu)	RET	P232L, P385L, P619L, P280L, P373L, P461L, P715L, P320L, P473L, P540L, P672L, P371L, P376L, P416L, P569L, P583L, P627L, P670L	Hereditary cancer-predisposing syndrome	VCV003432308	10	43612039	10	43116591	3432308	3593504		NC_000010.11:43116590:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 8, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2153A>T (p.Glu718Val)	RET	E235V, E283V, E379V, E586V, E630V, E675V, E323V, E374V, E388V, E464V, E673V, E572V, E622V, E718V, E376V, E419V, E476V, E543V	Hereditary cancer-predisposing syndrome	VCV003313750	10	43612048	10	43116600	3313750	3465480		NC_000010.11:43116599:A:T	single nucleotide variant	missense variant	Uncertain significance	Jun 17, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2158C>T (p.Pro720Ser)	RET	P720S, P466S, P376S, P381S, P545S, P677S, P237S, P378S, P574S, P390S, P478S, P588S, P624S, P632S, P675S, P285S, P325S, P421S	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000405521	10	43612053	10	43116605	405521	397461	rs1060500753	NC_000010.11:43116604:C:T	single nucleotide variant	missense variant	Uncertain significance	May 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2159C>T (p.Pro720Leu)	RET	P466L, P720L, P237L, P325L, P677L, P378L, P390L, P624L, P675L, P285L, P376L, P421L, P478L, P545L, P574L, P381L, P588L, P632L	Multiple endocrine neoplasia, type 2	VCV000648858	10	43612054	10	43116606	648858	638912	rs1588875462	NC_000010.11:43116605:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.2161C>G (p.Arg721Gly)	RET	R238G, R286G, R326G, R377G, R379G, R382G, R391G, R422G, R467G, R479G, R546G, R575G, R589G, R625G, R633G, R676G, R678G, R721G	Multiple endocrine neoplasia, type 2	VCV003074030	10	43612056	10	43116608	3074030	3231166		NC_000010.11:43116607:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 23, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2161C>T (p.Arg721Trp)	RET	R721W, R467W, R286W, R589W, R625W, R326W, R379W, R391W, R422W, R633W, R238W, R377W, R575W, R678W, R382W, R479W, R546W, R676W	Multiple endocrine neoplasia, type 2	VCV000543725	10	43612056	10	43116608	543725	525149	rs1554819146	NC_000010.11:43116607:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 21, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.2162G>A (p.Arg721Gln)	RET	R721Q, R467Q, R286Q, R377Q, R479Q, R625Q, R379Q, R391Q, R589Q, R676Q, R326Q, R422Q, R678Q, R238Q, R382Q, R546Q, R575Q, R633Q	Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Multiple endocrine neoplasia type 2B|not provided|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1	VCV000584563	10	43612057	10	43116609	584563	575554	rs1356141763	NC_000010.11:43116608:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2164A>C (p.Lys722Gln)	RET	K239Q, K383Q, K392Q, K423Q, K576Q, K327Q, K547Q, K590Q, K634Q, K287Q, K480Q, K626Q, K378Q, K380Q, K468Q, K677Q, K679Q, K722Q	Hereditary cancer-predisposing syndrome	VCV003432295	10	43612059	10	43116611	3432295	3593491		NC_000010.11:43116610:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 17, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2164A>G (p.Lys722Glu)	RET	K468E, K722E, K392E, K679E, K239E, K287E, K327E, K378E, K383E, K626E, K634E, K480E, K576E, K677E, K380E, K423E, K547E, K590E	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1	VCV001045058	10	43612059	10	43116611	1045058	1029543	rs1262183810	NC_000010.11:43116610:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2166G>T (p.Lys722Asn)	RET	K722N, K468N, K239N, K423N, K480N, K576N, K634N, K327N, K392N, K547N, K590N, K626N, K287N, K378N, K380N, K383N, K677N, K679N	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not provided|Hirschsprung disease, susceptibility to, 1|Hereditary cancer|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia type 2B	VCV000136108	10	43612061	10	43116613	136108	139820	rs527726480	NC_000010.11:43116612:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 29, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2168A>G (p.Asn723Ser)	RET	N381S, N393S, N548S, N577S, N591S, N424S, N481S, N627S, N635S, N288S, N379S, N469S, N240S, N328S, N384S, N678S, N680S, N723S	Multiple endocrine neoplasia, type 2	VCV003653427	10	43612063	10	43116615	3653427	3788860		NC_000010.11:43116614:A:G	single nucleotide variant	missense variant	Uncertain significance	May 15, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2169C>T (p.Asn723=)	RET		Hereditary cancer-predisposing syndrome	VCV000820816	10	43612064	10	43116616	820816	809949	rs1588875478	NC_000010.11:43116615:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 26, 2016	criteria provided, single submitter							
NM_020975.6(RET):c.2172G>A (p.Leu724=)	RET		Multiple endocrine neoplasia, type 2	VCV001128340	10	43612067	10	43116619	1128340	1120272	rs2132904323	NC_000010.11:43116618:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 28, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.2176C>A (p.Leu726Ile)	RET	L243I, L291I, L331I, L382I, L387I, L472I, L484I, L580I, L630I, L384I, L638I, L683I, L396I, L427I, L594I, L681I, L551I, L726I	Hereditary cancer-predisposing syndrome	VCV002568353	10	43612071	10	43116623	2568353	2734889		NC_000010.11:43116622:C:A	single nucleotide variant	missense variant	Uncertain significance	May 1, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2176C>T (p.Leu726Phe)	RET	L726F, L472F, L396F, L484F, L681F, L551F, L580F, L638F, L331F, L382F, L427F, L243F, L291F, L384F, L387F, L594F, L630F, L683F	Multiple endocrine neoplasia, type 2	VCV000953640	10	43612071	10	43116623	953640	946894	rs1838076418	NC_000010.11:43116622:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 11, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2177T>C (p.Leu726Pro)	RET	L243P, L291P, L331P, L382P, L384P, L387P, L396P, L427P, L472P, L484P, L551P, L580P, L594P, L630P, L638P, L681P, L683P, L726P	Hereditary cancer-predisposing syndrome	VCV003227523	10	43612072	10	43116624	3227523	3390735		NC_000010.11:43116623:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 12, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2182A>G (p.Lys728Glu)	RET	K728E, K474E, K245E, K389E, K553E, K333E, K632E, K293E, K386E, K429E, K486E, K582E, K596E, K640E, K384E, K398E, K683E, K685E	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A	VCV000570574	10	43612077	10	43116629	570574	564571	rs147216744	NC_000010.11:43116628:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2183A>G (p.Lys728Arg)	RET	K728R, K474R, K245R, K386R, K632R, K683R, K293R, K384R, K389R, K553R, K582R, K596R, K640R, K398R, K486R, K333R, K429R, K685R	Multiple endocrine neoplasia, type 2	VCV000645752	10	43612078	10	43116630	645752	638913	rs1042740895	NC_000010.11:43116629:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 9, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2186C>T (p.Thr729Ile)	RET	T475I, T729I, T399I, T334I, T597I, T684I, T246I, T294I, T385I, T430I, T487I, T641I, T686I, T387I, T390I, T554I, T583I, T633I	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001523134	10	43612081	10	43116633	1523134	1350303	rs2132904896	NC_000010.11:43116632:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2187T>C (p.Thr729=)	RET		Hereditary cancer-predisposing syndrome	VCV001787358	10	43612082	10	43116634	1787358	1850340		NC_000010.11:43116633:T:C	single nucleotide variant	synonymous variant	Likely benign	Sep 1, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.2188C>G (p.Leu730Val)	RET	L476V, L730V, L247V, L295V, L685V, L431V, L488V, L555V, L598V, L642V, L687V, L386V, L400V, L335V, L388V, L391V, L584V, L634V	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000943106	10	43612083	10	43116635	943106	935035	rs1838076782	NC_000010.11:43116634:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2190A>G (p.Leu730=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001152597	10	43612085	10	43116637	1152597	1141126	rs377616279	NC_000010.11:43116636:A:G	single nucleotide variant	synonymous variant	Likely benign	Jul 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2193A>G (p.Gly731=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001637640	10	43612088	10	43116640	1637640	1645233	rs2132905376	NC_000010.11:43116639:A:G	single nucleotide variant	synonymous variant	Likely benign	Nov 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2194G>A (p.Glu732Lys)	RET	E297K, E337K, E393K, E402K, E600K, E689K, E249K, E433K, E490K, E557K, E586K, E636K, E478K, E687K, E732K, E388K, E390K, E644K	Multiple endocrine neoplasia, type 2	VCV002830387	10	43612089	10	43116641	2830387	2997865		NC_000010.11:43116640:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 20, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2197G>A (p.Gly733Ser)	RET	G338S, G434S, G250S, G394S, G479S, G558S, G587S, G733S, G389S, G491S, G601S, G637S, G298S, G391S, G403S, G645S, G688S, G690S	Hereditary cancer-predisposing syndrome	VCV003432307	10	43612092	10	43116644	3432307	3593503		NC_000010.11:43116643:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 8, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2198G>A (p.Gly733Asp)	RET	G733D, G479D, G298D, G645D, G391D, G394D, G434D, G491D, G558D, G587D, G601D, G389D, G637D, G690D, G250D, G338D, G403D, G688D	not specified	VCV000633391	10	43612093	10	43116645	633391	621316	rs1564497340	NC_000010.11:43116644:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 29, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2199C>A (p.Gly733=)	RET		Hereditary cancer-predisposing syndrome	VCV001787528	10	43612094	10	43116646	1787528	1850509		NC_000010.11:43116645:C:A	single nucleotide variant	synonymous variant	Likely benign	Nov 12, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.2199C>T (p.Gly733=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia type 2B	VCV000136109	10	43612094	10	43116646	136109	139821	rs587780809	NC_000010.11:43116645:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 16, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2200G>A (p.Glu734Lys)	RET	E734K, E480K, E251K, E390K, E395K, E602K, E646K, E691K, E588K, E404K, E435K, E492K, E638K, E299K, E339K, E392K, E559K, E689K	Multiple endocrine neoplasia, type 2	VCV000948371	10	43612095	10	43116647	948371	925807	rs1838077120	NC_000010.11:43116646:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 17, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.2209A>C (p.Lys737Gln)	RET	K483Q, K737Q, K254Q, K302Q, K342Q, K393Q, K649Q, K398Q, K495Q, K605Q, K641Q, K395Q, K407Q, K562Q, K591Q, K438Q, K692Q, K694Q	Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Pheochromocytoma|RET-related disorder|Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|not provided	VCV000655391	10	43612104	10	43116656	655391	638914	rs768217520	NC_000010.11:43116655:A:C	single nucleotide variant	missense variant	Uncertain significance	May 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2210A>G (p.Lys737Arg)	RET	K483R, K737R, K393R, K562R, K605R, K641R, K694R, K254R, K342R, K395R, K649R, K407R, K438R, K495R, K302R, K398R, K591R, K692R	Multiple endocrine neoplasia, type 2	VCV001512010	10	43612105	10	43116657	1512010	1455645	rs2132906106	NC_000010.11:43116656:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 17, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2211A>C (p.Lys737Asn)	RET	K302N, K495N, K562N, K605N, K393N, K395N, K407N, K692N, K254N, K342N, K438N, K483N, K591N, K737N, K398N, K641N, K649N, K694N	Multiple endocrine neoplasia, type 2	VCV002962957	10	43612106	10	43116658	2962957	3120277		NC_000010.11:43116657:A:C	single nucleotide variant	missense variant	Uncertain significance	Jul 29, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2214G>A (p.Val738=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000697859	10	43612109	10	43116661	697859	687634	rs776073471	NC_000010.11:43116660:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2215G>A (p.Val739Ile)	RET	V485I, V739I, V256I, V304I, V397I, V497I, V564I, V593I, V694I, V395I, V607I, V643I, V409I, V440I, V696I, V344I, V400I, V651I	Multiple endocrine neoplasia, type 2	VCV001058520	10	43612110	10	43116662	1058520	1046536	rs2132906367	NC_000010.11:43116661:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 1, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.2217C>T (p.Val739=)	RET		Multiple endocrine neoplasia, type 2	VCV003645431	10	43612112	10	43116664	3645431	3783846		NC_000010.11:43116663:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 12, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2217C>G (p.Val739=)	RET		Multiple endocrine neoplasia, type 2	VCV003074143	10	43612112	10	43116664	3074143	3231279		NC_000010.11:43116663:C:G	single nucleotide variant	synonymous variant	Likely benign	Oct 23, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2218A>G (p.Lys740Glu)	RET	K486E, K740E, K396E, K401E, K441E, K498E, K695E, K697E, K305E, K398E, K608E, K257E, K345E, K410E, K594E, K644E, K652E, K565E	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000959937	10	43612113	10	43116665	959937	946895	rs1838077401	NC_000010.11:43116664:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2220G>A (p.Lys740=)	RET		Hereditary cancer-predisposing syndrome	VCV001787927	10	43612115	10	43116667	1787927	1847370		NC_000010.11:43116666:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 19, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2221G>A (p.Ala741Thr)	RET	A741T, A487T, A258T, A397T, A411T, A595T, A306T, A499T, A609T, A653T, A696T, A402T, A442T, A346T, A399T, A566T, A645T, A698T	Multiple endocrine neoplasia, type 2	VCV001409007	10	43612116	10	43116668	1409007	1496796	rs2132906751	NC_000010.11:43116667:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 3, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2222C>G (p.Ala741Gly)	RET	A487G, A741G, A402G, A499G, A595G, A645G, A696G, A258G, A346G, A397G, A411G, A609G, A566G, A698G, A306G, A399G, A442G, A653G	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001042395	10	43612117	10	43116669	1042395	1029544	rs761397627	NC_000010.11:43116668:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2225C>T (p.Thr742Met)	RET	T742M, T488M, T259M, T403M, T443M, T697M, T307M, T500M, T596M, T646M, T347M, T398M, T412M, T610M, T400M, T567M, T654M, T699M	not provided|Hereditary cancer-predisposing syndrome|Congenital central hypoventilation|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2	VCV000187701	10	43612120	10	43116672	187701	182955	rs773256580	NC_000010.11:43116671:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 4, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2226G>A (p.Thr742=)	RET		not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A	VCV000220507	10	43612121	10	43116673	220507	221967	rs762876946	NC_000010.11:43116672:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Nov 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2228C>T (p.Ala743Val)	RET	A308V, A348V, A444V, A489V, A700V, A260V, A404V, A413V, A568V, A611V, A743V, A399V, A501V, A597V, A647V, A655V, A401V, A698V	Hereditary cancer-predisposing syndrome	VCV001788023	10	43612123	10	43116675	1788023	1847466		NC_000010.11:43116674:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 26, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2229C>T (p.Ala743=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001107852	10	43612124	10	43116676	1107852	1098702	rs1838077833	NC_000010.11:43116675:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Dec 1, 2023	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2231T>C (p.Phe744Ser)	RET	F502S, F569S, F309S, F400S, F490S, F699S, F744S, F402S, F445S, F598S, F701S, F261S, F349S, F405S, F414S, F612S, F648S, F656S	Multiple endocrine neoplasia, type 2	VCV002722478	10	43612126	10	43116678	2722478	2891579		NC_000010.11:43116677:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 19, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2232C>G (p.Phe744Leu)	RET	F744L, F490L, F402L, F405L, F612L, F445L, F569L, F598L, F309L, F400L, F648L, F261L, F349L, F414L, F502L, F656L, F699L, F701L	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000951684	10	43612127	10	43116679	951684	925808	rs766035127	NC_000010.11:43116678:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2234A>G (p.His745Arg)	RET	H745R, H491R, H401R, H403R, H446R, H503R, H613R, H310R, H350R, H406R, H570R, H262R, H649R, H702R, H415R, H599R, H657R, H700R	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000820949	10	43612129	10	43116681	820949	809950	rs534094626	NC_000010.11:43116680:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 30, 2023	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2234A>C (p.His745Pro)	RET	H745P, H491P, H401P, H406P, H649P, H702P, H262P, H350P, H415P, H599P, H446P, H503P, H570P, H310P, H403P, H613P, H657P, H700P	Multiple endocrine neoplasia, type 2	VCV000543727	10	43612129	10	43116681	543727	525306	rs534094626	NC_000010.11:43116680:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 29, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2234A>T (p.His745Leu)	RET	H745L, H491L, H262L, H401L, H406L, H310L, H350L, H649L, H446L, H599L, H657L, H702L, H403L, H415L, H503L, H570L, H613L, H700L	Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Familial medullary thyroid carcinoma	VCV000201139	10	43612129	10	43116681	201139	197378	rs534094626	NC_000010.11:43116680:A:T	single nucleotide variant	missense variant	Uncertain significance	Dec 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2236C>G (p.Leu746Val)	RET	L492V, L746V, L404V, L416V, L351V, L407V, L650V, L703V, L263V, L447V, L504V, L600V, L614V, L701V, L311V, L402V, L571V, L658V	Multiple endocrine neoplasia, type 2	VCV000940090	10	43612131	10	43116683	940090	935036	rs1838078155	NC_000010.11:43116682:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 10, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.2237T>C (p.Leu746Pro)	RET	L746P, L492P, L402P, L407P, L311P, L504P, L600P, L650P, L658P, L701P, L263P, L351P, L404P, L416P, L447P, L571P, L614P, L703P	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A|not provided	VCV001383725	10	43612132	10	43116684	1383725	1354865	rs755085530	NC_000010.11:43116683:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2238G>T (p.Leu746=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001112555	10	43612133	10	43116685	1112555	1098704	rs1397237755	NC_000010.11:43116684:G:T	single nucleotide variant	synonymous variant	Likely benign	Dec 30, 2019	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2238G>A (p.Leu746=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001110138	10	43612133	10	43116685	1110138	1098703	rs1397237755	NC_000010.11:43116684:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2239A>G (p.Lys747Glu)	RET	K405E, K615E, K747E, K264E, K352E, K403E, K408E, K601E, K704E, K448E, K493E, K505E, K651E, K659E, K312E, K417E, K572E, K702E	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV003432259	10	43612134	10	43116686	3432259	3593455		NC_000010.11:43116685:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2239A>C (p.Lys747Gln)	RET	K264Q, K312Q, K408Q, K417Q, K572Q, K651Q, K747Q, K448Q, K505Q, K601Q, K702Q, K704Q, K352Q, K493Q, K615Q, K403Q, K405Q, K659Q	Multiple endocrine neoplasia, type 2	VCV002849248	10	43612134	10	43116686	2849248	3009039		NC_000010.11:43116685:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2240A>G (p.Lys747Arg)	RET	K264R, K312R, K352R, K403R, K405R, K408R, K417R, K448R, K493R, K505R, K572R, K601R, K615R, K651R, K659R, K702R, K704R, K747R	Hereditary cancer-predisposing syndrome	VCV003227524	10	43612135	10	43116687	3227524	3390736		NC_000010.11:43116686:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 22, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2241A>G (p.Lys747=)	RET		Multiple endocrine neoplasia, type 2	VCV002062858	10	43612136	10	43116688	2062858	2128133		NC_000010.11:43116687:A:G	single nucleotide variant	synonymous variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2243G>A (p.Gly748Asp)	RET	G494D, G748D, G313D, G404D, G418D, G616D, G652D, G703D, G353D, G409D, G449D, G602D, G705D, G265D, G660D, G406D, G506D, G573D	Multiple endocrine neoplasia, type 2|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B|Hereditary cancer-predisposing syndrome	VCV000661752	10	43612138	10	43116690	661752	638915	rs1314127008	NC_000010.11:43116689:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2245A>G (p.Arg749Gly)	RET	R749G, R495G, R354G, R450G, R653G, R266G, R405G, R410G, R574G, R661G, R706G, R407G, R419G, R507G, R603G, R314G, R617G, R704G	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001040791	10	43612140	10	43116692	1040791	1029545	rs1210164099	NC_000010.11:43116691:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2246G>C (p.Arg749Thr)	RET	R749T, R495T, R407T, R410T, R661T, R419T, R450T, R507T, R617T, R704T, R314T, R405T, R653T, R266T, R354T, R574T, R603T, R706T	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000220330	10	43612141	10	43116693	220330	221968	rs34288963	NC_000010.11:43116692:G:C	single nucleotide variant	missense variant	Benign/Likely benign	Jan 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2247A>G (p.Arg749=)	RET		Hereditary cancer-predisposing syndrome	VCV001788356	10	43612142	10	43116694	1788356	1844418		NC_000010.11:43116693:A:G	single nucleotide variant	synonymous variant	Likely benign	Dec 1, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2248G>C (p.Ala750Pro)	RET	A750P, A496P, A267P, A408P, A411P, A420P, A451P, A618P, A707P, A575P, A355P, A406P, A604P, A654P, A662P, A315P, A508P, A705P	Multiple endocrine neoplasia, type 2	VCV001446002	10	43612143	10	43116695	1446002	540551	rs1554819165	NC_000010.11:43116694:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 27, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2249C>G (p.Ala750Gly)	RET	A750G, A496G, A408G, A618G, A654G, A662G, A705G, A406G, A508G, A575G, A267G, A315G, A355G, A411G, A604G, A420G, A451G, A707G	Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|not provided|Multiple endocrine neoplasia, type 2	VCV000560866	10	43612144	10	43116696	560866	551870	rs752830000	NC_000010.11:43116695:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2251G>A (p.Gly751Arg)	RET	G497R, G751R, G268R, G409R, G421R, G452R, G576R, G655R, G509R, G605R, G706R, G316R, G356R, G663R, G407R, G412R, G619R, G708R	Multiple endocrine neoplasia, type 2	VCV000639162	10	43612146	10	43116698	639162	638916	rs756163867	NC_000010.11:43116697:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 26, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2252G>A (p.Gly751Glu)	RET	G268E, G409E, G619E, G751E, G509E, G655E, G706E, G708E, G407E, G497E, G576E, G605E, G316E, G356E, G412E, G421E, G452E, G663E	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001788459	10	43612147	10	43116699	1788459	1844520		NC_000010.11:43116698:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2253G>A (p.Gly751=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002047745	10	43612148	10	43116700	2047745	2110815		NC_000010.11:43116699:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2254T>G (p.Tyr752Asp)	RET	Y498D, Y752D, Y357D, Y453D, Y606D, Y269D, Y413D, Y510D, Y577D, Y656D, Y709D, Y317D, Y408D, Y620D, Y664D, Y410D, Y422D, Y707D	Hereditary cancer-predisposing syndrome	VCV000820972	10	43612149	10	43116701	820972	809951	rs984978805	NC_000010.11:43116700:T:G	single nucleotide variant	missense variant	Uncertain significance	Nov 2, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.2254T>C (p.Tyr752His)	RET	Y752H, Y498H, Y357H, Y408H, Y410H, Y620H, Y317H, Y577H, Y656H, Y664H, Y422H, Y453H, Y510H, Y707H, Y709H, Y269H, Y413H, Y606H	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1	VCV000486311	10	43612149	10	43116701	486311	475308	rs984978805	NC_000010.11:43116700:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2255A>G (p.Tyr752Cys)	RET	Y498C, Y752C, Y357C, Y510C, Y606C, Y408C, Y413C, Y656C, Y664C, Y707C, Y422C, Y577C, Y269C, Y317C, Y410C, Y453C, Y620C, Y709C	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001402378	10	43612150	10	43116702	1402378	1466505	rs909451217	NC_000010.11:43116701:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2256C>T (p.Tyr752=)	RET		Hereditary cancer-predisposing syndrome	VCV001788531	10	43612151	10	43116703	1788531	1844591		NC_000010.11:43116702:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 23, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2257A>C (p.Thr753Pro)	RET	T511P, T607P, T621P, T665P, T708P, T318P, T409P, T454P, T499P, T578P, T710P, T270P, T358P, T411P, T414P, T423P, T657P, T753P	Multiple endocrine neoplasia, type 2	VCV002751477	10	43612152	10	43116704	2751477	2908773		NC_000010.11:43116703:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 10, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2257A>G (p.Thr753Ala)	RET	T499A, T753A, T411A, T414A, T454A, T511A, T318A, T358A, T621A, T657A, T708A, T270A, T409A, T665A, T423A, T578A, T607A, T710A	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001018126	10	43612152	10	43116704	1018126	1008997	rs1838079291	NC_000010.11:43116703:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2258C>A (p.Thr753Asn)	RET	T270N, T318N, T454N, T657N, T710N, T753N, T409N, T411N, T423N, T578N, T665N, T708N, T358N, T414N, T499N, T511N, T607N, T621N	Hereditary cancer-predisposing syndrome	VCV001788545	10	43612153	10	43116705	1788545	1844605		NC_000010.11:43116704:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 18, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2259C>T (p.Thr753=)	RET		Hereditary cancer-predisposing syndrome	VCV003432233	10	43612154	10	43116706	3432233	3593429		NC_000010.11:43116705:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 13, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2260A>C (p.Thr754Pro)	RET	T359P, T500P, T622P, T754P, T271P, T455P, T608P, T319P, T410P, T424P, T512P, T579P, T709P, T412P, T415P, T658P, T666P, T711P	Hereditary cancer-predisposing syndrome	VCV002568354	10	43612155	10	43116707	2568354	2734890		NC_000010.11:43116706:A:C	single nucleotide variant	missense variant	Uncertain significance	May 1, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2261C>T (p.Thr754Met)	RET	T754M, T500M, T579M, T666M, T319M, T359M, T410M, T455M, T608M, T622M, T709M, T415M, T658M, T271M, T412M, T424M, T512M, T711M	Multiple endocrine neoplasia type 2A|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia|Multiple endocrine neoplasia, type 2|not provided|Hereditary cancer-predisposing syndrome	VCV000135177	10	43612156	10	43116708	135177	138916	rs181856591	NC_000010.11:43116707:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 13, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2262G>T (p.Thr754=)	RET		Multiple endocrine neoplasia, type 2	VCV001941421	10	43612157	10	43116709	1941421	1997706		NC_000010.11:43116708:G:T	single nucleotide variant	synonymous variant	Likely benign	Sep 23, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2262G>C (p.Thr754=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000771105	10	43612157	10	43116709	771105	701344	rs779080598	NC_000010.11:43116708:G:C	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Nov 6, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2262G>A (p.Thr754=)	RET		Hereditary cancer-predisposing syndrome|not specified|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2	VCV000477341	10	43612157	10	43116709	477341	460733	rs779080598	NC_000010.11:43116708:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2263G>T (p.Val755Leu)	RET	V411L, V413L, V501L, V272L, V320L, V360L, V416L, V712L, V456L, V513L, V580L, V667L, V755L, V425L, V609L, V623L, V659L, V710L	Hereditary cancer-predisposing syndrome	VCV002447534	10	43612158	10	43116710	2447534	2432428		NC_000010.11:43116709:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 7, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2263G>A (p.Val755Met)	RET	V501M, V755M, V272M, V360M, V413M, V513M, V609M, V667M, V320M, V416M, V456M, V580M, V623M, V659M, V710M, V411M, V712M, V425M	Multiple endocrine neoplasia, type 2	VCV001369747	10	43612158	10	43116710	1369747	1437453	rs2132909324	NC_000010.11:43116709:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 29, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2264T>C (p.Val755Ala)	RET	V755A, V501A, V456A, V609A, V667A, V272A, V580A, V659A, V712A, V320A, V413A, V425A, V710A, V360A, V411A, V416A, V513A, V623A	Multiple endocrine neoplasia, type 2	VCV000579107	10	43612159	10	43116711	579107	569658	rs1256848994	NC_000010.11:43116710:T:C	single nucleotide variant	missense variant	Uncertain significance	May 29, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.2267C>A (p.Ala756Asp)	RET	A502D, A756D, A273D, A412D, A414D, A581D, A624D, A660D, A668D, A713D, A426D, A457D, A610D, A711D, A417D, A514D, A321D, A361D	Multiple endocrine neoplasia, type 2	VCV001407876	10	43612162	10	43116714	1407876	1506754	rs1838079858	NC_000010.11:43116713:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 28, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2267C>G (p.Ala756Gly)	RET	A502G, A756G, A321G, A417G, A457G, A581G, A624G, A660G, A668G, A414G, A711G, A426G, A713G, A273G, A361G, A412G, A514G, A610G	Multiple endocrine neoplasia, type 2	VCV001026784	10	43612162	10	43116714	1026784	1008998	rs1838079858	NC_000010.11:43116713:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2268C>A (p.Ala756=)	RET		Multiple endocrine neoplasia, type 2	VCV001563938	10	43612163	10	43116715	1563938	1588959	rs370791179	NC_000010.11:43116714:C:A	single nucleotide variant	synonymous variant	Likely benign	Jun 4, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2268C>T (p.Ala756=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|not provided|Multiple endocrine neoplasia, type 2	VCV000477342	10	43612163	10	43116715	477342	460309	rs370791179	NC_000010.11:43116714:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2269G>A (p.Val757Met)	RET	V415M, V582M, V714M, V274M, V362M, V418M, V503M, V515M, V413M, V458M, V625M, V669M, V712M, V322M, V427M, V611M, V661M, V757M	Hereditary cancer-predisposing syndrome	VCV001788738	10	43612164	10	43116716	1788738	1840952		NC_000010.11:43116715:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 10, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2280G>A (p.Leu760=)	RET		Hereditary cancer-predisposing syndrome	VCV000821015	10	43612175	10	43116727	821015	809952	rs1588875562	NC_000010.11:43116726:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 9, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.2284+3A>G	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000936270	10	43612182	10	43116734	936270	940167	rs1838080251	NC_000010.11:43116733:A:G	single nucleotide variant	intron variant	Uncertain significance	Jul 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2284+4C>A	RET		Hereditary cancer-predisposing syndrome	VCV003432289	10	43612183	10	43116735	3432289	3593485		NC_000010.11:43116734:C:A	single nucleotide variant	intron variant	Uncertain significance	Nov 15, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2284+4C>T	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001913782	10	43612183	10	43116735	1913782	1970113		NC_000010.11:43116734:C:T	single nucleotide variant	intron variant	Uncertain significance	Nov 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2284+4C>G	RET		Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome	VCV000950458	10	43612183	10	43116735	950458	940957	rs1838080320	NC_000010.11:43116734:C:G	single nucleotide variant	intron variant	Uncertain significance	May 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2284+6_2284+7del	RET		Multiple endocrine neoplasia, type 2	VCV001061481	10	43612185 - 43612186	10	43116737 - 43116738	1061481	1046537	rs1163200373	NC_000010.11:43116736:TG:	Deletion	intron variant	Uncertain significance	Oct 16, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2284+7G>A	RET		Multiple endocrine neoplasia, type 2	VCV001668838	10	43612186	10	43116738	1668838	1602724	rs1181605359	NC_000010.11:43116737:G:A	single nucleotide variant	intron variant	Likely benign	Jan 3, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2284+7G>C	RET		Multiple endocrine neoplasia, type 2	VCV001623672	10	43612186	10	43116738	1623672	1594439	rs1181605359	NC_000010.11:43116737:G:C	single nucleotide variant	intron variant	Likely benign	Dec 24, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.2284+15C>T	RET		Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Pheochromocytoma|Multiple endocrine neoplasia, type 2	VCV001605446	10	43612194	10	43116746	1605446	1646500	rs768252806	NC_000010.11:43116745:C:T	single nucleotide variant	intron variant	Likely benign	Jan 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2284+17G>A	RET		Multiple endocrine neoplasia, type 2	VCV002893853	10	43612196	10	43116748	2893853	3045785		NC_000010.11:43116747:G:A	single nucleotide variant	intron variant	Likely benign	Dec 24, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2284+18G>A	RET		Multiple endocrine neoplasia, type 2	VCV002742651	10	43612197	10	43116749	2742651	2900414		NC_000010.11:43116748:G:A	single nucleotide variant	intron variant	Likely benign	May 2, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2284+18G>T	RET		Multiple endocrine neoplasia, type 2	VCV002091716	10	43612197	10	43116749	2091716	2156099		NC_000010.11:43116748:G:T	single nucleotide variant	intron variant	Likely benign	Jul 30, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2284+26C>T	RET		RET-related disorder	VCV003053100	10	43612205	10	43116757	3053100	3219061		NC_000010.11:43116756:C:T	single nucleotide variant	intron variant	Likely benign	Aug 20, 2019	no assertion criteria provided							
NM_020975.6(RET):c.2284+46G>C	RET		not provided	VCV001201147	10	43612225	10	43116777	1201147	1191059	rs147601354	NC_000010.11:43116776:G:C	single nucleotide variant	intron variant	Benign/Likely benign	Nov 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2284+47C>T	RET		Multiple endocrine neoplasia type 2B|not specified|not provided	VCV000261396	10	43612226	10	43116778	261396	253767	rs760466	NC_000010.11:43116777:C:T	single nucleotide variant	intron variant	Benign	Jul 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2284+54C>T	RET		RET-related disorder	VCV003037075	10	43612233	10	43116785	3037075	3202989		NC_000010.11:43116784:C:T	single nucleotide variant	intron variant	Likely benign	Nov 17, 2021	no assertion criteria provided							
NM_020975.6(RET):c.2284+54C>A	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not provided|not specified|Multiple endocrine neoplasia type 2A	VCV000220577	10	43612233	10	43116785	220577	221969	rs566375223	NC_000010.11:43116784:C:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Nov 1, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2285-85G>A	RET		not provided	VCV001232188	10	43613736	10	43118288	1232188	1219604	rs3026766	NC_000010.11:43118287:G:A	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, single submitter							
NM_020975.6(RET):c.2285-20T>C	RET		Multiple endocrine neoplasia, type 2	VCV002981265	10	43613801	10	43118353	2981265	3138562		NC_000010.11:43118352:T:C	single nucleotide variant	intron variant	Likely benign	Jan 28, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2285-16C>G	RET		Multiple endocrine neoplasia, type 2	VCV003642698	10	43613805	10	43118357	3642698	3765469		NC_000010.11:43118356:C:G	single nucleotide variant	intron variant	Likely benign	Feb 23, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2285-16C>A	RET		Multiple endocrine neoplasia, type 2	VCV002713378	10	43613805	10	43118357	2713378	2875676		NC_000010.11:43118356:C:A	single nucleotide variant	intron variant	Likely benign	Jan 25, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2285-16C>T	RET		Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2	VCV001569229	10	43613805	10	43118357	1569229	1603777	rs781027098	NC_000010.11:43118356:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Sep 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2285-14G>A	RET		Multiple endocrine neoplasia, type 2	VCV003069610	10	43613807	10	43118359	3069610	3230235		NC_000010.11:43118358:G:A	single nucleotide variant	intron variant	Likely benign	Feb 24, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2285-14G>C	RET		Multiple endocrine neoplasia, type 2	VCV002911649	10	43613807	10	43118359	2911649	3075629		NC_000010.11:43118358:G:C	single nucleotide variant	intron variant	Likely benign	Nov 17, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2285-10T>C	RET		not provided	VCV000735565	10	43613811	10	43118363	735565	759923	rs1588876423	NC_000010.11:43118362:T:C	single nucleotide variant	intron variant	Likely benign	Feb 2, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.2285-4T>G	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2	VCV000548893	10	43613817	10	43118369	548893	539284	rs376601566	NC_000010.11:43118368:T:G	single nucleotide variant	intron variant	Benign/Likely benign	Sep 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2285A>C (p.Glu762Ala)	RET	E418A, E420A, E587A, E616A, E463A, E630A, E719A, E279A, E432A, E508A, E666A, E717A, E762A, E327A, E367A, E423A, E520A, E674A	Multiple endocrine neoplasia, type 2	VCV003646168	10	43613821	10	43118373	3646168	3776687		NC_000010.11:43118372:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 16, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2286G>T (p.Glu762Asp)	RET	E508D, E762D, E367D, E420D, E520D, E719D, E279D, E717D, E327D, E432D, E587D, E630D, E666D, E674D, E418D, E423D, E463D, E616D	Multiple endocrine neoplasia, type 2	VCV001509387	10	43613822	10	43118374	1509387	1365008	rs1323183090	NC_000010.11:43118373:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 7, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2286G>C (p.Glu762Asp)	RET	E762D, E508D, E418D, E420D, E520D, E327D, E423D, E587D, E666D, E279D, E367D, E463D, E630D, E674D, E717D, E432D, E616D, E719D	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A	VCV000821031	10	43613822	10	43118374	821031	809953	rs1323183090	NC_000010.11:43118373:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2287A>G (p.Asn763Asp)	RET	N763D, N509D, N718D, N720D, N328D, N433D, N521D, N617D, N675D, N280D, N421D, N424D, N368D, N419D, N464D, N588D, N631D, N667D	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000241345	10	43613823	10	43118375	241345	240799	rs878855060	NC_000010.11:43118374:A:G	single nucleotide variant	missense variant	Uncertain significance	May 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2288A>C (p.Asn763Thr)	RET	N328T, N421T, N675T, N720T, N419T, N763T, N280T, N424T, N509T, N521T, N588T, N617T, N631T, N368T, N433T, N464T, N667T, N718T	Hereditary cancer-predisposing syndrome	VCV003432212	10	43613824	10	43118376	3432212	3593408		NC_000010.11:43118375:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 15, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2288A>G (p.Asn763Ser)	RET	N280S, N328S, N464S, N631S, N718S, N421S, N509S, N588S, N617S, N368S, N419S, N424S, N667S, N433S, N521S, N675S, N720S, N763S	Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Hereditary cancer-predisposing syndrome	VCV001789038	10	43613824	10	43118376	1789038	1841251		NC_000010.11:43118375:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2288A>T (p.Asn763Ile)	RET	N763I, N509I, N328I, N419I, N433I, N464I, N521I, N617I, N718I, N368I, N424I, N631I, N675I, N720I, N280I, N421I, N588I, N667I	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000041840	10	43613824	10	43118376	41840	50279	rs199882293	NC_000010.11:43118375:A:T	single nucleotide variant	missense variant	Uncertain significance	Sep 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2289C>T (p.Asn763=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not provided|Multiple endocrine neoplasia type 2A	VCV000215910	10	43613825	10	43118377	215910	212785	rs777349208	NC_000010.11:43118376:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2290G>A (p.Ala764Thr)	RET	A764T, A510T, A369T, A422T, A425T, A589T, A618T, A668T, A721T, A329T, A434T, A465T, A420T, A522T, A632T, A676T, A281T, A719T	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|not provided	VCV000486317	10	43613826	10	43118378	486317	475329	rs748799148	NC_000010.11:43118377:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 18, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2293T>C (p.Ser765Pro)	RET	S765P, S511P, S282P, S423P, S426P, S435P, S330P, S421P, S523P, S619P, S720P, S370P, S466P, S633P, S722P, S590P, S669P, S677P	Hirschsprung disease, susceptibility to, 1	VCV000013907	10	43613829	10	43118381	13907	28946	rs75075748	NC_000010.11:43118380:T:C	single nucleotide variant	missense variant	risk factor	Jan 27, 1994	no assertion criteria provided							
NM_020975.6(RET):c.2294C>T (p.Ser765Phe)	RET	S511F, S765F, S282F, S619F, S669F, S423F, S426F, S633F, S722F, S370F, S421F, S466F, S330F, S435F, S523F, S590F, S677F, S720F	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000848847	10	43613830	10	43118382	848847	836856	rs1442097853	NC_000010.11:43118381:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2295C>G (p.Ser765=)	RET		Multiple endocrine neoplasia, type 2	VCV003072377	10	43613831	10	43118383	3072377	3230818		NC_000010.11:43118382:C:G	single nucleotide variant	synonymous variant	Likely benign	Jul 10, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2297C>A (p.Pro766Gln)	RET	P424Q, P436Q, P371Q, P467Q, P524Q, P634Q, P670Q, P723Q, P331Q, P512Q, P620Q, P721Q, P283Q, P422Q, P427Q, P591Q, P678Q, P766Q	Multiple endocrine neoplasia, type 2	VCV002082971	10	43613833	10	43118385	2082971	2143483		NC_000010.11:43118384:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2297C>G (p.Pro766Arg)	RET	P512R, P766R, P283R, P331R, P620R, P422R, P427R, P371R, P424R, P436R, P678R, P721R, P723R, P467R, P524R, P591R, P634R, P670R	Multiple endocrine neoplasia, type 2	VCV001051662	10	43613833	10	43118385	1051662	1046538	rs1017108031	NC_000010.11:43118384:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 27, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2297C>T (p.Pro766Leu)	RET	P512L, P766L, P283L, P620L, P331L, P424L, P524L, P634L, P721L, P427L, P436L, P467L, P670L, P678L, P371L, P422L, P591L, P723L	Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2	VCV000936959	10	43613833	10	43118385	936959	935037	rs1017108031	NC_000010.11:43118384:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2298G>T (p.Pro766=)	RET		Multiple endocrine neoplasia, type 2	VCV002998547	10	43613834	10	43118386	2998547	3160139		NC_000010.11:43118385:G:T	single nucleotide variant	synonymous variant	Likely benign	Mar 7, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2298G>A (p.Pro766=)	RET		not provided|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A	VCV000220687	10	43613834	10	43118386	220687	221970	rs140658743	NC_000010.11:43118385:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 6, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2299A>C (p.Ser767Arg)	RET	S372R, S428R, S437R, S513R, S679R, S767R, S468R, S592R, S284R, S332R, S425R, S525R, S724R, S423R, S621R, S635R, S671R, S722R	Multiple endocrine neoplasia, type 2	VCV003720927	10	43613835	10	43118387	3720927	3856729		NC_000010.11:43118386:A:C	single nucleotide variant	missense variant	Uncertain significance	Oct 28, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2300G>A (p.Ser767Asn)	RET	S428N, S468N, S513N, S679N, S425N, S437N, S525N, S621N, S722N, S724N, S284N, S592N, S767N, S332N, S372N, S423N, S635N, S671N	Hereditary cancer-predisposing syndrome	VCV001789288	10	43613836	10	43118388	1789288	1850958		NC_000010.11:43118387:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2301T>C (p.Ser767=)	RET		Hereditary cancer-predisposing syndrome	VCV001789306	10	43613837	10	43118389	1789306	1850976		NC_000010.11:43118388:T:C	single nucleotide variant	synonymous variant	Likely benign	Jan 20, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2304_2307delinsCCTT (p.Glu768Asp)	RET	E285D, E333D, E373D, E424D, E426D, E429D, E438D, E469D, E514D, E526D, E593D, E622D, E636D, E672D, E680D, E723D, E725D, E768D	Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2	VCV002573246	10	43613840 - 43613843	10	43118392 - 43118395	2573246	2738194		NC_000010.11:43118391:GCTG:CCTT	Indel	missense variant	Pathogenic/Likely pathogenic	Aug 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2304G>A (p.Glu768=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002454152	10	43613840	10	43118392	2454152	2424041		NC_000010.11:43118391:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2304G>T (p.Glu768Asp)	RET	E768D, E514D, E333D, E426D, E469D, E424D, E723D, E725D, E373D, E438D, E636D, E672D, E285D, E429D, E526D, E593D, E622D, E680D	Multiple endocrine neoplasia type 2B|MEN2 phenotype: Unclassified|not provided|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000038611	10	43613840	10	43118392	38611	47215	rs78014899	NC_000010.11:43118391:G:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2304G>C (p.Glu768Asp)	RET	E768D, E514D, E636D, E333D, E424D, E526D, E593D, E723D, E285D, E426D, E429D, E438D, E622D, E672D, E680D, E725D, E373D, E469D	not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000013931	10	43613840	10	43118392	13931	28970	rs78014899	NC_000010.11:43118391:G:C	single nucleotide variant	missense variant	Pathogenic	Nov 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2305_2307delinsTTT (p.Leu769Phe)	RET	L286F, L334F, L374F, L425F, L427F, L430F, L439F, L470F, L515F, L527F, L594F, L623F, L637F, L673F, L681F, L724F, L726F, L769F	Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1	VCV003240302	10	43613841 - 43613843	10	43118393 - 43118395	3240302	3399289		NC_000010.11:43118392:CTG:TTT	Indel	missense variant	Uncertain significance	May 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2305C>T (p.Leu769=)	RET	L769F	Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|not provided|Multiple endocrine neoplasia, type 2	VCV000477343	10	43613841	10	43118393	477343	460027	rs142793711	NC_000010.11:43118392:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 30, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2307G>T (p.Leu769=)	RET		not specified|Pheochromocytoma|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A|not provided	VCV000167590	10	43613843	10	43118395	167590	175112	rs1800861	NC_000010.11:43118394:G:T	single nucleotide variant	synonymous variant	Benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2307= (p.Leu769=)	RET		not specified|Multiple endocrine neoplasia, type 2|not provided	VCV000024935	10	43613843	10	43118395	24935	36276	rs1800861	NC_000010.11:43118394:G:G	single nucleotide variant	synonymous variant|no sequence alteration	Benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2309G>C (p.Arg770Pro)	RET	R770P, R516P, R428P, R595P, R682P, R287P, R528P, R638P, R375P, R426P, R431P, R335P, R440P, R471P, R624P, R674P, R725P, R727P	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Pheochromocytoma	VCV000852665	10	43613845	10	43118397	852665	836857	rs377767414	NC_000010.11:43118396:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2309G>A (p.Arg770Gln)	RET	R516Q, R287Q, R335Q, R528Q, R595Q, R638Q, R375Q, R426Q, R624Q, R674Q, R727Q, R682Q, R428Q, R471Q, R431Q, R440Q, R725Q	Multiple endocrine neoplasia, type 2	VCV000024936	10	43613845	10	43118397	24936	36277	rs377767414	NC_000010.11:43118396:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 8, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2313C>T (p.Asp771=)	RET		Multiple endocrine neoplasia, type 2	VCV002862416	10	43613849	10	43118401	2862416	3026066		NC_000010.11:43118400:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 9, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2313C>G (p.Asp771Glu)	RET	D517E, D771E, D336E, D675E, D726E, D376E, D432E, D472E, D529E, D639E, D728E, D288E, D427E, D625E, D429E, D441E, D596E, D683E	Multiple endocrine neoplasia type 2B	VCV000930672	10	43613849	10	43118401	930672	919268	rs1838123343	NC_000010.11:43118400:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 20, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.2316G>C (p.Leu772=)	RET		Multiple endocrine neoplasia, type 2	VCV003714160	10	43613852	10	43118404	3714160	3841558		NC_000010.11:43118403:G:C	single nucleotide variant	synonymous variant	Likely benign	May 1, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2318T>G (p.Leu773Arg)	RET	L434R, L677R, L685R, L290R, L338R, L378R, L429R, L730R, L773R, L443R, L474R, L627R, L641R, L728R, L431R, L519R, L531R, L598R	Multiple endocrine neoplasia, type 2	VCV002119874	10	43613854	10	43118406	2119874	2176370		NC_000010.11:43118405:T:G	single nucleotide variant	missense variant	Uncertain significance	Mar 31, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2319G>A (p.Leu773=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001128766	10	43613855	10	43118407	1128766	1120273	rs1270003828	NC_000010.11:43118406:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2322A>G (p.Ser774=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001789591	10	43613858	10	43118410	1789591	1847722		NC_000010.11:43118409:A:G	single nucleotide variant	synonymous variant	Likely benign	Apr 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2325G>A (p.Glu775=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001569416	10	43613861	10	43118413	1569416	1603961	rs2132929261	NC_000010.11:43118412:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 2, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2326T>C (p.Phe776Leu)	RET	F432L, F644L, F776L, F293L, F381L, F434L, F437L, F522L, F534L, F601L, F688L, F341L, F446L, F630L, F731L, F733L, F477L, F680L	Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A	VCV003594932	10	43613862	10	43118414	3594932	3722632		NC_000010.11:43118413:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 8, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2327T>A (p.Phe776Tyr)	RET	F477Y, F733Y, F293Y, F434Y, F437Y, F601Y, F776Y, F381Y, F446Y, F644Y, F688Y, F341Y, F432Y, F522Y, F534Y, F630Y, F680Y, F731Y	Multiple endocrine neoplasia, type 2	VCV002000804	10	43613863	10	43118415	2000804	2061308		NC_000010.11:43118414:T:A	single nucleotide variant	missense variant	Uncertain significance	May 31, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2328C>T (p.Phe776=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001789672	10	43613864	10	43118416	1789672	1847803		NC_000010.11:43118415:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2330A>G (p.Asn777Ser)	RET	N523S, N435S, N438S, N447S, N602S, N689S, N734S, N382S, N535S, N681S, N294S, N342S, N433S, N631S, N478S, N645S, N732S	Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A	VCV000024937	10	43613866	10	43118418	24937	36278	rs377767415	NC_000010.11:43118417:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2331C>A (p.Asn777Lys)	RET	N294K, N382K, N435K, N645K, N681K, N732K, N447K, N602K, N631K, N433K, N535K, N734K, N777K, N342K, N438K, N478K, N523K, N689K	Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV002625015	10	43613867	10	43118419	2625015	2790510		NC_000010.11:43118418:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2331C>T (p.Asn777=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000413454	10	43613867	10	43118419	413454	397468	rs753977221	NC_000010.11:43118418:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2332G>T (p.Val778Phe)	RET	V524F, V778F, V434F, V632F, V646F, V735F, V383F, V439F, V479F, V603F, V690F, V448F, V536F, V733F, V295F, V343F, V436F, V682F	Multiple endocrine neoplasia, type 2	VCV001502831	10	43613868	10	43118420	1502831	1404424	rs75686697	NC_000010.11:43118419:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2332G>A (p.Val778Ile)	RET	V778I, V524I, V448I, V632I, V733I, V383I, V434I, V603I, V646I, V690I, V343I, V536I, V735I, V295I, V436I, V439I, V479I, V682I	Multiple endocrine neoplasia|Multiple endocrine neoplasia, type 2|Renal hypodysplasia/aplasia 1|Hereditary cancer-predisposing syndrome|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1	VCV000013955	10	43613868	10	43118420	13955	28994	rs75686697	NC_000010.11:43118419:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 21, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2334C>G (p.Val778=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001595145	10	43613870	10	43118422	1595145	1590785	rs1191447337	NC_000010.11:43118421:C:G	single nucleotide variant	synonymous variant	Likely benign	Dec 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2335C>G (p.Leu779Val)	RET	L384V, L537V, L734V, L344V, L440V, L449V, L525V, L683V, L691V, L779V, L435V, L437V, L480V, L633V, L296V, L604V, L647V, L736V	Hereditary cancer-predisposing syndrome	VCV001789766	10	43613871	10	43118423	1789766	1847897		NC_000010.11:43118422:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 3, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2337G>A (p.Leu779=)	RET		Hereditary cancer-predisposing syndrome	VCV003432303	10	43613873	10	43118425	3432303	3593499		NC_000010.11:43118424:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 3, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2340G>A (p.Lys780=)	RET		Multiple endocrine neoplasia, type 2	VCV000749904	10	43613876	10	43118428	749904	752101	rs1588876500	NC_000010.11:43118427:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 13, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2342A>G (p.Gln781Arg)	RET	Q781R, Q527R, Q346R, Q482R, Q386R, Q442R, Q649R, Q685R, Q738R, Q298R, Q439R, Q539R, Q635R, Q437R, Q451R, Q606R, Q693R, Q736R	not provided|Hereditary cancer|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|not specified	VCV000024938	10	43613878	10	43118430	24938	36279	rs377767416	NC_000010.11:43118429:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2343G>A (p.Gln781=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000821127	10	43613879	10	43118431	821127	809954	rs1588876509	NC_000010.11:43118430:G:A	single nucleotide variant	synonymous variant	Likely benign	May 11, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2344G>A (p.Val782Ile)	RET	V782I, V528I, V299I, V347I, V443I, V483I, V636I, V650I, V694I, V739I, V440I, V686I, V737I, V387I, V438I, V540I, V607I, V452I	Multiple endocrine neoplasia, type 2	VCV001413815	10	43613880	10	43118432	1413815	1361718	rs1838124605	NC_000010.11:43118431:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 16, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2344G>T (p.Val782Phe)	RET	V782F, V528F, V739F, V299F, V440F, V443F, V452F, V540F, V650F, V438F, V607F, V694F, V737F, V347F, V387F, V483F, V636F, V686F	Multiple endocrine neoplasia, type 2	VCV000834358	10	43613880	10	43118432	834358	836858	rs1838124605	NC_000010.11:43118431:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 17, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.2348A>G (p.Asn783Ser)	RET	N783S, N529S, N439S, N608S, N348S, N441S, N444S, N484S, N541S, N651S, N300S, N388S, N453S, N637S, N687S, N738S, N695S, N740S	not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000549812	10	43613884	10	43118436	549812	540553	rs587778656	NC_000010.11:43118435:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2348A>C (p.Asn783Thr)	RET	N783T, N529T, N439T, N651T, N738T, N441T, N444T, N695T, N300T, N388T, N348T, N453T, N484T, N541T, N608T, N740T, N637T, N687T	Multiple endocrine neoplasia type 2A|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|not provided|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000135178	10	43613884	10	43118436	135178	138917	rs587778656	NC_000010.11:43118435:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 3, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2349C>T (p.Asn783=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001096642	10	43613885	10	43118437	1096642	1077046	rs1160720188	NC_000010.11:43118436:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 21, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2352C>T (p.His784=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000765190	10	43613888	10	43118440	765190	767744	rs1588876518	NC_000010.11:43118439:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2356C>T (p.His786Tyr)	RET	H303Y, H351Y, H391Y, H442Y, H444Y, H447Y, H456Y, H487Y, H532Y, H544Y, H611Y, H640Y, H654Y, H690Y, H698Y, H741Y, H743Y, H786Y	Multiple endocrine neoplasia, type 2	VCV003071491	10	43613892	10	43118444	3071491	3233757		NC_000010.11:43118443:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 8, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2358T>C (p.His786=)	RET		not specified|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Pheochromocytoma	VCV000386728	10	43613894	10	43118446	386728	371676	rs758715544	NC_000010.11:43118445:T:C	single nucleotide variant	synonymous variant	Likely benign	Jul 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2359G>A (p.Val787Ile)	RET	V352I, V392I, V445I, V545I, V744I, V448I, V488I, V612I, V641I, V699I, V742I, V443I, V533I, V304I, V457I, V655I, V691I, V787I	Multiple endocrine neoplasia, type 2|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B	VCV003594935	10	43613895	10	43118447	3594935	3722642		NC_000010.11:43118446:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2362A>G (p.Ile788Val)	RET	I788V, I534V, I446V, I305V, I353V, I458V, I489V, I656V, I692V, I700V, I393V, I449V, I613V, I745V, I743V, I444V, I546V, I642V	Multiple endocrine neoplasia, type 2	VCV000646051	10	43613898	10	43118450	646051	638917	rs1588876533	NC_000010.11:43118449:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2363T>A (p.Ile788Asn)	RET	I446N, I546N, I642N, I692N, I353N, I393N, I534N, I613N, I700N, I449N, I656N, I743N, I788N, I305N, I444N, I458N, I489N, I745N	Hereditary cancer-predisposing syndrome	VCV001790190	10	43613899	10	43118451	1790190	1844936		NC_000010.11:43118450:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 27, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2364C>T (p.Ile788=)	RET		Hereditary cancer-predisposing syndrome	VCV001790198	10	43613900	10	43118452	1790198	540554	rs1554819400	NC_000010.11:43118451:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 22, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.2365A>C (p.Lys789Gln)	RET	K535Q, K789Q, K306Q, K394Q, K447Q, K490Q, K547Q, K614Q, K459Q, K744Q, K746Q, K445Q, K693Q, K354Q, K450Q, K643Q, K657Q, K701Q	Hereditary cancer-predisposing syndrome	VCV000821156	10	43613901	10	43118453	821156	809955	rs1352006130	NC_000010.11:43118452:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 11, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.2365A>G (p.Lys789Glu)	RET	K535E, K789E, K445E, K693E, K701E, K459E, K490E, K547E, K306E, K354E, K614E, K643E, K394E, K447E, K450E, K657E, K744E, K746E	Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not provided	VCV000655550	10	43613901	10	43118453	655550	638918	rs1352006130	NC_000010.11:43118452:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 13, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2366A>G (p.Lys789Arg)	RET	K354R, K447R, K450R, K701R, K306R, K459R, K490R, K547R, K643R, K394R, K693R, K744R, K746R, K445R, K535R, K614R, K657R, K789R	Hereditary cancer-predisposing syndrome	VCV002568338	10	43613902	10	43118454	2568338	2734875		NC_000010.11:43118453:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2367A>G (p.Lys789=)	RET		Hereditary cancer-predisposing syndrome	VCV001790226	10	43613903	10	43118455	1790226	1844971		NC_000010.11:43118454:A:G	single nucleotide variant	synonymous variant	Likely benign	Aug 29, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2369T>C (p.Leu790Ser)	RET	L355S, L491S, L644S, L658S, L747S, L448S, L745S, L446S, L451S, L536S, L615S, L694S, L790S, L307S, L395S, L460S, L548S, L702S	Multiple endocrine neoplasia, type 2	VCV002843367	10	43613905	10	43118457	2843367	3004022		NC_000010.11:43118456:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2370_2371delinsTC (p.Leu790_Tyr791delinsPheHis)	RET		Hereditary cancer-predisposing syndrome	VCV003227525	10	43613906 - 43613907	10	43118458 - 43118459	3227525	3390737		NC_000010.11:43118457:GT:TC	Indel	missense variant	Likely pathogenic	Mar 4, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2370G>A (p.Leu790=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001790299	10	43613906	10	43118458	1790299	1845044		NC_000010.11:43118457:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 1, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2370G>T (p.Leu790Phe)	RET	L790F, L536F, L395F, L491F, L745F, L747F, L446F, L615F, L355F, L448F, L460F, L548F, L644F, L658F, L702F, L307F, L451F, L694F	Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000038612	10	43613906	10	43118458	38612	47216	rs75030001	NC_000010.11:43118457:G:T	single nucleotide variant	missense variant	Pathogenic	Dec 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2370G>C (p.Leu790Phe)	RET	L790F, L536F, L307F, L355F, L395F, L448F, L615F, L745F, L446F, L460F, L644F, L702F, L658F, L694F, L747F, L451F, L491F, L548F	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|Familial medullary thyroid carcinoma	VCV000013935	10	43613906	10	43118458	13935	28974	rs75030001	NC_000010.11:43118457:G:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2371T>A (p.Tyr791Asn)	RET	Y537N, Y492N, Y616N, Y645N, Y748N, Y308N, Y447N, Y746N, Y356N, Y396N, Y449N, Y461N, Y659N, Y703N, Y452N, Y549N, Y695N	Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|not specified|Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Pheochromocytoma|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Congenital central hypoventilation|Familial medullary thyroid carcinoma|Pheochromocytoma|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2	VCV000024939	10	43613907	10	43118459	24939	36280	rs377767417	NC_000010.11:43118458:T:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 29, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2372A>G (p.Tyr791Cys)	RET	Y537C, Y791C, Y396C, Y461C, Y659C, Y492C, Y549C, Y616C, Y695C, Y703C, Y308C, Y356C, Y645C, Y447C, Y449C, Y452C, Y746C, Y748C	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001479171	10	43613908	10	43118460	1479171	1426542	rs77724903	NC_000010.11:43118459:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2372A>T (p.Tyr791Phe)	RET	Y791F, Y537F, Y447F, Y452F, Y461F, Y549F, Y616F, Y695F, Y703F, Y746F, Y748F, Y396F, Y492F, Y449F, Y645F, Y659F, Y308F, Y356F	Multiple endocrine neoplasia|not provided|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|not specified|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1	VCV000013936	10	43613908	10	43118460	13936	28975	rs77724903	NC_000010.11:43118459:A:T	single nucleotide variant	missense variant	Benign/Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2373T>C (p.Tyr791=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000543789	10	43613909	10	43118461	543789	525429	rs1554819406	NC_000010.11:43118460:T:C	single nucleotide variant	synonymous variant	Likely benign	Nov 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2374G>C (p.Gly792Arg)	RET	G792R, G538R, G550R, G646R, G749R, G309R, G357R, G617R, G747R, G397R, G462R, G493R, G660R, G696R, G704R, G448R, G450R, G453R	Hereditary cancer-predisposing syndrome	VCV000821178	10	43613910	10	43118462	821178	809956	rs1289075493	NC_000010.11:43118461:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 13, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.2375G>C (p.Gly792Ala)	RET	G792A, G538A, G357A, G397A, G448A, G453A, G696A, G747A, G309A, G550A, G617A, G704A, G450A, G646A, G462A, G493A, G660A, G749A	not provided	VCV000450909	10	43613911	10	43118463	450909	444603	rs1554819409	NC_000010.11:43118462:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 15, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2376G>A (p.Gly792=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001097116	10	43613912	10	43118464	1097116	1077047	rs756758769	NC_000010.11:43118463:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2377G>A (p.Ala793Thr)	RET	A310T, A358T, A454T, A463T, A494T, A539T, A647T, A697T, A451T, A551T, A661T, A748T, A793T, A398T, A449T, A618T, A705T, A750T	Multiple endocrine neoplasia, type 2	VCV002710597	10	43613913	10	43118465	2710597	2867738		NC_000010.11:43118464:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 21, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2378C>T (p.Ala793Val)	RET	A793V, A539V, A310V, A398V, A449V, A618V, A647V, A661V, A697V, A750V, A358V, A454V, A748V, A451V, A463V, A494V, A551V, A705V	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000477346	10	43613914	10	43118466	477346	459851	rs1554819410	NC_000010.11:43118465:C:T	single nucleotide variant	missense variant	Uncertain significance	May 25, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2382C>T (p.Cys794=)	RET		Multiple endocrine neoplasia, type 2	VCV000477347	10	43613918	10	43118470	477347	459855	rs1554819412	NC_000010.11:43118469:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2385C>A (p.Ser795Arg)	RET	S312R, S456R, S620R, S649R, S752R, S795R, S400R, S451R, S453R, S553R, S699R, S707R, S750R, S360R, S465R, S663R, S496R, S541R	Multiple endocrine neoplasia, type 2	VCV002735392	10	43613921	10	43118473	2735392	2901417		NC_000010.11:43118472:C:A	single nucleotide variant	missense variant	Uncertain significance	Mar 19, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2385C>T (p.Ser795=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001146197	10	43613921	10	43118473	1146197	1141127	rs2132932061	NC_000010.11:43118472:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 15, 2021	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2388G>T (p.Gln796His)	RET	Q313H, Q452H, Q454H, Q497H, Q554H, Q796H, Q361H, Q401H, Q457H, Q466H, Q650H, Q664H, Q542H, Q700H, Q621H, Q708H, Q751H, Q753H	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002587876	10	43613924	10	43118476	2587876	2760700		NC_000010.11:43118475:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2388G>A (p.Gln796=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000741097	10	43613924	10	43118476	741097	752102	rs1328507414	NC_000010.11:43118475:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2392G>A (p.Gly798Ser)	RET	G315S, G363S, G499S, G544S, G556S, G666S, G798S, G403S, G623S, G702S, G456S, G468S, G652S, G753S, G454S, G459S, G710S, G755S	Hereditary cancer-predisposing syndrome	VCV003432255	10	43613928	10	43118480	3432255	3593451		NC_000010.11:43118479:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 4, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2392+6G>A	RET		Multiple endocrine neoplasia, type 2	VCV000854880	10	43613934	10	43118486	854880	852545	rs1554819413	NC_000010.11:43118485:G:A	single nucleotide variant	intron variant	Uncertain significance	Jul 26, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2392+6G>T	RET		Multiple endocrine neoplasia, type 2	VCV000477348	10	43613934	10	43118486	477348	460312	rs1554819413	NC_000010.11:43118485:G:T	single nucleotide variant	intron variant	Uncertain significance	Jan 31, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2392+7C>T	RET		Multiple endocrine neoplasia, type 2	VCV000943556	10	43613935	10	43118487	943556	940168	rs1223172915	NC_000010.11:43118486:C:T	single nucleotide variant	intron variant	Uncertain significance	Jul 17, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2392+9A>G	RET		Multiple endocrine neoplasia, type 2	VCV003603412	10	43613937	10	43118489	3603412	3736126		NC_000010.11:43118488:A:G	single nucleotide variant	intron variant	Likely benign	Aug 5, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2392+10G>A	RET		Multiple endocrine neoplasia, type 2	VCV000794208	10	43613938	10	43118490	794208	787667	rs773999299	NC_000010.11:43118489:G:A	single nucleotide variant	intron variant	Likely benign	Sep 2, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.2392+11C>G	RET		Multiple endocrine neoplasia, type 2	VCV002044026	10	43613939	10	43118491	2044026	2099317		NC_000010.11:43118490:C:G	single nucleotide variant	intron variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2392+11C>A	RET		Multiple endocrine neoplasia, type 2	VCV001980870	10	43613939	10	43118491	1980870	2038741		NC_000010.11:43118490:C:A	single nucleotide variant	intron variant	Likely benign	Jul 25, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2392+13G>A	RET		Multiple endocrine neoplasia, type 2	VCV002881610	10	43613941	10	43118493	2881610	3036966		NC_000010.11:43118492:G:A	single nucleotide variant	intron variant	Likely benign	Dec 16, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2392+14C>T	RET		Multiple endocrine neoplasia, type 2	VCV002704948	10	43613942	10	43118494	2704948	2863360		NC_000010.11:43118493:C:T	single nucleotide variant	intron variant	Likely benign	Dec 22, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2392+17G>C	RET		Multiple endocrine neoplasia, type 2	VCV002792788	10	43613945	10	43118497	2792788	2953920		NC_000010.11:43118496:G:C	single nucleotide variant	intron variant	Likely benign	Nov 30, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2392+17G>A	RET		Multiple endocrine neoplasia, type 2	VCV001586567	10	43613945	10	43118497	1586567	1562724	rs1282018603	NC_000010.11:43118496:G:A	single nucleotide variant	intron variant	Likely benign	Jun 12, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2392+18G>A	RET		Multiple endocrine neoplasia, type 2	VCV002960012	10	43613946	10	43118498	2960012	3116471		NC_000010.11:43118497:G:A	single nucleotide variant	intron variant	Likely benign	Jan 14, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2392+19T>C	RET		not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma	VCV000548735	10	43613947	10	43118499	548735	539285	rs778745375	NC_000010.11:43118498:T:C	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 23, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2392+20G>A	RET		Multiple endocrine neoplasia, type 2	VCV002880531	10	43613948	10	43118500	2880531	3034024		NC_000010.11:43118499:G:A	single nucleotide variant	intron variant	Uncertain significance	Jun 2, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2392+159G>A	RET		not provided	VCV000677726	10	43614087	10	43118639	677726	664791	rs3026767	NC_000010.11:43118638:G:A	single nucleotide variant	intron variant	Likely benign	Jun 17, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.2392+302G>A	RET		not provided	VCV001222633	10	43614230	10	43118782	1222633	1213030	rs2075910	NC_000010.11:43118781:G:A	single nucleotide variant	intron variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.2393-94C>A	RET		not provided	VCV001250294	10	43614885	10	43119437	1250294	1239381	rs111264957	NC_000010.11:43119436:C:A	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, single submitter							
NM_020975.6(RET):c.2393-29C>T	RET		not specified	VCV002576508	10	43614950	10	43119502	2576508	2741404		NC_000010.11:43119501:C:T	single nucleotide variant	intron variant	Likely benign	Aug 15, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2393-20C>A	RET		Multiple endocrine neoplasia, type 2	VCV002819136	10	43614959	10	43119511	2819136	2977662		NC_000010.11:43119510:C:A	single nucleotide variant	intron variant	Likely benign	Dec 7, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2393-16del	RET		Multiple endocrine neoplasia, type 2	VCV002180407	10	43614959	10	43119511	2180407	1909223		NC_000010.11:43119510:CCCCC:CCCC	Deletion	intron variant	Benign	Jul 19, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2393-19C>T	RET		Multiple endocrine neoplasia, type 2	VCV001590450	10	43614960	10	43119512	1590450	1642343	rs1183461228	NC_000010.11:43119511:C:T	single nucleotide variant	intron variant	Likely benign	Aug 16, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2393-18C>G	RET		Multiple endocrine neoplasia, type 2	VCV003696154	10	43614961	10	43119513	3696154	3829055		NC_000010.11:43119512:C:G	single nucleotide variant	intron variant	Likely benign	Mar 9, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2393-18C>A	RET		Multiple endocrine neoplasia, type 2	VCV001569218	10	43614961	10	43119513	1569218	1603766	rs934773074	NC_000010.11:43119512:C:A	single nucleotide variant	intron variant	Likely benign	Nov 17, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2393-17C>T	RET		Multiple endocrine neoplasia, type 2	VCV001532911	10	43614962	10	43119514	1532911	1605465	rs1370176408	NC_000010.11:43119513:C:T	single nucleotide variant	intron variant	Likely benign	Mar 16, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2393-14C>G	RET		Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A	VCV001617726	10	43614965	10	43119517	1617726	1614579	rs144269978	NC_000010.11:43119516:C:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 26, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2393-14C>T	RET		Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia, type 2|not specified|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia	VCV000372082	10	43614965	10	43119517	372082	358829	rs144269978	NC_000010.11:43119516:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 26, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2393-12C>G	RET		Multiple endocrine neoplasia, type 2	VCV002893719	10	43614967	10	43119519	2893719	3049104		NC_000010.11:43119518:C:G	single nucleotide variant	intron variant	Likely benign	Nov 20, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2393-12C>T	RET		Multiple endocrine neoplasia, type 2	VCV001555068	10	43614967	10	43119519	1555068	1564812	rs2132941756	NC_000010.11:43119518:C:T	single nucleotide variant	intron variant	Likely benign	Dec 5, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2393-9C>T	RET		Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia type 2B|not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A	VCV000219833	10	43614970	10	43119522	219833	221971	rs567543719	NC_000010.11:43119521:C:T	single nucleotide variant	intron variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2393-8G>C	RET		Multiple endocrine neoplasia, type 2	VCV001104111	10	43614971	10	43119523	1104111	1098705	rs376151644	NC_000010.11:43119522:G:C	single nucleotide variant	intron variant	Likely benign	Nov 27, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.2393-8G>T	RET		Multiple endocrine neoplasia, type 2	VCV001090199	10	43614971	10	43119523	1090199	1077048	rs376151644	NC_000010.11:43119522:G:T	single nucleotide variant	intron variant	Likely benign	Oct 24, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2393-8G>A	RET		Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2	VCV000413479	10	43614971	10	43119523	413479	397723	rs376151644	NC_000010.11:43119522:G:A	single nucleotide variant	intron variant	Benign/Likely benign	Jan 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2393-7C>T	RET		Multiple endocrine neoplasia, type 2	VCV001622127	10	43614972	10	43119524	1622127	1593330	rs746844157	NC_000010.11:43119523:C:T	single nucleotide variant	intron variant	Likely benign	Sep 9, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2393-6C>G	RET		Multiple endocrine neoplasia, type 2	VCV002820763	10	43614973	10	43119525	2820763	2978008		NC_000010.11:43119524:C:G	single nucleotide variant	intron variant	Uncertain significance	Jan 5, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2393-6C>T	RET		Multiple endocrine neoplasia, type 2	VCV001537156	10	43614973	10	43119525	1537156	1596749	rs371646543	NC_000010.11:43119524:C:T	single nucleotide variant	intron variant	Likely benign	Sep 2, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2393-5C>A	RET		Multiple endocrine neoplasia, type 2	VCV000844975	10	43614974	10	43119526	844975	852251	rs1554819512	NC_000010.11:43119525:C:A	single nucleotide variant	intron variant	Likely benign	Nov 27, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2393-5C>T	RET		not specified|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000511190	10	43614974	10	43119526	511190	503225	rs1554819512	NC_000010.11:43119525:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Aug 2, 2023	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2393-4C>G	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001790581	10	43614975	10	43119527	1790581	1841482		NC_000010.11:43119526:C:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Apr 8, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2393-4C>A	RET		Hereditary cancer-predisposing syndrome	VCV001790580	10	43614975	10	43119527	1790580	1841481		NC_000010.11:43119526:C:A	single nucleotide variant	intron variant	Uncertain significance	Jun 2, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2393-4C>T	RET		Multiple endocrine neoplasia, type 2	VCV001147986	10	43614975	10	43119527	1147986	1141128	rs768398267	NC_000010.11:43119526:C:T	single nucleotide variant	intron variant	Likely benign	Sep 11, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.2393G>A (p.Gly798Asp)	RET	G798D, G544D, G315D, G403D, G459D, G755D, G363D, G454D, G468D, G666D, G753D, G623D, G652D, G702D, G456D, G499D, G556D, G710D	not specified|Multiple endocrine neoplasia, type 2	VCV000849440	10	43614979	10	43119531	849440	836859	rs1453303247	NC_000010.11:43119530:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2394C>T (p.Gly798=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001933040	10	43614980	10	43119532	1933040	1985458		NC_000010.11:43119531:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2394C>G (p.Gly798=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001087945	10	43614980	10	43119532	1087945	1077049	rs1838152776	NC_000010.11:43119531:C:G	single nucleotide variant	synonymous variant	Likely benign	Oct 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2396C>A (p.Pro799Gln)	RET	P364Q, P404Q, P460Q, P500Q, P455Q, P557Q, P469Q, P545Q, P754Q, P799Q, P316Q, P457Q, P624Q, P653Q, P667Q, P703Q, P711Q, P756Q	Multiple endocrine neoplasia, type 2	VCV002096287	10	43614982	10	43119534	2096287	2146438		NC_000010.11:43119533:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 30, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2396C>T (p.Pro799Leu)	RET	P316L, P460L, P545L, P667L, P703L, P711L, P799L, P455L, P557L, P624L, P756L, P364L, P404L, P457L, P469L, P500L, P754L, P653L	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001790624	10	43614982	10	43119534	1790624	1841525		NC_000010.11:43119533:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2397G>T (p.Pro799=)	RET		Hereditary cancer-predisposing syndrome	VCV001790640	10	43614983	10	43119535	1790640	1841541		NC_000010.11:43119534:G:T	single nucleotide variant	synonymous variant	Likely benign	Jul 24, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2397G>A (p.Pro799=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000707430	10	43614983	10	43119535	707430	692839	rs776737136	NC_000010.11:43119534:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2397G>C (p.Pro799=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000241346	10	43614983	10	43119535	241346	240800	rs776737136	NC_000010.11:43119534:G:C	single nucleotide variant	synonymous variant	Likely benign	Sep 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2400C>T (p.Leu800=)	RET		Hereditary cancer-predisposing syndrome	VCV001790735	10	43614986	10	43119538	1790735	1841636		NC_000010.11:43119537:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 7, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.2401C>T (p.Leu801Phe)	RET	L462F, L626F, L756F, L406F, L471F, L547F, L559F, L669F, L366F, L713F, L801F, L318F, L457F, L459F, L502F, L655F, L705F, L758F	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002134960	10	43614987	10	43119539	2134960	2190368		NC_000010.11:43119538:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2401C>G (p.Leu801Val)	RET	L547V, L801V, L459V, L462V, L713V, L457V, L559V, L655V, L669V, L705V, L502V, L626V, L758V, L318V, L366V, L406V, L471V, L756V	Multiple endocrine neoplasia, type 2	VCV001391524	10	43614987	10	43119539	1391524	1390204	rs1364361946	NC_000010.11:43119538:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 5, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2403C>T (p.Leu801=)	RET		Hirschsprung disease, susceptibility to, 1|Renal hypodysplasia/aplasia 1|Hereditary cancer-predisposing syndrome|Pheochromocytoma|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia	VCV000486304	10	43614989	10	43119541	486304	475107	rs1554819519	NC_000010.11:43119540:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Sep 30, 2023	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2405T>A (p.Leu802His)	RET	L367H, L548H, L560H, L714H, L759H, L802H, L458H, L656H, L706H, L319H, L407H, L460H, L463H, L503H, L670H, L472H, L627H, L757H	Hereditary cancer-predisposing syndrome	VCV002568378	10	43614991	10	43119543	2568378	2734914		NC_000010.11:43119542:T:A	single nucleotide variant	missense variant	Uncertain significance	Jun 2, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2406C>T (p.Leu802=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001078283	10	43614992	10	43119544	1078283	1077050	rs748339853	NC_000010.11:43119543:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2409C>A (p.Ile803=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000950459	10	43614995	10	43119547	950459	925809	rs535051804	NC_000010.11:43119546:C:A	single nucleotide variant	synonymous variant	Likely benign	Jun 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2409C>T (p.Ile803=)	RET		Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A	VCV000136110	10	43614995	10	43119547	136110	139822	rs535051804	NC_000010.11:43119546:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.4(RET):c.[2410G>A;2832C>G]	RET	V804M, V550M, V321M, V460M, V672M, V759M, V369M, V409M, V462M, V658M, V708M, V465M, V505M, V629M, V716M, V474M, V562M, V761M, I944M, I690M, I509M, I602M, I645M, I901M, I600M, I769M, I798M, I812M, I461M, I605M, I614M, I702M, I899M, I549M, I848M, I856M	Multiple endocrine neoplasia type 2A	VCV000618965	10|10	43614996	10|10	43119548	618965	28984|610366	rs79658334|rs755606269	NC_000010.11:43119547:G:A|NC_000010.11:43123700:C:G	Haplotype	missense variant	Pathogenic	Jun 15, 2016	criteria provided, single submitter							
NM_020975.6(RET):c.2410G>C (p.Val804Leu)	RET	V804L, V550L, V369L, V460L, V462L, V505L, V629L, V759L, V761L, V409L, V465L, V474L, V562L, V716L, V321L, V658L, V672L, V708L	not provided|MEN2 phenotype: Unclassified|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000038613	10	43614996	10	43119548	38613	47217	rs79658334	NC_000010.11:43119547:G:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2410G>A (p.Val804Met)	RET	V804M, V550M, V321M, V460M, V672M, V759M, V369M, V409M, V462M, V658M, V708M, V465M, V505M, V629M, V716M, V474M, V562M, V761M	Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Congenital central hypoventilation|Hirschsprung disease, susceptibility to, 1|Renal hypodysplasia/aplasia 1|Pheochromocytoma|Multiple endocrine neoplasia type 2B|MEN2 phenotype: Unclassified|Hirschsprung disease, susceptibility to, 1|RET-related disorder|Ovarian cancer|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia type 2B|not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000037102	10	43614996	10	43119548	37102	28984	rs79658334	NC_000010.11:43119547:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2410G>T (p.Val804Leu)	RET	V804L, V550L, V409L, V460L, V658L, V321L, V629L, V672L, V716L, V759L, V369L, V462L, V474L, V505L, V562L, V708L, V465L, V761L	Familial medullary thyroid carcinoma|Multiple endocrine neoplasia|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not provided|Multiple endocrine neoplasia type 2A	VCV000013946	10	43614996	10	43119548	13946	28985	rs79658334	NC_000010.11:43119547:G:T	single nucleotide variant	missense variant	Pathogenic	Sep 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2411T>C (p.Val804Ala)	RET	V804A, V550A, V672A, V759A, V321A, V409A, V474A, V505A, V761A, V369A, V460A, V658A, V708A, V462A, V465A, V562A, V629A, V716A	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001962568	10	43614997	10	43119549	1962568	540555	rs1554819520	NC_000010.11:43119548:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2412G>A (p.Val804=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001034965	10	43614998	10	43119550	1034965	1029546	rs767045208	NC_000010.11:43119549:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Dec 18, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2412G>T (p.Val804=)	RET		Multiple endocrine neoplasia, type 2	VCV000761815	10	43614998	10	43119550	761815	767745	rs767045208	NC_000010.11:43119549:G:T	single nucleotide variant	synonymous variant	Likely benign	Jun 29, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.2413G>A (p.Glu805Lys)	RET	E805K, E551K, E463K, E475K, E717K, E370K, E461K, E506K, E563K, E659K, E322K, E630K, E709K, E762K, E673K, E760K, E410K, E466K	Multiple endocrine neoplasia, type 2	VCV003071018	10	43614999	10	43119551	3071018	36282	rs377767418	NC_000010.11:43119550:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2413G>C (p.Glu805Gln)	RET	E805Q, E551Q, E461Q, E466Q, E709Q, E717Q, E762Q, E322Q, E410Q, E563Q, E659Q, E370Q, E463Q, E475Q, E506Q, E630Q, E673Q, E760Q	Multiple endocrine neoplasia, type 2	VCV000568399	10	43614999	10	43119551	568399	566294	rs377767418	NC_000010.11:43119550:G:C	single nucleotide variant	missense variant	Uncertain significance	May 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2414A>C (p.Glu805Ala)	RET	E322A, E461A, E463A, E551A, E630A, E673A, E709A, E805A, E506A, E762A, E370A, E410A, E466A, E475A, E760A, E563A, E659A, E717A	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002454148	10	43615000	10	43119552	2454148	2424037		NC_000010.11:43119551:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2414A>G (p.Glu805Gly)	RET	E466G, E370G, E475G, E630G, E709G, E762G, E805G, E463G, E563G, E673G, E551G, E717G, E322G, E410G, E461G, E506G, E659G, E760G	Hereditary cancer-predisposing syndrome	VCV002454141	10	43615000	10	43119552	2454141	2424030		NC_000010.11:43119551:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 1, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2415G>A (p.Glu805=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001605752	10	43615001	10	43119553	1605752	1646804	rs2132942981	NC_000010.11:43119552:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2416T>C (p.Tyr806His)	RET	Y552H, Y806H, Y323H, Y462H, Y674H, Y718H, Y761H, Y660H, Y464H, Y467H, Y476H, Y371H, Y411H, Y507H, Y564H, Y631H, Y710H, Y763H	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001026781	10	43615002	10	43119554	1026781	1008999	rs1838154415	NC_000010.11:43119553:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 26, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2417A>T (p.Tyr806Phe)	RET	Y323F, Y371F, Y411F, Y462F, Y464F, Y467F, Y476F, Y507F, Y552F, Y564F, Y631F, Y660F, Y674F, Y710F, Y718F, Y761F, Y763F, Y806F	Hereditary cancer-predisposing syndrome	VCV003227527	10	43615003	10	43119555	3227527	3390739		NC_000010.11:43119554:A:T	single nucleotide variant	missense variant	Uncertain significance	Dec 18, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2417A>G (p.Tyr806Cys)	RET	Y806C, Y552C, Y476C, Y710C, Y761C, Y763C, Y462C, Y507C, Y564C, Y323C, Y631C, Y674C, Y371C, Y411C, Y464C, Y467C, Y660C, Y718C	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000024942	10	43615003	10	43119555	24942	36283	rs377767419	NC_000010.11:43119554:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2418C>T (p.Tyr806=)	RET		Renal hypodysplasia/aplasia 1|not specified|not provided|Pheochromocytoma|Multiple endocrine neoplasia|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1	VCV000477349	10	43615004	10	43119556	477349	460316	rs553418132	NC_000010.11:43119555:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2418C>G (p.Tyr806Ter)	RET	Y806*, Y552*, Y323*, Y371*, Y462*, Y467*, Y507*, Y631*, Y761*, Y763*, Y464*, Y718*, Y411*, Y660*, Y476*, Y564*, Y674*, Y710*	not provided	VCV000290965	10	43615004	10	43119556	290965	275202	rs553418132	NC_000010.11:43119555:C:G	single nucleotide variant	nonsense	Pathogenic	Aug 30, 2016	criteria provided, single submitter							
NM_020975.6(RET):c.2419G>A (p.Ala807Thr)	RET	A807T, A553T, A412T, A468T, A711T, A719T, A324T, A508T, A675T, A762T, A764T, A372T, A565T, A632T, A463T, A465T, A477T, A661T	Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2	VCV001424992	10	43615005	10	43119557	1424992	1353499	rs760012685	NC_000010.11:43119556:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2419G>T (p.Ala807Ser)	RET	A807S, A553S, A412S, A324S, A477S, A508S, A675S, A711S, A762S, A764S, A372S, A463S, A468S, A565S, A661S, A719S, A465S, A632S	Multiple endocrine neoplasia, type 2	VCV000953827	10	43615005	10	43119557	953827	946896	rs760012685	NC_000010.11:43119556:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 22, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2420C>G (p.Ala807Gly)	RET	A324G, A372G, A412G, A463G, A465G, A468G, A477G, A508G, A553G, A565G, A632G, A661G, A675G, A711G, A719G, A762G, A764G, A807G	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A	VCV002444893	10	43615006	10	43119558	2444893	2418623		NC_000010.11:43119557:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2420C>T (p.Ala807Val)	RET	A807V, A553V, A463V, A465V, A477V, A632V, A764V, A324V, A412V, A508V, A675V, A711V, A565V, A719V, A372V, A468V, A661V, A762V	Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2	VCV000543744	10	43615006	10	43119558	543744	525436	rs1554819523	NC_000010.11:43119557:C:T	single nucleotide variant	missense variant	Uncertain significance	May 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2421C>G (p.Ala807=)	RET		Hereditary cancer-predisposing syndrome	VCV001791025	10	43615007	10	43119559	1791025	1851386		NC_000010.11:43119558:C:G	single nucleotide variant	synonymous variant	Likely benign	Jun 23, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2422A>G (p.Lys808Glu)	RET	K808E, K554E, K373E, K464E, K325E, K466E, K765E, K413E, K509E, K566E, K633E, K676E, K469E, K478E, K662E, K712E, K720E, K763E	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000477350	10	43615008	10	43119560	477350	460029	rs1372786615	NC_000010.11:43119559:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2423A>C (p.Lys808Thr)	RET	K808T, K554T, K373T, K464T, K712T, K469T, K478T, K325T, K466T, K633T, K676T, K566T, K763T, K413T, K509T, K662T, K720T, K765T	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B	VCV000659223	10	43615009	10	43119561	659223	638919	rs767945255	NC_000010.11:43119560:A:C	single nucleotide variant	missense variant	Uncertain significance	Jul 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2424A>C (p.Lys808Asn)	RET	K464N, K662N, K676N, K765N, K808N, K325N, K413N, K466N, K469N, K566N, K554N, K633N, K373N, K478N, K509N, K712N, K720N, K763N	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001991970	10	43615010	10	43119562	1991970	2048719		NC_000010.11:43119561:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 19, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2425T>C (p.Tyr809His)	RET	Y374H, Y479H, Y567H, Y634H, Y663H, Y713H, Y721H, Y326H, Y414H, Y467H, Y555H, Y465H, Y677H, Y764H, Y470H, Y510H, Y766H, Y809H	Hereditary cancer-predisposing syndrome	VCV001791087	10	43615011	10	43119563	1791087	1851448		NC_000010.11:43119562:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 27, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2426A>C (p.Tyr809Ser)	RET	Y470S, Y479S, Y634S, Y764S, Y766S, Y326S, Y713S, Y809S, Y374S, Y465S, Y467S, Y567S, Y677S, Y414S, Y510S, Y555S, Y663S, Y721S	Multiple endocrine neoplasia, type 2	VCV002767867	10	43615012	10	43119564	2767867	2932479		NC_000010.11:43119563:A:C	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2427C>A (p.Tyr809Ter)	RET	Y555*, Y809*, Y326*, Y465*, Y764*, Y766*, Y374*, Y467*, Y479*, Y414*, Y470*, Y510*, Y677*, Y721*, Y567*, Y634*, Y663*, Y713*	Multiple endocrine neoplasia, type 2	VCV001406541	10	43615013	10	43119565	1406541	1408562	rs577929869	NC_000010.11:43119564:C:A	single nucleotide variant	nonsense	Pathogenic	Jul 6, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2427C>T (p.Tyr809=)	RET		not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia, type 2	VCV000241347	10	43615013	10	43119565	241347	240801	rs577929869	NC_000010.11:43119564:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2428G>C (p.Gly810Arg)	RET	G375R, G480R, G635R, G664R, G722R, G765R, G415R, G568R, G714R, G810R, G466R, G468R, G556R, G678R, G327R, G471R, G511R, G767R	Multiple endocrine neoplasia, type 2	VCV003659647	10	43615014	10	43119566	3659647	3800595		NC_000010.11:43119565:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 16, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2428G>T (p.Gly810Cys)	RET	G466C, G568C, G714C, G375C, G415C, G511C, G635C, G767C, G327C, G471C, G480C, G664C, G678C, G468C, G556C, G722C, G765C, G810C	Neoplasm	VCV003257931	10	43615014	10	43119566	3257931	3416690		NC_000010.11:43119565:G:T	single nucleotide variant	missense variant							Likely oncogenic	Jul 31, 2024	criteria provided, single submitter	
NM_020975.6(RET):c.2428G>A (p.Gly810Ser)	RET	G810S, G556S, G466S, G511S, G678S, G471S, G714S, G765S, G327S, G375S, G415S, G480S, G568S, G722S, G468S, G635S, G664S, G767S	not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000543739	10	43615014	10	43119566	543739	525308	rs764784013	NC_000010.11:43119565:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2430C>G (p.Gly810=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000767614	10	43615016	10	43119568	767614	701345	rs749997455	NC_000010.11:43119567:C:G	single nucleotide variant	synonymous variant	Likely benign	Feb 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2432C>G (p.Ser811Cys)	RET	S811C, S557C, S376C, S472C, S512C, S723C, S416C, S467C, S469C, S665C, S481C, S569C, S679C, S328C, S636C, S715C, S766C, S768C	Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000135179	10	43615018	10	43119570	135179	138918	rs587778657	NC_000010.11:43119569:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2433C>T (p.Ser811=)	RET		Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001668576	10	43615019	10	43119571	1668576	1633950	rs1290818295	NC_000010.11:43119570:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2436G>A (p.Leu812=)	RET		Multiple endocrine neoplasia, type 2	VCV002076672	10	43615022	10	43119574	2076672	2138475		NC_000010.11:43119573:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 6, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2437C>G (p.Arg813Gly)	RET	R330G, R378G, R418G, R469G, R471G, R474G, R483G, R514G, R559G, R571G, R638G, R667G, R681G, R717G, R725G, R768G, R770G, R813G	not provided|Hereditary cancer-predisposing syndrome	VCV002412837	10	43615023	10	43119575	2412837	2401564		NC_000010.11:43119574:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2437C>A (p.Arg813=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001791242	10	43615023	10	43119575	1791242	1851603		NC_000010.11:43119574:C:A	single nucleotide variant	synonymous variant	Likely benign	Apr 9, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2437C>T (p.Arg813Trp)	RET	R813W, R559W, R471W, R474W, R571W, R330W, R469W, R483W, R681W, R378W, R418W, R638W, R667W, R717W, R725W, R514W, R768W, R770W	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000599633	10	43615023	10	43119575	599633	590969	rs779996040	NC_000010.11:43119574:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2438G>A (p.Arg813Gln)	RET	R813Q, R559Q, R330Q, R378Q, R474Q, R717Q, R770Q, R471Q, R571Q, R418Q, R469Q, R514Q, R667Q, R681Q, R725Q, R768Q, R483Q, R638Q	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000643114	10	43615024	10	43119576	643114	638920	rs1318733775	NC_000010.11:43119575:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2439G>A (p.Arg813=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001791275	10	43615025	10	43119577	1791275	1848095		NC_000010.11:43119576:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2441G>T (p.Gly814Val)	RET	G379V, G515V, G639V, G668V, G682V, G769V, G472V, G726V, G814V, G331V, G470V, G475V, G560V, G718V, G419V, G484V, G572V, G771V	Hereditary cancer-predisposing syndrome	VCV003432285	10	43615027	10	43119579	3432285	3593481		NC_000010.11:43119578:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 12, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2441G>A (p.Gly814Asp)	RET	G331D, G470D, G668D, G682D, G771D, G379D, G419D, G475D, G484D, G572D, G726D, G769D, G814D, G515D, G560D, G639D, G472D, G718D	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001791340	10	43615027	10	43119579	1791340	1848160		NC_000010.11:43119578:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2443T>C (p.Phe815Leu)	RET	F561L, F815L, F380L, F727L, F473L, F573L, F770L, F772L, F420L, F471L, F516L, F683L, F332L, F476L, F485L, F640L, F669L, F719L	Multiple endocrine neoplasia, type 2	VCV000945018	10	43615029	10	43119581	945018	925810	rs1838156276	NC_000010.11:43119580:T:C	single nucleotide variant	missense variant	Uncertain significance	May 27, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2444T>G (p.Phe815Cys)	RET	F815C, F561C, F516C, F772C, F420C, F471C, F640C, F727C, F770C, F332C, F473C, F573C, F719C, F380C, F476C, F485C, F669C, F683C	Multiple endocrine neoplasia, type 2	VCV001386963	10	43615030	10	43119582	1386963	1381328	rs2132944356	NC_000010.11:43119581:T:G	single nucleotide variant	missense variant	Uncertain significance	Apr 10, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2445C>G (p.Phe815Leu)	RET	F332L, F380L, F420L, F471L, F473L, F476L, F485L, F516L, F561L, F573L, F640L, F669L, F683L, F719L, F727L, F770L, F772L, F815L	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV003227528	10	43615031	10	43119583	3227528	3390740		NC_000010.11:43119582:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2445C>T (p.Phe815=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001595924	10	43615031	10	43119583	1595924	1569499	rs751447014	NC_000010.11:43119582:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2448C>T (p.Leu816=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001110826	10	43615034	10	43119586	1110826	1098706	rs368500000	NC_000010.11:43119585:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2448C>A (p.Leu816=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000486305	10	43615034	10	43119586	486305	475293	rs368500000	NC_000010.11:43119585:C:A	single nucleotide variant	synonymous variant	Likely benign	Dec 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2449C>T (p.Arg817Cys)	RET	R817C, R563C, R487C, R642C, R671C, R721C, R382C, R422C, R478C, R518C, R772C, R334C, R475C, R575C, R473C, R685C, R729C, R774C	Multiple endocrine neoplasia, type 2|not provided|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia type 2B	VCV000136111	10	43615035	10	43119587	136111	139823	rs142318626	NC_000010.11:43119586:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2450G>T (p.Arg817Leu)	RET	R334L, R382L, R422L, R473L, R475L, R478L, R487L, R518L, R563L, R575L, R642L, R671L, R685L, R721L, R729L, R772L, R774L, R817L	not provided	VCV002640418	10	43615036	10	43119588	2640418	2813110		NC_000010.11:43119587:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 1, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2450G>A (p.Arg817His)	RET	R563H, R817H, R382H, R478H, R487H, R575H, R642H, R334H, R475H, R685H, R518H, R671H, R729H, R772H, R422H, R473H, R721H, R774H	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A	VCV000821298	10	43615036	10	43119588	821298	809957	rs1345166214	NC_000010.11:43119587:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2451C>G (p.Arg817=)	RET		Hereditary cancer-predisposing syndrome	VCV002568326	10	43615037	10	43119589	2568326	2734863		NC_000010.11:43119588:C:G	single nucleotide variant	synonymous variant	Likely benign	Mar 17, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2451C>A (p.Arg817=)	RET		Multiple endocrine neoplasia, type 2	VCV001990005	10	43615037	10	43119589	1990005	2037550		NC_000010.11:43119588:C:A	single nucleotide variant	synonymous variant	Likely benign	Jun 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2451C>T (p.Arg817=)	RET		Hereditary cancer-predisposing syndrome|not specified|Multiple endocrine neoplasia, type 2	VCV000821301	10	43615037	10	43119589	821301	809958	rs747894751	NC_000010.11:43119588:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2452G>C (p.Glu818Gln)	RET	E335Q, E383Q, E423Q, E474Q, E476Q, E479Q, E488Q, E519Q, E564Q, E576Q, E643Q, E672Q, E686Q, E722Q, E730Q, E773Q, E775Q, E818Q	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV003075551	10	43615038	10	43119590	3075551	3233116		NC_000010.11:43119589:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2452G>A (p.Glu818Lys)	RET	E564K, E383K, E476K, E773K, E479K, E519K, E576K, E672K, E686K, E730K, E423K, E474K, E488K, E722K, E335K, E643K, E775K	Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma	VCV000024943	10	43615038	10	43119590	24943	36284	rs377767420	NC_000010.11:43119589:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 28, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2453A>G (p.Glu818Gly)	RET	E335G, E383G, E423G, E474G, E476G, E479G, E488G, E519G, E564G, E576G, E643G, E672G, E686G, E722G, E730G, E773G, E775G, E818G	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1	VCV003227529	10	43615039	10	43119591	3227529	3390741		NC_000010.11:43119590:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2454G>A (p.Glu818=)	RET		not provided|Multiple endocrine neoplasia, type 2|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Congenital central hypoventilation|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000194426	10	43615040	10	43119592	194426	191589	rs794727131	NC_000010.11:43119591:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Apr 24, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2456G>T (p.Ser819Ile)	RET	S565I, S384I, S480I, S489I, S774I, S336I, S520I, S644I, S723I, S475I, S477I, S577I, S731I, S776I, S424I, S673I, S687I	Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A	VCV003594956	10	43615042	10	43119594	3594956	36285	rs377767421	NC_000010.11:43119593:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 6, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2456G>C (p.Ser819Thr)	RET	S424T, S477T, S480T, S644T, S687T, S776T, S336T, S565T, S774T, S819T, S475T, S520T, S577T, S673T, S384T, S489T, S723T, S731T	Hereditary cancer-predisposing syndrome	VCV003432273	10	43615042	10	43119594	3432273	3593469		NC_000010.11:43119593:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2456G>A (p.Ser819Asn)	RET	S424N, S475N, S520N, S480N, S489N, S577N, S687N, S723N, S731N, S336N, S477N, S673N, S774N, S776N, S819N, S384N, S565N, S644N	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002496746	10	43615042	10	43119594	2496746	2467885		NC_000010.11:43119593:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2457C>G (p.Ser819Arg)	RET	S819R, S565R, S520R, S577R, S644R, S731R, S776R, S477R, S489R, S673R, S687R, S475R, S774R, S336R, S384R, S424R, S480R, S723R	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001481838	10	43615043	10	43119595	1481838	1367356	rs375322585	NC_000010.11:43119594:C:G	single nucleotide variant	missense variant	Uncertain significance	May 9, 2021	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2457C>T (p.Ser819=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001087471	10	43615043	10	43119595	1087471	1077051	rs375322585	NC_000010.11:43119594:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2458C>T (p.Arg820Cys)	RET	R645C, R775C, R337C, R425C, R478C, R481C, R521C, R674C, R688C, R724C, R476C, R566C, R578C, R732C, R777C, R820C, R385C, R490C	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001965277	10	43615044	10	43119596	1965277	2027869		NC_000010.11:43119595:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2459G>A (p.Arg820His)	RET	R385H, R481H, R645H, R688H, R775H, R820H, R478H, R724H, R777H, R337H, R476H, R490H, R521H, R578H, R674H, R425H, R566H, R732H	Multiple endocrine neoplasia, type 2	VCV003720928	10	43615045	10	43119597	3720928	3856730		NC_000010.11:43119596:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 30, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2461A>G (p.Lys821Glu)	RET	K821E, K567E, K338E, K477E, K482E, K522E, K579E, K426E, K675E, K725E, K733E, K776E, K386E, K479E, K491E, K778E, K646E, K689E	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|not provided	VCV000229991	10	43615047	10	43119599	229991	233787	rs749421642	NC_000010.11:43119598:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2462A>G (p.Lys821Arg)	RET	K821R, K567R, K426R, K482R, K675R, K689R, K733R, K338R, K579R, K386R, K477R, K479R, K522R, K646R, K725R, K778R, K491R, K776R	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000232644	10	43615048	10	43119600	232644	233788	rs876659895	NC_000010.11:43119599:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2464G>C (p.Val822Leu)	RET	V822L, V568L, V480L, V523L, V676L, V726L, V427L, V690L, V734L, V777L, V339L, V478L, V483L, V580L, V779L, V387L, V492L, V647L	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001355958	10	43615050	10	43119602	1355958	1354254	rs1588877202	NC_000010.11:43119601:G:C	single nucleotide variant	missense variant	Uncertain significance	May 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2464G>T (p.Val822Leu)	RET	V568L, V822L, V427L, V387L, V492L, V777L, V339L, V480L, V483L, V647L, V676L, V690L, V726L, V734L, V478L, V523L, V580L, V779L	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001000528	10	43615050	10	43119602	1000528	993817	rs1588877202	NC_000010.11:43119601:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2464G>A (p.Val822Met)	RET	V568M, V822M, V480M, V580M, V690M, V777M, V339M, V427M, V478M, V483M, V647M, V726M, V779M, V387M, V492M, V523M, V676M, V734M	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000821322	10	43615050	10	43119602	821322	809959	rs1588877202	NC_000010.11:43119601:G:A	single nucleotide variant	missense variant	Uncertain significance	May 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2465_2470delinsGGG (p.Val822_Pro824delinsGlyAla)	RET		Hereditary cancer-predisposing syndrome	VCV003227530	10	43615051 - 43615056	10	43119603 - 43119608	3227530	3390742		NC_000010.11:43119602:TGGGGC:GGG	Indel	inframe_indel	Uncertain significance	Dec 29, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2467G>T (p.Gly823Trp)	RET	G340W, G727W, G388W, G428W, G569W, G648W, G691W, G780W, G823W, G493W, G581W, G677W, G735W, G479W, G481W, G484W, G524W, G778W	Hereditary cancer-predisposing syndrome	VCV001791710	10	43615053	10	43119605	1791710	1845143		NC_000010.11:43119604:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 17, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2467G>A (p.Gly823Arg)	RET	G823R, G569R, G479R, G493R, G340R, G481R, G524R, G581R, G677R, G388R, G484R, G648R, G727R, G780R, G428R, G691R, G735R, G778R	Hirschsprung Disease, Dominant|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia|Multiple endocrine neoplasia, type 2|Pheochromocytoma|Hereditary cancer-predisposing syndrome	VCV000299898	10	43615053	10	43119605	299898	322068	rs138847998	NC_000010.11:43119604:G:A	single nucleotide variant	missense variant	Uncertain significance	May 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2468G>A (p.Gly823Glu)	RET	G569E, G823E, G388E, G677E, G778E, G340E, G484E, G524E, G581E, G691E, G735E, G481E, G493E, G648E, G428E, G479E, G727E, G780E	Multiple endocrine neoplasia, type 2	VCV001405906	10	43615054	10	43119606	1405906	1493168	rs142779213	NC_000010.11:43119605:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2469G>A (p.Gly823=)	RET		Multiple endocrine neoplasia, type 2	VCV000792660	10	43615055	10	43119607	792660	783591	rs1588877213	NC_000010.11:43119606:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 11, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.2471C>A (p.Pro824His)	RET	P341H, P389H, P429H, P482H, P570H, P582H, P692H, P485H, P494H, P649H, P728H, P736H, P480H, P781H, P824H, P525H, P678H, P779H	Hereditary cancer-predisposing syndrome	VCV001791786	10	43615057	10	43119609	1791786	1845219		NC_000010.11:43119608:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 14, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2472T>C (p.Pro824=)	RET		Multiple endocrine neoplasia, type 2	VCV002902655	10	43615058	10	43119610	2902655	3058251		NC_000010.11:43119609:T:C	single nucleotide variant	synonymous variant	Likely benign	Apr 5, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2474G>C (p.Gly825Ala)	RET	G342A, G390A, G430A, G481A, G483A, G486A, G495A, G526A, G571A, G583A, G650A, G679A, G693A, G729A, G737A, G780A, G782A, G825A	Multiple endocrine neoplasia, type 2	VCV003614406	10	43615060	10	43119612	3614406	3749101		NC_000010.11:43119611:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2025	criteria provided, single submitter							
NM_020975.6(RET):c.2476T>A (p.Tyr826Asn)	RET	Y572N, Y826N, Y482N, Y527N, Y781N, Y484N, Y694N, Y730N, Y738N, Y783N, Y391N, Y431N, Y496N, Y651N, Y343N, Y487N, Y584N, Y680N	Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome	VCV000839316	10	43615062	10	43119614	839316	836860	rs1445590151	NC_000010.11:43119613:T:A	single nucleotide variant	missense variant	Uncertain significance	May 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2476T>C (p.Tyr826His)	RET	Y826H, Y572H, Y680H, Y694H, Y781H, Y527H, Y651H, Y391H, Y431H, Y482H, Y484H, Y487H, Y496H, Y343H, Y584H, Y730H, Y738H, Y783H	Multiple endocrine neoplasia, type 2	VCV000570322	10	43615062	10	43119614	570322	566295	rs1445590151	NC_000010.11:43119613:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 9, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.2477A>G (p.Tyr826Cys)	RET	Y572C, Y826C, Y343C, Y694C, Y730C, Y584C, Y651C, Y484C, Y487C, Y496C, Y527C, Y680C, Y783C, Y391C, Y431C, Y482C, Y738C, Y781C	Multiple endocrine neoplasia, type 2	VCV000844448	10	43615063	10	43119615	844448	836861	rs34617196	NC_000010.11:43119614:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 22, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2477A>C (p.Tyr826Ser)	RET	Y826S, Y572S, Y482S, Y527S, Y694S, Y343S, Y431S, Y487S, Y651S, Y680S, Y781S, Y730S, Y783S, Y391S, Y484S, Y496S, Y584S, Y738S	not provided|Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|not specified	VCV000220530	10	43615063	10	43119615	220530	221972	rs34617196	NC_000010.11:43119614:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 29, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2478C>T (p.Tyr826=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000821338	10	43615064	10	43119616	821338	809960	rs1588877223	NC_000010.11:43119615:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2479C>G (p.Leu827Val)	RET	L573V, L827V, L483V, L485V, L488V, L731V, L344V, L432V, L528V, L739V, L782V, L784V, L392V, L497V, L585V, L652V, L681V, L695V	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001481958	10	43615065	10	43119617	1481958	1445194	rs1247476725	NC_000010.11:43119616:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	May 2, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2479C>T (p.Leu827=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000480782	10	43615065	10	43119617	480782	475332	rs1247476725	NC_000010.11:43119616:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2480T>C (p.Leu827Pro)	RET	L827P, L573P, L344P, L392P, L528P, L652P, L739P, L784P, L483P, L488P, L681P, L432P, L585P, L695P, L731P, L485P, L497P, L782P	Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1	VCV001521041	10	43615066	10	43119618	1521041	1446694	rs2132945857	NC_000010.11:43119617:T:C	single nucleotide variant	missense variant	Uncertain significance	May 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2481G>A (p.Leu827=)	RET		Multiple endocrine neoplasia, type 2	VCV001007381	10	43615067	10	43119619	1007381	993818	rs775022842	NC_000010.11:43119618:G:A	single nucleotide variant	synonymous variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2482G>A (p.Gly828Ser)	RET	G828S, G574S, G484S, G498S, G586S, G732S, G393S, G433S, G489S, G696S, G783S, G345S, G529S, G653S, G682S, G785S, G486S, G740S	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000860012	10	43615068	10	43119620	860012	836862	rs912196017	NC_000010.11:43119619:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2482G>C (p.Gly828Arg)	RET	G828R, G574R, G433R, G484R, G489R, G529R, G498R, G653R, G682R, G740R, G393R, G696R, G732R, G345R, G486R, G586R, G783R, G785R	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000477351	10	43615068	10	43119620	477351	460318	rs912196017	NC_000010.11:43119619:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2483G>T (p.Gly828Val)	RET	G828V, G574V, G393V, G486V, G489V, G696V, G682V, G732V, G345V, G484V, G529V, G653V, G433V, G498V, G586V, G740V, G783V, G785V	Multiple endocrine neoplasia, type 2	VCV000661266	10	43615069	10	43119621	661266	638921	rs1588877229	NC_000010.11:43119620:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 24, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.2485A>G (p.Ser829Gly)	RET	S829G, S575G, S587G, S346G, S434G, S485G, S530G, S786G, S487G, S499G, S654G, S683G, S733G, S394G, S490G, S697G, S741G, S784G	Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A	VCV000232162	10	43615071	10	43119623	232162	233789	rs113005278	NC_000010.11:43119622:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 2, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2486G>A (p.Ser829Asn)	RET	S394N, S485N, S487N, S575N, S683N, S784N, S499N, S654N, S733N, S434N, S490N, S741N, S829N, S346N, S530N, S587N, S697N, S786N	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001791991	10	43615072	10	43119624	1791991	1845424		NC_000010.11:43119623:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2486G>C (p.Ser829Thr)	RET	S829T, S575T, S394T, S530T, S733T, S346T, S485T, S587T, S741T, S487T, S490T, S654T, S683T, S434T, S499T, S697T, S784T, S786T	Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Hereditary cancer-predisposing syndrome|not provided|Hirschsprung disease, susceptibility to, 1	VCV000543736	10	43615072	10	43119624	543736	525642	rs943720843	NC_000010.11:43119623:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2487T>C (p.Ser829=)	RET		Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001136313	10	43615073	10	43119625	1136313	1120274	rs2132946081	NC_000010.11:43119624:T:C	single nucleotide variant	synonymous variant	Likely benign	May 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2488G>A (p.Gly830Arg)	RET	G830R, G576R, G491R, G531R, G734R, G785R, G787R, G435R, G488R, G742R, G395R, G486R, G588R, G655R, G684R, G698R, G347R, G500R	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Multiple endocrine neoplasia type 2B|RET-related disorder|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B	VCV000372078	10	43615074	10	43119626	372078	358830	rs200127630	NC_000010.11:43119625:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 20, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2489G>A (p.Gly830Glu)	RET	G576E, G830E, G347E, G435E, G742E, G500E, G531E, G395E, G588E, G655E, G684E, G734E, G785E, G787E, G486E, G488E, G491E, G698E	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001480116	10	43615075	10	43119627	1480116	1364786	rs1159027752	NC_000010.11:43119626:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2491G>A (p.Gly831Ser)	RET	G577S, G831S, G396S, G436S, G487S, G501S, G656S, G348S, G489S, G492S, G532S, G685S, G786S, G788S, G589S, G699S, G735S, G743S	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000646100	10	43615077	10	43119629	646100	638922	rs775981129	NC_000010.11:43119628:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2492G>T (p.Gly831Val)	RET	G831V, G577V, G396V, G487V, G589V, G656V, G786V, G501V, G532V, G735V, G348V, G436V, G489V, G788V, G492V, G685V, G699V, G743V	Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000232122	10	43615078	10	43119630	232122	233790	rs760924186	NC_000010.11:43119629:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Aug 13, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2493C>T (p.Gly831=)	RET		Multiple endocrine neoplasia, type 2|not provided|Hereditary cancer-predisposing syndrome	VCV001792106	10	43615079	10	43119631	1792106	1845538		NC_000010.11:43119630:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Dec 18, 2023	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2495G>A (p.Ser832Asn)	RET	S397N, S590N, S686N, S700N, S744N, S789N, S832N, S349N, S437N, S490N, S493N, S657N, S488N, S533N, S787N, S502N, S578N, S736N	Multiple endocrine neoplasia, type 2	VCV003643357	10	43615081	10	43119633	3643357	3776228		NC_000010.11:43119632:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 26, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2496C>T (p.Ser832=)	RET		Multiple endocrine neoplasia, type 2	VCV002779099	10	43615082	10	43119634	2779099	2940250		NC_000010.11:43119633:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 18, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2496C>G (p.Ser832Arg)	RET	S832R, S578R, S502R, S533R, S686R, S397R, S493R, S657R, S700R, S349R, S488R, S736R, S789R, S437R, S490R, S590R, S744R, S787R	Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2	VCV000486338	10	43615082	10	43119634	486338	475109	rs764979358	NC_000010.11:43119633:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2497C>T (p.Arg833Cys)	RET	R579C, R398C, R687C, R737C, R745C, R788C, R790C, R350C, R494C, R503C, R591C, R658C, R534C, R701C, R438C, R489C, R491C	Hereditary cancer-predisposing syndrome|not provided|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma	VCV000024945	10	43615083	10	43119635	24945	36286	rs377767422	NC_000010.11:43119634:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 6, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2498G>A (p.Arg833His)	RET	R833H, R579H, R438H, R489H, R591H, R790H, R687H, R701H, R350H, R491H, R503H, R534H, R658H, R737H, R398H, R494H, R745H, R788H	Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000142676	10	43615084	10	43119636	142676	152390	rs587782636	NC_000010.11:43119635:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2501A>C (p.Asn834Thr)	RET	N351T, N399T, N439T, N490T, N492T, N495T, N504T, N535T, N580T, N592T, N659T, N688T, N702T, N738T, N746T, N789T, N791T, N834T	Multiple endocrine neoplasia, type 2	VCV003074327	10	43615087	10	43119639	3074327	3231461		NC_000010.11:43119638:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 2, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2501A>G (p.Asn834Ser)	RET	N580S, N834S, N535S, N659S, N789S, N399S, N504S, N738S, N351S, N439S, N490S, N592S, N688S, N746S, N492S, N495S, N702S, N791S	Multiple endocrine neoplasia, type 2	VCV001368286	10	43615087	10	43119639	1368286	1424822	rs147433153	NC_000010.11:43119638:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2502C>T (p.Asn834=)	RET		Multiple endocrine neoplasia, type 2	VCV000543775	10	43615088	10	43119640	543775	525643	rs1554819542	NC_000010.11:43119639:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 20, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2503T>G (p.Ser835Ala)	RET	S581A, S835A, S400A, S491A, S496A, S660A, S440A, S493A, S593A, S689A, S703A, S352A, S505A, S536A, S739A, S792A, S747A, S790A	Multiple endocrine neoplasia, type 2	VCV001468890	10	43615089	10	43119641	1468890	1359249	rs2132946807	NC_000010.11:43119640:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 28, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2504C>G (p.Ser835Cys)	RET	S505C, S660C, S689C, S703C, S747C, S352C, S400C, S491C, S496C, S581C, S790C, S835C, S440C, S739C, S792C, S493C, S536C, S593C	Hereditary cancer-predisposing syndrome	VCV003432220	10	43615090	10	43119642	3432220	3593416		NC_000010.11:43119641:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 22, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2505C>T (p.Ser835=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000413467	10	43615091	10	43119643	413467	397825	rs1060504033	NC_000010.11:43119642:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2507G>A (p.Ser836Asn)	RET	S582N, S836N, S401N, S690N, S441N, S506N, S594N, S704N, S748N, S791N, S353N, S497N, S537N, S492N, S494N, S661N, S740N, S793N	Multiple endocrine neoplasia, type 2	VCV001057066	10	43615093	10	43119645	1057066	1046539	rs1280808741	NC_000010.11:43119644:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 21, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.2508C>T (p.Ser836=)	RET		Hereditary cancer-predisposing syndrome|Pheochromocytoma|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia|not provided|Renal hypodysplasia/aplasia 1|not specified|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2	VCV000024946	10	43615094	10	43119646	24946	36287	rs1800862	NC_000010.11:43119645:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2509T>C (p.Ser837Pro)	RET	S354P, S402P, S442P, S493P, S495P, S498P, S507P, S538P, S583P, S595P, S662P, S691P, S705P, S741P, S749P, S792P, S794P, S837P	Hereditary cancer-predisposing syndrome	VCV003227531	10	43615095	10	43119647	3227531	3390743		NC_000010.11:43119646:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 23, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2509T>G (p.Ser837Ala)	RET	S495A, S498A, S691A, S705A, S741A, S837A, S402A, S595A, S662A, S792A, S442A, S794A, S354A, S493A, S507A, S538A, S583A, S749A	Multiple endocrine neoplasia, type 2	VCV002870666	10	43615095	10	43119647	2870666	3031550		NC_000010.11:43119646:T:G	single nucleotide variant	missense variant	Uncertain significance	Jan 18, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2511C>T (p.Ser837=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001141061	10	43615097	10	43119649	1141061	1120275	rs2132947111	NC_000010.11:43119648:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2512C>T (p.Leu838=)	RET		Hereditary cancer-predisposing syndrome	VCV001792419	10	43615098	10	43119650	1792419	1842007		NC_000010.11:43119649:C:T	single nucleotide variant	synonymous variant	Likely benign	May 7, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2513T>A (p.Leu838Gln)	RET	L355Q, L403Q, L443Q, L494Q, L496Q, L499Q, L508Q, L539Q, L584Q, L596Q, L663Q, L692Q, L706Q, L742Q, L750Q, L793Q, L795Q, L838Q	Hereditary cancer-predisposing syndrome	VCV003227532	10	43615099	10	43119651	3227532	3390744		NC_000010.11:43119650:T:A	single nucleotide variant	missense variant	Uncertain significance	Jan 9, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2514G>C (p.Leu838=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002099307	10	43615100	10	43119652	2099307	2150628		NC_000010.11:43119651:G:C	single nucleotide variant	synonymous variant	Likely benign	Nov 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2515G>C (p.Asp839His)	RET	D500H, D707H, D796H, D404H, D444H, D794H, D839H, D495H, D497H, D509H, D585H, D597H, D664H, D356H, D540H, D693H, D743H, D751H	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002562606	10	43615101	10	43119653	2562606	2717448		NC_000010.11:43119652:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2515G>A (p.Asp839Asn)	RET	D404N, D500N, D693N, D356N, D444N, D495N, D497N, D585N, D664N, D796N, D839N, D743N, D751N, D794N, D509N, D540N, D597N, D707N	Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2	VCV001792463	10	43615101	10	43119653	1792463	1842051		NC_000010.11:43119652:G:A	single nucleotide variant	missense variant	Uncertain significance	May 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2517C>G (p.Asp839Glu)	RET	D444E, D495E, D839E, D356E, D404E, D500E, D509E, D693E, D751E, D794E, D585E, D664E, D796E, D497E, D540E, D597E, D707E, D743E	Multiple endocrine neoplasia, type 2	VCV002820101	10	43615103	10	43119655	2820101	2985032		NC_000010.11:43119654:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 11, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2519A>T (p.His840Leu)	RET	H501L, H510L, H708L, H744L, H795L, H498L, H541L, H586L, H797L, H840L, H357L, H405L, H445L, H665L, H694L, H496L, H598L, H752L	Multiple endocrine neoplasia, type 2	VCV002107354	10	43615105	10	43119657	2107354	2166518		NC_000010.11:43119656:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 7, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2519A>C (p.His840Pro)	RET	H586P, H840P, H405P, H445P, H795P, H797P, H496P, H498P, H501P, H510P, H752P, H541P, H665P, H694P, H744P, H357P, H598P, H708P	Multiple endocrine neoplasia, type 2	VCV001354191	10	43615105	10	43119657	1354191	1341309	rs1588877283	NC_000010.11:43119656:A:C	single nucleotide variant	missense variant	Uncertain significance	Mar 26, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2519A>G (p.His840Arg)	RET	H840R, H586R, H498R, H598R, H752R, H665R, H795R, H797R, H357R, H405R, H445R, H496R, H694R, H708R, H501R, H510R, H541R, H744R	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000821427	10	43615105	10	43119657	821427	809961	rs1588877283	NC_000010.11:43119656:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2521C>T (p.Pro841Ser)	RET	P358S, P406S, P446S, P497S, P499S, P502S, P511S, P542S, P587S, P599S, P666S, P695S, P709S, P745S, P753S, P796S, P798S, P841S	Multiple endocrine neoplasia, type 2	VCV003071159	10	43615107	10	43119659	3071159	3228740		NC_000010.11:43119658:C:T	single nucleotide variant	missense variant	Uncertain significance	May 31, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2522C>A (p.Pro841Gln)	RET	P446Q, P502Q, P511Q, P796Q, P358Q, P406Q, P499Q, P542Q, P695Q, P745Q, P798Q, P841Q, P497Q, P709Q, P753Q, P587Q, P599Q, P666Q	Multiple endocrine neoplasia, type 2	VCV002917954	10	43615108	10	43119660	2917954	3072153		NC_000010.11:43119659:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 15, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2522C>T (p.Pro841Leu)	RET	P587L, P499L, P502L, P745L, P798L, P358L, P497L, P511L, P542L, P695L, P666L, P709L, P796L, P406L, P446L, P599L, P753L	not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A|not specified|Pheochromocytoma|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2	VCV000024947	10	43615108	10	43119660	24947	36288	rs149891333	NC_000010.11:43119659:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 29, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2523G>T (p.Pro841=)	RET		Hereditary cancer-predisposing syndrome|not provided|not specified|Pheochromocytoma|Multiple endocrine neoplasia|Hirschsprung disease, susceptibility to, 1|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia, type 2	VCV000184140	10	43615109	10	43119661	184140	182956	rs56195026	NC_000010.11:43119660:G:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Feb 3, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2523G>A (p.Pro841=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|not provided|not specified|Multiple endocrine neoplasia type 2A	VCV000024948	10	43615109	10	43119661	24948	36289	rs56195026	NC_000010.11:43119660:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2524G>A (p.Asp842Asn)	RET	D588N, D842N, D447N, D500N, D512N, D754N, D543N, D600N, D710N, D797N, D359N, D407N, D498N, D503N, D667N, D696N, D746N, D799N	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000945181	10	43615110	10	43119662	945181	925811	rs1838161318	NC_000010.11:43119661:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2528_2530dup (p.Glu843_Arg844insGln)	RET		Multiple endocrine neoplasia, type 2	VCV000843856	10	43615113 - 43615114	10	43119665 - 43119666	843856	836863	rs1838161569	NC_000010.11:43119665:AGC:AGCAGC	Duplication	inframe_indel|inframe_insertion	Uncertain significance	Nov 27, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.2527G>A (p.Glu843Lys)	RET	E843K, E589K, E408K, E448K, E504K, E544K, E798K, E360K, E499K, E501K, E513K, E711K, E755K, E601K, E668K, E697K, E747K, E800K	not provided|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Congenital central hypoventilation|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2	VCV000405527	10	43615113	10	43119665	405527	397282	rs755837568	NC_000010.11:43119664:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 29, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2529G>A (p.Glu843=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002454128	10	43615115	10	43119667	2454128	2424017		NC_000010.11:43119666:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2530C>T (p.Arg844Trp)	RET	R590W, R361W, R698W, R756W, R514W, R409W, R449W, R505W, R545W, R602W, R712W, R799W, R801W, R500W, R502W, R669W, R748W	not provided|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Pheochromocytoma|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma	VCV000024950	10	43615116	10	43119668	24950	36291	rs377767424	NC_000010.11:43119667:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2531G>T (p.Arg844Leu)	RET	R844L, R590L, R502L, R514L, R669L, R698L, R799L, R801L, R409L, R449L, R748L, R500L, R602L, R712L, R756L, R361L, R505L, R545L	Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000024952	10	43615117	10	43119669	24952	36293	rs55947360	NC_000010.11:43119668:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2531G>A (p.Arg844Gln)	RET	R590Q, R361Q, R500Q, R698Q, R748Q, R502Q, R756Q, R409Q, R505Q, R514Q, R602Q, R669Q, R712Q, R799Q, R449Q, R545Q, R801Q	not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma	VCV000024951	10	43615117	10	43119669	24951	36292	rs55947360	NC_000010.11:43119668:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 22, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2532G>A (p.Arg844=)	RET		Multiple endocrine neoplasia, type 2	VCV002103123	10	43615118	10	43119670	2103123	2158427		NC_000010.11:43119669:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 2, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2532G>C (p.Arg844=)	RET		Hereditary cancer-predisposing syndrome	VCV001792716	10	43615118	10	43119670	1792716	1851765		NC_000010.11:43119669:G:C	single nucleotide variant	synonymous variant	Likely benign	May 24, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2533G>T (p.Ala845Ser)	RET	A501S, A603S, A699S, A713S, A749S, A845S, A362S, A515S, A670S, A757S, A450S, A503S, A591S, A800S, A802S, A410S, A506S, A546S	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002162427	10	43615119	10	43119671	2162427	1894724		NC_000010.11:43119670:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 6, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2534C>T (p.Ala845Val)	RET	A362V, A591V, A749V, A800V, A501V, A503V, A699V, A757V, A802V, A515V, A546V, A603V, A410V, A450V, A506V, A670V, A713V, A845V	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002140620	10	43615120	10	43119672	2140620	1878994		NC_000010.11:43119671:C:T	single nucleotide variant	missense variant	Uncertain significance	May 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2535C>T (p.Ala845=)	RET		Hereditary cancer-predisposing syndrome|Pheochromocytoma|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2	VCV000024953	10	43615121	10	43119673	24953	36294	rs377767425	NC_000010.11:43119672:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2536C>T (p.Leu846Phe)	RET	L363F, L758F, L803F, L411F, L451F, L516F, L700F, L801F, L846F, L502F, L504F, L507F, L604F, L750F, L547F, L592F, L671F, L714F	Multiple endocrine neoplasia, type 2	VCV002087222	10	43615122	10	43119674	2087222	2137283		NC_000010.11:43119673:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 17, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2538C>T (p.Leu846=)	RET		Multiple endocrine neoplasia|Pheochromocytoma|Renal hypodysplasia/aplasia 1|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|not specified	VCV000241348	10	43615124	10	43119676	241348	240802	rs201816539	NC_000010.11:43119675:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 21, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2542A>C (p.Met848Leu)	RET	M453L, M549L, M803L, M848L, M365L, M413L, M504L, M506L, M594L, M606L, M752L, M509L, M673L, M805L, M518L, M702L, M716L, M760L	Multiple endocrine neoplasia, type 2	VCV003717613	10	43615128	10	43119680	3717613	3852589		NC_000010.11:43119679:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 17, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2542A>T (p.Met848Leu)	RET	M594L, M848L, M453L, M702L, M716L, M752L, M803L, M413L, M504L, M509L, M518L, M549L, M673L, M805L, M365L, M506L, M606L, M760L	Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000662586	10	43615128	10	43119680	662586	638923	rs794728685	NC_000010.11:43119679:A:T	single nucleotide variant	missense variant	Uncertain significance	Feb 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2542A>G (p.Met848Val)	RET	M848V, M594V, M413V, M453V, M504V, M518V, M606V, M716V, M752V, M365V, M673V, M805V, M506V, M509V, M549V, M702V, M760V, M803V	Multiple endocrine neoplasia, type 2|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|not provided	VCV000201131	10	43615128	10	43119680	201131	197379	rs794728685	NC_000010.11:43119679:A:G	single nucleotide variant	missense variant	Uncertain significance	May 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2543T>G (p.Met848Arg)	RET	M365R, M413R, M453R, M504R, M506R, M509R, M518R, M549R, M594R, M606R, M673R, M702R, M716R, M752R, M760R, M803R, M805R, M848R	Multiple endocrine neoplasia, type 2	VCV003073914	10	43615129	10	43119681	3073914	3232784		NC_000010.11:43119680:T:G	single nucleotide variant	missense variant	Uncertain significance	Nov 30, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2543T>C (p.Met848Thr)	RET	M594T, M803T, M805T, M506T, M453T, M509T, M518T, M549T, M606T, M702T, M752T, M760T, M365T, M413T, M504T, M673T, M716T	Multiple endocrine neoplasia, type 2	VCV002724443	10	43615129	10	43119681	2724443	36295	rs201101792	NC_000010.11:43119680:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 8, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2543T>A (p.Met848Lys)	RET	M848K, M594K, M506K, M518K, M702K, M803K, M365K, M413K, M504K, M606K, M673K, M716K, M752K, M760K, M805K, M453K, M509K, M549K	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Familial medullary thyroid carcinoma|not provided|Multiple endocrine neoplasia type 2A	VCV000041841	10	43615129	10	43119681	41841	50280	rs201101792	NC_000010.11:43119680:T:A	single nucleotide variant	missense variant	Uncertain significance	Oct 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2544G>A (p.Met848Ile)	RET	M848I, M594I, M453I, M509I, M518I, M702I, M365I, M760I, M504I, M549I, M673I, M716I, M805I, M413I, M506I, M606I, M752I, M803I	Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000220266	10	43615130	10	43119682	220266	221973	rs772684105	NC_000010.11:43119681:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 12, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2545G>A (p.Gly849Ser)	RET	G414S, G510S, G550S, G595S, G607S, G674S, G703S, G753S, G505S, G519S, G717S, G366S, G507S, G761S, G849S, G454S, G804S, G806S	Hereditary cancer-predisposing syndrome	VCV001792878	10	43615131	10	43119683	1792878	1851927		NC_000010.11:43119682:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 17, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2546G>A (p.Gly849Asp)	RET	G849D, G595D, G454D, G505D, G510D, G550D, G804D, G366D, G507D, G674D, G717D, G761D, G414D, G607D, G703D, G753D, G519D, G806D	Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1	VCV000543757	10	43615132	10	43119684	543757	525153	rs761130672	NC_000010.11:43119683:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2547C>T (p.Gly849=)	RET		Hereditary cancer-predisposing syndrome|not specified|Multiple endocrine neoplasia, type 2	VCV000220085	10	43615133	10	43119685	220085	221974	rs770674650	NC_000010.11:43119684:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2548G>T (p.Asp850Tyr)	RET	D850Y, D596Y, D367Y, D455Y, D704Y, D762Y, D675Y, D754Y, D805Y, D415Y, D511Y, D520Y, D608Y, D506Y, D508Y, D551Y, D718Y, D807Y	not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1	VCV000233687	10	43615134	10	43119686	233687	233792	rs772862503	NC_000010.11:43119685:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2548G>A (p.Asp850Asn)	RET	D850N, D596N, D551N, D608N, D675N, D762N, D506N, D367N, D415N, D508N, D704N, D718N, D807N, D455N, D511N, D520N, D754N, D805N	Multiple endocrine neoplasia, type 2|not provided|Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000229747	10	43615134	10	43119686	229747	233791	rs772862503	NC_000010.11:43119685:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2549A>T (p.Asp850Val)	RET	D506V, D551V, D675V, D762V, D807V, D367V, D508V, D520V, D596V, D608V, D704V, D754V, D415V, D805V, D850V, D455V, D511V, D718V	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001792911	10	43615135	10	43119687	1792911	1851960		NC_000010.11:43119686:A:T	single nucleotide variant	missense variant	Uncertain significance	May 31, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2550C>T (p.Asp850=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001532361	10	43615136	10	43119688	1532361	1635972	rs1838163222	NC_000010.11:43119687:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2550C>G (p.Asp850Glu)	RET	D850E, D596E, D367E, D608E, D675E, D718E, D506E, D511E, D805E, D807E, D455E, D762E, D415E, D508E, D520E, D551E, D704E, D754E	Multiple endocrine neoplasia, type 2	VCV000937433	10	43615136	10	43119688	937433	935038	rs1838163222	NC_000010.11:43119687:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 3, 2025	criteria provided, single submitter							
NM_020975.6(RET):c.2551C>T (p.Leu851Phe)	RET	L851F, L597F, L416F, L705F, L755F, L763F, L808F, L456F, L609F, L676F, L368F, L507F, L512F, L719F, L509F, L521F, L552F, L806F	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000821465	10	43615137	10	43119689	821465	809962	rs1588877364	NC_000010.11:43119688:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2553C>A (p.Leu851=)	RET		Hereditary cancer-predisposing syndrome	VCV001792973	10	43615139	10	43119691	1792973	1852022		NC_000010.11:43119690:C:A	single nucleotide variant	synonymous variant	Likely benign	Aug 3, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.2553C>T (p.Leu851=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001097431	10	43615139	10	43119691	1097431	1077052	rs2132949279	NC_000010.11:43119690:C:T	single nucleotide variant	synonymous variant	Likely benign	May 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2554A>T (p.Ile852Phe)	RET	I369F, I522F, I706F, I852F, I508F, I677F, I720F, I553F, I598F, I756F, I417F, I457F, I510F, I513F, I610F, I764F, I807F, I809F	Multiple endocrine neoplasia, type 2	VCV002075038	10	43615140	10	43119692	2075038	2123836		NC_000010.11:43119691:A:T	single nucleotide variant	missense variant	Uncertain significance	Jan 5, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2554A>G (p.Ile852Val)	RET	I852V, I598V, I510V, I809V, I417V, I457V, I508V, I513V, I522V, I553V, I764V, I706V, I720V, I756V, I369V, I610V, I677V, I807V	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A	VCV000241349	10	43615140	10	43119692	241349	240803	rs561276725	NC_000010.11:43119691:A:G	single nucleotide variant	missense variant	Benign/Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2556C>G (p.Ile852Met)	RET	I598M, I457M, I522M, I677M, I807M, I369M, I553M, I610M, I706M, I764M, I809M, I417M, I510M, I720M, I508M, I513M, I756M	Multiple endocrine neoplasia type 2B|not specified|not provided|Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2	VCV000024955	10	43615142	10	43119694	24955	36296	rs377767426	NC_000010.11:43119693:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 31, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2557T>C (p.Ser853Pro)	RET	S599P, S853P, S418P, S458P, S509P, S514P, S554P, S765P, S523P, S611P, S757P, S808P, S511P, S370P, S678P, S707P, S721P, S810P	Multiple endocrine neoplasia, type 2	VCV001055443	10	43615143	10	43119695	1055443	1046540	rs2132949563	NC_000010.11:43119694:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 24, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2558C>T (p.Ser853Leu)	RET	S853L, S599L, S509L, S523L, S808L, S370L, S678L, S707L, S765L, S418L, S511L, S514L, S554L, S721L, S757L, S458L, S611L, S810L	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001430563	10	43615144	10	43119696	1430563	1471097	rs1406662248	NC_000010.11:43119695:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2560T>G (p.Phe854Val)	RET	F510V, F515V, F555V, F722V, F758V, F766V, F811V, F854V, F371V, F524V, F612V, F708V, F459V, F600V, F419V, F512V, F679V, F809V	Hereditary cancer-predisposing syndrome	VCV002568355	10	43615146	10	43119698	2568355	2734891		NC_000010.11:43119697:T:G	single nucleotide variant	missense variant	Uncertain significance	May 1, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2561T>C (p.Phe854Ser)	RET	F600S, F854S, F459S, F515S, F524S, F555S, F612S, F708S, F758S, F809S, F510S, F371S, F512S, F679S, F722S, F766S, F419S, F811S	Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia, type 2	VCV000942848	10	43615147	10	43119699	942848	935039	rs1838163624	NC_000010.11:43119698:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2565C>G (p.Ala855=)	RET		Multiple endocrine neoplasia, type 2	VCV003656888	10	43615151	10	43119703	3656888	3789744		NC_000010.11:43119702:C:G	single nucleotide variant	synonymous variant	Likely benign	Jun 18, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2565C>T (p.Ala855=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001548428	10	43615151	10	43119703	1548428	1657796	rs773912702	NC_000010.11:43119702:C:T	single nucleotide variant	synonymous variant	Likely benign	May 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2566T>C (p.Trp856Arg)	RET	W373R, W526R, W614R, W681R, W724R, W512R, W710R, W811R, W461R, W517R, W557R, W602R, W760R, W421R, W514R, W768R, W813R, W856R	Multiple endocrine neoplasia, type 2|not provided	VCV001977553	10	43615152	10	43119704	1977553	2023913		NC_000010.11:43119703:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2566T>G (p.Trp856Gly)	RET	W856G, W602G, W421G, W517G, W526G, W813G, W373G, W512G, W681G, W710G, W760G, W461G, W614G, W724G, W514G, W557G, W768G, W811G	Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001421734	10	43615152	10	43119704	1421734	1337349	rs1838163811	NC_000010.11:43119703:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2567G>C (p.Trp856Ser)	RET	W373S, W421S, W461S, W512S, W514S, W517S, W526S, W557S, W602S, W614S, W681S, W710S, W724S, W760S, W768S, W811S, W813S, W856S	not provided	VCV001800643	10	43615153	10	43119705	1800643	1857932		NC_000010.11:43119704:G:C	single nucleotide variant	missense variant	Uncertain significance	May 16, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2569C>G (p.Gln857Glu)	RET	Q374E, Q422E, Q513E, Q558E, Q615E, Q682E, Q711E, Q769E, Q812E, Q857E, Q515E, Q527E, Q603E, Q761E, Q814E, Q462E, Q518E, Q725E	Hereditary cancer-predisposing syndrome	VCV001793193	10	43615155	10	43119707	1793193	1848706		NC_000010.11:43119706:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 26, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2571G>T (p.Gln857His)	RET	Q603H, Q857H, Q422H, Q518H, Q711H, Q761H, Q769H, Q462H, Q513H, Q527H, Q682H, Q812H, Q558H, Q725H, Q814H, Q374H, Q515H, Q615H	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|RET-related disorder	VCV000665594	10	43615157	10	43119709	665594	638924	rs1588877374	NC_000010.11:43119708:G:T	single nucleotide variant	missense variant	Uncertain significance	May 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2572A>G (p.Ile858Val)	RET	I423V, I519V, I528V, I559V, I712V, I762V, I770V, I516V, I616V, I813V, I858V, I375V, I726V, I815V, I463V, I514V, I604V, I683V	Hereditary cancer-predisposing syndrome	VCV002562602	10	43615158	10	43119710	2562602	2717444		NC_000010.11:43119709:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 12, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2573T>C (p.Ile858Thr)	RET	I423T, I514T, I726T, I813T, I375T, I463T, I516T, I528T, I712T, I762T, I519T, I616T, I683T, I815T, I858T, I559T, I604T, I770T	Multiple endocrine neoplasia, type 2	VCV002868475	10	43615159	10	43119711	2868475	3020788		NC_000010.11:43119710:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2574C>T (p.Ile858=)	RET		Multiple endocrine neoplasia, type 2	VCV001153236	10	43615160	10	43119712	1153236	1141129	rs2132950497	NC_000010.11:43119711:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 9, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.2578_2579del (p.Gln860fs)	RET	Q377fs, Q425fs, Q465fs, Q516fs, Q518fs, Q521fs, Q530fs, Q561fs, Q606fs, Q618fs, Q685fs, Q714fs, Q728fs, Q764fs, Q772fs, Q815fs, Q817fs, Q860fs	RET-related disorder	VCV002630315	10	43615162 - 43615163	10	43119714 - 43119715	2630315	2798255		NC_000010.11:43119713:CACA:CA	Microsatellite	frameshift variant	Likely pathogenic	Jan 26, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2577A>C (p.Ser859=)	RET		Hereditary cancer-predisposing syndrome	VCV003313716	10	43615163	10	43119715	3313716	3465446		NC_000010.11:43119714:A:C	single nucleotide variant	synonymous variant	Likely benign	Apr 1, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2577A>G (p.Ser859=)	RET		Hereditary cancer-predisposing syndrome	VCV003227533	10	43615163	10	43119715	3227533	3390745		NC_000010.11:43119714:A:G	single nucleotide variant	synonymous variant	Likely benign	Feb 13, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2578C>G (p.Gln860Glu)	RET	Q465E, Q521E, Q561E, Q606E, Q685E, Q728E, Q764E, Q772E, Q377E, Q425E, Q530E, Q618E, Q516E, Q518E, Q815E, Q817E, Q860E, Q714E	Multiple endocrine neoplasia, type 2	VCV002887483	10	43615164	10	43119716	2887483	3044188		NC_000010.11:43119715:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 23, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2580G>T (p.Gln860His)	RET	Q377H, Q425H, Q465H, Q516H, Q518H, Q521H, Q530H, Q561H, Q606H, Q618H, Q685H, Q714H, Q728H, Q764H, Q772H, Q815H, Q817H, Q860H	Hereditary cancer-predisposing syndrome	VCV003227534	10	43615166	10	43119718	3227534	3390746		NC_000010.11:43119717:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 22, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2580G>A (p.Gln860=)	RET		Hirschsprung Disease, Dominant|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Pheochromocytoma	VCV000299899	10	43615166	10	43119718	299899	322098	rs886046988	NC_000010.11:43119717:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Nov 15, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2583G>A (p.Gly861=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001149215	10	43615169	10	43119721	1149215	1141130	rs146628741	NC_000010.11:43119720:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 9, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2583G>T (p.Gly861=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001010360	10	43615169	10	43119721	1010360	993819	rs146628741	NC_000010.11:43119720:G:T	single nucleotide variant	synonymous variant	Uncertain significance	Jan 31, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2586_2592del (p.Met862fs)	RET	M608fs, M862fs	not provided	VCV000194425	10	43615170 - 43615176	10	43119722 - 43119728	194425	191588	rs794727130	NC_000010.11:43119721:ATGCAGTAT:AT	Deletion	frameshift variant	Pathogenic	Jan 12, 2015	criteria provided, single submitter							
NM_020975.6(RET):c.2589G>A (p.Gln863=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000699650	10	43615175	10	43119727	699650	687635	rs985686811	NC_000010.11:43119726:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2590T>C (p.Tyr864His)	RET	Y520H, Y565H, Y381H, Y469H, Y610H, Y732H, Y429H, Y522H, Y525H, Y534H, Y768H, Y821H, Y622H, Y689H, Y718H, Y776H, Y819H, Y864H	Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1	VCV001980831	10	43615176	10	43119728	1980831	2038702		NC_000010.11:43119727:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2592T>C (p.Tyr864=)	RET		Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome	VCV000802568	10	43615178	10	43119730	802568	790959	rs1588877395	NC_000010.11:43119729:T:C	single nucleotide variant	synonymous variant	Likely benign	Nov 11, 2019	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2593C>T (p.Leu865=)	RET		Multiple endocrine neoplasia, type 2	VCV003073387	10	43615179	10	43119731	3073387	3234343		NC_000010.11:43119730:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 17, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2595G>A (p.Leu865=)	RET		Multiple endocrine neoplasia, type 2	VCV003664454	10	43615181	10	43119733	3664454	3791551		NC_000010.11:43119732:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 4, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2596G>A (p.Ala866Thr)	RET	A612T, A866T, A471T, A524T, A770T, A821T, A691T, A734T, A431T, A522T, A527T, A823T, A383T, A536T, A567T, A624T, A720T, A778T	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000665292	10	43615182	10	43119734	665292	638925	rs1334494092	NC_000010.11:43119733:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 4, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2597C>G (p.Ala866Gly)	RET	A536G, A612G, A720G, A471G, A624G, A821G, A823G, A431G, A522G, A866G, A383G, A524G, A527G, A567G, A691G, A734G, A770G, A778G	Hereditary cancer-predisposing syndrome	VCV002568356	10	43615183	10	43119735	2568356	2734892		NC_000010.11:43119734:C:G	single nucleotide variant	missense variant	Uncertain significance	May 3, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2598C>A (p.Ala866=)	RET		Multiple endocrine neoplasia, type 2	VCV003660045	10	43615184	10	43119736	3660045	3800993		NC_000010.11:43119735:C:A	single nucleotide variant	synonymous variant	Likely benign	Jul 21, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2598C>G (p.Ala866=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001120533	10	43615184	10	43119736	1120533	1120276	rs202029768	NC_000010.11:43119735:C:G	single nucleotide variant	synonymous variant	Likely benign	Aug 12, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2598C>T (p.Ala866=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000486318	10	43615184	10	43119736	486318	475336	rs202029768	NC_000010.11:43119735:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2599G>T (p.Glu867Ter)	RET	E384*, E432*, E472*, E523*, E525*, E528*, E537*, E568*, E613*, E625*, E692*, E721*, E735*, E771*, E779*, E822*, E824*, E867*	RET-related disorder	VCV003345856	10	43615185	10	43119737	3345856	3505525		NC_000010.11:43119736:G:T	single nucleotide variant	nonsense	Likely pathogenic	May 2, 2024	no assertion criteria provided							
NM_020975.6(RET):c.2599G>A (p.Glu867Lys)	RET	E867K, E613K, E771K, E432K, E525K, E568K, E625K, E779K, E528K, E537K, E692K, E721K, E735K, E384K, E472K, E523K, E822K, E824K	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000574781	10	43615185	10	43119737	574781	563750	rs758950128	NC_000010.11:43119736:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2600A>C (p.Glu867Ala)	RET	E384A, E432A, E472A, E523A, E525A, E528A, E537A, E568A, E613A, E625A, E692A, E721A, E735A, E771A, E779A, E822A, E824A, E867A	Hereditary cancer-predisposing syndrome	VCV003227535	10	43615186	10	43119738	3227535	3390747		NC_000010.11:43119737:A:C	single nucleotide variant	missense variant	Uncertain significance	Dec 20, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2601G>A (p.Glu867=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000486330	10	43615187	10	43119739	486330	475339	rs141459368	NC_000010.11:43119738:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2601G>T (p.Glu867Asp)	RET	E867D, E613D, E384D, E525D, E568D, E625D, E771D, E537D, E721D, E735D, E779D, E432D, E472D, E523D, E824D, E528D, E692D, E822D	not provided|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|not specified	VCV000216719	10	43615187	10	43119739	216719	212786	rs141459368	NC_000010.11:43119738:G:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 20, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2603T>G (p.Met868Arg)	RET	M385R, M433R, M473R, M524R, M526R, M529R, M538R, M569R, M614R, M626R, M693R, M722R, M736R, M772R, M780R, M823R, M825R, M868R	Hereditary cancer-predisposing syndrome	VCV003227536	10	43615189	10	43119741	3227536	3390748		NC_000010.11:43119740:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 23, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2604G>A (p.Met868Ile)	RET	M614I, M868I, M524I, M529I, M823I, M825I, M473I, M569I, M626I, M693I, M722I, M736I, M385I, M538I, M780I, M433I, M526I, M772I	Multiple endocrine neoplasia, type 2	VCV001002688	10	43615190	10	43119742	1002688	993820	rs1838165300	NC_000010.11:43119741:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 15, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2607+3G>A	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000241350	10	43615196	10	43119748	241350	240804	rs752538741	NC_000010.11:43119747:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Aug 27, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2607+3G>C	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A	VCV000232949	10	43615196	10	43119748	232949	233793	rs752538741	NC_000010.11:43119747:G:C	single nucleotide variant	intron variant	Uncertain significance	Jan 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2607+4C>T	RET		Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia, type 2|not provided|Multiple endocrine neoplasia type 2B	VCV000216720	10	43615197	10	43119749	216720	212787	rs200634990	NC_000010.11:43119748:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Nov 5, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2607+5G>C	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV003432249	10	43615198	10	43119750	3432249	3593445		NC_000010.11:43119749:G:C	single nucleotide variant	intron variant	Uncertain significance	Sep 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2607+5G>A	RET		Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|not specified|not provided|Multiple endocrine neoplasia type 2A	VCV000372491	10	43615198	10	43119750	372491	359964	rs143862573	NC_000010.11:43119749:G:A	single nucleotide variant	intron variant	Uncertain significance	Dec 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2607+9A>G	RET		Multiple endocrine neoplasia, type 2	VCV000650859	10	43615202	10	43119754	650859	652127	rs863224427	NC_000010.11:43119753:A:G	single nucleotide variant	intron variant	Likely benign	Mar 13, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2607+9A>T	RET		Multiple endocrine neoplasia, type 2	VCV000215911	10	43615202	10	43119754	215911	212788	rs863224427	NC_000010.11:43119753:A:T	single nucleotide variant	intron variant	Likely benign	May 21, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2607+10T>A	RET		Multiple endocrine neoplasia, type 2	VCV001124298	10	43615203	10	43119755	1124298	1120277	rs1319934228	NC_000010.11:43119754:T:A	single nucleotide variant	intron variant	Likely benign	Feb 3, 2025	criteria provided, single submitter							
NM_020975.6(RET):c.2607+11A>G	RET		Multiple endocrine neoplasia, type 2	VCV002728221	10	43615204	10	43119756	2728221	2889559		NC_000010.11:43119755:A:G	single nucleotide variant	intron variant	Likely benign	Apr 14, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2607+12T>C	RET		Multiple endocrine neoplasia, type 2	VCV002862609	10	43615205	10	43119757	2862609	3022658		NC_000010.11:43119756:T:C	single nucleotide variant	intron variant	Likely benign	Dec 16, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2607+15C>T	RET		Multiple endocrine neoplasia, type 2	VCV001964645	10	43615208	10	43119760	1964645	2031107		NC_000010.11:43119759:C:T	single nucleotide variant	intron variant	Likely benign	Feb 4, 2025	criteria provided, single submitter							
NM_020975.6(RET):c.2607+19G>A	RET		Multiple endocrine neoplasia, type 2	VCV001537789	10	43615212	10	43119764	1537789	1650068	rs1385656561	NC_000010.11:43119763:G:A	single nucleotide variant	intron variant	Likely benign	Nov 11, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2607+20C>A	RET		Multiple endocrine neoplasia, type 2	VCV002812728	10	43615213	10	43119765	2812728	2975960		NC_000010.11:43119764:C:A	single nucleotide variant	intron variant	Likely benign	Nov 10, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2607+20C>T	RET		Multiple endocrine neoplasia, type 2	VCV002726080	10	43615213	10	43119765	2726080	2892585		NC_000010.11:43119764:C:T	single nucleotide variant	intron variant	Likely benign	Nov 9, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2607+24C>T	RET		not specified	VCV000261397	10	43615217	10	43119769	261397	253768	rs779255047	NC_000010.11:43119768:C:T	single nucleotide variant	intron variant	Likely benign		criteria provided, single submitter							
NM_020975.6(RET):c.2607+136A>G	RET		not provided	VCV001196488	10	43615329	10	43119881	1196488	1187594	rs571991475	NC_000010.11:43119880:A:G	single nucleotide variant	intron variant	Likely benign	Jul 15, 2018	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2608-147C>T	RET		Multiple endocrine neoplasia, type 2|not provided	VCV000677058	10	43615382	10	43119934	677058	665138	rs11238441	NC_000010.11:43119933:C:T	single nucleotide variant	intron variant	Benign	Aug 6, 2019	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2608-124G>A	RET		not provided	VCV001252823	10	43615405	10	43119957	1252823	1242768	rs111306965	NC_000010.11:43119956:G:A	single nucleotide variant	intron variant	Benign	Jun 23, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.2608-117G>T	RET		not provided	VCV001195365	10	43615412	10	43119964	1195365	1184366	rs150916310	NC_000010.11:43119963:G:T	single nucleotide variant	intron variant	Likely benign	Jul 14, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.2608-24G>A	RET		Multiple endocrine neoplasia type 2B|not specified|not provided|Multiple endocrine neoplasia, type 2	VCV000024956	10	43615505	10	43120057	24956	36297	rs2472737	NC_000010.11:43120056:G:A	single nucleotide variant	intron variant	Benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2608-20C>T	RET		Multiple endocrine neoplasia, type 2	VCV001561849	10	43615509	10	43120061	1561849	1608388	rs758516402	NC_000010.11:43120060:C:T	single nucleotide variant	intron variant	Likely benign	Nov 11, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2608-19G>C	RET		Multiple endocrine neoplasia, type 2	VCV001614045	10	43615510	10	43120062	1614045	1536800	rs773241624	NC_000010.11:43120061:G:C	single nucleotide variant	intron variant	Likely benign	Jan 23, 2025	criteria provided, single submitter							
NM_020975.6(RET):c.2608-19G>A	RET		Multiple endocrine neoplasia, type 2	VCV001537788	10	43615510	10	43120062	1537788	1650067	rs773241624	NC_000010.11:43120061:G:A	single nucleotide variant	intron variant	Likely benign	Dec 31, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2608-16C>T	RET		Multiple endocrine neoplasia, type 2	VCV003006529	10	43615513	10	43120065	3006529	3165478		NC_000010.11:43120064:C:T	single nucleotide variant	intron variant	Likely benign	Nov 27, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2608-16C>G	RET		Multiple endocrine neoplasia, type 2	VCV001434888	10	43615513	10	43120065	1434888	1507092	rs2132957809	NC_000010.11:43120064:C:G	single nucleotide variant	intron variant	Likely benign	May 15, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2608-9dup	RET		Multiple endocrine neoplasia, type 2	VCV003071423	10	43615515 - 43615516	10	43120067 - 43120068	3071423	3233689		NC_000010.11:43120067:TTTTT:TTTTTT	Duplication	intron variant	Likely benign	May 30, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2608-14A>G	RET		Multiple endocrine neoplasia, type 2	VCV002169990	10	43615515	10	43120067	2169990	1900012		NC_000010.11:43120066:A:G	single nucleotide variant	intron variant	Likely benign	Dec 4, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2608-9del	RET		Multiple endocrine neoplasia, type 2	VCV002914957	10	43615516	10	43120068	2914957	3079695		NC_000010.11:43120067:TTTTT:TTTT	Deletion	intron variant	Likely benign	Jun 24, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2608-10T>C	RET		Multiple endocrine neoplasia, type 2	VCV002781723	10	43615519	10	43120071	2781723	2947620		NC_000010.11:43120070:T:C	single nucleotide variant	intron variant	Likely benign	Jul 16, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2608-8C>T	RET		Multiple endocrine neoplasia type 2A	VCV003379184	10	43615521	10	43120073	3379184	3538363		NC_000010.11:43120072:C:T	single nucleotide variant	intron variant	Benign	Sep 5, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2608-7C>G	RET		Multiple endocrine neoplasia, type 2	VCV003656686	10	43615522	10	43120074	3656686	3789542		NC_000010.11:43120073:C:G	single nucleotide variant	intron variant	Likely benign	Jun 15, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2608-6T>C	RET		Multiple endocrine neoplasia, type 2	VCV002995914	10	43615523	10	43120075	2995914	3166552		NC_000010.11:43120074:T:C	single nucleotide variant	intron variant	Likely benign	Nov 21, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2608-5C>G	RET		Multiple endocrine neoplasia, type 2	VCV001609228	10	43615524	10	43120076	1609228	1574098	rs2132958072	NC_000010.11:43120075:C:G	single nucleotide variant	intron variant	Likely benign	Aug 31, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2608-3C>T	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001960940	10	43615526	10	43120078	1960940	2009881		NC_000010.11:43120077:C:T	single nucleotide variant	intron variant	Uncertain significance	Feb 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2610C>T (p.Leu870=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000486301	10	43615531	10	43120083	486301	475340	rs575629307	NC_000010.11:43120082:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 7, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2611G>C (p.Val871Leu)	RET	V436L, V617L, V527L, V529L, V629L, V696L, V725L, V828L, V388L, V532L, V541L, V572L, V775L, V826L, V871L, V476L, V739L, V783L	Hereditary cancer-predisposing syndrome	VCV002454119	10	43615532	10	43120084	2454119	2424008		NC_000010.11:43120083:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 2, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2611G>A (p.Val871Ile)	RET	V871I, V617I, V572I, V739I, V826I, V828I, V436I, V476I, V527I, V725I, V529I, V629I, V783I, V388I, V532I, V541I, V696I, V775I	not specified|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|not provided|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B|Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Familial medullary thyroid carcinoma|Congenital central hypoventilation|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A	VCV000041842	10	43615532	10	43120084	41842	50281	rs145170911	NC_000010.11:43120083:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 28, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2616T>C (p.His872=)	RET		Multiple endocrine neoplasia, type 2	VCV002753336	10	43615537	10	43120089	2753336	2909334		NC_000010.11:43120088:T:C	single nucleotide variant	synonymous variant	Likely benign	Aug 17, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2617C>T (p.Arg873Trp)	RET	R390W, R438W, R478W, R529W, R531W, R534W, R543W, R574W, R619W, R631W, R698W, R727W, R741W, R777W, R785W, R828W, R830W, R873W	Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV002443064	10	43615538	10	43120090	2443064	2416784		NC_000010.11:43120089:C:T	single nucleotide variant	missense variant	Likely pathogenic	May 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2617C>A (p.Arg873=)	RET		Multiple endocrine neoplasia, type 2	VCV000942555	10	43615538	10	43120090	942555	935040	rs1838178513	NC_000010.11:43120089:C:A	single nucleotide variant	synonymous variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2619G>A (p.Arg873=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001097859	10	43615540	10	43120092	1097859	1077053	rs2132958733	NC_000010.11:43120091:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2622C>T (p.Asp874=)	RET		Hereditary cancer-predisposing syndrome	VCV001793969	10	43615543	10	43120095	1793969	1842249		NC_000010.11:43120094:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 16, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.2623T>G (p.Leu875Val)	RET	L875V, L621V, L392V, L480V, L531V, L576V, L830V, L536V, L729V, L743V, L779V, L787V, L832V, L440V, L533V, L633V, L545V, L700V	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1	VCV001483934	10	43615544	10	43120096	1483934	1458716	rs1588877642	NC_000010.11:43120095:T:G	single nucleotide variant	missense variant	Uncertain significance	Jul 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2623T>C (p.Leu875=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000749993	10	43615544	10	43120096	749993	752103	rs1588877642	NC_000010.11:43120095:T:C	single nucleotide variant	synonymous variant	Likely benign	Apr 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2628A>G (p.Ala876=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001794014	10	43615549	10	43120101	1794014	1842294		NC_000010.11:43120100:A:G	single nucleotide variant	synonymous variant	Likely benign	Jun 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2629G>T (p.Ala877Ser)	RET	A578S, A635S, A731S, A745S, A877S, A482S, A547S, A623S, A834S, A533S, A535S, A789S, A394S, A442S, A538S, A702S, A781S, A832S	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001794023	10	43615550	10	43120102	1794023	1842303		NC_000010.11:43120101:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2629G>C (p.Ala877Pro)	RET	A877P, A623P, A535P, A538P, A781P, A789P, A635P, A702P, A731P, A745P, A394P, A547P, A578P, A442P, A482P, A533P, A832P, A834P	Hirschsprung disease, susceptibility to, 1	VCV000870394	10	43615550	10	43120102	870394	858560	rs1838178869	NC_000010.11:43120101:G:C	single nucleotide variant	missense variant	Likely pathogenic	Aug 24, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.2631del (p.Arg878fs)	RET	R624fs, R878fs	Multiple endocrine neoplasia type 2B	VCV000932072	10	43615551	10	43120103	932072	919269	rs1838178970	NC_000010.11:43120102:CC:C	Deletion	frameshift variant	Pathogenic	Mar 19, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.2631C>T (p.Ala877=)	RET		Multiple endocrine neoplasia, type 2	VCV002024964	10	43615552	10	43120104	2024964	2088005		NC_000010.11:43120103:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 7, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2634A>G (p.Arg878=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001130195	10	43615555	10	43120107	1130195	1120278	rs2132959423	NC_000010.11:43120106:A:G	single nucleotide variant	synonymous variant	Likely benign	May 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2637C>T (p.Asn879=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001631219	10	43615558	10	43120110	1631219	1543630	rs1363015786	NC_000010.11:43120109:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 31, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2638A>G (p.Ile880Val)	RET	I626V, I880V, I485V, I536V, I538V, I638V, I541V, I581V, I705V, I445V, I550V, I748V, I784V, I792V, I837V, I397V, I734V, I835V	Hereditary cancer-predisposing syndrome	VCV000821598	10	43615559	10	43120111	821598	809963	rs1588877646	NC_000010.11:43120110:A:G	single nucleotide variant	missense variant	Likely benign	Mar 13, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.2640C>T (p.Ile880=)	RET		Multiple endocrine neoplasia, type 2	VCV001603868	10	43615561	10	43120113	1603868	1644935	rs2132959836	NC_000010.11:43120112:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 10, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2641C>T (p.Leu881=)	RET		Multiple endocrine neoplasia, type 2	VCV001555880	10	43615562	10	43120114	1555880	1626754	rs377767427	NC_000010.11:43120113:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 20, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2641C>G (p.Leu881Val)	RET	L627V, L639V, L537V, L706V, L785V, L838V, L398V, L446V, L793V, L836V, L486V, L539V, L542V, L551V, L582V, L735V, L749V	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|not provided	VCV000024957	10	43615562	10	43120114	24957	36298	rs377767427	NC_000010.11:43120113:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2643G>A (p.Leu881=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001161666	10	43615564	10	43120116	1161666	1141131	rs1227304934	NC_000010.11:43120115:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2644G>A (p.Val882Ile)	RET	V882I, V628I, V540I, V794I, V447I, V583I, V750I, V786I, V399I, V487I, V538I, V640I, V839I, V543I, V552I, V707I, V736I, V837I	Multiple endocrine neoplasia, type 2	VCV001471458	10	43615565	10	43120117	1471458	1488529	rs2132960093	NC_000010.11:43120116:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2647_2648delinsCT (p.Ala883Leu)	RET	A400L, A448L, A488L, A539L, A541L, A544L, A553L, A584L, A629L, A641L, A708L, A737L, A751L, A787L, A795L, A838L, A840L, A883L	not provided	VCV003379961	10	43615568 - 43615569	10	43120120 - 43120121	3379961	3539137		NC_000010.11:43120119:GC:CT	Indel	missense variant	Uncertain significance	Feb 28, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2647G>C (p.Ala883Pro)	RET	A541P, A584P, A641P, A400P, A539P, A544P, A787P, A708P, A751P, A883P, A448P, A629P, A737P, A795P, A840P, A488P, A553P, A838P	Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma	VCV002698806	10	43615568	10	43120120	2698806	2855097		NC_000010.11:43120119:G:C	single nucleotide variant	missense variant	Uncertain significance	May 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2647_2648delinsTT (p.Ala883Phe)	RET	A883F, A629F, A544F, A737F, A795F, A840F, A400F, A448F, A488F, A553F, A787F, A751F, A838F, A584F, A641F, A708F, A539F, A541F	not provided|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000038629	10	43615568 - 43615569	10	43120120 - 43120121	38629	47233	rs377767429	NC_000010.11:43120119:GC:TT	Indel	missense variant	Pathogenic/Likely pathogenic	Jun 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2647G>A (p.Ala883Thr)	RET	A629T, A400T, A448T, A541T, A544T, A751T, A795T, A488T, A584T, A737T, A840T, A641T, A539T, A553T, A708T, A787T, A838T	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000024958	10	43615568	10	43120120	24958	36299	rs377767428	NC_000010.11:43120119:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2648C>T (p.Ala883Val)	RET	A400V, A539V, A737V, A448V, A541V, A544V, A641V, A751V, A795V, A883V, A553V, A584V, A708V, A787V, A838V, A488V, A629V, A840V	Multiple endocrine neoplasia, type 2	VCV002893353	10	43615569	10	43120121	2893353	3055859		NC_000010.11:43120120:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 10, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2648C>A (p.Ala883Asp)	RET	A883D, A629D, A448D, A539D, A584D, A488D, A553D, A641D, A838D, A400D, A544D, A840D, A541D, A708D, A737D, A751D, A787D, A795D	Hereditary cancer-predisposing syndrome|not provided	VCV000618861	10	43615569	10	43120121	618861	609750	rs1293645997	NC_000010.11:43120120:C:A	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2649T>A (p.Ala883=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001087630	10	43615570	10	43120122	1087630	1077054	rs2132960541	NC_000010.11:43120121:T:A	single nucleotide variant	synonymous variant	Likely benign	Dec 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2653G>T (p.Gly885Trp)	RET	G631W, G885W, G402W, G541W, G546W, G753W, G797W, G490W, G739W, G842W, G555W, G586W, G710W, G450W, G543W, G643W, G789W, G840W	Multiple endocrine neoplasia, type 2	VCV001379480	10	43615574	10	43120126	1379480	1486708	rs201487882	NC_000010.11:43120125:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 7, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2654G>A (p.Gly885Glu)	RET	G885E, G631E, G541E, G543E, G402E, G586E, G643E, G753E, G789E, G450E, G490E, G546E, G710E, G739E, G842E, G555E, G797E, G840E	Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|not provided	VCV000405551	10	43615575	10	43120127	405551	397828	rs1010091281	NC_000010.11:43120126:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2655G>A (p.Gly885=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001108411	10	43615576	10	43120128	1108411	1098707	rs2132960866	NC_000010.11:43120127:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2656C>G (p.Arg886Gly)	RET	R403G, R632G, R740G, R491G, R542G, R587G, R841G, R843G, R451G, R544G, R644G, R754G, R790G, R886G, R547G, R556G, R711G, R798G	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001794379	10	43615577	10	43120129	1794379	1852125		NC_000010.11:43120128:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2656C>T (p.Arg886Trp)	RET	R632W, R754W, R542W, R547W, R843W, R403W, R451W, R491W, R587W, R790W, R841W, R544W, R556W, R644W, R711W, R740W, R798W	Renal hypoplasia/aplasia|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not provided	VCV000024960	10	43615577	10	43120129	24960	36301	rs146838520	NC_000010.11:43120128:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 5, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2657G>A (p.Arg886Gln)	RET	R886Q, R632Q, R451Q, R491Q, R556Q, R644Q, R740Q, R790Q, R542Q, R547Q, R843Q, R403Q, R754Q, R841Q, R544Q, R587Q, R711Q, R798Q	Hereditary cancer-predisposing syndrome|not provided|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype	VCV000543745	10	43615578	10	43120130	543745	525439	rs373594744	NC_000010.11:43120129:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 28, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2659A>C (p.Lys887Gln)	RET	K404Q, K452Q, K492Q, K543Q, K545Q, K548Q, K557Q, K588Q, K633Q, K645Q, K712Q, K741Q, K755Q, K791Q, K799Q, K842Q, K844Q, K887Q	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV003227537	10	43615580	10	43120132	3227537	3390749		NC_000010.11:43120131:A:C	single nucleotide variant	missense variant	Uncertain significance	Jul 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2661G>A (p.Lys887=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000215912	10	43615582	10	43120134	215912	212789	rs771617878	NC_000010.11:43120133:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2662A>G (p.Met888Val)	RET	M634V, M888V, M405V, M546V, M549V, M792V, M800V, M843V, M453V, M713V, M493V, M558V, M589V, M646V, M742V, M845V, M544V, M756V	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|not provided|Multiple endocrine neoplasia, type 2|RET-related disorder	VCV000844879	10	43615583	10	43120135	844879	836864	rs774930499	NC_000010.11:43120134:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2664G>A (p.Met888Ile)	RET	M405I, M453I, M493I, M544I, M546I, M549I, M558I, M589I, M634I, M646I, M713I, M742I, M756I, M792I, M800I, M843I, M845I, M888I	Multiple endocrine neoplasia, type 2	VCV003071298	10	43615585	10	43120137	3071298	3228879		NC_000010.11:43120136:G:A	single nucleotide variant	missense variant	Uncertain significance	May 31, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2664G>T (p.Met888Ile)	RET	M544I, M634I, M646I, M792I, M546I, M549I, M493I, M558I, M713I, M742I, M756I, M843I, M405I, M453I, M589I, M800I, M845I, M888I	Hereditary cancer-predisposing syndrome	VCV001794485	10	43615585	10	43120137	1794485	1852231		NC_000010.11:43120136:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 11, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2671T>G (p.Ser891Ala)	RET	S891A, S637A, S716A, S745A, S795A, S848A, S547A, S549A, S846A, S456A, S496A, S592A, S649A, S759A, S408A, S552A, S561A, S803A	Familial medullary thyroid carcinoma|MEN2 phenotype: Unclassified|not provided|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia II|Medullary thyroid carcinoma|Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A	VCV000013951	10	43615592	10	43120144	13951	28990	rs75234356	NC_000010.11:43120143:T:G	single nucleotide variant	missense variant	Pathogenic	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2672C>T (p.Ser891Leu)	RET	S456L, S637L, S408L, S552L, S745L, S848L, S496L, S716L, S759L, S795L, S803L, S846L, S547L, S549L, S561L, S592L, S649L, S891L	Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A	VCV003595005	10	43615593	10	43120145	3595005	3722728		NC_000010.11:43120144:C:T	single nucleotide variant	missense variant	Likely pathogenic	Jan 31, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2673G>A (p.Ser891=)	RET		not provided|Hereditary cancer-predisposing syndrome|not specified|Multiple endocrine neoplasia, type 2|Pheochromocytoma|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma	VCV000024961	10	43615594	10	43120146	24961	36302	rs201620214	NC_000010.11:43120145:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2676T>C (p.Asp892=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000704604	10	43615597	10	43120149	704604	692840	rs768753935	NC_000010.11:43120148:T:C	single nucleotide variant	synonymous variant	Likely benign	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2679C>T (p.Phe893=)	RET		Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000477352	10	43615600	10	43120152	477352	459857	rs768188546	NC_000010.11:43120151:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2682C>T (p.Gly894=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001794693	10	43615603	10	43120155	1794693	1852438		NC_000010.11:43120154:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 18, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2683T>A (p.Leu895Met)	RET	L895M, L641M, L653M, L799M, L852M, L551M, L763M, L412M, L556M, L565M, L749M, L460M, L500M, L553M, L596M, L720M, L807M, L850M	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000477353	10	43615604	10	43120156	477353	459861	rs761720362	NC_000010.11:43120155:T:A	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2686T>A (p.Ser896Thr)	RET	S896T, S642T, S554T, S597T, S808T, S413T, S501T, S552T, S721T, S750T, S800T, S461T, S654T, S853T, S557T, S566T, S764T, S851T	Multiple endocrine neoplasia, type 2	VCV001470825	10	43615607	10	43120159	1470825	1395052	rs2132962610	NC_000010.11:43120158:T:A	single nucleotide variant	missense variant	Uncertain significance	Dec 23, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.2688C>T (p.Ser896=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001794750	10	43615609	10	43120161	1794750	1848959		NC_000010.11:43120160:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2688C>A (p.Ser896=)	RET		Multiple endocrine neoplasia, type 2	VCV001674103	10	43615609	10	43120161	1674103	1617916	rs2132962713	NC_000010.11:43120160:C:A	single nucleotide variant	synonymous variant	Likely benign	Sep 8, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2689C>G (p.Arg897Gly)	RET	R553G, R567G, R852G, R414G, R722G, R751G, R809G, R854G, R502G, R598G, R643G, R765G, R897G, R462G, R555G, R558G, R655G, R801G	Multiple endocrine neoplasia, type 2	VCV001933764	10	43615610	10	43120162	1933764	1992645		NC_000010.11:43120161:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 2, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2689C>T (p.Arg897Ter)	RET	R897*, R643*, R558*, R598*, R765*, R414*, R567*, R722*, R502*, R553*, R751*, R462*, R555*, R655*, R801*, R809*, R852*, R854*	not provided|Multiple endocrine neoplasia, type 2	VCV000405536	10	43615610	10	43120162	405536	397472	rs1060500759	NC_000010.11:43120161:C:T	single nucleotide variant	nonsense	Pathogenic	Apr 11, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2690G>A (p.Arg897Gln)	RET	R897Q, R643Q, R502Q, R558Q, R598Q, R722Q, R765Q, R801Q, R854Q, R414Q, R567Q, R751Q, R553Q, R655Q, R809Q, R462Q, R555Q, R852Q	Hirschsprung disease, susceptibility to, 1	VCV000013921	10	43615611	10	43120163	13921	28960	rs76087194	NC_000010.11:43120162:G:A	single nucleotide variant	missense variant	risk factor	Jan 27, 1994	no assertion criteria provided							
NM_020975.6(RET):c.2694_2705del (p.Asp898_Glu901del)	RET		Hereditary cancer-predisposing syndrome	VCV000376314	10	43615612 - 43615623	10	43120164 - 43120175	376314	363193	rs121913309	NC_000010.11:43120163:AGATGTTTATGAAGA:AGA	Deletion	inframe_indel|inframe_deletion	Uncertain significance	Apr 19, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.2692G>A (p.Asp898Asn)	RET	D415N, D556N, D752N, D810N, D898N, D463N, D559N, D644N, D503N, D568N, D656N, D766N, D853N, D554N, D599N, D723N, D802N, D855N	Hereditary cancer-predisposing syndrome	VCV001794820	10	43615613	10	43120165	1794820	1849029		NC_000010.11:43120164:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 30, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2692G>C (p.Asp898His)	RET	D898H, D644H, D503H, D723H, D810H, D855H, D415H, D463H, D752H, D853H, D556H, D599H, D656H, D802H, D554H, D559H, D568H, D766H	Multiple endocrine neoplasia, type 2	VCV001386874	10	43615613	10	43120165	1386874	1381239	rs587780810	NC_000010.11:43120164:G:C	single nucleotide variant	missense variant	Uncertain significance	Jul 14, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2692G>T (p.Asp898Tyr)	RET	D898Y, D644Y, D415Y, D554Y, D568Y, D503Y, D559Y, D656Y, D766Y, D463Y, D752Y, D802Y, D810Y, D556Y, D599Y, D723Y, D853Y, D855Y	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000136112	10	43615613	10	43120165	136112	139824	rs587780810	NC_000010.11:43120164:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2693A>T (p.Asp898Val)	RET	D415V, D463V, D503V, D554V, D556V, D559V, D568V, D599V, D644V, D656V, D723V, D752V, D766V, D802V, D810V, D853V, D855V, D898V	Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV002678320	10	43615614	10	43120166	2678320	2833343		NC_000010.11:43120165:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2694T>C (p.Asp898=)	RET		Hereditary cancer-predisposing syndrome	VCV001794837	10	43615615	10	43120167	1794837	1849046		NC_000010.11:43120166:T:C	single nucleotide variant	synonymous variant	Likely benign	Nov 4, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.2694T>G (p.Asp898Glu)	RET	D898E, D644E, D559E, D656E, D723E, D415E, D556E, D752E, D853E, D855E, D463E, D503E, D568E, D766E, D802E, D554E, D599E, D810E	Multiple endocrine neoplasia, type 2	VCV000405535	10	43615615	10	43120167	405535	397477	rs1060500758	NC_000010.11:43120166:T:G	single nucleotide variant	missense variant	Uncertain significance	Sep 29, 2016	criteria provided, single submitter							
NM_020975.6(RET):c.2695G>A (p.Val899Ile)	RET	V504I, V557I, V560I, V753I, V803I, V856I, V569I, V645I, V767I, V416I, V657I, V811I, V464I, V555I, V600I, V724I, V854I, V899I	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001794846	10	43615616	10	43120168	1794846	1849055		NC_000010.11:43120167:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2699A>C (p.Tyr900Ser)	RET	Y505S, Y570S, Y646S, Y658S, Y725S, Y465S, Y855S, Y417S, Y556S, Y558S, Y601S, Y768S, Y804S, Y900S, Y561S, Y754S, Y812S, Y857S	Multiple endocrine neoplasia, type 2	VCV003008967	10	43615620	10	43120172	3008967	3158973		NC_000010.11:43120171:A:C	single nucleotide variant	missense variant	Uncertain significance	Dec 29, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2700T>C (p.Tyr900=)	RET		Multiple endocrine neoplasia, type 2|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome	VCV001103935	10	43615621	10	43120173	1103935	1098708	rs1185622721	NC_000010.11:43120172:T:C	single nucleotide variant	synonymous variant	Likely benign	Nov 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2705A>G (p.Glu902Gly)	RET	E467G, E507G, E563G, E648G, E727G, E857G, E660G, E770G, E806G, E859G, E558G, E756G, E419G, E560G, E572G, E603G, E814G, E902G	Multiple endocrine neoplasia, type 2	VCV002998526	10	43615626	10	43120178	2998526	3160118		NC_000010.11:43120177:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 17, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2705A>C (p.Glu902Ala)	RET	E648A, E902A, E814A, E859A, E560A, E563A, E727A, E756A, E770A, E507A, E660A, E806A, E857A, E419A, E467A, E558A, E572A, E603A	Multiple endocrine neoplasia, type 2	VCV001364129	10	43615626	10	43120178	1364129	1386068	rs2132963709	NC_000010.11:43120177:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 4, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2706G>A (p.Glu902=)	RET		Multiple endocrine neoplasia, type 2	VCV003645146	10	43615627	10	43120179	3645146	3783561		NC_000010.11:43120178:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 9, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2708A>G (p.Asp903Gly)	RET	D903G, D649G, D564G, D757G, D815G, D559G, D860G, D420G, D468G, D508G, D561G, D661G, D771G, D807G, D573G, D604G, D728G, D858G	Multiple endocrine neoplasia, type 2|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B|Hereditary cancer-predisposing syndrome	VCV000660190	10	43615629	10	43120181	660190	638926	rs1423488525	NC_000010.11:43120180:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2710T>G (p.Ser904Ala)	RET	S650A, S904A, S421A, S758A, S808A, S509A, S560A, S562A, S565A, S574A, S662A, S772A, S816A, S469A, S605A, S729A, S859A, S861A	Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2	VCV000665731	10	43615631	10	43120183	665731	638927	rs1588877711	NC_000010.11:43120182:T:G	single nucleotide variant	missense variant	Uncertain significance	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2711_2712delinsTG (p.Ser904Leu)	RET	S421L, S469L, S509L, S560L, S562L, S565L, S574L, S605L, S650L, S662L, S729L, S758L, S772L, S808L, S816L, S859L, S861L, S904L	Multiple endocrine neoplasia, type 2	VCV003072428	10	43615632 - 43615633	10	43120184 - 43120185	3072428	3230869		NC_000010.11:43120183:CC:TG	Indel	missense variant	Uncertain significance	Jul 10, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2711C>T (p.Ser904Phe)	RET	S650F, S421F, S662F, S816F, S469F, S562F, S574F, S808F, S509F, S560F, S565F, S729F, S758F, S772F, S861F, S605F, S859F	Multiple endocrine neoplasia type 2A|not provided	VCV000024963	10	43615632	10	43120184	24963	36304	rs267607011	NC_000010.11:43120183:C:T	single nucleotide variant	missense variant	Likely pathogenic	Nov 20, 2020	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2711C>G (p.Ser904Cys)	RET	S904C, S650C, S469C, S560C, S562C, S565C, S772C, S421C, S574C, S662C, S758C, S859C, S605C, S729C, S509C, S808C, S816C, S861C	Multiple endocrine neoplasia, type 2|not specified	VCV000024962	10	43615632	10	43120184	24962	36303	rs267607011	NC_000010.11:43120183:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 25, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.4(RET):c.[2410G>A;2711C>G]	RET	S904C, S650C, S469C, S560C, S562C, S565C, S772C, S421C, S574C, S662C, S758C, S859C, S605C, S729C, S509C, S808C, S816C, S861C, V804M, V550M, V321M, V460M, V672M, V759M, V369M, V409M, V462M, V658M, V708M, V465M, V505M, V629M, V716M, V474M, V562M, V761M	Multiple endocrine neoplasia type 2B	VCV000013945	10|10	43615632	10|10	43120184	13945	36303|28984	rs267607011|rs79658334	NC_000010.11:43120183:C:G|NC_000010.11:43119547:G:A	Haplotype	missense variant	Pathogenic	Jan 1, 2002	no assertion criteria provided							
NM_020975.6(RET):c.2712C>A (p.Ser904=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001558816	10	43615633	10	43120185	1558816	1563481	rs1800863	NC_000010.11:43120184:C:A	single nucleotide variant	synonymous variant	Likely benign	Sep 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2712C>G (p.Ser904=)	RET		not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A|not specified|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia, type 2|Pheochromocytoma|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1|Hirschsprung disease, susceptibility to, 1	VCV000024964	10	43615633	10	43120185	24964	36305	rs1800863	NC_000010.11:43120184:C:G	single nucleotide variant	synonymous variant	Benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2715C>A (p.Tyr905Ter)	RET	Y561*, Y606*, Y773*, Y809*, Y860*, Y422*, Y510*, Y563*, Y651*, Y663*, Y759*, Y817*, Y905*, Y575*, Y730*, Y470*, Y566*, Y862*	Multiple endocrine neoplasia, type 2	VCV003652177	10	43615636	10	43120188	3652177	3785457		NC_000010.11:43120187:C:A	single nucleotide variant	nonsense	Pathogenic	May 5, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2715C>T (p.Tyr905=)	RET		Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome	VCV000215913	10	43615636	10	43120188	215913	212790	rs755023496	NC_000010.11:43120187:C:T	single nucleotide variant	synonymous variant	Benign/Likely benign	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2716G>A (p.Val906Met)	RET	V906M, V652M, V423M, V664M, V810M, V818M, V567M, V607M, V760M, V562M, V774M, V861M, V471M, V511M, V564M, V576M, V731M, V863M	Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia type 2B|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|not provided|Multiple endocrine neoplasia, type 2	VCV000560867	10	43615637	10	43120189	560867	551871	rs200627072	NC_000010.11:43120188:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2718G>A (p.Val906=)	RET		Hereditary cancer-predisposing syndrome	VCV001795138	10	43615639	10	43120191	1795138	1849347		NC_000010.11:43120190:G:A	single nucleotide variant	synonymous variant	Likely benign	May 29, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.2718G>T (p.Val906=)	RET		Multiple endocrine neoplasia, type 2	VCV001651162	10	43615639	10	43120191	1651162	1578537	rs1369983912	NC_000010.11:43120190:G:T	single nucleotide variant	synonymous variant	Likely benign	Jun 8, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2719A>C (p.Lys907Gln)	RET	K907Q, K653Q, K424Q, K472Q, K565Q, K761Q, K819Q, K512Q, K563Q, K577Q, K608Q, K665Q, K732Q, K775Q, K811Q, K864Q, K568Q, K862Q	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000231958	10	43615640	10	43120192	231958	233794	rs377767430	NC_000010.11:43120191:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2720A>T (p.Lys907Met)	RET	K653M, K472M, K732M, K761M, K819M, K563M, K811M, K862M, K424M, K512M, K565M, K568M, K665M, K775M, K864M, K577M, K608M	Multiple endocrine neoplasia, type 2	VCV001406187	10	43615641	10	43120193	1406187	36307	rs377767431	NC_000010.11:43120192:A:T	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2721G>A (p.Lys907=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001795199	10	43615642	10	43120194	1795199	1853861		NC_000010.11:43120193:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2722A>C (p.Arg908=)	RET		Multiple endocrine neoplasia, type 2|not provided	VCV002762067	10	43615643	10	43120195	2762067	2930563		NC_000010.11:43120194:A:C	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 27, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2723G>A (p.Arg908Lys)	RET	R908K, R654K, R425K, R513K, R733K, R863K, R564K, R666K, R812K, R865K, R609K, R762K, R820K, R473K, R566K, R569K, R578K, R776K	Multiple endocrine neoplasia, type 2	VCV000477354	10	43615644	10	43120196	477354	460031	rs753156691	NC_000010.11:43120195:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 16, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2728C>G (p.Gln910Glu)	RET	Q656E, Q910E, Q568E, Q822E, Q865E, Q427E, Q566E, Q571E, Q580E, Q668E, Q814E, Q735E, Q764E, Q475E, Q515E, Q611E, Q778E, Q867E	Multiple endocrine neoplasia type 2B|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001009074	10	43615649	10	43120201	1009074	993821	rs1282729859	NC_000010.11:43120200:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2730+3G>A	RET		Multiple endocrine neoplasia, type 2	VCV003699244	10	43615654	10	43120206	3699244	3833422		NC_000010.11:43120205:G:A	single nucleotide variant	intron variant	Uncertain significance	Oct 13, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2730+4C>T	RET		not provided	VCV002501609	10	43615655	10	43120207	2501609	2524512		NC_000010.11:43120206:C:T	single nucleotide variant	intron variant	Uncertain significance	Nov 4, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2730+5C>T	RET		Multiple endocrine neoplasia, type 2	VCV000219889	10	43615656	10	43120208	219889	221975	rs864622296	NC_000010.11:43120207:C:T	single nucleotide variant	intron variant	Uncertain significance	Aug 19, 2015	criteria provided, single submitter							
NM_020975.6(RET):c.2730+6C>T	RET		Multiple endocrine neoplasia, type 2	VCV003387604	10	43615657	10	43120209	3387604	3546735		NC_000010.11:43120208:C:T	single nucleotide variant	intron variant	Uncertain significance	Aug 13, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2730+7A>T	RET		Multiple endocrine neoplasia, type 2	VCV002882757	10	43615658	10	43120210	2882757	3053066		NC_000010.11:43120209:A:T	single nucleotide variant	intron variant	Likely benign	Apr 27, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2730+12del	RET		Multiple endocrine neoplasia, type 2	VCV001152264	10	43615661	10	43120213	1152264	1141132	rs770024338	NC_000010.11:43120212:CCC:CC	Deletion	intron variant	Likely benign	Jul 23, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2730+11C>T	RET		Multiple endocrine neoplasia, type 2	VCV003610795	10	43615662	10	43120214	3610795	3748084		NC_000010.11:43120213:C:T	single nucleotide variant	intron variant	Likely benign	Sep 10, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2730+12C>T	RET		Multiple endocrine neoplasia, type 2|not specified	VCV001627862	10	43615663	10	43120215	1627862	1531080	rs372080924	NC_000010.11:43120214:C:T	single nucleotide variant	intron variant	Likely benign	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2730+13G>A	RET		Multiple endocrine neoplasia, type 2	VCV001571512	10	43615664	10	43120216	1571512	1572305	rs371761256	NC_000010.11:43120215:G:A	single nucleotide variant	intron variant	Likely benign	Sep 28, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2730+16G>T	RET		Multiple endocrine neoplasia, type 2	VCV002120462	10	43615667	10	43120219	2120462	2173182		NC_000010.11:43120218:G:T	single nucleotide variant	intron variant	Uncertain significance	Apr 22, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2730+17A>C	RET		Multiple endocrine neoplasia, type 2	VCV003644254	10	43615668	10	43120220	3644254	3765739		NC_000010.11:43120219:A:C	single nucleotide variant	intron variant	Likely benign	Mar 3, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2730+229T>C	RET		not provided	VCV000677754	10	43615880	10	43120432	677754	665142	rs3026768	NC_000010.11:43120431:T:C	single nucleotide variant	intron variant	Benign	Jun 12, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.2730+257C>T	RET		not provided	VCV001248996	10	43615908	10	43120460	1248996	1238087	rs2435353	NC_000010.11:43120459:C:T	single nucleotide variant	intron variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.2730+322C>T	RET		not provided	VCV001283127	10	43615973	10	43120525	1283127	1270836	rs3026769	NC_000010.11:43120524:C:T	single nucleotide variant	intron variant	Benign	Apr 16, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.2731-290A>G	RET		not provided	VCV001260135	10	43617104	10	43121656	1260135	1248345	rs2565202	NC_000010.11:43121655:A:G	single nucleotide variant	intron variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.2731-227C>G	RET		not provided	VCV000677755	10	43617167	10	43121719	677755	664795	rs3026771	NC_000010.11:43121718:C:G	single nucleotide variant	intron variant	Benign	Jun 12, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.2731-20T>C	RET		Multiple endocrine neoplasia, type 2	VCV001585029	10	43617374	10	43121926	1585029	1626964	rs571552488	NC_000010.11:43121925:T:C	single nucleotide variant	intron variant	Likely benign	Nov 16, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2731-18A>G	RET		Multiple endocrine neoplasia, type 2	VCV001570156	10	43617376	10	43121928	1570156	1623472	rs2132983528	NC_000010.11:43121927:A:G	single nucleotide variant	intron variant	Likely benign	Jun 4, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2731-15C>G	RET		Multiple endocrine neoplasia, type 2	VCV002024576	10	43617379	10	43121931	2024576	2077353		NC_000010.11:43121930:C:G	single nucleotide variant	intron variant	Likely benign	Jul 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2731-14C>T	RET		Multiple endocrine neoplasia, type 2	VCV001627129	10	43617380	10	43121932	1627129	1616154	rs1305296450	NC_000010.11:43121931:C:T	single nucleotide variant	intron variant	Likely benign	Jun 19, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2731-13A>G	RET		Multiple endocrine neoplasia, type 2	VCV001581984	10	43617381	10	43121933	1581984	1653945	rs1223648532	NC_000010.11:43121932:A:G	single nucleotide variant	intron variant	Likely benign	Jan 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2731-11C>T	RET		Multiple endocrine neoplasia, type 2	VCV002097022	10	43617383	10	43121935	2097022	2153631		NC_000010.11:43121934:C:T	single nucleotide variant	intron variant	Likely benign	Apr 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2731-11C>G	RET		Multiple endocrine neoplasia, type 2	VCV001638102	10	43617383	10	43121935	1638102	1560006	rs566489997	NC_000010.11:43121934:C:G	single nucleotide variant	intron variant	Likely benign	Jun 9, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2731-8_2731-6del	RET		Multiple endocrine neoplasia, type 2	VCV001543715	10	43617386 - 43617388	10	43121938 - 43121940	1543715	1557870	rs2132983658	NC_000010.11:43121937:CTC:	Deletion	intron variant	Likely benign	May 11, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2731-8C>G	RET		not provided|Multiple endocrine neoplasia, type 2	VCV000560868	10	43617386	10	43121938	560868	551872	rs1564499958	NC_000010.11:43121937:C:G	single nucleotide variant	intron variant	Likely benign	Jun 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2731-7T>G	RET		not provided	VCV003572303	10	43617387	10	43121939	3572303	3731203		NC_000010.11:43121938:T:G	single nucleotide variant	intron variant	Uncertain significance	Nov 22, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2731-7T>C	RET		Multiple endocrine neoplasia, type 2	VCV002109028	10	43617387	10	43121939	2109028	2170786		NC_000010.11:43121938:T:C	single nucleotide variant	intron variant	Likely benign	Oct 23, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2731-6C>T	RET		Multiple endocrine neoplasia, type 2	VCV002706997	10	43617388	10	43121940	2706997	2870570		NC_000010.11:43121939:C:T	single nucleotide variant	intron variant	Likely benign	Jan 2, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2731-5T>C	RET		Multiple endocrine neoplasia, type 2	VCV002074227	10	43617389	10	43121941	2074227	2141189		NC_000010.11:43121940:T:C	single nucleotide variant	intron variant	Likely benign	May 29, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2731-2A>G	RET		RET-related disorder	VCV002635087	10	43617392	10	43121944	2635087	2801988		NC_000010.11:43121943:A:G	single nucleotide variant	splice acceptor variant	Likely pathogenic	Dec 1, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2731G>T (p.Gly911Cys)	RET	G428C, G476C, G516C, G567C, G569C, G572C, G581C, G612C, G657C, G669C, G736C, G765C, G779C, G815C, G823C, G866C, G868C, G911C	Hereditary cancer-predisposing syndrome	VCV003227538	10	43617394	10	43121946	3227538	3390750		NC_000010.11:43121945:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2023	criteria provided, single submitter							
NM_020975.5(RET):c.2731-?_*(1_?)del	LOC130003710|RET		Multiple endocrine neoplasia, type 2	VCV000188371	10	43617394 - 43623718	10	43121946 - 43128270	188371	186114			Deletion		Uncertain significance	Dec 28, 2014	no assertion criteria provided							
NM_020975.6(RET):c.2734C>A (p.Arg912=)	RET		Hereditary cancer-predisposing syndrome	VCV001795319	10	43617397	10	43121949	1795319	1853980		NC_000010.11:43121948:C:A	single nucleotide variant	synonymous variant	Uncertain significance	Nov 19, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.2734C>T (p.Arg912Trp)	RET	R658W, R912W, R429W, R613W, R737W, R517W, R573W, R582W, R816W, R867W, R477W, R568W, R670W, R824W, R570W, R766W, R780W, R869W	Multiple endocrine neoplasia, type 2	VCV001054968	10	43617397	10	43121949	1054968	1046541	rs1838227061	NC_000010.11:43121948:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 13, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.2735G>A (p.Arg912Gln)	RET	R658Q, R573Q, R670Q, R780Q, R517Q, R570Q, R613Q, R867Q, R568Q, R582Q, R816Q, R869Q, R429Q, R477Q, R737Q, R766Q, R824Q	Hereditary cancer-predisposing syndrome	VCV003227539	10	43617398	10	43121950	3227539	36308	rs78347871	NC_000010.11:43121949:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 19, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2735G>T (p.Arg912Leu)	RET	R912L, R658L, R582L, R670L, R429L, R780L, R816L, R867L, R570L, R573L, R477L, R517L, R568L, R613L, R737L, R766L, R824L, R869L	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not provided	VCV000543737	10	43617398	10	43121950	543737	525315	rs78347871	NC_000010.11:43121949:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2735G>C (p.Arg912Pro)	RET	R912P, R658P, R573P, R582P, R613P, R766P, R867P, R869P, R429P, R670P, R780P, R477P, R517P, R570P, R737P, R816P, R568P, R824P	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000024968	10	43617398	10	43121950	24968	36309	rs78347871	NC_000010.11:43121949:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 14, 2020	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2736G>T (p.Arg912=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001795352	10	43617399	10	43121951	1795352	1854013		NC_000010.11:43121950:G:T	single nucleotide variant	synonymous variant	Likely benign	Jan 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2742A>C (p.Pro914=)	RET		Multiple endocrine neoplasia, type 2	VCV001104382	10	43617405	10	43121957	1104382	1098709	rs375963128	NC_000010.11:43121956:A:C	single nucleotide variant	synonymous variant	Likely benign	Feb 24, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2742A>G (p.Pro914=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia, type 2	VCV000241351	10	43617405	10	43121957	241351	240805	rs375963128	NC_000010.11:43121956:A:G	single nucleotide variant	synonymous variant	Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2748A>G (p.Lys916=)	RET		Multiple endocrine neoplasia, type 2	VCV003653177	10	43617411	10	43121963	3653177	3778566		NC_000010.11:43121962:A:G	single nucleotide variant	synonymous variant	Likely benign	May 13, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2748A>C (p.Lys916Asn)	RET	K433N, K481N, K521N, K572N, K574N, K577N, K586N, K617N, K662N, K674N, K741N, K770N, K784N, K820N, K828N, K871N, K873N, K916N	Multiple endocrine neoplasia, type 2	VCV003387605	10	43617411	10	43121963	3387605	3546736		NC_000010.11:43121962:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 10, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2752A>G (p.Met918Val)	RET	M918V, M664V, M483V, M588V, M743V, M822V, M574V, M619V, M772V, M786V, M875V, M435V, M576V, M579V, M676V, M873V, M523V, M830V	Multiple endocrine neoplasia type 2A|not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000038614	10	43617415	10	43121967	38614	47218	rs377767442	NC_000010.11:43121966:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2753T>C (p.Met918Thr)	RET	M918T, M664T, M579T, M676T, M772T, M786T, M875T, M830T, M873T, M483T, M574T, M588T, M743T, M822T, M435T, M576T, M619T, M523T	Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|not provided|Multiple endocrine neoplasia type 2B|Constipation|Thick vermilion border|Joint hypermobility|Hypertelorism|Tetralogy of Fallot|Hypothyroidism|Short stature|Gingival overgrowth|Medullary thyroid carcinoma|Hereditary cancer-predisposing syndrome|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2|not specified	VCV000013919	10	43617416	10	43121968	13919	28958	rs74799832	NC_000010.11:43121967:T:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2754G>A (p.Met918Ile)	RET	M918I, M664I, M743I, M579I, M588I, M619I, M435I, M576I, M830I, M875I, M676I, M772I, M786I, M873I, M483I, M523I, M574I, M822I	Multiple endocrine neoplasia, type 2	VCV001431378	10	43617417	10	43121969	1431378	1490677	rs753208054	NC_000010.11:43121968:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2755G>C (p.Ala919Pro)	RET	A919P, A665P, A620P, A677P, A744P, A787P, A575P, A577P, A580P, A589P, A831P, A436P, A773P, A484P, A524P, A823P, A874P, A876P	RET-related disorder|Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2	VCV000581770	10	43617418	10	43121970	581770	566297	rs1361265737	NC_000010.11:43121969:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2756C>A (p.Ala919Glu)	RET	A436E, A575E, A577E, A665E, A773E, A787E, A876E, A620E, A677E, A831E, A919E, A524E, A580E, A823E, A874E, A484E, A589E, A744E	Multiple endocrine neoplasia, type 2	VCV002754261	10	43617419	10	43121971	2754261	2916729		NC_000010.11:43121970:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 20, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2757A>G (p.Ala919=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001112610	10	43617420	10	43121972	1112610	1098710	rs1838227942	NC_000010.11:43121971:A:G	single nucleotide variant	synonymous variant	Likely benign	Oct 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2758A>G (p.Ile920Val)	RET	I920V, I666V, I437V, I576V, I590V, I788V, I875V, I485V, I578V, I621V, I678V, I774V, I824V, I832V, I525V, I581V, I745V, I877V	Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome	VCV000543746	10	43617421	10	43121973	543746	525164	rs527787676	NC_000010.11:43121972:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 28, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2759T>C (p.Ile920Thr)	RET	I581T, I590T, I877T, I920T, I525T, I678T, I788T, I437T, I576T, I578T, I621T, I774T, I832T, I875T, I485T, I666T, I745T, I824T	Hereditary cancer-predisposing syndrome	VCV001795647	10	43617422	10	43121974	1795647	1853006		NC_000010.11:43121973:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 1, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2760T>C (p.Ile920=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV003313688	10	43617423	10	43121975	3313688	3465418		NC_000010.11:43121974:T:C	single nucleotide variant	synonymous variant	Likely benign	Sep 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2765C>G (p.Ser922Cys)	RET	S580C, S623C, S578C, S879C, S439C, S487C, S592C, S747C, S776C, S790C, S826C, S527C, S583C, S668C, S680C, S834C, S877C, S922C	Hereditary cancer-predisposing syndrome	VCV002561478	10	43617428	10	43121980	2561478	2728244		NC_000010.11:43121979:C:G	single nucleotide variant	missense variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2765C>T (p.Ser922Phe)	RET	S668F, S922F, S487F, S623F, S776F, S826F, S834F, S439F, S527F, S680F, S747F, S790F, S578F, S580F, S583F, S592F, S877F, S879F	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001013765	10	43617428	10	43121980	1013765	1009000	rs377767432	NC_000010.11:43121979:C:T	single nucleotide variant	missense variant	Uncertain significance	May 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2765C>A (p.Ser922Tyr)	RET	S668Y, S439Y, S527Y, S580Y, S776Y, S834Y, S583Y, S747Y, S487Y, S623Y, S680Y, S578Y, S592Y, S790Y, S826Y, S877Y, S879Y	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2	VCV000024969	10	43617428	10	43121980	24969	36310	rs377767432	NC_000010.11:43121979:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 7, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2771T>A (p.Phe924Tyr)	RET	F670Y, F924Y, F529Y, F585Y, F749Y, F879Y, F582Y, F594Y, F625Y, F828Y, F881Y, F778Y, F792Y, F441Y, F489Y, F580Y, F682Y, F836Y	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1	VCV000857380	10	43617434	10	43121986	857380	836865	rs1838228352	NC_000010.11:43121985:T:A	single nucleotide variant	missense variant	Uncertain significance	Apr 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2776C>A (p.His926Asn)	RET	H584N, H443N, H531N, H627N, H672N, H596N, H830N, H838N, H491N, H582N, H587N, H684N, H751N, H780N, H794N, H881N, H883N, H926N	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002561467	10	43617439	10	43121991	2561467	2728233		NC_000010.11:43121990:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2776C>T (p.His926Tyr)	RET	H926Y, H672Y, H582Y, H584Y, H587Y, H596Y, H684Y, H883Y, H491Y, H531Y, H627Y, H751Y, H780Y, H830Y, H838Y, H443Y, H794Y, H881Y	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	VCV000578321	10	43617439	10	43121991	578321	566298	rs774215008	NC_000010.11:43121990:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2776C>G (p.His926Asp)	RET	H926D, H672D, H627D, H684D, H838D, H531D, H582D, H584D, H780D, H881D, H443D, H491D, H587D, H596D, H794D, H883D, H751D, H830D	Hereditary cancer-predisposing syndrome|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia, type 2|not provided|Multiple endocrine neoplasia type 2A	VCV000216721	10	43617439	10	43121991	216721	212791	rs774215008	NC_000010.11:43121990:C:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 31, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2778T>G (p.His926Gln)	RET	H672Q, H926Q, H443Q, H596Q, H684Q, H881Q, H883Q, H531Q, H582Q, H587Q, H751Q, H780Q, H830Q, H838Q, H491Q, H584Q, H627Q, H794Q	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000956979	10	43617441	10	43121993	956979	946897	rs1838228562	NC_000010.11:43121992:T:G	single nucleotide variant	missense variant	Uncertain significance	Apr 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2779A>C (p.Ile927Leu)	RET	I673L, I927L, I585L, I588L, I752L, I781L, I831L, I444L, I492L, I583L, I839L, I884L, I532L, I597L, I628L, I685L, I795L, I882L	Multiple endocrine neoplasia, type 2	VCV001021079	10	43617442	10	43121994	1021079	1009001	rs893151989	NC_000010.11:43121993:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 19, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2780del (p.Ile927fs)	RET	I444fs, I492fs, I532fs, I583fs, I585fs, I588fs, I597fs, I628fs, I673fs, I685fs, I752fs, I781fs, I795fs, I831fs, I839fs, I882fs, I884fs, I927fs	Hirschsprung disease, susceptibility to, 1	VCV003065254	10	43617443	10	43121995	3065254	3225277		NC_000010.11:43121994:T:	Deletion	frameshift variant	Likely pathogenic	Mar 26, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2781C>T (p.Ile927=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002454145	10	43617444	10	43121996	2454145	2424034		NC_000010.11:43121995:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2781C>G (p.Ile927Met)	RET	I673M, I927M, I583M, I585M, I781M, I882M, I884M, I628M, I839M, I444M, I532M, I588M, I752M, I492M, I597M, I685M, I795M, I831M	not specified|Multiple endocrine neoplasia, type 2	VCV001337120	10	43617444	10	43121996	1337120	1328130	rs1838228721	NC_000010.11:43121995:C:G	single nucleotide variant	missense variant	Uncertain significance	Feb 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2783A>G (p.Tyr928Cys)	RET	Y445C, Y493C, Y533C, Y584C, Y586C, Y589C, Y598C, Y629C, Y674C, Y686C, Y753C, Y782C, Y796C, Y832C, Y840C, Y883C, Y885C, Y928C	Hereditary cancer-predisposing syndrome	VCV003227541	10	43617446	10	43121998	3227541	3390752		NC_000010.11:43121997:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 15, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2784C>T (p.Tyr928=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000705326	10	43617447	10	43121999	705326	692841	rs779594537	NC_000010.11:43121998:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2787C>T (p.Thr929=)	RET		Multiple endocrine neoplasia, type 2	VCV001601875	10	43617450	10	43122002	1601875	1633001	rs747648232	NC_000010.11:43122001:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 30, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2787C>A (p.Thr929=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001125636	10	43617450	10	43122002	1125636	1120279	rs747648232	NC_000010.11:43122001:C:A	single nucleotide variant	synonymous variant	Likely benign	Apr 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2788A>G (p.Thr930Ala)	RET	T495A, T586A, T798A, T842A, T535A, T631A, T676A, T885A, T930A, T588A, T755A, T447A, T591A, T600A, T688A, T784A, T834A, T887A	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002812458	10	43617451	10	43122003	2812458	2965850		NC_000010.11:43122002:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2789C>G (p.Thr930Arg)	RET	T591R, T842R, T586R, T600R, T688R, T784R, T798R, T887R, T495R, T535R, T588R, T676R, T447R, T631R, T755R, T834R, T885R, T930R	Multiple endocrine neoplasia, type 2	VCV003659758	10	43617452	10	43122004	3659758	3800706		NC_000010.11:43122003:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 17, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2789C>T (p.Thr930Met)	RET	T676M, T930M, T447M, T588M, T755M, T631M, T688M, T887M, T535M, T586M, T600M, T842M, T885M, T495M, T591M, T784M, T798M, T834M	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001035325	10	43617452	10	43122004	1035325	1029547	rs1838228966	NC_000010.11:43122003:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2790G>T (p.Thr930=)	RET		Hereditary cancer-predisposing syndrome	VCV001796047	10	43617453	10	43122005	1796047	1853406		NC_000010.11:43122004:G:T	single nucleotide variant	synonymous variant	Likely benign	Dec 15, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2790G>C (p.Thr930=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001540424	10	43617453	10	43122005	1540424	1545041	rs746599792	NC_000010.11:43122004:G:C	single nucleotide variant	synonymous variant	Likely benign	May 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2790G>A (p.Thr930=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A	VCV000486323	10	43617453	10	43122005	486323	475296	rs746599792	NC_000010.11:43122004:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2791C>A (p.Gln931Lys)	LOC130003710|RET	Q536K, Q587K, Q632K, Q677K, Q785K, Q496K, Q756K, Q799K, Q835K, Q888K, Q448K, Q589K, Q689K, Q843K, Q886K, Q931K, Q592K, Q601K	Multiple endocrine neoplasia, type 2	VCV002723047	10	43617454	10	43122006	2723047	2888273		NC_000010.11:43122005:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 10, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2799T>C (p.Asp933=)	LOC130003710|RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001796116	10	43617462	10	43122014	1796116	1852551		NC_000010.11:43122013:T:C	single nucleotide variant	synonymous variant	Likely benign	Feb 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2800G>A (p.Val934Ile)	LOC130003710|RET	V451I, V499I, V539I, V590I, V592I, V595I, V604I, V635I, V680I, V692I, V759I, V788I, V802I, V838I, V846I, V889I, V891I, V934I	Hereditary cancer-predisposing syndrome|not provided	VCV003026657	10	43617463	10	43122015	3026657	3186967		NC_000010.11:43122014:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2801+3A>G	LOC130003710|RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001395989	10	43617467	10	43122019	1395989	1350768	rs768284486	NC_000010.11:43122018:A:G	single nucleotide variant	intron variant	Uncertain significance	May 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2801+8_2801+9del	LOC130003710|RET		Multiple endocrine neoplasia, type 2	VCV000798629	10	43617469 - 43617470	10	43122021 - 43122022	798629	787586	rs1445588303	NC_000010.11:43122020:GTGTG:GTG	Microsatellite	intron variant	Likely benign	Nov 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2801+7G>T	LOC130003710|RET		Multiple endocrine neoplasia, type 2	VCV002733686	10	43617471	10	43122023	2733686	2898021		NC_000010.11:43122022:G:T	single nucleotide variant	intron variant	Likely benign	Jun 30, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2801+7G>A	LOC130003710|RET		Multiple endocrine neoplasia, type 2	VCV000762818	10	43617471	10	43122023	762818	775485	rs1588878699	NC_000010.11:43122022:G:A	single nucleotide variant	intron variant	Likely benign	Apr 19, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.2801+8T>C	LOC130003710|RET		Multiple endocrine neoplasia, type 2	VCV001661821	10	43617472	10	43122024	1661821	1608182	rs2132987232	NC_000010.11:43122023:T:C	single nucleotide variant	intron variant	Likely benign	Dec 15, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.2801+11del	LOC130003710|RET		Multiple endocrine neoplasia, type 2	VCV001655052	10	43617473	10	43122025	1655052	1549625	rs2132987306	NC_000010.11:43122024:GGG:GG	Deletion	intron variant	Likely benign	Mar 31, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2801+9G>A	LOC130003710|RET		Multiple endocrine neoplasia, type 2	VCV000477355	10	43617473	10	43122025	477355	460320	rs780912886	NC_000010.11:43122024:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	May 6, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2801+12T>C	LOC130003710|RET		Multiple endocrine neoplasia, type 2	VCV002870705	10	43617476	10	43122028	2870705	3027885		NC_000010.11:43122027:T:C	single nucleotide variant	intron variant	Likely benign	Jun 16, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2801+13G>A	LOC130003710|RET		Multiple endocrine neoplasia, type 2	VCV001565027	10	43617477	10	43122029	1565027	1567981	rs2132987373	NC_000010.11:43122028:G:A	single nucleotide variant	intron variant	Likely benign	Jun 9, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2801+15T>C	LOC130003710|RET		Multiple endocrine neoplasia, type 2	VCV002818431	10	43617479	10	43122031	2818431	2984646		NC_000010.11:43122030:T:C	single nucleotide variant	intron variant	Likely benign	Oct 22, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2801+17C>T	LOC130003710|RET		Multiple endocrine neoplasia, type 2|not provided	VCV001319672	10	43617481	10	43122033	1319672	1309923	rs2132987446	NC_000010.11:43122032:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jul 28, 2023	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2801+19C>A	LOC130003710|RET		Multiple endocrine neoplasia, type 2	VCV002741884	10	43617483	10	43122035	2741884	2906530		NC_000010.11:43122034:C:A	single nucleotide variant	intron variant	Likely benign	Nov 10, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2801+19C>G	LOC130003710|RET		Multiple endocrine neoplasia, type 2	VCV002153627	10	43617483	10	43122035	2153627	1882489		NC_000010.11:43122034:C:G	single nucleotide variant	intron variant	Likely benign	May 15, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2801+19C>T	LOC130003710|RET		Multiple endocrine neoplasia, type 2	VCV002005044	10	43617483	10	43122035	2005044	2055672		NC_000010.11:43122034:C:T	single nucleotide variant	intron variant	Likely benign	Jun 12, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2801+54A>T	RET		not provided	VCV001293634	10	43617518	10	43122070	1293634	1283436	rs3026772	NC_000010.11:43122069:A:T	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2801+72G>A	RET		not provided	VCV001290908	10	43617536	10	43122088	1290908	1280736	rs3026773	NC_000010.11:43122087:G:A	single nucleotide variant	intron variant	Benign	Mar 3, 2015	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2801+225C>T	RET		not provided	VCV001201057	10	43617689	10	43122241	1201057	1191060	rs7923702	NC_000010.11:43122240:C:T	single nucleotide variant	intron variant	Likely benign	Jun 23, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.2801+243G>C	RET		not provided	VCV000677749	10	43617707	10	43122259	677749	664799	rs3026774	NC_000010.11:43122258:G:C	single nucleotide variant	intron variant	Likely benign	Jun 15, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.2802-20_2802-19delinsTT	RET		Multiple endocrine neoplasia, type 2	VCV001555476	10	43619099 - 43619100	10	43123651 - 43123652	1555476	1550181	rs2133003390	NC_000010.11:43123650:GG:TT	Indel	intron variant	Likely benign	Apr 18, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2802-19_2802-18insC	RET		Multiple endocrine neoplasia, type 2	VCV002757179	10	43619100 - 43619101	10	43123652 - 43123653	2757179	2920950		NC_000010.11:43123652::C	Insertion	intron variant	Likely benign	Sep 6, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2802-19G>A	RET		Multiple endocrine neoplasia, type 2	VCV001599049	10	43619100	10	43123652	1599049	1544486	rs765569833	NC_000010.11:43123651:G:A	single nucleotide variant	intron variant	Benign	Jan 17, 2025	criteria provided, single submitter							
NM_020975.6(RET):c.2802-17C>A	RET		Multiple endocrine neoplasia, type 2	VCV002710284	10	43619102	10	43123654	2710284	2871308		NC_000010.11:43123653:C:A	single nucleotide variant	intron variant	Likely benign	Jan 19, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2802-17C>T	RET		Multiple endocrine neoplasia, type 2	VCV001664427	10	43619102	10	43123654	1664427	1654596	rs750812195	NC_000010.11:43123653:C:T	single nucleotide variant	intron variant	Likely benign	Jan 12, 2025	criteria provided, single submitter							
NM_020975.6(RET):c.2802-17C>G	RET		Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2	VCV001611118	10	43619102	10	43123654	1611118	1640194	rs750812195	NC_000010.11:43123653:C:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Feb 12, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2802-16C>T	RET		Multiple endocrine neoplasia, type 2	VCV003725942	10	43619103	10	43123655	3725942	3857850		NC_000010.11:43123654:C:T	single nucleotide variant	intron variant	Likely benign	Nov 24, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2802-13del	RET		Multiple endocrine neoplasia, type 2	VCV002133298	10	43619104	10	43123656	2133298	2189987		NC_000010.11:43123655:TTT:TT	Deletion	intron variant	Likely benign	Jun 3, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2802-11A>T	RET		Multiple endocrine neoplasia, type 2|not specified	VCV001337176	10	43619108	10	43123660	1337176	1328186	rs1220802134	NC_000010.11:43123659:A:T	single nucleotide variant	intron variant	Likely benign	Jul 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2802-10CT[2]	RET		Multiple endocrine neoplasia, type 2	VCV002061403	10	43619109 - 43619110	10	43123661 - 43123662	2061403	2124095		NC_000010.11:43123660:CTCTCT:CTCT	Microsatellite	intron variant	Likely benign	Dec 27, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2802-10C>T	RET		Multiple endocrine neoplasia, type 2	VCV001918498	10	43619109	10	43123661	1918498	1974825		NC_000010.11:43123660:C:T	single nucleotide variant	intron variant	Likely benign	Feb 28, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2802-9T>G	RET		Multiple endocrine neoplasia, type 2	VCV000640762	10	43619110	10	43123662	640762	652032	rs1588879476	NC_000010.11:43123661:T:G	single nucleotide variant	intron variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2802-8C>T	RET		Multiple endocrine neoplasia, type 2	VCV003069308	10	43619111	10	43123663	3069308	3229935		NC_000010.11:43123662:C:T	single nucleotide variant	intron variant	Likely benign	Dec 2, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2802-8C>G	RET		Multiple endocrine neoplasia, type 2	VCV001569412	10	43619111	10	43123663	1569412	1603957	rs2133003582	NC_000010.11:43123662:C:G	single nucleotide variant	intron variant	Likely benign	Jun 30, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2802-7T>A	RET		Multiple endocrine neoplasia, type 2	VCV001422691	10	43619112	10	43123664	1422691	1412585	rs1838266905	NC_000010.11:43123663:T:A	single nucleotide variant	intron variant	Likely benign	Feb 17, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2802-4G>A	RET		Multiple endocrine neoplasia, type 2	VCV002099204	10	43619115	10	43123667	2099204	2150525		NC_000010.11:43123666:G:A	single nucleotide variant	intron variant	Likely benign	Feb 19, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2802-4G>C	RET		Multiple endocrine neoplasia, type 2	VCV001572331	10	43619115	10	43123667	1572331	1538400	rs878855061	NC_000010.11:43123666:G:C	single nucleotide variant	intron variant	Likely benign	Jul 17, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2802-4G>T	RET		Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome	VCV000241352	10	43619115	10	43123667	241352	240806	rs878855061	NC_000010.11:43123666:G:T	single nucleotide variant	intron variant	Likely benign	Jan 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2802-3C>T	RET		Multiple endocrine neoplasia, type 2	VCV003074979	10	43619116	10	43123668	3074979	3234631		NC_000010.11:43123667:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Aug 15, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2802-3C>A	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000821834	10	43619116	10	43123668	821834	815425	rs754733091	NC_000010.11:43123667:C:A	single nucleotide variant	intron variant	Uncertain significance	Feb 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2802A>T (p.Val934=)	RET		Multiple endocrine neoplasia, type 2	VCV001392049	10	43619119	10	43123671	1392049	1409390	rs2133003717	NC_000010.11:43123670:A:T	single nucleotide variant	synonymous variant	Uncertain significance	Nov 8, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2814T>C (p.Gly938=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001648699	10	43619131	10	43123683	1648699	1600852	rs1838267124	NC_000010.11:43123682:T:C	single nucleotide variant	synonymous variant	Likely benign	Dec 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2815G>A (p.Val939Ile)	RET	V939I, V685I, V544I, V597I, V600I, V640I, V456I, V595I, V697I, V793I, V851I, V609I, V894I, V896I, V504I, V764I, V807I, V843I	Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2	VCV000486347	10	43619132	10	43123684	486347	475073	rs1554819950	NC_000010.11:43123683:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2817C>T (p.Val939=)	RET		Multiple endocrine neoplasia, type 2	VCV001584404	10	43619134	10	43123686	1584404	1592041	rs2133003827	NC_000010.11:43123685:C:T	single nucleotide variant	synonymous variant	Likely benign	May 2, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2818C>T (p.Leu940=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001796396	10	43619135	10	43123687	1796396	1852831		NC_000010.11:43123686:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2819T>C (p.Leu940Pro)	RET	L641P, L686P, L808P, L852P, L895P, L940P, L596P, L610P, L698P, L897P, L457P, L598P, L765P, L844P, L505P, L545P, L601P, L794P	Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A	VCV003595029	10	43619136	10	43123688	3595029	3722760		NC_000010.11:43123687:T:C	single nucleotide variant	missense variant	Uncertain significance	Apr 7, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2822T>C (p.Leu941Pro)	RET	L766P, L809P, L845P, L599P, L642P, L898P, L458P, L506P, L546P, L597P, L602P, L687P, L795P, L853P, L896P, L941P, L611P, L699P	Multiple endocrine neoplasia, type 2	VCV002821694	10	43619139	10	43123691	2821694	2985347		NC_000010.11:43123690:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 17, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2823G>A (p.Leu941=)	RET		Multiple endocrine neoplasia, type 2	VCV001669388	10	43619140	10	43123692	1669388	1665642	rs747696868	NC_000010.11:43123691:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 16, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2829G>A (p.Glu943=)	RET		Hereditary cancer-predisposing syndrome	VCV003227542	10	43619146	10	43123698	3227542	3390753		NC_000010.11:43123697:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 2, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2830A>C (p.Ile944Leu)	RET	I600L, I614L, I702L, I899L, I901L, I509L, I549L, I645L, I812L, I848L, I944L, I461L, I602L, I690L, I798L, I605L, I769L, I856L	Multiple endocrine neoplasia, type 2	VCV003648608	10	43619147	10	43123699	3648608	3784465		NC_000010.11:43123698:A:C	single nucleotide variant	missense variant	Uncertain significance	Apr 3, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2831T>G (p.Ile944Ser)	RET	I944S, I690S, I702S, I798S, I812S, I856S, I600S, I769S, I901S, I614S, I645S, I848S, I899S, I461S, I509S, I549S, I602S, I605S	Hereditary cancer-predisposing syndrome	VCV002568340	10	43619148	10	43123700	2568340	197380	rs794728686	NC_000010.11:43123699:T:G	single nucleotide variant	missense variant	Uncertain significance	Apr 25, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2832C>A (p.Ile944=)	RET		Hereditary cancer-predisposing syndrome	VCV002568369	10	43619149	10	43123701	2568369	2734905		NC_000010.11:43123700:C:A	single nucleotide variant	synonymous variant	Likely benign	May 21, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2832C>T (p.Ile944=)	RET		Multiple endocrine neoplasia, type 2|not provided|Hereditary cancer-predisposing syndrome	VCV001595845	10	43619149	10	43123701	1595845	1569421	rs755606269	NC_000010.11:43123700:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2832C>G (p.Ile944Met)	RET	I944M, I690M, I509M, I602M, I645M, I901M, I600M, I769M, I798M, I812M, I461M, I605M, I614M, I702M, I899M, I549M, I848M, I856M	not provided|Multiple endocrine neoplasia, type 2	VCV000618966	10	43619149	10	43123701	618966	610366	rs755606269	NC_000010.11:43123700:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2833G>T (p.Val945Leu)	RET	V462L, V691L, V849L, V900L, V550L, V603L, V606L, V799L, V857L, V902L, V945L, V615L, V646L, V770L, V813L, V510L, V601L, V703L	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001796618	10	43619150	10	43123702	1796618	1855193		NC_000010.11:43123701:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2833G>A (p.Val945Met)	RET	V945M, V691M, V510M, V603M, V606M, V703M, V799M, V849M, V902M, V550M, V601M, V646M, V857M, V615M, V770M, V900M, V462M, V813M	Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome	VCV000136113	10	43619150	10	43123702	136113	139825	rs587780811	NC_000010.11:43123701:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2834T>G (p.Val945Gly)	RET	V462G, V550G, V849G, V945G, V601G, V606G, V615G, V770G, V510G, V691G, V703G, V799G, V857G, V900G, V902G, V603G, V646G, V813G	Hereditary cancer-predisposing syndrome	VCV003432302	10	43619151	10	43123703	3432302	3593498		NC_000010.11:43123702:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 2, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2834T>C (p.Val945Ala)	RET	V945A, V691A, V462A, V510A, V601A, V603A, V646A, V799A, V857A, V703A, V849A, V606A, V615A, V900A, V902A, V550A, V770A, V813A	Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A	VCV000584749	10	43619151	10	43123703	584749	575805	rs1408196943	NC_000010.11:43123702:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2835G>C (p.Val945=)	RET		Hereditary cancer-predisposing syndrome	VCV001796636	10	43619152	10	43123704	1796636	1855211		NC_000010.11:43123703:G:C	single nucleotide variant	synonymous variant	Likely benign	Jun 26, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.2839del (p.Thr946_Leu947insTer)	RET		not provided	VCV000201140	10	43619154	10	43123706	201140	197382	rs794728691	NC_000010.11:43123705:CCC:CC	Deletion	frameshift variant|nonsense	Pathogenic	Jun 10, 2013	criteria provided, single submitter							
NM_020975.6(RET):c.2837C>T (p.Thr946Ile)	RET	T946I, T692I, T551I, T607I, T800I, T901I, T602I, T616I, T647I, T771I, T858I, T463I, T604I, T903I, T511I, T704I, T814I, T850I	not provided	VCV000201133	10	43619154	10	43123706	201133	197381	rs794728687	NC_000010.11:43123705:C:T	single nucleotide variant	missense variant	Likely pathogenic	Aug 30, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2838C>T (p.Thr946=)	RET		Hereditary cancer-predisposing syndrome	VCV003313741	10	43619155	10	43123707	3313741	3465471		NC_000010.11:43123706:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 1, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2838C>G (p.Thr946=)	RET		Multiple endocrine neoplasia, type 2	VCV002692889	10	43619155	10	43123707	2692889	2863716		NC_000010.11:43123706:C:G	single nucleotide variant	synonymous variant	Likely benign	Nov 3, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2839C>T (p.Leu947=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001132970	10	43619156	10	43123708	1132970	1120280	rs1027913092	NC_000010.11:43123707:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 26, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2841A>C (p.Leu947=)	RET		Hereditary cancer-predisposing syndrome	VCV002454155	10	43619158	10	43123710	2454155	2424044		NC_000010.11:43123709:A:C	single nucleotide variant	synonymous variant	Likely benign	Mar 12, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2846del (p.Gly949fs)	RET	G949fs, G695fs	not provided	VCV000201137	10	43619159	10	43123711	201137	197383	rs794728689	NC_000010.11:43123710:GGGGG:GGGG	Deletion	frameshift variant	Pathogenic	Jan 17, 2017	criteria provided, single submitter							
NM_020975.6(RET):c.2843G>C (p.Gly948Ala)	RET	G465A, G513A, G618A, G706A, G773A, G816A, G948A, G604A, G852A, G553A, G606A, G609A, G802A, G903A, G905A, G649A, G694A, G860A	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002085879	10	43619160	10	43123712	2085879	2133468		NC_000010.11:43123711:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2844G>A (p.Gly948=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001602076	10	43619161	10	43123713	1602076	1633202	rs749196396	NC_000010.11:43123712:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2845G>A (p.Gly949Arg)	RET	G466R, G514R, G554R, G605R, G607R, G610R, G619R, G650R, G695R, G707R, G774R, G803R, G817R, G853R, G861R, G904R, G906R, G949R	not provided	VCV003369388	10	43619162	10	43123714	3369388	3528579		NC_000010.11:43123713:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 20, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2846G>T (p.Gly949Val)	RET	G466V, G514V, G554V, G605V, G607V, G610V, G619V, G650V, G695V, G707V, G774V, G803V, G817V, G853V, G861V, G904V, G906V, G949V	Multiple endocrine neoplasia, type 2	VCV001720423	10	43619163	10	43123715	1720423	1776605		NC_000010.11:43123714:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 23, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2847A>G (p.Gly949=)	RET		Hirschsprung Disease, Dominant|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia|Pheochromocytoma|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A	VCV000299900	10	43619164	10	43123716	299900	310292	rs886046989	NC_000010.11:43123715:A:G	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Nov 26, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2848A>C (p.Asn950His)	RET	N611H, N620H, N905H, N950H, N606H, N651H, N696H, N804H, N818H, N854H, N907H, N467H, N515H, N555H, N708H, N775H, N608H, N862H	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002050341	10	43619165	10	43123717	2050341	2104344		NC_000010.11:43123716:A:C	single nucleotide variant	missense variant	Uncertain significance	Jan 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2849A>G (p.Asn950Ser)	RET	N818S, N854S, N611S, N708S, N905S, N907S, N608S, N620S, N651S, N696S, N804S, N515S, N606S, N862S, N467S, N555S, N775S, N950S	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV003313746	10	43619166	10	43123718	3313746	3465476		NC_000010.11:43123717:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2853del (p.Tyr952fs)	RET	Y469fs, Y517fs, Y557fs, Y608fs, Y610fs, Y613fs, Y622fs, Y653fs, Y698fs, Y710fs, Y777fs, Y806fs, Y820fs, Y856fs, Y864fs, Y907fs, Y909fs, Y952fs	RET-related disorder	VCV002630657	10	43619167	10	43123719	2630657	2796412		NC_000010.11:43123718:CCCC:CCC	Deletion	frameshift variant	Likely pathogenic	Sep 8, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2850C>T (p.Asn950=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001594798	10	43619167	10	43123719	1594798	1621922	rs2133004987	NC_000010.11:43123718:C:T	single nucleotide variant	synonymous variant	Likely benign	May 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2853C>G (p.Pro951=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002454149	10	43619170	10	43123722	2454149	2424038		NC_000010.11:43123721:C:G	single nucleotide variant	synonymous variant	Likely benign	Dec 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2859T>C (p.Pro953=)	RET		Hereditary cancer-predisposing syndrome	VCV003227543	10	43619176	10	43123728	3227543	3390754		NC_000010.11:43123727:T:C	single nucleotide variant	synonymous variant	Likely benign	Feb 16, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2859T>G (p.Pro953=)	RET		Multiple endocrine neoplasia, type 2	VCV002842743	10	43619176	10	43123728	2842743	2997449		NC_000010.11:43123727:T:G	single nucleotide variant	synonymous variant	Likely benign	Mar 3, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2862G>T (p.Gly954=)	RET		Hereditary cancer-predisposing syndrome	VCV003432250	10	43619179	10	43123731	3432250	3593446		NC_000010.11:43123730:G:T	single nucleotide variant	synonymous variant	Likely benign	Aug 28, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2862G>A (p.Gly954=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000413476	10	43619179	10	43123731	413476	397832	rs1060504036	NC_000010.11:43123730:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2865dup (p.Pro956fs)	RET	P956fs, P702fs	not provided|Multiple endocrine neoplasia, type 2	VCV000599634	10	43619180 - 43619181	10	43123732 - 43123733	599634	590970	rs1564500612	NC_000010.11:43123732:TT:TTT	Duplication	frameshift variant	Pathogenic	Sep 10, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2866C>T (p.Pro956Ser)	RET	P521S, P617S, P824S, P956S, P473S, P612S, P626S, P657S, P781S, P868S, P911S, P561S, P614S, P702S, P714S, P810S, P860S, P913S	Multiple endocrine neoplasia, type 2	VCV002171041	10	43619183	10	43123735	2171041	1903692		NC_000010.11:43123734:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 4, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2867C>T (p.Pro956Leu)	RET	P956L, P702L, P521L, P614L, P860L, P612L, P868L, P911L, P561L, P626L, P657L, P714L, P473L, P617L, P781L, P810L, P824L, P913L	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	VCV000841846	10	43619184	10	43123736	841846	836866	rs1838269153	NC_000010.11:43123735:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2870C>G (p.Pro957Arg)	RET	P474R, P522R, P562R, P613R, P615R, P618R, P627R, P658R, P703R, P715R, P782R, P811R, P825R, P861R, P869R, P912R, P914R, P957R	RET-related disorder	VCV002634001	10	43619187	10	43123739	2634001	2799327		NC_000010.11:43123738:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 2, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2870C>T (p.Pro957Leu)	RET	P957L, P703L, P562L, P613L, P627L, P825L, P869L, P522L, P658L, P861L, P615L, P715L, P782L, P912L, P914L, P474L, P618L, P811L	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1	VCV000543731	10	43619187	10	43123739	543731	525445	rs1259087541	NC_000010.11:43123738:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2871T>C (p.Pro957=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001077345	10	43619188	10	43123740	1077345	1077055	rs2133005496	NC_000010.11:43123739:T:C	single nucleotide variant	synonymous variant	Likely benign	Feb 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2872G>C (p.Glu958Gln)	RET	E619Q, E628Q, E704Q, E870Q, E913Q, E523Q, E812Q, E862Q, E958Q, E475Q, E563Q, E616Q, E716Q, E783Q, E826Q, E614Q, E659Q, E915Q	Multiple endocrine neoplasia, type 2	VCV002119281	10	43619189	10	43123741	2119281	2183627		NC_000010.11:43123740:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 29, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2874G>A (p.Glu958=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000761153	10	43619191	10	43123743	761153	767746	rs1588879531	NC_000010.11:43123742:G:A	single nucleotide variant	synonymous variant	Likely benign	May 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2875C>A (p.Arg959=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV003227544	10	43619192	10	43123744	3227544	3390755		NC_000010.11:43123743:C:A	single nucleotide variant	synonymous variant	Likely benign	Mar 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2875C>G (p.Arg959Gly)	RET	R476G, R615G, R629G, R959G, R564G, R617G, R620G, R705G, R717G, R784G, R813G, R660G, R827G, R863G, R524G, R871G, R914G, R916G	Multiple endocrine neoplasia, type 2|not provided|Hereditary cancer-predisposing syndrome	VCV002886843	10	43619192	10	43123744	2886843	3050888		NC_000010.11:43123743:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2875C>T (p.Arg959Trp)	RET	R959W, R705W, R476W, R617W, R620W, R827W, R524W, R615W, R629W, R784W, R813W, R863W, R871W, R564W, R660W, R717W, R914W, R916W	Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Hereditary cancer-predisposing syndrome|not provided	VCV000135180	10	43619192	10	43123744	135180	138919	rs587778658	NC_000010.11:43123743:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2876G>T (p.Arg959Leu)	RET	R476L, R524L, R717L, R784L, R813L, R863L, R916L, R617L, R629L, R660L, R827L, R564L, R914L, R615L, R620L, R705L, R871L, R959L	Hereditary cancer-predisposing syndrome	VCV003432266	10	43619193	10	43123745	3432266	3593462		NC_000010.11:43123744:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 19, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2876G>A (p.Arg959Gln)	RET	R959Q, R705Q, R629Q, R717Q, R813Q, R914Q, R476Q, R524Q, R827Q, R871Q, R916Q, R615Q, R863Q, R564Q, R617Q, R620Q, R660Q, R784Q	Multiple endocrine neoplasia|not provided|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Hirschsprung disease, susceptibility to, 1|Renal hypodysplasia/aplasia 1|Hereditary cancer-predisposing syndrome|Pheochromocytoma	VCV000299901	10	43619193	10	43123745	299901	322103	rs745650861	NC_000010.11:43123744:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2877G>T (p.Arg959=)	RET		Multiple endocrine neoplasia, type 2	VCV001653910	10	43619194	10	43123746	1653910	1614260	rs2133005808	NC_000010.11:43123745:G:T	single nucleotide variant	synonymous variant	Likely benign	Nov 5, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2880C>G (p.Leu960=)	RET		Hereditary cancer-predisposing syndrome	VCV003227545	10	43619197	10	43123749	3227545	3390756		NC_000010.11:43123748:C:G	single nucleotide variant	synonymous variant	Likely benign	Oct 1, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2880C>T (p.Leu960=)	RET		Multiple endocrine neoplasia, type 2	VCV000755228	10	43619197	10	43123749	755228	767747	rs1588879539	NC_000010.11:43123748:C:T	single nucleotide variant	synonymous variant	Likely benign	Apr 1, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2881T>C (p.Phe961Leu)	RET	F865L, F478L, F526L, F617L, F619L, F719L, F786L, F873L, F961L, F622L, F631L, F815L, F566L, F662L, F707L, F829L, F916L, F918L	Hereditary cancer-predisposing syndrome	VCV001797184	10	43619198	10	43123750	1797184	1855758		NC_000010.11:43123749:T:C	single nucleotide variant	missense variant	Uncertain significance	May 18, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2883C>T (p.Phe961=)	RET		Multiple endocrine neoplasia, type 2	VCV002025303	10	43619200	10	43123752	2025303	2084506		NC_000010.11:43123751:C:T	single nucleotide variant	synonymous variant	Likely benign	Sep 13, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2886C>T (p.Asn962=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000477356	10	43619203	10	43123755	477356	460032	rs772329940	NC_000010.11:43123754:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2887C>A (p.Leu963Ile)	RET	L963I, L709I, L624I, L817I, L918I, L633I, L664I, L788I, L831I, L875I, L528I, L619I, L621I, L721I, L867I, L480I, L568I, L920I	not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1	VCV000220609	10	43619204	10	43123756	220609	221976	rs864622603	NC_000010.11:43123755:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2888T>C (p.Leu963Pro)	RET	L480P, L528P, L568P, L619P, L621P, L624P, L633P, L664P, L709P, L721P, L788P, L817P, L831P, L867P, L875P, L918P, L920P, L963P	Hirschsprung disease, susceptibility to, 1	VCV003236357	10	43619205	10	43123757	3236357	3395477		NC_000010.11:43123756:T:C	single nucleotide variant	missense variant	Likely pathogenic	Sep 15, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2890C>G (p.Leu964Val)	RET	L710V, L964V, L529V, L569V, L665V, L789V, L868V, L919V, L481V, L634V, L818V, L876V, L620V, L625V, L722V, L832V, L622V, L921V	Multiple endocrine neoplasia, type 2	VCV001063321	10	43619207	10	43123759	1063321	1046542	rs533682776	NC_000010.11:43123758:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 23, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.2895G>A (p.Lys965=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002561475	10	43619212	10	43123764	2561475	2728241		NC_000010.11:43123763:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2895G>T (p.Lys965Asn)	RET	K666N, K723N, K482N, K530N, K877N, K920N, K626N, K635N, K869N, K570N, K621N, K623N, K711N, K790N, K819N, K833N, K922N, K965N	Hereditary cancer-predisposing syndrome	VCV002454137	10	43619212	10	43123764	2454137	2424026		NC_000010.11:43123763:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 12, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2897C>T (p.Thr966Ile)	RET	T966I, T712I, T483I, T667I, T724I, T878I, T921I, T622I, T627I, T531I, T571I, T624I, T636I, T791I, T834I, T923I, T820I, T870I	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000543738	10	43619214	10	43123766	543738	525446	rs760765930	NC_000010.11:43123765:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2898C>G (p.Thr966=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002898638	10	43619215	10	43123767	2898638	3060273		NC_000010.11:43123766:C:G	single nucleotide variant	synonymous variant	Likely benign	Feb 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2898C>A (p.Thr966=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001797368	10	43619215	10	43123767	1797368	1854286		NC_000010.11:43123766:C:A	single nucleotide variant	synonymous variant	Likely benign	May 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2898C>T (p.Thr966=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000241353	10	43619215	10	43123767	241353	240807	rs373693875	NC_000010.11:43123766:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2899G>A (p.Gly967Ser)	RET	G484S, G625S, G725S, G821S, G871S, G532S, G637S, G713S, G572S, G668S, G879S, G922S, G623S, G628S, G792S, G835S, G924S, G967S	Hereditary cancer-predisposing syndrome	VCV002562605	10	43619216	10	43123768	2562605	2717447		NC_000010.11:43123767:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 19, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2900G>A (p.Gly967Asp)	RET	G713D, G967D, G532D, G623D, G625D, G637D, G668D, G821D, G871D, G792D, G835D, G922D, G924D, G484D, G572D, G628D, G725D, G879D	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Familial medullary thyroid carcinoma	VCV001041774	10	43619217	10	43123769	1041774	1029548	rs1838270446	NC_000010.11:43123768:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2901C>T (p.Gly967=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001638470	10	43619218	10	43123770	1638470	1624156	rs2133006358	NC_000010.11:43123769:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2902C>T (p.His968Tyr)	RET	H638Y, H485Y, H533Y, H626Y, H925Y, H968Y, H629Y, H669Y, H726Y, H793Y, H822Y, H880Y, H573Y, H624Y, H714Y, H836Y, H872Y, H923Y	Hereditary cancer-predisposing syndrome	VCV003313725	10	43619219	10	43123771	3313725	3465455		NC_000010.11:43123770:C:T	single nucleotide variant	missense variant	Likely benign	Apr 22, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2904C>T (p.His968=)	RET		Hereditary cancer-predisposing syndrome	VCV003432243	10	43619221	10	43123773	3432243	3593439		NC_000010.11:43123772:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 7, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2905C>A (p.Arg969=)	RET		Hereditary cancer-predisposing syndrome	VCV003227546	10	43619222	10	43123774	3227546	3390757		NC_000010.11:43123773:C:A	single nucleotide variant	synonymous variant	Likely benign	Nov 11, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2905C>T (p.Arg969Trp)	RET	R486W, R534W, R574W, R625W, R627W, R630W, R639W, R670W, R715W, R727W, R794W, R823W, R837W, R873W, R881W, R924W, R926W, R969W	not provided	VCV001801002	10	43619222	10	43123774	1801002	1858290		NC_000010.11:43123773:C:T	single nucleotide variant	missense variant	Likely pathogenic	May 24, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2906G>A (p.Arg969Gln)	RET	R486Q, R794Q, R823Q, R837Q, R670Q, R727Q, R873Q, R924Q, R574Q, R627Q, R715Q, R926Q, R969Q, R534Q, R625Q, R630Q, R639Q, R881Q	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001980323	10	43619223	10	43123775	1980323	2042095		NC_000010.11:43123774:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2908A>T (p.Met970Leu)	RET	M631L, M640L, M671L, M716L, M874L, M925L, M927L, M487L, M575L, M626L, M795L, M824L, M970L, M628L, M728L, M838L, M535L, M882L	Multiple endocrine neoplasia, type 2	VCV003705310	10	43619225	10	43123777	3705310	3846089		NC_000010.11:43123776:A:T	single nucleotide variant	missense variant	Uncertain significance	Jul 4, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2909T>C (p.Met970Thr)	RET	M487T, M535T, M575T, M626T, M628T, M631T, M640T, M671T, M716T, M728T, M795T, M824T, M838T, M874T, M882T, M925T, M927T, M970T	RET-related disorder	VCV003349751	10	43619226	10	43123778	3349751	3508979		NC_000010.11:43123777:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 8, 2024	no assertion criteria provided							
NM_020975.6(RET):c.2913G>A (p.Glu971=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000233088	10	43619230	10	43123782	233088	233795	rs876660184	NC_000010.11:43123781:G:A	single nucleotide variant	synonymous variant	Likely benign	Apr 17, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2914A>C (p.Arg972=)	RET		Multiple endocrine neoplasia, type 2	VCV001612716	10	43619231	10	43123783	1612716	1601799	rs76534745	NC_000010.11:43123782:A:C	single nucleotide variant	synonymous variant	Likely benign	Apr 18, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2914A>G (p.Arg972Gly)	RET	R972G, R718G, R537G, R577G, R797G, R876G, R489G, R630G, R633G, R884G, R927G, R628G, R673G, R730G, R826G, R642G, R840G, R929G	Multiple endocrine neoplasia type 2A|Pheochromocytoma|Multiple endocrine neoplasia type 2B|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1	VCV000013922	10	43619231	10	43123783	13922	28961	rs76534745	NC_000010.11:43123782:A:G	single nucleotide variant	missense variant	Likely pathogenic	Mar 22, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2915G>A (p.Arg972Lys)	RET	R718K, R972K, R537K, R577K, R628K, R730K, R927K, R673K, R929K, R489K, R633K, R826K, R884K, R630K, R642K, R797K, R840K, R876K	not specified|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001337771	10	43619232	10	43123784	1337771	1328780	rs1384605415	NC_000010.11:43123783:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2916G>A (p.Arg972=)	RET		Hereditary cancer-predisposing syndrome	VCV001797631	10	43619233	10	43123785	1797631	1854549		NC_000010.11:43123784:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 12, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2919A>G (p.Pro973=)	RET		Hereditary cancer-predisposing syndrome	VCV003227547	10	43619236	10	43123788	3227547	3390758		NC_000010.11:43123787:A:G	single nucleotide variant	synonymous variant	Likely benign	Oct 27, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2922C>G (p.Asp974Glu)	RET	D644E, D720E, D878E, D974E, D491E, D632E, D675E, D931E, D539E, D630E, D635E, D799E, D842E, D886E, D579E, D732E, D828E, D929E	Hereditary cancer-predisposing syndrome	VCV001797725	10	43619239	10	43123791	1797725	1854642		NC_000010.11:43123790:C:G	single nucleotide variant	missense variant	Uncertain significance	Nov 29, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2922C>T (p.Asp974=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001621022	10	43619239	10	43123791	1621022	1615270	rs2133006784	NC_000010.11:43123790:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2923A>T (p.Asn975Tyr)	RET	N721Y, N975Y, N733Y, N879Y, N580Y, N843Y, N887Y, N932Y, N492Y, N540Y, N631Y, N676Y, N800Y, N930Y, N633Y, N636Y, N645Y, N829Y	not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000664667	10	43619240	10	43123792	664667	638928	rs1194221807	NC_000010.11:43123791:A:T	single nucleotide variant	missense variant	Uncertain significance	Jun 27, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2924A>T (p.Asn975Ile)	RET	N540I, N580I, N676I, N930I, N633I, N800I, N887I, N631I, N636I, N721I, N733I, N843I, N879I, N932I, N492I, N645I, N829I, N975I	Multiple endocrine neoplasia, type 2	VCV003648843	10	43619241	10	43123793	3648843	3784700		NC_000010.11:43123792:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 5, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2928C>T (p.Cys976=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001797765	10	43619245	10	43123797	1797765	1854681		NC_000010.11:43123796:C:T	single nucleotide variant	synonymous variant	Likely benign	Mar 11, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2929A>G (p.Ser977Gly)	RET	S542G, S638G, S735G, S802G, S889G, S977G, S582G, S633G, S678G, S845G, S934G, S635G, S881G, S494G, S647G, S723G, S831G, S932G	Hereditary cancer-predisposing syndrome	VCV001797772	10	43619246	10	43123798	1797772	1854688		NC_000010.11:43123797:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 17, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2930G>T (p.Ser977Ile)	RET	S831I, S932I, S633I, S635I, S494I, S542I, S638I, S647I, S678I, S723I, S735I, S845I, S582I, S802I, S881I, S889I, S934I, S977I	Hereditary cancer-predisposing syndrome	VCV001797815	10	43619247	10	43123799	1797815	1853434		NC_000010.11:43123798:G:T	single nucleotide variant	missense variant	Uncertain significance	May 26, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2930G>C (p.Ser977Thr)	RET	S635T, S647T, S678T, S831T, S889T, S934T, S542T, S633T, S932T, S494T, S638T, S723T, S735T, S881T, S977T, S582T, S802T, S845T	Hereditary cancer-predisposing syndrome	VCV001797813	10	43619247	10	43123799	1797813	1853432		NC_000010.11:43123798:G:C	single nucleotide variant	missense variant	Uncertain significance	May 17, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2931C>T (p.Ser977=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000579590	10	43619248	10	43123800	579590	563752	rs375414982	NC_000010.11:43123799:C:T	single nucleotide variant	synonymous variant	Uncertain significance	Nov 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2931C>G (p.Ser977Arg)	RET	S977R, S723R, S635R, S647R, S845R, S889R, S542R, S735R, S831R, S881R, S494R, S582R, S638R, S678R, S934R, S633R, S802R, S932R	Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|not provided	VCV000216722	10	43619248	10	43123800	216722	212792	rs375414982	NC_000010.11:43123799:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2932G>C (p.Glu978Gln)	RET	E583Q, E634Q, E933Q, E978Q, E639Q, E724Q, E803Q, E736Q, E935Q, E495Q, E543Q, E648Q, E679Q, E832Q, E846Q, E882Q, E890Q, E636Q	Multiple endocrine neoplasia, type 2	VCV002797784	10	43619249	10	43123801	2797784	2958904		NC_000010.11:43123800:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 30, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2932G>A (p.Glu978Lys)	RET	E978K, E724K, E636K, E639K, E648K, E495K, E832K, E935K, E583K, E634K, E679K, E803K, E882K, E890K, E543K, E736K, E846K, E933K	not provided|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome	VCV000405522	10	43619249	10	43123801	405522	397480	rs758800351	NC_000010.11:43123800:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Nov 4, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2934G>A (p.Glu978=)	RET		not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000477357	10	43619251	10	43123803	477357	459862	rs767306671	NC_000010.11:43123802:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 28, 2020	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2935G>A (p.Glu979Lys)	RET	E725K, E979K, E544K, E936K, E496K, E649K, E833K, E891K, E934K, E635K, E640K, E737K, E804K, E883K, E584K, E637K, E680K, E847K	not specified	VCV001337535	10	43619252	10	43123804	1337535	1328544	rs2133007152	NC_000010.11:43123803:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 3, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.2936A>G (p.Glu979Gly)	RET	E725G, E979G, E635G, E804G, E833G, E891G, E640G, E680G, E544G, E584G, E637G, E649G, E936G, E496G, E737G, E847G, E883G, E934G	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001015149	10	43619253	10	43123805	1015149	1009002	rs752352085	NC_000010.11:43123804:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2937G>A (p.Glu979=)	RET		Hereditary cancer-predisposing syndrome	VCV001797871	10	43619254	10	43123806	1797871	1853490		NC_000010.11:43123805:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 1, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2939T>C (p.Met980Thr)	RET	M545T, M636T, M834T, M884T, M641T, M738T, M848T, M937T, M980T, M638T, M681T, M805T, M935T, M497T, M585T, M650T, M726T, M892T	Multiple endocrine neoplasia, type 2	VCV003720930	10	43619256	10	43123808	3720930	3856732		NC_000010.11:43123807:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 24, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2939+4_2939+5del	RET		Multiple endocrine neoplasia, type 2	VCV002809866	10	43619259 - 43619260	10	43123811 - 43123812	2809866	2972235		NC_000010.11:43123810:GAG:G	Deletion	intron variant	Uncertain significance	Oct 27, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2939+3G>A	RET		Multiple endocrine neoplasia, type 2	VCV001508912	10	43619259	10	43123811	1508912	1452029	rs2133007253	NC_000010.11:43123810:G:A	single nucleotide variant	intron variant	Uncertain significance	Jan 12, 2025	criteria provided, single submitter							
NM_020975.6(RET):c.2939+3G>C	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001504178	10	43619259	10	43123811	1504178	1337054	rs2133007253	NC_000010.11:43123810:G:C	single nucleotide variant	intron variant	Uncertain significance	Sep 17, 2021	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2939+5G>A	RET		RET-related disorder	VCV002632146	10	43619261	10	43123813	2632146	2798778		NC_000010.11:43123812:G:A	single nucleotide variant	intron variant	Uncertain significance	Jun 7, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2939+10dup	RET		Multiple endocrine neoplasia, type 2	VCV002714217	10	43619262 - 43619263	10	43123814 - 43123815	2714217	2868755		NC_000010.11:43123814:GGGG:GGGGG	Duplication	intron variant	Benign	Jan 30, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2939+6C>T	RET		Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|not provided	VCV000216723	10	43619262	10	43123814	216723	212793	rs181245759	NC_000010.11:43123813:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 7, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2939+10del	RET		Multiple endocrine neoplasia, type 2	VCV000543763	10	43619263	10	43123815	543763	525644	rs1554819978	NC_000010.11:43123814:GGGG:GGG	Deletion	intron variant	Likely benign	May 1, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2939+7G>A	RET		Multiple endocrine neoplasia|Multiple endocrine neoplasia, type 2|Renal hypodysplasia/aplasia 1|not specified|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1	VCV000477358	10	43619263	10	43123815	477358	460325	rs374565577	NC_000010.11:43123814:G:A	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Aug 19, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2939+10G>C	RET		Multiple endocrine neoplasia, type 2	VCV001119528	10	43619266	10	43123818	1119528	1098711	rs2133007338	NC_000010.11:43123817:G:C	single nucleotide variant	intron variant	Likely benign	Nov 3, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.2939+12C>G	RET		Multiple endocrine neoplasia, type 2	VCV003690278	10	43619268	10	43123820	3690278	3820576		NC_000010.11:43123819:C:G	single nucleotide variant	intron variant	Likely benign	Dec 18, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2939+13T>C	RET		Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Multiple endocrine neoplasia, type 2	VCV001598128	10	43619269	10	43123821	1598128	1660734	rs149417158	NC_000010.11:43123820:T:C	single nucleotide variant	intron variant	Likely benign	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2939+16C>T	RET		Multiple endocrine neoplasia, type 2	VCV001648489	10	43619272	10	43123824	1648489	1600642	rs2133007408	NC_000010.11:43123823:C:T	single nucleotide variant	intron variant	Likely benign	May 13, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2939+20G>A	RET		Multiple endocrine neoplasia, type 2|not specified	VCV000383638	10	43619276	10	43123828	383638	371682	rs201756161	NC_000010.11:43123827:G:A	single nucleotide variant	intron variant	Likely benign	Jan 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2939+110del	RET		not provided	VCV001220093	10	43619361	10	43123913	1220093	1210069	rs201104591	NC_000010.11:43123912:GGGGGG:GGGGG	Deletion	intron variant	Likely benign	Mar 10, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.2939+258G>A	RET		not provided	VCV001195108	10	43619514	10	43124066	1195108	1184367	rs116380716	NC_000010.11:43124065:G:A	single nucleotide variant	intron variant	Likely benign	Apr 24, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.2939+286A>G	RET		not provided	VCV001208596	10	43619542	10	43124094	1208596	1198046	rs76718568	NC_000010.11:43124093:A:G	single nucleotide variant	intron variant	Likely benign	Jan 10, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.2940-252G>A	RET		not provided	VCV001237657	10	43620079	10	43124631	1237657	1229277	rs11238443	NC_000010.11:43124630:G:A	single nucleotide variant	intron variant	Benign	Apr 4, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.2940-197C>T	RET		not provided	VCV000677074	10	43620134	10	43124686	677074	664829	rs3026781	NC_000010.11:43124685:C:T	single nucleotide variant	intron variant	Benign	Jun 20, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.2940-45C>T	RET		not specified	VCV001697459	10	43620286	10	43124838	1697459	1689845	rs370072408	NC_000010.11:43124837:C:T	single nucleotide variant	intron variant	Likely benign	Aug 15, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2940-26A>C	RET		not provided	VCV002576108	10	43620305	10	43124857	2576108	2741005		NC_000010.11:43124856:A:C	single nucleotide variant	intron variant	Uncertain significance	Mar 29, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2940-20C>T	RET		Multiple endocrine neoplasia, type 2	VCV002778969	10	43620311	10	43124863	2778969	2940120		NC_000010.11:43124862:C:T	single nucleotide variant	intron variant	Likely benign	Mar 27, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2940-18G>A	RET		Multiple endocrine neoplasia, type 2	VCV002993365	10	43620313	10	43124865	2993365	3148504		NC_000010.11:43124864:G:A	single nucleotide variant	intron variant	Likely benign	Nov 17, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2940-13C>T	RET		Multiple endocrine neoplasia, type 2	VCV001614233	10	43620318	10	43124870	1614233	1612820	rs2133015664	NC_000010.11:43124869:C:T	single nucleotide variant	intron variant	Likely benign	Dec 22, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2940-12T>C	RET		Multiple endocrine neoplasia, type 2	VCV001990534	10	43620319	10	43124871	1990534	2044473		NC_000010.11:43124870:T:C	single nucleotide variant	intron variant	Likely benign	Apr 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2940-11C>T	RET		Multiple endocrine neoplasia, type 2	VCV002067018	10	43620320	10	43124872	2067018	2122280		NC_000010.11:43124871:C:T	single nucleotide variant	intron variant	Likely benign	Jul 30, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2940-10T>C	RET		Multiple endocrine neoplasia, type 2	VCV003069909	10	43620321	10	43124873	3069909	3233484		NC_000010.11:43124872:T:C	single nucleotide variant	intron variant	Likely benign	Mar 23, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2940-9T>C	RET		Multiple endocrine neoplasia, type 2	VCV002733239	10	43620322	10	43124874	2733239	2890699		NC_000010.11:43124873:T:C	single nucleotide variant	intron variant	Likely benign	Dec 18, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2940-9T>G	RET		Multiple endocrine neoplasia, type 2	VCV002131904	10	43620322	10	43124874	2131904	2187745		NC_000010.11:43124873:T:G	single nucleotide variant	intron variant	Likely benign	May 3, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2940-8C>T	RET		Multiple endocrine neoplasia, type 2	VCV001134060	10	43620323	10	43124875	1134060	1120281	rs753438225	NC_000010.11:43124874:C:T	single nucleotide variant	intron variant	Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2940-6C>T	RET		Multiple endocrine neoplasia, type 2	VCV002179540	10	43620325	10	43124877	2179540	1916060		NC_000010.11:43124876:C:T	single nucleotide variant	intron variant	Likely benign	Jan 2, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2940-5A>C	RET		Hereditary cancer-predisposing syndrome	VCV001797909	10	43620326	10	43124878	1797909	1853528		NC_000010.11:43124877:A:C	single nucleotide variant	intron variant	Uncertain significance	May 19, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2940-5A>T	RET		Multiple endocrine neoplasia, type 2	VCV001619127	10	43620326	10	43124878	1619127	1548901	rs2133015763	NC_000010.11:43124877:A:T	single nucleotide variant	intron variant	Likely benign	Nov 29, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2940-4C>T	RET		Multiple endocrine neoplasia, type 2	VCV001103416	10	43620327	10	43124879	1103416	1098712	rs2133015776	NC_000010.11:43124878:C:T	single nucleotide variant	intron variant	Likely benign	Dec 19, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2940-3C>T	RET		Multiple endocrine neoplasia, type 2	VCV002710398	10	43620328	10	43124880	2710398	2871422		NC_000010.11:43124879:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Aug 28, 2023	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2940G>A (p.Met980Ile)	RET	M497I, M638I, M641I, M738I, M935I, M937I, M585I, M805I, M848I, M892I, M545I, M636I, M650I, M681I, M980I, M726I, M834I, M884I	Multiple endocrine neoplasia, type 2	VCV002733449	10	43620331	10	43124883	2733449	2890908		NC_000010.11:43124882:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 30, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2943C>T (p.Tyr981=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000413474	10	43620334	10	43124886	413474	397294	rs147318495	NC_000010.11:43124885:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 14, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2944C>A (p.Arg982Ser)	RET	R499S, R547S, R587S, R638S, R640S, R643S, R652S, R683S, R728S, R740S, R807S, R836S, R850S, R886S, R894S, R937S, R939S, R982S	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV003069281	10	43620335	10	43124887	3069281	3229908		NC_000010.11:43124886:C:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jul 3, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2944C>T (p.Arg982Cys)	RET	R982C, R728C, R547C, R587C, R640C, R836C, R807C, R886C, R939C, R499C, R643C, R683C, R740C, R850C, R638C, R652C, R894C, R937C	Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Renal hypodysplasia/aplasia 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Breast-ovarian cancer, familial, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia|Hereditary cancer-predisposing syndrome|not provided|not specified|Multiple endocrine neoplasia, type 2	VCV000013938	10	43620335	10	43124887	13938	28977	rs17158558	NC_000010.11:43124886:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 4, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2945G>T (p.Arg982Leu)	RET	R728L, R982L, R499L, R587L, R640L, R643L, R807L, R547L, R652L, R836L, R850L, R937L, R638L, R683L, R740L, R886L, R894L, R939L	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001008954	10	43620336	10	43124888	1008954	993822	rs368550200	NC_000010.11:43124887:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 16, 2021	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2945G>A (p.Arg982His)	RET	R982H, R728H, R640H, R643H, R740H, R836H, R547H, R638H, R683H, R807H, R499H, R937H, R939H, R587H, R652H, R850H, R886H, R894H	not provided|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Congenital central hypoventilation|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000477359	10	43620336	10	43124888	477359	459871	rs368550200	NC_000010.11:43124887:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 19, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2952G>T (p.Met984Ile)	RET	M685I, M501I, M589I, M809I, M852I, M888I, M939I, M941I, M984I, M642I, M645I, M654I, M730I, M742I, M838I, M896I, M549I, M640I	Hereditary cancer-predisposing syndrome	VCV003313734	10	43620343	10	43124895	3313734	3465464		NC_000010.11:43124894:G:T	single nucleotide variant	missense variant	Uncertain significance	May 15, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2952G>A (p.Met984Ile)	RET	M501I, M742I, M809I, M838I, M888I, M941I, M589I, M642I, M645I, M654I, M640I, M685I, M730I, M852I, M939I, M984I, M549I, M896I	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1	VCV001798073	10	43620343	10	43124895	1798073	1853691		NC_000010.11:43124894:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2953C>A (p.Leu985Met)	RET	L502M, L550M, L590M, L641M, L643M, L646M, L655M, L686M, L731M, L743M, L810M, L839M, L853M, L889M, L897M, L940M, L942M, L985M	Hereditary cancer-predisposing syndrome	VCV003227548	10	43620344	10	43124896	3227548	3390759		NC_000010.11:43124895:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 28, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2953C>T (p.Leu985=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001798084	10	43620344	10	43124896	1798084	1853702		NC_000010.11:43124895:C:T	single nucleotide variant	synonymous variant	Likely benign	Oct 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2954T>G (p.Leu985Arg)	RET	L985R, L731R, L550R, L590R, L686R, L743R, L810R, L897R, L641R, L646R, L889R, L502R, L839R, L940R, L643R, L655R, L853R, L942R	not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001046535	10	43620345	10	43124897	1046535	1029549	rs1240309421	NC_000010.11:43124896:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2955G>A (p.Leu985=)	RET		Multiple endocrine neoplasia, type 2	VCV002835080	10	43620346	10	43124898	2835080	3002131		NC_000010.11:43124897:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 3, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2958A>G (p.Gln986=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001488566	10	43620349	10	43124901	1488566	1420037	rs2133016266	NC_000010.11:43124900:A:G	single nucleotide variant	synonymous variant	Likely benign	Apr 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2961C>T (p.Cys987=)	RET		Hereditary cancer-predisposing syndrome	VCV001798174	10	43620352	10	43124904	1798174	1853792		NC_000010.11:43124903:C:T	single nucleotide variant	synonymous variant	Likely benign	Jul 5, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.2965A>G (p.Lys989Glu)	RET	K989E, K735E, K594E, K645E, K747E, K857E, K893E, K647E, K814E, K843E, K506E, K554E, K659E, K901E, K944E, K650E, K690E, K946E	Multiple endocrine neoplasia, type 2	VCV000477360	10	43620356	10	43124908	477360	460051	rs1554820052	NC_000010.11:43124907:A:G	single nucleotide variant	missense variant	Uncertain significance	May 11, 2017	criteria provided, single submitter							
NM_020975.6(RET):c.2967G>T (p.Lys989Asn)	RET	K989N, K735N, K506N, K554N, K659N, K893N, K944N, K645N, K647N, K814N, K843N, K594N, K650N, K747N, K901N, K946N, K690N, K857N	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1	VCV001489884	10	43620358	10	43124910	1489884	1514877	rs2133016421	NC_000010.11:43124909:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2971G>A (p.Glu991Lys)	RET	E647K, E649K, E661K, E845K, E737K, E859K, E948K, E596K, E652K, E749K, E895K, E946K, E991K, E508K, E556K, E692K, E816K, E903K	Hereditary cancer-predisposing syndrome	VCV002562600	10	43620362	10	43124914	2562600	2717442		NC_000010.11:43124913:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 19, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2971_2972delinsAG (p.Glu991Arg)	RET	E647R, E649R, E692R, E737R, E845R, E946R, E991R, E508R, E652R, E661R, E859R, E895R, E596R, E749R, E816R, E948R, E556R, E903R	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001986571	10	43620362 - 43620363	10	43124914 - 43124915	1986571	2047017		NC_000010.11:43124913:GA:AG	Indel	missense variant	Uncertain significance	Oct 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2972A>G (p.Glu991Gly)	RET	E903G, E991G, E649G, E652G, E692G, E816G, E508G, E737G, E845G, E859G, E946G, E556G, E596G, E647G, E661G, E749G, E895G, E948G	Hereditary cancer-predisposing syndrome	VCV002562601	10	43620363	10	43124915	2562601	2717443		NC_000010.11:43124914:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 19, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2973G>A (p.Glu991=)	RET		Hereditary cancer-predisposing syndrome	VCV003432290	10	43620364	10	43124916	3432290	3593486		NC_000010.11:43124915:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 3, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2973G>T (p.Glu991Asp)	RET	E661D, E946D, E556D, E596D, E647D, E652D, E737D, E895D, E991D, E749D, E816D, E859D, E508D, E649D, E692D, E845D, E903D, E948D	Hereditary cancer-predisposing syndrome	VCV003432215	10	43620364	10	43124916	3432215	3593411		NC_000010.11:43124915:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2973G>C (p.Glu991Asp)	RET	E737D, E991D, E508D, E749D, E895D, E946D, E948D, E596D, E649D, E661D, E647D, E816D, E859D, E556D, E652D, E692D, E845D, E903D	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000657264	10	43620364	10	43124916	657264	638929	rs1351903863	NC_000010.11:43124915:G:C	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2974C>G (p.Pro992Ala)	RET	P597A, P662A, P693A, P738A, P947A, P557A, P750A, P817A, P846A, P896A, P949A, P509A, P860A, P648A, P650A, P653A, P904A, P992A	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002587884	10	43620365	10	43124917	2587884	2760708		NC_000010.11:43124916:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2975C>G (p.Pro992Arg)	RET	P557R, P648R, P662R, P846R, P896R, P949R, P597R, P650R, P653R, P738R, P817R, P860R, P509R, P750R, P904R, P992R, P693R, P947R	Multiple endocrine neoplasia, type 2	VCV002039355	10	43620366	10	43124918	2039355	2094678		NC_000010.11:43124917:C:G	single nucleotide variant	missense variant	Uncertain significance	Jun 22, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2975C>A (p.Pro992Gln)	RET	P648Q, P693Q, P738Q, P992Q, P650Q, P653Q, P904Q, P509Q, P662Q, P846Q, P947Q, P557Q, P597Q, P750Q, P817Q, P860Q, P896Q, P949Q	Multiple endocrine neoplasia, type 2	VCV002015654	10	43620366	10	43124918	2015654	2064582		NC_000010.11:43124917:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 10, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2975C>T (p.Pro992Leu)	RET	P992L, P738L, P597L, P846L, P650L, P653L, P662L, P860L, P896L, P949L, P509L, P557L, P693L, P750L, P904L, P648L, P817L, P947L	Multiple endocrine neoplasia, type 2	VCV000963212	10	43620366	10	43124918	963212	946898	rs758191409	NC_000010.11:43124917:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2976G>C (p.Pro992=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001149992	10	43620367	10	43124919	1149992	1141133	rs528823385	NC_000010.11:43124918:G:C	single nucleotide variant	synonymous variant	Likely benign	Jul 12, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2976G>A (p.Pro992=)	RET		Renal hypodysplasia/aplasia 1|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia, type 2|not specified|Hereditary cancer-predisposing syndrome	VCV000132724	10	43620367	10	43124919	132724	136472	rs528823385	NC_000010.11:43124918:G:A	single nucleotide variant	synonymous variant	Benign/Likely benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2977G>A (p.Asp993Asn)	RET	D651N, D739N, D818N, D950N, D598N, D654N, D694N, D897N, D993N, D510N, D558N, D847N, D861N, D948N, D649N, D663N, D751N, D905N	Multiple endocrine neoplasia, type 2	VCV003652250	10	43620368	10	43124920	3652250	3785530		NC_000010.11:43124919:G:A	single nucleotide variant	missense variant	Uncertain significance	May 6, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2979C>T (p.Asp993=)	RET		Hereditary cancer-predisposing syndrome	VCV003313744	10	43620370	10	43124922	3313744	3465474		NC_000010.11:43124921:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 9, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.2979C>A (p.Asp993Glu)	RET	D558E, D663E, D694E, D751E, D847E, D905E, D948E, D510E, D651E, D739E, D818E, D897E, D993E, D649E, D861E, D598E, D654E, D950E	Hereditary cancer-predisposing syndrome	VCV001798359	10	43620370	10	43124922	1798359	1856499		NC_000010.11:43124921:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 30, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.2979C>G (p.Asp993Glu)	RET	D739E, D993E, D651E, D897E, D510E, D649E, D663E, D847E, D948E, D598E, D694E, D751E, D818E, D861E, D558E, D654E, D905E, D950E	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001005962	10	43620370	10	43124922	1005962	993823	rs1368893442	NC_000010.11:43124921:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2980A>G (p.Lys994Glu)	RET	K994E, K740E, K695E, K819E, K559E, K599E, K655E, K862E, K898E, K511E, K664E, K752E, K949E, K650E, K652E, K848E, K906E, K951E	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000971678	10	43620371	10	43124923	971678	956051	rs1490223704	NC_000010.11:43124922:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2980A>C (p.Lys994Gln)	RET	K740Q, K994Q, K599Q, K664Q, K695Q, K652Q, K559Q, K650Q, K655Q, K752Q, K819Q, K906Q, K951Q, K511Q, K848Q, K862Q, K898Q, K949Q	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000960619	10	43620371	10	43124923	960619	946899	rs1490223704	NC_000010.11:43124922:A:C	single nucleotide variant	missense variant	Uncertain significance	Sep 28, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2981A>G (p.Lys994Arg)	RET	K511R, K655R, K848R, K862R, K949R, K951R, K559R, K650R, K695R, K740R, K819R, K994R, K664R, K898R, K906R, K599R, K652R, K752R	Hereditary cancer-predisposing syndrome	VCV002587889	10	43620372	10	43124924	2587889	2760713		NC_000010.11:43124923:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 3, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2982A>G (p.Lys994=)	RET		Multiple endocrine neoplasia, type 2	VCV002705824	10	43620373	10	43124925	2705824	2856961		NC_000010.11:43124924:A:G	single nucleotide variant	synonymous variant	Likely benign	Dec 27, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2982A>C (p.Lys994Asn)	RET	K994N, K740N, K511N, K599N, K819N, K898N, K949N, K650N, K655N, K664N, K862N, K559N, K695N, K752N, K906N, K652N, K848N, K951N	Multiple endocrine neoplasia, type 2|not provided|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Familial medullary thyroid carcinoma|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia|Pheochromocytoma|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1	VCV000041843	10	43620373	10	43124925	41843	50282	rs199718928	NC_000010.11:43124924:A:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 28, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2985G>A (p.Arg995=)	RET		Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001084292	10	43620376	10	43124928	1084292	1077056	rs1252674267	NC_000010.11:43124927:G:A	single nucleotide variant	synonymous variant	Likely benign	Jul 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2987C>T (p.Pro996Leu)	RET	P996L, P742L, P513L, P657L, P666L, P821L, P951L, P561L, P652L, P654L, P900L, P697L, P754L, P953L, P601L, P850L, P864L, P908L	Pheochromocytoma|Multiple endocrine neoplasia type 2B|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000822438	10	43620378	10	43124930	822438	809964	rs1588880114	NC_000010.11:43124929:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2988G>A (p.Pro996=)	RET		not provided|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia|Hirschsprung disease, susceptibility to, 1|not specified|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia, type 2|Pheochromocytoma	VCV000215914	10	43620379	10	43124931	215914	212794	rs145798106	NC_000010.11:43124930:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Feb 2, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.2989G>T (p.Val997Leu)	RET	V562L, V698L, V997L, V514L, V655L, V667L, V743L, V851L, V909L, V653L, V755L, V901L, V602L, V658L, V822L, V865L, V952L, V954L	Multiple endocrine neoplasia, type 2	VCV002108448	10	43620380	10	43124932	2108448	2159862		NC_000010.11:43124931:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 6, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2989G>C (p.Val997Leu)	RET	V997L, V743L, V514L, V562L, V655L, V658L, V653L, V698L, V822L, V865L, V952L, V667L, V909L, V602L, V755L, V851L, V901L, V954L	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000477361	10	43620380	10	43124932	477361	459872	rs781236624	NC_000010.11:43124931:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2991G>A (p.Val997=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001096240	10	43620382	10	43124934	1096240	1077057	rs1564501216	NC_000010.11:43124933:G:A	single nucleotide variant	synonymous variant	Likely benign	May 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2992T>G (p.Phe998Val)	RET	F744V, F998V, F656V, F659V, F953V, F563V, F603V, F668V, F756V, F866V, F515V, F654V, F699V, F852V, F902V, F823V, F910V, F955V	Multiple endocrine neoplasia, type 2	VCV001424562	10	43620383	10	43124935	1424562	1438438	rs2133017302	NC_000010.11:43124934:T:G	single nucleotide variant	missense variant	Uncertain significance	May 1, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.2994T>G (p.Phe998Leu)	RET	F515L, F563L, F603L, F654L, F656L, F659L, F668L, F699L, F744L, F756L, F823L, F852L, F866L, F902L, F910L, F953L, F955L, F998L	RET-related disorder	VCV002630747	10	43620385	10	43124937	2630747	2796502		NC_000010.11:43124936:T:G	single nucleotide variant	missense variant	Uncertain significance	Aug 11, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.2994T>C (p.Phe998=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001798561	10	43620385	10	43124937	1798561	1856700		NC_000010.11:43124936:T:C	single nucleotide variant	synonymous variant	Likely benign	Jun 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2995G>A (p.Ala999Thr)	RET	A999T, A745T, A516T, A655T, A660T, A911T, A956T, A669T, A903T, A564T, A657T, A700T, A757T, A604T, A824T, A853T, A867T, A954T	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000486353	10	43620386	10	43124938	486353	475074	rs1363037947	NC_000010.11:43124937:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 11, 2020	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2996C>G (p.Ala999Gly)	RET	A516G, A564G, A604G, A655G, A657G, A660G, A669G, A700G, A745G, A757G, A824G, A853G, A867G, A903G, A911G, A954G, A956G, A999G	RET-related disorder|Multiple endocrine neoplasia type 2A	VCV002503515	10	43620387	10	43124939	2503515	2668701		NC_000010.11:43124938:C:G	single nucleotide variant	missense variant	Uncertain significance	Jul 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2996C>T (p.Ala999Val)	RET	A999V, A745V, A516V, A669V, A867V, A954V, A604V, A700V, A757V, A911V, A564V, A657V, A853V, A956V, A655V, A660V, A824V, A903V	Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000543734	10	43620387	10	43124939	543734	525450	rs748288493	NC_000010.11:43124938:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2997G>A (p.Ala999=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000136114	10	43620388	10	43124940	136114	139826	rs376487144	NC_000010.11:43124939:G:A	single nucleotide variant	synonymous variant	Likely benign	Aug 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2998G>A (p.Asp1000Asn)	RET	D1000N, D746N, D517N, D868N, D957N, D605N, D854N, D912N, D955N, D656N, D658N, D670N, D825N, D904N, D565N, D661N, D701N, D758N	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001520441	10	43620389	10	43124941	1520441	1516435	rs2133017433	NC_000010.11:43124940:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.2999A>G (p.Asp1000Gly)	RET	D1000G, D517G, D565G, D605G, D656G, D658G, D661G, D670G, D701G, D746G, D758G, D825G, D854G, D868G, D904G, D912G, D955G, D957G	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001719396	10	43620390	10	43124942	1719396	1774700		NC_000010.11:43124941:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3000C>T (p.Asp1000=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001665172	10	43620391	10	43124943	1665172	1621041	rs2133017462	NC_000010.11:43124942:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 4, 2021	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3003C>T (p.Ile1001=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001579603	10	43620394	10	43124946	1579603	1533561	rs1385462063	NC_000010.11:43124945:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 22, 2021	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3004A>G (p.Ser1002Gly)	RET	S1002G, S519G, S567G, S607G, S658G, S660G, S663G, S672G, S703G, S748G, S760G, S827G, S856G, S870G, S906G, S914G, S957G, S959G	Hirschsprung disease, susceptibility to, 1	VCV002678321	10	43620395	10	43124947	2678321	2833344		NC_000010.11:43124946:A:G	single nucleotide variant	missense variant	Uncertain significance	Jun 28, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3005G>A (p.Ser1002Asn)	RET	S1002N, S748N, S658N, S760N, S827N, S856N, S959N, S519N, S663N, S672N, S870N, S957N, S914N, S567N, S607N, S660N, S703N, S906N	not provided|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000241355	10	43620396	10	43124948	241355	240808	rs763489828	NC_000010.11:43124947:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 28, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.3006C>T (p.Ser1002=)	RET		Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|not provided	VCV000543767	10	43620397	10	43124949	543767	525317	rs370970483	NC_000010.11:43124948:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3007A>C (p.Lys1003Gln)	RET	K749Q, K1003Q, K659Q, K673Q, K871Q, K915Q, K958Q, K661Q, K761Q, K857Q, K907Q, K960Q, K568Q, K704Q, K520Q, K608Q, K664Q, K828Q	Multiple endocrine neoplasia, type 2	VCV001515991	10	43620398	10	43124950	1515991	1407269	rs1392503702	NC_000010.11:43124949:A:C	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3007A>G (p.Lys1003Glu)	RET	K1003E, K749E, K659E, K664E, K828E, K915E, K520E, K661E, K761E, K871E, K907E, K960E, K608E, K857E, K568E, K673E, K704E, K958E	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001474254	10	43620398	10	43124950	1474254	1410785	rs1392503702	NC_000010.11:43124949:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3008A>G (p.Lys1003Arg)	RET	K749R, K761R, K871R, K958R, K520R, K608R, K659R, K661R, K673R, K704R, K828R, K915R, K960R, K664R, K907R, K1003R, K568R, K857R	Multiple endocrine neoplasia, type 2	VCV003658588	10	43620399	10	43124951	3658588	3797009		NC_000010.11:43124950:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 3, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3011A>G (p.Asp1004Gly)	RET	D1004G, D750G, D660G, D665G, D674G, D916G, D908G, D569G, D705G, D858G, D872G, D959G, D521G, D609G, D662G, D762G, D829G, D961G	Multiple endocrine neoplasia, type 2	VCV000652513	10	43620402	10	43124954	652513	638930	rs1328724775	NC_000010.11:43124953:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 27, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.3015G>T (p.Leu1005=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001798848	10	43620406	10	43124958	1798848	1856117		NC_000010.11:43124957:G:T	single nucleotide variant	synonymous variant	Likely benign	May 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3016G>C (p.Glu1006Gln)	RET	E611Q, E664Q, E764Q, E874Q, E961Q, E752Q, E831Q, E860Q, E1006Q, E662Q, E667Q, E676Q, E910Q, E918Q, E963Q, E523Q, E571Q, E707Q	Multiple endocrine neoplasia, type 2	VCV003728530	10	43620407	10	43124959	3728530	3851861		NC_000010.11:43124958:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 6, 2025	criteria provided, single submitter							
NM_020975.6(RET):c.3017A>G (p.Glu1006Gly)	RET	E1006G, E523G, E571G, E611G, E662G, E664G, E667G, E676G, E707G, E752G, E764G, E831G, E860G, E874G, E910G, E918G, E961G, E963G	Multiple endocrine neoplasia, type 2	VCV003069870	10	43620408	10	43124960	3069870	3233446		NC_000010.11:43124959:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 4, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3018G>C (p.Glu1006Asp)	RET	E1006D, E662D, E664D, E667D, E874D, E910D, E963D, E571D, E611D, E764D, E860D, E918D, E523D, E676D, E831D, E707D, E752D, E961D	Multiple endocrine neoplasia, type 2	VCV002854143	10	43620409	10	43124961	2854143	3010509		NC_000010.11:43124960:G:C	single nucleotide variant	missense variant	Uncertain significance	Apr 9, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3019A>G (p.Lys1007Glu)	RET	K1007E, K753E, K572E, K663E, K665E, K677E, K964E, K708E, K832E, K919E, K524E, K861E, K875E, K911E, K612E, K668E, K765E, K962E	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000660617	10	43620410	10	43124962	660617	638931	rs774840230	NC_000010.11:43124961:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3020A>T (p.Lys1007Met)	RET	K753M, K861M, K911M, K962M, K524M, K663M, K765M, K1007M, K665M, K668M, K708M, K832M, K875M, K919M, K964M, K572M, K612M, K677M	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002625014	10	43620411	10	43124963	2625014	2790509		NC_000010.11:43124962:A:T	single nucleotide variant	missense variant	Uncertain significance	Jun 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3020A>C (p.Lys1007Thr)	RET	K1007T, K753T, K668T, K765T, K964T, K524T, K665T, K832T, K861T, K875T, K919T, K612T, K663T, K911T, K962T, K572T, K677T, K708T	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001010142	10	43620411	10	43124963	1010142	993824	rs759798237	NC_000010.11:43124962:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 20, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3021G>C (p.Lys1007Asn)	RET	K1007N, K753N, K663N, K665N, K668N, K832N, K875N, K524N, K612N, K677N, K708N, K765N, K861N, K964N, K572N, K911N, K919N, K962N	Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2|Ovarian cancer	VCV000662820	10	43620412	10	43124964	662820	638932	rs786204098	NC_000010.11:43124963:G:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jun 15, 2022	criteria provided, conflicting classifications							
NM_020975.6(RET):c.3021G>T (p.Lys1007Asn)	RET	K1007N, K753N, K677N, K911N, K612N, K663N, K668N, K708N, K765N, K832N, K875N, K524N, K861N, K962N, K964N, K572N, K665N, K919N	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000188140	10	43620412	10	43124964	188140	186119	rs786204098	NC_000010.11:43124963:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 31, 2021	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3022A>T (p.Met1008Leu)	RET	M1008L, M754L, M525L, M669L, M678L, M912L, M920L, M963L, M965L, M613L, M664L, M666L, M766L, M862L, M573L, M709L, M833L, M876L	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A	VCV000486329	10	43620413	10	43124965	486329	475297	rs1554820077	NC_000010.11:43124964:A:T	single nucleotide variant	missense variant	Uncertain significance	Feb 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3023T>C (p.Met1008Thr)	RET	M613T, M666T, M965T, M525T, M709T, M754T, M766T, M912T, M963T, M573T, M920T, M1008T, M664T, M669T, M678T, M833T, M862T, M876T	Hereditary cancer-predisposing syndrome	VCV003432248	10	43620414	10	43124966	3432248	3593444		NC_000010.11:43124965:T:C	single nucleotide variant	missense variant	Uncertain significance	Sep 11, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3027_3039+19dup	RET		Multiple endocrine neoplasia, type 2	VCV003716197	10	43620415 - 43620416	10	43124967 - 43124968	3716197	3852462		NC_000010.11:43124967:ATGGTTAAGAGGAGAGTGAGTGCCTGGGTCCAAT:ATGGTTAAGAGGAGAGTGAGTGCCTGGGTCCAATGGTTAAGAGGAGAGTGAGTGCCTGGGTCCAAT	Duplication	splice donor variant	Uncertain significance	Jun 19, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3026T>G (p.Met1009Arg)	RET	M526R, M670R, M913R, M966R, M710R, M767R, M921R, M964R, M614R, M665R, M755R, M834R, M863R, M877R, M1009R, M574R, M667R, M679R	Multiple endocrine neoplasia, type 2|not provided|Hereditary cancer-predisposing syndrome	VCV001798968	10	43620417	10	43124969	1798968	1856237		NC_000010.11:43124968:T:G	single nucleotide variant	missense variant	Uncertain significance	Nov 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3026T>A (p.Met1009Lys)	RET	M755K, M1009K, M526K, M574K, M665K, M670K, M863K, M614K, M877K, M921K, M679K, M767K, M913K, M667K, M710K, M834K, M964K, M966K	Multiple endocrine neoplasia, type 2	VCV000968700	10	43620417	10	43124969	968700	956052	rs375213011	NC_000010.11:43124968:T:A	single nucleotide variant	missense variant	Uncertain significance	Nov 13, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.3026T>C (p.Met1009Thr)	RET	M1009T, M755T, M679T, M913T, M526T, M574T, M665T, M767T, M863T, M921T, M964T, M667T, M670T, M877T, M614T, M710T, M834T, M966T	Multiple endocrine neoplasia type 2A|not provided|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome	VCV000822646	10	43620417	10	43124969	822646	809965	rs375213011	NC_000010.11:43124968:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3027G>A (p.Met1009Ile)	RET	M1009I, M755I, M665I, M667I, M913I, M921I, M574I, M614I, M670I, M710I, M834I, M863I, M964I, M526I, M767I, M966I, M679I, M877I	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1	VCV000570387	10	43620418	10	43124970	570387	566300	rs1007307889	NC_000010.11:43124969:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3028G>T (p.Val1010Phe)	RET	V1010F, V756F, V666F, V680F, V878F, V668F, V711F, V835F, V922F, V527F, V864F, V967F, V575F, V615F, V671F, V768F, V914F, V965F	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000477362	10	43620419	10	43124971	477362	460067	rs1554820081	NC_000010.11:43124970:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3030T>C (p.Val1010=)	RET		Multiple endocrine neoplasia, type 2	VCV002124544	10	43620421	10	43124973	2124544	2185005		NC_000010.11:43124972:T:C	single nucleotide variant	synonymous variant	Likely benign	Apr 11, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.3031A>T (p.Lys1011Ter)	RET	K667*, K681*, K757*, K769*, K865*, K923*, K672*, K968*, K528*, K669*, K712*, K836*, K576*, K616*, K879*, K915*, K966*, K1011*	Hereditary cancer-predisposing syndrome	VCV001799048	10	43620422	10	43124974	1799048	1856317		NC_000010.11:43124973:A:T	single nucleotide variant	nonsense	Pathogenic	Mar 25, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.3031A>G (p.Lys1011Glu)	RET	K757E, K1011E, K712E, K865E, K879E, K923E, K528E, K576E, K669E, K672E, K681E, K769E, K966E, K836E, K915E, K968E, K616E, K667E	Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Hereditary cancer-predisposing syndrome	VCV000972031	10	43620422	10	43124974	972031	956053	rs368345402	NC_000010.11:43124973:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3033G>A (p.Lys1011=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002789441	10	43620424	10	43124976	2789441	2953170		NC_000010.11:43124975:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3033G>C (p.Lys1011Asn)	RET	K1011N, K712N, K769N, K923N, K576N, K667N, K672N, K681N, K757N, K836N, K865N, K879N, K966N, K616N, K528N, K669N, K915N, K968N	Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Hereditary cancer-predisposing syndrome	VCV001799067	10	43620424	10	43124976	1799067	1856335		NC_000010.11:43124975:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3033GAG[1] (p.Arg1013del)	RET	R1013del, R759del	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000945144	10	43620424 - 43620426	10	43124976 - 43124978	945144	925812	rs1838299309	NC_000010.11:43124975:GAGGAG:GAG	Microsatellite	frameshift variant|inframe_deletion	Uncertain significance	Oct 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3035G>A (p.Arg1012Lys)	RET	R668K, R713K, R758K, R880K, R969K, R529K, R577K, R770K, R837K, R1012K, R670K, R673K, R682K, R866K, R916K, R617K, R924K, R967K	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001799083	10	43620426	10	43124978	1799083	1856351		NC_000010.11:43124977:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3036G>A (p.Arg1012=)	RET		Hereditary cancer-predisposing syndrome	VCV001691915	10	43620427	10	43124979	1691915	1684357	rs1196348217	NC_000010.11:43124978:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 11, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.3038G>A (p.Arg1013Lys)	RET	R1013K, R759K, R838K, R867K, R970K, R618K, R714K, R925K, R530K, R578K, R669K, R683K, R881K, R671K, R674K, R771K, R917K, R968K	Multiple endocrine neoplasia, type 2	VCV001369261	10	43620429	10	43124981	1369261	1414275	rs1838299542	NC_000010.11:43124980:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 22, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.3038G>C (p.Arg1013Thr)	RET	R1013T, R759T, R669T, R683T, R671T, R771T, R917T, R578T, R618T, R867T, R968T, R530T, R674T, R714T, R838T, R881T, R925T, R970T	Multiple endocrine neoplasia, type 2	VCV000850423	10	43620429	10	43124981	850423	836867	rs1838299542	NC_000010.11:43124980:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 19, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.3039A>T (p.Arg1013Ser)	RET	R1013S, R530S, R578S, R618S, R669S, R671S, R674S, R683S, R714S, R759S, R771S, R838S, R867S, R881S, R917S, R925S, R968S, R970S	RET-related disorder	VCV003348295	10	43620430	10	43124982	3348295	3507525		NC_000010.11:43124981:A:T	single nucleotide variant	missense variant	Uncertain significance	Mar 25, 2024	no assertion criteria provided							
NM_020975.6(RET):c.3039+2T>G	RET		Hereditary cancer-predisposing syndrome	VCV003313742	10	43620432	10	43124984	3313742	3465472		NC_000010.11:43124983:T:G	single nucleotide variant	splice donor variant	Uncertain significance	Jun 24, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3039+5G>C	RET		Hereditary cancer-predisposing syndrome	VCV000233891	10	43620435	10	43124987	233891	233796	rs876660714	NC_000010.11:43124986:G:C	single nucleotide variant	intron variant	Uncertain significance	Sep 13, 2015	criteria provided, single submitter							
NM_020975.6(RET):c.3039+7G>T	RET		Multiple endocrine neoplasia, type 2	VCV000543791	10	43620437	10	43124989	543791	525165	rs761410293	NC_000010.11:43124988:G:T	single nucleotide variant	intron variant	Likely benign	Sep 23, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3039+9del	RET		Multiple endocrine neoplasia, type 2	VCV001143120	10	43620438	10	43124990	1143120	1141134	rs1442745002	NC_000010.11:43124989:CC:C	Deletion	intron variant	Likely benign	Jan 8, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.3039+9C>T	RET		Multiple endocrine neoplasia, type 2	VCV003722303	10	43620439	10	43124991	3722303	3860407		NC_000010.11:43124990:C:T	single nucleotide variant	intron variant	Likely benign	Oct 6, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3039+11_3039+12delinsTC	RET		Multiple endocrine neoplasia, type 2	VCV002851914	10	43620441 - 43620442	10	43124993 - 43124994	2851914	3016242		NC_000010.11:43124992:GG:TC	Indel	intron variant	Uncertain significance	Nov 3, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.3039+18A>G	RET		Multiple endocrine neoplasia, type 2	VCV001614145	10	43620448	10	43125000	1614145	1612732	rs1838300264	NC_000010.11:43124999:A:G	single nucleotide variant	intron variant	Likely benign	Nov 24, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3039+19T>C	RET		Multiple endocrine neoplasia, type 2	VCV001616419	10	43620449	10	43125001	1616419	1526609	rs2133018583	NC_000010.11:43125000:T:C	single nucleotide variant	intron variant	Likely benign	Nov 10, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.3040-311A>G	RET		not provided	VCV001268550	10	43621712	10	43126264	1268550	1258457	rs2742239	NC_000010.11:43126263:A:G	single nucleotide variant	intron variant	Benign	Jan 10, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.3040-20C>T	RET		not specified|Multiple endocrine neoplasia, type 2|not provided	VCV000388803	10	43622003	10	43126555	388803	371683	rs372172456	NC_000010.11:43126554:C:T	single nucleotide variant	intron variant	Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3040-19G>A	RET		Multiple endocrine neoplasia, type 2	VCV001575562	10	43622004	10	43126556	1575562	1551590	rs376588907	NC_000010.11:43126555:G:A	single nucleotide variant	intron variant	Likely benign	Oct 27, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3040-17C>T	RET		Multiple endocrine neoplasia, type 2	VCV001614563	10	43622006	10	43126558	1614563	1663837	rs1191850114	NC_000010.11:43126557:C:T	single nucleotide variant	intron variant	Likely benign	Dec 26, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3040-16C>T	RET		Multiple endocrine neoplasia, type 2	VCV003686083	10	43622007	10	43126559	3686083	3816375		NC_000010.11:43126558:C:T	single nucleotide variant	intron variant	Likely benign	Jun 4, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3040-13C>G	RET		Multiple endocrine neoplasia, type 2	VCV002728911	10	43622010	10	43126562	2728911	2882937		NC_000010.11:43126561:C:G	single nucleotide variant	intron variant	Likely benign	Jan 25, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3040-13C>T	RET		Multiple endocrine neoplasia, type 2	VCV001576462	10	43622010	10	43126562	1576462	1586793	rs1838332583	NC_000010.11:43126561:C:T	single nucleotide variant	intron variant	Likely benign	Dec 30, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3040-11C>T	RET		Multiple endocrine neoplasia, type 2	VCV001570703	10	43622012	10	43126564	1570703	1537198	rs1057517646	NC_000010.11:43126563:C:T	single nucleotide variant	intron variant	Likely benign	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3040-11C>G	RET		Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2	VCV000372099	10	43622012	10	43126564	372099	358831	rs1057517646	NC_000010.11:43126563:C:G	single nucleotide variant	intron variant	Likely benign	May 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3040-10T>C	RET		Multiple endocrine neoplasia, type 2	VCV002198061	10	43622013	10	43126565	2198061	1924222		NC_000010.11:43126564:T:C	single nucleotide variant	intron variant	Likely benign	May 21, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3040-9G>C	RET		Multiple endocrine neoplasia, type 2	VCV002073931	10	43622014	10	43126566	2073931	2120579		NC_000010.11:43126565:G:C	single nucleotide variant	intron variant	Likely benign	May 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3040-8T>C	RET		Multiple endocrine neoplasia, type 2	VCV001628536	10	43622015	10	43126567	1628536	1648180	rs2133032145	NC_000010.11:43126566:T:C	single nucleotide variant	intron variant	Likely benign	Jan 20, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.3040-3del	RET		Hereditary cancer-predisposing syndrome	VCV001799157	10	43622019	10	43126571	1799157	1854767		NC_000010.11:43126570:CC:C	Deletion	intron variant	Uncertain significance	Jul 11, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.3040-4C>A	RET		Multiple endocrine neoplasia, type 2	VCV001611269	10	43622019	10	43126571	1611269	1640344	rs2133032215	NC_000010.11:43126570:C:A	single nucleotide variant	intron variant	Likely benign	Oct 18, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.3040-3C>T	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002139233	10	43622020	10	43126572	2139233	1875027		NC_000010.11:43126571:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Nov 18, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.3040-2A>G	RET		Multiple endocrine neoplasia, type 2	VCV001469524	10	43622021	10	43126573	1469524	1475473	rs2133032257	NC_000010.11:43126572:A:G	single nucleotide variant	splice acceptor variant	Likely pathogenic	Aug 1, 2024	criteria provided, single submitter							
NC_000010.11:g.43126578_43126586del	RET		Multiple endocrine neoplasia, type 2	VCV001428581	10	43622022 - 43622030	10	43126574 - 43126582	1428581	1379871	rs2133032314	NC_000010.11:43126573:GGACTACTTGGAC:GGAC	Deletion		Uncertain significance	Nov 8, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.3040G>T (p.Asp1014Tyr)	RET	D531Y, D579Y, D684Y, D760Y, D971Y, D619Y, D882Y, D918Y, D969Y, D670Y, D868Y, D926Y, D1014Y, D672Y, D675Y, D715Y, D772Y, D839Y	Hereditary cancer-predisposing syndrome	VCV002568360	10	43622023	10	43126575	2568360	2734896		NC_000010.11:43126574:G:T	single nucleotide variant	missense variant	Uncertain significance	May 25, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3040G>A (p.Asp1014Asn)	RET	D1014N, D760N, D579N, D675N, D926N, D969N, D531N, D672N, D772N, D882N, D619N, D670N, D684N, D715N, D918N, D839N, D868N, D971N	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000648907	10	43622023	10	43126575	648907	638933	rs1371047639	NC_000010.11:43126574:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3043T>A (p.Tyr1015Asn)	RET	Y620N, Y773N, Y883N, Y927N, Y676N, Y716N, Y972N, Y1015N, Y532N, Y869N, Y580N, Y671N, Y673N, Y685N, Y761N, Y840N, Y919N, Y970N	Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A	VCV003595072	10	43622026	10	43126578	3595072	3722785		NC_000010.11:43126577:T:A	single nucleotide variant	missense variant	Uncertain significance	Jan 28, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3043T>G (p.Tyr1015Asp)	RET	Y685D, Y773D, Y883D, Y927D, Y972D, Y1015D, Y532D, Y676D, Y716D, Y919D, Y580D, Y761D, Y869D, Y970D, Y620D, Y671D, Y673D, Y840D	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001799180	10	43622026	10	43126578	1799180	1854790		NC_000010.11:43126577:T:G	single nucleotide variant	missense variant	Uncertain significance	Jan 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3043T>C (p.Tyr1015His)	RET	Y620H, Y671H, Y716H, Y761H, Y869H, Y927H, Y1015H, Y532H, Y580H, Y673H, Y676H, Y685H, Y883H, Y972H, Y773H, Y840H, Y919H, Y970H	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001799179	10	43622026	10	43126578	1799179	1854789		NC_000010.11:43126577:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3044A>G (p.Tyr1015Cys)	RET	Y761C, Y1015C, Y673C, Y773C, Y869C, Y883C, Y919C, Y671C, Y840C, Y972C, Y532C, Y580C, Y676C, Y685C, Y927C, Y970C, Y620C, Y716C	RET-related disorder|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Hereditary cancer-predisposing syndrome	VCV000971865	10	43622027	10	43126579	971865	956054	rs1438192223	NC_000010.11:43126578:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3046T>A (p.Leu1016Met)	RET	L762M, L1016M, L672M, L884M, L920M, L533M, L674M, L971M, L581M, L717M, L774M, L870M, L621M, L677M, L686M, L841M, L928M, L973M	Multiple endocrine neoplasia, type 2	VCV001480170	10	43622029	10	43126581	1480170	1364840	rs2133032658	NC_000010.11:43126580:T:A	single nucleotide variant	missense variant	Uncertain significance	Aug 3, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.3047T>C (p.Leu1016Ser)	RET	L1016S, L581S, L686S, L774S, L841S, L621S, L973S, L717S, L870S, L928S, L533S, L672S, L674S, L677S, L762S, L884S, L920S, L971S	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002625019	10	43622030	10	43126582	2625019	2790514		NC_000010.11:43126581:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3048G>C (p.Leu1016Phe)	RET	L686F, L717F, L762F, L774F, L920F, L581F, L672F, L677F, L971F, L533F, L870F, L928F, L1016F, L621F, L674F, L841F, L884F, L973F	Multiple endocrine neoplasia, type 2	VCV002108098	10	43622031	10	43126583	2108098	2163271		NC_000010.11:43126582:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 16, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.3049G>A (p.Asp1017Asn)	RET	D1017N, D763N, D622N, D687N, D775N, D675N, D718N, D842N, D871N, D929N, D673N, D921N, D534N, D582N, D678N, D885N, D972N, D974N	Multiple endocrine neoplasia, type 2	VCV000549824	10	43622032	10	43126584	549824	540557	rs1554820153	NC_000010.11:43126583:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 29, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3050A>G (p.Asp1017Gly)	RET	D1017G, D763G, D673G, D678G, D718G, D675G, D775G, D871G, D885G, D921G, D534G, D582G, D622G, D842G, D974G, D687G, D929G, D972G	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000577439	10	43622033	10	43126585	577439	566302	rs762414334	NC_000010.11:43126584:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3051C>A (p.Asp1017Glu)	RET	D622E, D763E, D921E, D929E, D673E, D675E, D842E, D871E, D1017E, D534E, D718E, D885E, D582E, D678E, D687E, D775E, D972E, D974E	Multiple endocrine neoplasia, type 2|not provided|Hereditary cancer-predisposing syndrome	VCV001799271	10	43622034	10	43126586	1799271	1854880		NC_000010.11:43126585:C:A	single nucleotide variant	missense variant	Uncertain significance	Feb 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3051C>T (p.Asp1017=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001105358	10	43622034	10	43126586	1105358	1098713	rs993057046	NC_000010.11:43126585:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3051C>G (p.Asp1017Glu)	RET	D1017E, D763E, D622E, D842E, D871E, D885E, D972E, D974E, D718E, D582E, D678E, D687E, D775E, D929E, D534E, D673E, D675E, D921E	Multiple endocrine neoplasia, type 2	VCV001058279	10	43622034	10	43126586	1058279	1046543	rs993057046	NC_000010.11:43126585:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 23, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3052C>A (p.Leu1018Ile)	RET	L764I, L1018I, L623I, L674I, L719I, L886I, L679I, L872I, L922I, L973I, L535I, L688I, L843I, L930I, L975I, L583I, L676I, L776I	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000644790	10	43622035	10	43126587	644790	638934	rs766330880	NC_000010.11:43126586:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 1, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3052C>T (p.Leu1018Phe)	RET	L1018F, L764F, L535F, L583F, L623F, L674F, L676F, L679F, L688F, L719F, L843F, L872F, L930F, L922F, L776F, L886F, L973F, L975F	Multiple endocrine neoplasia|not provided|not specified|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Renal hypodysplasia/aplasia 1	VCV000543741	10	43622035	10	43126587	543741	525176	rs766330880	NC_000010.11:43126586:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 2, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.3053T>G (p.Leu1018Arg)	RET	L583R, L688R, L776R, L623R, L674R, L676R, L843R, L886R, L1018R, L535R, L719R, L764R, L930R, L975R, L679R, L872R, L922R, L973R	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001942819	10	43622036	10	43126588	1942819	2001680		NC_000010.11:43126587:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3054T>C (p.Leu1018=)	RET		Hereditary cancer-predisposing syndrome	VCV001799294	10	43622037	10	43126589	1799294	1854903		NC_000010.11:43126588:T:C	single nucleotide variant	synonymous variant	Likely benign	Aug 16, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.3056C>G (p.Ala1019Gly)	RET	A1019G, A765G, A974G, A976G, A624G, A675G, A689G, A873G, A677G, A680G, A720G, A844G, A887G, A536G, A584G, A777G, A923G, A931G	Multiple endocrine neoplasia, type 2	VCV001054885	10	43622039	10	43126591	1054885	1046544	rs1371891301	NC_000010.11:43126590:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 6, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.3056C>T (p.Ala1019Val)	RET	A1019V, A765V, A677V, A689V, A720V, A777V, A887V, A974V, A976V, A536V, A584V, A624V, A675V, A844V, A873V, A680V, A923V, A931V	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not provided	VCV000572031	10	43622039	10	43126591	572031	569660	rs1371891301	NC_000010.11:43126590:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3057G>T (p.Ala1019=)	RET		Multiple endocrine neoplasia, type 2	VCV001080139	10	43622040	10	43126592	1080139	1077058	rs369579749	NC_000010.11:43126591:G:T	single nucleotide variant	synonymous variant	Likely benign	Aug 4, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.3057G>A (p.Ala1019=)	RET		Multiple endocrine neoplasia type 2A|not provided|Multiple endocrine neoplasia, type 2|not specified|Multiple endocrine neoplasia type 2B|Hereditary cancer-predisposing syndrome	VCV000132727	10	43622040	10	43126592	132727	136475	rs369579749	NC_000010.11:43126591:G:A	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Dec 26, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.3058G>C (p.Ala1020Pro)	RET	A1020P, A585P, A676P, A681P, A721P, A845P, A625P, A678P, A766P, A924P, A932P, A975P, A977P, A537P, A690P, A778P, A874P, A888P	Multiple endocrine neoplasia, type 2	VCV002866789	10	43622041	10	43126593	2866789	3020397		NC_000010.11:43126592:G:C	single nucleotide variant	missense variant	Uncertain significance	May 22, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3060_3062del (p.Ser1021del)	RET	S1021del, S767del, S538del, S586del, S677del, S679del, S779del, S875del, S889del, S925del, S976del, S626del, S722del, S978del, S691del, S846del, S933del, S682del	Multiple endocrine neoplasia, type 2	VCV000580867	10	43622042 - 43622044	10	43126594 - 43126596	580867	563754	rs1564501844	NC_000010.11:43126593:CGTC:C	Deletion	inframe_indel|inframe_deletion	Uncertain significance	May 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3059C>T (p.Ala1020Val)	RET	A1020V, A766V, A625V, A690V, A721V, A845V, A888V, A975V, A537V, A678V, A924V, A681V, A778V, A932V, A977V, A585V, A676V, A874V	Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1	VCV000477363	10	43622042	10	43126594	477363	459879	rs372191563	NC_000010.11:43126593:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3060G>A (p.Ala1020=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000477364	10	43622043	10	43126595	477364	460738	rs767152839	NC_000010.11:43126594:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3063C>G (p.Ser1021=)	RET		Hereditary cancer-predisposing syndrome	VCV003432236	10	43622046	10	43126598	3432236	3593432		NC_000010.11:43126597:C:G	single nucleotide variant	synonymous variant	Likely benign	Aug 5, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3064A>G (p.Thr1022Ala)	RET	T1022A, T539A, T587A, T627A, T678A, T680A, T683A, T692A, T723A, T768A, T780A, T847A, T876A, T890A, T926A, T934A, T977A, T979A	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV003075552	10	43622047	10	43126599	3075552	3233117		NC_000010.11:43126598:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3065C>A (p.Thr1022Asn)	RET	T587N, T847N, T876N, T934N, T692N, T768N, T979N, T539N, T680N, T890N, T977N, T1022N, T627N, T678N, T683N, T723N, T780N, T926N	Multiple endocrine neoplasia, type 2	VCV003722829	10	43622048	10	43126600	3722829	3853922		NC_000010.11:43126599:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3068C>T (p.Pro1023Leu)	RET	P1023L, P769L, P540L, P628L, P679L, P693L, P724L, P781L, P848L, P877L, P980L, P891L, P588L, P681L, P684L, P927L, P935L, P978L	not provided|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000543758	10	43622051	10	43126603	543758	525461	rs138912894	NC_000010.11:43126602:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3069A>T (p.Pro1023=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001111801	10	43622052	10	43126604	1111801	1098714	rs1588880984	NC_000010.11:43126603:A:T	single nucleotide variant	synonymous variant	Likely benign	Sep 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3069A>G (p.Pro1023=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000822790	10	43622052	10	43126604	822790	809966	rs1588880984	NC_000010.11:43126603:A:G	single nucleotide variant	synonymous variant	Likely benign	Jan 5, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3071C>G (p.Ser1024Cys)	RET	S589C, S685C, S936C, S979C, S1024C, S629C, S680C, S770C, S782C, S849C, S878C, S541C, S682C, S694C, S981C, S725C, S892C, S928C	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001903164	10	43622054	10	43126606	1903164	1961241		NC_000010.11:43126605:C:G	single nucleotide variant	missense variant	Uncertain significance	May 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3075C>T (p.Asp1025=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001144872	10	43622058	10	43126610	1144872	1141135	rs1838334962	NC_000010.11:43126609:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3076T>G (p.Ser1026Ala)	RET	S591A, S631A, S682A, S687A, S851A, S880A, S938A, S1026A, S727A, S894A, S930A, S772A, S983A, S543A, S684A, S696A, S784A, S981A	Multiple endocrine neoplasia, type 2	VCV002008564	10	43622059	10	43126611	2008564	2066514		NC_000010.11:43126610:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 19, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.3076T>C (p.Ser1026Pro)	RET	S1026P, S772P, S682P, S684P, S727P, S894P, S938P, S784P, S880P, S981P, S543P, S591P, S696P, S851P, S930P, S983P, S631P, S687P	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000656446	10	43622059	10	43126611	656446	638935	rs1588880990	NC_000010.11:43126610:T:C	single nucleotide variant	missense variant	Uncertain significance	Nov 11, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3077C>T (p.Ser1026Phe)	RET	S772F, S1026F, S591F, S727F, S894F, S938F, S631F, S687F, S784F, S880F, S851F, S930F, S981F, S983F, S543F, S682F, S684F, S696F	Multiple endocrine neoplasia, type 2	VCV001370273	10	43622060	10	43126612	1370273	1352612	rs1588880993	NC_000010.11:43126611:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 23, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.3077C>A (p.Ser1026Tyr)	RET	S772Y, S1026Y, S684Y, S851Y, S894Y, S938Y, S591Y, S631Y, S682Y, S687Y, S727Y, S784Y, S880Y, S696Y, S983Y, S543Y, S930Y, S981Y	Multiple endocrine neoplasia, type 2	VCV000656577	10	43622060	10	43126612	656577	638936	rs1588880993	NC_000010.11:43126611:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 27, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.3078C>A (p.Ser1026=)	RET		Multiple endocrine neoplasia, type 2	VCV001937856	10	43622061	10	43126613	1937856	1996730		NC_000010.11:43126612:C:A	single nucleotide variant	synonymous variant	Likely benign	Sep 15, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.3078C>T (p.Ser1026=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000822816	10	43622061	10	43126613	822816	809967	rs756466984	NC_000010.11:43126612:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3079C>T (p.Leu1027=)	RET		Hereditary cancer-predisposing syndrome	VCV003227549	10	43622062	10	43126614	3227549	3390760		NC_000010.11:43126613:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 8, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3079C>A (p.Leu1027Met)	RET	L1027M, L544M, L592M, L632M, L683M, L685M, L688M, L697M, L728M, L773M, L785M, L852M, L881M, L895M, L931M, L939M, L982M, L984M	Multiple endocrine neoplasia, type 2	VCV003075316	10	43622062	10	43126614	3075316	3232883		NC_000010.11:43126613:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3079C>G (p.Leu1027Val)	RET	L1027V, L773V, L632V, L688V, L881V, L931V, L982V, L544V, L683V, L697V, L895V, L592V, L685V, L939V, L728V, L785V, L852V, L984V	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000584564	10	43622062	10	43126614	584564	575555	rs1564501868	NC_000010.11:43126613:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 21, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3081G>A (p.Leu1027=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001153005	10	43622064	10	43126616	1153005	1141136	rs1838335372	NC_000010.11:43126615:G:A	single nucleotide variant	synonymous variant	Likely benign	Oct 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3086A>G (p.Tyr1029Cys)	RET	Y594C, Y854C, Y984C, Y1029C, Y634C, Y685C, Y730C, Y787C, Y897C, Y986C, Y687C, Y690C, Y699C, Y775C, Y883C, Y941C, Y546C, Y933C	Multiple endocrine neoplasia, type 2	VCV003722035	10	43622069	10	43126621	3722035	3860139		NC_000010.11:43126620:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 2, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3089ACG[1] (p.Asp1031del)	RET	D1031del, D777del, D548del, D689del, D692del, D789del, D856del, D885del, D899del, D935del, D988del, D596del, D687del, D943del, D636del, D701del, D732del, D986del	Multiple endocrine neoplasia, type 2	VCV001035240	10	43622071 - 43622073	10	43126623 - 43126625	1035240	1029550	rs1260448063	NC_000010.11:43126622:GACGACG:GACG	Microsatellite	inframe_indel|inframe_deletion	Uncertain significance	Feb 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3090C>A (p.Asp1030Glu)	RET	D1030E, D547E, D595E, D635E, D686E, D688E, D691E, D700E, D731E, D776E, D788E, D855E, D884E, D898E, D934E, D942E, D985E, D987E	Multiple endocrine neoplasia, type 2	VCV003075356	10	43622073	10	43126625	3075356	3232923		NC_000010.11:43126624:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3090C>T (p.Asp1030=)	RET		Multiple endocrine neoplasia, type 2|not specified|Hereditary cancer-predisposing syndrome	VCV000413465	10	43622073	10	43126625	413465	397295	rs142859395	NC_000010.11:43126624:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3091G>A (p.Asp1031Asn)	RET	D1031N, D777N, D636N, D732N, D789N, D687N, D701N, D856N, D885N, D899N, D988N, D596N, D935N, D986N, D548N, D689N, D692N, D943N	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2	VCV000543720	10	43622074	10	43126626	543720	525320	rs200989078	NC_000010.11:43126625:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3093C>T (p.Asp1031=)	RET		not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000560869	10	43622076	10	43126628	560869	551873	rs369116900	NC_000010.11:43126627:C:T	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Jan 21, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.3094G>T (p.Gly1032Cys)	RET	G1032C, G778C, G549C, G690C, G702C, G857C, G900C, G989C, G733C, G790C, G886C, G944C, G597C, G688C, G987C, G637C, G693C, G936C	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001522704	10	43622077	10	43126629	1522704	1459899	rs757373375	NC_000010.11:43126628:G:T	single nucleotide variant	missense variant	Uncertain significance	Feb 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3094G>A (p.Gly1032Ser)	RET	G1032S, G778S, G886S, G549S, G733S, G790S, G857S, G900S, G989S, G597S, G702S, G936S, G944S, G637S, G688S, G690S, G693S, G987S	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|not provided	VCV000582597	10	43622077	10	43126629	582597	563758	rs757373375	NC_000010.11:43126628:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 24, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.3095G>A (p.Gly1032Asp)	RET	G1032D, G778D, G549D, G690D, G693D, G790D, G886D, G989D, G597D, G637D, G733D, G857D, G944D, G987D, G688D, G702D, G900D, G936D	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001008648	10	43622078	10	43126630	1008648	993825	rs1838335979	NC_000010.11:43126629:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3096C>T (p.Gly1032=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002454135	10	43622079	10	43126631	2454135	2424024		NC_000010.11:43126630:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3097C>T (p.Leu1033Phe)	RET	L550F, L598F, L694F, L703F, L937F, L990F, L689F, L691F, L791F, L1033F, L638F, L858F, L945F, L734F, L779F, L887F, L901F, L988F	Multiple endocrine neoplasia, type 2	VCV002765218	10	43622080	10	43126632	2765218	2925965		NC_000010.11:43126631:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 28, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3100_3101del (p.Ser1034fs)	RET	S1034fs, S780fs	Hereditary cancer-predisposing syndrome	VCV001727640	10	43622080 - 43622081	10	43126632 - 43126633	1727640	1785120		NC_000010.11:43126631:CTCTC:CTC	Microsatellite	frameshift variant	Pathogenic	Jan 6, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.3098T>C (p.Leu1033Pro)	RET	L1033P, L550P, L598P, L638P, L689P, L691P, L694P, L703P, L734P, L779P, L791P, L858P, L887P, L901P, L937P, L945P, L988P, L990P	Hereditary cancer-predisposing syndrome	VCV003227550	10	43622081	10	43126633	3227550	3390761		NC_000010.11:43126632:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 14, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3102A>G (p.Ser1034=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000779509	10	43622085	10	43126637	779509	712367	rs1455526573	NC_000010.11:43126636:A:G	single nucleotide variant	synonymous variant	Likely benign	Jan 8, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3105G>A (p.Glu1035=)	RET		Hereditary cancer-predisposing syndrome	VCV002568331	10	43622088	10	43126640	2568331	2734868		NC_000010.11:43126639:G:A	single nucleotide variant	synonymous variant	Likely benign	Mar 30, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3106G>C (p.Glu1036Gln)	RET	E697Q, E991Q, E1036Q, E601Q, E692Q, E706Q, E940Q, E948Q, E993Q, E553Q, E641Q, E782Q, E794Q, E890Q, E694Q, E737Q, E861Q, E904Q	Multiple endocrine neoplasia, type 2	VCV002702396	10	43622089	10	43126641	2702396	2856113		NC_000010.11:43126640:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3106G>A (p.Glu1036Lys)	RET	E1036K, E782K, E553K, E641K, E697K, E706K, E861K, E940K, E948K, E993K, E692K, E794K, E890K, E737K, E601K, E694K, E904K, E991K	Multiple endocrine neoplasia, type 2	VCV001041508	10	43622089	10	43126641	1041508	1029551	rs1838336457	NC_000010.11:43126640:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 3, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.3108G>C (p.Glu1036Asp)	RET	E692D, E940D, E993D, E641D, E697D, E694D, E706D, E737D, E794D, E861D, E991D, E1036D, E553D, E601D, E782D, E890D, E904D, E948D	Hereditary cancer-predisposing syndrome	VCV003432274	10	43622091	10	43126643	3432274	3593470		NC_000010.11:43126642:G:C	single nucleotide variant	missense variant	Uncertain significance	Oct 10, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3112A>T (p.Thr1038Ser)	RET	T1038S, T784S, T739S, T863S, T906S, T993S, T555S, T643S, T708S, T892S, T603S, T696S, T699S, T950S, T995S, T694S, T796S, T942S	Multiple endocrine neoplasia, type 2	VCV001052170	10	43622095	10	43126647	1052170	1046545	rs201740483	NC_000010.11:43126646:A:T	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.3112A>G (p.Thr1038Ala)	RET	T1038A, T784A, T603A, T699A, T739A, T796A, T863A, T892A, T950A, T995A, T555A, T696A, T708A, T942A, T993A, T643A, T694A, T906A	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Ewing sarcoma of soft tissue|not provided|Pheochromocytoma|Renal hypodysplasia/aplasia 1|not specified|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia	VCV000136115	10	43622095	10	43126647	136115	139827	rs201740483	NC_000010.11:43126646:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 3, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.3113C>T (p.Thr1038Ile)	RET	T1038I, T784I, T796I, T863I, T906I, T942I, T739I, T694I, T993I, T555I, T603I, T643I, T696I, T699I, T708I, T892I, T950I, T995I	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2|not specified|not provided	VCV000241356	10	43622096	10	43126648	241356	240809	rs200021472	NC_000010.11:43126647:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 30, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.3115C>T (p.Pro1039Ser)	RET	P556S, P695S, P943S, P994S, P1039S, P604S, P644S, P740S, P785S, P864S, P951S, P709S, P797S, P907S, P697S, P700S, P893S, P996S	Multiple endocrine neoplasia, type 2	VCV003721869	10	43622098	10	43126650	3721869	3850369		NC_000010.11:43126649:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3115C>G (p.Pro1039Ala)	RET	P1039A, P785A, P709A, P740A, P864A, P943A, P994A, P556A, P951A, P996A, P695A, P907A, P604A, P644A, P697A, P700A, P797A, P893A	Multiple endocrine neoplasia, type 2	VCV001473829	10	43622098	10	43126650	1473829	1387825	rs2133035293	NC_000010.11:43126649:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 12, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.3115C>A (p.Pro1039Thr)	RET	P785T, P1039T, P556T, P644T, P697T, P604T, P740T, P864T, P951T, P994T, P709T, P893T, P943T, P996T, P695T, P700T, P797T, P907T	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001427632	10	43622098	10	43126650	1427632	1441166	rs2133035293	NC_000010.11:43126649:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 26, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3116C>G (p.Pro1039Arg)	RET	P695R, P556R, P709R, P785R, P943R, P951R, P996R, P1039R, P700R, P740R, P797R, P864R, P893R, P907R, P604R, P644R, P697R, P994R	Multiple endocrine neoplasia, type 2	VCV002179095	10	43622099	10	43126651	2179095	1919492		NC_000010.11:43126650:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 18, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3116C>A (p.Pro1039Gln)	RET	P1039Q, P785Q, P604Q, P697Q, P740Q, P797Q, P996Q, P556Q, P943Q, P951Q, P994Q, P644Q, P695Q, P700Q, P709Q, P864Q, P893Q, P907Q	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000135182	10	43622099	10	43126651	135182	138921	rs79853121	NC_000010.11:43126650:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3116C>T (p.Pro1039Leu)	RET	P1039L, P785L, P893L, P943L, P556L, P700L, P864L, P697L, P797L, P907L, P996L, P644L, P709L, P951L, P604L, P695L, P740L, P994L	Multiple endocrine neoplasia type 2A|not specified|not provided|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1	VCV000013948	10	43622099	10	43126651	13948	28987	rs79853121	NC_000010.11:43126650:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 1, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.3117G>A (p.Pro1039=)	RET		not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000413466	10	43622100	10	43126652	413466	397484	rs775773414	NC_000010.11:43126651:G:A	single nucleotide variant	synonymous variant	Likely benign	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3118C>G (p.Leu1040Val)	RET	L605V, L645V, L698V, L865V, L894V, L952V, L997V, L701V, L710V, L944V, L557V, L741V, L1040V, L696V, L786V, L798V, L908V, L995V	Multiple endocrine neoplasia, type 2	VCV002757143	10	43622101	10	43126653	2757143	2920914		NC_000010.11:43126652:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3118C>T (p.Leu1040=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002146239	10	43622101	10	43126653	2146239	1876844		NC_000010.11:43126652:C:T	single nucleotide variant	synonymous variant	Likely benign	Jun 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3120G>A (p.Leu1040=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001727863	10	43622103	10	43126655	1727863	1794731		NC_000010.11:43126654:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3121G>A (p.Val1041Met)	RET	V606M, V702M, V742M, V953M, V996M, V711M, V866M, V909M, V1041M, V787M, V799M, V895M, V998M, V558M, V646M, V697M, V699M, V945M	Multiple endocrine neoplasia, type 2	VCV002071942	10	43622104	10	43126656	2071942	2123319		NC_000010.11:43126655:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 3, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.3121G>T (p.Val1041Leu)	RET	V1041L, V787L, V646L, V711L, V742L, V799L, V866L, V909L, V606L, V699L, V945L, V953L, V558L, V697L, V702L, V895L, V996L, V998L	Multiple endocrine neoplasia, type 2	VCV001501513	10	43622104	10	43126656	1501513	1398381	rs2133035526	NC_000010.11:43126655:G:T	single nucleotide variant	missense variant	Uncertain significance	Oct 28, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3122T>C (p.Val1041Ala)	RET	V787A, V1041A, V558A, V646A, V697A, V953A, V998A, V702A, V742A, V799A, V945A, V996A, V606A, V699A, V711A, V866A, V895A, V909A	Multiple endocrine neoplasia, type 2	VCV001413907	10	43622105	10	43126657	1413907	1361810	rs1554820165	NC_000010.11:43126656:T:C	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.3123G>A (p.Val1041=)	RET		Multiple endocrine neoplasia, type 2	VCV000705106	10	43622106	10	43126658	705106	692842	rs147437610	NC_000010.11:43126657:G:A	single nucleotide variant	synonymous variant	Likely benign	Jan 12, 2025	criteria provided, single submitter							
NM_020975.6(RET):c.3124G>A (p.Asp1042Asn)	RET	D1042N, D788N, D559N, D698N, D954N, D999N, D647N, D700N, D703N, D743N, D800N, D896N, D910N, D946N, D607N, D712N, D867N, D997N	Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2	VCV001001262	10	43622107	10	43126659	1001262	993826	rs867206631	NC_000010.11:43126658:G:A	single nucleotide variant	missense variant	Uncertain significance	Aug 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3126C>A (p.Asp1042Glu)	RET	D647E, D698E, D703E, D800E, D946E, D954E, D999E, D1042E, D743E, D867E, D559E, D712E, D788E, D896E, D607E, D700E, D910E, D997E	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001727897	10	43622109	10	43126661	1727897	1794765		NC_000010.11:43126660:C:A	single nucleotide variant	missense variant	Uncertain significance	Aug 11, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3126C>G (p.Asp1042Glu)	RET	D1042E, D788E, D607E, D712E, D896E, D999E, D647E, D700E, D910E, D559E, D698E, D703E, D800E, D946E, D954E, D743E, D867E, D997E	Multiple endocrine neoplasia, type 2|not specified|Hereditary cancer-predisposing syndrome	VCV000477366	10	43622109	10	43126661	477366	460069	rs1554820168	NC_000010.11:43126660:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3127T>C (p.Cys1043Arg)	RET	C704R, C713R, C911R, C1000R, C1043R, C608R, C699R, C701R, C789R, C897R, C648R, C868R, C560R, C744R, C801R, C947R, C955R, C998R	Hereditary cancer-predisposing syndrome	VCV003313694	10	43622110	10	43126662	3313694	3465424		NC_000010.11:43126661:T:C	single nucleotide variant	missense variant	Uncertain significance	May 31, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3127T>G (p.Cys1043Gly)	RET	C1043G, C789G, C868G, C955G, C648G, C701G, C744G, C801G, C911G, C560G, C998G, C1000G, C608G, C699G, C704G, C713G, C897G, C947G	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000822956	10	43622110	10	43126662	822956	809968	rs1367574614	NC_000010.11:43126661:T:G	single nucleotide variant	missense variant	Uncertain significance	Jan 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3128G>A (p.Cys1043Tyr)	RET	C1043Y, C608Y, C699Y, C704Y, C713Y, C868Y, C897Y, C911Y, C947Y, C955Y, C998Y, C1000Y, C560Y, C648Y, C744Y, C701Y, C789Y, C801Y	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002496745	10	43622111	10	43126663	2496745	2467884		NC_000010.11:43126662:G:A	single nucleotide variant	missense variant|splice donor variant	Uncertain significance	Sep 17, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3131A>G (p.Asn1044Ser)	RET	N1044S, N790S, N702S, N705S, N912S, N745S, N999S, N700S, N802S, N869S, N898S, N956S, N1001S, N561S, N714S, N609S, N649S, N948S	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000543754	10	43622114	10	43126666	543754	525324	rs772807570	NC_000010.11:43126665:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3132T>G (p.Asn1044Lys)	RET	N802K, N1044K, N561K, N609K, N649K, N869K, N898K, N745K, N790K, N912K, N948K, N956K, N1001K, N700K, N702K, N705K, N714K, N999K	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002891224	10	43622115	10	43126667	2891224	3055035		NC_000010.11:43126666:T:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3133A>T (p.Asn1045Tyr)	RET	N715Y, N791Y, N803Y, N899Y, N1002Y, N1045Y, N701Y, N706Y, N957Y, N1000Y, N703Y, N746Y, N913Y, N562Y, N610Y, N650Y, N870Y, N949Y	Multiple endocrine neoplasia, type 2	VCV002873027	10	43622116	10	43126668	2873027	3034901		NC_000010.11:43126667:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 23, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3133A>G (p.Asn1045Asp)	RET	N870D, N1000D, N650D, N715D, N746D, N791D, N899D, N1002D, N803D, N949D, N562D, N610D, N701D, N703D, N913D, N957D, N1045D, N706D	Multiple endocrine neoplasia, type 2	VCV002715866	10	43622116	10	43126668	2715866	2869104		NC_000010.11:43126667:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 15, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3135T>C (p.Asn1045=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000730152	10	43622118	10	43126670	730152	737486	rs1217348681	NC_000010.11:43126669:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3137C>T (p.Ala1046Val)	RET	A1003V, A651V, A716V, A747V, A914V, A1001V, A611V, A707V, A804V, A1046V, A704V, A900V, A958V, A563V, A702V, A792V, A871V, A950V	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001728025	10	43622120	10	43126672	1728025	1794893		NC_000010.11:43126671:C:T	single nucleotide variant	missense variant	Uncertain significance	Aug 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3137C>A (p.Ala1046Asp)	RET	A1046D, A792D, A611D, A651D, A914D, A563D, A716D, A900D, A1001D, A704D, A707D, A958D, A1003D, A702D, A747D, A804D, A871D, A950D	Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2|Familial medullary thyroid carcinoma	VCV000997534	10	43622120	10	43126672	997534	985270	rs945693739	NC_000010.11:43126671:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3138C>T (p.Ala1046=)	RET		Hereditary cancer-predisposing syndrome	VCV001728032	10	43622121	10	43126673	1728032	1794900		NC_000010.11:43126672:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Sep 11, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.3138C>G (p.Ala1046=)	RET		Multiple endocrine neoplasia, type 2	VCV001544477	10	43622121	10	43126673	1544477	1524755	rs201576838	NC_000010.11:43126672:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	May 16, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.3138_3139delinsTT (p.Pro1047Ser)	RET	P1047S, P793S, P1002S, P1004S, P705S, P901S, P951S, P959S, P564S, P612S, P717S, P652S, P748S, P805S, P703S, P708S, P872S, P915S	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not provided	VCV001017129	10	43622121 - 43622122	10	43126673 - 43126674	1017129	1009003	rs1838338388	NC_000010.11:43126672:CC:TT	Indel	missense variant	Uncertain significance	Jul 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3138C>A (p.Ala1046=)	RET		not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000184537	10	43622121	10	43126673	184537	182957	rs201576838	NC_000010.11:43126672:C:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3139C>T (p.Pro1047Ser)	RET	P793S, P1047S, P708S, P717S, P805S, P872S, P1004S, P652S, P748S, P901S, P1002S, P564S, P612S, P703S, P705S, P915S, P951S, P959S	not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000834355	10	43622122	10	43126674	834355	836868	rs369152977	NC_000010.11:43126673:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 20, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.3140C>T (p.Pro1047Leu)	RET	P1047L, P793L, P1004L, P564L, P612L, P872L, P705L, P748L, P805L, P901L, P1002L, P652L, P717L, P915L, P951L, P703L, P708L, P959L	Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1	VCV000946452	10	43622123	10	43126675	946452	925813	rs1305293392	NC_000010.11:43126674:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 3, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3141C>T (p.Pro1047=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|not provided	VCV002038497	10	43622124	10	43126676	2038497	2101565		NC_000010.11:43126675:C:T	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Aug 23, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.3141C>A (p.Pro1047=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000822980	10	43622124	10	43126676	822980	809969	rs372673589	NC_000010.11:43126675:C:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3141C>G (p.Pro1047=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000727081	10	43622124	10	43126676	727081	737487	rs372673589	NC_000010.11:43126675:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3142C>G (p.Leu1048Val)	RET	L1048V, L794V, L565V, L706V, L806V, L873V, L1005V, L613V, L653V, L704V, L749V, L902V, L1003V, L709V, L718V, L916V, L952V, L960V	Multiple endocrine neoplasia type 2B|not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A	VCV000372080	10	43622125	10	43126677	372080	358832	rs774347808	NC_000010.11:43126676:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 6, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3142C>T (p.Leu1048Phe)	RET	L1048F, L794F, L613F, L706F, L806F, L1003F, L565F, L709F, L718F, L749F, L873F, L653F, L704F, L916F, L1005F, L902F, L952F, L960F	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000241357	10	43622125	10	43126677	241357	240810	rs774347808	NC_000010.11:43126676:C:T	single nucleotide variant	missense variant	Likely benign	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3143T>C (p.Leu1048Pro)	RET	L916P, L952P, L1003P, L1048P, L718P, L749P, L873P, L1005P, L565P, L706P, L709P, L794P, L806P, L960P, L613P, L653P, L704P, L902P	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002568366	10	43622126	10	43126678	2568366	2734902		NC_000010.11:43126677:T:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3143del (p.Leu1048fs)	RET	L1048fs, L794fs	Aganglionic megacolon	VCV000599635	10	43622126	10	43126678	599635	590971	rs1564501934	NC_000010.11:43126677:T:	Deletion	frameshift variant	Pathogenic	Jan 1, 2013	no assertion criteria provided							
NM_020975.6(RET):c.3144C>G (p.Leu1048=)	RET		Multiple endocrine neoplasia, type 2	VCV002693494	10	43622127	10	43126679	2693494	2853627		NC_000010.11:43126678:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Nov 5, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3145C>T (p.Pro1049Ser)	RET	P1049S, P795S, P654S, P807S, P874S, P707S, P917S, P1004S, P1006S, P566S, P614S, P719S, P750S, P961S, P705S, P710S, P903S, P953S	Multiple endocrine neoplasia, type 2	VCV000657547	10	43622128	10	43126680	657547	638937	rs1588881090	NC_000010.11:43126679:C:T	single nucleotide variant	missense variant	Uncertain significance	Jul 17, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3146C>G (p.Pro1049Arg)	RET	P1006R, P654R, P705R, P719R, P917R, P614R, P707R, P795R, P807R, P903R, P1004R, P566R, P961R, P1049R, P710R, P750R, P874R, P953R	Multiple endocrine neoplasia, type 2	VCV001959459	10	43622129	10	43126681	1959459	2019593		NC_000010.11:43126680:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 20, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.3146C>T (p.Pro1049Leu)	RET	P1049L, P795L, P614L, P707L, P961L, P705L, P719L, P903L, P917L, P1004L, P1006L, P566L, P710L, P750L, P807L, P953L, P654L, P874L	Multiple endocrine neoplasia, type 2	VCV001407243	10	43622129	10	43126681	1407243	1483452	rs1490712863	NC_000010.11:43126680:C:T	single nucleotide variant	missense variant	Uncertain significance	May 27, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.3148C>T (p.Arg1050Ter)	RET	R1050*, R796*, R1005*, R711*, R808*, R904*, R918*, R655*, R708*, R720*, R567*, R615*, R751*, R875*, R962*, R1007*, R706*, R954*	Hereditary cancer-predisposing syndrome|not provided	VCV000995823	10	43622131	10	43126683	995823	983518	rs767479170	NC_000010.11:43126682:C:T	single nucleotide variant	nonsense	Pathogenic/Likely pathogenic	Jul 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3148C>G (p.Arg1050Gly)	RET	R796G, R1050G, R567G, R655G, R808G, R875G, R1005G, R720G, R751G, R1007G, R615G, R706G, R708G, R711G, R904G, R918G, R954G, R962G	Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome|RET-related disorder|not specified|Multiple endocrine neoplasia, type 2	VCV000822992	10	43622131	10	43126683	822992	809970	rs767479170	NC_000010.11:43126682:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3149G>T (p.Arg1050Leu)	RET	R1005L, R1007L, R1050L, R567L, R615L, R655L, R706L, R708L, R711L, R720L, R751L, R796L, R808L, R875L, R904L, R918L, R954L, R962L	Multiple endocrine neoplasia, type 2	VCV003075553	10	43622132	10	43126684	3075553	3233118		NC_000010.11:43126683:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 30, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3149_3150delinsCT (p.Arg1050Pro)	RET	R615P, R655P, R1007P, R567P, R706P, R720P, R796P, R808P, R904P, R918P, R954P, R1050P, R708P, R711P, R875P, R1005P, R751P, R962P	Multiple endocrine neoplasia, type 2	VCV002007519	10	43622132 - 43622133	10	43126684 - 43126685	2007519	2073180		NC_000010.11:43126683:GA:CT	Indel	missense variant	Uncertain significance	Apr 15, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3149G>A (p.Arg1050Gln)	RET	R1050Q, R796Q, R720Q, R875Q, R1005Q, R655Q, R751Q, R918Q, R1007Q, R567Q, R706Q, R708Q, R711Q, R904Q, R615Q, R808Q, R954Q, R962Q	not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Hereditary cancer|not specified|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1	VCV000241358	10	43622132	10	43126684	241358	240811	rs200956659	NC_000010.11:43126683:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 3, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.3151G>A (p.Ala1051Thr)	RET	A1051T, A797T, A1008T, A752T, A905T, A919T, A568T, A616T, A876T, A709T, A721T, A963T, A1006T, A656T, A707T, A712T, A809T, A955T	Multiple endocrine neoplasia, type 2	VCV001052683	10	43622134	10	43126686	1052683	1046546	rs2133036726	NC_000010.11:43126685:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 17, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.3152C>T (p.Ala1051Val)	RET	A1051V, A797V, A616V, A709V, A712V, A752V, A955V, A963V, A1006V, A1008V, A656V, A568V, A707V, A721V, A809V, A876V, A905V, A919V	Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Familial medullary thyroid carcinoma|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000568036	10	43622135	10	43126687	568036	569662	rs1564501944	NC_000010.11:43126686:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 20, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.3153C>A (p.Ala1051=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001538914	10	43622136	10	43126688	1538914	1597795	rs755946631	NC_000010.11:43126687:C:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Feb 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3153C>G (p.Ala1051=)	RET		Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	VCV000486303	10	43622136	10	43126688	486303	475078	rs755946631	NC_000010.11:43126687:C:G	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Nov 26, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.3154C>G (p.Leu1052Val)	RET	L1052V, L798V, L877V, L920V, L964V, L617V, L713V, L722V, L810V, L1007V, L1009V, L569V, L708V, L710V, L906V, L657V, L753V, L956V	Multiple endocrine neoplasia, type 2	VCV000566706	10	43622137	10	43126689	566706	563761	rs1564501947	NC_000010.11:43126688:C:G	single nucleotide variant	missense variant	Uncertain significance	Mar 2, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3155T>C (p.Leu1052Pro)	RET	L798P, L1052P, L1007P, L1009P, L722P, L920P, L617P, L810P, L569P, L657P, L708P, L710P, L877P, L906P, L964P, L713P, L753P, L956P	Multiple endocrine neoplasia, type 2	VCV001485228	10	43622138	10	43126690	1485228	1393954	rs2133036884	NC_000010.11:43126689:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 13, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.3156C>T (p.Leu1052=)	RET		Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome	VCV000477367	10	43622139	10	43126691	477367	459882	rs191769748	NC_000010.11:43126690:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3157C>T (p.Pro1053Ser)	RET	P957S, P965S, P1008S, P1010S, P754S, P811S, P907S, P921S, P618S, P658S, P711S, P714S, P723S, P878S, P1053S, P570S, P709S, P799S	Multiple endocrine neoplasia, type 2	VCV002807353	10	43622140	10	43126692	2807353	2964588		NC_000010.11:43126691:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Apr 18, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3157C>A (p.Pro1053Thr)	RET	P1053T, P799T, P1008T, P1010T, P618T, P907T, P921T, P570T, P957T, P658T, P711T, P714T, P723T, P811T, P965T, P709T, P754T, P878T	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000569954	10	43622140	10	43126692	569954	564585	rs754066766	NC_000010.11:43126691:C:A	single nucleotide variant	missense variant	Uncertain significance	Jul 12, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3158C>T (p.Pro1053Leu)	RET	P1053L, P723L, P754L, P811L, P907L, P921L, P1010L, P618L, P709L, P714L, P570L, P658L, P711L, P878L, P1008L, P799L, P957L, P965L	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001728252	10	43622141	10	43126693	1728252	1791652		NC_000010.11:43126692:C:T	single nucleotide variant	missense variant	Uncertain significance	Sep 15, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3160T>C (p.Ser1054Pro)	RET	S1009P, S712P, S755P, S812P, S908P, S659P, S715P, S800P, S879P, S966P, S1011P, S571P, S958P, S1054P, S619P, S710P, S724P, S922P	Hereditary cancer-predisposing syndrome	VCV001728308	10	43622143	10	43126695	1728308	1791708		NC_000010.11:43126694:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3162C>T (p.Ser1054=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001594601	10	43622145	10	43126697	1594601	1621725	rs2133037102	NC_000010.11:43126696:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Dec 25, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3162C>G (p.Ser1054=)	RET		Multiple endocrine neoplasia, type 2	VCV001079488	10	43622145	10	43126697	1079488	1077059	rs2133037102	NC_000010.11:43126696:C:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 27, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.3163A>G (p.Thr1055Ala)	RET	T1010A, T1012A, T1055A, T572A, T620A, T660A, T711A, T713A, T716A, T725A, T756A, T801A, T813A, T880A, T909A, T923A, T959A, T967A	Multiple endocrine neoplasia, type 2	VCV003387607	10	43622146	10	43126698	3387607	3546738		NC_000010.11:43126697:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 10, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3163A>T (p.Thr1055Ser)	RET	T1012S, T1055S, T660S, T813S, T909S, T572S, T725S, T756S, T620S, T711S, T801S, T880S, T959S, T967S, T1010S, T713S, T716S, T923S	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002496742	10	43622146	10	43126698	2496742	2467881		NC_000010.11:43126697:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3163A>C (p.Thr1055Pro)	RET	T801P, T1055P, T620P, T711P, T967P, T1010P, T1012P, T713P, T716P, T909P, T923P, T572P, T660P, T880P, T959P, T725P, T756P, T813P	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001035737	10	43622146	10	43126698	1035737	1029552	rs1439440590	NC_000010.11:43126697:A:C	single nucleotide variant	missense variant	Uncertain significance	May 16, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3164C>A (p.Thr1055Lys)	RET	T1010K, T1012K, T1055K, T713K, T756K, T923K, T711K, T725K, T801K, T880K, T967K, T572K, T620K, T660K, T716K, T813K, T909K, T959K	Multiple endocrine neoplasia, type 2	VCV003680359	10	43622147	10	43126699	3680359	3807799		NC_000010.11:43126698:C:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 30, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3164C>T (p.Thr1055Ile)	RET	T1010I, T1012I, T1055I, T572I, T620I, T660I, T711I, T713I, T716I, T725I, T756I, T801I, T813I, T880I, T909I, T923I, T959I, T967I	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV003387608	10	43622147	10	43126699	3387608	3546739		NC_000010.11:43126698:C:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3165A>G (p.Thr1055=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000413475	10	43622148	10	43126700	413475	397837	rs200289472	NC_000010.11:43126699:A:G	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Apr 22, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.3166T>A (p.Trp1056Arg)	RET	W802R, W1056R, W1013R, W661R, W714R, W814R, W960R, W968R, W621R, W717R, W726R, W924R, W1011R, W757R, W881R, W573R, W712R, W910R	Multiple endocrine neoplasia, type 2	VCV001479121	10	43622149	10	43126701	1479121	1426492	rs373423271	NC_000010.11:43126700:T:A	single nucleotide variant	missense variant	Uncertain significance	Jun 24, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3166T>C (p.Trp1056Arg)	RET	W1056R, W802R, W573R, W712R, W881R, W717R, W726R, W910R, W1011R, W1013R, W621R, W714R, W814R, W960R, W968R, W661R, W757R, W924R	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000543728	10	43622149	10	43126701	543728	525331	rs373423271	NC_000010.11:43126700:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 23, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3167G>A (p.Trp1056Ter)	RET	W1056*, W802*, W573*, W621*, W714*, W910*, W1013*, W726*, W881*, W1011*, W712*, W757*, W814*, W924*, W661*, W717*, W960*, W968*	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000486334	10	43622150	10	43126702	486334	475112	rs1425454966	NC_000010.11:43126701:G:A	single nucleotide variant	nonsense	Uncertain significance	Feb 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3168G>C (p.Trp1056Cys)	RET	W1013C, W661C, W712C, W726C, W757C, W814C, W960C, W1056C, W621C, W714C, W717C, W924C, W968C, W1011C, W802C, W881C, W910C, W573C	Multiple endocrine neoplasia, type 2	VCV002754129	10	43622151	10	43126703	2754129	2916597		NC_000010.11:43126702:G:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Aug 23, 2023	criteria provided, single submitter							
GRCh38/hg38 10q11.21(chr10:43126703-43372908)x3	CSGALNACT2|CSGALNACT2-DT|FXYD4|LOC126860919|LOC130003711|LOC130003712|LOC130003713|LOC130003714|LOC130003715|LOC130003716|LOC130003717|LOC130003718|LOC130003719|LOC130003720|LOC130003721|LOC130003722|LOC130003723|LOC130003724|LOC132089774|LOC132089775|RASGEF1A|RET		See cases	VCV000150132	10	43622151 - 43868356	10	43126703 - 43372908	150132	159883			copy number gain		Uncertain significance	Jul 2, 2012	no assertion criteria provided							
NM_020975.6(RET):c.3169A>T (p.Ile1057Phe)	RET	I574F, I713F, I718F, I803F, I815F, I1012F, I622F, I727F, I961F, I1014F, I715F, I758F, I882F, I969F, I1057F, I662F, I911F, I925F	Multiple endocrine neoplasia, type 2	VCV003001259	10	43622152	10	43126704	3001259	3164087		NC_000010.11:43126703:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 1, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3169A>G (p.Ile1057Val)	RET	I1057V, I803V, I1012V, I1014V, I882V, I911V, I574V, I758V, I925V, I961V, I622V, I662V, I713V, I715V, I718V, I727V, I815V, I969V	Multiple endocrine neoplasia, type 2	VCV001447038	10	43622152	10	43126704	1447038	1410531	rs750501039	NC_000010.11:43126703:A:G	single nucleotide variant	missense variant	Uncertain significance	May 7, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.3170T>A (p.Ile1057Asn)	RET	I1012N, I713N, I815N, I882N, I911N, I1057N, I727N, I758N, I803N, I961N, I969N, I1014N, I622N, I662N, I574N, I715N, I718N, I925N	Multiple endocrine neoplasia, type 2	VCV002045092	10	43622153	10	43126705	2045092	2092665		NC_000010.11:43126704:T:A	single nucleotide variant	missense variant	Uncertain significance	Jan 7, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.3170T>C (p.Ile1057Thr)	RET	I1057T, I803T, I622T, I758T, I925T, I1014T, I574T, I662T, I715T, I882T, I911T, I961T, I713T, I727T, I815T, I969T, I1012T, I718T	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A	VCV000664228	10	43622153	10	43126705	664228	638938	rs758877145	NC_000010.11:43126704:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3171T>A (p.Ile1057=)	RET		Hereditary cancer-predisposing syndrome	VCV003313718	10	43622154	10	43126706	3313718	3465448		NC_000010.11:43126705:T:A	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 7, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3171T>C (p.Ile1057=)	RET		not provided|Hereditary cancer-predisposing syndrome	VCV001728439	10	43622154	10	43126706	1728439	1791839		NC_000010.11:43126705:T:C	single nucleotide variant	synonymous variant|intron variant	Conflicting classifications of pathogenicity	Dec 3, 2022	criteria provided, conflicting classifications							
NM_020975.6(RET):c.3172G>C (p.Glu1058Gln)	RET	E1013Q, E575Q, E623Q, E716Q, E816Q, E883Q, E1015Q, E1058Q, E714Q, E728Q, E912Q, E759Q, E804Q, E663Q, E719Q, E926Q, E962Q, E970Q	Hereditary cancer-predisposing syndrome	VCV001728452	10	43622155	10	43126707	1728452	1791852		NC_000010.11:43126706:G:C	single nucleotide variant	missense variant	Uncertain significance	Nov 22, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.3172G>A (p.Glu1058Lys)	RET	E1058K, E804K, E912K, E926K, E962K, E970K, E1015K, E623K, E728K, E1013K, E575K, E716K, E759K, E816K, E663K, E714K, E719K, E883K	Multiple endocrine neoplasia, type 2	VCV001368380	10	43622155	10	43126707	1368380	1339973	rs1838340845	NC_000010.11:43126706:G:A	single nucleotide variant	missense variant	Uncertain significance	Apr 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3173A>C (p.Glu1058Ala)	RET	E575A, E714A, E759A, E912A, E1015A, E623A, E663A, E716A, E804A, E883A, E1013A, E1058A, E719A, E926A, E962A, E970A, E728A, E816A	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002893616	10	43622156	10	43126708	2893616	3049002		NC_000010.11:43126707:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Sep 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3173A>G (p.Glu1058Gly)	RET	E1058G, E804G, E719G, E728G, E883G, E926G, E1015G, E623G, E663G, E759G, E1013G, E714G, E816G, E962G, E575G, E716G, E912G, E970G	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001044090	10	43622156	10	43126708	1044090	1029553	rs780578577	NC_000010.11:43126707:A:G	single nucleotide variant	missense variant	Uncertain significance	Oct 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3173A>T (p.Glu1058Val)	RET	E1058V, E804V, E663V, E728V, E926V, E623V, E716V, E759V, E816V, E883V, E970V, E1013V, E1015V, E575V, E912V, E714V, E719V, E962V	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A	VCV000486309	10	43622156	10	43126708	486309	475345	rs780578577	NC_000010.11:43126707:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3174A>C (p.Glu1058Asp)	RET	E1058D, E804D, E714D, E728D, E926D, E962D, E1013D, E1015D, E663D, E816D, E883D, E623D, E716D, E719D, E759D, E970D, E575D, E912D	Multiple endocrine neoplasia, type 2|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Familial medullary thyroid carcinoma|Hereditary cancer-predisposing syndrome	VCV001436497	10	43622157	10	43126709	1436497	1340888	rs569004816	NC_000010.11:43126708:A:C	single nucleotide variant	missense variant	Uncertain significance	Nov 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3175A>T (p.Asn1059Tyr)	RET	N576Y, N1016Y, N1059Y, N664Y, N805Y, N884Y, N913Y, N1014Y, N715Y, N720Y, N760Y, N817Y, N927Y, N971Y, N624Y, N717Y, N729Y, N963Y	Multiple endocrine neoplasia, type 2	VCV003712920	10	43622158	10	43126710	3712920	3841184		NC_000010.11:43126709:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jul 11, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3175A>C (p.Asn1059His)	RET	N1059H, N805H, N1014H, N664H, N720H, N760H, N624H, N971H, N1016H, N715H, N717H, N913H, N963H, N576H, N729H, N817H, N884H, N927H	Multiple endocrine neoplasia, type 2	VCV001471729	10	43622158	10	43126710	1471729	1388756	rs1055571837	NC_000010.11:43126709:A:C	single nucleotide variant	missense variant	Uncertain significance	Aug 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3175A>G (p.Asn1059Asp)	RET	N805D, N1059D, N1016D, N576D, N760D, N927D, N624D, N717D, N817D, N971D, N720D, N729D, N884D, N963D, N1014D, N664D, N715D, N913D	Multiple endocrine neoplasia, type 2	VCV000849397	10	43622158	10	43126710	849397	836869	rs1055571837	NC_000010.11:43126709:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3176A>T (p.Asn1059Ile)	RET	N805I, N1059I, N664I, N717I, N817I, N913I, N715I, N729I, N760I, N1014I, N1016I, N720I, N884I, N963I, N971I, N576I, N624I, N927I	Multiple endocrine neoplasia, type 2	VCV000664740	10	43622159	10	43126711	664740	638939	rs772395752	NC_000010.11:43126710:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3176A>G (p.Asn1059Ser)	RET	N1059S, N805S, N664S, N927S, N1014S, N1016S, N576S, N717S, N715S, N760S, N817S, N884S, N913S, N971S, N624S, N720S, N729S, N963S	Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|not provided|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1	VCV000548922	10	43622159	10	43126711	548922	539286	rs772395752	NC_000010.11:43126710:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3177C>A (p.Asn1059Lys)	RET	N1059K, N805K, N1014K, N1016K, N720K, N624K, N664K, N717K, N760K, N913K, N963K, N817K, N884K, N971K, N576K, N715K, N729K, N927K	Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000949525	10	43622160	10	43126712	949525	925814	rs1014122393	NC_000010.11:43126711:C:A	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3177C>T (p.Asn1059=)	RET		Multiple endocrine neoplasia, type 2	VCV000543776	10	43622160	10	43126712	543776	525332	rs1014122393	NC_000010.11:43126711:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 15, 2017	criteria provided, single submitter							
NM_020975.6(RET):c.3177C>G (p.Asn1059Lys)	RET	N1059K, N805K, N1016K, N720K, N729K, N913K, N971K, N664K, N760K, N927K, N963K, N1014K, N576K, N717K, N624K, N715K, N817K, N884K	not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000405548	10	43622160	10	43126712	405548	397846	rs1014122393	NC_000010.11:43126711:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3179A>T (p.Lys1060Ile)	RET	K1015I, K1017I, K730I, K928I, K1060I, K577I, K625I, K818I, K914I, K716I, K721I, K964I, K665I, K718I, K761I, K806I, K885I, K972I	Multiple endocrine neoplasia, type 2	VCV003727737	10	43622162	10	43126714	3727737	3858360		NC_000010.11:43126713:A:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Dec 22, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3179A>G (p.Lys1060Arg)	RET	K806R, K1060R, K1015R, K625R, K718R, K761R, K885R, K972R, K716R, K721R, K818R, K964R, K1017R, K577R, K914R, K928R, K665R, K730R	Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Hereditary cancer-predisposing syndrome|not provided	VCV001385324	10	43622162	10	43126714	1385324	1368070	rs370756353	NC_000010.11:43126713:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3180A>C (p.Lys1060Asn)	RET	K1060N, K806N, K730N, K625N, K665N, K885N, K1015N, K1017N, K716N, K721N, K761N, K928N, K964N, K577N, K718N, K818N, K914N, K972N	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001407322	10	43622163	10	43126715	1407322	1483531	rs1361161086	NC_000010.11:43126714:A:C	single nucleotide variant	missense variant	Uncertain significance	Dec 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3180A>T (p.Lys1060Asn)	RET	K806N, K1060N, K1017N, K718N, K730N, K914N, K1015N, K885N, K972N, K625N, K665N, K721N, K761N, K964N, K577N, K716N, K818N, K928N	Multiple endocrine neoplasia, type 2	VCV001041498	10	43622163	10	43126715	1041498	1029554	rs1361161086	NC_000010.11:43126714:A:T	single nucleotide variant	missense variant	Uncertain significance	Aug 20, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.3182T>A (p.Leu1061His)	RET	L1016H, L578H, L717H, L722H, L819H, L929H, L973H, L1018H, L1061H, L965H, L626H, L731H, L807H, L886H, L915H, L666H, L719H, L762H	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002911079	10	43622165	10	43126717	2911079	3070504		NC_000010.11:43126716:T:A	single nucleotide variant	missense variant|intron variant	Uncertain significance	Mar 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3182T>G (p.Leu1061Arg)	RET	L807R, L1061R, L719R, L819R, L965R, L973R, L578R, L626R, L731R, L886R, L1016R, L1018R, L666R, L915R, L929R, L717R, L722R, L762R	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000840944	10	43622165	10	43126717	840944	836870	rs536486113	NC_000010.11:43126716:T:G	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3182T>C (p.Leu1061Pro)	RET	L1061P, L807P, L578P, L626P, L719P, L722P, L819P, L965P, L929P, L1018P, L666P, L731P, L886P, L915P, L973P, L1016P, L717P, L762P	not specified|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|not provided|Hirschsprung disease, susceptibility to, 1	VCV000216725	10	43622165	10	43126717	216725	212795	rs536486113	NC_000010.11:43126716:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3183C>T (p.Leu1061=)	RET		Multiple endocrine neoplasia, type 2	VCV002850647	10	43622166	10	43126718	2850647	3013003		NC_000010.11:43126717:C:T	single nucleotide variant	synonymous variant|intron variant	Likely benign	Apr 20, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3183C>G (p.Leu1061=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001524073	10	43622166	10	43126718	1524073	1382635	rs2133037902	NC_000010.11:43126717:C:G	single nucleotide variant	synonymous variant|intron variant	Uncertain significance	May 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3184_3186inv (p.Tyr1062Ile)	RET	Y1019I, Y1062I, Y579I, Y667I, Y763I, Y966I, Y627I, Y723I, Y1017I, Y718I, Y720I, Y732I, Y974I, Y808I, Y820I, Y887I, Y916I, Y930I	Hereditary cancer-predisposing syndrome	VCV001728568	10	43622167 - 43622169	10	43126719 - 43126721	1728568	1788203		NC_000010.11:43126718:TAT:ATA	Inversion	missense variant	Uncertain significance	Jun 30, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.3184T>G (p.Tyr1062Asp)	RET	Y1062D, Y808D, Y1017D, Y723D, Y820D, Y974D, Y718D, Y763D, Y966D, Y1019D, Y627D, Y732D, Y930D, Y579D, Y667D, Y720D, Y887D, Y916D	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000834470	10	43622167	10	43126719	834470	836871	rs138010639	NC_000010.11:43126718:T:G	single nucleotide variant	missense variant	Uncertain significance	Jun 5, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3184T>C (p.Tyr1062His)	RET	Y1062H, Y808H, Y1017H, Y718H, Y723H, Y930H, Y974H, Y579H, Y732H, Y763H, Y916H, Y1019H, Y627H, Y667H, Y887H, Y720H, Y820H, Y966H	Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome	VCV000823117	10	43622167	10	43126719	823117	809971	rs138010639	NC_000010.11:43126718:T:C	single nucleotide variant	missense variant	Uncertain significance	Dec 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3184T>A (p.Tyr1062Asn)	RET	Y1062N, Y808N, Y820N, Y974N, Y1019N, Y732N, Y763N, Y887N, Y579N, Y1017N, Y627N, Y667N, Y718N, Y720N, Y723N, Y916N, Y930N, Y966N	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000486344	10	43622167	10	43126719	486344	475114	rs138010639	NC_000010.11:43126718:T:A	single nucleotide variant	missense variant	Uncertain significance	Aug 23, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3185A>C (p.Tyr1062Ser)	RET	Y1062S, Y667S, Y720S, Y887S, Y966S, Y1017S, Y1019S, Y723S, Y732S, Y974S, Y916S, Y930S, Y579S, Y627S, Y718S, Y763S, Y808S, Y820S	Multiple endocrine neoplasia, type 2	VCV003014858	10	43622168	10	43126720	3014858	3181647		NC_000010.11:43126719:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 24, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3185A>G (p.Tyr1062Cys)	RET	Y1062C, Y808C, Y579C, Y627C, Y732C, Y930C, Y974C, Y667C, Y763C, Y820C, Y916C, Y1017C, Y1019C, Y720C, Y887C, Y966C, Y718C, Y723C	Multiple endocrine neoplasia type 2A|Pheochromocytoma|Familial medullary thyroid carcinoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|not provided|Hirschsprung disease, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000135181	10	43622168	10	43126720	135181	138920	rs587778659	NC_000010.11:43126719:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 15, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.3186T>C (p.Tyr1062=)	RET		Hereditary cancer-predisposing syndrome	VCV003432242	10	43622169	10	43126721	3432242	3593438		NC_000010.11:43126720:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Aug 6, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3187G>A (p.Gly1063Ser)	RET	G1063S, G809S, G580S, G668S, G733S, G764S, G931S, D764N, D821N, G1018S, G719S, D1063N, G1020S, G721S, G821S, G888S, G917S, G975S, G628S, G724S, G967S	Multiple endocrine neoplasia, type 2	VCV001010590	10	43622170	10	43126722	1010590	993827	rs1564502015	NC_000010.11:43126721:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 26, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3187G>C (p.Gly1063Arg)	RET	G1063R, G809R, D821H, G580R, G628R, G724R, G821R, G917R, G1018R, G719R, D1063H, G668R, G721R, G888R, D764H, G1020R, G733R, G764R, G931R, G967R, G975R	Multiple endocrine neoplasia, type 2	VCV000571596	10	43622170	10	43126722	571596	563766	rs1564502015	NC_000010.11:43126721:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 31, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3187+1G>C	RET	G1018A, G724A, G821A, G888A, G917A, G967A, G1020A, G1063A, G721A, G764A, G931A, G580A, G628A, G719A, G809A, G668A, G733A, G975A	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002778924	10	43622171	10	43126723	2778924	2940075		NC_000010.11:43126722:G:C	single nucleotide variant	missense variant|splice donor variant|intron variant	Uncertain significance	Dec 14, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3187+3A>T	RET	R629*, R725*, R810*, R822*, R889*, R968*, R976*, R1019*, R581*, R669*, R734*, R918*, R1021*, R722*, R1064*, R720*, R765*, R932*	Hereditary cancer-predisposing syndrome	VCV002568341	10	43622173	10	43126725	2568341	2734877		NC_000010.11:43126724:A:T	single nucleotide variant	nonsense|intron variant	Uncertain significance	May 15, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3187+3A>G	RET	R1021G, R1064G, R722G, R765G, R810G, R822G, R629G, R669G, R720G, R734G, R889G, R976G, R1019G, R725G, R918G, R968G, R581G, R932G	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001728601	10	43622173	10	43126725	1728601	1788236		NC_000010.11:43126724:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jun 8, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3187+4G>T	RET	R581I, R765I, R822I, R889I, R1021I, R629I, R810I, R918I, R968I, R725I, R734I, R976I, R1019I, R1064I, R669I, R720I, R722I, R932I	Multiple endocrine neoplasia, type 2	VCV002086643	10	43622174	10	43126726	2086643	2140684		NC_000010.11:43126725:G:T	single nucleotide variant	missense variant|intron variant	Uncertain significance	Jan 17, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.3187+6dup	RET	I1065fs, I811fs	Multiple endocrine neoplasia, type 2	VCV001092434	10	43622174 - 43622175	10	43126726 - 43126727	1092434	1077060	rs2133038243	NC_000010.11:43126726:AA:AAA	Duplication	frameshift variant|intron variant	Likely benign	Mar 8, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.3187+5A>C	RET	R1064S, R810S, R1021S, R581S, R822S, R918S, R968S, R669S, R722S, R1019S, R734S, R765S, R932S, R976S, R629S, R720S, R725S, R889S	Multiple endocrine neoplasia, type 2	VCV000947879	10	43622175	10	43126727	947879	940958	rs1457645623	NC_000010.11:43126726:A:C	single nucleotide variant	missense variant|intron variant	Uncertain significance	May 10, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.3187+6A>G	RET	I1065V, I582V, I630V, I811V, I823V, I890V, I969V, I977V, I723V, I735V, I919V, I1020V, I1022V, I721V, I933V, I670V, I726V, I766V	Multiple endocrine neoplasia, type 2	VCV002773138	10	43622176	10	43126728	2773138	2930416		NC_000010.11:43126727:A:G	single nucleotide variant	missense variant|intron variant	Uncertain significance	Nov 1, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3187+7T>C	RET	I1065T, I811T, I723T, I726T, I890T, I933T, I1020T, I1022T, I582T, I630T, I969T, I721T, I735T, I766T, I823T, I919T, I670T, I977T	Multiple endocrine neoplasia, type 2	VCV001100199	10	43622177	10	43126729	1100199	1098715	rs2133038267	NC_000010.11:43126728:T:C	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 3, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.3187+9T>G	RET	S1066A, S727A, S736A, S824A, S920A, S1021A, S1023A, S583A, S631A, S891A, S934A, S671A, S722A, S724A, S970A, S978A, S767A, S812A	Multiple endocrine neoplasia, type 2	VCV002105906	10	43622179	10	43126731	2105906	2166367		NC_000010.11:43126730:T:G	single nucleotide variant	missense variant|intron variant	Likely benign	Mar 3, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.3187+9T>C	RET	S1066P, S812P, S1021P, S631P, S727P, S891P, S920P, S671P, S767P, S934P, S978P, S1023P, S722P, S736P, S824P, S583P, S724P, S970P	Multiple endocrine neoplasia, type 2	VCV001587335	10	43622179	10	43126731	1587335	1541851	rs2133038319	NC_000010.11:43126730:T:C	single nucleotide variant	missense variant|intron variant	Likely benign	Nov 10, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.3187+12C>A	RET	H1067N, H813N, H1024N, H584N, H632N, H728N, H737N, H768N, H935N, H672N, H825N, H921N, H892N, H971N, H1022N, H723N, H725N, H979N	Multiple endocrine neoplasia, type 2	VCV001607739	10	43622182	10	43126734	1607739	1637693	rs897706317	NC_000010.11:43126733:C:A	single nucleotide variant	missense variant|intron variant	Likely benign	Oct 2, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.3187+12C>T	RET	H1067Y, H813Y, H584Y, H632Y, H672Y, H737Y, H768Y, H725Y, H892Y, H921Y, H935Y, H979Y, H1022Y, H1024Y, H723Y, H728Y, H825Y, H971Y	Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia, type 2	VCV001561653	10	43622182	10	43126734	1561653	1555078	rs897706317	NC_000010.11:43126733:C:T	single nucleotide variant	missense variant|intron variant	Conflicting classifications of pathogenicity	Aug 6, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.3187+13A>G	RET	H1022R, H584R, H728R, H737R, H768R, H935R, H1067R, H632R, H813R, H971R, H1024R, H725R, H825R, H892R, H672R, H723R, H921R, H979R	Multiple endocrine neoplasia, type 2	VCV002784919	10	43622183	10	43126735	2784919	2938721		NC_000010.11:43126734:A:G	single nucleotide variant	missense variant|intron variant	Likely benign	Jul 20, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3187+14T>C	RET		Multiple endocrine neoplasia, type 2	VCV001621048	10	43622184	10	43126736	1621048	1615296	rs2133038456	NC_000010.11:43126735:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 17, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.3187+15_3187+16delinsTT	RET	A1023L, A814L, A922L, A1025L, A585L, A726L, A738L, A633L, A729L, A769L, A893L, A980L, A1068L, A673L, A724L, A826L, A936L, A972L	Multiple endocrine neoplasia, type 2	VCV002767319	10	43622185 - 43622186	10	43126737 - 43126738	2767319	2922893		NC_000010.11:43126736:GC:TT	Indel	missense variant|intron variant	Uncertain significance	Aug 25, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3187+15G>A	RET	A1068T, A814T, A633T, A673T, A738T, A769T, A826T, A922T, A1025T, A980T, A585T, A724T, A726T, A936T, A1023T, A729T, A893T, A972T	Multiple endocrine neoplasia, type 2	VCV001574924	10	43622185	10	43126737	1574924	1585247	rs1177156248	NC_000010.11:43126736:G:A	single nucleotide variant	missense variant|intron variant	Likely benign	Apr 22, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3187+16C>T	RET	A922V, A972V, A1025V, A729V, A814V, A893V, A1068V, A585V, A633V, A673V, A769V, A980V, A1023V, A724V, A726V, A738V, A826V, A936V	Multiple endocrine neoplasia, type 2	VCV002160625	10	43622186	10	43126738	2160625	1894218		NC_000010.11:43126737:C:T	single nucleotide variant	missense variant|intron variant	Likely benign	Nov 4, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3187+17A>G	RET		Multiple endocrine neoplasia, type 2	VCV002748900	10	43622187	10	43126739	2748900	2915260		NC_000010.11:43126738:A:G	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jul 31, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3187+20T>C	RET		Multiple endocrine neoplasia, type 2	VCV001662289	10	43622190	10	43126742	1662289	1642513	rs2133038565	NC_000010.11:43126741:T:C	single nucleotide variant	synonymous variant|intron variant	Likely benign	Jan 31, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3187+37G>C	RET		RET-related disorder	VCV003035313	10	43622207	10	43126759	3035313	3202528		NC_000010.11:43126758:G:C	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Jul 29, 2019	no assertion criteria provided							
NM_020975.6(RET):c.3187+47T>C	RET		Pheochromocytoma|not provided|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|not specified	VCV000165056	10	43622217	10	43126769	165056	174666	rs2075912	NC_000010.11:43126768:T:C	single nucleotide variant	intron variant	Benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3187+198T>A	RET		not provided	VCV001230253	10	43622368	10	43126920	1230253	1218958	rs2075913	NC_000010.11:43126919:T:A	single nucleotide variant	intron variant	Benign	Jun 24, 2018	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3188-19G>A	RET		Multiple endocrine neoplasia, type 2	VCV002862387	10	43623541	10	43128093	2862387	3026037		NC_000010.11:43128092:G:A	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Aug 4, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3188-19G>T	RET		Multiple endocrine neoplasia, type 2	VCV001530343	10	43623541	10	43128093	1530343	1582128	rs571011726	NC_000010.11:43128092:G:T	single nucleotide variant	intron variant	Likely benign	Jan 23, 2025	criteria provided, single submitter							
NM_020975.6(RET):c.3188-16C>G	RET		Multiple endocrine neoplasia, type 2	VCV002167349	10	43623544	10	43128096	2167349	1906469		NC_000010.11:43128095:C:G	single nucleotide variant	intron variant	Likely benign	Oct 30, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.3188-15T>A	RET		Multiple endocrine neoplasia, type 2	VCV001530577	10	43623545	10	43128097	1530577	1635049	rs1588881831	NC_000010.11:43128096:T:A	single nucleotide variant	intron variant	Likely benign	Oct 13, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.3188-9C>T	RET		Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|not specified|Pheochromocytoma|Renal hypodysplasia/aplasia 1|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia|Hereditary cancer-predisposing syndrome	VCV000136116	10	43623551	10	43128103	136116	139828	rs551159582	NC_000010.11:43128102:C:T	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Feb 2, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.3188-3del	RET		Multiple endocrine neoplasia, type 2	VCV000942045	10	43623553	10	43128105	942045	940169	rs1838373407	NC_000010.11:43128104:TTTTT:TTTT	Deletion	intron variant	Uncertain significance	Jun 17, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.3188-6T>C	RET		Multiple endocrine neoplasia, type 2	VCV001617201	10	43623554	10	43128106	1617201	1548278	rs2133047490	NC_000010.11:43128105:T:C	single nucleotide variant	intron variant	Likely benign	Sep 7, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.3188-4T>G	RET		not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000413469	10	43623556	10	43128108	413469	397847	rs748501516	NC_000010.11:43128107:T:G	single nucleotide variant	intron variant	Conflicting classifications of pathogenicity	Jan 30, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.3188-3T>C	RET		Multiple endocrine neoplasia, type 2	VCV001353284	10	43623557	10	43128109	1353284	1499283	rs2133047522	NC_000010.11:43128108:T:C	single nucleotide variant	intron variant	Uncertain significance	Sep 1, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.3188-2A>G	RET		Multiple endocrine neoplasia type 2A	VCV000548919	10	43623558	10	43128110	548919	539287	rs1554820302	NC_000010.11:43128109:A:G	single nucleotide variant	3 prime UTR variant|splice acceptor variant|intron variant	Uncertain significance	May 30, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.3188-1G>C	RET		Multiple endocrine neoplasia, type 2	VCV000665911	10	43623559	10	43128111	665911	652034	rs1588881837	NC_000010.11:43128110:G:C	single nucleotide variant	3 prime UTR variant|splice acceptor variant|intron variant	Uncertain significance	Aug 15, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.3189C>G (p.Gly1063=)	RET	C801W, C1043W, C560W	Hereditary cancer-predisposing syndrome	VCV002568358	10	43623561	10	43128113	2568358	2734894		NC_000010.11:43128112:C:G	single nucleotide variant	synonymous variant|3 prime UTR variant|missense variant|intron variant	Likely benign	May 7, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3189C>T (p.Gly1063=)	RET		Hereditary cancer-predisposing syndrome	VCV001728612	10	43623561	10	43128113	1728612	1788247		NC_000010.11:43128112:C:T	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Likely benign	Jan 8, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.3190A>T (p.Met1064Leu)	RET	M1064L, M561L, M802L, M822L, M918L, M765L, M1021L, M581L, M669L, M722L, M1019L, M1044L, M932L, M968L	Hereditary cancer-predisposing syndrome	VCV002454118	10	43623562	10	43128114	2454118	2424007		NC_000010.11:43128113:A:T	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Nov 9, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.3190A>C (p.Met1064Leu)	RET	M1019L, M1064L, M581L, M765L, M932L, M561L, M722L, M822L, M918L, M1021L, M669L, M802L, M968L, M1044L	Multiple endocrine neoplasia, type 2	VCV002045181	10	43623562	10	43128114	2045181	2092753		NC_000010.11:43128113:A:C	single nucleotide variant	missense variant	Uncertain significance	Dec 17, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.3191T>C (p.Met1064Thr)	RET	M1064T	not provided|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Hereditary cancer-predisposing syndrome	VCV000161359	10	43623563	10	43128115	161359	171126	rs149513065	NC_000010.11:43128114:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 31, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3192G>A (p.Met1064Ile)	RET	M1064I	not provided|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Hereditary cancer-predisposing syndrome	VCV000851935	10	43623564	10	43128116	851935	836872	rs144730090	NC_000010.11:43128115:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 24, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.3196G>A (p.Asp1066Asn)	RET	D1066N	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001039531	10	43623568	10	43128120	1039531	1029555	rs180700967	NC_000010.11:43128119:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3196G>C (p.Asp1066His)	RET	D1066H	Multiple endocrine neoplasia, type 2	VCV000573638	10	43623568	10	43128120	573638	569666	rs180700967	NC_000010.11:43128119:G:C	single nucleotide variant	missense variant	Uncertain significance	Mar 14, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3198C>T (p.Asp1066=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001112697	10	43623570	10	43128122	1112697	1098716	rs2133047683	NC_000010.11:43128121:C:T	single nucleotide variant	synonymous variant	Likely benign	Jan 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3199C>T (p.Pro1067Ser)	RET	P1067S	Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A|not provided	VCV000543760	10	43623571	10	43128123	543760	525471	rs775583354	NC_000010.11:43128122:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 17, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.3200C>T (p.Pro1067Leu)	RET	P1067L	Hereditary cancer-predisposing syndrome|not provided|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2	VCV000477369	10	43623572	10	43128124	477369	460070	rs760625882	NC_000010.11:43128123:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Sep 15, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.3201G>C (p.Pro1067=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001128807	10	43623573	10	43128125	1128807	1120282	rs878855062	NC_000010.11:43128124:G:C	single nucleotide variant	synonymous variant	Likely benign	Jan 19, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3201G>A (p.Pro1067=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000241359	10	43623573	10	43128125	241359	240812	rs878855062	NC_000010.11:43128124:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 15, 2021	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3203del (p.Asn1068fs)	RET	N1068fs	Multiple endocrine neoplasia, type 2	VCV000241360	10	43623574	10	43128126	241360	240813	rs878855063	NC_000010.11:43128125:AA:A	Deletion	frameshift variant	Uncertain significance	Feb 5, 2016	criteria provided, single submitter							
NM_020975.6(RET):c.3204C>A (p.Asn1068Lys)	RET	N673K, N806K, N1068K, N585K, N726K, N769K, N1023K, N1025K, N1048K, N565K, N826K, N922K, N936K, N972K	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001728852	10	43623576	10	43128128	1728852	1788487		NC_000010.11:43128127:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3204C>G (p.Asn1068Lys)	RET	N1068K	Hereditary cancer-predisposing syndrome	VCV000823183	10	43623576	10	43128128	823183	809972	rs768699100	NC_000010.11:43128127:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 8, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.3204C>T (p.Asn1068=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000794949	10	43623576	10	43128128	794949	783592	rs768699100	NC_000010.11:43128127:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 8, 2020	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3205T>C (p.Trp1069Arg)	RET	W1069R, W923R, W1026R, W1049R, W566R, W1024R, W674R, W827R, W937R, W586R, W727R, W770R, W807R, W973R	Hereditary cancer-predisposing syndrome	VCV002568374	10	43623577	10	43128129	2568374	2734910		NC_000010.11:43128128:T:C	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Jun 1, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3206G>C (p.Trp1069Ser)	RET	W1069S	not provided|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1	VCV000220521	10	43623578	10	43128130	220521	221977	rs776615468	NC_000010.11:43128129:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 22, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3207G>T (p.Trp1069Cys)	RET	W1024C, W1026C, W1069C, W586C, W674C, W727C, W807C, W937C, W1049C, W566C, W827C, W923C, W973C, W770C	Hereditary cancer-predisposing syndrome	VCV001728879	10	43623579	10	43128131	1728879	1785170		NC_000010.11:43128130:G:T	single nucleotide variant	missense variant	Uncertain significance	May 3, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.3209C>G (p.Pro1070Arg)	RET	P1027R, P587R, P675R, P808R, P828R, P938R, P1025R, P567R, P1050R, P771R, P974R, P1070R, P728R, P924R	Multiple endocrine neoplasia, type 2	VCV001983101	10	43623581	10	43128133	1983101	2046161		NC_000010.11:43128132:C:G	single nucleotide variant	missense variant	Uncertain significance	May 29, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.3210T>C (p.Pro1070=)	RET		Hereditary cancer-predisposing syndrome	VCV003227551	10	43623582	10	43128134	3227551	3390762		NC_000010.11:43128133:T:C	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Likely benign	Oct 2, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3217_3218dup (p.Ser1073fs)	RET	S1073fs	Multiple endocrine neoplasia, type 2|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Familial medullary thyroid carcinoma|Hereditary cancer-predisposing syndrome	VCV001433312	10	43623583 - 43623584	10	43128135 - 43128136	1433312	1493885	rs1428704590	NC_000010.11:43128135:GAGAGAG:GAGAGAGAG	Microsatellite	frameshift variant	Uncertain significance	Jan 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3211G>A (p.Gly1071Arg)	RET	G1071R	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001368696	10	43623583	10	43128135	1368696	1340288	rs1321512022	NC_000010.11:43128134:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3212G>A (p.Gly1071Glu)	RET	G1026E, G588E, G676E, G809E, G1071E, G1028E, G1051E, G729E, G829E, G568E, G772E, G925E, G939E, G975E	Hereditary cancer-predisposing syndrome	VCV003432269	10	43623584	10	43128136	3432269	3593465		NC_000010.11:43128135:G:A	single nucleotide variant	3 prime UTR variant|missense variant|intron variant	Likely benign	Sep 22, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3214G>C (p.Glu1072Gln)	RET	E589Q, E677Q, E730Q, E1052Q, E569Q, E926Q, E940Q, E1029Q, E773Q, E810Q, E830Q, E976Q, E1027Q, E1072Q	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002781405	10	43623586	10	43128138	2781405	2937803		NC_000010.11:43128137:G:C	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Mar 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3215A>G (p.Glu1072Gly)	RET	E1027G, E1052G, E940G, E1072G, E677G, E1029G, E569G, E773G, E810G, E926G, E589G, E730G, E830G, E976G	Multiple endocrine neoplasia, type 2	VCV001989878	10	43623587	10	43128139	1989878	2037424		NC_000010.11:43128138:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 22, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.3217A>C (p.Ser1073Arg)	RET	S831R, S941R, S1053R, S570R, S678R, S774R, S811R, S1028R, S1030R, S590R, S927R, S1073R, S731R, S977R	Hereditary cancer-predisposing syndrome	VCV001728999	10	43623589	10	43128141	1728999	1785289		NC_000010.11:43128140:A:C	single nucleotide variant	missense variant	Uncertain significance	May 14, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.3219T>C (p.Ser1073=)	RET		Hereditary cancer-predisposing syndrome	VCV003432276	10	43623591	10	43128143	3432276	3593472		NC_000010.11:43128142:T:C	single nucleotide variant	3 prime UTR variant|synonymous variant|intron variant	Likely benign	Oct 11, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3219T>A (p.Ser1073Arg)	RET	S1073R	Multiple endocrine neoplasia, type 2	VCV001389081	10	43623591	10	43128143	1389081	1476661	rs1838374750	NC_000010.11:43128142:T:A	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3220C>G (p.Pro1074Ala)	RET	P1054A, P591A, P775A, P928A, P1074A, P571A, P732A, P812A, P1029A, P679A, P1031A, P832A, P942A, P978A	Hereditary cancer-predisposing syndrome	VCV001729078	10	43623592	10	43128144	1729078	1785367		NC_000010.11:43128143:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 16, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.3222dup (p.Val1075fs)	RET	V1075fs	Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2	VCV000979070	10	43623593 - 43623594	10	43128145 - 43128146	979070	967151	rs1838374810	NC_000010.11:43128145:T:TT	Duplication	frameshift variant	Conflicting classifications of pathogenicity	Apr 24, 2023	criteria provided, conflicting classifications							
NM_020975.6(RET):c.3223G>C (p.Val1075Leu)	RET	V1030L, V1032L, V1055L, V572L, V592L, V733L, V979L, V680L, V776L, V943L, V813L, V1075L, V833L, V929L	Multiple endocrine neoplasia, type 2	VCV002781178	10	43623595	10	43128147	2781178	2937576		NC_000010.11:43128146:G:C	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Sep 30, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3223G>A (p.Val1075Ile)	RET	V572I, V733I, V1032I, V680I, V776I, V813I, V943I, V1030I, V592I, V833I, V979I, V1055I, V1075I, V929I	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001729105	10	43623595	10	43128147	1729105	1785394		NC_000010.11:43128146:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 15, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3226C>A (p.Pro1076Thr)	RET	P1033T, P593T, P734T, P777T, P814T, P834T, P944T, P980T, P1031T, P1076T, P681T, P1056T, P573T, P930T	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001729126	10	43623598	10	43128150	1729126	1785415		NC_000010.11:43128149:C:A	single nucleotide variant	missense variant	Uncertain significance	Oct 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3226C>T (p.Pro1076Ser)	RET	P1076S	Multiple endocrine neoplasia, type 2	VCV001378768	10	43623598	10	43128150	1378768	1407960	rs2133048192	NC_000010.11:43128149:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 13, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.3230T>C (p.Leu1077Pro)	RET	L1032P, L1034P, L1057P, L1077P, L574P, L594P, L682P, L735P, L778P, L815P, L835P, L931P, L945P, L981P	Multiple endocrine neoplasia, type 2	VCV003074602	10	43623602	10	43128154	3074602	3229569		NC_000010.11:43128153:T:C	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Nov 20, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3231C>A (p.Leu1077=)	RET		not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001729198	10	43623603	10	43128155	1729198	1785487		NC_000010.11:43128154:C:A	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Conflicting classifications of pathogenicity	Jun 13, 2023	criteria provided, conflicting classifications							
NM_020975.6(RET):c.3231C>G (p.Leu1077=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000215915	10	43623603	10	43128155	215915	212796	rs765409417	NC_000010.11:43128154:C:G	single nucleotide variant	synonymous variant	Likely benign	Nov 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3232A>G (p.Thr1078Ala)	RET	T1078A, T575A, T779A, T836A, T1033A, T1035A, T816A, T1058A, T595A, T946A, T982A, T683A, T736A, T932A	Hereditary cancer-predisposing syndrome	VCV001729207	10	43623604	10	43128156	1729207	1785496		NC_000010.11:43128155:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 5, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.3233C>A (p.Thr1078Lys)	RET	T1033K, T575K, T595K, T816K, T932K, T1035K, T836K, T946K, T1058K, T1078K, T683K, T736K, T779K, T982K	Hereditary cancer-predisposing syndrome	VCV003432238	10	43623605	10	43128157	3432238	3593434		NC_000010.11:43128156:C:A	single nucleotide variant	3 prime UTR variant|missense variant|intron variant	Uncertain significance	Jul 24, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3233C>G (p.Thr1078Arg)	RET	T1078R	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000823248	10	43623605	10	43128157	823248	809973	rs762952212	NC_000010.11:43128156:C:G	single nucleotide variant	missense variant	Uncertain significance	Sep 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3233C>T (p.Thr1078Met)	RET	T1078M	Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|not provided|not specified	VCV000405556	10	43623605	10	43128157	405556	397494	rs762952212	NC_000010.11:43128156:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3234G>A (p.Thr1078=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001141918	10	43623606	10	43128158	1141918	1141137	rs766376008	NC_000010.11:43128157:G:A	single nucleotide variant	synonymous variant	Likely benign	Sep 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3237_3238del (p.Arg1079fs)	RET	R1079fs	not specified	VCV000403372	10	43623606 - 43623607	10	43128158 - 43128159	403372	389956	rs1060499895	NC_000010.11:43128157:GAGAG:GAG	Microsatellite	frameshift variant	Uncertain significance	Dec 16, 2016	criteria provided, single submitter							
NM_020975.6(RET):c.3240T>C (p.Ala1080=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV003432268	10	43623612	10	43128164	3432268	3593464		NC_000010.11:43128163:T:C	single nucleotide variant	3 prime UTR variant|synonymous variant|intron variant	Likely benign	Sep 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3240T>A (p.Ala1080=)	RET		Hereditary cancer-predisposing syndrome	VCV001729305	10	43623612	10	43128164	1729305	1785593		NC_000010.11:43128163:T:A	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Likely benign	Mar 4, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.3241G>A (p.Asp1081Asn)	RET	D1081N	Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000405528	10	43623613	10	43128165	405528	397313	rs745955777	NC_000010.11:43128164:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 23, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3243T>A (p.Asp1081Glu)	RET	D1036E, D1061E, D598E, D839E, D985E, D1038E, D739E, D782E, D578E, D949E, D1081E, D686E, D819E, D935E	Hereditary cancer-predisposing syndrome	VCV001729327	10	43623615	10	43128167	1729327	1795003		NC_000010.11:43128166:T:A	single nucleotide variant	missense variant	Uncertain significance	Nov 24, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.3243T>C (p.Asp1081=)	RET		Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Renal hypodysplasia/aplasia 1|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia|Hereditary cancer-predisposing syndrome	VCV000136118	10	43623615	10	43128167	136118	139830	rs144192900	NC_000010.11:43128166:T:C	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Feb 2, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.3244G>A (p.Gly1082Ser)	RET	G1037S, G579S, G936S, G950S, G1062S, G783S, G986S, G1039S, G1082S, G740S, G599S, G687S, G820S, G840S	Multiple endocrine neoplasia, type 2	VCV003650070	10	43623616	10	43128168	3650070	3788066		NC_000010.11:43128167:G:A	single nucleotide variant	3 prime UTR variant|missense variant|intron variant	Uncertain significance	Apr 16, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3245del (p.Gly1082fs)	RET	G1037fs, G1039fs, G1062fs, G1082fs, G579fs, G599fs, G687fs, G740fs, G783fs, G820fs, G840fs, G936fs, G950fs, G986fs	Hereditary cancer-predisposing syndrome	VCV003227552	10	43623616	10	43128168	3227552	3390763		NC_000010.11:43128167:GG:G	Deletion	frameshift variant|3 prime UTR variant|intron variant	Uncertain significance	Jan 18, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3245G>A (p.Gly1082Asp)	RET	G1082D	Multiple endocrine neoplasia, type 2	VCV000477371	10	43623617	10	43128169	477371	460753	rs1554820310	NC_000010.11:43128168:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 11, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.3247_3254del (p.Thr1083fs)	RET	T1083fs	Multiple endocrine neoplasia, type 2	VCV001017166	10	43623618 - 43623625	10	43128170 - 43128177	1017166	1009004	rs1838375749	NC_000010.11:43128169:CACTAACAC:C	Deletion	frameshift variant	Uncertain significance	Jun 4, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.3247A>T (p.Thr1083Ser)	RET	T1038S, T1040S, T1063S, T1083S, T580S, T600S, T688S, T741S, T784S, T821S, T841S, T937S, T951S, T987S	Hereditary cancer-predisposing syndrome	VCV003227553	10	43623619	10	43128171	3227553	3390764		NC_000010.11:43128170:A:T	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Jan 22, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3247A>G (p.Thr1083Ala)	RET	T1083A	Multiple endocrine neoplasia, type 2	VCV000241361	10	43623619	10	43128171	241361	240814	rs878855064	NC_000010.11:43128170:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 24, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3249T>C (p.Thr1083=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001161054	10	43623621	10	43128173	1161054	1141138	rs2133048607	NC_000010.11:43128172:T:C	single nucleotide variant	synonymous variant	Likely benign	Oct 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3252C>T (p.Asn1084=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000486356	10	43623624	10	43128176	486356	475349	rs1172754809	NC_000010.11:43128175:C:T	single nucleotide variant	synonymous variant	Likely benign	May 22, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3253A>T (p.Thr1085Ser)	RET	T1042S, T1065S, T1085S, T743S, T823S, T989S, T582S, T602S, T690S, T953S, T1040S, T786S, T843S, T939S	Hereditary cancer-predisposing syndrome	VCV001729442	10	43623625	10	43128177	1729442	1795118		NC_000010.11:43128176:A:T	single nucleotide variant	missense variant	Uncertain significance	May 21, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.3253A>G (p.Thr1085Ala)	RET	T1085A	Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|not provided|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Renal hypodysplasia/aplasia 1|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia	VCV000183744	10	43623625	10	43128177	183744	182958	rs756465544	NC_000010.11:43128176:A:G	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 22, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.3256G>A (p.Gly1086Arg)	RET	G1086R	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000568473	10	43623628	10	43128180	568473	563773	rs778452896	NC_000010.11:43128179:G:A	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 16, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.3257G>C (p.Gly1086Ala)	RET	G1041A, G1066A, G603A, G787A, G844A, G1043A, G990A, G583A, G824A, G940A, G954A, G1086A, G691A, G744A	Hereditary cancer-predisposing syndrome	VCV002587895	10	43623629	10	43128181	2587895	2760719		NC_000010.11:43128180:G:C	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Sep 14, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3262C>T (p.Pro1088Ser)	RET	P789S, P956S, P1043S, P1068S, P1045S, P1088S, P605S, P693S, P826S, P942S, P585S, P746S, P846S, P992S	Multiple endocrine neoplasia, type 2	VCV003652847	10	43623634	10	43128186	3652847	3778236		NC_000010.11:43128185:C:T	single nucleotide variant	3 prime UTR variant|missense variant|intron variant	Uncertain significance	Aug 13, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3264A>G (p.Pro1088=)	RET		Hereditary cancer-predisposing syndrome	VCV000486333	10	43623636	10	43128188	486333	475298	rs1554820314	NC_000010.11:43128187:A:G	single nucleotide variant	synonymous variant	Likely benign	Mar 4, 2016	criteria provided, single submitter							
NM_020975.6(RET):c.3265A>G (p.Arg1089Gly)	RET	R1089G	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001345530	10	43623637	10	43128189	1345530	1452398	rs864622486	NC_000010.11:43128188:A:G	single nucleotide variant	missense variant	Uncertain significance	May 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3265A>C (p.Arg1089=)	RET		Multiple endocrine neoplasia, type 2	VCV000220347	10	43623637	10	43128189	220347	221978	rs864622486	NC_000010.11:43128188:A:C	single nucleotide variant	synonymous variant	Likely benign	Apr 30, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.3266G>A (p.Arg1089Lys)	RET	R1089K, R586K, R606K, R943K, R957K, R747K, R993K, R1046K, R694K, R790K, R827K, R847K, R1044K, R1069K	Multiple endocrine neoplasia, type 2	VCV002793841	10	43623638	10	43128190	2793841	2961011		NC_000010.11:43128189:G:A	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Feb 23, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3266G>T (p.Arg1089Ile)	RET	R1089I	Multiple endocrine neoplasia, type 2	VCV001518654	10	43623638	10	43128190	1518654	1509047	rs1245283352	NC_000010.11:43128189:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 22, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3268T>C (p.Tyr1090His)	RET	Y1045H, Y1047H, Y1070H, Y1090H, Y587H, Y607H, Y695H, Y748H, Y791H, Y828H, Y848H, Y944H, Y958H, Y994H	Multiple endocrine neoplasia, type 2	VCV003387609	10	43623640	10	43128192	3387609	3546740		NC_000010.11:43128191:T:C	single nucleotide variant	3 prime UTR variant|missense variant|intron variant	Uncertain significance	Sep 23, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3270T>C (p.Tyr1090=)	RET		Multiple endocrine neoplasia, type 2	VCV001538309	10	43623642	10	43128194	1538309	1619535	rs745469112	NC_000010.11:43128193:T:C	single nucleotide variant	synonymous variant	Likely benign	Nov 8, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3271C>A (p.Pro1091Thr)	RET	P1091T	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000572394	10	43623643	10	43128195	572394	569668	rs1564502605	NC_000010.11:43128194:C:A	single nucleotide variant	missense variant	Uncertain significance	Nov 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3274A>T (p.Asn1092Tyr)	RET	N850Y, N996Y, N1072Y, N589Y, N960Y, N1047Y, N1049Y, N750Y, N830Y, N609Y, N793Y, N1092Y, N697Y, N946Y	Hereditary cancer-predisposing syndrome	VCV001729653	10	43623646	10	43128198	1729653	1795328		NC_000010.11:43128197:A:T	single nucleotide variant	missense variant	Uncertain significance	Sep 30, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.3274A>G (p.Asn1092Asp)	RET	N1047D, N1049D, N1072D, N830D, N996D, N1092D, N946D, N609D, N697D, N793D, N589D, N750D, N850D, N960D	Hereditary cancer-predisposing syndrome	VCV001729652	10	43623646	10	43128198	1729652	1795327		NC_000010.11:43128197:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 16, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3274A>C (p.Asn1092His)	RET	N830H, N1047H, N1072H, N750H, N946H, N1049H, N1092H, N793H, N589H, N609H, N697H, N850H, N960H, N996H	Hereditary cancer-predisposing syndrome	VCV001729651	10	43623646	10	43128198	1729651	1795326		NC_000010.11:43128197:A:C	single nucleotide variant	missense variant	Uncertain significance	May 26, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.3275A>G (p.Asn1092Ser)	RET	N1092S	Multiple endocrine neoplasia, type 2	VCV002778419	10	43623647	10	43128199	2778419	197385	rs757852794	NC_000010.11:43128198:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 16, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3277G>A (p.Asp1093Asn)	RET	D1093N	Multiple endocrine neoplasia, type 2	VCV000999762	10	43623649	10	43128201	999762	993828	rs1838376422	NC_000010.11:43128200:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 13, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.3278A>G (p.Asp1093Gly)	RET	D1093G	Multiple endocrine neoplasia, type 2|Hirschsprung disease, susceptibility to, 1	VCV001416919	10	43623650	10	43128202	1416919	1487659	rs1564502609	NC_000010.11:43128201:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3280dup (p.Ser1094fs)	RET	S1049fs, S1051fs, S1074fs, S1094fs, S591fs, S611fs, S699fs, S752fs, S795fs, S832fs, S852fs, S948fs, S962fs, S998fs	Hereditary cancer-predisposing syndrome	VCV003227554	10	43623651 - 43623652	10	43128203 - 43128204	3227554	3390765		NC_000010.11:43128203:A:AA	Duplication	frameshift variant|3 prime UTR variant|intron variant	Uncertain significance	Oct 6, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3279T>C (p.Asp1093=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000220623	10	43623651	10	43128203	220623	221979	rs864622608	NC_000010.11:43128202:T:C	single nucleotide variant	synonymous variant	Likely benign	Aug 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3280A>G (p.Ser1094Gly)	RET	S1094G	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001016923	10	43623652	10	43128204	1016923	1009005	rs1171787901	NC_000010.11:43128203:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3280A>C (p.Ser1094Arg)	RET	S1094R	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000569236	10	43623652	10	43128204	569236	564590	rs1171787901	NC_000010.11:43128203:A:C	single nucleotide variant	missense variant	Uncertain significance	Jun 24, 2022	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3281G>T (p.Ser1094Ile)	RET	S1074I, S591I, S752I, S852I, S1049I, S1051I, S611I, S998I, S1094I, S832I, S699I, S795I, S948I, S962I	Multiple endocrine neoplasia, type 2	VCV002745332	10	43623653	10	43128205	2745332	2907392		NC_000010.11:43128204:G:T	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Jul 19, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3281G>A (p.Ser1094Asn)	RET	S1094N	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|not provided	VCV000543722	10	43623653	10	43128205	543722	525337	rs1198591686	NC_000010.11:43128204:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3282T>C (p.Ser1094=)	RET		Multiple endocrine neoplasia, type 2	VCV002889747	10	43623654	10	43128206	2889747	3054858		NC_000010.11:43128205:T:C	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Likely benign	Oct 30, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3283G>A (p.Val1095Ile)	RET	V1075I, V1095I, V592I, V963I, V999I, V1052I, V833I, V1050I, V612I, V853I, V949I, V700I, V753I, V796I	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001729771	10	43623655	10	43128207	1729771	1791978		NC_000010.11:43128206:G:A	single nucleotide variant	missense variant	Uncertain significance	May 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3284T>A (p.Val1095Glu)	RET	V612E, V700E, V753E, V833E, V949E, V1050E, V1052E, V796E, V1075E, V963E, V999E, V1095E, V592E, V853E	Multiple endocrine neoplasia, type 2	VCV002702807	10	43623656	10	43128208	2702807	2866358		NC_000010.11:43128207:T:A	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Dec 14, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3285A>G (p.Val1095=)	RET		Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	VCV000938274	10	43623657	10	43128209	938274	935041	rs1838376770	NC_000010.11:43128208:A:G	single nucleotide variant	synonymous variant	Conflicting classifications of pathogenicity	Apr 24, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.3292_3302del (p.Asn1098fs)	RET	N1002fs, N1053fs, N1078fs, N836fs, N856fs, N615fs, N799fs, N703fs, N756fs, N952fs, N966fs, N1055fs, N1098fs, N595fs	Hereditary cancer-predisposing syndrome	VCV003432287	10	43623659 - 43623669	10	43128211 - 43128221	3432287	3593483		NC_000010.11:43128210:ATGCTAACTGGATGCT:ATGCT	Deletion	3 prime UTR variant|frameshift variant|intron variant	Uncertain significance	Nov 14, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3287A>G (p.Tyr1096Cys)	RET	Y1096C	Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Pheochromocytoma|Multiple endocrine neoplasia type 2A|Familial medullary thyroid carcinoma|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000543742	10	43623659	10	43128211	543742	525645	rs768752146	NC_000010.11:43128210:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3288T>C (p.Tyr1096=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002496744	10	43623660	10	43128212	2496744	2467883		NC_000010.11:43128211:T:C	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Likely benign	Feb 6, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3288T>G (p.Tyr1096Ter)	RET	Y1096*	not provided	VCV000430252	10	43623660	10	43128212	430252	421788	rs1131691861	NC_000010.11:43128211:T:G	single nucleotide variant	nonsense	Likely pathogenic	Dec 2, 2019	criteria provided, single submitter							
NM_020975.6(RET):c.3289G>A (p.Ala1097Thr)	RET	A1097T	Hereditary cancer-predisposing syndrome	VCV000823434	10	43623661	10	43128213	823434	809974	rs1588881946	NC_000010.11:43128212:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 17, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.3291T>C (p.Ala1097=)	RET		Multiple endocrine neoplasia, type 2	VCV003619050	10	43623663	10	43128215	3619050	3759530		NC_000010.11:43128214:T:C	single nucleotide variant	3 prime UTR variant|synonymous variant|intron variant	Likely benign	Nov 18, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3294C>G (p.Asn1098Lys)	RET	N1002K, N1053K, N1055K, N1078K, N1098K, N595K, N615K, N703K, N756K, N799K, N836K, N856K, N952K, N966K	Hereditary cancer-predisposing syndrome	VCV003227555	10	43623666	10	43128218	3227555	3390766		NC_000010.11:43128217:C:G	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Nov 22, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3294C>A (p.Asn1098Lys)	RET	N1098K	not provided|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000823477	10	43623666	10	43128218	823477	809975	rs1298393691	NC_000010.11:43128217:C:A	single nucleotide variant	missense variant	Uncertain significance	Sep 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3295T>C (p.Trp1099Arg)	RET	W1079R, W704R, W967R, W1054R, W616R, W757R, W596R, W837R, W857R, W953R, W1003R, W1056R, W1099R, W800R	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001729880	10	43623667	10	43128219	1729880	1792087		NC_000010.11:43128218:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 11, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3297G>T (p.Trp1099Cys)	RET	W1056C, W1099C, W757C, W967C, W1003C, W1079C, W704C, W800C, W857C, W953C, W1054C, W596C, W616C, W837C	Hereditary cancer-predisposing syndrome	VCV001729901	10	43623669	10	43128221	1729901	1792108		NC_000010.11:43128220:G:T	single nucleotide variant	missense variant	Uncertain significance	Sep 10, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.3297G>A (p.Trp1099Ter)	RET	W1003*, W1056*, W1079*, W857*, W953*, W596*, W800*, W837*, W1054*, W1099*, W967*, W616*, W704*, W757*	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001729899	10	43623669	10	43128221	1729899	1792106		NC_000010.11:43128220:G:A	single nucleotide variant	nonsense	Uncertain significance	May 14, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3298A>G (p.Met1100Val)	RET	M1100V	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001525849	10	43623670	10	43128222	1525849	1395905	rs2133049527	NC_000010.11:43128221:A:G	single nucleotide variant	missense variant	Uncertain significance	Jul 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3299T>C (p.Met1100Thr)	RET	M1080T, M758T, M801T, M954T, M1057T, M597T, M617T, M705T, M838T, M968T, M1004T, M1055T, M1100T, M858T	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002618909	10	43623671	10	43128223	2618909	2782654		NC_000010.11:43128222:T:C	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Aug 28, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3300G>T (p.Met1100Ile)	RET	M1100I, M597I, M617I, M705I, M758I, M801I, M838I, M858I, M954I, M968I, M1004I, M1055I, M1057I, M1080I	Hereditary cancer-predisposing syndrome	VCV003227556	10	43623672	10	43128224	3227556	3390767		NC_000010.11:43128223:G:T	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Oct 5, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3300G>C (p.Met1100Ile)	RET	M1100I	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000967314	10	43623672	10	43128224	967314	956055	rs747917164	NC_000010.11:43128223:G:C	single nucleotide variant	missense variant	Uncertain significance	Jun 1, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3301C>T (p.Leu1101Phe)	RET	L1058F, L759F, L802F, L839F, L859F, L1005F, L598F, L969F, L1081F, L618F, L955F, L1056F, L1101F, L706F	Hereditary cancer-predisposing syndrome	VCV003313740	10	43623673	10	43128225	3313740	3465470		NC_000010.11:43128224:C:T	single nucleotide variant	3 prime UTR variant|missense variant|intron variant	Uncertain significance	May 31, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3302T>A (p.Leu1101His)	RET	L1005H, L1056H, L1058H, L1081H, L1101H, L598H, L618H, L706H, L759H, L802H, L839H, L859H, L955H, L969H	Multiple endocrine neoplasia, type 2	VCV003387610	10	43623674	10	43128226	3387610	3546741		NC_000010.11:43128225:T:A	single nucleotide variant	3 prime UTR variant|missense variant|intron variant	Uncertain significance	Jun 17, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3302T>C (p.Leu1101Pro)	RET	L1101P, L618P, L759P, L839P, L1056P, L955P, L1081P, L598P, L706P, L969P, L1005P, L1058P, L802P, L859P	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001961265	10	43623674	10	43128226	1961265	2020111		NC_000010.11:43128225:T:C	single nucleotide variant	missense variant	Uncertain significance	Feb 22, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3303T>G (p.Leu1101=)	RET		Multiple endocrine neoplasia, type 2	VCV003018318	10	43623675	10	43128227	3018318	3182494		NC_000010.11:43128226:T:G	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Likely benign	Feb 8, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3303T>C (p.Leu1101=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000543788	10	43623675	10	43128227	543788	525178	rs1554820320	NC_000010.11:43128226:T:C	single nucleotide variant	synonymous variant	Likely benign	Dec 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3304T>C (p.Ser1102Pro)	RET	S1102P	not provided|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000823518	10	43623676	10	43128228	823518	809976	rs1305555370	NC_000010.11:43128227:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Dec 3, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.3305C>T (p.Ser1102Leu)	RET	S1102L	Multiple endocrine neoplasia, type 2	VCV001004869	10	43623677	10	43128229	1004869	993829	rs773306778	NC_000010.11:43128228:C:T	single nucleotide variant	missense variant	Uncertain significance	Feb 24, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3307C>T (p.Pro1103Ser)	RET	P1007S, P804S, P957S, P600S, P620S, P1058S, P761S, P861S, P1060S, P1083S, P1103S, P708S, P841S, P971S	Hereditary cancer-predisposing syndrome	VCV003432204	10	43623679	10	43128231	3432204	3593401		NC_000010.11:43128230:C:T	single nucleotide variant	3 prime UTR variant|missense variant|intron variant	Uncertain significance	Oct 25, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3308C>T (p.Pro1103Leu)	RET	P1058L, P841L, P861L, P1103L, P600L, P708L, P761L, P804L, P957L, P1083L, P620L, P1007L, P1060L, P971L	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV001730035	10	43623680	10	43128232	1730035	1792241		NC_000010.11:43128231:C:T	single nucleotide variant	missense variant	Uncertain significance	May 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3309C>T (p.Pro1103=)	RET		Hereditary cancer-predisposing syndrome	VCV002587882	10	43623681	10	43128233	2587882	2760706		NC_000010.11:43128232:C:T	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Likely benign	Jul 20, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3310T>C (p.Ser1104Pro)	RET	S601P, S621P, S762P, S958P, S1061P, S1084P, S805P, S842P, S1008P, S1059P, S1104P, S709P, S862P, S972P	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV002734004	10	43623682	10	43128234	2734004	2898337		NC_000010.11:43128233:T:C	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Jun 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3311C>T (p.Ser1104Leu)	RET	S1104L	Multiple endocrine neoplasia, type 2	VCV001026400	10	43623683	10	43128235	1026400	1009006	rs1838377764	NC_000010.11:43128234:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 21, 2020	criteria provided, single submitter							
NM_020975.6(RET):c.3312A>C (p.Ser1104=)	RET		Hereditary cancer-predisposing syndrome	VCV002454138	10	43623684	10	43128236	2454138	2424027		NC_000010.11:43128235:A:C	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Likely benign	Jan 12, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3312A>G (p.Ser1104=)	RET		Multiple endocrine neoplasia, type 2	VCV002201347	10	43623684	10	43128236	2201347	1924884		NC_000010.11:43128235:A:G	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Likely benign	Feb 27, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.3314C>T (p.Ala1105Val)	RET	A1105V	Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|not specified|Hirschsprung disease, susceptibility to, 1|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Familial medullary thyroid carcinoma	VCV000201136	10	43623686	10	43128238	201136	197386	rs532862288	NC_000010.11:43128237:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Jan 13, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.3315G>A (p.Ala1105=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000941324	10	43623687	10	43128239	941324	935042	rs766572480	NC_000010.11:43128238:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 25, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3316G>A (p.Ala1106Thr)	RET	A1106T	Multiple endocrine neoplasia, type 2	VCV001038777	10	43623688	10	43128240	1038777	1029556	rs1838377953	NC_000010.11:43128239:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 23, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.3317C>G (p.Ala1106Gly)	RET	A1106G	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000653252	10	43623689	10	43128241	653252	638940	rs1338777037	NC_000010.11:43128240:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3321A>G (p.Lys1107=)	RET		Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000704393	10	43623693	10	43128245	704393	692843	rs1588881974	NC_000010.11:43128244:A:G	single nucleotide variant	synonymous variant	Likely benign	Nov 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3322T>C (p.Leu1108=)	RET		Multiple endocrine neoplasia, type 2	VCV002917109	10	43623694	10	43128246	2917109	3077171		NC_000010.11:43128245:T:C	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Likely benign	Nov 23, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.3322T>G (p.Leu1108Val)	RET	L1063V, L1108V, L962V, L1065V, L605V, L1088V, L713V, L809V, L866V, L1012V, L625V, L766V, L846V, L976V	Multiple endocrine neoplasia, type 2	VCV001983139	10	43623694	10	43128246	1983139	2046199		NC_000010.11:43128245:T:G	single nucleotide variant	missense variant	Uncertain significance	May 6, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3324A>C (p.Leu1108Phe)	RET	L1012F, L1063F, L1065F, L1088F, L1108F, L605F, L625F, L713F, L766F, L809F, L846F, L866F, L962F, L976F	Hereditary cancer-predisposing syndrome	VCV003227557	10	43623696	10	43128248	3227557	3390768		NC_000010.11:43128247:A:C	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Likely benign	Feb 1, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3325A>G (p.Met1109Val)	RET	M1013V, M1064V, M1089V, M963V, M1109V, M626V, M714V, M810V, M847V, M1066V, M606V, M767V, M867V, M977V	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002196812	10	43623697	10	43128249	2196812	1929871		NC_000010.11:43128248:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 16, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3326T>G (p.Met1109Arg)	RET	M1109R	not provided	VCV003381603	10	43623698	10	43128250	3381603	796401	rs587780813	NC_000010.11:43128249:T:G	single nucleotide variant	missense variant	Uncertain significance	May 21, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3326T>C (p.Met1109Thr)	RET	M1109T	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not provided|Hirschsprung disease, susceptibility to, 1	VCV000136119	10	43623698	10	43128250	136119	139831	rs587780813	NC_000010.11:43128249:T:C	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Feb 2, 2025	criteria provided, conflicting classifications							
NM_020975.6(RET):c.3332C>T (p.Thr1111Met)	RET	T1111M	not specified|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV000964019	10	43623704	10	43128256	964019	946900	rs1003057639	NC_000010.11:43128255:C:T	single nucleotide variant	missense variant	Conflicting classifications of pathogenicity	Oct 28, 2024	criteria provided, conflicting classifications							
NM_020975.6(RET):c.3333G>A (p.Thr1111=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV000241362	10	43623705	10	43128257	241362	240815	rs753203348	NC_000010.11:43128256:G:A	single nucleotide variant	synonymous variant	Likely benign	Jun 29, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3335T>C (p.Phe1112Ser)	RET	F1016S, F1067S, F1112S, F609S, F850S, F1092S, F629S, F980S, F1069S, F717S, F813S, F870S, F966S, F770S	Hereditary cancer-predisposing syndrome	VCV001730353	10	43623707	10	43128259	1730353	1788687		NC_000010.11:43128258:T:C	single nucleotide variant	missense variant	Uncertain significance	Jun 6, 2023	criteria provided, single submitter							
NM_020975.6(RET):c.3336T>C (p.Phe1112=)	RET		Hereditary cancer-predisposing syndrome|not provided|Multiple endocrine neoplasia, type 2	VCV000477372	10	43623708	10	43128260	477372	459886	rs146049841	NC_000010.11:43128259:T:C	single nucleotide variant	synonymous variant	Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3337G>A (p.Asp1113Asn)	RET	D1113N	Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome	VCV001019577	10	43623709	10	43128261	1019577	1009007	rs1838378725	NC_000010.11:43128260:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 19, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3339dup (p.Ser1114Ter)	RET	S1114*	Hereditary cancer-predisposing syndrome	VCV000486335	10	43623710 - 43623711	10	43128262 - 43128263	486335	475351	rs1554820326	NC_000010.11:43128262:T:TT	Duplication	nonsense	Uncertain significance	Mar 14, 2016	criteria provided, single submitter							
NM_020975.6(RET):c.3339T>C (p.Asp1113=)	RET		Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not provided	VCV000806459	10	43623711	10	43128263	806459	796402	rs1198032104	NC_000010.11:43128262:T:C	single nucleotide variant	synonymous variant	Likely benign	Aug 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3340A>T (p.Ser1114Cys)	RET	S1071C, S631C, S815C, S852C, S872C, S968C, S1018C, S611C, S719C, S772C, S1069C, S1094C, S1114C, S982C	Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2	VCV002993024	10	43623712	10	43128264	2993024	3148163		NC_000010.11:43128263:A:T	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Uncertain significance	Dec 15, 2023	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.3341G>A (p.Ser1114Asn)	RET	S1018N, S1069N, S1094N, S1114N, S852N, S1071N, S772N, S982N, S611N, S631N, S872N, S968N, S719N, S815N	Hereditary cancer-predisposing syndrome	VCV003313720	10	43623713	10	43128265	3313720	3465450		NC_000010.11:43128264:G:A	single nucleotide variant	3 prime UTR variant|missense variant|intron variant	Uncertain significance	Apr 13, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.3342T>C (p.Ser1114=)	RET		Hereditary cancer-predisposing syndrome	VCV001730437	10	43623714	10	43128266	1730437	1788771		NC_000010.11:43128265:T:C	single nucleotide variant	synonymous variant|3 prime UTR variant|intron variant	Likely benign	Apr 29, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.3342T>G (p.Ser1114Arg)	RET	S1114R	Multiple endocrine neoplasia, type 2	VCV001390173	10	43623714	10	43128266	1390173	1373772	rs2133050305	NC_000010.11:43128265:T:G	single nucleotide variant	missense variant	Uncertain significance	Oct 29, 2021	criteria provided, single submitter							
NM_020975.6(RET):c.*5T>C	RET		Multiple endocrine neoplasia, type 2	VCV003387611	10	43623722	10	43128274	3387611	3546742		NC_000010.11:43128273:T:C	single nucleotide variant	3 prime UTR variant|intron variant	Uncertain significance	Jul 10, 2024	criteria provided, single submitter							
NM_020975.6(RET):c.*6C>G	RET		not specified|not provided	VCV001723364	10	43623723	10	43128275	1723364	1780851		NC_000010.11:43128274:C:G	single nucleotide variant	3 prime UTR variant	Uncertain significance	Aug 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.*29C>A	RET		Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|not specified|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1	VCV000877386	10	43623746	10	43128298	877386	865868	rs199639914	NC_000010.11:43128297:C:A	single nucleotide variant	3 prime UTR variant	Conflicting classifications of pathogenicity	Aug 15, 2023	criteria provided, conflicting classifications							
NM_020975.6(RET):c.*84G>A	RET		Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia|Pheochromocytoma|Renal hypodysplasia/aplasia 1	VCV000299902	10	43623801	10	43128353	299902	310293	rs558718557	NC_000010.11:43128352:G:A	single nucleotide variant	3 prime UTR variant	Conflicting classifications of pathogenicity	Jan 13, 2018	criteria provided, conflicting classifications							
NM_020975.6(RET):c.*95C>T	RET		Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia|Pheochromocytoma|Renal hypodysplasia/aplasia 1|not provided	VCV000299903	10	43623812	10	43128364	299903	322120	rs17028	NC_000010.11:43128363:C:T	single nucleotide variant	3 prime UTR variant	Benign	Jan 13, 2018	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.*159G>T	RET		Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1	VCV000879000	10	43623876	10	43128428	879000	865869	rs1838381962	NC_000010.11:43128427:G:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Apr 27, 2017	criteria provided, single submitter							
NM_020975.6(RET):c.*175C>G	RET		Multiple endocrine neoplasia|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Renal hypodysplasia/aplasia 1	VCV000299904	10	43623892	10	43128444	299904	315394	rs886046990	NC_000010.11:43128443:C:G	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.*180G>A	RET		Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1	VCV000880217	10	43623897	10	43128449	880217	865870	rs1838382247	NC_000010.11:43128448:G:A	single nucleotide variant	3 prime UTR variant	Uncertain significance	Apr 27, 2017	criteria provided, single submitter							
NM_020975.6(RET):c.*330A>G	RET		Multiple endocrine neoplasia|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Renal hypodysplasia/aplasia 1	VCV000299905	10	43624047	10	43128599	299905	315397	rs141460872	NC_000010.11:43128598:A:G	single nucleotide variant	3 prime UTR variant	Benign/Likely benign	Jan 13, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.*358G>T	RET		Multiple endocrine neoplasia|Pheochromocytoma|Renal hypodysplasia/aplasia 1|Hirschsprung Disease, Dominant	VCV000299906	10	43624075	10	43128627	299906	310301	rs886046991	NC_000010.11:43128626:G:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jun 14, 2016	criteria provided, single submitter							
NM_020975.6(RET):c.*368G>T	RET		Multiple endocrine neoplasia|Pheochromocytoma|Renal hypodysplasia/aplasia 1|Hirschsprung Disease, Dominant	VCV000299907	10	43624085	10	43128637	299907	315398	rs756051983	NC_000010.11:43128636:G:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jun 14, 2016	criteria provided, single submitter							
NM_020975.6(RET):c.*388G>A	RET		Multiple endocrine neoplasia|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Renal hypodysplasia/aplasia 1|not provided	VCV000299908	10	43624105	10	43128657	299908	321398	rs3026782	NC_000010.11:43128656:G:A	single nucleotide variant	3 prime UTR variant	Benign	Jan 12, 2018	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.*446A>G	RET		Multiple endocrine neoplasia|Pheochromocytoma|Renal hypodysplasia/aplasia 1|Hirschsprung Disease, Dominant	VCV000299909	10	43624163	10	43128715	299909	315399	rs886046992	NC_000010.11:43128714:A:G	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jun 14, 2016	criteria provided, single submitter							
NM_020975.6(RET):c.*453G>T	RET		Multiple endocrine neoplasia|Pheochromocytoma|Renal hypodysplasia/aplasia 1|Hirschsprung Disease, Dominant	VCV000299910	10	43624170	10	43128722	299910	315400	rs886046993	NC_000010.11:43128721:G:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jun 14, 2016	criteria provided, single submitter							
NM_020975.6(RET):c.*499dup	RET		Multiple endocrine neoplasia|Pheochromocytoma|Renal hypodysplasia/aplasia 1|Hirschsprung Disease, Dominant	VCV000299911	10	43624208 - 43624209	10	43128760 - 43128761	299911	322121	rs201945709	NC_000010.11:43128760:GGGGGGGG:GGGGGGGGG	Duplication	3 prime UTR variant	Likely benign	Jun 14, 2016	criteria provided, single submitter							
NM_020975.6(RET):c.*492G>C	RET		Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1	VCV000877445	10	43624209	10	43128761	877445	865871	rs568766449	NC_000010.11:43128760:G:C	single nucleotide variant	3 prime UTR variant	Benign/Likely benign	Jan 13, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.*500C>T	RET		not provided	VCV002640419	10	43624217	10	43128769	2640419	2813111		NC_000010.11:43128768:C:T	single nucleotide variant	3 prime UTR variant|intron variant	Likely benign	Dec 1, 2022	criteria provided, single submitter							
NM_020975.6(RET):c.*500C>G	RET		Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1	VCV000878467	10	43624217	10	43128769	878467	865872	rs564665995	NC_000010.11:43128768:C:G	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.*506G>T	RET		Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1	VCV000299912	10	43624223	10	43128775	299912	310303	rs886046995	NC_000010.11:43128774:G:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.*509A>G	RET		Pheochromocytoma|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1|Hirschsprung Disease, Dominant	VCV000299913	10	43624226	10	43128778	299913	315401	rs886046996	NC_000010.11:43128777:A:G	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jun 14, 2016	criteria provided, single submitter							
NM_020975.6(RET):c.*538G>T	RET		Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1	VCV000299914	10	43624255	10	43128807	299914	321411	rs886046997	NC_000010.11:43128806:G:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.*553G>T	RET		Pheochromocytoma|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1|Hirschsprung Disease, Dominant	VCV000299915	10	43624270	10	43128822	299915	310308	rs886046998	NC_000010.11:43128821:G:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jun 14, 2016	criteria provided, single submitter							
NM_020975.6(RET):c.*576G>A	RET		Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1|not provided	VCV000299916	10	43624293	10	43128845	299916	310309	rs185408658	NC_000010.11:43128844:G:A	single nucleotide variant	3 prime UTR variant	Benign/Likely benign	Jan 13, 2018	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.*600delinsTT	RET		Pheochromocytoma|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1|Hirschsprung Disease, Dominant	VCV000299917	10	43624317	10	43128869	299917	322125	rs1588882236	NC_000010.11:43128868:A:TT	Indel	3 prime UTR variant	Uncertain significance	Jun 14, 2016	criteria provided, single submitter							
NM_020975.6(RET):c.*749dup	RET		Pheochromocytoma|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1|Hirschsprung Disease, Dominant	VCV000299918	10	43624461 - 43624462	10	43129013 - 43129014	299918	322128	rs886047000	NC_000010.11:43129013:CCCCC:CCCCCC	Duplication	3 prime UTR variant	Uncertain significance	Jun 14, 2016	criteria provided, single submitter							
NM_020975.6(RET):c.*763C>T	RET		Pheochromocytoma|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1|Hirschsprung Disease, Dominant	VCV000299919	10	43624480	10	43129032	299919	322139	rs886047001	NC_000010.11:43129031:C:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jun 14, 2016	criteria provided, single submitter							
NM_020975.6(RET):c.*824G>T	RET		Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1	VCV000299920	10	43624541	10	43129093	299920	310315	rs886047002	NC_000010.11:43129092:G:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.*883G>A	RET		Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1	VCV000877490	10	43624600	10	43129152	877490	865873	rs1838396430	NC_000010.11:43129151:G:A	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.*935C>A	RET		Pheochromocytoma|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1|Hirschsprung Disease, Dominant	VCV000299921	10	43624652	10	43129204	299921	310324	rs886047003	NC_000010.11:43129203:C:A	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jun 14, 2016	criteria provided, single submitter							
NM_020975.6(RET):c.*1020G>T	RET		Pheochromocytoma|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1|Hirschsprung Disease, Dominant	VCV000299922	10	43624737	10	43129289	299922	322140	rs886047004	NC_000010.11:43129288:G:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jun 14, 2016	criteria provided, single submitter							
NM_020975.6(RET):c.*1046G>C	RET		Hirschsprung disease, susceptibility to, 1|not provided|Pheochromocytoma|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1	VCV000878517	10	43624763	10	43129315	878517	865874	rs143948954	NC_000010.11:43129314:G:C	single nucleotide variant	3 prime UTR variant	Conflicting classifications of pathogenicity	Mar 1, 2023	criteria provided, conflicting classifications							
NM_020975.6(RET):c.*1103C>T	RET		Pheochromocytoma|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia|Hirschsprung Disease, Dominant	VCV000299923	10	43624820	10	43129372	299923	322141	rs886047005	NC_000010.11:43129371:C:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jun 14, 2016	criteria provided, single submitter							
NM_020975.6(RET):c.*1109T>C	RET		Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1	VCV000299924	10	43624826	10	43129378	299924	310330	rs886047006	NC_000010.11:43129377:T:C	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.*1112A>G	RET		Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1	VCV000879101	10	43624829	10	43129381	879101	865875	rs1353594500	NC_000010.11:43129380:A:G	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.*1116T>C	RET		Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1|not provided	VCV000299925	10	43624833	10	43129385	299925	322142	rs2435355	NC_000010.11:43129384:T:C	single nucleotide variant	3 prime UTR variant	Benign	May 14, 2021	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.*1130A>G	RET		Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1|not provided	VCV000299926	10	43624847	10	43129399	299926	310333	rs572936041	NC_000010.11:43129398:A:G	single nucleotide variant	3 prime UTR variant	Conflicting classifications of pathogenicity	Apr 1, 2023	criteria provided, conflicting classifications							
NM_020975.6(RET):c.*1212C>T	RET		Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1	VCV000299927	10	43624929	10	43129481	299927	321412	rs551902553	NC_000010.11:43129480:C:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.*1233T>C	RET		Pheochromocytoma|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1|Hirschsprung Disease, Dominant	VCV000299928	10	43624950	10	43129502	299928	321414	rs886047007	NC_000010.11:43129501:T:C	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jun 14, 2016	criteria provided, single submitter							
NM_020975.6(RET):c.*1278del	RET		Pheochromocytoma|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia|Hirschsprung Disease, Dominant	VCV000299929	10	43624991	10	43129543	299929	322151	rs886047008	NC_000010.11:43129542:GGGGG:GGGG	Deletion	3 prime UTR variant	Uncertain significance	Jun 14, 2016	criteria provided, single submitter							
NM_020975.6(RET):c.*1326T>C	RET		Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1	VCV000877535	10	43625043	10	43129595	877535	865876	rs141016377	NC_000010.11:43129594:T:C	single nucleotide variant	3 prime UTR variant	Conflicting classifications of pathogenicity	Jan 12, 2018	criteria provided, conflicting classifications							
NM_020975.6(RET):c.*1337A>T	RET		Pheochromocytoma|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia|Hirschsprung Disease, Dominant	VCV000299930	10	43625054	10	43129606	299930	322153	rs886047009	NC_000010.11:43129605:A:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jun 14, 2016	criteria provided, single submitter							
NM_020975.6(RET):c.*1345G>T	RET		Pheochromocytoma|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia|Hirschsprung Disease, Dominant	VCV000299931	10	43625062	10	43129614	299931	315409	rs886047010	NC_000010.11:43129613:G:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jun 14, 2016	criteria provided, single submitter							
NM_020975.6(RET):c.*1348G>A	RET		Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia	VCV000299932	10	43625065	10	43129617	299932	322160	rs149252070	NC_000010.11:43129616:G:A	single nucleotide variant	3 prime UTR variant	Conflicting classifications of pathogenicity	Jan 12, 2018	criteria provided, conflicting classifications							
NM_020975.6(RET):c.*1430A>G	RET		Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|not provided|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1	VCV000878562	10	43625147	10	43129699	878562	865877	rs775114955	NC_000010.11:43129698:A:G	single nucleotide variant	3 prime UTR variant	Conflicting classifications of pathogenicity	Jan 1, 2023	criteria provided, conflicting classifications							
NM_020975.6(RET):c.*1489G>A	RET		Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia	VCV000299933	10	43625206	10	43129758	299933	315411	rs535080963	NC_000010.11:43129757:G:A	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.*1506G>A	RET		Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia|not provided	VCV000299934	10	43625223	10	43129775	299934	315412	rs2742241	NC_000010.11:43129774:G:A	single nucleotide variant	3 prime UTR variant	Benign	May 14, 2021	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.*1516C>T	RET		Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1	VCV000880357	10	43625233	10	43129785	880357	865878	rs886985086	NC_000010.11:43129784:C:T	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.*1533A>G	RET		Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1	VCV000877587	10	43625250	10	43129802	877587	865879	rs1838409564	NC_000010.11:43129801:A:G	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.*1558A>C	RET		Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia	VCV000299935	10	43625275	10	43129827	299935	315418	rs142572876	NC_000010.11:43129826:A:C	single nucleotide variant	3 prime UTR variant	Benign/Likely benign	Jan 12, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.*1583G>A	RET		Hirschsprung disease, susceptibility to, 1|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia|Pheochromocytoma	VCV000299936	10	43625300	10	43129852	299936	321415	rs192065891	NC_000010.11:43129851:G:A	single nucleotide variant	3 prime UTR variant	Benign/Likely benign	Jan 13, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.*1591G>A	RET		Hirschsprung disease, susceptibility to, 1|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia|Pheochromocytoma|not provided	VCV000299937	10	43625308	10	43129860	299937	321417	rs76759170	NC_000010.11:43129859:G:A	single nucleotide variant	3 prime UTR variant	Benign/Likely benign	May 15, 2021	criteria provided, multiple submitters, no conflicts							
NM_020975.6(RET):c.*1599G>A	RET		Hirschsprung disease, susceptibility to, 1|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia|Pheochromocytoma	VCV000299938	10	43625316	10	43129868	299938	321419	rs145954635	NC_000010.11:43129867:G:A	single nucleotide variant	3 prime UTR variant	Benign/Likely benign	Jan 13, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.*1644G>C	RET		Hirschsprung disease, susceptibility to, 1|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia|Pheochromocytoma	VCV000299939	10	43625361	10	43129913	299939	315419	rs117119161	NC_000010.11:43129912:G:C	single nucleotide variant	3 prime UTR variant	Conflicting classifications of pathogenicity	Jan 12, 2018	criteria provided, conflicting classifications							
NM_020975.6(RET):c.*1646T>G	RET		Hirschsprung disease, susceptibility to, 1|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia|Pheochromocytoma	VCV000299940	10	43625363	10	43129915	299940	322161	rs886047011	NC_000010.11:43129914:T:G	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.*1659T>C	RET		Hirschsprung disease, susceptibility to, 1|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia|Pheochromocytoma	VCV000299941	10	43625376	10	43129928	299941	310334	rs886047012	NC_000010.11:43129927:T:C	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.*1742G>A	RET		Pheochromocytoma|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia|Hirschsprung Disease, Dominant	VCV000299942	10	43625459	10	43130011	299942	310337	rs143369221	NC_000010.11:43130010:G:A	single nucleotide variant	3 prime UTR variant	Likely benign	Jun 14, 2016	criteria provided, single submitter							
NM_020975.6(RET):c.*1797T>G	RET		Hirschsprung disease, susceptibility to, 1|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia|Pheochromocytoma	VCV000299944	10	43625514	10	43130066	299944	322168	rs886047013	NC_000010.11:43130065:T:G	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.*1797T>C	RET		Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia	VCV000299943	10	43625514	10	43130066	299943	321420	rs886047013	NC_000010.11:43130065:T:C	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.*1812C>A	RET		Renal hypodysplasia/aplasia 1|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia	VCV000877645	10	43625529	10	43130081	877645	865880	rs183817000	NC_000010.11:43130080:C:A	single nucleotide variant	3 prime UTR variant	Conflicting classifications of pathogenicity	Jan 12, 2018	criteria provided, conflicting classifications							
NM_020975.6(RET):c.*1870C>T	RET		Hirschsprung disease, susceptibility to, 1|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia|Pheochromocytoma	VCV000299945	10	43625587	10	43130139	299945	321423	rs146771196	NC_000010.11:43130138:C:T	single nucleotide variant	3 prime UTR variant	Benign/Likely benign	Jan 12, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.*1886T>G	RET		Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1	VCV000878659	10	43625603	10	43130155	878659	865881	rs1019095754	NC_000010.11:43130154:T:G	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 13, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.*1900C>A	RET		Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1	VCV000879260	10	43625617	10	43130169	879260	865882	rs956882000	NC_000010.11:43130168:C:A	single nucleotide variant	3 prime UTR variant	Uncertain significance	Jan 12, 2018	criteria provided, single submitter							
NM_020975.6(RET):c.*1969T>C	RET		not provided|Pheochromocytoma|Renal hypodysplasia/aplasia 1|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia	VCV000013954	10	43625686	10	43130238	13954	28993	rs3026785	NC_000010.11:43130237:T:C	single nucleotide variant	3 prime UTR variant	Benign/Likely benign	May 15, 2021	criteria provided, multiple submitters, no conflicts							
NC_000010.10:g.(?_43619099)_(43623717_?)dup	RET		Multiple endocrine neoplasia, type 2	VCV003244918	10	43619099 - 43623717			3244918	3402280			Duplication		Uncertain significance	Dec 28, 2023	criteria provided, single submitter							
NC_000010.10:g.(?_43614959)_(43623717_?)dup	RET		Multiple endocrine neoplasia, type 2	VCV003244917	10	43614959 - 43623717			3244917	3402279			Duplication		Uncertain significance	Jan 24, 2024	criteria provided, single submitter							
GRCh37/hg19 10q11.21-24.2(chr10:42709645-100834951)x3	RRP12|RTKN2|RUFY2|SAMD8|SAR1A|SEC24C|SFRP5|SFTPA1|SFTPA2|SFTPD|SGMS1|SGPL1|SH2D4B|SHLD2|SIRT1|SLC16A12|SLC16A9|SLC18A3|SLC25A16|SLC29A3|SLC35G1|SLIT1|SNCG|SORBS1|SPOCK2|SRGN|STAMBPL1|STOX1|SUPV3L1|SYNPO2L|SYT15|TACR2|TBATA|TBC1D12|TCTN3|TET1|TFAM|TIMM23|TLL2|TM9SF3|TMEM254|TMEM26|TMEM273|TMEM72|TNKS2|TSPAN14|TSPAN15|TYSND1|UBE2D1|UBTD1|UNC5B|USP54|VCL|VDAC2|VPS26A|VSIR|VSTM4|WAPL|WASHC2A|WASHC2C|WDFY4|ZCCHC24|ZDHHC16|ZFAND4|ZFYVE27|ZMIZ1|ZNF22|ZNF22-AS1|ZNF239|ZNF32|ZNF33B|ZNF365|ZNF485|ZNF488|ZNF503|ZNF518A|ZSWIM8|ZWINT|A1CF|ACSM6|ACTA2|ADAMTS14|ADIRF|ADIRF-AS1|ADK|ADO|AGAP10|AGAP11|AGAP4|AGAP5|AGAP6|AGAP9|AIFM2|ALDH18A1|ALOX5|ANAPC16|ANK3|ANKRD1|ANKRD2|ANKRD22|ANXA11|ANXA7|ANXA8|ANXA8L1|AP3M1|ARHGAP19|ARHGAP22|ARID5B|ASAH2|ASAH2B|ASCC1|ATAD1|ATOH7|AVPI1|BICC1|BLNK|BMPR1A|BMS1|BTAF1|C10orf105|C10orf12|C10orf131|C10orf53|C10orf55|C10orf62|C10orf71|CABCOCO1|CAMK2G|CC2D2B|CCAR1|CCDC6|CCNJ|CCSER2|CDH23|CDHR1|CDK1|CEP55|CFAP70|CH25H|CHAT|CHCHD1|CHST3|CISD1|COL13A1|COMTD1|CPEB3|CRTAC1|CSGALNACT2|CSTF2T|CTNNA3|CXCL12|CYP26A1|CYP26C1|CYP2C18|CYP2C19|CYP2C8|CYP2C9|DDIT4|DDX21|DDX50|DEPP1|DKK1|DLG5|DNA2|DNAJB12|DNAJC12|DNAJC9|DNTT|DRGX|DUSP13B|DUSP29|DYDC1|DYDC2|ECD|EGR2|EIF4EBP2|EIF5AL1|ENTPD1|ERCC6|EXOC6|EXOSC1|FAM13C|FAM149B1|FAM170B|FAM241B|FAM25A|FAM25C|FAM25E|FAM25G|FAS|FAS-AS1|FFAR4|FGFBP3|FRA10AC1|FRAT1|FRAT2|FRMPD2|FUT11|FXYD4|GDF10|GDF2|GHITM|GLUD1|GOLGA7B|GPR15LG|GPRIN2|GRID1|HECTD2|HELLS|HERC4|HHEX|HK1|HKDC1|HNRNPF|HNRNPH3|HOGA1|HPS1|HPSE2|HTR7|IDE|IFIT1|IFIT1B|IFIT2|IFIT3|IFIT5|IPMK|JMJD1C|KAT6B|KCNMA1|KIF11|KIF20B|KIFBP|KLLN|LCOR|LDB3|LGI1|LINC01520|LIPA|LIPF|LIPJ|LIPK|LIPM|LIPN|LOC101929662|LOXL4|LRIT1|LRIT2|LRMDA|LRRC18|LRRC20|LRRTM3|MACROH2A2|MAPK8|MARCHF5|MARCHF8|MARVELD1|MAT1A|MBL2|MCU|MICU1|MINPP1|MIR107|MIR346|MMRN2|MMS19|MORN4|MRPS16|MSMB|MSS51|MTRNR2L5|MYOF|MYOZ1|MYPN|NCOA4|NDST2|NEUROG3|NOC3L|NODAL|NPFFR1|NPY4R|NRBF2|NRG3|NUDT13|NUTM2A|NUTM2B|OGDHL|OIT3|OPALIN|OPN4|OR13A1|P4HA1|PALD1|PANK1|PAPSS2|PARG|PBLD|PCBD1|PCDH15|PCGF5|PDE6C|PDLIM1|PGAM1|PGBD3|PHYHIPL|PI4K2A|PIK3AP1|PLA2G12B|PLAC9|PLAU|PLCE1|POLR3A|PPA1|PPIF|PPP1R3C|PPP3CB|PRF1|PRKG1|PRXL2A|PSAP|PTEN|PTPN20|PYROXD2|R3HCC1L|RASGEF1A|RASSF4|RBP3|RBP4|REEP3|RET|RGR|RHOBTB1|RNLS|RPP30|RPS24		not provided	VCV002684602	10	42709645 - 100834951			2684602	2845637			copy number gain		Pathogenic	Jul 9, 2022	criteria provided, single submitter							
GRCh37/hg19 10p14-q26.3(chr10:11138692-135427143)	AGAP5|CRTAC1|CSGALNACT2|CYP2C18|AGAP6|ANKRD1|AGAP9|AIFM2|ALDH18A1|ALOX5|ANAPC16|ANK3|CSTF2T|CTBP2|CWF19L1|CXCL12|CYP17A1|CYP26A1|CYP26C1|A1CF|ABCC2|ABI1|ABLIM1|ABRAXAS2|ACADSB|ACBD5|ACBD7|ACSL5|ACSM6|ACTA2|ACTR1A|ADAM12|ADAM8|ADAMTS14|ADD3|ADGRA1|ADIRF|ADIRF-AS1|ADK|ADO|ADRA2A|ADRB1|AFAP1L2|AGAP10|AGAP11|AGAP4|ANKRD2|ANKRD22|ANKRD26|ANKRD30A|ANXA11|ANXA7|ANXA8|ANXA8L1|AP3M1|APBB1IP|ARHGAP12|ARHGAP19|ARHGAP21|ARHGAP22|ARID5B|ARL3|ARL5B|ARMC3|ARMH3|ARMS2|AS3MT|ASAH2|ASAH2B|ASCC1|ATAD1|ATE1|ATOH7|ATP5MK|ATRNL1|AVPI1|BAG3|BAMBI|BBIP1|BCCIP|BEND7|BICC1|BLNK|BLOC1S2|BMI1|BMPR1A|BMS1|BNIP3|BORCS7|BTAF1|BTBD16|BTRC|BUB3|C10orf105|C10orf113|C10orf12|C10orf120|C10orf126|C10orf131|C10orf53|C10orf55|C10orf62|C10orf67|C10orf71|C10orf88|C10orf90|C10orf95|C1QL3|CABCOCO1|CACNB2|CACUL1|CALHM1|CALHM2|CALHM3|CALY|CAMK1D|CAMK2G|CASC2|CASP7|CC2D2B|CCAR1|CCDC172|CCDC186|CCDC3|CCDC6|CCDC7|CCNJ|CCNY|CCSER2|CDC123|CDH23|CDHR1|CDK1|CDNF|CELF2|CEP55|CFAP43|CFAP46|CFAP58|CFAP70|CH25H|CHAT|CHCHD1|CHST15|CHST3|CHUK|CISD1|CLRN3|CNNM1|CNNM2|COL13A1|COL17A1|COMMD3|COMMD3-BMI1|COMTD1|COX15|CPEB3|CPN1|CPXM2|CREM|CTNNA3|CUBN|CUEDC2|CUL2|CUTC|CUZD1|CYP2C19|CYP2C8|CYP2C9|CYP2E1|DCLRE1A|DCLRE1C|DDIT4|DDX21|DDX50|DENND10|DEPP1|DHTKD1|DHX32|DKK1|DLG5|DMBT1|DNA2|DNAJB12|DNAJC1|DNAJC12|DNAJC9|DNMBP|DNTT|DOCK1|DPCD|DPYSL4|DRGX|DUSP13B|DUSP29|DUSP5|DYDC1|DYDC2|EBF3|EBLN1|ECD|ECHDC3|ECHS1|EDRF1|EEF1AKMT2|EGR2|EIF3A|EIF4EBP2|EIF5AL1|ELOVL3|EMX2|EMX2OS|ENKUR|ENO4|ENTPD1|ENTPD7|EPC1|ERCC6|ERLIN1|EXOC6|EXOSC1|FAM107B|FAM13C|FAM149B1|FAM170B|FAM171A1|FAM204A|FAM241B|FAM24A|FAM24B|FAM25A|FAM25C|FAM25E|FAM25G|FAM53B|FANK1|FAS|FAS-AS1|FBXL15|FBXW4|FFAR4|FGF8|FGFBP3|FGFR2|FHIP2A|FOXI2|FRA10AC1|FRAT1|FRAT2|FRMD4A|FRMPD2|FUOM|FUT11|FXYD4|FZD8|GAD2|GBF1|GDF10|GDF2|GFRA1|GHITM|GJD4|GLRX3|GLUD1|GOLGA7B|GOT1|GPAM|GPR158|GPR15LG|GPR26|GPRIN2|GRID1|GRK5|GSTO1|GSTO2|HABP2|HACD1|HECTD2|HELLS|HERC4|HHEX|HIF1AN|HK1|HKDC1|HMX2|HMX3|HNRNPF|HNRNPH3|HOGA1|HPS1|HPS6|HPSE2|HSPA12A|HSPA14|HTR7|HTRA1|IDE|IFIT1|IFIT1B|IFIT2|IFIT3|IFIT5|IKZF5|INA|INPP5A|INPP5F|INSYN2A|IPMK|ITGA8|ITGB1|ITPRIP|JAKMIP3|JCAD|JMJD1C|KAT6B|KAZALD1|KCNIP2|KCNK18|KCNMA1|KIAA1217|KIF11|KIF20B|KIF5B|KIFBP|KLLN|KNDC1|LBX1|LCOR|LDB1|LDB3|LGI1|LHPP|LINC01166|LINC01520|LINC02870|LIPA|LIPF|LIPJ|LIPK|LIPM|LIPN|LOC101929662|LOXL4|LRIT1|LRIT2|LRMDA|LRRC18|LRRC20|LRRC27|LRRTM3|LYZL1|LYZL2|LZTS2|MACROH2A2|MAP3K8|MAPK8|MARCHF5|MARCHF8|MARVELD1|MASTL|MAT1A|MBL2|MCM10|MCMBP|MCU|MEIG1|MFSD13A|MGMT|MICU1|MINDY3|MINPP1|MIR107|MIR146B|MIR1915|MIR1915HG|MIR346|MKI67|MKX|MLLT10|MMP21|MMRN2|MMS19|MORN4|MPP7|MRPL43|MRPS16|MSMB|MSRB2|MSS51|MTG1|MTPAP|MTRNR2L5|MTRNR2L7|MXI1|MYO3A|MYOF|MYOZ1|MYPN|NANOS1|NCOA4|NDST2|NDUFB8|NEBL|NEURL1|NEUROG3|NFKB2|NHLRC2|NKX1-2|NKX2-3|NKX6-2|NMT2|NOC3L|NODAL|NOLC1|NPFFR1|NPM3|NPS|NPY4R|NRAP|NRBF2|NRG3|NRP1|NSMCE4A|NSUN6|NT5C2|NUDT13|NUDT5|NUTM2A|NUTM2B|OAT|ODAD2|OGA|OGDHL|OIT3|OLAH|OPALIN|OPN4|OPTN|OR13A1|OTUD1|P4HA1|PALD1|PANK1|PAOX|PAPSS2|PARD3|PARG|PAX2|PBLD|PCBD1|PCDH15|PCGF5|PCGF6|PDCD11|PDCD4|PDE6C|PDLIM1|PDSS1|PDZD7|PDZD8|PGAM1|PGBD3|PHYH|PHYHIPL|PI4K2A|PIK3AP1|PIP4K2A|PITX3|PKD2L1|PLA2G12B|PLAC9|PLAU|PLCE1|PLEKHA1|PLEKHS1|PLPP4|PLXDC2|PNLIP|PNLIPRP1|PNLIPRP2|PNLIPRP3|POLL|POLR3A|PPA1|PPIF|PPP1R3C|PPP2R2D|PPP3CB|PPRC1|PRAP1|PRDX3|PRF1|PRINS|PRKG1|PRLHR|PROSER2|PRPF18|PRTFDC1|PRXL2A|PSAP|PSD|PSTK|PTCHD3|PTEN|PTER|PTF1A|PTPN20|PTPRE|PWWP2B|PYROXD2|R3HCC1L|RAB11FIP2|RAB18|RASGEF1A|RASSF4|RBM20|RBP3|RBP4|REEP3|RET|RGR|RGS10|RHOBTB1|RNLS|RPP30|RPP38|RPP38-DT|RPS24|RRP12|RSU1|RTKN2|RUFY2|SAMD8|SAR1A|SCD|SEC23IP|SEC24C|SEC31B|SEC61A2|SEMA4G|SEPHS1|SFR1|SFRP5|SFTPA1|SFTPA2|SFTPD|SFXN2|SFXN3|SFXN4|SGMS1|SGPL1|SH2D4B|SH3PXD2A|SHLD2|SHOC2|SHTN1|SIRT1|SKIDA1|SLC16A12|SLC16A9|SLC18A2|SLC18A3|SLC25A16|SLC25A28|SLC29A3|SLC35G1|SLC39A12|SLF2|SLIT1|SLK|SMC3|SMNDC1|SNCG|SNORA12|SORBS1|SORCS1|SORCS3|SPAG6|SPMIP5|SPOCK2|SPRN|SRGN|ST8SIA6|STAM|STAMBPL1|STK32C|STN1|STOX1|SUFU|SUPV3L1|SUV39H2|SVIL|SYCE1|SYNPO2L|SYT15|TACC2|TACR2|TAF5|TBATA|TBC1D12|TCERG1L|TCERG1L-AS1|TCF7L2|TCTN3|TDRD1|TECTB|TET1|TEX36|TFAM|THNSL1|TIAL1|TIMM23|TLL2|TLX1|TLX1NB|TM9SF3|TMEM254|TMEM26|TMEM273|TMEM72|TNKS2|TRDMT1|TRIM8|TRUB1|TSPAN14|TSPAN15|TUBGCP2|TWNK|TYSND1|UBE2D1|UBTD1|UCMA|UNC5B|UPF2|UROS|USP54|USP6NL|UTF1|VAX1|VCL|VDAC2|VENTX|VIM|VPS26A|VSIR|VSTM4|VTI1A|VWA2|WAC|WAPL|WASHC2A|WASHC2C|WBP1L|WDFY4|WDR11|WNT8B|XPNPEP1|YME1L1|ZCCHC24|ZDHHC16|ZDHHC6|ZEB1|ZFAND4|ZFYVE27|ZMIZ1|ZNF22|ZNF22-AS1|ZNF239|ZNF248|ZNF25|ZNF32|ZNF33A|ZNF33B|ZNF365|ZNF37A|ZNF438|ZNF485|ZNF488|ZNF503|ZNF511|ZNF518A|ZRANB1|ZSWIM8|ZWINT		Distal trisomy 10q	VCV002574696	10	11138692 - 135427143			2574696	2739632			copy number gain		Pathogenic		no assertion criteria provided							
GRCh37/hg19 10p13-q26.3(chr10:12829206-135427143)	ABRAXAS2|CHCHD1|CLRN3|CHST3|CHST15|CHUK|CISD1|ADRA2A|PHYH|PHYHIPL|SYCE1|ACADSB|ACBD5|ACBD7|ACSL5|ACSM6|ADIRF-AS1|ADGRA1|ADIRF|ADK|ADO|A1CF|ABCC2|ABI1|ABLIM1|ACTA2|ACTR1A|ADAM12|ADAM8|ADAMTS14|ADD3|ADRB1|AFAP1L2|AGAP10|AGAP11|AGAP4|AGAP5|AGAP6|AGAP9|AIFM2|ALDH18A1|ALOX5|ANAPC16|ANK3|ANKRD1|ANKRD2|ANKRD22|ANKRD26|ANKRD30A|ANXA11|ANXA7|ANXA8|ANXA8L1|AP3M1|APBB1IP|ARHGAP12|ARHGAP19|ARHGAP21|ARHGAP22|ARID5B|ARL3|ARL5B|ARMC3|ARMH3|ARMS2|AS3MT|ASAH2|ASAH2B|ASCC1|ATAD1|ATE1|ATOH7|ATP5MK|ATRNL1|AVPI1|BAG3|BAMBI|BBIP1|BCCIP|BEND7|BICC1|BLNK|BLOC1S2|BMI1|BMPR1A|BMS1|BNIP3|BORCS7|BTAF1|BTBD16|BTRC|BUB3|C10orf105|C10orf113|C10orf12|C10orf120|C10orf126|C10orf131|C10orf53|C10orf55|C10orf62|C10orf67|C10orf71|C10orf88|C10orf90|C10orf95|C1QL3|CABCOCO1|CACNB2|CACUL1|CALHM1|CALHM2|CALHM3|CALY|CAMK1D|CAMK2G|CASC2|CASP7|CC2D2B|CCAR1|CCDC172|CCDC186|CCDC3|CCDC6|CCDC7|CCNJ|CCNY|CCSER2|CDH23|CDHR1|CDK1|CDNF|CEP55|CFAP43|CFAP46|CFAP58|CFAP70|CH25H|CHAT|CNNM1|CNNM2|COL13A1|COL17A1|COMMD3|COMMD3-BMI1|COMTD1|COX15|CPEB3|CPN1|CPXM2|CREM|CRTAC1|CSGALNACT2|CSTF2T|CTBP2|CTNNA3|CUBN|CUEDC2|CUL2|CUTC|CUZD1|CWF19L1|CXCL12|CYP17A1|CYP26A1|CYP26C1|CYP2C18|CYP2C19|CYP2C8|CYP2C9|CYP2E1|DCLRE1A|DCLRE1C|DDIT4|DDX21|DDX50|DENND10|DEPP1|DHX32|DKK1|DLG5|DMBT1|DNA2|DNAJB12|DNAJC1|DNAJC12|DNAJC9|DNMBP|DNTT|DOCK1|DPCD|DPYSL4|DRGX|DUSP13B|DUSP29|DUSP5|DYDC1|DYDC2|EBF3|EBLN1|ECD|ECHS1|EDRF1|EEF1AKMT2|EGR2|EIF3A|EIF4EBP2|EIF5AL1|ELOVL3|EMX2|EMX2OS|ENKUR|ENO4|ENTPD1|ENTPD7|EPC1|ERCC6|ERLIN1|EXOC6|EXOSC1|FAM107B|FAM13C|FAM149B1|FAM170B|FAM171A1|FAM204A|FAM241B|FAM24A|FAM24B|FAM25A|FAM25C|FAM25E|FAM25G|FAM53B|FANK1|FAS|FAS-AS1|FBXL15|FBXW4|FFAR4|FGF8|FGFBP3|FGFR2|FHIP2A|FOXI2|FRA10AC1|FRAT1|FRAT2|FRMD4A|FRMPD2|FUOM|FUT11|FXYD4|FZD8|GAD2|GBF1|GDF10|GDF2|GFRA1|GHITM|GJD4|GLRX3|GLUD1|GOLGA7B|GOT1|GPAM|GPR158|GPR15LG|GPR26|GPRIN2|GRID1|GRK5|GSTO1|GSTO2|HABP2|HACD1|HECTD2|HELLS|HERC4|HHEX|HIF1AN|HK1|HKDC1|HMX2|HMX3|HNRNPF|HNRNPH3|HOGA1|HPS1|HPS6|HPSE2|HSPA12A|HSPA14|HTR7|HTRA1|IDE|IFIT1|IFIT1B|IFIT2|IFIT3|IFIT5|IKZF5|INA|INPP5A|INPP5F|INSYN2A|IPMK|ITGA8|ITGB1|ITPRIP|JAKMIP3|JCAD|JMJD1C|KAT6B|KAZALD1|KCNIP2|KCNK18|KCNMA1|SYNPO2L|PLEKHA1|PLPP4|PLXDC2|PNLIP|PLEKHS1|PIK3AP1|SYT15|TACC2|LIPA|LINC01166|LINC01520|LINC02870|KLLN|TACR2|TAF5|TBATA|TBC1D12|TCERG1L|KIFBP|PI4K2A|PIP4K2A|KNDC1|KIAA1217|KIF11|KIF20B|KIF5B|LBX1|LCOR|LDB1|LDB3|LGI1|LHPP|LIPF|LIPJ|LIPK|LIPM|LIPN|LOC101929662|LOXL4|LRIT1|LRIT2|LRMDA|LRRC18|LRRC20|LRRC27|LRRTM3|LYZL1|LYZL2|LZTS2|MACROH2A2|MAP3K8|MAPK8|MARCHF5|MARCHF8|MARVELD1|MASTL|MAT1A|MBL2|MCM10|MCMBP|MCU|MEIG1|MFSD13A|MGMT|MICU1|MINDY3|MINPP1|MIR107|MIR146B|MIR1915|MIR1915HG|MIR346|MKI67|MKX|MLLT10|MMP21|MMRN2|MMS19|MORN4|MPP7|MRPL43|MRPS16|MSMB|MSRB2|MSS51|MTG1|MTPAP|MTRNR2L5|MTRNR2L7|MXI1|MYO3A|MYOF|MYOZ1|MYPN|NANOS1|NCOA4|NDST2|NDUFB8|NEBL|NEURL1|NEUROG3|NFKB2|NHLRC2|NKX1-2|NKX2-3|NKX6-2|NMT2|NOC3L|NODAL|NOLC1|NPFFR1|NPM3|NPS|NPY4R|NRAP|NRBF2|NRG3|NRP1|NSMCE4A|NSUN6|NT5C2|NUDT13|NUTM2A|NUTM2B|OAT|ODAD2|OGA|OGDHL|OIT3|OLAH|OPALIN|OPN4|OPTN|OR13A1|OTUD1|P4HA1|PALD1|PANK1|PAOX|PAPSS2|PARD3|PARG|PAX2|PBLD|PCBD1|PCDH15|PCGF5|PCGF6|PDCD11|PDCD4|PDE6C|PDLIM1|PDSS1|PDZD7|PDZD8|PGAM1|PGBD3|PITX3|PKD2L1|PLA2G12B|PLAC9|PLAU|PLCE1|PNLIPRP1|PNLIPRP2|PNLIPRP3|POLL|POLR3A|PPA1|PPIF|PPP1R3C|PPP2R2D|PPP3CB|PPRC1|PRAP1|PRDX3|PRF1|PRINS|PRKG1|PRLHR|PRPF18|PRTFDC1|PRXL2A|PSAP|PSD|PSTK|PTCHD3|PTEN|PTER|PTF1A|PTPN20|PTPRE|PWWP2B|PYROXD2|R3HCC1L|RAB11FIP2|RAB18|RASGEF1A|RASSF4|RBM20|RBP3|RBP4|REEP3|RET|RGR|RGS10|RHOBTB1|RNLS|RPP30|RPP38|RPP38-DT|RPS24|RRP12|RSU1|RTKN2|RUFY2|SAMD8|SAR1A|SCD|SEC23IP|SEC24C|SEC31B|SEMA4G|SEPHS1|SFR1|SFRP5|SFTPA1|SFTPA2|SFTPD|SFXN2|SFXN3|SFXN4|SGMS1|SGPL1|SH2D4B|SH3PXD2A|SHLD2|SHOC2|SHTN1|SIRT1|SKIDA1|SLC16A12|SLC16A9|SLC18A2|SLC18A3|SLC25A16|SLC25A28|SLC29A3|SLC35G1|SLC39A12|SLF2|SLIT1|SLK|SMC3|SMNDC1|SNCG|SNORA12|SORBS1|SORCS1|SORCS3|SPAG6|SPMIP5|SPOCK2|SPRN|SRGN|ST8SIA6|STAM|STAMBPL1|STK32C|STN1|STOX1|SUFU|SUPV3L1|SUV39H2|SVIL|TCERG1L-AS1|TCF7L2|TCTN3|TDRD1|TECTB|TET1|TEX36|TFAM|THNSL1|TIAL1|TIMM23|TLL2|TLX1|TLX1NB|TM9SF3|TMEM254|TMEM26|TMEM273|TMEM72|TNKS2|TRDMT1|TRIM8|TRUB1|TSPAN14|TSPAN15|TUBGCP2|TWNK|TYSND1|UBE2D1|UBTD1|UCMA|UNC5B|UROS|USP54|UTF1|VAX1|VCL|VDAC2|VENTX|VIM|VPS26A|VSIR|VSTM4|VTI1A|VWA2|WAC|WAPL|WASHC2A|WASHC2C|WBP1L|WDFY4|WDR11|WNT8B|XPNPEP1|YME1L1|ZCCHC24|ZDHHC16|ZDHHC6|ZEB1|ZFAND4|ZFYVE27|ZMIZ1|ZNF22|ZNF22-AS1|ZNF239|ZNF248|ZNF25|ZNF32|ZNF33A|ZNF33B|ZNF365|ZNF37A|ZNF438|ZNF485|ZNF488|ZNF503|ZNF511|ZNF518A|ZRANB1|ZSWIM8|ZWINT		Distal 10q deletion syndrome	VCV002574686	10	12829206 - 135427143			2574686	2739622			copy number loss		Pathogenic		no assertion criteria provided							
NC_000010.10:g.(?_43620311)_(43623717_?)dup	RET		Multiple endocrine neoplasia, type 2	VCV002426638	10	43620311 - 43623717			2426638	1950834			Duplication		Uncertain significance	Mar 1, 2022	criteria provided, single submitter							
NC_000010.10:g.(?_43595897)_(43623725_?)dup	RET		Multiple endocrine neoplasia, type 2	VCV001442472	10	43595897 - 43623725			1442472	1375236			Duplication		Uncertain significance	Sep 5, 2023	criteria provided, single submitter							
NC_000010.10:g.(?_43600390)_(43623725_?)dup	RET		Multiple endocrine neoplasia, type 2	VCV001401577	10	43600390 - 43623725			1401577	1457237			Duplication		Uncertain significance	Jun 30, 2023	criteria provided, single submitter							
GRCh37/hg19 10p15.3-q11.22(chr10:135655-47688677)x4	ARL5B|LARP4B|LYZL1|LYZL2|TUBAL3|ZNF32|ZNF33A|UCMA|YME1L1|ZEB1|ZFAND4|MIR1915HG|MKX|MLLT10|MSRB2|MTPAP|MEIG1|ZNF33B|UCN3|WDR37|MAP3K8|MARCHF8|MASTL|C10orf126|C10orf67|C1QL3|CACNB2|CALML3|CALML3-AS1|ASB13|ATP5F1C|BAMBI|BEND7|BMI1|BMS1|MPP7|MCM10|MINDY3|MIR1915|ARMC3|C10orf113|ABI1|ACBD5|ACBD7|ADARB2|AGAP10|AGAP4|AKR1C1|AKR1C2|AKR1C3|AKR1C4|AKR1E2|ALOX5|ANKRD16|ANKRD26|ANKRD30A|ANXA8L1|APBB1IP|ARHGAP12|ARHGAP21|CALML5|CAMK1D|CCDC3|CCDC7|CCNY|CDC123|CDNF|CELF2|COMMD3|COMMD3-BMI1|CREM|CSGALNACT2|CUBN|CUL2|CXCL12|DCLRE1C|DEPP1|DHTKD1|DIP2C|DNAJC1|EBLN1|ECHDC3|ENKUR|EPC1|FAM107B|FAM171A1|FAM25E|FBH1|FRMD4A|FXYD4|FZD8|GAD2|GATA3|GDI2|GJD4|GPR158|GPRIN2|GTPBP4|HACD1|HNRNPF|HSPA14|IDI1|IDI2|IL15RA|IL2RA|ITGA8|ITGB1|ITIH2|ITIH5|JCAD|KIAA1217|KIF5B|KIN|KLF6|MTRNR2L7|MYO3A|NEBL|NET1|NMT2|NPY4R|NRP1|NSUN6|NUDT5|ODAD2|OLAH|OPTN|OR13A1|OTUD1|PARD3|PDSS1|PFKFB3|PFKP|PHYH|PIP4K2A|PITRM1|PLXDC2|PRINS|PRKCQ|PROSER2|PRPF18|PRTFDC1|PTCHD3|PTER|PTF1A|RAB18|RASGEF1A|RASSF4|RBM17|RET|RPP38|RPP38-DT|RSU1|SEC61A2|SEPHS1|SFMBT2|SKIDA1|SLC39A12|SPAG6|ST8SIA6|STAM|SUV39H2|SVIL|SYT15|TAF3|TASOR2|THNSL1|TMEM72|TRDMT1|UPF2|USP6NL|VIM|WAC|WASHC2C|ZMYND11|ZNF22|ZNF22-AS1|ZNF239|ZNF248|ZNF25|ZNF37A|ZNF438|ZNF485		Mosaic supernumerary isodicentric chromosome 10	VCV001339781	10	135655 - 47688677			1339781	1330991			copy number gain		not provided		no classification provided							
NC_000010.10:g.(?_43595901)_(43598083_?)del	RET		Multiple endocrine neoplasia, type 2	VCV001066631	10	43595901 - 43598083			1066631	1054482			Deletion		Likely pathogenic	Sep 19, 2018	criteria provided, single submitter							
NC_000010.10:g.(?_43572512)_(43596180_?)dup	RET		Multiple endocrine neoplasia, type 2	VCV001054477	10	43572512 - 43596180			1054477	1039143			Duplication		Uncertain significance	Jul 6, 2021	criteria provided, single submitter							
NC_000010.10:g.(?_43617300)_(43623793_?)dup	RET		Multiple endocrine neoplasia, type 2	VCV001017413	10	43617300 - 43623793			1017413	1001635			Duplication		Uncertain significance	Dec 28, 2014	criteria provided, single submitter							
NC_000010.11:g.(?_43077064)_(43128277_?)dup	RET		Multiple endocrine neoplasia, type 2	VCV000832506	10	43572512 - 43623725			832506	820205			Duplication		Uncertain significance	Oct 30, 2022	criteria provided, single submitter							
NC_000010.11:g.(?_43077064)_(43077341_?)dup	RET		Multiple endocrine neoplasia, type 2	VCV000830573	10	43572512 - 43572789			830573	820204			Duplication		Uncertain significance	Sep 6, 2022	criteria provided, single submitter							
NC_000010.11:g.(?_43118363)_(43128277_?)dup	RET		Multiple endocrine neoplasia, type 2	VCV000830544	10	43613811 - 43623725			830544	820206			Duplication		Uncertain significance	Nov 25, 2019	criteria provided, single submitter							
GRCh37/hg19 10p11.21-q11.22(chr10:37149872-46169876)x3	ALOX5|ANKRD30A|BMS1|CSGALNACT2|CXCL12|DEPP1|FXYD4|HNRNPF|MARCHF8|MTRNR2L7|OR13A1|RASGEF1A|RASSF4|RET|TMEM72|ZFAND4|ZNF22|ZNF22-AS1|ZNF239|ZNF248|ZNF25|ZNF32|ZNF33A|ZNF33B|ZNF37A|ZNF485		not provided	VCV000624469	10	37149872 - 46169876			624469	613294			copy number gain		Likely pathogenic	Jun 11, 2018	criteria provided, single submitter							
GRCh37/hg19 10q11.21-26.3(chr10:42347406-135534747)x1	COX15|CPEB3|FAM204A|FAM241B|HOGA1|HPS1|CPN1|FAM24A|FAM24B|HPS6|HPSE2|MAPK8|OPN4|OR13A1|RASGEF1A|TCERG1L-AS1|TCF7L2|ZNF485|ZNF488|ZSWIM8|ZRANB1|ZNF503|ZWINT|ZNF511|ZNF518A|TECTB|TET1|TEX36|TFAM|TIAL1|TIMM23|TLL2|TCTN3|TDRD1|TMEM273|TMEM72|TNKS2|TLX1|TLX1NB|TM9SF3|TMEM254|TMEM26|SFR1|SFRP5|SFTPA1|REEP3|SCD|RASSF4|RBM20|RBP3|SEC23IP|SEC24C|SFTPA2|RBP4|SEC31B|SEMA4G|PDLIM1|PDZD7|PDZD8|PGAM1|P4HA1|PALD1|PGBD3|PANK1|PAOX|PAPSS2|PARG|PDCD11|PDCD4|PDE6C|MIR146B|MARCHF5|MFSD13A|MGMT|MICU1|MINPP1|MIR107|MARCHF8|MARVELD1|MAT1A|MBL2|MCMBP|MCU|HSPA12A|IFIT1|IFIT1B|IFIT2|IFIT3|INA|INPP5A|IFIT5|IKZF5|INPP5F|INSYN2A|HTR7|HTRA1|IDE|FGFR2|FHIP2A|FAM25C|FAM25E|FAM25G|FAM53B|FANK1|FGF8|FGFBP3|FOXI2|FRA10AC1|FAM25A|CYP2C8|CYP2C9|CTBP2|CYP17A1|CYP26A1|CYP26C1|CYP2C18|CYP2C19|CYP2E1|CPXM2|CRTAC1|CSGALNACT2|CSTF2T|C10orf55|C10orf62|C10orf12|C10orf120|C10orf105|C10orf131|C10orf53|BTAF1|BTBD16|BTRC|BUB3|C10orf71|C10orf82|C10orf88|C10orf90|C10orf95|CABCOCO1|CACUL1|CALHM1|CALHM2|CALHM3|CALY|CAMK2G|CASC2|CASP7|CC2D2B|CCAR1|CCDC172|CCDC186|CCDC6|CCNJ|CCSER2|CDH23|CDHR1|CDK1|CEP55|CFAP43|CFAP46|CFAP58|CFAP70|CH25H|CHAT|CHCHD1|CHST15|CHST3|CHUK|CISD1|CLRN3|CNNM1|CNNM2|COL13A1|COL17A1|COMTD1|CTNNA3|CUEDC2|CUTC|CUZD1|CWF19L1|CXCL12|DCLRE1A|DDIT4|DDX21|DDX50|DENND10|DEPP1|DHX32|DKK1|DLG5|DMBT1|DNA2|DNAJB12|DNAJC12|DNAJC9|DNMBP|DNTT|DOCK1|DPCD|DPYSL4|DRGX|DUSP13B|DUSP29|DUSP5|DYDC1|DYDC2|EBF3|ECD|ECHS1|EDRF1|EEF1AKMT2|EGR2|EIF3A|EIF4EBP2|EIF5AL1|ELOVL3|EMX2|EMX2OS|ENO4|ENTPD1|ENTPD7|ERCC6|ERLIN1|EXOC6|EXOSC1|FAM13C|FAM149B1|FAM170B|FAS|FAS-AS1|FBXL15|FBXW4|FFAR4|FRAT1|FRAT2|FRG2B|FRMPD2|FUOM|FUT11|FXYD4|GBF1|GDF10|GDF2|GFRA1|GHITM|GLRX3|GLUD1|GOLGA7B|GOT1|GPAM|GPR15LG|GPR26|GPRIN2|GRID1|GRK5|GSTO1|GSTO2|HABP2|HECTD2|HELLS|HERC4|HHEX|HIF1AN|HK1|HKDC1|HMX2|HMX3|HNRNPF|HNRNPH3|IPMK|ITPRIP|JAKMIP3|JMJD1C|KAT6B|KAZALD1|KCNIP2|KCNK18|KCNMA1|KIF11|KIF20B|KIFBP|KLLN|KNDC1|LBX1|LCOR|LDB1|LDB3|LGI1|LHPP|LINC01166|LINC01520|LINC02870|LIPA|LIPF|LIPJ|LIPK|LIPM|LIPN|LOC100131132|LOC101929662|LOXL4|LRIT1|LRIT2|LRMDA|LRRC18|LRRC20|LRRC27|LRRTM3|LZTS2|MACROH2A2|MIR346|MKI67|MMP21|MMRN2|MMS19|MORN4|MRPL43|MRPS16|MSMB|MSS51|MTG1|MTRNR2L5|MXI1|MYOF|MYOZ1|MYPN|NANOS1|NCOA4|NDST2|NDUFB8|NEURL1|NEUROG3|NFKB2|NHLRC2|NKX1-2|NKX2-3|NKX6-2|NOC3L|NODAL|NOLC1|NPFFR1|NPM3|NPS|NPY4R|NRAP|NRBF2|NRG3|NSMCE4A|NT5C2|NUDT13|NUTM2A|NUTM2B|OAT|OGA|OGDHL|OIT3|OPALIN|PAX2|PBLD|PCBD1|PCDH15|PCGF5|PCGF6|PHYHIPL|PI4K2A|PIK3AP1|PITX3|PKD2L1|PLA2G12B|PLAC9|PLAU|PLCE1|PLEKHA1|PLEKHS1|PLPP4|PNLIP|PNLIPRP1|PNLIPRP2|PNLIPRP3|POLL|POLR3A|PPA1|PPIF|PPP1R3C|PPP2R2D|PPP3CB|PPRC1|PRAP1|PRDX3|PRF1|PRKG1|PRLHR|PRXL2A|PSAP|PSD|PSTK|PTEN|PTPN20|PTPRE|PWWP2B|PYROXD2|R3HCC1L|RAB11FIP2|RET|RGR|RGS10|RHOBTB1|RNLS|RPP30|RPS24|RRP12|RTKN2|RUFY2|SAMD8|SAR1A|SFTPD|SFXN2|SFXN3|SFXN4|SGMS1|SGPL1|SH2D4B|SH3PXD2A|SHLD2|SHOC2|SHTN1|SIRT1|SLC16A12|SLC16A9|SLC18A2|SLC18A3|SLC25A16|SLC25A28|SLC29A3|SLC35G1|SLF2|SLIT1|SLK|SMC3|SMNDC1|SNCG|SNORA12|SORBS1|SORCS1|SORCS3|SPOCK2|SPRN|SRGN|STAMBPL1|STK32C|STN1|STOX1|SUFU|SUPV3L1|SYCE1|SYNPO2L|SYT15|TACC2|TACR2|TAF5|TBATA|TBC1D12|TCERG1L|TRIM8|TRUB1|TSPAN14|TSPAN15|TUBGCP2|TWNK|TYSND1|UBE2D1|UBTD1|UNC5B|UROS|USP54|UTF1|VAX1|VCL|VDAC2|VENTX|VPS26A|VSIR|VSTM4|VTI1A|VWA2|WAPL|WASHC2A|WASHC2C|WBP1L|WDFY4|WDR11|WNT8B|XPNPEP1|ZCCHC24|ZDHHC16|ZDHHC6|ZFAND4|ZFYVE27|ZMIZ1|ZNF22|ZNF22-AS1|ZNF239|ZNF32|ZNF33B|ZNF365|A1CF|ABCC2|ABLIM1|ABRAXAS2|ACADSB|ACSL5|ACSM6|ACTA2|ACTR1A|ADAM12|ADAM8|ADAMTS14|ADD3|ADGRA1|ADIRF|ADIRF-AS1|ADK|ADO|ADRA2A|ADRB1|AFAP1L2|AGAP10|AGAP11|AGAP4|AGAP5|AGAP6|AGAP9|AIFM2|ALDH18A1|ALOX5|ANAPC16|ANK3|ANKRD1|ANKRD2|ANKRD22|ANXA11|ANXA7|ANXA8|ANXA8L1|AP3M1|ARHGAP19|ARHGAP22|ARID5B|ARL3|ARMH3|ARMS2|AS3MT|ASAH2|ASAH2B|ASCC1|ATAD1|ATE1|ATOH7|ATP5MK|ATRNL1|AVPI1|BAG3|BBIP1|BCCIP|BICC1|BLNK|BLOC1S2|BMPR1A|BMS1|BNIP3|BORCS7		Poly (ADP-Ribose) polymerase inhibitor response	VCV000523165	10	42347406 - 135534747			523165	513797			copy number loss		drug response	Nov 27, 2017	no assertion criteria provided							
NC_000010.10:g.43611191_61663279inv	CCDC6|ZNF32|CHAT|CISD1|ZNF485|ZNF488|ZWINT|ERCC6|FAM13C|CSGALNACT2|CSTF2T|FAM170B|FAM25C|FRMPD2|FXYD4|FAM25E|FAM25G|CXCL12|DEPP1|DKK1|DRGX|A1CF|AGAP10|AGAP4|AGAP6|AGAP9|ALOX5|ANXA8|ANXA8L1|ARHGAP22|ASAH2|ASAH2B|BICC1|C10orf53|C10orf71|GDF10|GDF2|GPRIN2|HNRNPF|IPMK|LRRC18|MAPK8|MARCHF8|MBL2|MSMB|MTRNR2L5|NCOA4|NPY4R|OGDHL|OR13A1|PARG|PCDH15|PGBD3|PHYHIPL|PRKG1|PTPN20|RASGEF1A|RASSF4|RBP3|RET|SGMS1|SLC16A9|SLC18A3|SYT15|TFAM|TIMM23|TMEM273|TMEM72|UBE2D1|VSTM4|WASHC2A|WASHC2C|WDFY4|ZFAND4|ZNF22|ZNF22-AS1|ZNF239		Pediatric metastatic thyroid tumour	VCV000495230	10	43611191 - 61663279			495230	486727			Inversion		Likely pathogenic	Jan 19, 2018	no assertion criteria provided							
GRCh37/hg19 10q11.21(chr10:42706947-44489498)x3	BMS1|CSGALNACT2|FXYD4|HNRNPF|RASGEF1A|RET|ZNF239|ZNF32|ZNF33B|ZNF485		See cases	VCV000443388	10	42706947 - 44489498			443388	437050			copy number gain		Uncertain significance	Sep 12, 2014	no assertion criteria provided							
GRCh37/hg19 10p15.3-q11.23(chr10:100026-50961640)x3	ABI1|ACBD5|ACBD7|ADARB2|AGAP10|AGAP4|AGAP9|AKR1C1|AKR1C2|AKR1C3|AKR1C4|AKR1E2|ALOX5|ANKRD16|ANKRD26|ANKRD30A|ANXA8|ANXA8L1|APBB1IP|ARHGAP12|ARHGAP21|ARHGAP22|ARL5B|ARMC3|ASB13|ATP5F1C|BAMBI|BEND7|BMI1|BMS1|C10orf113|C10orf126|C10orf53|C10orf67|C10orf71|C1QL3|CACNB2|CALML3|CALML3-AS1|CALML5|CAMK1D|CCDC3|CCDC7|CCNY|CDC123|CDNF|CELF2|CHAT|COMMD3|COMMD3-BMI1|CREM|CSGALNACT2|CUBN|CUL2|CXCL12|DCLRE1C|DEPP1|DHTKD1|DIP2C|DNAJC1|DRGX|EBLN1|ECHDC3|ENKUR|EPC1|ERCC6|FAM107B|FAM170B|FAM171A1|FAM25C|FAM25E|FAM25G|FBH1|FRMD4A|FRMPD2|FXYD4|FZD8|GAD2|GATA3|GDF10|GDF2|GDI2|GJD4|GPR158|GPRIN2|GTPBP4|HACD1|HNRNPF|HSPA14|IDI1|IDI2|IL15RA|IL2RA|ITGA8|ITGB1|ITIH2|ITIH5|JCAD|KIAA1217|KIF5B|KIN|KLF6|LARP4B|LRRC18|LYZL1|LYZL2|MAP3K8|MAPK8|MARCHF8|MASTL|MCM10|MEIG1|MINDY3|MIR1915|MIR1915HG|MKX|MLLT10|MPP7|MSRB2|MTPAP|MTRNR2L7|MYO3A|NEBL|NET1|NMT2|NPY4R|NRP1|NSUN6|NUDT5|ODAD2|OGDHL|OLAH|OPTN|OR13A1|OTUD1|PARD3|PDSS1|PFKFB3|PFKP|PGBD3|PHYH|PIP4K2A|PITRM1|PLXDC2|PRINS|PRKCQ|PROSER2|PRPF18|PRTFDC1|PTCHD3|PTER|PTF1A|PTPN20|RAB18|RASGEF1A|RASSF4|RBM17|RBP3|RET|RPP38|RPP38-DT|RSU1|SEC61A2|SEPHS1|SFMBT2|SKIDA1|SLC18A3|SLC39A12|SPAG6|ST8SIA6|STAM|SUV39H2|SVIL|SYT15|TAF3|TASOR2|THNSL1|TMEM273|TMEM72|TRDMT1|TUBAL3|UCMA|UCN3|UPF2|USP6NL|VIM|VSTM4|ZFAND4|WAC|WASHC2C|WDFY4|WDR37|YME1L1|ZEB1|ZMYND11|ZNF22|ZNF22-AS1|ZNF239|ZNF248|ZNF25|ZNF32|ZNF33A|ZNF33B|ZNF37A|ZNF438|ZNF485|ZNF488		See cases	VCV000443260	10	100026 - 50961640			443260	436922			copy number gain		Pathogenic	Jun 3, 2014	no assertion criteria provided							
GRCh37/hg19 10p15.3-q26.3(chr10:100027-135427143)	INA|INPP5A|INPP5F|INSYN2A|IPMK|ITGA8|ITGB1|ITIH2|ITIH5|ITPRIP|JAKMIP3|JCAD|JMJD1C|KAT6B|KAZALD1|KCNIP2|KCNK18|KCNMA1|KIAA1217|KIF11|KIF20B|KIF5B|KIFBP|KIN|KLF6|KLLN|KNDC1|LARP4B|LBX1|LCOR|LDB1|LDB3|LGI1|LHPP|LINC01166|LINC01520|LINC02870|LIPA|LIPF|LIPJ|LIPK|LIPM|LIPN|LOC101929662|LOXL4|LRIT1|LRIT2|LRMDA|LRRC18|LRRC20|LRRC27|LRRTM3|LYZL1|LYZL2|LZTS2|MACROH2A2|MAP3K8|MAPK8|MARCHF5|MARCHF8|MARVELD1|MASTL|MAT1A|MBL2|MCM10|MCMBP|MCU|MEIG1|MFSD13A|MGMT|MICU1|MINDY3|MINPP1|MIR107|MIR146B|MIR1915|MIR1915HG|MIR346|MKI67|MKX|MLLT10|MMP21|MMRN2|MMS19|MORN4|MPP7|MRPL43|MRPS16|MSMB|MSRB2|MSS51|MTG1|MTPAP|MTRNR2L5|MTRNR2L7|MXI1|MYO3A|MYOF|MYOZ1|MYPN|NANOS1|NCOA4|NDST2|NDUFB8|NEBL|NET1|NEURL1|NEUROG3|NFKB2|NHLRC2|NKX1-2|NKX2-3|NKX6-2|NMT2|NOC3L|NODAL|NOLC1|NPFFR1|NPM3|NPS|NPY4R|NRAP|NRBF2|NRG3|NRP1|NSMCE4A|NSUN6|NT5C2|NUDT13|NUDT5|NUTM2A|NUTM2B|OAT|ODAD2|OGA|OGDHL|OIT3|OLAH|OPALIN|OPN4|OPTN|OR13A1|OTUD1|P4HA1|PALD1|PANK1|PAOX|PAPSS2|PARD3|PARG|PAX2|PBLD|PCBD1|PCDH15|PCGF5|PCGF6|PDCD11|PDCD4|PDE6C|PDLIM1|PDSS1|PDZD7|PDZD8|PFKFB3|PFKP|PGAM1|PGBD3|PHYH|PHYHIPL|PI4K2A|PIK3AP1|PIP4K2A|PITRM1|PITX3|PKD2L1|PLA2G12B|PLAC9|PLAU|PLCE1|PLEKHA1|PLEKHS1|PLPP4|PLXDC2|PNLIP|PNLIPRP1|PNLIPRP2|PNLIPRP3|POLL|POLR3A|PPA1|PPIF|PPP1R3C|PPP2R2D|PPP3CB|PPRC1|PRAP1|PRDX3|PRF1|PRINS|PRKCQ|PRKG1|PRLHR|PROSER2|PRPF18|PRTFDC1|PRXL2A|PSAP|PSD|PSTK|PTCHD3|PTEN|PTER|PTF1A|PTPN20|PTPRE|PWWP2B|PYROXD2|R3HCC1L|RAB11FIP2|RAB18|RASGEF1A|RASSF4|RBM17|RBM20|RBP3|RBP4|REEP3|RET|RGR|RGS10|RHOBTB1|RNLS|RPP30|RPP38|RPP38-DT|RPS24|RRP12|RSU1|RTKN2|RUFY2|SAMD8|SAR1A|SCD|SEC23IP|SEC24C|SEC31B|SEC61A2|SEMA4G|SEPHS1|SFMBT2|SFR1|SFRP5|SFTPA1|SFTPA2|SFTPD|SFXN2|SFXN3|SFXN4|SGMS1|SGPL1|SH2D4B|SH3PXD2A|SHLD2|SHOC2|SHTN1|SIRT1|SKIDA1|SLC16A12|SLC16A9|SLC18A2|SLC18A3|SLC25A16|SLC25A28|SLC29A3|SLC35G1|SLC39A12|SLF2|SLIT1|SLK|SMC3|SMNDC1|SNCG|SNORA12|SORBS1|SORCS1|SORCS3|SPAG6|SPMIP5|SPOCK2|SPRN|SRGN|ST8SIA6|STAM|STAMBPL1|STK32C|STN1|STOX1|SUFU|SUPV3L1|SUV39H2|SVIL|SYCE1|SYNPO2L|SYT15|TACC2|TACR2|TAF3|TAF5|TASOR2|TBATA|TBC1D12|TCERG1L|TCERG1L-AS1|TCF7L2|TCTN3|TDRD1|TECTB|TET1|TEX36|TFAM|THNSL1|TIAL1|TIMM23|TLL2|TLX1|TLX1NB|TM9SF3|TMEM254|TMEM26|TMEM273|TMEM72|TNKS2|TRDMT1|TRIM8|TRUB1|TSPAN14|TSPAN15|TUBAL3|TUBGCP2|TWNK|TYSND1|UBE2D1|UBTD1|UCMA|UCN3|UNC5B|UPF2|UROS|USP54|USP6NL|UTF1|VAX1|VCL|VDAC2|VENTX|VIM|VPS26A|VSIR|VSTM4|VTI1A|VWA2|WAC|WAPL|WASHC2A|WASHC2C|WBP1L|WDFY4|WDR11|WDR37|WNT8B|XPNPEP1|YME1L1|ZCCHC24|ZDHHC16|ZDHHC6|ZEB1|ZFAND4|ZFYVE27|ZMIZ1|ZMYND11|ZNF22|ZNF22-AS1|ZNF239|ZNF248|ZNF25|ZNF32|ZNF33A|ZNF33B|ZNF365|ZNF37A|ZNF438|ZNF485|ZNF488|ZNF503|ZNF511|ZNF518A|ZRANB1|ZSWIM8|ZWINT|A1CF|ABCC2|ABI1|ABLIM1|ABRAXAS2|ACADSB|ACBD5|ACBD7|ACSL5|ACSM6|ACTA2|ACTR1A|ADAM12|ADAM8|ADAMTS14|ADARB2|ADD3|ADGRA1|ADIRF|ADIRF-AS1|ADK|ADO|ADRA2A|ADRB1|AFAP1L2|AGAP10|AGAP11|AGAP4|AGAP5|AGAP6|AGAP9|AIFM2|AKR1C1|AKR1C2|AKR1C3|AKR1C4|AKR1E2|ALDH18A1|ALOX5|ANAPC16|ANK3|ANKRD1|ANKRD16|ANKRD2|ANKRD22|ANKRD26|ANKRD30A|ANXA11|ANXA7|ANXA8|ANXA8L1|AP3M1|APBB1IP|ARHGAP12|ARHGAP19|ARHGAP21|ARHGAP22|ARID5B|ARL3|ARL5B|ARMC3|ARMH3|ARMS2|AS3MT|ASAH2|ASAH2B|ASB13|ASCC1|ATAD1|ATE1|ATOH7|ATP5F1C|ATP5MK|ATRNL1|AVPI1|BAG3|BAMBI|BBIP1|BCCIP|BEND7|BICC1|BLNK|BLOC1S2|BMI1|BMPR1A|BMS1|BNIP3|BORCS7|BTAF1|BTBD16|BTRC|BUB3|C10orf105|C10orf113|C10orf12|C10orf120|C10orf126|C10orf131|C10orf53|C10orf55|C10orf62|C10orf67|C10orf71|C10orf88|C10orf90|C10orf95|C1QL3|CABCOCO1|CACNB2|CACUL1|CALHM1|CALHM2|CALHM3|CALML3|CALML3-AS1|CALML5|CALY|CAMK1D|CAMK2G|CASC2|CASP7|CC2D2B|CCAR1|CCDC172|CCDC186|CCDC3|CCDC6|CCDC7|CCNJ|CCNY|CCSER2|CDC123|CDH23|CDHR1|CDK1|CDNF|CELF2|CEP55|CFAP43|CFAP46|CFAP58|CFAP70|CH25H|CHAT|CHCHD1|CHST15|CHST3|CHUK|CISD1|CLRN3|CNNM1|CNNM2|COL13A1|COL17A1|COMMD3|COMMD3-BMI1|COMTD1|COX15|CPEB3|CPN1|CPXM2|CREM|CRTAC1|CSGALNACT2|CSTF2T|CTBP2|CTNNA3|CUBN|CUEDC2|CUL2|CUTC|CUZD1|CWF19L1|CXCL12|CYP17A1|CYP26A1|CYP26C1|CYP2C18|CYP2C19|CYP2C8|CYP2C9|CYP2E1|DCLRE1A|DCLRE1C|DDIT4|DDX21|DDX50|DENND10|DEPP1|DHTKD1|DHX32|DIP2C|DKK1|DLG5|DMBT1|DNA2|DNAJB12|DNAJC1|DNAJC12|DNAJC9|DNMBP|DNTT|DOCK1|DPCD|DPYSL4|DRGX|DUSP13B|DUSP29|DUSP5|DYDC1|DYDC2|EBF3|EBLN1|ECD|ECHDC3|ECHS1|EDRF1|EEF1AKMT2|EGR2|EIF3A|EIF4EBP2|EIF5AL1|ELOVL3|EMX2|EMX2OS|ENKUR|ENO4|ENTPD1|ENTPD7|EPC1|ERCC6|ERLIN1|EXOC6|EXOSC1|FAM107B|FAM13C|FAM149B1|FAM170B|FAM171A1|FAM204A|FAM241B|FAM24A|FAM24B|FAM25A|FAM25C|FAM25E|FAM25G|FAM53B|FANK1|FAS|FAS-AS1|FBH1|FBXL15|FBXW4|FFAR4|FGF8|FGFBP3|FGFR2|FHIP2A|FOXI2|FRA10AC1|FRAT1|FRAT2|FRMD4A|FRMPD2|FUOM|FUT11|FXYD4|FZD8|GAD2|GATA3|GBF1|GDF10|GDF2|GDI2|GFRA1|GHITM|GJD4|GLRX3|GLUD1|GOLGA7B|GOT1|GPAM|GPR158|GPR15LG|GPR26|GPRIN2|GRID1|GRK5|GSTO1|GSTO2|GTPBP4|HABP2|HACD1|HECTD2|HELLS|HERC4|HHEX|HIF1AN|HK1|HKDC1|HMX2|HMX3|HNRNPF|HNRNPH3|HOGA1|HPS1|HPS6|HPSE2|HSPA12A|HSPA14|HTR7|HTRA1|IDE|IDI1|IDI2|IFIT1|IFIT1B|IFIT2|IFIT3|IFIT5|IKZF5|IL15RA|IL2RA		See cases	VCV000441987	10	100027 - 135427143			441987	435649			copy number gain		Pathogenic	Jul 14, 2015	no assertion criteria provided							
GRCh37/hg19 10p15.3-q26.3(chr10:100027-135427143)x3	A1CF|ABCC2|ABI1|ABLIM1|ABRAXAS2|ACADSB|ACBD5|ACBD7|ACSL5|ACSM6|ACTA2|ACTR1A|ADAM12|ADAM8|ADAMTS14|ADARB2|ADD3|ADGRA1|ADIRF|ADIRF-AS1|ADK|ADO|ADRA2A|ADRB1|AFAP1L2|AGAP10|AGAP11|AGAP4|AGAP5|AGAP6|AGAP9|AIFM2|AKR1C1|AKR1C2|AKR1C3|AKR1C4|AKR1E2|ALDH18A1|ALOX5|ANAPC16|ANK3|ANKRD1|ANKRD16|ANKRD2|ANKRD22|ANKRD26|ANKRD30A|ANXA11|ANXA7|ANXA8|ANXA8L1|AP3M1|APBB1IP|ARHGAP12|ARHGAP19|ARHGAP21|ARHGAP22|ARID5B|ARL3|ARL5B|ARMC3|ARMH3|ARMS2|AS3MT|ASAH2|ASAH2B|ASB13|ASCC1|ATAD1|ATE1|ATOH7|ATP5F1C|ATP5MK|ATRNL1|AVPI1|BAG3|BAMBI|BBIP1|BCCIP|BEND7|BICC1|BLNK|BLOC1S2|BMI1|BMPR1A|BMS1|BNIP3|BORCS7|BTAF1|BTBD16|BTRC|BUB3|C10orf105|C10orf113|C10orf12|C10orf120|C10orf126|C10orf131|C10orf53|C10orf55|C10orf62|C10orf67|C10orf71|C10orf88|C10orf90|C10orf95|C1QL3|CABCOCO1|CACNB2|CACUL1|CALHM1|CALHM2|CALHM3|CALML3|CALML3-AS1|CALML5|CALY|CAMK1D|CAMK2G|CASC2|CASP7|CC2D2B|CCAR1|CCDC172|CCDC186|CCDC3|CCDC6|CCDC7|CCNJ|CCNY|CCSER2|CDC123|CDH23|CDHR1|CDK1|CDNF|CELF2|CEP55|CFAP43|CFAP46|CFAP58|CFAP70|CH25H|CHAT|CHCHD1|CHST15|CHST3|CHUK|CISD1|CLRN3|CNNM1|CNNM2|COL13A1|COL17A1|COMMD3|COMMD3-BMI1|COMTD1|COX15|CPEB3|CPN1|CPXM2|CREM|CRTAC1|CSGALNACT2|CSTF2T|CTBP2|CTNNA3|CUBN|CUEDC2|CUL2|CUTC|CUZD1|CWF19L1|CXCL12|CYP17A1|CYP26A1|CYP26C1|CYP2C18|CYP2C19|CYP2C8|CYP2C9|CYP2E1|DCLRE1A|DCLRE1C|DDIT4|DDX21|DDX50|DENND10|DEPP1|DHTKD1|DHX32|DIP2C|DKK1|DLG5|DMBT1|DNA2|DNAJB12|DNAJC1|DNAJC12|DNAJC9|DNMBP|DNTT|DOCK1|DPCD|DPYSL4|DRGX|DUSP13B|DUSP29|DUSP5|DYDC1|DYDC2|EBF3|EBLN1|ECD|ECHDC3|ECHS1|EDRF1|EEF1AKMT2|EGR2|EIF3A|EIF4EBP2|EIF5AL1|ELOVL3|EMX2|EMX2OS|ENKUR|ENO4|ENTPD1|ENTPD7|EPC1|ERCC6|ERLIN1|EXOC6|EXOSC1|FAM107B|FAM13C|FAM149B1|FAM170B|FAM171A1|FAM204A|FAM241B|FAM24A|FAM24B|FAM25A|FAM25C|FAM25E|FAM25G|FAM53B|FANK1|FAS|FAS-AS1|FBH1|FBXL15|FBXW4|FFAR4|FGF8|FGFBP3|FGFR2|FHIP2A|FOXI2|FRA10AC1|FRAT1|FRAT2|FRMD4A|FRMPD2|FUOM|FUT11|FXYD4|FZD8|GAD2|GATA3|GBF1|GDF10|GDF2|GDI2|GFRA1|GHITM|GJD4|GLRX3|GLUD1|GOLGA7B|GOT1|GPAM|GPR158|GPR15LG|GPR26|GPRIN2|GRID1|GRK5|GSTO1|GSTO2|GTPBP4|HABP2|HACD1|HECTD2|HELLS|HERC4|HHEX|HIF1AN|HK1|HKDC1|HMX2|HMX3|HNRNPF|HNRNPH3|HOGA1|HPS1|HPS6|HPSE2|HSPA12A|HSPA14|HTR7|HTRA1|IDE|IDI1|IDI2|IFIT1|IFIT1B|IFIT2|IFIT3|IFIT5|IKZF5|IL15RA|IL2RA|INA|INPP5A|INPP5F|INSYN2A|IPMK|ITGA8|ITGB1|ITIH2|ITIH5|ITPRIP|JAKMIP3|JCAD|JMJD1C|KAT6B|KAZALD1|KCNIP2|KCNK18|KCNMA1|KIAA1217|KIF11|KIF20B|KIF5B|KIFBP|KIN|KLF6|KLLN|KNDC1|LARP4B|LBX1|LCOR|LDB1|LDB3|LGI1|LHPP|LINC01166|LINC01520|LINC02870|LIPA|LIPF|LIPJ|LIPK|LIPM|LIPN|LOC101929662|LOXL4|LRIT1|LRIT2|LRMDA|LRRC18|LRRC20|LRRC27|LRRTM3|LYZL1|LYZL2|LZTS2|MACROH2A2|MAP3K8|MAPK8|MARCHF5|MARCHF8|MARVELD1|MASTL|MAT1A|MBL2|MCM10|MCMBP|MCU|MEIG1|MFSD13A|MGMT|MICU1|MINDY3|MINPP1|MIR107|MIR146B|MIR1915|MIR1915HG|MIR346|MKI67|MKX|MLLT10|MMP21|MMRN2|MMS19|MORN4|MPP7|MRPL43|MRPS16|MSMB|MSRB2|MSS51|MTG1|MTPAP|MTRNR2L5|MTRNR2L7|MXI1|MYO3A|MYOF|MYOZ1|MYPN|NANOS1|NCOA4|NDST2|NDUFB8|NEBL|NET1|NEURL1|NEUROG3|NFKB2|NHLRC2|NKX1-2|NKX2-3|NKX6-2|NMT2|NOC3L|NODAL|NOLC1|NPFFR1|NPM3|NPS|NPY4R|NRAP|NRBF2|NRG3|NRP1|NSMCE4A|NSUN6|NT5C2|NUDT13|NUDT5|NUTM2A|NUTM2B|OAT|ODAD2|OGA|OGDHL|OIT3|OLAH|OPALIN|OPN4|OPTN|OR13A1|OTUD1|P4HA1|PALD1|PANK1|PAOX|PAPSS2|PARD3|PARG|PAX2|PBLD|PCBD1|PCDH15|PCGF5|PCGF6|PDCD11|PDCD4|PDE6C|PDLIM1|PDSS1|PDZD7|PDZD8|PFKFB3|PFKP|PGAM1|PGBD3|PHYH|PHYHIPL|PI4K2A|PIK3AP1|PIP4K2A|PITRM1|PITX3|PKD2L1|PLA2G12B|PLAC9|PLAU|PLCE1|PLEKHA1|PLEKHS1|PLPP4|PLXDC2|PNLIP|PNLIPRP1|PNLIPRP2|PNLIPRP3|PPP3CB|POLL|POLR3A|PPA1|PPIF|PPP1R3C|PPP2R2D|PPRC1|PRAP1|PRDX3|PRF1|PRINS|PRKCQ|PRKG1|PRLHR|PROSER2|PRPF18|PRTFDC1|PRXL2A|PSAP|PSD|PSTK|PTCHD3|PTEN|PTER|PTF1A|PTPN20|PTPRE|PWWP2B|PYROXD2|R3HCC1L|RAB11FIP2|RAB18|RASGEF1A|RASSF4|RBM17|RBM20|RBP3|RBP4|REEP3|RET|RGR|RGS10|RHOBTB1|RNLS|RPP30|RPP38|RPP38-DT|RPS24|RRP12|RSU1|RTKN2|RUFY2|SAMD8|SAR1A|SCD|SEC23IP|SEC24C|SEC31B|SEC61A2|SEMA4G|SEPHS1|SFMBT2|SFR1|SFRP5|SFTPA1|SFTPA2|SFTPD|SFXN2|SFXN3|SFXN4|SGMS1|SGPL1|SH2D4B|SH3PXD2A|SHLD2|SHOC2|SHTN1|SIRT1|SKIDA1|SLC16A12|SLC16A9|SLC18A2|SLC18A3|SLC25A16|SLC25A28|SLC29A3|SLC35G1|SLC39A12|SLF2|SLIT1|SLK|SMC3|SMNDC1|SNCG|SNORA12|SORBS1|SORCS1|SORCS3|SPAG6|SPMIP5|SPOCK2|SPRN|SRGN|ST8SIA6|STAM|STAMBPL1|STK32C|STN1|STOX1|SUFU|SUPV3L1|SUV39H2|SVIL|SYCE1|SYNPO2L|SYT15|TACC2|TACR2|TAF3|TAF5|TASOR2|TBATA|TBC1D12|TCERG1L|TCERG1L-AS1|TCF7L2|TCTN3|TDRD1|TECTB|TET1|TEX36|TFAM|THNSL1|TIAL1|TIMM23|TLL2|TLX1|TLX1NB|TM9SF3|TMEM254|TMEM26|TMEM273|TMEM72|TNKS2|TRDMT1|TRIM8|TRUB1|TSPAN14|TSPAN15|TUBAL3|TUBGCP2|TWNK|TYSND1|UBE2D1|UBTD1|UCMA|UCN3|UNC5B|UPF2|UROS|USP54|USP6NL|UTF1|VAX1|VCL|VDAC2|VENTX|VIM|VPS26A|VSIR|VSTM4|VTI1A|VWA2|WAC|WAPL|WASHC2A|WASHC2C|WBP1L|WDFY4|WDR11|WDR37|WNT8B|XPNPEP1|YME1L1|ZCCHC24|ZDHHC16|ZDHHC6|ZEB1|ZFAND4|ZFYVE27|ZMIZ1|ZMYND11|ZNF22|ZNF22-AS1|ZNF239|ZNF248|ZNF25|ZNF32|ZNF33A|ZNF33B|ZNF365|ZNF37A|ZNF438|ZNF485|ZNF488|ZNF503|ZNF511|ZNF518A|ZRANB1|ZSWIM8|ZWINT		See cases	VCV000441986	10	100027 - 135427143			441986	435648			copy number gain		Pathogenic	Dec 2, 2014	no assertion criteria provided							
GRCh37/hg19 10q11.21(chr10:43600657-43600691)x3	RET		See cases	VCV000395039	10	43600657 - 43600691			395039	381932			copy number gain		Benign		no assertion criteria provided							
GRCh37/hg19 10q11.21(chr10:43600625-43600691)x3	RET		See cases	VCV000394036	10	43600625 - 43600691			394036	380929			copy number gain		Benign		no assertion criteria provided							
GRCh37/hg19 10p15.3-q26.3(chr10:93297-135378918)x3	A1CF|ABCC2|ABI1|ABLIM1|ABRAXAS2|ACADSB|ACBD5|ACBD7|ACSL5|ACSM6|ACTA2|ACTR1A|ADAM12|ADAM8|ADAMTS14|ADARB2|ADD3|ADGRA1|ADIRF|ADIRF-AS1|ADK|ADO|ADRA2A|ADRB1|AFAP1L2|AGAP10|AGAP11|AGAP4|AGAP5|AGAP6|AGAP9|AIFM2|AKR1C1|AKR1C2|AKR1C3|AKR1C4|AKR1E2|ALDH18A1|ALOX5|ANAPC16|ANK3|ANKRD1|ANKRD16|ANKRD2|ANKRD22|ANKRD26|ANKRD30A|ANXA11|ANXA7|ANXA8|ANXA8L1|AP3M1|APBB1IP|ARHGAP12|ARHGAP19|ARHGAP21|ARHGAP22|ARID5B|ARL3|ARL5B|ARMC3|ARMH3|ARMS2|AS3MT|ASAH2|ASAH2B|ASB13|ASCC1|ATAD1|ATE1|ATOH7|ATP5F1C|ATP5MK|ATRNL1|AVPI1|BAG3|BAMBI|BBIP1|BCCIP|BEND7|BICC1|BLNK|BLOC1S2|BMI1|BMPR1A|BMS1|BNIP3|BORCS7|BTAF1|BTBD16|BTRC|BUB3|C10orf105|C10orf113|C10orf12|C10orf120|C10orf126|C10orf131|C10orf53|C10orf55|C10orf62|C10orf67|C10orf71|C10orf88|C10orf90|C10orf95|C1QL3|CABCOCO1|CACNB2|CACUL1|CALHM1|CALHM2|CALHM3|CALML3|CALML3-AS1|CALML5|CALY|CAMK1D|CAMK2G|CASC2|CASP7|CC2D2B|CCAR1|CCDC172|CCDC186|CCDC3|CCDC6|CCDC7|CCNJ|CCNY|CCSER2|CDC123|CDH23|CDHR1|CDK1|CDNF|CELF2|CEP55|CFAP43|CFAP46|CFAP58|CFAP70|CH25H|CHAT|CHCHD1|CHST15|CHST3|CHUK|CISD1|CLRN3|CNNM1|CNNM2|COL13A1|COL17A1|COMMD3|COMMD3-BMI1|COMTD1|COX15|CPEB3|CPN1|CPXM2|CREM|CRTAC1|CSGALNACT2|CSTF2T|CTBP2|CTNNA3|CUBN|CUEDC2|CUL2|CUTC|CUZD1|CWF19L1|CXCL12|CYP17A1|CYP26A1|CYP26C1|CYP2C18|CYP2C19|CYP2C8|CYP2C9|CYP2E1|DCLRE1A|DCLRE1C|DDIT4|DDX21|DDX50|DENND10|DEPP1|DHTKD1|DHX32|DIP2C|DKK1|DLG5|DMBT1|DNA2|DNAJB12|DNAJC1|DNAJC12|DNAJC9|DNMBP|DNTT|DOCK1|DPCD|DPYSL4|DRGX|DUSP13B|DUSP29|DUSP5|DYDC1|DYDC2|EBF3|EBLN1|ECD|ECHDC3|ECHS1|EDRF1|EEF1AKMT2|EGR2|EIF3A|EIF4EBP2|EIF5AL1|ELOVL3|EMX2|EMX2OS|ENKUR|ENO4|ENTPD1|ENTPD7|EPC1|ERCC6|ERLIN1|EXOC6|EXOSC1|FAM107B|FAM13C|FAM149B1|FAM170B|FAM171A1|FAM204A|FAM241B|FAM24A|FAM24B|FAM25A|FAM25C|FAM25E|FAM25G|FAM53B|FANK1|FAS|FAS-AS1|FBH1|FBXL15|FBXW4|FFAR4|FGF8|FGFBP3|FGFR2|FHIP2A|FOXI2|FRA10AC1|FRAT1|FRAT2|FRMD4A|FRMPD2|FUOM|FUT11|FXYD4|FZD8|GAD2|GATA3|GBF1|GDF10|GDF2|GDI2|GFRA1|GHITM|GJD4|GLRX3|GLUD1|GOLGA7B|GOT1|GPAM|GPR158|GPR15LG|GPR26|GPRIN2|GRID1|GRK5|GSTO1|GSTO2|GTPBP4|HABP2|HACD1|HECTD2|HELLS|HERC4|HHEX|HIF1AN|HK1|HKDC1|HMX2|HMX3|HNRNPF|HNRNPH3|HOGA1|HPS1|HPS6|HPSE2|HSPA12A|HSPA14|HTR7|HTRA1|IDE|IDI1|IDI2|IFIT1|IFIT1B|IFIT2|IFIT3|IFIT5|IKZF5|IL15RA|IL2RA|INA|INPP5A|INPP5F|INSYN2A|IPMK|ITGA8|ITGB1|ITIH2|ITIH5|ITPRIP|JAKMIP3|JCAD|JMJD1C|KAT6B|KAZALD1|KCNIP2|KCNK18|KCNMA1|KIAA1217|KIF11|KIF20B|KIF5B|KIFBP|KIN|KLF6|KLLN|KNDC1|LARP4B|LBX1|LCOR|LDB1|LDB3|LGI1|LHPP|LINC01166|LINC01520|LINC02870|LIPA|LIPF|LIPJ|LIPK|LIPM|LIPN|LOC101929662|LOXL4|LRIT1|LRIT2|LRMDA|LRRC18|LRRC20|LRRC27|LRRTM3|LYZL1|LYZL2|LZTS2|MACROH2A2|MAP3K8|MAPK8|MARCHF5|MARCHF8|MARVELD1|MASTL|MAT1A|MBL2|MCM10|MCMBP|MCU|MEIG1|MFSD13A|MGMT|MICU1|MINDY3|MINPP1|MIR107|MIR146B|MIR1915|MIR1915HG|MIR346|MKI67|MKX|MLLT10|MMP21|MMRN2|MMS19|MORN4|MPP7|MRPL43|MRPS16|MSMB|MSRB2|MSS51|MTG1|MTPAP|MTRNR2L5|MTRNR2L7|MXI1|MYO3A|MYOF|MYOZ1|MYPN|NANOS1|NCOA4|NDST2|NDUFB8|NEBL|NET1|NEURL1|NEUROG3|NFKB2|NHLRC2|NKX1-2|NKX2-3|NKX6-2|NMT2|NOC3L|NODAL|NOLC1|NPFFR1|NPM3|NPS|NPY4R|NRAP|NRBF2|NRG3|NRP1|NSMCE4A|NSUN6|NT5C2|NUDT13|NUDT5|NUTM2A|NUTM2B|OAT|ODAD2|OGA|OGDHL|OIT3|OLAH|OPALIN|OPN4|OPTN|OR13A1|OTUD1|P4HA1|PALD1|PANK1|PAOX|PAPSS2|PARD3|PARG|PAX2|PBLD|PCBD1|PCDH15|PCGF5|PCGF6|PDCD11|PDCD4|PDE6C|PDLIM1|PDSS1|PDZD7|PDZD8|PFKFB3|PFKP|PGAM1|PGBD3|PHYH|PHYHIPL|PI4K2A|PIK3AP1|PIP4K2A|PITRM1|PITX3|PKD2L1|PLA2G12B|PLAC9|PLAU|PLCE1|PLEKHA1|PLEKHS1|PLPP4|PLXDC2|PNLIP|PNLIPRP1|PNLIPRP2|PNLIPRP3|PPP3CB|POLL|POLR3A|PPA1|PPIF|PPP1R3C|PPP2R2D|PPRC1|PRAP1|PRDX3|PRF1|PRINS|PRKCQ|PRKG1|PRLHR|PROSER2|PRPF18|PRTFDC1|PRXL2A|PSAP|PSD|PSTK|PTCHD3|PTEN|PTER|PTF1A|PTPN20|PTPRE|PWWP2B|PYROXD2|R3HCC1L|RAB11FIP2|RAB18|RASGEF1A|RASSF4|RBM17|RBM20|RBP3|RBP4|REEP3|RET|RGR|RGS10|RHOBTB1|RNLS|RPP30|RPP38|RPP38-DT|RPS24|RRP12|RSU1|RTKN2|RUFY2|SAMD8|SAR1A|SCD|SEC23IP|SEC24C|SEC31B|SEC61A2|SEMA4G|SEPHS1|SFMBT2|SFR1|SFRP5|SFTPA1|SFTPA2|SFTPD|SFXN2|SFXN3|SFXN4|SGMS1|SGPL1|SH2D4B|SH3PXD2A|SHLD2|SHOC2|SHTN1|SIRT1|SKIDA1|SLC16A12|SLC16A9|SLC18A2|SLC18A3|SLC25A16|SLC25A28|SLC29A3|SLC35G1|SLC39A12|SLF2|SLIT1|SLK|SMC3|SMNDC1|SNCG|SNORA12|SORBS1|SORCS1|SORCS3|SPAG6|SPMIP5|SPOCK2|SPRN|SRGN|ST8SIA6|STAM|STAMBPL1|STK32C|STN1|STOX1|SUFU|SUPV3L1|SUV39H2|SVIL|SYCE1|SYNPO2L|SYT15|TACC2|TACR2|TAF3|TAF5|TASOR2|TBATA|TBC1D12|TCERG1L|TCERG1L-AS1|TCF7L2|TCTN3|TDRD1|TECTB|TET1|TEX36|TFAM|THNSL1|TIAL1|TIMM23|TLL2|TLX1|TLX1NB|TM9SF3|TMEM254|TMEM26|TMEM273|TMEM72|TNKS2|TRDMT1|TRIM8|TRUB1|TSPAN14|TSPAN15|TUBAL3|TUBB8|TUBGCP2|TWNK|TYSND1|UBE2D1|UBTD1|UCMA|UCN3|UNC5B|UPF2|UROS|USP54|USP6NL|UTF1|VAX1|VCL|VDAC2|VENTX|VIM|VPS26A|VSIR|VSTM4|VTI1A|VWA2|WAC|WAPL|WASHC2A|WASHC2C|WBP1L|WDFY4|WDR11|WDR37|WNT8B|XPNPEP1|YME1L1|ZCCHC24|ZDHHC16|ZDHHC6|ZEB1|ZFAND4|ZFYVE27|ZMIZ1|ZMYND11|ZNF22|ZNF22-AS1|ZNF239|ZNF248|ZNF25|ZNF32|ZNF33A|ZNF33B|ZNF365|ZNF37A|ZNF438|ZNF485|ZNF488|ZNF503|ZNF511|ZNF518A|ZRANB1|ZSWIM8|ZWINT		See cases	VCV000393995	10	93297 - 135378918			393995	380888			copy number gain		Pathogenic		no assertion criteria provided							
NM_020975.4(RET):c.(?_-1)_(*1_?)dup	RET		Multiple endocrine neoplasia, type 2	VCV000216711					216711	213513			Duplication		Uncertain significance	Jun 13, 2015	criteria provided, single submitter							
NM_020630.4:c.*750+d611T>C	RET		not provided	VCV000041838					41838	50277			single nucleotide variant		Uncertain significance	Jul 13, 2012	no assertion criteria provided							
RET, 1-BP DEL, G1120	RET		Hirschsprung disease, susceptibility to, 1	VCV000013920					13920	28959			Deletion		risk factor	Jan 27, 1994	no assertion criteria provided							
